PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Toyoshima, C; Nomura, H; Tsuda, T				Toyoshima, C; Nomura, H; Tsuda, T			Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; INSENSITIVE PHOSPHOENZYME INTERMEDIATE; RESPONSE REGULATOR PROTEIN; HIGH-AFFINITY; A-DOMAIN; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL CONSEQUENCES; PHOSPHORYL TRANSFER; TRANSPORT SITES	P-type ion transporting ATPases are ATP-powered ion pumps that establish ion concentration gradients across biological membranes. Transfer of bound cations to the lumenal or extracellular side occurs while the ATPase is phosphorylated. Here we report at 2.3 Angstrom resolution the structure of the calcium-ATPase of skeletal muscle sarcoplasmic reticulum, a representative P-type ATPase that is crystallized in the absence of Ca2+ but in the presence of magnesium fluoride, a stable phosphate analogue. This and other crystal structures determined previously provide atomic models for all four principal states in the reaction cycle. These structures show that the three cytoplasmic domains rearrange to move six out of ten transmembrane helices, thereby changing the affinity of the Ca2+-binding sites and the gating of the ion pathway. Release of ADP triggers the opening of the lumenal gate and release of phosphate its closure, effected mainly through movement of the A-domain, the actuator of transmembrane gates.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; COLL RJ, 1984, J BIOL CHEM, V259, P4249; COLL RJ, 1992, J BIOL CHEM, V267, P21584; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POST RL, 1972, J BIOL CHEM, V247, P6530; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2002, J BIOL CHEM, V277, P13615, DOI 10.1074/jbc.M200625200; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	47	364	376	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					361	368		10.1038/nature02981	http://dx.doi.org/10.1038/nature02981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15448704				2022-12-01	WOS:000225161400047
J	Oguma, T; Palmer, LJ; Birben, E; Sonna, LA; Asano, K; Lilly, CM				Oguma, T; Palmer, LJ; Birben, E; Sonna, LA; Asano, K; Lilly, CM			Role of prostanoid DP receptor variants in susceptibility to asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIONAL CLONING; GENE; LINKAGE; EOTAXIN; CELLS	BACKGROUND: Previous genetic studies have associated the region of the human genome (14q22.1) containing the gene for the prostanoid DP receptor (PTGDR) with asthma. A study of a mouse model suggests that the receptor is required for the expression of the asthma phenotype. Our associations of asthma with functional genetic variants of PTGDR link these observations. METHODS: We identified and evaluated combinations of genetic variants that influence PTGDR transcription for disease association in case-control studies of 518 white patients with asthma and 175 white controls and 80 black patients with asthma and 45 black controls. RESULTS: We identified four novel and two previously reported single-nucleotide polymorphisms (SNPs) in PTGDR and its vicinity. These define four common three-SNP haplotypes, which vary in their ability to support transcription of PTGDR and have distinct DNA-binding-protein affinity profiles. Individual PTGDR SNPs were significantly associated with asthma in both populations. Specific PTGDR haplotypes were significantly associated with a diagnosis of asthma in a large case-control study of whites (P=0.002); we confirmed these findings in a second population of blacks (P=0.01). Multivariate analysis of the haplotype combinations (diplotypes) demonstrated that both whites (odds ratio, 0.55; 95 percent confidence interval, 0.38 to 0.80; P=0.002) and blacks (odds ratio, 0.32; 95 percent confidence interval, 0.12 to 0.89; P=0.03) who had at least one copy of the haplotype with a low transcriptional efficiency had a lower risk of asthma than subjects with no copies of the haplotype. CONCLUSIONS: Our functional and genetic findings identify PTGDR as an asthma-susceptibility gene.	Brigham & Womens Hosp, Div Pulm & Crit Care, Combined Program Pulm & Crit Care Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Western Australian Inst Med Res, Perth, WA, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; USA, Inst Environm Med, Natick, MA 01760 USA; Keio Univ, Sch Med, Dept Med, Cardiopulm Div, Tokyo 160, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Western Australia; University of Western Australia; Keio University	Lilly, CM (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, Combined Program Pulm & Crit Care Med, 75 Francis St,Thorn 826C, Boston, MA 02115 USA.	clilly@partners.org	Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; BIRBEN, ESRA/0000-0003-1192-309X				Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; Hall IP, 1998, CLIN EXP ALLERGY, V28, P74; HALL IP, 1998, CLIN EXP ALLERGY S1, V28, P80; Jedrzkiewicz S, 2000, AM J PHYSIOL-LUNG C, V279, pL1058, DOI 10.1152/ajplung.2000.279.6.L1058; JOHNSTON SL, 1995, EUR RESPIR J, V8, P411, DOI 10.1183/09031936.95.08030411; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; Malerba G, 2001, J ALLERGY CLIN IMMUN, V107, P654, DOI 10.1067/mai.2001.113865; Mansur AH, 1999, AM J RESP CRIT CARE, V159, P1796, DOI 10.1164/ajrccm.159.6.9804036; Marsh DG, 1997, NAT GENET, V15, P389; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; McCullagh P., 1989, GEN LINEAR MODELS, P511, DOI [10.1201/9780203753736, DOI 10.1007/978-1-4899-3242-6]; Mehta C R, 1994, Stat Methods Med Res, V3, P135, DOI 10.1177/096228029400300203; Nakamura H, 2001, J ALLERGY CLIN IMMUN, V108, P946, DOI 10.1067/mai.2001.120135; Oguma T, 2002, AM J RESP CRIT CARE, V165, P382, DOI 10.1164/ajrccm.165.3.2103093; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Shikanai T, 2002, J APPL PHYSIOL, V93, P37, DOI 10.1152/japplphysiol.00993.2001; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Sonna LA, 2001, CHEST, V119, P1676, DOI 10.1378/chest.119.6.1676; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166; 1997, GUIDELINES DIAGNOSIS, P1	33	113	126	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1752	1763		10.1056/NEJMoa031785	http://dx.doi.org/10.1056/NEJMoa031785			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15496624				2022-12-01	WOS:000224585200010
J	Arrasate, M; Mitra, S; Schweitzer, ES; Segal, MR; Finkbeiner, S				Arrasate, M; Mitra, S; Schweitzer, ES; Segal, MR; Finkbeiner, S			Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE EXPANSIONS; NEUROLOGICAL PHENOTYPE; IN-VITRO; AGGREGATION; DISEASE; NUCLEAR; REPEAT; FRAGMENTS	Huntington's disease is caused by an abnormal polyglutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron. Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial. To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage. Here we show, by survival analysis, that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and polyglutamine expansion; many neurons die without forming an inclusion body. Rather, the amount of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur. Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron. Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94141 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94141 USA; Univ Calif San Francisco, Med Sci Training Program, San Francisco, CA 94141 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol & Physiol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.	sfinkbeiner@gladstone.ucsf.edu	Arrasate, Montserrat/ABB-4450-2020	Arrasate, Montserrat/0000-0002-8911-8990; Mitra, Siddhartha/0000-0003-3967-1496				Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; ARRASATE M, 2003, SOC NEUR ABSTR, V29; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Collett D., 1994, MODELING SURVIVAL DA; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hack NJ, 2000, J NEUROSCI METH, V95, P177, DOI 10.1016/S0165-0270(99)00178-8; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim M, 1999, J NEUROSCI, V19, P964; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kuemmerle S, 1999, ANN NEUROL, V46, P842; MACDONALD ME, 1998, TRINUCLEOTIDE DIS IN, P47; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Moulder KL, 1999, J NEUROSCI, V19, P705; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Preisinger E, 1999, PHILOS T ROY SOC B, V354, P1029, DOI 10.1098/rstb.1999.0455; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Richfield EK, 1995, ANN NEUROL, V38, P852, DOI 10.1002/ana.410380605; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shimohata T, 2002, NEUROSCI LETT, V323, P215, DOI 10.1016/S0304-3940(02)00162-3; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X	50	1477	1507	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					805	810		10.1038/nature02998	http://dx.doi.org/10.1038/nature02998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483602	Bronze			2022-12-01	WOS:000224435500037
J	Yamamoto, Y; Stock, DW; Jeffery, WR				Yamamoto, Y; Stock, DW; Jeffery, WR			Hedgehog signalling controls eye degeneration in blind cavefish	NATURE			English	Article							SONIC HEDGEHOG; GENE; ASTYANAX; EXPRESSION; EVOLUTION; SYSTEM; RETINA; PAX2	Hedgehog (Hh) proteins are responsible for critical signalling events during development(1) but their evolutionary roles remain to be determined. Here we show that hh gene expression at the embryonic midline controls eye degeneration in blind cavefish. We use the teleost Astyanax mexicanus, a single species with an eyed surface-dwelling form ( surface fish) and many blind cave forms ( cavefish) 2, to study the evolution of eye degeneration. Small eye primordia are formed during cavefish embryogenesis, which later arrest in development, degenerate and sink into the orbits. Eye degeneration is caused by apoptosis of the embryonic lens, and transplanting a surface fish embryonic lens into a cavefish optic cup can restore a complete eye(3-5). Here we show that sonic hedgehog (shh) and tiggy-winkle hedgehog ( twhh) gene expression is expanded along the anterior embryonic midline in several different cavefish populations. The expansion of hh signalling results in hyperactivation of downstream genes, lens apoptosis and arrested eye growth and development. These features can be mimicked in surface fish by twhh and/or shh overexpression, supporting the role of hh signalling in the evolution of cavefish eye regression.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	jeffery@umd.edu	Zebrafish, UCL/A-3125-2009	Yamamoto, Yoshiyuki/0000-0003-4830-5703	NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014619] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Culver DC, 1982, CAVE LIFE EVOLUTION; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 1998, AM ZOOL, V38, P685; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; Li HS, 1997, DEVELOPMENT, V124, P603; MACDONALD JM, 1995, VET DERMATOL, V6, P121, DOI 10.1111/j.1365-3164.1995.tb00055.x; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mitchell RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631	26	181	186	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					844	847		10.1038/nature02864	http://dx.doi.org/10.1038/nature02864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483612				2022-12-01	WOS:000224435500047
J	Buckner, M				Buckner, M			Sickle-cell disease: from sierra Leone to southeast London	LANCET			English	Editorial Material																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 9	2004	364	9442					1361	1361		10.1016/S0140-6736(04)17193-6	http://dx.doi.org/10.1016/S0140-6736(04)17193-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474139				2022-12-01	WOS:000224349700032
J	Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH				Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH			A role for the immunological synapse in lineage commitment of CD4 lymphocytes	NATURE			English	Article							HELPER T-CELLS; LIPID RAFTS; LEISHMANIA-MAJOR; INTERFERON-GAMMA; IL-2 PRODUCTION; DIFFERENTIATION; PHOSPHORYLATION; MICRODOMAINS; INHIBITION; ACTIVATION	Activation of the naive T-helper lymphocyte (Thp) directs it down one of two major developmental pathways called Th1 and Th2. Signals transmitted by T cell, co-stimulatory and cytokine receptors control Thp lineage commitment but the mechanism by which these signals are integrated remains a mystery. The interferon-gamma ( IFNGR) and interleukin 4 (IL-4R) cytokine receptors, in particular, direct the earliest stages of T-helper commitment. Here we report that on engagement of the T-cell receptor (TCR) on Thp cells, rapid co-polarization of IFNGR with the TCR occurs within the developing immunological synapse. Thp cells from the intrinsically Th1-like C57BL/6 mouse strain have significantly more receptor co-polarization than Th2-prone BALB/c Thp cells. Remarkably, in the presence of IL-4, a cytokine required for Th2 differentiation, IFNGR co-polarization with TCR is prevented. This inhibition depends on Stat6, the transcription factor downstream of IL-4R that is required for Th2 differentiation. This cytokine receptor crossregulation provides an explanation for the effect of IL-4 in inhibiting Th1 differentiation. These observations suggest a scenario in which physical co-polarization of critical receptors directs the fate of the naive Thp, and offer a novel function for the immunological synapse in directing cell differentiation. They further suggest a new mechanism of membrane-bound signalling control by the physical disruption of large receptor-rich domains on signalling through a functionally antagonistic receptor.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; MIT, Dept Mat Sci & Engn, Biol Engn Div, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu		Schreiber, Robert/0000-0003-1590-2341				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Gamero AM, 2000, J BIOL CHEM, V275, P16574, DOI 10.1074/jbc.M910149199; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Madrenas J, 2003, IMMUNITY, V18, P459, DOI 10.1016/S1074-7613(03)00089-X; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	30	152	155	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					527	532		10.1038/nature02916	http://dx.doi.org/10.1038/nature02916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15386021				2022-12-01	WOS:000224156700035
J	Yaffe, MJ				Yaffe, MJ			What should the burden of proof be for acceptance of a new breast-cancer screening technique?	LANCET			English	Editorial Material							FOLLOW-UP; MAMMOGRAPHY; PROGRESSION; MORTALITY		Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto	Yaffe, MJ (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada.	martin.yaffe@swri.ca						*AM COLL RAD IM NE, CURR PROT; GUSTERSON BA, 1995, DRUG HORMONAL RESIST, P39; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Heimann R, 1998, J CLIN ONCOL, V16, P2686, DOI 10.1200/JCO.1998.16.8.2686; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hellman S, 2000, CANCER J, V6, pS131; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Irwig L, 2004, BRIT J CANCER, V90, P2118, DOI 10.1038/sj.bjc.6601836; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; TRUDEAU ME, IN PRESS BREAST CANC; WARNER E, IN PRESS JAMA	14	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1111	1112		10.1016/S0140-6736(04)17121-3	http://dx.doi.org/10.1016/S0140-6736(04)17121-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451209				2022-12-01	WOS:000224102400010
J	Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN				Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN			SOS response induction by beta-lactams and bacterial defense against antibiotic lethality	SCIENCE			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI PLASMIDS; CELL-DIVISION; GENE-EXPRESSION; MUTANTS; REPLICATION; INHERITANCE; CHROMOSOMES; INVOLVEMENT; PSC101	The SOS response aids bacterial propagation by inhibiting cell division during repair of DNA damage. We report that inactivation of the ftsl gene product, penicillin binding protein 3, by either beta-lactam antibiotics or genetic mutation induces SOS in Escherichia coli through the DpiBA two-component signal transduction system. This event, which requires the SOS-promoting recA and lexA genes as well as dpiA, transiently halts bacterial cell division, enabling survival to otherwise lethal antibiotic exposure. Our findings reveal defective cell wait synthesis as an unexpected initiator of the bacterial SOS response, indicate that beta-lactam antibiotics are extracellular stimuli of this response, and demonstrate a novel mechanism for mitigation of antimicrobial lethality.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Royal Vet & Agr Univ, Dept Vet Pathobiol, DK-1870 Frederiksberg C, Denmark	Stanford University; University of Copenhagen	Cohen, SN (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	sncohen@stanford.edu		Ingmer, Hanne/0000-0002-8350-5631; Thomsen, Line Elnif/0000-0001-5460-9178	NIAID NIH HHS [R01 AI08619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BIEK DP, 1989, J BACTERIOL, V171, P2066, DOI 10.1128/jb.171.4.2066-2074.1989; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Chadwick D., 1997, ANTIBIOTIC RESISTANC; Chen J., COMMUNICATION; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Ingmer H, 1998, MOL MICROBIOL, V29, P49, DOI 10.1046/j.1365-2958.1998.00895.x; Miller C, 2003, J BACTERIOL, V185, P6025, DOI 10.1128/JB.185.20.6025-6031.2003; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Sleator RD, 2000, INT J FOOD MICROBIOL, V60, P261, DOI 10.1016/S0168-1605(00)00316-0; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977; TOMASZ A, 1974, MODE ACTION ANTIBIOT, P439; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984	25	397	431	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1629	1631		10.1126/science.1101630	http://dx.doi.org/10.1126/science.1101630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308764				2022-12-01	WOS:000223891200046
J	Mulligan, SJ; MacVicar, BA				Mulligan, SJ; MacVicar, BA			Calcium transients in astrocyte endfeet cause cerebrovascular constrictions	NATURE			English	Article							CEREBRAL-BLOOD-FLOW; ARACHIDONIC-ACID; BRAIN-SLICES; PHOTOLYSIS; MICROSCOPY; EXCITATION; 20-HETE; CORTEX	Cerebral blood flow (CBF) is coupled to neuronal activity and is imaged in vivo to map brain activation(1). CBF is also modified by afferent projection fibres that release vasoactive neurotransmitters(2,3) in the perivascular region, principally on the astrocyte endfeet(4,5) that outline cerebral blood vessels(6). However, the role of astrocytes in the regulation of cerebrovascular tone remains uncertain. Here we determine the impact of intracellular Ca2+ concentrations ([Ca2+](i)) in astrocytes on the diameter of small arterioles by using two-photon Ca2+ uncaging(7,8) to increase [Ca2+](i). Vascular constrictions occurred when Ca2+ waves evoked by uncaging propagated into the astrocyte endfeet and caused large increases in [Ca2+](i). The vasoactive neurotransmitter noradrenaline(2,3) increased [Ca2+](i) in the astrocyte endfeet, the peak of which preceded the onset of arteriole constriction. Depressing increases in astrocyte [Ca2+](i) with BAPTA inhibited the vascular constrictions in noradrenaline. We find that constrictions induced in the cerebrovasculature by increased [Ca2+](i) in astrocyte endfeet are generated through the phospholipase A(2)-arachidonic acid pathway and 20-hydroxyeicosatetraenoic acid production. Vasoconstriction by astrocytes is a previously unknown mechanism for the regulation of CBF.	Univ British Columbia, Dept Psychiat, Brain Res Inst, Vancouver, BC V6T 2B5, Canada	University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Inst, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	bmacvica@interchange.ubc.ca	MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				Basarsky TA, 1998, J NEUROSCI, V18, P7189; Brown EB, 1999, BIOPHYS J, V76, P489, DOI 10.1016/S0006-3495(99)77217-6; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chillon J., 2002, CEREBRAL BLOOD FLOW, P395; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Dreier JP, 2001, J PHYSIOL-LONDON, V531, P515, DOI 10.1111/j.1469-7793.2001.0515i.x; DUFFY S, 1995, J NEUROSCI, V15, P5535; Duffy S, 1996, J NEUROSCI, V16, P71; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; GOADSBY PJ, 2002, CEREBRAL BLOOD FLOW, P172; KANG J, 2000, IMAGING NEURONS LAB; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Paspalas CD, 1996, GLIA, V17, P133, DOI 10.1002/(SICI)1098-1136(199606)17:2<133::AID-GLIA5>3.0.CO;2-3; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Simard M, 2003, J NEUROSCI, V23, P9254; Soeller C, 1999, MICROSC RES TECHNIQ, V47, P182; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; WALZ W, 1988, BRAIN RES, V443, P321, DOI 10.1016/0006-8993(88)91626-5; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	24	639	663	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					195	199		10.1038/nature02827	http://dx.doi.org/10.1038/nature02827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356633				2022-12-01	WOS:000223746000047
J	Luoma, P; Melberg, A; Rinne, JO; Kaukonen, JA; Nupponen, NN; Chalmers, RM; Oldfors, A; Rautakorpi, I; Peltonen, L; Majamaa, K; Somer, H; Suomalainen, A				Luoma, P; Melberg, A; Rinne, JO; Kaukonen, JA; Nupponen, NN; Chalmers, RM; Oldfors, A; Rautakorpi, I; Peltonen, L; Majamaa, K; Somer, H; Suomalainen, A			Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study	LANCET			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; AUTOSOMAL-DOMINANT; MULTIPLE DELETIONS; MTDNA DELETIONS; POLG MUTATIONS; DISEASE; FEATURES; DISORDERS; ENCEPHALOMYOPATHY; HYPOGONADISM	Background Mutations in the gene encoding mitochondrial DNA polymerase gamma (POLG), the enzyme that synthesises mitochondrial DNA (mtDNA), have been associated with a mitochondrial disease-autosomal dominant or recessive progressive external ophthalmoplegia-and multiple deletions of mtDNA. Mitochondrial dysfunction is also suspected to participate in the pathogenesis of Parkinson's disease. However, no primary gene defects affecting mitochondrial proteins causing mendelian transmission of parkinsonism have been characterised. We aimed to analyse the gene sequence of POLG in patients with progressive external ophthalmoplegia and their healthy relatives. Methods In seven families of various ethnic origins we assessed patients with progressive external ophthalmoplegia and unaffected individuals by clinical, biochemical, morphological, and molecular genetic characterisation and positron emission tomography (PET). Findings We recorded mutations in POLG in members of all seven families. Clinical assessment showed significant cosegregation of parkinsonism with POLG mutations (p<0.0001), and PET findings were consistent with dopaminergic neuron loss. Post-mortem examination in two individuals showed loss of pigmented neurons and pigment phagocytosis in substantia nigra without Lewy bodies. Furthermore, most women with progressive external ophthalmoplegia had early menopause before age 35 years. The POLG gene defect resulted in secondary accumulation of mtDNA deletions in patients' tissues. Interpretation Dysfunction of mitochondrial POLG causes a severe progressive multisystem disorder including parkinsonism and premature menopause, which are not typical of mitochondrial disease. Cosegregation of parkinsonism and POLG mutations in our families suggests that when defective, this gene can underlie mendelian transmission of parkinsonism. Relevance to practice Awareness that mitochondrial POLG mutations can underlie parkinsonism is important for clinicians working in diagnosis of movement disorders, as well as for studies of the genetics of Parkinson's disease. Further, progressive external ophthalmoplegia with muscle weakness and neuropathy can mask symptoms of parkinsonism, and clinicians should pay special attention to detect and treat parkinsonism in those individuals.	Univ Helsinki, Biomedicum Helsinki, Programme Neurosci, FIN-00290 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Dept Neurol, FIN-00290 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Uppsala Hosp, Dept Neurosci & Neurol, Uppsala, Sweden; Univ Turku, Turku PET Ctr, Turku, Finland; Inst Neurol, Univ Dept Clin Neurol, London WC1N 3BG, England; Gothenburg Univ, Sahlgrens Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Cent Hosp Lapland, Dept Neurol, Rovaniemi, Finland; Univ Oulu, Bioctr, Oulu, Finland; Univ Oulu, Dept Neurol, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Uppsala University; Uppsala University Hospital; University of Turku; University of London; University College London; Sahlgrenska University Hospital; University of Gothenburg; University of Oulu; University of Oulu	Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Programme Neurosci, Room C522B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	anu.wartiovaara@helsinki.fi	Majamaa, Kari/A-1344-2012	Majamaa, Kari/0000-0002-9070-3791; Oldfors, Anders/0000-0002-5758-7397; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802; Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9; CHECCARELLI N, 1994, J NEUROL SCI, V123, P74, DOI 10.1016/0022-510X(94)90206-2; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x; Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9; LUNDBERG PO, 1962, ACTA NEUROL SCAND, V38, P142; Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8; Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79; Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Rinne JO, 1999, SYNAPSE, V31, P119, DOI 10.1002/(SICI)1098-2396(199902)31:2<119::AID-SYN4>3.0.CO;2-O; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; *STANF GEN TECHN C, DHPLC MELT PROGR; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379; Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246; Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4	40	420	437	2	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					875	882		10.1016/S0140-6736(04)16983-3	http://dx.doi.org/10.1016/S0140-6736(04)16983-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351195				2022-12-01	WOS:000223685200034
J	Giulini, A; Wang, J; Jackson, D				Giulini, A; Wang, J; Jackson, D			Control of phyllotaxy by the cytokinin-inducible response regulator homologue ABPHYL1	NATURE			English	Article							TRANSCRIPTION FACTOR; GENE ENCODES; SHOOT; EXPRESSION; PATTERN; MAIZE; PHOSPHORELAY; GROWTH; AMP1	Phyllotaxy describes the geometric pattern of leaves and flowers, and has intrigued botanists and mathematicians for centuries(1,2). How these patterns are initiated is poorly understood, and this is partly due to the paucity of mutants(3). Signalling by the plant hormone auxin appears to determine the site of leaf initiation; however, this observation does not explain how distinct patterns of phyllotaxy are initiated(4). abphyl1 (abph1) mutants of maize initiate leaves in a decussate pattern ( that is, paired at 1808), in contrast to the alternating or distichous phyllotaxy observed in wild-type maize and other grasses(5). Here we show that ABPH1 is homologous to two-component response regulators and is induced by the plant hormone cytokinin. ABPH1 is expressed in the embryonic shoot apical meristem, and its spatial expression pattern changes rapidly with cytokinin treatment. We propose that ABPH1 controls phyllotactic patterning by negatively regulating the cytokinin-induced expansion of the shoot meristem, thereby limiting the space available for primordium initiation at the apex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu						Asakura Y, 2003, PLANT MOL BIOL, V52, P331, DOI 10.1023/A:1023971315108; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; CALLOS JD, 1994, PLANT J, V6, P1, DOI 10.1046/j.1365-313X.1994.6010001.x; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; GREEN PB, 1994, J EXP BOT, V45, P1775, DOI 10.1093/jxb/45.Special_Issue.1775; GREYSON RI, 1978, CAN J BOT, V56, P1545, DOI 10.1139/b78-183; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jackson D, 1999, DEVELOPMENT, V126, P315; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jean R. V., 1994, PHYLLOTAXIS SYSTEMIC; Klar AJS, 2002, NATURE, V417, P595, DOI 10.1038/417595a; Kuhlemeier C, 2001, TRENDS PLANT SCI, V6, P187, DOI 10.1016/S1360-1385(01)01894-5; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; ROBERTS J, 1994, J CURRICULUM SUPERVI, V9, P136; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sakakibara H, 1998, PLANT J, V14, P337, DOI 10.1046/j.1365-313X.1998.00134.x; SCHWABE WW, 1984, POSITIONAL CONTROLS; Sheen J, 2002, SCIENCE, V296, P1650, DOI 10.1126/science.1071883; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098	30	211	232	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1031	1034		10.1038/nature02778	http://dx.doi.org/10.1038/nature02778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329722				2022-12-01	WOS:000223514900044
J	Reddy, KC; Villeneuve, AM				Reddy, KC; Villeneuve, AM			C-elegans HIM-17 links chromatin modification and competence for initiation of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; CAENORHABDITIS-ELEGANS; CROSSING-OVER; HISTONE DEACETYLASE; DNA-REPLICATION; PROTEIN; MEIOSIS; GENE; PATHWAY; COMPLEX	Initiation of meiotic recombination by double-strand breaks (DSBs) must occur in a controlled fashion to avoid jeopardizing genome integrity. Here, we identify chromatin-associated protein HIM-17 as a link between chromatin state and DSB formation during C. elegans meiosis. Dependencies of several meiotic prophase events on HIM-17 parallel those seen for DSB-generating enzyme SPO-11: HIM-17 is essential for DSB formation but dispensable for homolog synapsis. Crossovers and chiasmata are eliminated in him-17 null mutants but are restored by artificially induced DSBs, indicating that all components required to convert DSBs into chiasmata are present. Unlike SPO-11, HIM-17 is also required for proper accumulation of histone H3 methylation at lysine 9 on meiotic prophase chromosomes. HIM-17 shares structural features with three proteins that interact genetically with LIN-35/Rb, a known component of chromatin-modifying complexes. Furthermore, DSB levels and incidence of chiasmata can be modulated by loss of LIN-35/Rb. These and other data suggest that chromatin state governs the timing of DSB competence.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	villen@cmgm.stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804, R01GM067268] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053804, R01 GM067268, R01GM67268, R01GM53804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/s004120050088; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Boxem M, 2001, DEVELOPMENT, V128, P4349; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BRENNER S, 1974, GENETICS, V77, P71; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; CLARK SG, 1994, GENETICS, V137, P987; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Colaiacovo MP, 2002, GENETICS, V162, P113; Davis L, 2001, GENETICS, V157, P1179; DEMBURG AF, 1998, CELL, V94, P387; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans DH, 1997, GENETICS, V146, P1253; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; FERGUSON EL, 1989, GENETICS, V123, P109; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gardiner JM, 1997, GENETICS, V146, P1265; GOLDSTEIN P, 1982, CHROMOSOMA, V86, P577, DOI 10.1007/BF00330128; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiao K, 2003, MOL CELL BIOL, V23, P5928, DOI 10.1128/MCB.23.16.5928-5938.2003; JOHZUKA K, 1995, GENETICS, V139, P1521; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; KLECKNER N, 2004, IN PRESS P NATL ACAD; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee CC, 1998, EMBO J, V17, P4166, DOI 10.1093/emboj/17.14.4166; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Praitis V, 2001, GENETICS, V157, P1217; Priess J. R., 1997, C ELEGANS 2; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rinaldo C, 2002, GENETICS, V160, P471; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; STOLAZZI A, 2003, GENE DEV, V17, P2675; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Thomas JH, 1999, DEVELOPMENT, V126, P3449; VILLENEUVE AM, 1994, GENETICS, V136, P887; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS BD, 1992, GENETICS, V131, P609; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	76	119	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					439	452		10.1016/j.cell.2004.07.026	http://dx.doi.org/10.1016/j.cell.2004.07.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315757	Bronze			2022-12-01	WOS:000223650900007
J	Popescu, G; Robert, A; Howe, JR; Auerbach, A				Popescu, G; Robert, A; Howe, JR; Auerbach, A			Reaction mechanism determines NMDA receptor response to repetitive stimulation	NATURE			English	Article							METHYL-D-ASPARTATE; GLUTAMATE; SYNAPSES; TRANSMITTER; CHANNELS; NEURONS; AMPA; NONSATURATION; KINETICS; SUBUNIT	At central excitatory synapses, N-methyl-D-aspartate (NMDA) receptors, which have a high affinity for glutamate(1), produce a slowly rising synaptic current in response to a single transmitter pulse and an additional current after a second, closely timed stimulus(2). Here we show, by examining the kinetics of transmitter binding and channel gating in single-channel currents from recombinant NR1/NR2A receptors, that the synaptic response to trains of impulses is determined by the molecular reaction mechanism of the receptor. The rate constants estimated for the activation reaction predict that, after binding neurotransmitter, receptors hesitate for similar to4 ms in a closed high-affinity conformation before they either proceed towards opening or release neurotransmitter, with about equal probabilities. Because only about half of the initially fully occupied receptors become active, repetitive stimulation elicits currents with distinct waveforms depending on pulse frequency. This high-affinity/low-efficiency activation mechanism might serve as a link between stimulation frequency and the directionality of the ensuing synaptic plasticity.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University	Popescu, G (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NIDA NIH HHS [F32 DA015164] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anson LC, 1998, J NEUROSCI, V18, P581; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen NS, 2001, MOL PHARMACOL, V59, P212, DOI 10.1124/mol.59.2.212; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Diamond JS, 1997, J NEUROSCI, V17, P4672; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Magleby KL, 2004, TRENDS NEUROSCI, V27, P231, DOI 10.1016/j.tins.2004.03.001; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Popescu G, 2004, NEUROSCIENTIST, V10, P192, DOI 10.1177/1073858404263483; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	101	104	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					790	793		10.1038/nature02775	http://dx.doi.org/10.1038/nature02775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306812				2022-12-01	WOS:000223233600044
J	Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG				Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG			Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; COMPONENTS	In 1999, the UK implemented universal leucoreduction as a precaution against transmission of variant Creutzfeldt-Jakob disease by transfusion of domestic blood or red blood cells. We aimed to assess how effectively leucoreduction reduced infectivity of transmissible spongiform encephalopathies (TSEs) in blood. 450 mL of whole blood collected and pooled from scrapie-infected hamsters was leucoreduced with a commercial filter. Blood cell concentrations were quantified, and infectivity titres measured. Blood cell recovery and white blood cell removal complied with American Association of Blood Banks standards. Leucofiltration removed 42% (SD 12) of the total TSE infectivity in endogenously infected blood. Leucoreduction is necessary for the removal of white-cell-associated TSE infectivity from blood; however, it is not, by itself, sufficient to remove all blood-borne TSE infectivity.	Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Hlth Canada, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; Canadian Blood Serv, Ottawa, ON, Canada; Pall Corp, Port Washington, NY USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Health Canada; Canadian Blood Services; Pall Corporation	Rohwer, RG (corresponding author), Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, 10 N Greene St, Baltimore, MD 21201 USA.	rrohwer@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063930] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-63930] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Prowse CV, 2000, VOX SANG, V79, P248, DOI 10.1046/j.1423-0410.2000.7940248.x; Williamson LM, 2000, BRIT J HAEMATOL, V110, P256, DOI 10.1046/j.1365-2141.2000.02062.x; 1998, AABB BLOOD BANK OPER, P24	7	154	156	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					529	531		10.1016/S0140-6736(04)16812-8	http://dx.doi.org/10.1016/S0140-6736(04)16812-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302197				2022-12-01	WOS:000223132700033
J	Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS				Nioche, P; Berka, V; Vipond, J; Minton, N; Tsai, AL; Raman, CS			Femtomolar sensitivity of a NO sensor from Clostridium botulinum	SCIENCE			English	Article							SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE; OXYGEN-BINDING; BOVINE LUNG; HEME; RESONANCE; PROTEINS; FNR	Nitric oxide (NO) is extremely toxic to Clostridium botulinum, but its molecular targets are unknown. Here, we identify a heme protein sensor (SONO) that displays femtomolar affinity for NO. The crystal structure of the SONO heme domain reveals a previously undescribed fold and a strategically placed tyrosine residue that modulates heme-nitrosyl coordination. Furthermore, the domain architecture of a SONO ortholog cloned from Chlamydomonas reinhardtii indicates that NO signaling through cyclic guanosine monophosphate arose before the origin of multicellular eukaryotes. Our findings have broad implications for understanding bacterial responses to NO, as well as for the activation of mammalian NO-sensitive guanylyl cyclase.	Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Houston, TX 77030 USA; Hlth Protect Agcy, Salisbury SP4 0JG, Wilts, England; Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England; Univ Nottingham, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England	University of Texas System; University of Texas System; University of Texas System; Health Protection Agency; University of Nottingham; University of Nottingham	Raman, CS (corresponding author), Univ Texas, Sch Med, Struct Biol Res Ctr, Houston, TX 77030 USA.	c.s.raman@uth.tmc.edu		Minton, Nigel/0000-0002-9277-1261; Raman, C. S./0000-0002-1036-3193	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054444] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054444, R01 AI054444-05] Funding Source: Medline; PHS HHS [AY343540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CAMILLI A, COMMUNICATION; Cammack R, 1999, BBA-BIOENERGETICS, V1411, P475, DOI 10.1016/S0005-2728(99)00033-X; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Davidson M., 2001, FOOD MICROBIOLOGY FU, P593; FERGUSON SJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P17, DOI 10.1016/S0005-2728(05)80259-2; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA, P3; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; OLSON JS, COMMUNICATION; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thomas MR, 2001, BIOCHEMISTRY-US, V40, P15047, DOI 10.1021/bi011440l; TIMKOVICH R, COMMUNICATION; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; WILLIAMS RJP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P71, DOI 10.1016/S0005-2728(05)80272-5; Wyllie GRA, 2002, CHEM REV, V102, P1067, DOI 10.1021/cr000080p; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323; Zumft WG, 2002, J MOL MICROB BIOTECH, V4, P277	33	169	177	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2004	306	5701					1550	1553		10.1126/science.1103596	http://dx.doi.org/10.1126/science.1103596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	875ST	15472039				2022-12-01	WOS:000225442700057
J	Cai, DS; Frantz, JD; Tawa, NE; Melendez, PA; Oh, BC; Lidov, HGW; Hasselgren, PO; Frontera, WR; Lee, J; Glass, DJ; Shoelson, SE				Cai, DS; Frantz, JD; Tawa, NE; Melendez, PA; Oh, BC; Lidov, HGW; Hasselgren, PO; Frontera, WR; Lee, J; Glass, DJ; Shoelson, SE			IKK beta/NF-kappa B activation causes severe muscle wasting in mice	CELL			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FOXO TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR; SKELETAL-MUSCLE; TNF-ALPHA; PROTEIN BREAKDOWN; ATROPHY; KINASE; CACHEXIA; EXPRESSION	Muscle wasting,accompanies aging and pathological conditions ranging from cancer, cachexia, and diabetes to denervation and immobilization. We show that activation of NF-kappaB, through muscle-specific transgenic expression of activated IkappaB kinase beta (MIKK), causes profound muscle wasting that resembles clinical cachexia. In contrast, no overt phenotype was seen upon muscle-specific inhibition of NF-kappaB through expression of IkappaBalpha superrepressor (MISR). Muscle loss was due to accelerated protein breakdown through ubiquitin-dependent proteolysis. Expression of the E3 ligase MuRF1, a mediator of muscle atrophy, was increased in MIKK mice. Pharmacological or genetic inhibition of the IKKbeta/NF-kappaB/MuRF1 pathway reversed muscle atrophy. Denervation- and tumor-induced muscle loss were substantially reduced and survival rates improved by NF-kappaB inhibition in MISR mice, consistent with a critical role for NF-kappaB in the pathology of muscle wasting and establishing it as an important clinical target for the treatment of muscle atrophy.	Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Regeneron Pharmaceut Inc, Muscle Program, Tarrytown, NY 10591 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Spaulding Rehabilitation Hospital; Regeneron; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shoelson, SE (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	steven.shoelson@joslin.harvard.edu	Glass, David/AAI-3910-2021; Lee, Jongsoon/AAG-1674-2020	Lee, Jongsoon/0000-0002-0891-5059; Oh, Byung-Chul/0000-0002-4277-7083	NIDDK NIH HHS [DK51729, R01 DK045943-08, DK45943, R01 DK051729-09, DK36836, R01 DK051729-07, R01 DK045943-07, R01 DK051729-08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R37DK051729, R01DK045943, R01DK051729] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.3.CO;2-E; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carpenter S, 2001, PATHOLOGY SKELETAL M; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Fanelli FR, 1995, NUTRITION, V11, P595; Fang CH, 1998, INT J MOL MED, V1, P163; Fiorucci S, 2002, P NATL ACAD SCI USA, V99, P15770, DOI 10.1073/pnas.232583599; FONG Y, 1989, AM J PHYSIOL, V256, pR659, DOI 10.1152/ajpregu.1989.256.3.R659; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LopezSoriano J, 1996, MOL CELL BIOCHEM, V165, P17; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pC766, DOI 10.1152/ajpcell.1987.253.6.C766; MORA M, 1989, EUR HEART J, V10, P103, DOI 10.1093/eurheartj/10.suppl_D.103; MULLEN BJ, 1990, P SOC EXP BIOL MED, V193, P318; Penner CG, 2001, BIOCHEM BIOPH RES CO, V281, P1331, DOI 10.1006/bbrc.2001.4497; ROTHWARF DM, 2000, SCI STKE; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sylla BS, 1998, P NATL ACAD SCI USA, V95, P10106, DOI 10.1073/pnas.95.17.10106; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; VAN AD, 1996, SCIENCE, V274, P787; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	45	989	1034	4	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					285	298		10.1016/j.cell.2004.09.027	http://dx.doi.org/10.1016/j.cell.2004.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479644	Bronze			2022-12-01	WOS:000224577200015
J	Karhadkar, SS; Bova, GS; Abdallah, N; Dhara, S; Gardner, D; Maitra, A; Isaacs, JT; Berman, DM; Beachy, PA				Karhadkar, SS; Bova, GS; Abdallah, N; Dhara, S; Gardner, D; Maitra, A; Isaacs, JT; Berman, DM; Beachy, PA			Hedgehog signalling in prostate regeneration, neoplasia and metastasis	NATURE			English	Article							INTERMEDIATE FILAMENT PROTEIN; SONIC-HEDGEHOG; STEM-CELLS; SUPPRESSOR GENE; CANCER; GROWTH; INHIBITION; RAT; DIFFERENTIATION; PROLIFERATION	Metastatic cancers adopt certain properties of normal cells in developing or regenerating organs, such as the ability to proliferate and alter tissue organization. We find here that activity of the Hedgehog (Hh) signalling pathway, which has essential roles in developmental patterning(1-6), is required for regeneration of prostate epithelium, and that continuous pathway activation transforms prostate progenitor cells and renders them tumorigenic. Elevated pathway activity furthermore distinguishes metastatic from localized prostate cancer, and pathway manipulation can modulate invasiveness and metastasis. Pathway activity is triggered in response to endogenous expression of Hh ligands, and is dependent upon the expression of Smoothened, an essential Hh response component(1,2,7) that is not expressed in benign prostate epithelial cells. Monitoring and manipulating Hh pathway activity may thus offer significant improvements in diagnosis and treatment of prostate cancers with metastatic potential.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; ARS, USDA, Poisonous Plant Res Lab, Logan, UT 84341 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Agriculture (USDA)	Berman, DM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	dberman@jhmi.edu; pbeachy@jhmi.edu	Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698; Bova, George/0000-0003-1639-3104				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALBINI A, 1987, CANCER RES, V47, P3239; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Garraway LA, 2003, PROSTATE, V55, P206, DOI 10.1002/pros.10244; Guang RJ, 2000, CANCER RES, V60, P749; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Meeker AK, 1996, ENDOCRINOLOGY, V137, P5743, DOI 10.1210/en.137.12.5743; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park HL, 2000, DEVELOPMENT, V127, P1593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	32	852	949	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					707	712		10.1038/nature02962	http://dx.doi.org/10.1038/nature02962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15361885				2022-12-01	WOS:000224299300045
J	Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P				Debiec, H; Nauta, J; Coulet, F; van der Burg, M; Guigonis, V; Schurmans, T; de Heer, E; Soubrier, F; Janssen, F; Ronco, P			Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies	LANCET			English	Article							LYMPHOBLASTIC-LEUKEMIA ANTIGEN; NEUTRAL ENDOPEPTIDASE; MEMBRANOUS NEPHROPATHY; NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; GLOMERULONEPHRITIS; ANTIBODIES; ENKEPHALINASE; ONTOGENESIS; NEPRILYSIN	Background Membranous glomerulonephritis is an immune-mediated disease. In a recent case of antenatal membranous glomerulonephritis, we identified neutral endopeptidase (NEP) as the podocyte target antigen of circulating antibodies produced by the mother who failed to express NEP on granulocytes. We aimed to investigate whether the disease could affect other families, to search for mutations in the metallomembrane endopeptidase (MME) gene for NEP, and to analyse the outcome of the antenatal renal insult. Methods From three families with a case of neonatal membranous glomerulopathy, we detected mutations by direct sequencing of genomic PCR products. Single nucleotide polymorphism (SNP) analysis was undertaken with five SNPs located in the MME gene. IgG subclasses with anti-NEP activity were determined by western blotting. Findings In five mothers, we identified two compound heterozygous or homozygous mutations in the MME gene. The first, a 1342C-->T nonsense mutation, was detected in one family. The second, 446delC, was detected in all three families; all chromosomes bearing this mutation had the same alleles for the five SNPs. Severity of neonatal renal disease was determined by the mothers' IgG response to fetal NEP antigens expressed on glomerular podocytes. The oldest affected individual, now aged 20 years, has developed severe chronic renal failure. Interpretation Truncating mutations in the MME gene are the cause of alloimmunisation during pregnancy. idiopathic renal failure in early adulthood might be caused by immune-mediated fetal nephron loss. We show that disease caused by fetomaternal alloimmunisation secondary to a genetic defect is not restricted to blood cells. Relevance to clinical practice During pregnancy, the absence of the NEP protein induces an alloimmunisation process against NEP presented by fetal cells, including syncytiotrophoblasts. The fetal podocyte insult and ensuing nephron loss could lead to chronic renal failure in early adulthood. Alloimmunisation against NEP should be considered as a leading cause of membranous glomerulopathy early in life. Concentrations of circulating anti-NEP antibodies should be carefully monitored during subsequent pregnancies, and specific therapeutic approaches developed. This new disease might also account for idiopathic chronic renal failure detected during adolescence, in individuals who can be identified by searching for anti-NEP antibodies in their mother and by MME gene mutation analysis. NEP deficiency should also be considered in patients developing de-novo membranous glomerulopathy after renal transplantation.	Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France; Tenon Hosp, APHP, Dept Human Genet, Paris, France; Univ Paris 06, Paris, France; Armand Trousseau Hosp, APHP, Dept Pediat Nephrol, Paris, France; Erasmus MC, Sophia Childrens Hosp, Rotterdam, Netherlands; Erasmus MC, Sophia Childrens Hosp, Dept Immunol, Rotterdam, Netherlands; Free Univ Brussels, Dept Pediat Nephrol, Brussels, Belgium; Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Debiec, H (corresponding author), Tenon Hosp, APHP, INSERM, U489, F-75020 Paris, France.	hanna.debiec@tnn.ap-hop-paris.fr	Guigonis, Vincent/O-8863-2016; Debiec, Hanna/AAL-8144-2021; Ronco, Pierre/AAC-8390-2022; De Heer, Emile/C-1110-2009	Guigonis, Vincent/0000-0002-2529-0919; Debiec, Hanna/0000-0002-8946-8245; 				APPAY MD, 1985, CLIN IMMUNOL IMMUNOP, V37, P103, DOI 10.1016/0090-1229(85)90141-2; ARDAILLOU N, 1992, J CELL PHYSIOL, V152, P599, DOI 10.1002/jcp.1041520320; Bonvouloir N, 2001, DNA CELL BIOL, V20, P493, DOI 10.1089/104454901316976127; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bowman John M., 1994, P553; Clark MR, 1997, CHEM IMMUNOL, V65, P88; CYBULSKY AV, 2000, KIDNEY PHYSL PATHOPH, P2645; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Horl WH, 2000, J NEPHROL, V13, P291; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JOHNSON AR, 1984, PEPTIDES, V5, P789, DOI 10.1016/0196-9781(84)90023-8; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2000, J NEPHROL, V13, pS96; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; METZGAR RS, 1981, J EXP MED, V154, P1249, DOI 10.1084/jem.154.4.1249; NAUTA J, 1990, PEDIATR NEPHROL, V4, P111, DOI 10.1007/BF00858820; PLATT JL, 1983, J EXP MED, V157, P155, DOI 10.1084/jem.157.1.155; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; RONCO P, 1988, LAB INVEST, V58, P210; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Squarer A, 1998, J AM SOC NEPHROL, V9, P1389; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Usmani BA, 2000, CLIN CANCER RES, V6, P1664; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Wasserstein AG, 1997, J AM SOC NEPHROL, V8, P664	34	141	155	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1252	1259		10.1016/S0140-6736(04)17142-0	http://dx.doi.org/10.1016/S0140-6736(04)17142-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464186				2022-12-01	WOS:000224254200032
J	Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D				Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D			Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth	CELL			English	Article							DROSOPHILA DERAILED RECEPTOR; NEURONAL PATHWAY SELECTION; TRANSCRIPTION FACTOR LEF-1; NEURAL CREST DEVELOPMENT; BETA-CATENIN; INT-1 PROTOONCOGENE; WNT/BETA-CATENIN; XENOPUS EMBRYOS; GENE LINOTTE; PROTEIN	The Ryk receptor belongs to the atypical receptor tyrosine kinase family. It is a new member of the family of Wnt receptor proteins. However, the molecular mechanisms by which the Ryk receptor functions remain unknown. Here, we report that mammalian Ryk, unlike the Drosophila Ryk homolog Derailed, functions as a coreceptor along with Frizzled for Wnt ligands. Ryk also binds to Dishevelled, through which it activates the canonical Writ pathway, providing a link between Wnt and Dishevelled. Transgenic mice expressing Ryk siRNA exhibit defects in axon guidance, and Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1. Thus, Ryk appears to play a crucial role in Wnt-mediated signaling.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu			NCI NIH HHS [2R01 CA51462-13] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051462] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kamitori K, 1999, DEV BRAIN RES, V114, P149, DOI 10.1016/S0165-3806(99)00033-4; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanaka M, 1997, P NATL ACAD SCI USA, V94, P4493, DOI 10.1073/pnas.94.9.4493; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; YEE K, 1993, BLOOD, V82, P1335; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	57	342	367	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					97	108		10.1016/j.cell.2004.09.019	http://dx.doi.org/10.1016/j.cell.2004.09.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454084	Bronze			2022-12-01	WOS:000224292600012
J	Beachy, PA; Karhadkar, SS; Berman, DM				Beachy, PA; Karhadkar, SS; Berman, DM			Mending and malignancy	NATURE			English	Editorial Material							HEDGEHOG		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; KARHADKAR SS, 2004, NATURE          0912, DOI DOI 10.1038/NATURE02962; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493	6	48	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					402	402		10.1038/431402a	http://dx.doi.org/10.1038/431402a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15385990	Bronze			2022-12-01	WOS:000224000500020
J	Wilkinson, P; Pattenden, S; Armstrong, B; Fletcher, A; Kovats, RS; Mangtani, P; McMichael, AJ				Wilkinson, P; Pattenden, S; Armstrong, B; Fletcher, A; Kovats, RS; Mangtani, P; McMichael, AJ			Vulnerability to winter mortality in elderly people in Britain: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEASONAL-VARIATION; TEMPERATURE; DEPRIVATION; ENGLAND; RISK	Objective To examine the determinants of vulnerability to winter mortality in elderly British people. Design Population based cohort study (119389 person years of follow up). Setting 106 general practices from the Medical Research Council trial of assessment and management of older people in Britain. Participants People aged greater than or equal to75 years. Main outcome measures Mortality (10123 deaths) determined by follow up through the Office for National Statistics. Results Month to month variation accounted for 17% of annual all cause mortality, but only 7.8% after adjustment for temperature. The overall winter:non-winter rate ratio was 1.31 (95% confidence interval 1.26 to 1.36). There was little evidence that this ratio varied by geographical region, age, or any of the personal, socioeconomic, or clinical factors examined, with two exceptions: after adjustment for all major covariates the winter:non-winter ratio in women compared with men was 1.11 (1.00 to 1.23), and those with a self reported history of respiratory illness had a winter:non-winter ratio of 1.20 (1.08 to 1.34) times that of people without a history of respiratory illness. There was no evidence that socioeconomic deprivation or self reported financial worries were predictive of winter death. Conclusion Except for female sex and pre-existing respiratory illness, there was little evidence for vulnerability to winter death associated with factors thought to lead to vulnerability. The lack of socioeconomic gradient suggests that policies aimed at relief of fuel poverty may need to be supplemented by additional measures to tackle the burden of excess winter deaths in elderly people.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk		Wilkinson, Paul/0000-0001-7456-259X; armstrong, benedict/0000-0003-4407-0409; Mangtani, Punam/0000-0001-7074-2999; Kovats, Sari/0000-0002-4823-8099				Armstong B, 2000, EPIDEMIOLOGY, V11, pS113; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Bokenes L, 2000, Int J Circumpolar Health, V59, P216; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Curwen M., 1990, HLTH TRENDS, V22, P169; Fletcher AE, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-21; Goodwin J, 2000, Int J Circumpolar Health, V59, P195; Huber P.J., 1981, ROBUST STAT; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1989, INT J BIOMETEOROL, V33, P71, DOI 10.1007/BF01686280; Laake K, 1996, AGE AGEING, V25, P343, DOI 10.1093/ageing/25.5.343; Lawlor DA, 2000, J PUBLIC HEALTH MED, V22, P176, DOI 10.1093/pubmed/22.2.176; MCKEE CM, 1989, EUR J EPIDEMIOL, V5, P178, DOI 10.1007/BF00156826; NEILD PJ, 1994, CLIN SCI, V86, P43, DOI 10.1042/cs0860043; O'Neill M, 2003, EPIDEMIOLOGY, V14, pS101, DOI 10.1097/00001648-200309001-00244; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Schwartz J B, 1996, PDA J Pharm Sci Technol, V50, P197; Shah S, 1999, J EPIDEMIOL COMMUN H, V53, P499, DOI 10.1136/jech.53.8.499; Sheth T, 1999, J AM COLL CARDIOL, V33, P1916, DOI 10.1016/S0735-1097(99)00137-0; Smolander J, 2002, INT J SPORTS MED, V23, P86, DOI 10.1055/s-2002-20137; Stout RW, 1996, AGE AGEING, V25, P256, DOI 10.1093/ageing/25.3.256; van Rossum CTM, 2001, INT J EPIDEMIOL, V30, P1109, DOI 10.1093/ije/30.5.1109; Wilkinson P, 2001, COLD COMFORT SOCIAL; WOODHOUSE PR, 1993, J HYPERTENS, V11, P1267	26	176	180	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					647	651		10.1136/bmj.38167.589907.55	http://dx.doi.org/10.1136/bmj.38167.589907.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15315961	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-01	WOS:000224042300016
J	Blight, SK; Larue, RC; Mahapatra, A; Longstaff, DG; Chang, E; Zhao, G; Kang, PT; Church-Church, KB; Chan, MK; Krzycki, JA				Blight, SK; Larue, RC; Mahapatra, A; Longstaff, DG; Chang, E; Zhao, G; Kang, PT; Church-Church, KB; Chan, MK; Krzycki, JA			Direct charging of tRNA(CUA) with pyrrolysine in vitro and in vivo	NATURE			English	Article							TRANSFER-RNA-SYNTHETASES; AMINOACYL-TRANSFER-RNAS; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; GENETIC-CODE; CORRINOID PROTEIN; METHYLTRANSFERASE; ACID; MONOMETHYLAMINE; SELENOCYSTEINE	Pyrrolysine is the 22nd amino acid(1-3). An unresolved question has been how this atypical genetically encoded residue is inserted into proteins, because all previously described naturally occurring aminoacyl-tRNA synthetases are specific for one of the 20 universally distributed amino acids. Here we establish that synthetic L-pyrrolysine is attached as a free molecule to tRNA(CUA) by PylS, an archaeal class II aminoacyl-tRNA synthetase. PylS activates pyrrolysine with ATP and ligates pyrrolysine to tRNA(CUA) in vitro in reactions specific for pyrrolysine. The addition of pyrrolysine to Escherichia coli cells expressing pylT (encoding tRNA(CUA)) and pylS results in the translation of UAG in vivo as a sense codon. This is the first example from nature of direct aminoacylation of a tRNA with a non-canonical amino acid and shows that the genetic code of E. coli can be expanded to include UAG-directed pyrrolysine incorporation into proteins.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, CCIC Mass Spectrometry & Proteom Facil, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu	Green, Kari B/H-3541-2011	Larue, Ross/0000-0002-0170-7345				Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; COLE FX, 1970, BIOCHEMISTRY-US, V9, P480, DOI 10.1021/bi00805a005; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; HAO B, IN PRESS CHEM BIOL; HO YS, 1987, P NATL ACAD SCI USA, V84, P2185, DOI 10.1073/pnas.84.8.2185; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; Jester BC, 2003, P NATL ACAD SCI USA, V100, P14351, DOI 10.1073/pnas.2036253100; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Paul L, 1996, J BACTERIOL, V178, P6599, DOI 10.1128/jb.178.22.6599-6607.1996; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2003, MOL CELL, V12, P287, DOI 10.1016/S1097-2765(03)00280-6; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891; Sowers K. R., 1995, P459; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	27	181	196	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					333	335		10.1038/nature02895	http://dx.doi.org/10.1038/nature02895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15329732				2022-12-01	WOS:000223864000047
J	Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M				Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M			Genomic analysis of regulatory network dynamics reveals large topological changes	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; SMALL-WORLD; PROGRAM; MOTIFS; CELLS	Network analysis has been applied widely, providing a unifying language to describe disparate systems ranging from social interactions to power grids. It has recently been used in molecular biology, but so far the resulting networks have only been analysed statically(1-8). Here we present the dynamics of a biological network on a genomic scale, by integrating transcriptional regulatory information(9-11) and gene-expression data(12-16) for multiple conditions in Saccharomyces cerevisiae. We develop an approach for the statistical analysis of network dynamics, called SANDY, combining well-known global topological measures, local motifs and newly derived statistics. We uncover large changes in underlying network architecture that are unexpected given current viewpoints and random simulations. In response to diverse stimuli, transcription factors alter their interactions to varying degrees, thereby rewiring the network. A few transcription factors serve as permanent hubs, but most act transiently only during certain conditions. By studying sub-network structures, we show that environmental responses facilitate fast signal propagation (for example, with short regulatory cascades), whereas the cell cycle and sporulation direct temporal progression through multiple stages (for example, with highly inter-connected transcription factors). Indeed, to drive the latter processes forward, phase-specific transcription factors interregulate serially, and ubiquitously active transcription factors layer above them in a two-tiered hierarchy. We anticipate that many of the concepts presented here-particularly the large-scale topological changes and hub transience-will apply to other biological networks, including complex sub-systems in higher eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 2QH, England	Yale University; Yale University; Yale University; MRC Laboratory Molecular Biology	Luscombe, NM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	sandy@bioinfo.mbb.yale.edu	白, 纯歌/V-1853-2017; Mohan, Babu P./I-7362-2019; Califano, Andrea/F-7239-2012	Snyder, Michael/0000-0003-0784-7987; Teichmann, Sarah/0000-0002-6294-6366				Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	28	685	709	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					308	312		10.1038/nature02782	http://dx.doi.org/10.1038/nature02782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372033				2022-12-01	WOS:000223864000041
J	Schlienger, RG; Kraenzlin, ME; Jick, SS; Meier, CR				Schlienger, RG; Kraenzlin, ME; Jick, SS; Meier, CR			Use of beta-blockers and risk of fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE RESEARCH DATABASE; OSTEOBLAST-LIKE CELLS; BONE-MINERAL DENSITY; THIAZIDE-DIURETICS; HIP FRACTURE; ADRENERGIC RECEPTORS; CONTROLLED-TRIAL; NERVOUS-SYSTEM; HYDROCHLOROTHIAZIDE; RESORPTION	Context Animal studies suggest that the beta-blocker propranolol increases bone formation, but data on whether use of beta-blockers (with or without concomitant use of thiazide diuretics) is associated with reduced fracture risk in humans are limited. Objective To determine whether use of beta-blockers alone or in combination with thiazides is associated with a decreased risk of fracture in adults. Design, Setting, and Participants Case-control analysis using the UK General Practice Research Database (GPRD). The study included 30601 case patients aged 30 to 79 years with an incident fracture diagnosis between 1993 and 1999 and 120819 controls, matched to cases on age, sex, calendar time, and general practice attended. Main Outcome Measures Odds ratios (ORs) of having a fracture in association with use of beta-blockers or a combination of beta-blockers with thiazides. Results The most frequent fractures were of the hand/lower arm (n=12837 [42.0%]) and of the foot (n=4627 [15.1%]). Compared with patients who did not use either beta-blockers or thiazide diuretics, the OR for current use of beta-blockers only (greater than or equal to3 prescriptions) was 0.77 (95% confidence interval [CI], 0.72-0.83); for current use of thiazides only (greater than or equal to3 prescriptions), 0.80 (95% CI, 0.74-0.86); and for combined current use of beta-blockers and thiazides, 0.71 (95% CI, 0.64-0.79). Data were adjusted for smoking; body mass index; number of practice visits; and use of calcium channel blockers, angiotensin-converting enzyme inhibitors, antipsychotics, antidepressants, statins, antiepileptics, benzodiazepines, corticosteroids, and estrogens. Conclusions Our data suggest that current use of beta-blockers is associated with a reduced risk of fractures, taken alone as well as in combination with thiazide diuretics. Many elderly patients with hypertension who are at risk of developing osteoporosis may potentially benefit from combined therapy with beta-blockers and thiazides.	Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Endocrinol Diabet & Clin Nutr, CH-4031 Basel, Switzerland; Univ Basel, Dept Pharmaceut Sci, Inst Clin Pharm, Basel, Switzerland; Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA	University of Basel; University of Basel; University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel Pharmacoepidemiol Unit, Hebelstr 2, CH-4031 Basel, Switzerland.	Meierch@uhbs.ch		Jick, Susan/0000-0002-2215-1067				Arai M, 2003, BBA-MOL CELL RES, V1640, P137, DOI 10.1016/S0167-4889(03)00042-9; Arnett TR, 1996, BONE, V18, P277, DOI 10.1016/8756-3282(95)00486-6; Aubin R, 1996, KIDNEY INT, V50, P1476, DOI 10.1038/ki.1996.461; Barry ELR, 1997, AM J PHYSIOL-CELL PH, V272, pC109, DOI 10.1152/ajpcell.1997.272.1.C109; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Cherruau M, 1999, BONE, V25, P545, DOI 10.1016/S8756-3282(99)00211-2; Cherruau M, 2003, J CELL PHYSIOL, V194, P341, DOI 10.1002/jcp.10209; Cock TA, 2003, LANCET, V362, P1572, DOI 10.1016/S0140-6736(03)14747-2; Cumming RG, 2003, CNS DRUGS, V17, P825, DOI 10.2165/00023210-200317110-00004; Ensrud KE, 2003, ARCH INTERN MED, V163, P949, DOI 10.1001/archinte.163.8.949; Feskanich D, 1997, OSTEOPOROSIS INT, V7, P79, DOI 10.1007/BF01623465; HALL TJ, 1994, CALCIFIED TISSUE INT, V55, P266, DOI 10.1007/BF00310404; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, EPIDEMIOLOGY, V8, P446, DOI 10.1097/00001648-199707000-00017; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Meier CR, 2000, ARCH INTERN MED, V160, P349, DOI 10.1001/archinte.160.3.349; MINKOWITZ B, 1991, J ORTHOPAED RES, V9, P869, DOI 10.1002/jor.1100090613; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Moser M, 1998, JAMA-J AM MED ASSOC, V279, P1813, DOI 10.1001/jama.279.22.1813; Pasco JA, 2004, J BONE MINER RES, V19, P19, DOI 10.1359/JBMR.0301214; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; RAY WA, 1989, LANCET, V1, P687; Reid IR, 2000, AM J MED, V109, P362, DOI 10.1016/S0002-9343(00)00510-6; Rejnmark L, 2003, EUR J CLIN INVEST, V33, P41, DOI 10.1046/j.1365-2362.2003.01103.x; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476, DOI 10.7326/0003-4819-139-6-200309160-00010; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Togari A, 2002, MICROSC RES TECHNIQ, V58, P77, DOI 10.1002/jemt.10121; van Staa TP, 2000, RHEUMATOLOGY, V39, P1383, DOI 10.1093/rheumatology/39.12.1383; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; ZAWADA ET, 1987, MINER ELECTROL METAB, V13, P72	36	259	274	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1326	1332		10.1001/jama.292.11.1326	http://dx.doi.org/10.1001/jama.292.11.1326			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367554	Bronze			2022-12-01	WOS:000223866800024
J	Kolbe, JJ; Glor, RE; Schettino, LRG; Lara, AC; Larson, A; Losos, JB				Kolbe, JJ; Glor, RE; Schettino, LRG; Lara, AC; Larson, A; Losos, JB			Genetic variation increases during biological invasion by a Cuban lizard	NATURE			English	Article							POPULATION BIOLOGY; UNITED-STATES; ANOLIS-SAGREI; EVOLUTION; PHENETICS; FLORIDA	A genetic paradox(1,2) exists in invasion biology: how do introduced populations, whose genetic variation has probably been depleted by population bottlenecks, persist and adapt to new conditions? Lessons from conservation genetics show that reduced genetic variation due to genetic drift and founder effects limits the ability of a population to adapt, and small population size increases the risk of extinction(1,3,4). Nonetheless, many introduced species experiencing these same conditions during initial introductions persist, expand their ranges, evolve rapidly and become invasive. To address this issue, we studied the brown anole, a worldwide invasive lizard. Genetic analyses indicate that at least eight introductions have occurred in Florida from across this lizard's native range, blending genetic variation from different geographic source populations and producing populations that contain substantially more, not less, genetic variation than native populations. Moreover, recently introduced brown anole populations around the world originate from Florida, and some have maintained these elevated levels of genetic variation. Here we show that one key to invasion success may be the occurrence of multiple introductions that transform among-population variation in native ranges to within-population variation in introduced areas. Furthermore, these genetically variable populations may be particularly potent sources for introductions elsewhere. The growing problem of invasive species introductions brings considerable economic and biological costs(5,6). If these costs are to be mitigated, a greater understanding of the causes, progression and consequences of biological invasions is needed(7).	Washington Univ, Dept Biol, St Louis, MO 63130 USA; CITMA, Inst Ecol & Sistemat, Havana 10800, Cuba	Washington University (WUSTL)	Kolbe, JJ (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kolbe@biology.wustl.edu	Glor, Richard/N-4656-2013	Glor, Richard/0000-0002-3359-1631				Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Campbell TS, 2003, BIOL INVASIONS, V5, P193, DOI 10.1023/A:1026172314139; Campbell Todd S., 1996, Herpetological Review, V27, P155; Campbell TS, 2000, ANAL EFFECTS EXOTIC; EHRLICH PR, 1989, BIOL INVASIONS GLOBA, P3125; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Frankham R., 2010, INTRO CONSERVATION G; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; LEE JC, 1992, COPEIA, P942, DOI 10.2307/1446624; LEE JC, 1985, COPEIA, P182, DOI 10.2307/1444808; LOSOS JB, 1993, OECOLOGIA, V95, P525, DOI 10.1007/BF00317437; Macey JR, 1997, J MOL EVOL, V44, P660, DOI 10.1007/PL00006190; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Nylander J.A.A., 2002, MRMODELTEST V1 0B; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Queller DC, 2000, NATURE, V405, P519, DOI 10.1038/35014705; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WILLIAMS EE, 1969, Q REV BIOL, V44, P345, DOI 10.1086/406245; Williamson M, 1996, BIOL INVASIONS	30	775	817	7	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					177	181		10.1038/nature02807	http://dx.doi.org/10.1038/nature02807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356629				2022-12-01	WOS:000223746000042
J	Poulton, SW; Fralick, PW; Canfield, DE				Poulton, SW; Fralick, PW; Canfield, DE			The transition to a sulphidic ocean similar to 1.84 billion years ago	NATURE			English	Article							GUNFLINT FORMATION; PYRITE FORMATION; IRON; EVOLUTION; ANOXIA; MODEL; CHEMISTRY; SULFATE; ONTARIO; ISOTOPE	The Proterozoic aeon (2.5 to 0.54 billion years (Gyr) ago) marks the time between the largely anoxic world of the Archean (>2.5Gyr ago)(1) and the dominantly oxic world of the Phanerozoic (<0.54 Gyr ago). The course of ocean chemistry through the Proterozoic has traditionally been explained by progressive oxygenation of the deep ocean in response to an increase in atmospheric oxygen around 2.3 Gyr ago. This postulated rise in the oxygen content of the ocean is in turn thought to have led to the oxidation of dissolved iron, Fe(II), thus ending the deposition of banded iron formations (BIF) around 1.8 Gyr ago(1,2). An alternative interpretation suggests that the increasing atmospheric oxygen levels enhanced sulphide weathering on land and the flux of sulphate to the oceans. This increased rates of sulphate reduction, resulting in Fe(II) removal in the form of pyrite as the oceans became sulphidic(3). Here we investigate sediments from the similar to 1.8-Gyr-old Animikie group, Canada, which were deposited during the final stages of the main global period of BIF deposition. This allows us to evaluate the two competing hypotheses for the termination of BIF deposition. We use iron-sulphur-carbon (Fe-S-C) systematics to demonstrate continued ocean anoxia after the final global deposition of BIF and show that a transition to sulphidic bottom waters was ultimately responsible for the termination of BIF deposition. Sulphidic conditions may have persisted until a second major rise in oxygen between 0.8 to 0.58 Gyr ago(4,5), possibly reducing global rates of primary production and arresting the pace of algal evolution(6).	Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Lakehead Univ, Dept Geol, Thunder Bay, ON P7B 5E1, Canada	University of Southern Denmark; Lakehead University	Poulton, SW (corresponding author), Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.	s.poulton@biology.sdu.dk	Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; BERNER RA, 1984, GEOLOGY, V12, P365, DOI 10.1130/0091-7613(1984)12<365:CMFDFF>2.0.CO;2; Brocks JJ, 2004, GEOCHIM COSMOCHIM AC, V68, pA796; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; CARRIGAN WJ, 1991, PRECAMBRIAN RES, V52, P347, DOI 10.1016/0301-9268(91)90088-R; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; DREVER JI, 1974, GEOL SOC AM BULL, V85, P1099, DOI 10.1130/0016-7606(1974)85<1099:GMFTOO>2.0.CO;2; Fralick P, 2002, CAN J EARTH SCI, V39, P1085, DOI 10.1139/E02-028; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holland H. D., 1984, CHEM EVOLUTION ATMOS; KISSIN SA, 2003, LAKE SUPERIOR I P, V49, P43; Lyons TW, 1997, GEOCHIM COSMOCHIM AC, V61, P3367, DOI 10.1016/S0016-7037(97)00174-9; OJAKANGAS RW, 1983, GEOL SOC AM MEM, V160, P49; Passier HF, 1999, NATURE, V397, P146, DOI 10.1038/16441; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; POULTON SW, UNPUB CHEM GEOL; Pufahl PK, 2004, SEDIMENTOLOGY, V51, P791, DOI 10.1111/j.1365-3091.2004.00651.x; RAISWELL R, 1985, AM J SCI, V285, P710, DOI 10.2475/ajs.285.8.710; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2001, J SEDIMENT RES, V71, P286, DOI 10.1306/070300710286; Schidlowski M., 1983, P149; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z	30	334	353	5	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					173	177		10.1038/nature02912	http://dx.doi.org/10.1038/nature02912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356628				2022-12-01	WOS:000223746000041
J	Leung, GM; Rainer, TH; Lau, FL; Wong, IOL; Tong, A; Wong, TW; Kong, JHB; Hedley, AJ; Lam, TH				Leung, GM; Rainer, TH; Lau, FL; Wong, IOL; Tong, A; Wong, TW; Kong, JHB; Hedley, AJ; Lam, TH		Hosp Authority SARS Collaborative	A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department	ANNALS OF INTERNAL MEDICINE			English	Article							HONG-KONG; SARS CORONAVIRUS; LABORATORY TESTS; OUTBREAK; VALIDATION; PNEUMONIA; MORTALITY; INFECTION; DISEASE; MODELS	Background: Accurate, objective models of triage for patients with suspected severe acute respiratory syndrome (SARS) could assess risks and improve decisions about isolation and inpatient treatment. Objective: To develop and validate a clinical prediction rule for identifying patients with SARS in an emergency department setting. Design: Retrospective analysis using a 2-step coefficient-based multivariable logistic regression scoring method with internal validation by bootstrapping. Setting: 2 hospitals in Hong Kong Participants: 1274 consecutive patients from 1 hospital and 1375 consecutive patients from another hospital. Measurements: Points were assigned on the basis of history, physical examination, and simple investigations obtained at presentation. The outcome measure was a final diagnosis of SARS, as confirmed by World Health Organization laboratory criteria. Results: Predictors for SARS on the basis of history (step 1) included previous contact with a patient with SARS and the presence of fever, myalgia, and malaise. Age 65 years and older and younger than 18 years and the presence of sputum, abdominal pain, sore throat, and rhinorrhea were inversely related to having SARS. In step 2, haziness or pneumonic consolidation on chest radiographs and low lymphocyte and platelet counts, in addition to a positive contact history and fever were associated with a higher probability of SARS. A high neutrophil count, the extremes of age, and sputum production were associated with a lower probability of SARS. In the derivation sample, the observed incidence of SARS was 4.4% for those assigned to the low-risk group (in steps 1 or 2); in the high-risk group, incidence of SARS was 21.0% for quartile 1, 39.5% for quartile 2, 61.2% for quartile 3, and 79.7% for quartile 4. This prediction rule achieved an optimism-corrected sensitivity of 0.90, a specificity of 0.62, and an area under the receiver-operating characteristic curve of 0.85. Limitations: The prediction rule may not apply to isolated cases occurring during an interepidemic period. Generalizability of the findings should be confirmed in other SARS-affected countries and should be prospectively validated if SARS returns. Conclusions: our findings suggest that a simple model that uses clinical data at the time of presentation to an emergency department during an acute outbreak predicted the incidence of SARS and provided good diagnostic utility.	Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, United Christian Hosp, Pamela Youde Nethersole E Hosp, Shatin, Hong Kong, Peoples R China; Hong Kong Hosp Author, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; United Christian Hospital	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China.	b875722@mailserv.cuhk.edu.hk	Wong, Tze Wai/K-5344-2013; Hedley, Anthony J/A-9113-2013; Leung, Gabriel Matthew/C-4336-2009; Rainer, Timothy/I-2591-2013; Hedley, Anthony/C-4305-2009; Wong, Oi Ling/C-4538-2009; Lam, Tai Hing/C-4317-2009	Rainer, Timothy/0000-0003-3355-3237; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971				David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Efron B., 1998, INTRO BOOTSTRAP; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fouchier RAM, 2004, CAN MED ASSOC J, V170, P63; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; LEUNG CM, IN PRESS EMERG INFEC; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; LEUNG GM, IN PRESS SARS 1 PLAG; Ng EKO, 2003, CLIN CHEM, V49, P1976, DOI 10.1373/clinchem.2003.024125; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004; Rainer TH, 2004, ANN INTERN MED, V140, P614, DOI 10.7326/0003-4819-140-8-200404200-00008; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tang P, 2004, CAN MED ASSOC J, V170, P47; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, US LAB METH SARS DIA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong KT, 2003, RADIOLOGY, V228, P395, DOI 10.1148/radiol.2283030541; World Health Organization, 2003, CAS DEF SURV SEV AC	29	33	33	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					333	342		10.7326/0003-4819-141-5-200409070-00106	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00106			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15326019	Green Accepted, Green Submitted			2022-12-01	WOS:000223733800001
J	Kerr, DJ				Kerr, DJ			Two errors	LANCET			English	Editorial Material									Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England	Radcliffe Infirmary	Kerr, DJ (corresponding author), Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.	david.kerr@clinical-pharmacology.oxford.ac.uk							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					907	907		10.1016/S0140-6736(04)16988-2	http://dx.doi.org/10.1016/S0140-6736(04)16988-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351200				2022-12-01	WOS:000223685200039
J	Chang, CP; Neilson, JR; Bayle, JH; Gestwicki, JE; Kuo, A; Stankunas, K; Graef, IA; Crabtree, GR				Chang, CP; Neilson, JR; Bayle, JH; Gestwicki, JE; Kuo, A; Stankunas, K; Graef, IA; Crabtree, GR			A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; GROWTH-FACTOR; EMBRYONIC LETHALITY; CARDIAC DEVELOPMENT; CUSHION FORMATION; DNA-BINDING; CALCINEURIN; VEGF; IDENTIFICATION	The delicate leaflets that make up vertebrate heart valves are essential for our moment-to-moment existence. Abnormalities of valve formation are the most common serious human congenital defect. Despite their importance, relatively little is known about valve development. We show that the initiation of heart valve morphogenesis in mice requires calcineurin/NFAT to repress VEGF expression in the myocardium underlying the site of prospective valve formation. This repression of VEGF at E9 is essential for endocardial cells to transform into mesenchymal cells. Later, at Ell, a second wave of calcineurin/NFAT signaling is required in the endocardium, adjacent to the earlier myocardial site of NFAT action, to direct valvular elongation and refinement. Thus, NFAT signaling functions sequentially from myocardium to endocardium within a valvular morphogenetic field to initiate and perpetuate embryonic valve formation. This mechanism also operates in zebrafish, indicating a conserved role for calcineurin/NFAT signaling in vertebrate heart valve morphogenesis.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Cardiovasc, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	crabtree@stanford.edu		Neilson, Joel R./0000-0002-3408-608X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL072092] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL72092-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CARPENTER SJ, 1980, ANAT REC, V197, P221, DOI 10.1002/ar.1091970211; Chang CP, 2003, GENESIS, V36, P7, DOI 10.1002/gene.10186; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dor Y, 2001, DEVELOPMENT, V128, P1531; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; DVORAK HF, 1979, J IMMUNOL, V122, P166; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; MJAATVEDT CH, 1989, DEV BIOL, V136, P118, DOI 10.1016/0012-1606(89)90135-8; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; PARR MB, 1986, BIOL REPROD, V34, P393, DOI 10.1095/biolreprod34.2.393; Ramsdell AF, 1998, ACTA ANAT, V162, P1; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STURM K, 1993, METHOD ENZYMOL, V225, P164; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Westerfield M., 1995, ZEBRAFISH BOOK; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0	56	257	263	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					649	663		10.1016/j.cell.2004.08.010	http://dx.doi.org/10.1016/j.cell.2004.08.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339668	Bronze			2022-12-01	WOS:000223730300014
J	Matroule, JY; Lam, H; Burnette, DT; Jacobs-Wagner, C				Matroule, JY; Lam, H; Burnette, DT; Jacobs-Wagner, C			Cytokinesis monitoring during development: Rapid pole-to-pole shuttling of a signaling protein by localized kinase and phosphatase in Caulobacter	CELL			English	Article							ASYMMETRIC CELL-DIVISION; RESPONSE REGULATOR; ESCHERICHIA-COLI; DYNAMIC LOCALIZATION; CYCLE REGULATION; CRESCENTUS; DIFFERENTIATION; TRANSDUCTION; DOMAIN; ENVZ	For successful generation of different cell types by asymmetric cell division, cell differentiation should be initiated only after completion of division. Here, we describe a control mechanism by which Caulobacter couples the initiation of a developmental program to the completion of cytokinesis. Genetic evidence indicates that localization of the signaling protein DivK at the flagellated pole prevents premature initiation of development. Photobleaching and FRET experiments show that polar localization of DivK is dynamic with rapid pole-to-pole shuttling of diffusible DivK generated by the localized activities of PleC phosphatase and DivJ kinase at opposite poles. This shuttling is interrupted upon completion of cytokinesis by the segregation of PleC and DivJ to different daughter cells, resulting in disruption of DivK localization at the flagellated pole and subsequent initiation of development in the flagellated progeny. Thus, dynamic polar localization of a diffusible protein provides a control mechanism that monitors cytokinesis to regulate development.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065835] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOL CHEM, V264, P14090; Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Alley MRK, 2001, MOL MICROBIOL, V40, P1335, DOI 10.1046/j.1365-2958.2001.02476.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; HUGUENEL ED, 1982, DIFFERENTIATION, V21, P71, DOI 10.1111/j.1432-0436.1982.tb01199.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Losick R, 1999, GENE DEV, V13, P377, DOI 10.1101/gad.13.4.377; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Ohta N, 1996, TRENDS MICROBIOL, V4, P326, DOI 10.1016/0966-842X(96)10050-0; Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; OSLEY MA, 1977, P NATL ACAD SCI USA, V74, P124, DOI 10.1073/pnas.74.1.124; OSLEY MA, 1977, CELL, V12, P393, DOI 10.1016/0092-8674(77)90115-5; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; SOMMER JM, 1991, GENETICS, V129, P623; SPRATT BG, 1986, GENE, V41, P337, DOI 10.1016/0378-1119(86)90117-4; TERRANA B, 1976, J BACTERIOL, V128, P456, DOI 10.1128/JB.128.1.456-462.1976; Tomomori C., 2003, HISTIDINE KINASES SI, P11, DOI [10.1016/B978-012372484-7/50003-5, DOI 10.1016/B978-012372484-7/50003-5]; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yang MM, 1997, BIOTECHNOLOGY, V3, P1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	108	109	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					579	590		10.1016/j.cell.2004.08.019	http://dx.doi.org/10.1016/j.cell.2004.08.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339663	Bronze			2022-12-01	WOS:000223730300009
J	Bourc'his, D; Bestor, TH				Bourc'his, D; Bestor, TH			Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L	NATURE			English	Article							CYTOSINE METHYLATION; GENE FAMILY; EXPRESSION; IMPRINTS; MICE	Mammalian genomes employ heritable cytosine methylation in the long-term silencing of retrotransposons and genes subject to genomic imprinting and X chromosome inactivation. Little is known of the mechanisms that direct cytosine methylation to specific sequences. Here we show that DNA methyltransferase 3-like (Dnmt3L (ref. 1)) is expressed in testes during a brief perinatal period in the non-dividing precursors of spermatogonial stem cells at a stage where retrotransposons undergo de novo methylation. Deletion of the Dnmt3L gene prevented the de novo methylation of both long-terminal-repeat (LTR) and non-LTR retrotransposons, which were transcribed at high levels in spermatogonia and spermatocytes. Loss of Dnmt3L from early germ cells also caused meiotic failure in spermatocytes, which do not express Dnmt3L. Whereas dispersed repeated sequences were demethylated in mutant germ cells, tandem repeats in pericentric regions were methylated normally. This result indicates that the Dnmt3L protein might have a function in the de novo methylation of dispersed repeated sequences in a premeiotic genome scanning process that occurs in male germ cells at about the time of birth.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	thb12@columbia.edu		Bourc'his, Deborah/0000-0001-9499-7291				Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Bestor TH, 2003, TRENDS GENET, V19, P185, DOI 10.1016/S0168-9525(03)00049-0; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; DOBSON MJ, 1994, J CELL SCI, V107, P2749; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Hata K, 2002, DEVELOPMENT, V129, P1983; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PIETRAS DF, 1983, NUCLEIC ACIDS RES, V11, P6965, DOI 10.1093/nar/11.20.6965; PONZETTOZIMMERMAN C, 1984, NUCLEIC ACIDS RES, V12, P2807, DOI 10.1093/nar/12.6.2807; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2822; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	25	816	838	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					96	99		10.1038/nature02886	http://dx.doi.org/10.1038/nature02886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15318244				2022-12-01	WOS:000223641500049
J	Portenoy, RK				Portenoy, RK			Appropriate use of opioids for persistent non-cancer pain	LANCET			English	Editorial Material									Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Portenoy, RK (corresponding author), Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA.	Rportenoy@chpnet.org						American Academy of Pain Medicine and American Pain Society, US OP TREATM CHRON P; [Anonymous], 2000, ACH BAL NAT OP CONTR; Chou R, 2003, J PAIN SYMPTOM MANAG, V26, P1026, DOI 10.1016/j.jpainsymman.2003.03.003; Portenoy RK, 1997, COMPREHENSIVE TXB SU, P563; Rosenblum A, 2003, JAMA-J AM MED ASSOC, V289, P2370, DOI 10.1001/jama.289.18.2370; *ROYAL COLL AN ROY, 2004, REC APPR US OP PERS; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6; ZENZ M, 1992, J PAIN SYMPTOM MANAG, V7, P69, DOI 10.1016/0885-3924(92)90116-Y	8	26	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					739	740		10.1016/S0140-6736(04)16951-1	http://dx.doi.org/10.1016/S0140-6736(04)16951-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337386				2022-12-01	WOS:000223569600007
J	Schulz, R; Belle, SH; Czaja, SJ; McGinnis, KA; Stevens, A; Zhang, S				Schulz, R; Belle, SH; Czaja, SJ; McGinnis, KA; Stevens, A; Zhang, S			Long-term care placement of dementia patients and caregiver health and well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NURSING-HOME PLACEMENT; ALZHEIMERS-DISEASE; FAMILY CAREGIVERS; OLDER-PEOPLE; INSTITUTIONALIZATION; BURDEN; REACH; PREDICTORS; PROJECT; TIME	Context Placing a relative with dementia into a long-term care facility is common among caregivers. Placement transition and factors that affect caregiver health and well-being after placement of the patient are not well described. Objective To assess the impact of placing a relative with dementia in a long-term care facility on caregivers' health and well-being. Design, Setting, and Participants Prospective study from 1996 to 2000 of the placement transition in a sample of 1222 caregiver-patient dyads recruited from 6 US sites. A total of 180 patients were placed in a long-term care facility during the 18-month follow-up period. Data collected before and after placement were analyzed to identify factors associated with placement, the nature of contact between caregivers and their institutionalized relatives after placement, and the relation of both of these factors to health outcomes among dementia caregivers. Main Outcome Measures Caregiver depression (symptoms on the Center for Epidemiological Studies-Depression [CES-D] scale; range, 0-60) and anxiety (State Trait Inventory; range, 10-40) and use of prescription medications for depression and anxiety. Results Caregivers who institutionalized their relative reported depressive symptoms and anxiety to be as high as they were while in-home caregivers. Overall CES-D scores for depression did not change from before to after placement (median [IQR], 15.0 [8-24.5] and 15.0 [7.7-28]; P=.64). Overall anxiety scores on the State Trait Inventory also did not change significantly (median [IQR], 22.0 (19-27] before vs 21.1 [18-27] after; P=.21). These effects were most pronounced among caregivers who were married to the patient (P=.02 for depression), visited more frequently (P=.01 for depression and P<.001 for anxiety), and were less satisfied with the help they received from others (P=.003 for depression and P<.001 for anxiety). The use of antidepressants did not change significantly before (21.1%) to after (17.9%) placement (P=.16). The use of anxiolytics before to after placement increased from 14.6% to 19% (P=.02), and nearly half of caregivers (48.3%) were at risk for clinical depression following placement of their relative. Conclusions The transition to institutional care is particularly difficult for spouses, almost half of whom visit the patient daily and continue to provide help with physical care during their visits. Clinical interventions that better prepare the caregiver for a placement transition and treat their depression and anxiety following placement may be of great benefit to these individuals.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Univ Ctr Social & Urban Res, Pittsburgh, PA 15260 USA; Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA; Univ Miami, Ctr Aging, Miami, FL 33152 USA; Univ Alabama Birmingham, Div Gerontol & Geriatr Med, Birmingham, AL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Miami; University of Alabama System; University of Alabama Birmingham	Schulz, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 121 Univ Pl,6th Floor, Pittsburgh, PA 15260 USA.	schulz@pitt.edu			NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000207] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL065112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH052247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG013305] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL65112] Funding Source: Medline; NIA NIH HHS [UO1-AG13305] Funding Source: Medline; NIMHD NIH HHS [P60 MD000207] Funding Source: Medline; NIMH NIH HHS [P30 MH52247] Funding Source: Medline; NINR NIH HHS [U01-NR04261] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; COLLINS C, 1994, NURS RES, V43, P221; COX DR, 1972, J R STAT SOC B, V34, P187; Dellasega C, 1991, J Community Health Nurs, V8, P197, DOI 10.1207/s15327655jchn0804_2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; GRAFSTROM M, 1995, ALZ DIS ASSOC DIS, V9, P78, DOI 10.1097/00002093-199509020-00004; Hebert R, 2001, J GERONTOL A-BIOL, V56, pM693, DOI 10.1093/gerona/56.11.M693; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Kaplan L, 1999, FAM PROCESS, V38, P85, DOI 10.1111/j.1545-5300.1999.00085.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keefe J, 2000, FAM RELAT, V49, P235, DOI 10.1111/j.1741-3729.2000.00235.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levesque L., 2000, AM OURNAL ALZHEIMERS, V15, P229; Magaziner J, 2000, GERONTOLOGIST, V40, P663, DOI 10.1093/geront/40.6.663; McDowell I, 2002, GERONTOLOGIST, V42, P643; MONTGOMERY RJV, 1994, J GERONTOL, V49, pS62, DOI 10.1093/geronj/49.2.S62; Pot AM, 2001, INT J GERIATR PSYCH, V16, P273, DOI 10.1002/gps.331; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROTHENHAEUSLER HB, 1997, Z GERONTOPSYCHOL PSY, V10, P61; Schulz R, 2001, JAMA-J AM MED ASSOC, V285, P3123, DOI 10.1001/jama.285.24.3123; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; Spielberger CD., 1983, STATE TRAIT ANXIETY; Stevens A, 2004, J AGING HEALTH, V16, P375, DOI 10.1177/0898264304264206; STEVENS AB, IN PRESS AGING MENT; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Tornatore JB, 2002, GERONTOLOGIST, V42, P497, DOI 10.1093/geront/42.4.497; Whitlatch CJ, 2001, GERONTOLOGIST, V41, P462, DOI 10.1093/geront/41.4.462; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yamamoto-Mitani N, 2002, J GERONTOL B-PSYCHOL, V57, pS234, DOI 10.1093/geronb/57.4.S234; ZARIT SH, 1992, GERONTOLOGIST, V32, P665, DOI 10.1093/geront/32.5.665	37	228	234	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					961	967		10.1001/jama.292.8.961	http://dx.doi.org/10.1001/jama.292.8.961			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	847WR	15328328				2022-12-01	WOS:000223429200021
J	Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y				Kobasa, D; Takada, A; Shinya, K; Hatta, M; Halfmann, P; Theriault, S; Suzuki, H; Nishimura, H; Mitamura, K; Sugaya, N; Usui, T; Murata, T; Maeda, Y; Watanabe, S; Suresh, M; Suzuki, T; Suzuki, Y; Feldmann, H; Kawaoka, Y			Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus	NATURE			English	Article							INFECTION; CYTOKINE; PATHOGENICITY; RESPONSES; PROTEIN; GENES	The 'Spanish' influenza pandemic of 1918-19 was the most devastating outbreak of infectious disease in recorded history. At least 20 million people(1) died from their illness, which was characterized by an unusually severe and rapid clinical course. The complete sequencing of several genes of the 1918 influenza virus has made it possible to study the functions of the proteins encoded by these genes in viruses generated by reverse genetics, a technique that permits the generation of infectious viruses entirely from cloned complementary DNA. Thus, to identify properties of the 1918 pandemic influenza A strain that might be related to its extraordinary virulence, viruses were produced containing the viral haemagglutinin(2) (HA) and neuraminidase(3) (NA) genes of the 1918 strain. The HA of this strain supports the pathogenicity of a mouse-adapted virus in this animal(4,5). Here we demonstrate that the HA of the 1918 virus confers enhanced pathogenicity in mice to recent human viruses that are otherwise non-pathogenic in this host. Moreover, these highly virulent recombinant viruses expressing the 1918 viral HA could infect the entire lung and induce high levels of macrophage-derived chemokines and cytokines, which resulted in infiltration of inflammatory cells and severe haemorrhage, hallmarks of the illness produced during the original pandemic(6).	Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; Hlth Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 3R2, Canada; Niigata Univ, Sch Med, Dept Publ Hlth, Niigata 9518510, Japan; Sendai Natl Hosp, Div Clin Res, Viral Res Ctr, Sendai, Miyagi 9838520, Japan; Nippon Kokan Ltd Co Hosp, Dept Pediat, Kawasaki, Kanagawa 2100852, Japan; Univ Shizuoka, Dept Appl Biol Chem, Shizuoka 4228529, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; COE Program 21st Century, Shizuoka 4228526, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Japan Science & Technology Agency (JST); Health Canada; University of Manitoba; Niigata University; University of Shizuoka; University of Shizuoka	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Takada, Ayato/A-6679-2012; Halfmann, Peter/W-8084-2019	Suresh, Marulasiddappa/0000-0003-1794-3358; Yasuo, Suzuki/0000-0003-3518-5642				Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; [Anonymous], FIELDS VIROLOGY; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; CONNOR JS, 1994, VIROLOGY, V15, P17; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Totani K, 2003, GLYCOBIOLOGY, V13, P315, DOI 10.1093/glycob/cwg032; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699	30	359	407	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					703	707		10.1038/nature02951	http://dx.doi.org/10.1038/nature02951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470432	Bronze			2022-12-01	WOS:000224299300044
J	Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP				Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP			Multicompartment micelles from ABC miktoarm stars in water	SCIENCE			English	Article							FLUOROCARBON; HYDROCARBON; NANOTECHNOLOGY; POLYMERS; STRATEGY	By combining three mutually immiscible polymeric components in a mixed-arm star block terpolymer architecture, we have observed the formation of a previously unknown class of multicompartment micelles in dilute aqueous solution. Connection of water-soluble poly(ethylene oxide) and two hydrophobic but immiscible components (a polymeric hydrocarbon and a perfluorinated polyether) at a common junction leads to molecular frustration when dispersed in aqueous solution. The incompatible hydrophobic blocks form cores that are protected from the water by the poly(ethylene oxide) blocks, but both are forced to make contact with the poly(ethylene oxide) by virtue of the chain architecture. The structures that emerge depend on the relative lengths of the blocks and can be tuned from discrete multicompartment micelles to extended wormlike structures with segmented cores.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Technion Israel Institute of Technology	Hillmyer, MA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hillmyer@chem.umn.edu; lodge@chem.umn.edu	Li, Zhibo/K-1614-2013; Talmon, Yeshayahu/N-1076-2019	Li, Zhibo/0000-0001-9512-1507; Talmon, Yeshayahu/0000-0002-9854-3972; Hillmyer, Marc/0000-0001-8255-3853; Lodge, Timothy/0000-0001-5916-8834				Bailey TS, 2002, MACROMOLECULES, V35, P7007, DOI 10.1021/ma011716x; Balsamo V, 2003, MACROMOLECULES, V36, P4515, DOI 10.1021/ma020129o; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Collier JH, 2001, ANNU REV MATER RES, V31, P237, DOI 10.1146/annurev.matsci.31.1.237; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Dormidontova EE, 1997, MACROMOLECULES, V30, P1980, DOI 10.1021/ma961076b; Gohy JF, 2001, ANGEW CHEM INT EDIT, V40, P3214, DOI 10.1002/1521-3773(20010903)40:17<3214::AID-ANIE3214>3.0.CO;2-F; Goldacker T, 1999, NATURE, V398, P137, DOI 10.1038/18191; Hadjichristidis N, 1999, J POLYM SCI POL CHEM, V37, P857, DOI 10.1002/(SICI)1099-0518(19990401)37:7<857::AID-POLA1>3.0.CO;2-P; HALPERIN A, 1992, ADV POLYM SCI, V100, P31; Hamley IW, 1998, PHYS BLOCK COPOLYMER; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197; Kotzev A, 2002, MACROMOLECULES, V35, P1091, DOI 10.1021/ma011047n; Laschewsky A, 2003, CURR OPIN COLLOID IN, V8, P274, DOI 10.1016/S1359-0294(03)00049-9; Li Z.B., UNPUB; Lodge TP, 2004, MACROMOLECULES, V37, P6680, DOI 10.1021/ma048708b; Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073; Park C, 2003, POLYMER, V44, P6725, DOI 10.1016/j.polymer.2003.08.011; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; SEMENOV AN, 1995, MACROMOLECULES, V28, P7491, DOI 10.1021/ma00126a029; Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9; Sioula S, 1998, MACROMOLECULES, V31, P8429, DOI 10.1021/ma980622t; Stahler K, 1999, LANGMUIR, V15, P7565, DOI 10.1021/la990431z; Weberskirch R, 2000, MACROMOL CHEM PHYSIC, V201, P995, DOI 10.1002/1521-3935(20000601)201:10<995::AID-MACP995>3.0.CO;2-T; Zhou ZL, 2003, J AM CHEM SOC, V125, P10182, DOI 10.1021/ja036551h	29	890	909	4	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					98	101		10.1126/science.1103350	http://dx.doi.org/10.1126/science.1103350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459387				2022-12-01	WOS:000224304000044
J	Potts, M; Campbell, M				Potts, M; Campbell, M			Three meetings and fewer funerals - misoprostol in postpartum haemorrhage	LANCET			English	Editorial Material							MORTALITY		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	potts@socrates.berkeley.edu						AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; FORTNEY JA, 1986, AM J PUBLIC HEALTH, V76, P134, DOI 10.2105/AJPH.76.2.134; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; Tsu VD, 2004, LANCET, V363, P75, DOI 10.1016/S0140-6736(03)15180-X	4	16	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1110	1111		10.1016/S0140-6736(04)17120-1	http://dx.doi.org/10.1016/S0140-6736(04)17120-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451208				2022-12-01	WOS:000224102400009
J	Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR				Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR			Age and timing of the Permian mass extinctions: U/Pb dating of closed-system zircons	SCIENCE			English	Article							TRIASSIC BOUNDARY; END; IMPACT; PB; GEOCHRONOLOGY	The age and timing of the Permian-Triassic mass extinction have been difficult to determine because zircon populations from the type sections are typically affected by pervasive lead loss and contamination by indistinguishable older xenocrysts. Zircons from nine ash beds within the Shangsi and Meishan sections (China), pretreated by annealing followed by partial attack with hydrofluoric acid, result in suites of consistent and concordant uranium/lead (U/Pb) ages, eliminating the effects of lead loss. The U/Pb age of the main pulse of the extinction is 252.6 +/- 0.2 million years, synchronous with the Siberian flood volcanism, and it occurred within the quoted uncertainty.	Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ New England, Asia Ctr, Armidale, NSW 2351, Australia; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of New England; University of California System; University of California Berkeley	Mundil, R (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.		Mundil, Roland/E-5174-2011; Metcalfe, Ian/AAK-3429-2020	Metcalfe, Ian/0000-0003-3538-1686; Renne, Paul/0000-0003-1769-5235				Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brown SJA, 1999, GEOLOGY, V27, P1035, DOI 10.1130/0091-7613(1999)027<1035:SUPDOT>2.3.CO;2; Buck CE, 1996, BAYESIAN APPROACH IN; Cherniak DJ, 2001, CHEM GEOL, V172, P5, DOI 10.1016/S0009-2541(00)00233-3; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Farley KA, 2001, SCIENCE, V293, P2343; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Koeberl C, 2002, GEOLOGY, V30, P855, DOI 10.1130/0091-7613(2002)030<0855:EPCBBI>2.0.CO;2; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Kwon JY, 2002, MATH GEOL, V34, P457, DOI 10.1023/A:1015035228810; Lee JKW, 1997, NATURE, V390, P159, DOI 10.1038/36554; LI ZS, 1986, ACTA GEOL SIN-ENGL, V60, P1; Litton C.D., 1995, ARCHAEOMETRY, V37, P1, DOI DOI 10.1111/J.1475-4754.1995.TB00723.X; Ludwig K.R, 2003, USERS MANUAL ISOPLOT; Ludwig KR, 1998, GEOCHIM COSMOCHIM AC, V62, P665, DOI 10.1016/S0016-7037(98)00059-3; MATTINSON JM, 1994, CONTRIB MINERAL PETR, V116, P117, DOI 10.1007/BF00310694; MATTINSON JM, UNPUB; MATTINSON JM, 2001, AM GEOPH UN M SAN FR; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; NICHOLLS G, 1998, 407 U AUCKL; Nicoll RS, 2002, J ASIAN EARTH SCI, V20, P609, DOI 10.1016/S1367-9120(02)00021-4; Ramsey CB, 1998, RADIOCARBON, V40, P461; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Ryskin G, 2003, GEOLOGY, V31, P741, DOI 10.1130/G19518.1; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; STEIN C, 1954, 3 BERK S MATH STAT P; *STEIN C, 1955, 3 BERK S MATH STAT P; Yin H.F., 1992, PERMOTRIASSIC EVENTS, P1; Yin HF, 2001, EPISODES, V24, P102; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2	37	486	539	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1760	1763		10.1126/science.1101012	http://dx.doi.org/10.1126/science.1101012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375264				2022-12-01	WOS:000224039500037
J	Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G				Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G			Two distinct actin networks drive the protrusion of migrating cells	SCIENCE			English	Article							FLUORESCENT SPECKLE MICROSCOPY; FILAMENTS; MOTILITY; POLYMERIZATION; ELONGATION	Cell migration initiates by extension of the actin cytoskeleton at the leading edge. Computational analysis of fluorescent speckle microscopy movies of migrating epithelial cells revealed this process is mediated by two spatially colocalized but kinematically, kinetically, molecularly, and functionally distinct actin networks. A lamelhpodium network assembled at the leading edge but completely disassembled within 1 to 3 micrometers. It was weakly coupled to the rest of the cytoskeleton and promoted the random protrusion and retraction of the leading edge. Productive cell advance was a function of the second colocalized network, the lamella, where actomyosin contraction was integrated with substrate adhesion.	Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Waterman-Storer, CM (corresponding author), Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA.	waterman@scripps.edu; gdanuser@scripps.edu		Waterman, Clare/0000-0001-6142-6775; Danuser, Gaudenz/0000-0001-8583-2014	NIGMS NIH HHS [GM67230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM067230, R01GM067230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Danuser G, 2003, J MICROSC-OXFORD, V211, P191, DOI 10.1046/j.1365-2818.2003.01222.x; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	18	577	586	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1782	1786		10.1126/science.1100533	http://dx.doi.org/10.1126/science.1100533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375270				2022-12-01	WOS:000224039500044
J	Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL				Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL			Identification of a human heme exporter that is essential for erythropoiesis	CELL			English	Article							FELINE LEUKEMIA-VIRUS; RED-CELL APLASIA; SUBGROUP-C; BINDING PROTEIN; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; ANEMIA RETROVIRUS; SURFACE RECEPTOR; IRON; TRANSPORTER	FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-erythroid, CFU-E) and severe anemia in cats. In this report, we demonstrate that human FLVCR exports cytoplasmic heme and hypothesize that human FLVCR is required on developing erythroid cells to protect them from heme toxicity. Inhibition of FLVCR in K562 cells decreases heme export, impairs their erythroid maturation and leads to apoptosis. FLVCR is upregulated on CFU-E, indicating that heme export is important in primary cells at this stage. Studies of FLVCR expression in cell lines suggest this exporter also impacts heme trafficking in intestine and liver. To our knowledge, this is the first description of a mammalian heme transporter.	Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Virginia, Dept Med Gastroenterol, Charlottesville, VA 22908 USA; Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; Rockefeller Univ, Lab Biochem Hematol, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; Utah System of Higher Education; University of Utah; Rockefeller University	Abkowitz, JL (corresponding author), Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA.	janabk@u.washington.edu	Quigley, John/X-4366-2019	quigley, john/0000-0003-3116-4545	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020503, R37DK020503, R01DK032890] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00037] Funding Source: Medline; NHLBI NIH HHS [HL31823] Funding Source: Medline; NIDDK NIH HHS [R01 DK020503, DK20503, DK32890] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott BL, 2003, HEMATOL ONCOL, V21, P115, DOI 10.1002/hon.714; ABKOWITZ JL, 1987, J CLIN INVEST, V80, P1056, DOI 10.1172/JCI113160; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; BORSOOK H, 1969, BLOOD-J HEMATOL, V34, P32, DOI 10.1182/blood.V34.1.32.32; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; Charles RJ, 1996, BLOOD, V87, P4831, DOI 10.1182/blood.V87.11.4831.bloodjournal87114831; DEAN GA, 1992, J VIROL, V66, P5561, DOI 10.1128/JVI.66.9.5561-5568.1992; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; GALBRAITH RA, 1990, J HEPATOL, V10, P305, DOI 10.1016/0168-8278(90)90137-G; Harlow E LD, 1988, ANTIBODIES LAB MANUA, V1st; HOLDEN SA, 1983, EXP HEMATOL, V11, P953; IBRAHIM NG, 1982, BRIT J HAEMATOL, V50, P17, DOI 10.1111/j.1365-2141.1982.tb01886.x; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; KINNESAFFRAN E, 1989, METHOD ENZYMOL, V172, P3; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; ONIONS D, 1982, NATURE, V296, P156, DOI 10.1038/296156a0; PAO SS, 1994, MICROBIOL MOL BIOL R, V62, P1; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; PONKA P, 1982, BIOCHIM BIOPHYS ACTA, V720, P96, DOI 10.1016/0167-4889(82)90043-X; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; RIEDEL N, 1988, P NATL ACAD SCI USA, V85, P2758, DOI 10.1073/pnas.85.8.2758; RIEDEL N, 1986, J VIROL, V60, P242, DOI 10.1128/JVI.60.1.242-250.1986; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; Rudra-Ganguly N, 1998, BBA-GENE STRUCT EXPR, V1443, P407, DOI 10.1016/S0167-4781(98)00241-3; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Smith K.M., 1975, PORPHYRINS METALLOPO; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Uzel C, 1998, SEMIN HEMATOL, V35, P27; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; WARDROP KJ, 1986, AM J VET RES, V47, P2274; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172	49	305	318	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					757	766		10.1016/j.cell.2004.08.014	http://dx.doi.org/10.1016/j.cell.2004.08.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369674	Bronze			2022-12-01	WOS:000223992400011
J	Singh, JA				Singh, JA			Standards of care in the antiretroviral rollout world	LANCET			English	Editorial Material							PERINATAL TRANSMISSION; TRIALS		CAPRISA, Durban, South Africa; Univ KwaZulu Natal, Howard Coll, Sch Law, ZA-4041 Durban, South Africa; Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Toronto	Singh, JA (corresponding author), CAPRISA, Durban, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; *COUNC INT ORG MED, 2002, INT ETH GUID BIOM RE; Institute of Medicine, 2004, SCAL TREATM GLOB AID; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P564, DOI 10.2105/AJPH.88.4.564; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH PRINC G; *OHCHR UNAIDS, HIV AIDS HUM RIGHTS; *TREATM ACT CAMP A, 2004, 1 TREATM ACT CAMP AI; *WHO, TREAT 3 MILL 2005 MA; *WHO, 2003, SCAL ANT THER RES SE; *WHO, 2004, 3 5 PROGR REP; World Medical Association, DECL HELS ETH PRINC	12	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					920	922		10.1016/S0140-6736(04)17040-2	http://dx.doi.org/10.1016/S0140-6736(04)17040-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364176				2022-12-01	WOS:000223831000009
J	Meng, QJ; Liu, JY; Varricchio, DJ; Huang, T; Gao, CL				Meng, QJ; Liu, JY; Varricchio, DJ; Huang, T; Gao, CL			Parental care in an ornithischian dinosaur	NATURE			English	Article							BIRDS		Dalian Nat Hist Museum, Dalian, Peoples R China; Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; Paleo World Res Fdn, Asian Operat B122 2, Taipei 106, Taiwan	Montana State University System; Montana State University Bozeman	Meng, QJ (corresponding author), Dalian Nat Hist Museum, 40 Xicun St, Dalian, Peoples R China.	djv@montana.edu		Huang, Timothy/0000-0001-5381-2596				[Anonymous], 1985, NATL GEOGRAPHIC SOC; Bakker RT, 2004, LIFE O PAST, P301; Carpenter K., 1999, EGGS NESTS BABY DINO; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gill FB, 1990, ORNITHOLOGY; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Kavanau JL., 1987, LOVEBIRDS COCKATIELS; MAGNUSSON WE, 1989, REPROD CROCODILES AL, P118; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	13	70	76	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					145	146		10.1038/431145a	http://dx.doi.org/10.1038/431145a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356619				2022-12-01	WOS:000223746000032
J	Salic, A; Waters, JC; Mitchison, TJ				Salic, A; Waters, JC; Mitchison, TJ			Vertebrate shugoshin links sister centromere cohesion and kinetochore microtubule stability in mitosis	CELL			English	Article							MEIOSIS-I; CHROMOSOME CONGRESSION; CHROMATID COHESION; AURORA-B; CENP-E; SPINDLE; ANAPHASE; PROTEIN; ATTACHMENT; CLEAVAGE	Drosophila MEI-S332 and fungal Sgo1 genes are essential for sister centromere cohesion in meiosis I. We demonstrate that the related vertebrate Sgo localizes to kinetochores and is required to prevent premature sister centromere separation in mitosis, thus providing an explanation for the differential cohesion observed between the arms and the centromeres of mitotic sister chromatids. Sgo is degraded by the anaphase-promoting complex, allowing the separation of sister centromeres in anaphase. Intriguingly, we show that Sgo interacts strongly with microtubules in vitro and that it regulates kinetochore microtubule stability in vivo, consistent with a direct microtubule interaction. Sgo is thus critical for mitotic progression and chromosome segregation and provides an unexpected link between sister centromere cohesion and microtubule interactions at kinetochores.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Salic, A (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 240 Longwood Ave, Boston, MA 02115 USA.	adrian_salic@hms.harvard.edu	Salic, Adrian/GXG-1611-2022					Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Moore DP, 1998, J CELL BIOL, V140, P1003, DOI 10.1083/jcb.140.5.1003; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Rieder CL, 1999, J CELL SCI, V112, P2607; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Scanlan M J, 2001, Cancer Immun, V1, P4; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Waters JC, 1999, CURR BIOL, V9, P649, DOI 10.1016/S0960-9822(99)80287-5; Waters JC, 1996, J CELL SCI, V109, P2823; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	37	250	255	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					567	578		10.1016/j.cell.2004.08.016	http://dx.doi.org/10.1016/j.cell.2004.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339662	Bronze			2022-12-01	WOS:000223730300008
J	Stroud, RM; Nittler, LR; Alexander, CMO				Stroud, RM; Nittler, LR; Alexander, CMO			Polymorphism in presolar Al2O3 grains from asymptotic giant branch stars	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; DUST FEATURES; AMORPHIZATION; GRAPHITE; EMISSION; SPECTRA; ORIGIN; GAS	We report microstructural and isotopic analyses of two presolar Al2O3 grains. Aluminum oxide is important cosmically, because its presence has been detected in the infrared spectra of the circumstellar envelopes of O-rich asymptotic giant branch stars and because it is predicted to be the first solid to condense in these stellar environments. The two grain structures, one corundum and the other amorphous, confirm that asymptotic giant branch stars produce both phases. The variation in structure and Ti content demonstrates that Al2O3 can condense in the absence of TiO2 seed clusters but that Ti may be important in determining the crystal structure.	USN, Res Lab, Washington, DC 20375 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Carnegie Institution for Science	Stroud, RM (corresponding author), USN, Res Lab, Code 6360, Washington, DC 20375 USA.	stroud@nrl.navy.mil	Stroud, Rhonda M/S-4584-2018; Stroud, Rhonda M./C-5503-2008; Stroud, Rhonda/GQZ-0151-2022; Alexander, Conel M. O'D./N-7533-2013	Stroud, Rhonda M/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Stroud, Rhonda/0000-0001-5242-8015; Alexander, Conel M. O'D./0000-0002-8558-1427				Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; Boothroyd AI, 1999, ASTROPHYS J, V510, P232, DOI 10.1086/306546; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; Croat TK, 2003, GEOCHIM COSMOCHIM AC, V67, P4705, DOI 10.1016/S0016-7037(03)00463-0; Daulton TL, 2002, SCIENCE, V296, P1852, DOI 10.1126/science.1071136; Daulton TL, 1996, GEOCHIM COSMOCHIM AC, V60, P4853, DOI 10.1016/S0016-7037(96)00223-2; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; Dwek E, 1996, ASTROPHYS J, V457, P244, DOI 10.1086/176725; Gail HP, 1998, FARADAY DISCUSS, V109, P303, DOI 10.1039/a709290c; Gail HP, 2003, LECT NOTES PHYS, V609, P55; Glaccum W, 1995, ASTR SOC P, V73, P395; Heaney PJ, 2001, AM MINERAL, V86, P1094; Jager C, 2003, ASTRON ASTROPHYS, V401, P57, DOI 10.1051/0004-6361:20030002; Jeong KS, 1999, IAU SYMP, P233; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Lee MR, 2003, MINERAL MAG, V67, P581, DOI 10.1180/0026461036730119; Levin I, 1998, J AM CERAM SOC, V81, P1995; LITTLEMARENIN IR, 1986, 88342 NASA, P137; Lodders K, 1999, IAU SYMP, P279; Lodders K, 1997, AIP CONF PROC, P391, DOI 10.1063/1.53317; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Nittler LR, 2003, EARTH PLANET SC LETT, V209, P259, DOI 10.1016/S0012-821X(02)01153-6; NITTLER LR, 2001, METEORIT PLANET SCI, V36, pA149; Posch T, 1999, ASTRON ASTROPHYS, V352, P609; SALPETER EE, 1977, ANNU REV ASTRON ASTR, V15, P267, DOI 10.1146/annurev.aa.15.090177.001411; Sloan GC, 2003, ASTROPHYS J, V594, P483, DOI 10.1086/376857; Sogawa H, 1999, ASTROPHYS J, V516, pL33, DOI 10.1086/311992; Speck AK, 2000, ASTRON ASTROPHYS SUP, V146, P437, DOI 10.1051/aas:2000274; Stround RM, 2002, METEORIT PLANET SCI, V37, pA137; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; TIELENS AGGM, 1990, FROM MIRAS TO PLANETARY NEBULAE : WHICH PATH FOR STELLAR EVOLUTION ?, P186; Wang SX, 1997, J APPL PHYS, V81, P587, DOI 10.1063/1.364219; Zinkle SJ, 1996, NUCL INSTRUM METH B, V116, P92, DOI 10.1016/0168-583X(96)00016-X; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147	35	79	79	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1455	1457		10.1126/science.1101099	http://dx.doi.org/10.1126/science.1101099			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353800				2022-12-01	WOS:000223761900046
J	Levine, F; Mercola, M				Levine, F; Mercola, M			No pancreatic endocrine stem cells?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA-CELLS		Burnham Inst, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Diego	Levine, F (corresponding author), Burnham Inst, San Diego, CA USA.		Levine, Fred/L-2693-2013	Levine, Fred/0000-0002-7336-2526				BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458	5	9	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2004	351	10					1024	1026		10.1056/NEJMcibr041779	http://dx.doi.org/10.1056/NEJMcibr041779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	850UB	15342812				2022-12-01	WOS:000223637400015
J	Pawlak, DB; Kushner, JA; Ludwig, DS				Pawlak, DB; Kushner, JA; Ludwig, DS			Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals	LANCET			English	Article							INSULIN-RESISTANCE; OBESITY; RISK; ADIPONECTIN; LOAD; FAT; SECRETION; PROFILE; FIBER; RATS	Background Clinical studies suggest a role for dietary glycaemic index (GI) in bodyweight regulation and diabetes risk. However, partly because manipulation of GI can produce changes in potentially confounding dietary factors such as fibre content, palatability, and energy density, its relevance to human health remains controversial. This study examined the independent effects of GI in animals. Methods Partially pancreatectomised male Sprague-Dawley rats were given diets with identical nutrients, except for the type of starch: high-GI (n=11) or low-GI (n=10). The animals were fed in a controlled way to maintain the same mean bodyweight in the two groups for 18 weeks. Further experiments examined the effects of GI in rats in a crossover design and C57BL/6J mice in a parallel design. Findings Despite having similar mean bodyweight (547.9 [SE 13.4] vs 549.2 [15.2] g), rats given high-GI food had more body fat (97.8 [13.6] vs 57.3 [7.2] g; p=0.0152) and less lean body mass (450.1 [9.6] vs 491.9 [11.7] g; p=0.0120) than those given low-GI food. The high-GI group also had greater increases over time in the areas under the curve for blood glucose and plasma insulin after oral glucose, lower plasma adiponectin concentrations, higher plasma triglyceride concentrations, and severe disruption of islet-cell architecture. Mice on the high-GI diet had almost twice the body fat of those on the low-GI diet after 9 weeks. Interpretation These findings provide a mechanistic basis for interpretation of studies of GI in human beings. Relevance to practice The term GI describes how a food, meal, or diet affects blood sugar during the postprandial. period. GI as an independent factor can cause obesity and increase risks of diabetes and heart disease in animals. Use of low-GI diets in prevention and treatment of human disease merits thorough examination.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Ludwig, David/0000-0003-3307-8544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NICHD NIH HHS [T32HD07277] Funding Source: Medline; NIDDK NIH HHS [1R01DK059240] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CUMMINGS JH, 1995, AM J CLIN NUTR, V61, p938S, DOI 10.1093/ajcn/61.4.938S; Cusin Isabelle, 1992, International Journal of Obesity, V16, pS1; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; FROST G, 1994, DIABETIC MED, V11, P397, DOI 10.1111/j.1464-5491.1994.tb00292.x; JENKINS DJA, 1987, AM J CLIN NUTR, V46, P968, DOI 10.1093/ajcn/46.6.968; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KLOPPEL G, SURV SYNTH PATHOL RE, V4, P110; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; LAJVARDI A, 1993, J NUTR, V123, P2059; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; LererMetzger M, 1996, BRIT J NUTR, V75, P723, DOI 10.1079/BJN19960176; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Morita T, 1999, J NUTR, V129, P2081, DOI 10.1093/jn/129.11.2081; OSCAI LB, 1982, AM J PHYSIOL, V242, pR212, DOI 10.1152/ajpregu.1982.242.3.R212; PIROZZO S, 2002, COCHRANE LIB; RASTOGI GK, 1973, DIABETES, V22, P804, DOI 10.2337/diab.22.11.804; ROTHWELL NJ, 1979, BRIT J NUTR, V41, P625, DOI 10.1079/BJN19790078; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Senn S., 2002, CONFOUNDER CONFUSION, V2nd ed.; Song SH, 2003, ENDOCRINOLOGY, V144, P3399, DOI 10.1210/en.2003-0056; Spieth LE, 2000, ARCH PEDIAT ADOL MED, V154, P947, DOI 10.1001/archpedi.154.9.947; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; TISAVIPAT A, 1974, J APPL PHYSIOL, V37, P699, DOI 10.1152/jappl.1974.37.5.699; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zietz B, 2003, FEBS LETT, V545, P103, DOI 10.1016/S0014-5793(03)00568-4	34	234	240	2	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					778	785		10.1016/S0140-6736(04)16937-7	http://dx.doi.org/10.1016/S0140-6736(04)16937-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337404				2022-12-01	WOS:000223569600029
J	Harfe, BD; Scherz, PJ; Nissim, S; Tian, F; McMahon, AP; Tabin, CJ				Harfe, BD; Scherz, PJ; Nissim, S; Tian, F; McMahon, AP; Tabin, CJ			Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities	CELL			English	Article							DEVELOPING CHICK LIMB; SONIC-HEDGEHOG; RETINOIC ACID; POLARIZING ACTIVITY; SIGNALING ACTIVITY; LOCAL APPLICATION; REPORTER STRAIN; FEEDBACK LOOP; LONG-RANGE; EXPRESSION	The zone of polarizing activity (ZPA) in the posterior limb bud produces Sonic Hedgehog (Shh) protein, which plays a critical role in establishing distinct fates along the anterior-posterior axis. This activity has been modeled as a concentration-dependent response to a diffusible morphogen. Using recombinase base mapping in the mouse, we determine the ultimate fate of the Shh-producing cells. Strikingly, the descendants of the Shh-producing cells encompass all cells in the two most posterior digits and also contribute to the middle digit. Our analysis suggests that, while specification of the anterior digits depends upon differential concentrations of Shh, the length of time of exposure to Shh is critical in the specification of the differences between the most posterior digits. Genetic studies of the effects of limiting accessibility of Shh within the limb support this, model, in which the effect of the Shh morphogen is dictated by a temporal as well as a spatial gradient.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Harvard Univ, Biolabs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB Room 360,77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	McMahon, Andrew P/ABE-7520-2020	Nissim, Sahar/0000-0002-2303-6415	NIAMS NIH HHS [AR08642] Funding Source: Medline; NICHD NIH HHS [HD32443] Funding Source: Medline; NINDS NIH HHS [NS33642] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443, R01HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Goff DJ, 1997, DEVELOPMENT, V124, P627; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HELMS J, 1994, DEVELOPMENT, V120, P3267; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Marigo V, 1996, DEVELOPMENT, V122, P1225; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Park HL, 2000, DEVELOPMENT, V127, P1593; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Saunders J.W., 1967, MAJOR PROBLEMS DEV B, P289; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; TIAN H, 2004, IN PRESS DEVELOPEMEN; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wilkinson DG, 1992, WHOLE MOUNT IN SITU, P75; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393	46	727	739	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					517	528		10.1016/j.cell.2004.07.024	http://dx.doi.org/10.1016/j.cell.2004.07.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315763	Bronze			2022-12-01	WOS:000223650900013
J	Kozar, K; Ciemerych, MA; Rebel, VI; Shigematsu, H; Zagozdon, A; Sicinska, E; Geng, Y; Yu, QY; Bhattacharya, S; Bronson, RT; Akashi, K; Sicinski, P				Kozar, K; Ciemerych, MA; Rebel, VI; Shigematsu, H; Zagozdon, A; Sicinska, E; Geng, Y; Yu, QY; Bhattacharya, S; Bronson, RT; Akashi, K; Sicinski, P			Mouse development and cell proliferation in the absence of D-cyclins	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; CDK INHIBITORS; MICE; PROGRESSION; PROGENITOR; P27(KIP1); BMI-1; PHOSPHORYLATION	D-type cyclins (cyclins D1, D2, and D3 are regarded as essential links between cell environment and the core cell cycle machinery. We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins. We found that these cyclin D1(-/-)D2(-/-)D3(-/-) mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia. Our analyses revealed that the D-cyclin; are critically required for the expansion of hematopoietic stem cells. In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry. We found that the proliferation of cyclin D1(-/-)D2(-/-)D3(-/-) cells is resistant to the inhibition by p16(INK4a), but it critically depends on CDK2. Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation. Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-indeperdent fashion.	Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Tufts University	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA.	peter_sicinski@dfci.harvard.edu	Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Ciemerych, Maria A./0000-0003-0387-4179; Kozar-Kaminska, Katarzyna/0000-0002-2397-2975; Rebel, Vivienne/0000-0002-3862-3903	NCI NIH HHS [CA108420, CA85296] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085296, R01CA108420] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Colucci F, 2000, J IMMUNOL, V164, P5140, DOI 10.4049/jimmunol.164.10.5140; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park M, 1999, DEVELOPMENT, V126, P4849; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	38	514	534	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					477	491		10.1016/j.cell.2004.07.025	http://dx.doi.org/10.1016/j.cell.2004.07.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315760	Bronze			2022-12-01	WOS:000223650900010
J	Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E				Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E			Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHICILLIN-RESISTANT; NASAL CARRIAGE; COMMUNITY; COLONIZATION; INHABITANTS; PREVALENCE; CAVITIES; VACCINE	Context Widespread pneumococcal conjugate vaccination may bring about epidemiologic changes in upper respiratory tract flora of children. Of particular significance may be an interaction between Streptococcus pneumoniae and Staphylococcus aureus, in view of the recent emergence of community-acquired methicillin-resistant S aureus. Objective To examine the prevalence and risk factors of carriage of S pneumoniae and S aureus in the prevaccination era in young children. Design, Setting, and Patients Cross-sectional surveillance study of nasopharyngeal carriage of S pneumoniae and nasal carriage of S aureus by 790 children aged 40 months or younger seen at primary care clinics in central Israel during February 2002. Main Outcome Measures Carriage rates of S pneumoniae (by serotype) and S aureus; risk factors associated with carriage of each pathogen. Results Among 790 children screened, 43% carried S pneumoniae and 10% carried S aureus. Staphylococcus aureus carriage among S pneumoniae carriers was 6.5% vs 12.9% in S pneumoniae noncarriers. Streptococcus pneumoniae carriage among S aureus carriers was 27.5% vs 44.8% in S aureus noncarriers. Only 2.8% carried both pathogens concomitantly vs 4.3% expected dual carriage (P=.03). Risk factors for S pneumoniae carriage (attending day care, having young siblings, and age older than 3 months) were negatively associated with S aureus carriage. Conclusions Streptococcus pneumoniae carriage, specifically of vaccine-type strains, is negatively associated with S aureus carriage in children. The implications of these findings in the pneumococcal vaccine era require further investigation.	Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Soroka Univ, Med Ctr, Beer Sheva, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Regev-Yochay, G (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Ramat Gan, Israel.	gili.regev@sheba.health.gov.il		Regev-Yochay, Gili/0000-0001-7163-4607				Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BERGOVAC J, 1993, EUR J EPIDEMIOL, V9, P405; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Nakamura MM, 2002, PEDIATR INFECT DIS J, V21, P917, DOI 10.1097/00006454-200210000-00006; *NAT COMM CLIN LAB, 2001, PUBL NAT COMM CLIN L; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; POUTREL B, 1980, ANN RECH VET, V11, P327; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Uehara Y, 2001, CLIN INFECT DIS, V32, P1408, DOI 10.1086/320179; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102	19	215	220	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					716	720		10.1001/jama.292.6.716	http://dx.doi.org/10.1001/jama.292.6.716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304469	Bronze			2022-12-01	WOS:000223177300026
J	Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH				Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH			Multiple rare Alleles contribute to low plasma levels of HDL cholesterol	SCIENCE			English	Article							ABCA1 GENE; FAMILIAL HYPOALPHALIPOPROTEINEMIA; EFFLUX; DISEASE; SUSCEPTIBILITY; DEFICIENCY; MUTATIONS; VARIANTS	Heritable variation in complex traits is generally considered to be conferred by common DNA sequence polymorphisms. We tested whether rare DNA sequence variants collectively contribute to variation in plasma levels of high-density lipoprotein cholesterol (HDL-C). We sequenced three candidate genes (ABCA1, APOA1, and LCAT) that cause Mendelian forms of low HDL-C levels in individuals from a population-based study. Nonsynonymous sequence variants were significantly more common (16% versus 2%) in individuals with low HDL-C (<fifth percentile) than in those with high HDL-C (>95th percentile). Similar findings were obtained in an independent population, and biochemical studies indicated that most sequence variants in the low HDL-C group were functionally important. Thus, rare alleles with major phenotypic effects contribute significantly to low plasma HDL-C levels in the general population.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Ottawa, ON K7Y 4W7, Canada	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Ottawa; University of Ottawa Heart Institute	Cohen, JC (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; ymarcel@ottawaheart.ca	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066880, R01HL053917] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53917, UO1-HL66880] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMANN G, 1993, CIRCULATION, V87, P28; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; Hovingh GK, 2003, J LIPID RES, V44, P1251, DOI 10.1194/jlr.M300080-JLR200; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mott S, 2000, ATHEROSCLEROSIS, V152, P457, DOI 10.1016/S0021-9150(99)00498-0; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tregouet DA, 2004, ARTERIOSCL THROM VAS, V24, P775, DOI 10.1161/01.ATV.0000121573.29550.1a; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; [No title captured]	15	838	863	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					869	872		10.1126/science.1099870	http://dx.doi.org/10.1126/science.1099870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297675				2022-12-01	WOS:000223104900050
J	Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D				Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D			Accumulation of Mn(II) in, Deinococcus radiodurans facilitates gamma-radiation resistance	SCIENCE			English	Article							IONIZING-RADIATION; MICROCOCCUS-RADIODURANS; SUPEROXIDE-DISMUTASE; TARGETED MUTAGENESIS; HYDROGEN-PEROXIDE; GENOME SEQUENCE; BACTERIUM; IRON; DNA; RADIORESISTANCE	Deinococcus radiodurans is extremely resistant to ionizing radiation. How this bacterium can grow under chronic gamma radiation [50 grays (Gy) per hour] or recover from acute doses greater than 10 kGy is unknown. We show that D. radiodurans accumulates very high intracellular manganese and low iron levels compared with radiation-sensitive bacteria and that resistance exhibits a concentration-dependent response to manganous chloride [Mn(II)]. Among the most radiation-resistant bacterial groups reported, Deinococcus, Enterococcus, Lactobacillus, and cyanobacteria accumulate Mn(II). in contrast, Shewanella oneidensis and Pseudomonas putida have high iron but low intracellular manganese concentrations and are very sensitive. We propose that Mn(II) accumulation facilitates recovery from radiation injury.	Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; NIH, Bethesda, MD 20894 USA; Pacific NW Natl Lab, Richland, WA 99352 USA; Univ Minnesota, St Paul, MN 55108 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	mdaly@usuhs.mil	Hess, Matthias/B-1783-2012; Matrosova, Vera/AAX-4125-2020; Hess, Matthias/R-3006-2017	Hess, Matthias/0000-0003-0321-0380				ARCHIBALD FS, 1986, INFECT IMMUN, V51, P631, DOI 10.1128/IAI.51.2.631-641.1986; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; HASTINGS JW, 1986, APPL ENVIRON MICROB, V52, P898, DOI 10.1128/AEM.52.4.898-901.1986; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Keren N, 2002, BIOCHEMISTRY-US, V41, P15085, DOI 10.1021/bi026892s; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; OYAIZU H, 1987, INT J SYST BACTERIOL, V37, P62, DOI 10.1099/00207713-37-1-62; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Reelfs O, 2004, J INVEST DERMATOL, V122, P1440, DOI 10.1111/j.0022-202X.2004.22620.x; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; THORNLEY MJ, 1965, ARCH MIKROBIOL, V51, P267, DOI 10.1007/BF00408143; van Gerwen SJC, 1999, J FOOD PROTECT, V62, P1024, DOI 10.4315/0362-028X-62.9.1024; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; WANG P, 1995, CAN J MICROBIOL, V41, P170, DOI 10.1139/m95-023; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	27	458	481	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2004	306	5698					1025	1028		10.1126/science.1103185	http://dx.doi.org/10.1126/science.1103185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15459345				2022-12-01	WOS:000225001100041
J	Reber, M; Burrola, P; Lemke, G				Reber, M; Burrola, P; Lemke, G			A relative signalling model for the formation of a topographic neural map	NATURE			English	Article							RETINAL AXON GUIDANCE; GANGLION-CELL AXONS; VISUAL-SYSTEM; EPH RECEPTORS; IN-VITRO; PROJECTION; KINASE; ELF-1; CONNECTIONS; MODULATION	The highly ordered wiring of retinal ganglion cell (RGC) neurons in the eye to their synaptic targets in the superior colliculus of the midbrain has long served as the dominant experimental system for the analysis of topographic neural maps(1-3). Here we describe a quantitative model for the development of one arm of this map the wiring of the nasal - temporal axis of the retina to the caudal rostral axis of the superior colliculus. The model is based on RGC - RGC competition that is governed by comparisons of EphA receptor signalling intensity, which are made using ratios of, rather than absolute differences in, EphA signalling between RGCs(4). Molecular genetic experiments, exploiting a combinatorial series of EphA receptor knock-in and knockout mice, confirm the salient predictions of the model, and show that it both describes and predicts topographic mapping.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	lemke@salk.edu	Reber, Michael/D-6250-2012	Reber, Michael/0000-0001-8842-7276				Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; SIMON DK, 1992, J NEUROSCI, V12, P1212; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; WALTER J, 1987, DEVELOPMENT, V101, P685; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001	30	95	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					847	853		10.1038/nature02957	http://dx.doi.org/10.1038/nature02957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483613				2022-12-01	WOS:000224435500048
J	Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN				Tu, DC; Batten, ML; Palczewski, K; Van Gelder, RN			Nonvisual photoreception in the chick iris	SCIENCE			English	Article							BLUE-LIGHT PHOTORECEPTORS; PROTEIN-KINASES; SMOOTH-MUSCLE; MICE; CRYPTOCHROMES; PHOTOSENSITIVITY; STAUROSPORINE; CONTRACTION; MELANOPSIN; RESPONSES	The embryonic chicken iris constricts to light ex vivo, but with characteristics atypical of visual phototransduction. The chick iris was most sensitive to short-wavelength light, demonstrating an action spectrum consistent with cryptochrome rather than with opsin pigments. Pupillary responses did not attenuate after saturating light exposure, but showed paradoxical potentiation. Iris photosensitivity was not affected by retinoid depletion or inhibitors of visual phototransduction. Knockdown of cryptochrome expression, but not of melanopsin expression, decreased iris photosensitivity. These data characterize a non-opsin photoreception mechanism in a vertebrate eye and suggest a conserved photoreceptive role for cryptochromes in vertebrates.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	Vangelder@vision.wustl.edu	Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659				Abdel-Latif AA, 2001, EXP BIOL MED, V226, P153, DOI 10.1177/153537020122600302; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown-Sequard E., 1847, CR HEBD ACAD SCI, V25, P482; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; DEGUCHI T, 1981, NATURE, V290, P706, DOI 10.1038/290706a0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Kureishi Y, 1999, EUR J PHARMACOL, V376, P315, DOI 10.1016/S0014-2999(99)00367-2; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; Moriya T, 1996, J EXP ZOOL, V276, P11, DOI 10.1002/(SICI)1097-010X(19960901)276:1<11::AID-JEZ2>3.3.CO;2-N; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pasqualetti M, 2003, EUR J NEUROSCI, V18, P364, DOI 10.1046/j.1460-9568.2003.02770.x; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; TU DC, UNPUB; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200	23	48	49	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					129	131		10.1126/science.1101484	http://dx.doi.org/10.1126/science.1101484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459395				2022-12-01	WOS:000224304000053
J	Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D				Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D			Restricted fetal growth and adverse maternal psychosocial and socioeconomic conditions as risk factors for suicidal behaviour of offspring: a cohort study	LANCET			English	Article							28-YEAR FOLLOW-UP; BODY-MASS INDEX; BIRTH COHORT; PERINATAL COMPLICATIONS; PSYCHIATRIC-DISORDERS; ADOLESCENT SUICIDE; PRENATAL EXPOSURE; EARLY ADULTHOOD; SCHIZOPHRENIA; ASSOCIATION	Background Until now, sparse and contradictory results about an association between adverse neonatal, obstetric, and maternal conditions and heightened suicide risk in adolescents have been reported. The aims of this study were to investigate the relations between fetal growth, obstetric complications, and the mother's psychosocial and socioeconomic situation and the risk in early adulthood of suicide and attempted suicide in the offspring. Methods Obstetric, neonatal, and maternal risk factors for suicide and attempted suicide in 713 370 young adults, born in Sweden between 1973 and 1980, who were followed-up until Dec 31, 1999, were examined by data linkage between Swedish registers. Univariate and multivariate hazard ratios, derived from proportional-hazard models, were estimated. Findings Significantly raised risk of attempted suicide was reported for individuals of short birth length, adjusted for gestational age (hazard ratio 1.29, 95% Cl 1.18-1.41, p < 0.0001); born fourth or more in birth order (1.79, 1.62-1.97, p < 0.0001); born to mothers with a low educational level (1.36, 1.27-1.46, p < 0.0001) (attributable proportion 10.3%); and those who, at time of delivery, had mothers aged 19 years or younger (2.09, 1.89-2.32, p < 0.0001). Significant predictors of suicide were low birthweight, adjusted for gestational age (2.23, 1.43-3.46, p < 0.0001), and teenage motherhood (2.30, 1.64-3.22, p < 0.0001). Interpretation Multiparity and low maternal education predicted suicide attempt, whereas restricted fetal growth and teenage motherhood were associated with both suicide completion and attempt in offspring.	Natl Inst Psychosocial Med, Ctr Suicide Res & Prevent Mental Ill Hlth, Swedish Natl & Stockholm Cty Council, Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet	Wasserman, D (corresponding author), Natl Ctr Suicide Res & Prevent Mental Ill Hlth, Box 230, SE-17177 Stockholm, Sweden.	Danuta.Wasserman@ipm.ki.se		Rasmussen, Finn/0000-0001-7915-7809				Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P20; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; ANDREWS JA, 1992, J AM ACAD CHILD PSY, V31, P655, DOI 10.1097/00004583-199207000-00012; BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203; Bennedsen BE, 1999, BRIT J PSYCHIAT, V175, P239, DOI 10.1192/bjp.175.3.239; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gunther N, 2003, SOC PSYCH PSYCH EPID, V38, P101, DOI 10.1007/s00127-003-0607-6; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Kemppainen L, 2000, SOC PSYCH PSYCH EPID, V35, P104, DOI 10.1007/s001270050191; Kessler RC, 1997, AM J PSYCHIAT, V154, P1405; Lawrence C, 1989, Acta Paediatr Scand Suppl, V350, P55; LEWINSOHN PM, 1994, J CONSULT CLIN PSYCH, V62, P297, DOI 10.1037/0022-006X.62.2.297; Li CI, 2003, PAEDIATR PERINAT EP, V17, P164, DOI 10.1046/j.1365-3016.2003.00487.x; Madge N, 1999, EUR CHILD ADOLES PSY, V8, P283, DOI 10.1007/s007870050103; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Neugebauer R, 1998, ACTA PSYCHIAT SCAND, V97, P412, DOI 10.1111/j.1600-0447.1998.tb10024.x; Nilsson PM, 2001, INT J EPIDEMIOL, V30, P75, DOI 10.1093/ije/30.1.75; Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752; SALK L, 1985, LANCET, V1, P624; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Walker A, 1999, CHILD ADOL PSYCH CL, V8, P845	28	127	128	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1135	1140		10.1016/S0140-6736(04)17099-2	http://dx.doi.org/10.1016/S0140-6736(04)17099-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451220				2022-12-01	WOS:000224102400026
J	Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ				Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ			Avian extinction and mammalian introductions on oceanic islands	SCIENCE			English	Article							PREHISTORIC EXTINCTIONS; PATTERNS; BIRDS	The arrival of humans on oceanic islands has precipitated a wave of extinctions among the islands' native birds. Nevertheless, the magnitude of this extinction event varies markedly between avifaunas. We show that the probability that a bird species has been extirpated from each of 220 oceanic islands is positively correlated with the number of exotic predatory mamma[ species established on those islands after European colonization and that the effect of these predators is greater on island endemic species. In contrast, the proportions of currently threatened species are independent of the numbers of exotic mammalian predator species, suggesting that the principal threat to island birds has changed through time as species susceptible to exotic predators have been driven extinct.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Lincoln Univ, Bioprotect & Ecol Div, Lincoln, New Zealand; Landcare Res, Lincoln, New Zealand; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	University of Birmingham; Lincoln University - New Zealand; Landcare Research - New Zealand; University of Sheffield	Blackburn, TM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	t.blackburn@bham.ac.uk	Duncan, Richard P/E-7899-2013; Blackburn, Tim/AAC-3144-2019; Bond, Alexander L/A-3786-2010; Blackburn, Tim M/A-7685-2011; Duncan, Richard/ABD-4099-2020	Duncan, Richard P/0000-0003-2295-449X; Blackburn, Tim/0000-0003-0152-2663; Duncan, Richard/0000-0003-2295-449X; Cassey, Phillip/0000-0002-2626-0172				Ashmole NP, 1994, SEABIRDS ISLANDS THR, P94; Atkinson I., 2000, INVASIVE SPECIES PAC, P19; Atkinson I.A.E., 1985, CONSERVATION ISLAND, V3rd ed, pp., P35; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Biber E, 2002, ECOGRAPHY, V25, P661, DOI 10.1034/j.1600-0587.2002.t01-1-250603.x; Blackburn TM, 2004, ECOGRAPHY, V27, P124, DOI 10.1111/j.0906-7590.2004.03775.x; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Cassels R., 1984, P741; Curnutt J, 2001, STUD AVIAN BIOL-SER, P15; Diamond J.M., 1984, P824; Diamond J.M., 1984, P191; DIAMOND JM, 1989, PHILOS T ROY SOC B, V325, P469, DOI 10.1098/rstb.1989.0100; FLANNERTY TF, 1994, FUTURE EATERS; GASTON KJ, 2002, ENCY EVOLUTION, V1, P344; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Holdaway Richard N., 1999, P189; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; *LYNX ED BIRDLIFE, 2000, THREAT BIRDS WORLD; MAC ARTHUR ROBERT H., 1967; MacPhee R.D.E., 1999, EXTINCTIONS NEAR TIM; Martin P.S., 1984, P354; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; Martin P. S., 1984, QUATERNARY EXTINCTIO; MARTIN PS, 2001, ENCY BIODIVERSITY, V3, P825; MILBERG P, 1993, ECOGRAPHY, V16, P229, DOI 10.1111/j.1600-0587.1993.tb00213.x; Pimm Stuart L., 1995, P75; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Roff DA, 2003, EVOL ECOL RES, V5, P759; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857	32	559	589	4	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1955	1958		10.1126/science.1101617	http://dx.doi.org/10.1126/science.1101617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448269				2022-12-01	WOS:000224136000046
J	Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F				Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F			Physical activity, including walking, and cognitive function in older women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; IMPAIRMENT; EXERCISE; COMMUNITY; DEMENTIA; HEALTH; AGE; MACARTHUR; DECLINE; POPULATION	Context Physical activity may help maintain cognitive function in older adults. Objective To examine the relation of long-term regular physical activity, including walking, to cognitive function, Design Women reported participation in leisure-time physical activities on biennial mailed questionnaires beginning in 1986. We assessed long-term activity by averaging energy expenditures from questionnaires in 1986 through participants' baseline cognitive assessments (1995 to 2001). We used linear regression to estimate adjusted mean differences in baseline cognitive performance and cognitive decline over 2 years, across levels of physical activity and walking. Setting and Participants Nurses' Health Study, including 18766 US women aged 70 to 81 years. Main Outcome Measure Validated telephone assessments of cognition administered twice approximately 2 years apart (1995 to 2001 and 1997 to 2003), including tests of general cognition, verbal memory, category fluency, and attention. Results Higher levels of activity were associated with better cognitive performance. On a global score combining results of all 6 tests, women in the second through fifth quintiles of energy expenditure scored an average of 0.06, 0.06, 0.09, and 0.10 Standard units higher than women in the lowest quintile (P for trend <.001). Compared with women in the lowest physical activity quintile, we found a 20% lower risk of cognitive impairment for women in the highest quintile of activity. Among women performing the equivalent of walking at an easy pace for at least 1.5 h/wk, mean global scores were 0.06 to 0.07 units higher compared with walking less than 40 min/wk (P <=.003). We also observed less cognitive decline among women who were more active, especially those in the 2 highest quintiles of energy expenditure. Women in the fourth and fifth quintiles had mean changes in global scores that were 0.04 (95% confidence interval, 0.02-0.10) and 0.06 (95% confidence interval, 0.02-0.11) standard units better than those in the lowest quintile. Conclusion Long-term regular physical activity, including walking, is associated with significantly better cognitive function and less cognitive decline in older women.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC	Weuve, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr,East Wing,3rd Floor,401 Pk Dr, Boston, MA 02215 USA.	jweuve@hsph.harvard.edu	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015424] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIA NIH HHS [AG000158, AG15424] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; [Anonymous], 1996, PHYS ACT HLTH REP SU, P175; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Carmelli D, 1997, NEUROEPIDEMIOLOGY, V16, P285, DOI 10.1159/000109699; Chandra V, 1998, J GERIATR PSYCH NEUR, V11, P11, DOI 10.1177/089198879801100104; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; CLARKSONSMITH L, 1990, PSYCHOL AGING, V5, P437; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; EMERY CF, 1995, GERONTOLOGIST, V35, P378, DOI 10.1093/geront/35.3.378; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GANGULI M, 1993, J GERONTOL, V48, pM152, DOI 10.1093/geronj/48.4.M152; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Goodglass H, 1983, ASSESSMENT APHASIA; Ho SC, 2001, INT J EPIDEMIOL, V30, P1389, DOI 10.1093/ije/30.6.1389; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lezak M., 1995, NEUROPSYCHOLOGICAL A, P335; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; U.S. Bureau of the Census, 1996, CURR POP REP SPEC ST, P23; van Dam RM, 2002, MED SCI SPORT EXER, V34, P1132, DOI 10.1097/00005768-200207000-00013; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604	47	765	790	0	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1454	1461		10.1001/jama.292.12.1454	http://dx.doi.org/10.1001/jama.292.12.1454			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	856FT	15383516	Bronze			2022-12-01	WOS:000224031800027
J	Harling, R; Hayward, A; Watson, JM				Harling, R; Hayward, A; Watson, JM			Implications of the incidence of influenza-like illness in nursing homes for influenza chemoprophylaxis: descriptive study	BRITISH MEDICAL JOURNAL			English	Article									UCL, Royal Free Hosp, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Dept Resp Dis, London NW9 5EQ, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency	Harling, R (corresponding author), UCL, Royal Free Hosp, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England.	r.harling@pcps.ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232				Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Department of Health, 2002, RES CAR NURS HOM SEC; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; *HLTH PROT AG, HPA NAT SURV INFL WE; *NAT I CLIN EXC, 2003, TECHN APPR GUID, V67	5	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2004	329	7467					663	664		10.1136/bmj.38204.674595.AE	http://dx.doi.org/10.1136/bmj.38204.674595.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15333451	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000224042300022
J	Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D				Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D			Zooming in on a quantitative trait for tomato yield using interspecific introgressions	SCIENCE			English	Article							BACKCROSS QTL ANALYSIS; GENETIC ARCHITECTURE; SUGAR CONTENT; INVERTASE; IDENTIFICATION; DISSECTION; PENNELLII; GENOMICS; LEVEL; CROSS	To explore natural biodiversity we developed and examined introgression lines (ILs) containing chromosome segments of wild species (Solanum pennellii) in the background of the cultivated tomato (S. lycopersicum). We identified Brix9-2-5, which is a S. pennellii quantitative trait locus (QTL) that increases sugar yield of tomatoes and was mapped within a flower- and fruit-specific invertase (LIN5). QTL analysis representing five different tomato species delimited the functional polymorphism of Brix-9-2-5 to an amino acid near the catalytic site of the invertase crystal, affecting enzyme kinetics and fruit sink strength. These results underline the power of diverse ILs for high-resolution perspectives on complex phenotypes.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Hebrew University of Jerusalem; Max Planck Society	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	zamir@agri.huji.ac.il		Fridman, Eyal/0000-0003-1275-7791				Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Bernacchi D, 1998, THEOR APPL GENET, V97, P170, DOI 10.1007/s001220050882; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2004, THEOR APPL GENET, V108, P485, DOI 10.1007/s00122-003-1422-x; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fridman E, 2003, PLANT PHYSIOL, V131, P603, DOI 10.1104/pp.014431; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Fulton TM, 2000, THEOR APPL GENET, V100, P1025, DOI 10.1007/s001220051384; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; GOZALBO D, 1990, CURR GENET, V17, P77, DOI 10.1007/BF00313252; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Gur A, 2004, TRENDS PLANT SCI, V9, P107, DOI 10.1016/j.tplants.2004.01.003; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stam LF, 1996, GENETICS, V144, P1559; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	27	360	397	10	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1786	1789		10.1126/science.1101666	http://dx.doi.org/10.1126/science.1101666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375271				2022-12-01	WOS:000224039500045
J	Bahatyrova, S; Frese, RN; Siebert, CA; Olsen, JD; van der Werf, KO; van Grondelle, R; Niederman, RA; Bullough, PA; Otto, C; Hunter, CN				Bahatyrova, S; Frese, RN; Siebert, CA; Olsen, JD; van der Werf, KO; van Grondelle, R; Niederman, RA; Bullough, PA; Otto, C; Hunter, CN			The native architecture of a photosynthetic membrane	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; ATOMIC-FORCE MICROSCOPY; RHODOBACTER-SPHAEROIDES; CORE COMPLEX; RHODOPSEUDOMONAS-SPHAEROIDES; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PROTEIN SUBUNITS; ANTENNA COMPLEX	In photosynthesis, the harvesting of solar energy and its subsequent conversion into a stable charge separation are dependent upon an interconnected macromolecular network of membrane-associated chlorophyll-protein complexes. Although the detailed structure of each complex has been determined(1-4), the size and organization of this network are unknown. Here we show the use of atomic force microscopy to directly reveal a native bacterial photosynthetic membrane. This first view of any multi-component membrane shows the relative positions and associations of the photosynthetic complexes and reveals crucial new features of the organization of the network: we found that the membrane is divided into specialized domains each with a different network organization and in which one type of complex predominates. Two types of organization were found for the peripheral light-harvesting LH2 complex. In the first, groups of 10-20 molecules of LH2 form light-capture domains that interconnect linear arrays of dimers of core reaction centre (RC)-light-harvesting 1 (RC-LH1-PufX) complexes; in the second they were found outside these arrays in larger clusters. The LH1 complex is ideally positioned to function as an energy collection hub, temporarily storing it before transfer to the RC where photochemistry occurs: the elegant economy of the photosynthetic membrane is demonstrated by the close packing of these linear arrays, which are often only separated by narrow 'energy conduits' of LH2 just two or three complexes wide.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Twente, Biophys Tech Grp, Dept Sci & Technol, BMTI,MESA, NL-7500 AE Enschede, Netherlands; Vrije Univ Amsterdam, Fac Sci, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; Rutgers State University New Brunswick; University of Twente; Vrije Universiteit Amsterdam	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@shef.ac.uk	Otto, Cees/H-8421-2019	Siebert, charles/0000-0002-8126-1979; Bullough, Per/0000-0001-8147-1127; frese, raoul/0000-0001-8243-9954				AAGAARD J, 1972, PHOTOCHEM PHOTOBIOL, V15, P209, DOI 10.1111/j.1751-1097.1972.tb06240.x; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; BEEKMAN LMP, 1994, BIOCHEMISTRY-US, V33, P3143, DOI 10.1021/bi00177a001; BERRY EA, IN PRESS PHOTOSYN RE; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Feniouk BA, 2002, BIOPHYS J, V82, P1115, DOI 10.1016/S0006-3495(02)75470-2; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797; Hess S, 1995, P NATL ACAD SCI USA, V92, P12333, DOI 10.1073/pnas.92.26.12333; HUNTER CN, 1985, BIOCHIM BIOPHYS ACTA, V807, P44, DOI 10.1016/0005-2728(85)90051-9; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MONGER TG, 1977, BIOCHIM BIOPHYS ACTA, V460, P393, DOI 10.1016/0005-2728(77)90080-9; Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7; NIEDERMAN RA, 1979, BIOCHIM BIOPHYS ACTA, V555, P210, DOI 10.1016/0005-2736(79)90161-5; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Sturgis JN, 1996, ARCH MICROBIOL, V165, P235, DOI 10.1007/s002030050321; VANDERWERF KO, 1993, REV SCI INSTRUM, V64, P2892, DOI 10.1063/1.1144378; VISSCHER KJ, 1989, PHOTOSYNTH RES, V22, P211, DOI 10.1007/BF00048300; VOS M, 1988, BIOCHIM BIOPHYS ACTA, V933, P132, DOI 10.1016/0005-2728(88)90063-1; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050	28	382	400	3	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1058	1062		10.1038/nature02823	http://dx.doi.org/10.1038/nature02823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329728	Green Accepted			2022-12-01	WOS:000223514900050
J	Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR				Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR			DNA-functionalized nanotube membranes with single-base mismatch selectivity	SCIENCE			English	Article							TRANSPORT	We describe synthetic membranes in which the molecular recognition chemistry used to accomplish selective permeation is DNA hybridization. These membranes contain template-synthesized gold nanotubes with inside diameters of 12 nanometers, and a "transporter" DNA-hairpin molecule is attached to the inside walls of these nanotubes. These DNA-functionalized nanotube membranes selectively recognize and transport the DNA strand that is complementary to the transporter strand, relative to DNA strands that are not complementary to the transporter. Under optimal conditions, single-base mismatch transport selectivity can be obtained.	Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res Bionano Interface, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	crmartin@chern.ufl.edu	Tan, Weihong/AAA-4536-2020; Martin, Charles/AAA-1040-2019					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Hill, 2001, ION CHANNELS EXCITAB, P441; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961; Martin CR, 2001, J PHYS CHEM B, V105, P1925, DOI 10.1021/jp003486e; MULDER M, 1996, BASIC PRINCIPLES MEM, P342; OSADA Y, 1992, MEMBRANE SCI TECHNOL, P377	15	282	293	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					984	986		10.1126/science.1100024	http://dx.doi.org/10.1126/science.1100024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310896				2022-12-01	WOS:000223250700041
J	Somorjai, GA				Somorjai, GA			On the move	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Somorjai, GA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Anderson, David G/E-6125-2014	Anderson, David G/0000-0002-9624-5867				Somorjai G.A., 2010, INTRO SURFACE CHEM C; Thomas J.M., 1996, PRINCIPLES PRACTICE; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158	3	33	33	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					730	730		10.1038/430730a	http://dx.doi.org/10.1038/430730a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306789				2022-12-01	WOS:000223233600022
J	Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM				Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM			Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-SAVING STRATEGY; URINE SPECIMENS; AZITHROMYCIN; INFECTION; DISEASE; NEPAL; BLINDNESS; PROGRAMS; AREAS; PCR	Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported. Objective To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community. Design, Setting, and Participants Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment. Interventions All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment. Main Outcome Measures Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination. Results The prevalence of. infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% Cl, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% Cl, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% Cl, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection. Conclusion The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.	Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, San Francisco, CA 94143 USA; ORBIS Int, Addis Ababa, Ethiopia; Univ Calif San Francisco, Inst Global Hlth, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, Room 307,95 Kirkhan St, San Francisco, CA 94143 USA.	tml@itsa.ucsf.edu		Chidambaram, Jaya/0000-0001-5438-2858	NIAID NIH HHS [R01 AI48789, R21 AI055752] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048789, R21AI055752] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Farid M. A., 1980, World Health Forum, V1, P8; FRIEDERICH R, 1982, ANN OPHTHALMOL, V14, P38; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Kacena KA, 1998, J CLIN MICROBIOL, V36, P481, DOI 10.1128/JCM.36.2.481-485.1998; KATZ J, 1993, INT J EPIDEMIOL, V22, P709, DOI 10.1093/ije/22.4.709; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; McOrist S, 2000, TRENDS MICROBIOL, V8, P483, DOI 10.1016/S0966-842X(00)01854-0; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; Murray D.M., 1998, DESIGN ANAL GROUP RA; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Saltelli A., 2000, SENSITIVITY ANAL; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TAYLOR HR, 1990, SCIENCE, V250, P116, DOI 10.1126/science.2218502; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; World Health Organization, 1997, 1 M WHO ALL GLOB EL	27	97	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					721	725		10.1001/jama.292.6.721	http://dx.doi.org/10.1001/jama.292.6.721			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304470	Green Accepted, Bronze			2022-12-01	WOS:000223177300027
J	Raoult, D; Audic, S; Robert, C; Abergel, C; Renesto, P; Ogata, H; La Scola, B; Suzan, M; Claverie, JM				Raoult, D; Audic, S; Robert, C; Abergel, C; Renesto, P; Ogata, H; La Scola, B; Suzan, M; Claverie, JM			The 1.2-megabase genome sequence of mimivirus	SCIENCE			English	Article							ORIGIN; EVOLUTION; PROTEIN; FAMILIES; DATABASE; VIRUSES	We recently reported the discovery and preliminary characterization of Mimivirus, the largest known virus, with a 400-nanometer particle size comparable to mycoplasma. Mimivirus is a double-stranded DNA virus growing in amoebae. We now present its 1,181,404-base pair genome sequence, consisting of 1262 putative open reading frames, 10% of which exhibit a similarity to proteins of known functions. In addition to exceptional genome size, Mimivirus exhibits many features that distinguish it from other nucleocytoplasmic large DNA viruses. The most unexpected is the presence of numerous genes encoding central protein-translation components, including four amino-acyl transfer RNA synthetases, peptide release factor 1, translation elongation factor EF-TU, and translation initiation factor 1. The genome also exhibits six tRNAs. Other notable features include the presence of both type I and type II topoisomerases, components of all DNA repair pathways, many polysaccharide synthesis enzymes, and one intein-containing gene. The size and complexity of the Mimivirus genome challenge the established frontier between viruses and parasitic cellular organisms. This new sequence data might help shed a new light on the origin of DNA viruses and their role in the early evolution of eukaryotes.	Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille 05, France; Inst Biol Struct & Microbiol, CNRS, UPR 2589, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Raoult, D (corresponding author), Univ Mediterranee, CNRS, UMR 6020, Unite Rickettsies, F-13385 Marseille 05, France.	Didier.Raoult@medecine.univ-mrs.fr; Jean-Michel.Claverie@igs.cnrs-mrs.fr	renesto, patricia/T-6446-2019; Renesto, patricia/M-6105-2014; Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019; RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	renesto, patricia/0000-0002-6749-7862; Claverie, Jean-Michel/0000-0003-1424-0315; RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Audic, Stephane/0000-0001-6193-4374; Abergel, Chantal/0000-0003-1875-4049				ABERGEL C, UNPUB; Afonso CL, 1999, J VIROL, V73, P533, DOI 10.1128/JVI.73.1.533-552.1999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bell PJL, 2001, J MOL EVOL, V53, P251; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Forterre P, 2001, CR ACAD SCI III-VIE, V324, P1067, DOI 10.1016/S0764-4469(01)01403-2; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kawasaki T, 2002, VIROLOGY, V302, P123, DOI 10.1006/viro.2002.1572; La Scola B, 2003, SCIENCE, V299, P2033; Lazarevic V, 1998, P NATL ACAD SCI USA, V95, P1692, DOI 10.1073/pnas.95.4.1692; LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mindell DP, 2003, SCIENCE, V302, P1677; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; OGATA H, UNPUB; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pennisi E, 2004, SCIENCE, V305, P766, DOI 10.1126/science.305.5685.766; Pietrokovski S, 1998, CURR BIOL, V8, pR634, DOI 10.1016/S0960-9822(07)00409-5; Pietrokovski S, 2001, TRENDS GENET, V17, P465, DOI 10.1016/S0168-9525(01)02365-4; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Takemura M, 2001, J MOL EVOL, V52, P419, DOI 10.1007/s002390010171; TARNAS I, 2002, SCIENCE, V296, P2376; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; Villarreal LP, 2000, J VIROL, V74, P7079, DOI 10.1128/JVI.74.15.7079-7084.2000; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; YAMADA T, 1993, VIROLOGY, V197, P742, DOI 10.1006/viro.1993.1650; Zillig W, 1998, EXTREMOPHILES, V2, P131, DOI 10.1007/s007920050052	36	709	1655	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1344	1350		10.1126/science.1101485	http://dx.doi.org/10.1126/science.1101485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15486256				2022-12-01	WOS:000225301600043
J	Donnez, J; Dolmans, MM; Demylle, D; Jadoul, P; Pirard, C; Squifflet, J; Martinez-Madrid, B; Van Langendonckt, A				Donnez, J; Dolmans, MM; Demylle, D; Jadoul, P; Pirard, C; Squifflet, J; Martinez-Madrid, B; Van Langendonckt, A			Livebirth after orthotopic transplantation of cryopreserved ovarian tissue	LANCET			English	Article							CHILDHOOD-CANCER; CORTICAL STRIPS; FERTILITY; AUTOGRAFTS; FROZEN; SHEEP; LYMPHOMA; FRESH; RESTORATION; SURVIVORS	Background The lifesaving treatment endured by cancer patients leads, in many women, to early menopause and subsequent infertility. In clinical situations for which chemotherapy needs to be started, ovarian tissue cryopreservation looks to be a promising option to restore fertility. In 1997, biopsy samples of ovarian cortex were taken from a woman with stage IV Hodgkin's lymphoma and cryopreserved before chemotherapy was initiated. After her cancer treatment, the patient had premature ovarian failure. Methods In 2003, after freeze-thawing, orthotopic autotransplantation of ovarian cortical tissue was done by laparoscopy. Findings 5 months after reimplantation, basal body temperature, menstrual cycles, vaginal ultrasonography, and hormone concentrations indicated recovery of regular ovulatory cycles. Laparoscopy at 5 months confirmed the ultrasonographic data and showed the presence of a follicle at the site of reimplantation, clearly situated outside the ovaries, both of which appeared atrophic. From 5 to 9 months, the patient had menstrual bleeding and development of a follicle or corpus luteum with every cycle. 11 months after reimplantation, human chorionic gonadotrophin concentrations and vaginal echography confirmed a viable intrauterine pregnancy, which has resulted in a livebirth. Interpretation We have described a livebirth after orthotopic autotransplantation of cryopreserved ovarian tissue. Our findings suggest that cryopreservation of ovarian tissue should be offered to all young women diagnosed with cancer.	Univ Catholique Louvain, Clin Univ St Luc, Dept Gynaecol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Gynaecol Res Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Donnez, J (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Gynaecol, Ave Hippocrate 10, B-1200 Brussels, Belgium.	donnez@gyne.ud.ac.be	Dolmans, Marie-Madeleine/AAI-7167-2020; Martinez-Madrid, Belen/K-7493-2017	Martinez-Madrid, Belen/0000-0001-6852-4597				Aubard Y, 1999, HUM REPROD, V14, P2149, DOI 10.1093/humrep/14.8.2149; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; Callejo J, 2001, J CLIN ENDOCR METAB, V86, P4489, DOI 10.1210/jc.86.9.4489; Campbell BK, 2000, MOL CELL ENDOCRINOL, V163, P131, DOI 10.1016/S0303-7207(00)00217-3; CANDY CJ, 1995, HUM REPROD, V10, P2334; Candy CJ, 2000, HUM REPROD, V15, P1300, DOI 10.1093/humrep/15.6.1300; Cortvrindt RG, 2001, FERTIL STERIL, V75, P588, DOI 10.1016/S0015-0282(00)01754-4; Donnez J, 1998, HUM REPROD UPDATE, V4, P248, DOI 10.1093/humupd/4.3.248; Donnez J, 2000, CURR OPIN OBSTET GYN, V12, P1, DOI 10.1097/00001703-200002000-00001; Galant C, 2004, AM J PATHOL, V165, P83, DOI 10.1016/S0002-9440(10)63277-4; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Kim SS, 2001, HUM REPROD, V16, P2056, DOI 10.1093/humrep/16.10.2056; Kim SS, 2003, HUM REPROD, V18, P1759, DOI 10.1093/humrep/deg381; Kim SS, 2001, FERTIL STERIL, V75, P1049, DOI 10.1016/S0015-0282(01)01790-3; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Lee DM, 2004, NATURE, V428, P137, DOI 10.1038/428137a; Meirow D, 1999, FERTIL STERIL, V71, P948, DOI 10.1016/S0015-0282(99)00067-9; Meirow D, 1998, FERTIL STERIL, V69, P996; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Oktay K, 2001, JAMA-J AM MED ASSOC, V286, P1490, DOI 10.1001/jama.286.12.1490; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Rao GD, 2004, LANCET, V363, P1829, DOI 10.1016/S0140-6736(04)16320-4; Shaw JM, 1996, HUM REPROD, V11, P1668	27	1101	1194	3	65	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1405	1410		10.1016/S0140-6736(04)17222-X	http://dx.doi.org/10.1016/S0140-6736(04)17222-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488215				2022-12-01	WOS:000224485300026
J	Forde, SE; Thompson, JN; Bohannan, BJM				Forde, SE; Thompson, JN; Bohannan, BJM			Adaptation varies through space and time in a coevolving host-parasitoid interaction	NATURE			English	Article							LOCAL ADAPTATION; ANTAGONISTIC COEVOLUTION; RESOURCE ENRICHMENT; GENE FLOW; MODEL; COMMUNITY; BACTERIA; PRODUCTIVITY; POPULATIONS; SELECTION	One of the central challenges of evolutionary biology is to understand how coevolution organizes biodiversity over complex geographic landscapes. Most species are collections of genetically differentiated populations, and these populations have the potential to become adapted to their local environments in different ways. The geographic mosaic theory of coevolution incorporates this idea by proposing that spatial variation in natural selection and gene flow across a landscape can shape local coevolutionary dynamics(1-7). These effects may be particularly strong when populations differ across productivity gradients, where gene flow will often be asymmetric among populations(8). Conclusive empirical tests of this theory have been particularly difficult to perform because they require knowledge of patterns of gene flow, historical population relationships and local selection pressures(2). We have tested these predictions empirically using a model community of bacteria and bacteriophage ( viral parasitoids of bacteria). We show that gene flow across a spatially structured landscape alters coevolution of parasitoids and their hosts and that the resulting patterns of adaptation can fluctuate in both space and time.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University	Forde, SE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	forde@biology.ucsc.edu	Bohannan, Brendan J. M./R-1582-2017; Thompson, Jessica/GXW-0323-2022	Bohannan, Brendan J. M./0000-0003-2907-1016; 				Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brodie ED, 2002, EVOLUTION, V56, P2067; Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Futuyma D.J., 1998, EVOL BIOL; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Nuismer SL, 1999, P ROY SOC B-BIOL SCI, V266, P605, DOI 10.1098/rspb.1999.0679; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SHRAG SJ, 1996, AM NAT, V148, P348; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Thompson J.N., 1994, COEVOLUTIONARY PROCE; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	25	159	162	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					841	844		10.1038/nature02906	http://dx.doi.org/10.1038/nature02906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483611				2022-12-01	WOS:000224435500046
J	Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ				Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ			A single population of olfactory sensory neurons mediates an innate avoidance behaviour in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MUSHROOM BODIES; MANDUCA-SEXTA; CENTRAL PROJECTIONS; SPHINX MOTH; MELANOGASTER; LEPIDOPTERA; ATTRACTION; RESPONSES; MOSQUITOS	All animals exhibit innate behaviours in response to specific sensory stimuli that are likely to result from the activation of developmentally programmed neural circuits. Here we observe that Drosophila exhibit robust avoidance to odours released by stressed flies. Gas chromatography and mass spectrometry identifies one component of this 'Drosophila stress odorant (dSO)' as CO2. CO2 elicits avoidance behaviour, at levels as low as 0.1%. We used two-photon imaging with the Ca2+-sensitive fluorescent protein G-CaMP to map the primary sensory neurons governing avoidance to CO2. CO2 activates only a single glomerulus in the antennal lobe, the V glomerulus; moreover, this glomerulus is not activated by any of 26 other odorants tested. Inhibition of synaptic transmission in sensory neurons that innervate the V glomerulus, using a temperature-sensitive Shibire gene (Shi(ts))(1), blocks the avoidance response to CO2. Inhibition of synaptic release in the vast majority of other olfactory receptor neurons has no effect on this behaviour. These data demonstrate that the activation of a single population of sensory neurons innervating one glomerulus is responsible for an innate avoidance behaviour in Drosophila.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 216 76 & 156 29, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Columbia University	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Wang, Jing W/C-3885-2008; Simon, Anne/J-9199-2015	Wang, Jing W/0000-0001-6291-5802; Simon, Anne/0000-0002-6509-4541; Suh, Greg/0000-0003-4381-658X; Axel, Richard/0000-0002-3141-4076				Anton S, 1996, CIBA F SYMP, V200, P184; ANTON S, 1996, CIBA F SYMP, V200, P226; ANTON S, 1996, CIBA F SYMP, V200, P192; Beck CDO, 2000, J NEUROSCI, V20, P2944; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; CHRISTENSEN TA, 1995, CHEM SENSES, V20, P313, DOI 10.1093/chemse/20.3.313; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Distler PG, 1997, J EXP BIOL, V200, P1873; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Enserink M, 2002, SCIENCE, V298, P90, DOI 10.1126/science.298.5591.90; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; KENT KS, 1986, CELL TISSUE RES, V245, P237; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Stange G., 1996, Advances in Bioclimatology, V4, P223; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	32	390	394	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					854	859		10.1038/nature02980	http://dx.doi.org/10.1038/nature02980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15372051				2022-12-01	WOS:000224435500049
J	Molassiotis, A				Molassiotis, A			The prince and the professor - With respect, Professor Baum, you've got it wrong	BRITISH MEDICAL JOURNAL			English	Letter									Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England	University of Manchester	Molassiotis, A (corresponding author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England.	alex.molassiotis@man.ac.uk		Molassiotis, Alex/0000-0001-6351-9991				Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; BRIGHTHOPE I, DO YOU TRUST ORTHODO	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858-a	http://dx.doi.org/10.1136/bmj.329.7470.858-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472282	Green Published			2022-12-01	WOS:000224472800040
J	Kaplan, AE				Kaplan, AE			The long and the short of it...	NATURE			English	Editorial Material									Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Kaplan, AE (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.		Kaplan, Alexander E/A-8132-2009	Kaplan, Alexander E/0000-0002-8094-5332				Greene Brian, 2003, ELEGANT UNIVERSE; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Kaplan AE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.074801; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Zewail AH, 2001, NATURE, V412, P279, DOI 10.1038/35085661	5	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					633	633		10.1038/431633a	http://dx.doi.org/10.1038/431633a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470407	Bronze			2022-12-01	WOS:000224299300021
J	Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL				Tsai, CJ; Leitzmann, MF; Willett, WC; Giovannucci, EL			The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men - A prospective cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-FAT; CHOLESTEROL CHOLELITHIASIS; GALLBLADDER-DISEASE; INSULIN-RESISTANCE; LIPIDS; ACIDS; PREVALENCE; HAMSTERS; QUESTIONNAIRE; POPULATION	Background: Monounsaturated and polyunsaturated fats act as inhibitors of cholesterol cholelithiasis in animal experiments. Objective: To examine the association between long-term intake of cis unsaturated fats and the incidence of gallstone disease in humans. Design: Prospective population-based cohort study. Setting: The Health Professional Follow-up Study. Participants: 45 756 men, age 40 to 75 years in 1986, who were free of gallstone disease. Measurements: Consumption of cis unsaturated fats was assessed starting in 1986 as part of the 131-item semi-quantitative food-frequency questionnaires. Questionnaires were mailed to participants every 2 years. The main outcome measure was self-reported newly diagnosed symptomatic gallstone disease. Results: During 14 years of follow-up, 2323 new cases of gallstone disease were documented. After adjustment for age and other potential risk factors, the relative risk for gallstone disease among men in the highest quintile of dietary intake of cis unsaturated fats compared with men in the lowest quintile was 0.82 (95% Cl, 0.69 to 0.96; P for trend = 0.006). The relative risk among men in the highest quintile of polyunsaturated fat consumption compared with men in the lowest quintile was 0.84 (Cl, 0.73 to 0.96; P for trend = 0.01), and the relative risk among men in the highest quintile of monounsaturated fat consumption compared with men in the lowest quintile was 0.83 (Cl, 0.70 to 1.00; P for trend = 0.01). Limitations: Outcomes were restricted to men with cholecystectomy or diagnostically confirmed but unremoved symptomatic gallstones. Conclusions: A high intake of polyunsaturated and monounsaturated fats in the context of an energy-balanced diet is associated with a reduced risk for gallstone disease in men.	Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Tsai, CJ (corresponding author), Univ Kentucky, Med Ctr, Div Digest Dis & Nutr, 800 Rose St,MN649, Lexington, KY 40536 USA.	hpcjt@channing.harvard.edu			NCI NIH HHS [CA55075] Funding Source: Medline; NIDDK NIH HHS [DK46200] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ayyad N, 1996, LIPIDS, V31, P721, DOI 10.1007/BF02522888; CHAIT A, 1979, J CLIN INVEST, V64, P1309, DOI 10.1172/JCI109587; CLANDININ MT, 1993, ANN NY ACAD SCI, V683, P151, DOI 10.1111/j.1749-6632.1993.tb35701.x; COHEN BI, 1992, LIPIDS, V27, P526, DOI 10.1007/BF02536135; Cox DR., 1984, ANAL SURVIVAL DATA; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Diehl AK, 2000, HEPATOLOGY, V31, P528, DOI 10.1002/hep.510310238; DIEHL AK, 1989, GASTROENTEROLOGY, V97, P1527, DOI 10.1016/0016-5085(89)90399-5; Dowling RH, 2000, ALIMENT PHARM THER, V14, P39, DOI 10.1046/j.1365-2036.2000.014s2039.x; Dubrac S, 2001, J HEPATOL, V35, P550, DOI 10.1016/S0168-8278(01)00180-5; Eritsland J, 2000, AM J CLIN NUTR, V71, p197S, DOI 10.1093/ajcn/71.1.197S; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Flanders W D, 1990, Epidemiology, V1, P239, DOI 10.1097/00001648-199005000-00010; GILAT T, 1985, AM J CLIN NUTR, V41, P336, DOI 10.1093/ajcn/41.2.336; HAY DW, 1990, HEPATOLOGY, V12, pS6; HAYES KC, 1992, ANNU REV NUTR, V12, P299, DOI 10.1146/annurev.nu.12.070192.001503; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S; JONNALAGADDA SS, 1995, LIPIDS, V30, P415, DOI 10.1007/BF02536299; JORGENSEN T, 1989, SCAND J GASTROENTERO, V24, P821, DOI 10.3109/00365528909089221; JORGENSEN T, 1989, HEPATOLOGY, V9, P856, DOI 10.1002/hep.1840090611; LINOS AD, 1989, HPB SURG, V18, P221; Lovejoy J C, 1999, Curr Atheroscler Rep, V1, P215, DOI 10.1007/s11883-999-0035-5; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; MIETTINEN M, 1976, ANN CLIN RES, V8, P111; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Moerman Clara J., 1994, Annals of Epidemiology, V4, P248, DOI 10.1016/1047-2797(94)90104-X; *NAT HOSP DISCH SU, 2000, ADV DAT VIT HLTH STA; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V160, P387, DOI 10.1016/0003-9861(74)90412-3; Oliver MF, 1997, AM J CLIN NUTR, V66, P980; Ortega RM, 1997, J AM COLL NUTR, V16, P88, DOI 10.1080/07315724.1997.10718655; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rivellese AA, 2002, ANN NY ACAD SCI, V967, P329; Rose DP, 1997, AM J CLIN NUTR, V66, P998; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SCOBEY MW, 1991, HEPATOLOGY, V14, P679, DOI 10.1002/hep.1840140417; SHIFFMAN ML, 1993, GASTROENTEROLOGY, V105, P1200, DOI 10.1016/0016-5085(93)90968-I; *USDA, 1998, AGR HDB USDA, V8; Willett W, 2001, AM J EPIDEMIOL, V154, P1107, DOI 10.1093/aje/154.12.1107; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd	41	47	49	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					514	522		10.7326/0003-4819-141-7-200410050-00007	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466768				2022-12-01	WOS:000224467800003
J	Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ				Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ			New evidence on the earliest human presence at high northern latitudes in northeast Asia	NATURE			English	Article							INDONESIA; HOMINIDS; DMANISI; GEORGIA; CHINA; HOMO; JAVA; AGE	The timing of early human dispersal to Asia is a central issue in the study of human evolution. Excavations in predominantly lacustrine sediments at Majuangou, Nihewan basin, north China, uncovered four layers of indisputable hominin stone tools. Here we report magnetostratigraphic results that constrain the age of the four artefact layers to an interval of nearly 340,000 yr between the Olduvai subchron and the Cobb Mountain event. The lowest layer, about 1.66 million years old (Myr), provides the oldest record of stone-tool processing of animal tissues in east Asia. The highest layer, at about 1.32 Myr, correlates with the stone tool layer at Xiaochangliang(1), previously considered the oldest archaeological site in this region. The findings at Majuangou indicate that the oldest known human presence in northeast Asia at 40degreesN is only slightly younger than that in western Asia(2,3). This result implies that a long yet rapid migration from Africa, possibly initiated during a phase of warm climate, enabled early human populations to inhabit northern latitudes of east Asia over a prolonged period.	Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China; Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Hebei Prov Inst Cultural Rel, Shijiazhuang 050000, Peoples R China; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93410 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; California State University System; California Polytechnic State University San Luis Obispo	Zhu, RX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China.	rxzhucn@yahoo.com; potts.rick@nmnh.si.edu	Deng, Chenglong/B-8871-2009; Zhu, Rixiang/F-2126-2018; Pan, Yongxin/B-4302-2008; Deng, Chenglong/B-8881-2009	Deng, Chenglong/0000-0003-1848-3170; Zhu, Rixiang/0000-0002-4985-925X; Pan, Yongxin/0000-0002-4227-3061; 				AN ZH, 1989, QUATERNARY RES, V32, P213, DOI 10.1016/0033-5894(89)90077-X; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; de Heinzelin J, 1999, SCIENCE, V284, P625; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; HPICR, 1998, PAP ARCH HEB PROV, P30; HUANG WP, 1991, WUSHAN HOMINID SITE, P105; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Li H.M., 1982, QUATERNARY GEOLOGY E, P33; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R., 1988, EARLY HOMINID ACTIVI; POTTS R, 2001, HUMAN ROOTS AFRICA A, P5; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Singer BS, 1999, J GEOPHYS RES-SOL EA, V104, P679, DOI 10.1029/1998JB900016; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Tang Yingjun, 1995, Vertebrata Palasiatica, V33, P74; Tian J, 2002, EARTH PLANET SC LETT, V203, P1015, DOI 10.1016/S0012-821X(02)00923-8; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wei Q., 1994, ACTA ANTHR SIN, V13, P223; Wei Q., 1997, EVIDENCE EVOLUTION E, P193; Zhu RX, 2003, EARTH-SCI REV, V61, P341, DOI 10.1016/S0012-8252(02)00132-0; Zhu RX, 2001, NATURE, V413, P413, DOI 10.1038/35096551	23	235	307	4	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					559	562		10.1038/nature02829	http://dx.doi.org/10.1038/nature02829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457258				2022-12-01	WOS:000224156700044
J	Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA				Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA			Defining a link with asthma in mice congenitally deficient in eosinophils	SCIENCE			English	Article							AIRWAYS HYPERREACTIVITY; TRANSGENIC MICE; MOUSE; GENE; EXPRESSION; CLONING; IL-5; HYPERRESPONSIVENESS; IDENTIFICATION; INFLAMMATION	Eosinophils are often dominant inflammatory cells present in the lungs of asthma patients. Nonetheless, the role of these leukocytes remains poorly understood. We have created a transgenic line of mice (PHIL) that are specifically devoid of eosinophils, but otherwise have a full complement of hematopoietically derived cells. Allergen challenge of PHIL mice demonstrated that eosinophils were required for pulmonary mucus accumulation and the airway hyperresponsiveness associated with asthma. The development of an eosinophil-less mouse now permits an unambiguous assessment of a number of human diseases that have been linked to this granulocyte, including allergic diseases, parasite infections, and tumorigenesis.	Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Div Hematol Oncol, Scottsdale, AZ 85259 USA; Univ Vermont, Dept Med, Vermont Lung Ctr, Burlington, VT 05405 USA; Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Vermont; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, JJ (corresponding author), Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA.	jjlee@mayo.edu; nlee@mayo.edu	Cormier, Stephania A/I-7382-2017	Cormier, Stephania A/0000-0002-6050-6172	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067273, P01HL067004, R01HL065228, R01HL058723, F32HL010105, R56HL058723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025230, R01AI033043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008545] Funding Source: NIH RePORTER; NCRR NIH HHS [NCRR-COBRE P20RR1555] Funding Source: Medline; NHLBI NIH HHS [P01-HL67004, HL10105, HLEB67273, HL058723, HL065228] Funding Source: Medline; NIAID NIH HHS [AI025230, AI033043] Funding Source: Medline; NIAMS NIH HHS [F32 AR008545-03, F32 AR008545-02, F32 AR008545, AR08545, F32 AR008545-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; BUSSE WW, 1993, AM REV RESPIR DIS, V147, P20; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Hogan SP, 1998, J IMMUNOL, V161, P1501; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Irvin CG, 1997, AM J PHYSIOL-LUNG C, V272, pL1053, DOI 10.1152/ajplung.1997.272.6.L1053; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; LARSON KA, 1995, J IMMUNOL, V155, P3002; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Macias MP, 2000, J LEUKOCYTE BIOL, V67, P567, DOI 10.1002/jlb.67.4.567; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; O'Byrne P, 1998, J ALLERGY CLIN IMMUN, V102, pS85, DOI 10.1016/S0091-6749(98)70036-3; OCHKUR SI, UNPUB; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PAUL CC, 1994, J LEUKOCYTE BIOL, V56, P74, DOI 10.1002/jlb.56.1.74; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945	28	555	578	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1773	1776		10.1126/science.1099472	http://dx.doi.org/10.1126/science.1099472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375267	Green Submitted			2022-12-01	WOS:000224039500041
J	Yurimoto, H; Kuramoto, K				Yurimoto, H; Kuramoto, K			Molecular cloud origin for the oxygen isotope heterogeneity in the solar system	SCIENCE			English	Article							ROTATIONAL-EXCITATION; INTERSTELLAR CLOUDS; CARBON-MONOXIDE; CHEMISTRY; CO; PHOTODISSOCIATION; METEORITES; EXTINCTION; NEBULA; GRAIN	Meteorites and their components have anomalous oxygen isotopic compositions characterized by large variations in O-18/O-16 and O-17/O-16 ratios. On the basis of recent observations of star-forming regions and models of accreting protoplanetary disks, we suggest that these variations may originate in a parent molecular cloud by ultraviolet photodissociation processes. Materials with anomalous isotopic compositions were then transported into the solar nebula by icy dust grains during the collapse of the cloud. The icy dust grains drifted toward the Sun in the disk, and their subsequent evaporation resulted in the O-17- and O-18-enrichment of the inner disk gas.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Hokkaido Univ, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan	Tokyo Institute of Technology; Hokkaido University	Yurimoto, H (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	yuri@geo.titech.ac.jp	Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Kuramoto, Kiyoshi/0000-0002-6757-8064				Ando M, 2002, ASTROPHYS J, V574, P187, DOI 10.1086/340922; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Beckwith S. V. W., 2000, Protostars and planets 4, P533; Bergin EA, 2000, ASTROPHYS J, V539, pL129, DOI 10.1086/312843; Calvet N., 2000, Protostars and planets 4, P377; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CHU YH, 1983, ASTROPHYS J, V267, P151, DOI 10.1086/160852; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1988, PHILOS T R SOC A, V325, P483, DOI 10.1098/rsta.1988.0062; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CUZZI JN, IN PRESS ASTROPHYS J; GLASSGOLD AE, 1985, ASTROPHYS J, V290, P615, DOI 10.1086/163019; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; KITAMURA Y, 1983, MOON PLANETS, V29, P199, DOI 10.1007/BF00928327; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Kurtz S., 2000, Protostars and planets 4, P299; LADA CJ, 1994, ASTROPHYS J, V429, P694, DOI 10.1086/174354; LANGER WD, 2000, PROTOSTARS PLANETS, V4, P29; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; Marechal P, 1997, ASTRON ASTROPHYS, V324, P221; Marechal P, 1997, ASTRON ASTROPHYS, V328, P617; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Ruffle DP, 2001, MON NOT R ASTRON SOC, V324, P1054, DOI 10.1046/j.1365-8711.2001.04394.x; Sheffer Y, 2002, ASTROPHYS J, V574, pL171, DOI 10.1086/342501; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; van Dishoeck E. F., 1993, PROTOSTARS PLANETS, P163; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Warin S, 1996, ASTRON ASTROPHYS, V308, P535; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Whittet DCB, 2001, ASTROPHYS J, V547, P872, DOI 10.1086/318421; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153	35	320	321	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1763	1766		10.1126/science.1100989	http://dx.doi.org/10.1126/science.1100989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375265				2022-12-01	WOS:000224039500038
J	Pui, CH; Relling, MV				Pui, CH; Relling, MV			Can the genotoxicity of chemotherapy be predicted?	LANCET			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; CHILDREN; SURVIVORS		St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	Ching-hon.pui@stjude.org	Pui, Ching-Hon/N-8076-2018	Pui, Ching-Hon/0000-0003-0303-5658	NCI NIH HHS [CA 36401, CA 71907, CA 21765, CA 60419, CA 78224, CA 71970, CA 51001] Funding Source: Medline; NIGMS NIH HHS [GM 61393, GM 61374] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA036401, R29CA051001, R01CA036401, R01CA078224, R01CA060419, P01CA071907, U01CA060419, P30CA021765, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhatia S, 2002, NAT REV CANCER, V2, P124, DOI 10.1038/nrc722; CROM WR, 1987, CLIN PHARMACOKINET, V12, P168, DOI 10.2165/00003088-198712030-00002; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Fuscoe JC, 1998, MUTAT RES-GEN TOX EN, V419, P107, DOI 10.1016/S1383-5718(98)00129-6; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Rice SC, 2004, CANCER RES, V64, P4464, DOI 10.1158/0008-5472.CAN-03-3940; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	10	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					917	918		10.1016/S0140-6736(04)17038-4	http://dx.doi.org/10.1016/S0140-6736(04)17038-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364174				2022-12-01	WOS:000223831000007
J	Ehrlich, M; Boll, W; van Oijen, A; Hariharan, R; Chandran, K; Nibert, ML; Kirchhausen, T				Ehrlich, M; Boll, W; van Oijen, A; Hariharan, R; Chandran, K; Nibert, ML; Kirchhausen, T			Endocytosis by random initiation and stabilization of clathrin-coated pits	CELL			English	Article							MEDIATED ENDOCYTOSIS; VESICLE FORMATION; PLASMA-MEMBRANE; AP COMPLEXES; DYNAMIN; FIBROBLASTS; RECEPTOR; CELL; DIFFUSION; SIGNALS	Clathrin-coated vesicles carry traffic from the plasma membrane to endosomes. We report here the real-time visualization of cargo sorting and endocytosis by clathrin-coated pits in living cells. We have detected the formation of coats by monitoring incorporation of fluorescently tagged clathrin or its adaptor AP-2; we have also followed clathrin-mediated uptake of transferrin and of single LDL or reovirus particles. The intensity of a cargo-loaded clathrin cluster grows steadily during its lifetime, and the time required to complete assembly is proportional to the size of the cargo particle. These results are consistent with a nucleation-growth mechanism and an approximately constant growth rate. There are no strongly preferred nucleation sites. A proportion of the nucleation events are weak and short lived. Cargo incorporation occurs primarily or exclusively in a newly formed coated pit. Our data lead to a model in which coated pits initiate randomly but collapse unless stabilized, perhaps by cargo capture.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Indian Inst Sci, Dept Comp Sci, Bangalore 560012, Karnataka, India; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Indian Institute of Science (IISC) - Bangalore; Harvard University; Harvard Medical School	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	van Oijen, Antoine/I-3167-2014; Chandran, Kartik/I-2232-2012	van Oijen, Antoine/0000-0002-1794-5161; Ehrlich, Marcelo/0000-0002-2352-1808	NIGMS NIH HHS [GM36548] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036548] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Clairmont KB, 1997, CELL MOL LIFE SCI, V53, P611, DOI 10.1007/s000180050080; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Forrest JC, 2003, J BIOL CHEM, V278, P48434, DOI 10.1074/jbc.M305649200; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GOLDSTEIN B, 1981, P NATL ACAD SCI USA, V7, P5695; HANSEN SH, 1992, EXP CELL RES, V199, P19, DOI 10.1016/0014-4827(92)90457-J; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251	30	657	670	4	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					591	605		10.1016/j.cell.2004.08.017	http://dx.doi.org/10.1016/j.cell.2004.08.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339664	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000223730300010
J	Reed, MB; Domenech, P; Manca, C; Su, H; Barczak, AK; Kreiswirth, BN; Kaplan, G; Barry, CE				Reed, MB; Domenech, P; Manca, C; Su, H; Barczak, AK; Kreiswirth, BN; Kaplan, G; Barry, CE			A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENE; SUPPRESSION; COMPLEX; LEPRAE; BIOSYNTHESIS; VIRULENT; FAMILY; MICE	Fifty million new infections with Mycobacterium tuberculosis occur annually, claiming 2 - 3 million lives from tuberculosis worldwide(1). Despite the apparent lack of significant genetic heterogeneity between strains of M. tuberculosis(2,3), there is mounting evidence that considerable heterogeneity exists in molecules important in disease pathogenesis. These differences may manifest in the ability of some isolates to modify the host cellular immune response, thereby contributing to the observed diversity of clinical outcomes(4-7). Here we describe the identification and functional relevance of a highly biologically active lipid species - a polyketide synthase-derived phenolic glycolipid (PGL) produced by a subset of M. tuberculosis isolates belonging to the W-Beijing family(8) that show 'hyperlethality' in murine disease models. Disruption of PGL synthesis results in loss of this hypervirulent phenotype without significantly affecting bacterial load during disease. Loss of PGL was found to correlate with an increase in the release of the pro-inflammatory cytokines tumour-necrosis factor-alpha and interleukins 6 and 12 in vitro. Furthermore, the overproduction of PGL by M. tuberculosis or the addition of purified PGL to monocyte-derived macrophages was found to inhibit the release of these pro-inflammatory mediators in a dose-dependent manner.	NIAID, TB Res Sect, NIH, Rockville, MD 20852 USA; Publ Hlth Res Inst, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; Publ Hlth Res Inst, TB Ctr, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barry, CE (corresponding author), NIAID, TB Res Sect, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	clifton_barry@nih.gov	Barry, Clifton E/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline; NIAID NIH HHS [R01 AI054338-01, R01 AI054338] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338, Z01AI000783] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; FOURNIE JJ, 1989, INFECT IMMUN, V57, P3653, DOI 10.1128/IAI.57.11.3653-3659.1989; Gaora PO, 1997, MED PRIN PRACT, V6, P91; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hashimoto K, 2002, INFECT IMMUN, V70, P5167, DOI 10.1128/IAI.70.9.5167-5176.2002; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MANCA C, IN PRESS INFECT IMMU; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; MEHRA V, 1984, NATURE, V308, P194, DOI 10.1038/308194a0; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; North RJ, 1999, INFECT IMMUN, V67, P5483, DOI 10.1128/IAI.67.10.5483-5485.1999; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; SILVA CL, 1993, INT J LEPROSY, V61, P107; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Slayden R A, 2001, Methods Mol Med, V54, P229, DOI 10.1385/1-59259-147-7:229; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tiruviluamala P, 2002, ANNU REV PUBL HEALTH, V23, P403, DOI 10.1146/annurev.publhealth.23.100901.140519; VACHULA M, 1989, J IMMUNOL, V142, P1696; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Vergne I, 1998, FRONT BIOSCI, V3, pd865	30	570	594	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					84	87		10.1038/nature02837	http://dx.doi.org/10.1038/nature02837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343336				2022-12-01	WOS:000223641500046
J	Tanimoto, H; Heisenberg, M; Gerber, B				Tanimoto, H; Heisenberg, M; Gerber, B			Event timing turns punishment to reward	NATURE			English	Editorial Material							SYNAPTIC MODIFICATION; DOPAMINE NEURONS; INHIBITION		Univ Wurzburg, Biozentrum, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany	University of Wurzburg	Tanimoto, H (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany.	hiromut@biozentrum.uni-wuerzburg.de	Tanimoto, Hiromu/J-6810-2016	Gerber, Bertram/0000-0003-3003-0051				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; RESCORLA RA, 1965, J COMP PHYSIOL PSYCH, V59, P406, DOI 10.1037/h0022060; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tobler PN, 2003, J NEUROSCI, V23, P10402; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wagner A.R., 1981, P5	11	126	126	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					983	983		10.1038/430983a	http://dx.doi.org/10.1038/430983a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329711	Bronze			2022-12-01	WOS:000223514900031
J	Leung, TH; Hoffmann, A; Baltimore, D				Leung, TH; Hoffmann, A; Baltimore, D			One nucleotide in a kappa B site can determine cofactor specificity for NF-kappa B dimers	CELL			English	Article							BETA GENE-EXPRESSION; TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; IMMUNE-RESPONSES; DNA-BINDING; COOPERATIVE INTERACTION; VIRUS INDUCTION; IFN-GAMMA; C-MYC; ACTIVATION	The transcription factor NF-kappaB regulates a wide variety of genes involved in multiple processes. Although the apparent consensus sequence of DNA binding sites for NF-kappaB (kappaB sites) is very broad, the sites active in any one gene show remarkable evolutionary stability. Using a lentivirus-based methodology for implantation of gene regulatory sequences we show that for genes with two kappaB sites both are required for activity. Swapping sites between kappaB-dependent genes altered NF-kappaB dimer specificity of the promoters and revealed that two kappaB sites can function together as a module to regulate gene activation. Further, although the sequence of the kappaB site is important for determining kappaB family member specificity, rather than determining the ability of a particular dimer to bind effectively, the sequence affect which coactivators will form productive interactions, with the bound NF-kappaB dinner. This suggests that binding sites may impart a specific configuration to bound transcription factors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM39458-20] Funding Source: Medline; PHS HHS [R01-A1042549-061] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; FUJITA T, 1993, GENE DEV, V7, P354; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KUNSCH C, 1992, MOL CELL BIOL, V12, P442; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Ping DS, 1999, J IMMUNOL, V162, P727; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	54	331	342	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					453	464		10.1016/j.cell.2004.08.007	http://dx.doi.org/10.1016/j.cell.2004.08.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315758	Bronze			2022-12-01	WOS:000223650900008
J	Pelling, AE; Sehati, S; Gralla, EB; Valentine, JS; Gimzewski, JK				Pelling, AE; Sehati, S; Gralla, EB; Valentine, JS; Gimzewski, JK			Local nanomechanical motion of the cell wall of Saccharomyces cerevisiae	SCIENCE			English	Article							SPONTANEOUS OSCILLATIONS; MECHANICAL-PROPERTIES; MICROBIAL-CELLS; FORCE; ELASTICITY; MOVEMENT; PULSE	We demonstrate that the cell wall of living Saccharomyces cerevisiae (baker's yeast) exhibits local temperature-dependent nanomechanical motion at characteristic frequencies. The periodic motions in the range of 0.8 to 1.6 kHz with amplitudes of similar to3 nm were measured using the cantilever of an atomic force microscope (AFM). Exposure of the cells to a metabolic inhibitor causes the periodic motion to cease. From the strong frequency dependence on temperature, we derive an activation energy of 58 kj/mol, which is consistent with the cell's metabolism involving molecular motors such as kinesin, dynein, and myosin. The magnitude of the forces observed (similar to10 nN) suggests concerted nanomechanical activity is operative in the cell.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Gimzewski, JK (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	gim@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X; Pelling, Andrew/0000-0003-3732-7472; gimzewski, james/0000-0003-4333-6957	NIDDK NIH HHS [DK46828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5; Ding DQ, 1998, J CELL SCI, V111, P701; Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Gad M, 1997, CELL BIOL INT, V21, P697, DOI 10.1006/cbir.1997.0214; HARRIS CM, 1988, SHOCK VIBRATION HDB; HOH JH, 1994, J CELL SCI, V107, P1105; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; JOHNSTON M, 1992, MOL BIOL YEAST SACCH; Julicher F, 2001, CR ACAD SCI IV-PHYS, V2, P849, DOI 10.1016/S1296-2147(01)01228-8; Julicher F, 1997, PHYS REV LETT, V78, P4510, DOI 10.1103/PhysRevLett.78.4510; KAMIMURA S, 1989, NATURE, V340, P476, DOI 10.1038/340476a0; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kawaguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P41, DOI 10.1002/cm.1019; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Maksym GN, 2000, J APPL PHYSIOL, V89, P1619, DOI 10.1152/jappl.2000.89.4.1619; Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213; Szabo B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041910; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Vilfan A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.114101; Yasuda K, 1996, BIOPHYS J, V70, P1823, DOI 10.1016/S0006-3495(96)79747-3; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578	27	279	292	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1147	1150		10.1126/science.1097640	http://dx.doi.org/10.1126/science.1097640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326353				2022-12-01	WOS:000223557400046
J	Jiang, QX; Wang, DN; MacKinnon, R				Jiang, QX; Wang, DN; MacKinnon, R			Electron microscopic analysis of KvAP voltage-dependent K+ channels in an open conformation	NATURE			English	Article							ION CHANNELS; ANGULAR RECONSTITUTION; GATING CHARGE; S4 SEGMENT; RESOLUTION; CRYOMICROSCOPY; ORIENTATION; PERSPECTIVE; MOVEMENTS; PROTEIN	Voltage-dependent ion channels serve as field-effect transistors by opening a gate in response to membrane voltage changes(1). The gate's response to voltage is mediated by voltage sensors(2), which are arginine-containing structures that must move with respect to the membrane electric field. We have analysed by electron microscopy a voltage-dependent K+ channel from Aeropyrum pernix (KvAP)(3). Fab fragments were attached to 'voltage sensor paddles' and identified in the electron microscopy map at 10.5 Angstrom resolution. The extracellular surface location of the Fab fragments in the map is consistent with the membrane-depolarized, open conformation of the channel in electrophysiological experiments. Comparison of the map with a crystal structure(4) demonstrates that the voltage sensor paddles are 'up' ( that is, near the channel's extracellular surface) and situated at the protein - lipid interface. This finding supports the hypothesis that in response to changes in voltage the sensors move at the protein - lipid interface(5) rather than in a gating pore surrounded by protein(6,7).	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; New York University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu	Jiang, Qiu-Xing/ABF-1143-2021	Wang, Da-Neng/0000-0002-6496-4699				Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Hawkes P W., 1980, COMPUTER PROCESSING, P1; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	30	95	98	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					806	810		10.1038/nature02735	http://dx.doi.org/10.1038/nature02735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306816				2022-12-01	WOS:000223233600048
J	Dennis, C				Dennis, C			Cooling off	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					605	605						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15309806				2022-12-01	WOS:000223085400015
J	Lindsberg, PJ; Soinne, L; Tatlisumak, T; Roine, RO; Kallela, M; Happola, O; Kaste, M				Lindsberg, PJ; Soinne, L; Tatlisumak, T; Roine, RO; Kallela, M; Happola, O; Kaste, M			Long-term outcome after intravenous thrombolysis of basilar artery occlusion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC-STROKE; THERAPY; ASSOCIATION; QUALITY; LIFE; CARE	Context Basilar artery occlusion (BAO) is an infrequent disease with high morbidity and mortality. Intra-arterial thrombolysis is advocated for treatment but is limited to use at specialized centers. Objective To evaluate outcomes for patients with BAO treated with intravenous thrombolytic therapy. Design, Setting, and Participants During 1995 to 2003, 50 consecutive patients with angiographically proven BAO were treated according to an institutional therapy protocol based on intravenous thrombolysis with recombinant tissue plasminogen activator (alteplase). Patients were treated at an urban university teaching hospital receiving all patients with ischemic stroke who were considered for thrombolysis in a catchment area of 1.5 million inhabitants in Helsinki, Finland. Intervention Intravenous administration of alteplase (0.9 mg/kg) during a 1-hour infusion. Main Outcome Measures Basilar artery recanalization determined by magnetic resonance angiography and clinical outcomes at 3 months and at 1 year or longer determined by modified Rankin Scale and Barthel index scores. Results Recanalization was studied in 43 patients and verified in 26 (52%) of all patients. By 3 months, 20 patients (40%) had died while 11 had good outcomes (modified Rankin Scale score, 0-2); 12 (24%) reached independence in activities of daily living (Barthel Index score, 95-100), and 6 (16%) were severely disabled (Barthel Index score, 0-50). in the long term (median follow-up 2.8 years), 15 patients (30%) reached good outcomes (modified Rankin Scale score, 0-2) while 23 (46%) died. Conclusions Intravenous administration of alteplase for patients with BAO appears to be associated with rates of survival, recanalization, and independent functional outcome comparable with those reported with endovascular approaches. These data suggest that a randomized trial is needed to compare these approaches for treatment of BAO.	Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki 00029, Finland; Biomedicum Helsinki, Program Neurosci, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Lindsberg, PJ (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurol, POB 340, Helsinki 00029, Finland.	perttu.lindsberg@hus.fi	Soinne, Lauri/E-3703-2019; Lindsberg, Perttu J/F-1271-2010	Lindsberg, Perttu/0000-0001-7690-811X				Adams HP, 1996, STROKE, V27, P1711; Brandt T, 1996, STROKE, V27, P875, DOI 10.1161/01.STR.27.5.875; Cross DT, 1997, AM J NEURORADIOL, V18, P1221; Devuyst G, 2002, ARCH NEUROL-CHICAGO, V59, P567, DOI 10.1001/archneur.59.4.567; Eckert B, 2002, CEREBROVASC DIS, V14, P42, DOI 10.1159/000063722; HACKE W, 1988, STROKE, V19, P1216, DOI 10.1161/01.STR.19.10.1216; Hacke W, 2004, LANCET, V363, P768; Levy EI, 1999, NEUROSURGERY, V45, P539, DOI 10.1097/00006123-199909000-00025; Lindsberg P J, 1998, Duodecim, V114, P889; Lindsberg PJ, 2003, STROKE, V34, P1443, DOI 10.1161/01.STR.0000071111.98505.C7; Lindsberg PJ, 2003, CURR OPIN NEUROL, V16, P73, DOI 10.1097/00019052-200302000-00010; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Patrick DL, 2000, J CLIN EPIDEMIOL, V53, P779, DOI 10.1016/S0895-4356(00)00205-5; Richardson P G, 2001, Emerg Med (Fremantle), V13, P367, DOI 10.1046/j.1035-6851.2001.00242.x; Wijdicks EFM, 1997, MAYO CLIN PROC, V72, P1005, DOI 10.4065/72.11.1005	15	141	153	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2004	292	15					1862	1866		10.1001/jama.292.15.1862	http://dx.doi.org/10.1001/jama.292.15.1862			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IV	15494584	Bronze			2022-12-01	WOS:000224485100025
J	Belenkaya, TY; Han, C; Yan, D; Opoka, RJ; Khodoun, M; Liu, HZ; Lin, XH				Belenkaya, TY; Han, C; Yan, D; Opoka, RJ; Khodoun, M; Liu, HZ; Lin, XH			Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans	CELL			English	Article							GRADIENT FORMATION; TOUT-VELU; HEDGEHOG; GENE; PATTERN; PROTEIN; WINGLESS; DISTINCT; INTERNALIZATION; TRANSDUCTION	The Drosophila transforming growth factor beta(TGF-beta) homolog Decapentaplegic (Dpp) acts as a morphogen that forms a long-range concentration gradient to direct the anteroposterior patterning of the wing. Both planar transcytosis initiated by Dynamin-mediated endocytosis and extracellular diffusion have been proposed for Dpp movement across cells. In this work, we found that Dpp is mainly extracellular, and its extracellular gradient coincides with its activity gradient. We demonstrate that a blockage of endocytosis by the dynamin mutant shibire does not block Dpp movement but rather inhibits Dpp signal transduction, suggesting that endocytosis is not essential for Dpp movement but is involved in Dpp signaling. Furthermore, we show that Dpp fails to move across cells mutant for daily and daily-like (dly), two Drosophila glypican members of heparin sulfate proteoglycan (HSPG). Our results support a model in which Dpp moves along the cell surface by restricted extracellular diffusion involving the glypicans Daily and Dly.	Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Childrens Hosp, Coll Med, Med Ctr,Grad Program Mol & Dev Biol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lin, XH (corresponding author), Univ Cincinnati, Coll Med, Div Dev Biol, Cincinnati, OH 45229 USA.	linyby@chmcc.org		Han, Chun/0000-0001-7319-8095	NHLBI NIH HHS [R01 HL-071898] Funding Source: Medline; NIGMS NIH HHS [R01 GM-63891] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063891] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baeg GH, 2001, DEVELOPMENT, V128, P87; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vincent JP, 2002, DEV CELL, V3, P615, DOI 10.1016/S1534-5807(02)00323-4; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; XU T, 1993, DEVELOPMENT, V117, P1223	58	239	246	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					231	244		10.1016/j.cell.2004.09.031	http://dx.doi.org/10.1016/j.cell.2004.09.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479640	Bronze			2022-12-01	WOS:000224577200011
J	Pang, PT; Teng, HK; Zaitsev, E; Woo, NT; Sakata, K; Zhen, SH; Teng, KK; Yung, WH; Hempstead, BL; Lu, B				Pang, PT; Teng, HK; Zaitsev, E; Woo, NT; Sakata, K; Zhen, SH; Teng, KK; Yung, WH; Hempstead, BL; Lu, B			Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity	SCIENCE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACTIVITY-DEPENDENT SECRETION; NEUROTROPHIC FACTOR; LATE-PHASE; LASTING POTENTIATION; EXCITATORY SYNAPSES; BDNF; GROWTH; MEMORY; MICE	Long-term memory is thought to be mediated by protein synthesis-dependent, late-phase tong-term potentiation (L-LTP). Two secretory proteins, tissue plasminogen activator (tPA) and brain-derived neurotrophic factor (BDNF), have been implicated in this process, but their relationship is unclear. Here we report that tPA, by activating the extracellular protease plasmin, converts the precursor proBDNF to the mature BDNF (mBDNF), and that such conversion is critical for L-LTP expression in mouse hippocampus. Moreover, application of mBDNF is sufficient to rescue L-LTP when protein synthesis is inhibited, which suggests that mBDNF is a key protein synthesis product for L-LTP expression.	NICHD, Sect Neural Dev & Plast, Lab Cellular & Synapt Neurophysiol, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Dept Med, Div Hematol, New York, NY 10021 USA; Chinese Univ Hong Kong, Fac Med, Dept Physiol, Shatin, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; Chinese University of Hong Kong	Lu, B (corresponding author), NICHD, Sect Neural Dev & Plast, Lab Cellular & Synapt Neurophysiol, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012; Yung, Ho/R-6161-2018; Sakata, Kazuko/I-2351-2017	Yung, Ho/0000-0002-5542-8173; Teng, Kenneth/0000-0002-9392-2172; Lu, Bai/0000-0001-5418-9759	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Frey U, 1996, J NEUROSCI, V16, P2057; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li TS, 2002, BIOPOLYMERS, V67, P10, DOI 10.1002/bip.10038; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295	31	851	894	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					487	491		10.1126/science.1100135	http://dx.doi.org/10.1126/science.1100135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486301				2022-12-01	WOS:000224626500054
J	Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F				Newell, ML; Coovadia, H; Cortina-Borja, M; Rollins, N; Gaillard, P; Dabis, F		IAS	Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis	LANCET			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ORAL ZIDOVUDINE; COTE-DIVOIRE; FOLLOW-UP; PREVENTION; REGIMEN	Background HIV contributes substantially to child mortality, but factors underlying these deaths are inadequately described. With individual data from seven randomised mother-to-child transmission (MTCT) intervention trials, we estimate mortality in African children born to HIV-infected mothers and analyse selected risk factors. Methods Early HIV infection was defined as a positive HIV-PCR test before 4 weeks of age; and late infection by a negative PCR test at or after 4 weeks of age, followed by a positive test. Mortality rate was expressed per 1000 child-years. We investigated the effect of maternal health, infant HIV infection, feeding practices, and age at acquisition of infection on mortality assessed with Cox proportional hazards models, and allowed for random effects for trials grouped geographically. Findings 378 (11%) of 3468 children died. By age 1 year, an estimated 35.2% infected and 4.9% unindected children will have died; by 2 years of age, 52.5% and 7.6% will have died, respectively. Mortality varied by geographical region, and was associated with maternal death (adjusted odds ratio 2.27, 95% CI 1.62-3.19), CD4+ cell counts <200 per mu L (1.91, 1.39-2.62), and infant HIV infection (8.16, 6.43-10.33). Mortality was not associated with either ever breastfeeding and never breastfeeding in either infected or uninfected children. In infected children, mortality was significantly lower for those with late infection than those with early infection (0.52, 0.39-0.70). This effect was also seen in analyses of survival from the age at infection (0.74, 0.55-0.99). Interpretation These findings highlight the necessity for timely antiretroviral care, for support for HIV-infected women and children in developing countries, and for assessment of prophylactic programmes to prevent MTCT, including child mortality and infection averted.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Ghent Int AIDS Soc, Working Grp HIV Infect Women & Children, Ghent, Belgium	University of London; University College London	Newell, ML (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	m.newell@ich.ucl.ac.uk	Gaillard, Philippe/E-7256-2019; Newell, Marie-Louise/AAE-8222-2019; DABIS, FRANCOIS/S-9298-2019; Borja, Mario Cortina/A-3847-2009; Sharma, Sushma/AAA-4966-2022; Van de Perre, Philippe/B-9692-2008	Newell, Marie-Louise/0000-0002-1074-7699; DABIS, FRANCOIS/0000-0002-1614-8857; Borja, Mario Cortina/0000-0003-0627-2624; Van de Perre, Philippe/0000-0002-3912-0427	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD033345] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrams EJ, 2003, AIDS, V17, P867, DOI 10.1097/00002030-200304110-00012; [Anonymous], 2004, 2004 REP GLOB AIDS E; BECQUET R, 2003, ANTIRETROVIRAL TH S1, V8, pS200; Bertolli J, 2003, AIDS, V17, P2089, DOI 10.1097/00002030-200309260-00010; Brahmbhatt H, 2002, SOC SCI MED, V55, P585, DOI 10.1016/S0277-9536(01)00189-7; Coutsoudis A, 1999, AIDS, V13, P1517, DOI 10.1097/00002030-199908200-00012; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2003, ACTA PAEDIATR, V92, P890, DOI 10.1080/08035250310004261; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Gaillard P, 2001, AIDS, V15, P389, DOI 10.1097/00002030-200102160-00012; Gray L, 2001, PEDIATRICS, V108, P116, DOI 10.1542/peds.108.1.116; Ioannidis JPA, 2004, AIDS, V18, P99, DOI 10.1097/00002030-200401020-00012; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lepage P, 1998, PEDIATR INFECT DIS J, V17, P581, DOI 10.1097/00006454-199807000-00002; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; Mandelbrot L, 2002, SEX TRANSM INFECT, V78, P267, DOI 10.1136/sti.78.4.267; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004; NEWELL ML, 2003, 2 IAS C HIV PATH TRE, P97; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Saba J, 2002, LANCET, V359, P1178; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Therneau T.M., 2000, MODELLING SURVIVAL D, P39, DOI [10.1007/978-1-4757-3294-8_3, DOI 10.1007/978-1-4757-3294-8]; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Zijenah LS, 2004, AIDS, V18, P273, DOI 10.1097/00002030-200401230-00017	32	848	867	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1236	1243		10.1016/S0140-6736(04)17140-7	http://dx.doi.org/10.1016/S0140-6736(04)17140-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464184				2022-12-01	WOS:000224254200030
J	Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G				Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G			Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SKIN FIBROBLAST COLLAGENASE; MATRIX METALLOPROTEINASES; MOLECULAR MOTORS; ACTIVE-SITE; I COLLAGEN; KINETICS; PROTEIN	We show that activated collagenase (MMP-1) moves processively on the collagen fibril. The mechanism of movement is a biased diffusion with the bias component dependent on the proteolysis of its substrate, not adenosine triphosphate (ATP) hydrolysis. inactivation of the enzyme by a single amino acid residue substitution in the active center eliminates the bias without noticeable effect on rate of diffusion. Monte Carlo simulations using a model similar to a "burnt bridge" Brownian ratchet accurately describe our experimental results and previous observations on kinetics of collagen digestion. The biological implications of MMP-1 acting as a molecular ratchet tethered to the cell surface suggest new mechanisms for its role in tissue remodeling and cell-matrix interaction.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldberg, G (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	goldberg@medicine.wustl.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039472, R01AR040618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038838] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39472, AR40618] Funding Source: Medline; NIGMS NIH HHS [GM-38838] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Derenyi I, 1999, PHYS REV LETT, V83, P903, DOI 10.1103/PhysRevLett.83.903; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feynman R. P., 1966, FEYNMAN LECT PHYS, VI; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; Fox RF, 1998, PHYS REV E, V57, P2177, DOI 10.1103/PhysRevE.57.2177; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; JEFFREY JJ, 1983, J BIOL CHEM, V258, P1123; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kadler KE, 1996, BIOCHEM J, V316, P1; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; MAGDE D, 1978, BIOPOLYMERS, V17, P361, DOI 10.1002/bip.1978.360170208; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROST J, 1994, PHYS REV LETT, V72, P2652, DOI 10.1103/PhysRevLett.72.2652; Qian H, 2000, BIOPHYS CHEM, V83, P35, DOI 10.1016/S0301-4622(99)00121-0; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; SAFFARIAN S, UNPUB; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Steele DL, 2000, PROTEIN ENG, V13, P397, DOI 10.1093/protein/13.6.397; TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WELGUS HG, 1980, J BIOL CHEM, V255, P6806; WINDSOR LJ, 1994, J BIOL CHEM, V269, P26201	30	143	146	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					108	111		10.1126/science.1099179	http://dx.doi.org/10.1126/science.1099179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459390	Green Submitted			2022-12-01	WOS:000224304000047
J	Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F				Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F			Autoimmune lymphoproliferative syndrome with somatic Fas mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IN-VIVO REVERSION; GENE-MUTATIONS; CELL APOPTOSIS; HUMAN-DISEASE; T-CELLS; EXPRESSION; DOMINANT; PATIENT; LYMPHOCYTE	BACKGROUND: Impaired Fas-induced apoptosis of lymphocytes in vitro is a principal feature of the autoimmune lymphoproliferative syndrome (ALPS). We studied six children with ALPS whose lymphocytes had normal sensitivity to Fas-induced apoptosis in vitro. METHODS: Susceptibility to Fas-mediated apoptosis and the Fas gene were analyzed in purified subgroups of T cells and other mononuclear cells from six patients with ALPS type III. RESULTS: Heterozygous dominant Fas mutations were detected in the polyclonal double-negative T cells from all six patients. In two patients, these mutations were found in a fraction of CD4+ and CD8+ T cells, monocytes, and CD34+ hematopoietic precursors, but not in hair or mucosal epithelial cells. CONCLUSIONS: Somatic heterozygous mutations of Fas can cause a sporadic form of ALPS by allowing lymphoid precursors to resist the normal process of cell death.	Hop Necker Enfants Malad, INSERM, U429, Paris, France; Hop Necker Enfants Malad, Unite Immunol Hematol Pediat, Paris, France; Univ Manchester, Booth Hall Childrens Hosp, Acad Unit Child Hlth, Manchester, Lancs, England; Charles Univ, Sch Med 2, Inst Immunol, Prague, Czech Republic; Hop Robert Debre, Unite Immunohematol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Holzelova, E (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.		Rieux-Laucat, Frédéric/A-7916-2017; Stolzenberg, Marie-Claude/I-6281-2017; Arkwright, Peter/C-5149-2012	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Stolzenberg, Marie-Claude/0000-0001-8026-0360; Arkwright, Peter/0000-0002-7411-5375				Bensoussan D, 2002, BRIT J HAEMATOL, V117, P899, DOI 10.1046/j.1365-2141.2002.03496.x; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bleesing JJH, 2001, CLIN IMMUNOL, V100, P314, DOI 10.1006/clim.2001.5069; CANALE VC, 1967, J PEDIATR-US, V70, P891, DOI 10.1016/S0022-3476(67)80262-2; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fuss IJ, 1997, J IMMUNOL, V158, P1912; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hezard N, 1998, THROMB HAEMOSTASIS, V79, P1054; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; ILLUM N, 1991, SCAND J IMMUNOL, V34, P635, DOI 10.1111/j.1365-3083.1991.tb01587.x; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Kasahara Y, 1998, INT IMMUNOL, V10, P195, DOI 10.1093/intimm/10.2.195; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; LeDeist F, 1996, LANCET, V348, P719, DOI 10.1016/S0140-6736(96)02293-3; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Ramenghi U, 2000, BLOOD, V95, P3176; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schneider E, 1999, BLOOD, V94, P2613, DOI 10.1182/blood.V94.8.2613.420k33_2613_2621; Senju S, 1996, INT IMMUNOL, V8, P423, DOI 10.1093/intimm/8.3.423; Simon HU, 1996, J EXP MED, V183, P1071, DOI 10.1084/jem.183.3.1071; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strain L, 1998, NEW ENGL J MED, V338, P166, DOI 10.1056/NEJM199801153380305; Vaishnaw AK, 1999, J CLIN INVEST, V103, P1099, DOI 10.1172/JCI5121C1; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; van der Burg M, 2000, PEDIATR RES, V47, P336, DOI 10.1203/00006450-200003000-00009; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	37	210	235	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1409	1418		10.1056/NEJMoa040036	http://dx.doi.org/10.1056/NEJMoa040036			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459302				2022-12-01	WOS:000224153900009
J	Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY				Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY			Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	36th Annual Meeting of the American-Society-of-Nephrology	NOV 12-17, 2003	SAN DIEGO, CA	Amer Soc Nephrol			CHRONIC RENAL-INSUFFICIENCY; 3RD NATIONAL-HEALTH; SERUM CREATININE; ALL-CAUSE; MORTALITY; OUTCOMES; CARE; HYPERTENSION; IMPACT; COHORT	Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	Go, Alan S./AAE-7745-2019	Chertow, Glenn/0000-0002-7599-0534; Hsu, Chi-yuan/0000-0001-8182-1238	NIDDK NIH HHS [R01 DK58411] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 2003, USRDS 2003 ANN DAT R; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2002, JAMA-J AM MED ASSOC, V288, P46; Khan SS, 2002, KIDNEY INT, V62, P229, DOI 10.1046/j.1523-1755.2002.00432.x; Landis JR, 2003, J AM SOC NEPHROL, V14, p294A; LANGFORD HG, 1986, PROG CARDIOVASC DIS, V29, P29, DOI 10.1016/0033-0620(86)90033-2; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; *US BUR CENS, 2001, 2000 CENS POP HOUS S; Wang JG, 2001, HYPERTENSION, V37, P1069, DOI 10.1161/01.HYP.37.4.1069; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557	42	8338	8652	10	597	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1296	1305		10.1056/NEJMoa041031	http://dx.doi.org/10.1056/NEJMoa041031			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	855TP	15385656				2022-12-01	WOS:000223997700007
J	Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL				Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL			Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STATIN THERAPY; UNITED-STATES; ASPIRIN; MORTALITY; PREVENTION; ANGINA; TRIAL	Background: Despite recent advances in the treatment and prevention of cardiovascular disease, a treatment gap for secondary prevention medications still exists. Objective: To develop and implement a program ensuring appropriate prescription of aspirin, statins, beta-blockers, angiotensin-converting enzyme inhibitors, and warfarin at hospital discharge. Design: A nonrandomized before-after study comparing patients hospitalized before (1996-1998) and after (1999-2002) implementation of a discharge medication program (DMP). Patients were followed for up to 1 year. Setting: The 10 largest hospitals in the Utah-based Intermountain Health Care system. Patients: In the pre-DMP and DMP time periods, 26 000 and 31465 patients, respectively, were admitted to cardiovascular services (n = 57 465). Measurements: Prescription of indicated medications at hospital discharge; postdischarge death or readmission. Results: By 1 year, the rate of prescription of each medication increased significantly to more than 90% (P < 0.001); this rate was sustained. At 1 year, unadjusted absolute event rates for readmission and death, respectively, were 210 per 1000 years and 96 per 1000 person-years before DMP implementation and 191 per 1000 person-years and 70 per 1000 person-years afterward. Relative risk for death and readmission at 30 days decreased after DMP implementation; hazard ratios (HRs) for death and readmission were 0.81 (95% Cl, 0.73 to 0.89) and 0.92 (Cl, 0.87 to 0.99) (P < 0.001 and P = 0.017, respectively). At 1 year, risk for death continued to decrease (hazard ratio, 0.79 [Cl, 0.75 to 0.84]; P < 0.001) while risk for readmission stabilized (hazard ratio, 0.94 [Cl, 0.90 to 0.98]; P = 0.002), probably because survivors had more opportunities to be readmitted. Limitations: The study design was observational and nonrandomized, and the authors could not control for potential confounders or determine the extent to which secular trends accounted for the observed improvements. Conclusions: A relatively simple quality improvement program aimed at enhancing the prescription of appropriate discharge medications among cardiovascular patients is feasible and can be sustained within an integrated multihospital system. Such a program may be associated with improvements in cardiovascular readmission rates and mortality.	LDS Hosp, Intermt Hlth Care, Salt Lake City, UT USA	Intermountain Healthcare	Muhlestein, JB (corresponding author), Hosp Cardiovasc Dept, 8th Ave & C St, Salt Lake City, UT 84143 USA.		Horne, Benjamin/GQP-7851-2022					*AM HEART ASS, 2001, HEART DIS STROK STAT; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Frolkis JP, 1998, CIRCULATION, V98, P851, DOI 10.1161/01.CIR.98.9.851; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Horne BD, 2000, J AM COLL CARDIOL, V36, P1774, DOI 10.1016/S0735-1097(00)00950-5; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Maycock CAA, 2002, J AM COLL CARDIOL, V40, P1777, DOI 10.1016/S0735-1097(02)02477-4; Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEDERSEN TR, 1994, LANCET, V344, P1383; PETERSEN P, 1989, LANCET, V1, P175; Stafford RS, 2000, CIRCULATION, V101, P1097, DOI 10.1161/01.CIR.101.10.1097; Sueta CA, 1999, AM J CARDIOL, V83, P1303, DOI 10.1016/S0002-9149(99)00117-4; *UT DEP HLTH CTR H, 2001, UT VIT STAT 2001; *UT DEP HTLH CTR H, 1998, VIT STAT 1998; 1929, N ENGL J MED, V328, P293	20	104	103	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					446	453		10.7326/0003-4819-141-6-200409210-00010	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381518				2022-12-01	WOS:000224067900005
J	Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S				Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S			Bacterial persistence as a phenotypic switch	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ANTIBIOTIC-RESISTANCE; SOFT LITHOGRAPHY; LETHALITY; MUTANTS; DEATH; HIPA	A fraction of a genetically homogeneous microbial population may survive exposure to stress such as antibiotic treatment. Unlike resistant mutants, cells regrown from such persistent bacteria remain sensitive to the antibiotic. We investigated the persistence of single cells of Escherichia coli with the use of microfluidic devices. Persistence was linked to preexisting heterogeneity in bacterial populations because phenotypic switching occurred between normally growing cells and persister cells having reduced growth rates. Quantitative measurements led to a simple mathematical description of the persistence switch. Inherent heterogeneity of bacterial populations may be important in adaptation to fluctuating environments and in the persistence of bacterial infections.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Rockefeller University; Rockefeller University; Hebrew University of Jerusalem	Balaban, NQ (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.	nathalieqb@phys.huji.ac.il	Balaban, Nathalie/AAH-1004-2019; Balaban, Nathalie/AGI-1487-2022; Sandstedt, Sara A/A-3001-2010	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; Chait, Remy/0000-0003-0876-3187				Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bigger JW, 1944, LANCET, V2, P497; BRADFORD MJ, 1993, ECOLOGY, V74, P1129, DOI 10.2307/1940482; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	18	1881	1963	15	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1622	1625		10.1126/science.1099390	http://dx.doi.org/10.1126/science.1099390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308767				2022-12-01	WOS:000223891200044
J	Fortin, NJ; Wright, SP; Eichenbaum, H				Fortin, NJ; Wright, SP; Eichenbaum, H			Recollection-like memory retrieval in rats is dependent on the hippocampus	NATURE			English	Article							HUMAN RECOGNITION MEMORY; OBJECT-RECOGNITION; EPISODIC MEMORY; FAMILIARITY; DAMAGE; LESIONS; MONKEYS; INFORMATION; COMPONENTS; INSIGHTS	Recognition memory may be supported by two independent types of retrieval, conscious recollection of a specific experience and a sense of familiarity gained from previous exposure to particular stimuli(1,2). In humans, signal detection techniques have been used to distinguish recollection and familiarity, respectively, in asymmetrical and curvilinear components of their receiver operating characteristic (ROC) curves, standard curves that represent item recognition across different levels of confidence or bias. To determine whether animals also employ multiple processes in recognition memory and to explore the anatomical basis of this distinction, we adapted these techniques to examine odour recognition memory in rats. Their ROC curve had asymmetrical and curvilinear components, indicating the existence of both recollection and familiarity in rats. Furthermore, following selective damage to the hippocampus the ROC curve became entirely symmetrical and remained curvilinear, supporting the view that the hippocampus specifically mediates the capacity for recollection.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Fortin, Norbert/0000-0002-6793-6984	NIA NIH HHS [P01 AG009973, P01 AG009973-070005] Funding Source: Medline; NIMH NIH HHS [R01 MH052090-05, R01 MH052090] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beason-Held LL, 1999, HIPPOCAMPUS, V9, P562, DOI 10.1002/(SICI)1098-1063(1999)9:5<562::AID-HIPO10>3.0.CO;2-X; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; HOCKLEY WE, 1992, J EXP PSYCHOL LEARN, V18, P1321, DOI 10.1037/0278-7393.18.6.1321; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; MacMillan N. A, 1991, DETECTION THEORY USE; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1998, J NEUROSCI, V18, P6568; Nemanic S, 2004, J NEUROSCI, V24, P2013, DOI 10.1523/JNEUROSCI.3763-03.2004; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Sherman SJ, 2003, BEHAV NEUROSCI, V117, P526, DOI 10.1037/0735-7044.117.3.526; Stark CEL, 2000, J NEUROSCI, V20, P7776; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	30	329	336	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					188	191		10.1038/nature02853	http://dx.doi.org/10.1038/nature02853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356631	Green Accepted			2022-12-01	WOS:000223746000045
J	Baumiller, TK; Gahn, FJ				Baumiller, TK; Gahn, FJ			Testing predator-driven evolution with paleozoic crinoid arm regeneration	SCIENCE			English	Article							FLOROMETRA-SERRATISSIMA ECHINODERMATA; ADAPTATIONS; AUTOTOMY; TIME	Regenerating arms of crinoids represent direct evidence of nonlethal attacks by predators and provide an opportunity for exploring the importance of predation through geologic time. Analysis of 11 Paleozoic crinoid Lagerstatten revealed a significant increase in arm regeneration during the Siluro-Devonian. During this interval, referred to as the Middle Pateozoic Marine Revolution, the diversity of shell-crushing predators increased, and antipredatory morphologies among invertebrate prey, such as crinoids, became more common. Crinoid arm-regeneration data suggest an increase in nonlethal attacks at this time and represent a causal link between those patterns, which implies an important role for predator-driven evolution.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48105 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian National Museum of Natural History	Baumiller, TK (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48105 USA.	tomaszb@umich.edu; gahn.forest@nmnh.si.edu	Baumiller, Tomasz K/C-3596-2012	Baumiller, Tomasz K/0000-0002-4506-9330				ALLMON WD, 1990, PALAEONTOLOGY, V33, P595; Baumiller T.K., 2003, P243; Baumiller TK, 2001, ECHINODERMS 2000, P3; BAUMILLER TK, 1994, ECHINODERMS THROUGH TIME, P193; Brett CE, 2003, T GEOBIOL, V20, P401; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; FISHELSON L, 1974, MAR BIOL, V26, P183, DOI 10.1007/BF00388888; FOOTE M, 1995, PALEOBIOLOGY, V21, P273, DOI 10.1017/S0094837300013300; HOLLAND ND, 1981, ZOOMORPHOLOGY, V98, P169, DOI 10.1007/BF00310434; MEYER DL, 1985, PALEOBIOLOGY, V11, P154, DOI 10.1017/S0094837300011477; MEYER DL, 1984, MAR BIOL, V78, P179, DOI 10.1007/BF00394698; MEYER DL, 1993, J PALEONTOL, V67, P250, DOI 10.1017/S0022336000032170; MLADENOV PV, 1983, CAN J ZOOL, V61, P2873, DOI 10.1139/z83-375; NEUMANN C, 1998, FOSSILIEN, P175; OJI T, 1994, PALEOBIOLOGY, V20, P27, DOI 10.1017/S0094837300011118; Oji T, 1996, PALEOBIOLOGY, V22, P339, DOI 10.1017/S0094837300016328; Schneider J.A., 1988, P531; SCOTESE CR, 1990, GEO SOC MEM, V12, P1, DOI 10.1144/GSL.MEM.1990.012.01.01; SIGNOR PW, 1984, PALEOBIOLOGY, V10, P229, DOI 10.1017/S0094837300008174; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VERMEIJ GJ, 1981, SCIENCE, V214, P1024, DOI 10.1126/science.214.4524.1024; VERMEIJ GJ, 1985, AM NAT, V125, P470, DOI 10.1086/284354; WATERS JA, 1991, PALEOBIOLOGY, V17, P400, DOI 10.1017/S0094837300010733	26	72	80	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1453	1455		10.1126/science.1101009	http://dx.doi.org/10.1126/science.1101009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353799				2022-12-01	WOS:000223761900045
J	Kiso, M; Mitamura, K; Sakai-Tagawa, Y; Shiraishi, K; Kawakami, C; Kimura, K; Hayden, FG; Sugaya, N; Kawaoka, Y				Kiso, M; Mitamura, K; Sakai-Tagawa, Y; Shiraishi, K; Kawakami, C; Kimura, K; Hayden, FG; Sugaya, N; Kawaoka, Y			Resistant influenza A viruses in children treated with oseltarnivir: descriptive study	LANCET			English	Article							INHIBITOR SUSCEPTIBILITY NETWORK; NEURAMINIDASE INHIBITORS; SIALIC-ACID; IN-VITRO; ACTIVE-SITE; OSELTAMIVIR; SELECTION; CELLS; 4-GUANIDINO-NEU5AC2EN; SENSITIVITY	Background Oseltamivir is an effective inhibitor of influenza virus neuraminidase. Although viruses resistant to oseltamivir emerge less frequently than those resistant to amantadine or rimantadine, information on oseltamivir-resistant viruses arising during clinical use of the drug in children is limited. Our aim was to investigate oseltamivir resistance in a group of children treated for influenza. Methods We analysed influenza A viruses (H3N2) collected from 50 children before and during treatment with oseltamivir. We sequenced the genes for neuraminidase and haemagglutinin and studied the mutant neuraminidases for their sensitivity to oseltamivir carboxylate. Findings We found neuraminidase mutations in viruses from nine patients (18%), six of whom had mutations at position 292 (Arg292Lys) and two at position 119 (Glu119Val), which are known to confer resistance to neuraminidase inhibitors. We also identified another mutation (Asn294Ser) in one patient. Sensitivity testing to oseltamivir carboxylate revealed that the neuraminidases of viruses that have an Arg292Lys, Glu119Val, or Asn294Ser mutation were about 10(4)-10(5)-fold, 500-fold, or 300-fold more resistant than their pretreatment neuraminidases, respectively. Oseltamivir-resistant viruses were first detected at day 4 of treatment and on each successive day of the study. More than 10(3) infectious units per mL of virus were detected in some of the patients who did not shed drug-resistant viruses, even after 5 days of treatment. Interpretation Oseltamivir-resistant mutants in children being treated for influenza with oseltamivir arise more frequently than previously reported. Furthermore, children can be a source of viral transmission, even after 5 days of treatment with oseltamivir.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; Kawasaki Municipal Hosp, Dept Paediat, Kawasaki, Kanagawa, Japan; Yokohama City Inst Hlth, Yokohama, Kanagawa, Japan; Isehara Kyodo Hosp, Dept Paediat, Isehara, Kanagawa, Japan; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Keiyu Hosp, Dept Paediat, Yokohama, Kanagawa, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; Japan Science & Technology Agency (JST); University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp						Barnett JM, 1999, VIROLOGY, V265, P286, DOI 10.1006/viro.1999.0058; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Herlocher ML, 2003, J INFECT DIS, V188, P1355, DOI 10.1086/379049; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Jackson HC, 2000, CLIN DRUG INVEST, V20, P447, DOI 10.2165/00044011-200020060-00007; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; OXFORD JS, 1970, NATURE, V226, P82, DOI 10.1038/226082a0; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Tisdale M, 2000, REV MED VIROL, V10, P45, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;45::AID-RMV265&gt;3.0.CO;2-R; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3	30	594	670	2	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					759	765		10.1016/S0140-6736(04)16934-1	http://dx.doi.org/10.1016/S0140-6736(04)16934-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337401				2022-12-01	WOS:000223569600026
J	Benvenuti, F; Hugues, S; Walmsley, M; Ruf, S; Fetler, L; Popoff, M; Tybulewicz, VLJ; Amigorena, S				Benvenuti, F; Hugues, S; Walmsley, M; Ruf, S; Fetler, L; Popoff, M; Tybulewicz, VLJ; Amigorena, S			Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; CYTOSKELETON; RHO; GTPASE	Upon maturation, dendritic cells (DCs) acquire the unique ability to activate naive T cells. We used time-lapse video microscopy and two-photon imaging of intact lymph nodes to show that after establishing initial contact between their dendrites and naive T lymphocytes, mature DCs migrate toward the contacted lymphocytes. Subsequently, the DCs; tightly entrap the T cells within a complex net of membrane extensions. The Rho family guanosine triphosphatases Rac1 and Rac2 but not Rho itself control the formation of dendrites in mature DCs, their polarized short-range migration toward T cells, and T cell priming.	Inst Curie, INSERM, U365, F-75005 Paris, France; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Inst Curie, CNRS, UMR 168, F-75005 Paris, France; Inst Pasteur, Unite Toxines Microbiennes, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Amigorena, S (corresponding author), Inst Curie, INSERM, U365, 26 Rue Ulm, F-75005 Paris, France.	sebastian.amigorena@curie.fr	Benvenuti, Federica/O-1100-2013; Fetler, luc/M-9034-2018	Benvenuti, Federica/0000-0002-1908-8052; Amigorena, Sebastian/0000-0001-8583-8416; hugues, stephanie/0000-0002-1031-5909; Tybulewicz, Victor/0000-0003-2439-0798				Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Kobayashi M, 2001, J IMMUNOL, V167, P3585, DOI 10.4049/jimmunol.167.7.3585; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997	16	188	197	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1150	1153		10.1126/science.1099159	http://dx.doi.org/10.1126/science.1099159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326354				2022-12-01	WOS:000223557400047
J	Lane, R				Lane, R			On reflection - The perils of myopia	LANCET			English	Article									Lancet, London NW1 7BY, England		Lane, R (corresponding author), Lancet, London NW1 7BY, England.								0	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					575	575		10.1016/S0140-6736(04)16834-7	http://dx.doi.org/10.1016/S0140-6736(04)16834-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15329944				2022-12-01	WOS:000223275100014
J	Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O				Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O			MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode	NATURE			English	Article							NEURONS; EXPRESSION; PATTERN; SYSTEM	Animal microRNAs ( miRNAs) are gene regulatory factors that prevent the expression of specific messenger RNA targets by binding to their 3' untranslated region(1-3). The Caenorhabditis elegans lsy-6 miRNA ( for lateral symmetry defective) is required for the left/right asymmetric expression of guanyl cyclase (gcy) genes in two chemosensory neurons termed ASE left (ASEL) and ASE right (ASER)(4,5). The asymmetric expression of these putative chemoreceptors in turn correlates with the functional lateralization of the ASE neurons(6). Here we find that a mutation in the die-1 zinc-finger transcription factor disrupts both the chemosensory laterality and left/right asymmetric expression of chemoreceptor genes in the ASE neurons. die-1 controls chemosensory laterality by activating the expression of lsy-6 specifically in ASEL, but not in ASER, where die-1 expression is downregulated through two sites in its 30 untranslated region. These two sites are complementary to mir-273, a previously uncharacterized miRNA, whose expression is strongly biased towards ASER. Forced bilateral expression of mir-273 in ASEL and ASER causes a loss of asymmetric die-1 expression and ASE laterality. Thus, an inverse distribution of two sequentially acting miRNAs in two bilaterally symmetric neurons controls laterality of the nematode chemosensory system.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Columbia University; University of Oregon	Hobert, O (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	or38@columbia.edu	Frøkjær-Jensen, Christian/ABB-4637-2020	Hobert, Oliver/0000-0002-7634-2854; Frokjaer-Jensen, Christian/0000-0002-3178-0906	NINDS NIH HHS [R01 NS050266-05, R01 NS050266] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulyk ML, 2004, GENOME BIOL, V5; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	17	269	315	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					785	789		10.1038/nature02752	http://dx.doi.org/10.1038/nature02752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306811				2022-12-01	WOS:000223233600043
J	Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL				Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL			Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; BETA-CATENIN; GENE-TRANSFER; CHRONIC-PHASE; BONE-MARROW; IN-VITRO; ACTIVATION; EXPRESSION	Background: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the (beta)-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the (beta)-catenin pathway for self-renewal. Methods: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, (beta)-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear (beta)-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on (beta)-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the (beta)-catenin pathway. Results: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear (beta)-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. Conclusions: Activation of (beta)-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.	Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Inst Canc & Stem Cell Biol & Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Univ Calif Los Angeles, Los Angeles, CA USA	Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Los Angeles	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, 279 Campus Dr, Stanford, CA 94305 USA.	ljquinn@stanford.edu	Sawyers, Charles/G-5327-2016; Manz, Markus G/C-7588-2011	Manz, Markus/0000-0002-4676-7931	NATIONAL CANCER INSTITUTE [P01CA049605, R01CA086017] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NCI NIH HHS [2PO1CA49605, CA86017, CA55209] Funding Source: Medline; NHLBI NIH HHS [K23 HL04409] Funding Source: Medline; NIAID NIH HHS [5T32AI07290] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFAR DEH, 1995, P NATL ACAD SCI USA, V92, P9540, DOI 10.1073/pnas.92.21.9540; AFAR DEH, 1994, SCIENCE, V264, P424, DOI 10.1126/science.8153630; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Chomel JC, 2000, BLOOD, V95, P404, DOI 10.1182/blood.V95.2.404; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Haraguchi K, 2004, BIOCHEM BIOPH RES CO, V313, P841, DOI 10.1016/j.bbrc.2003.12.021; Huettner CS, 2003, BLOOD, V102, P3363, DOI 10.1182/blood-2003-03-0768; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, RES PER NEUROSCI, P157; Jones CD, 2003, AM J CLIN PATHOL, V120, P42, DOI 10.1309/60A9C8WGEGHRNXEE; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NOWELL PC, 1960, SCIENCE, V132, P1497; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Raaijmakers MHGP, 2002, EXP HEMATOL, V30, P481, DOI 10.1016/S0301-472X(02)00787-7; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schmelz EM, 2001, CANCER RES, V61, P6723; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sirard C, 1996, BLOOD, V87, P1539, DOI 10.1182/blood.V87.4.1539.bloodjournal8741539; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; UDOMSAKDI C, 1992, P NATL ACAD SCI USA, V89, P6192, DOI 10.1073/pnas.89.13.6192; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	58	1154	1262	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					657	667		10.1056/NEJMoa040258	http://dx.doi.org/10.1056/NEJMoa040258			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306667	Bronze			2022-12-01	WOS:000223225500008
J	Clark, M; Price, PE				Clark, M; Price, PE			Is wound healing a true science or a clinical art?	LANCET			English	Editorial Material							GENE-TRANSFER		Cardiff Univ, Cardiff Medictr, Wound Healing Res Unit, Cardiff CF14 4UJ, S Glam, Wales	Cardiff University	Clark, M (corresponding author), Cardiff Univ, Cardiff Medictr, Wound Healing Res Unit, Heath Pk, Cardiff CF14 4UJ, S Glam, Wales.	clarkm@whru.co.uk						Andreadis ST, 2004, EXPERT OPIN BIOL TH, V4, P783, DOI 10.1517/14712598.4.6.783; Appleton I, 2003, IDRUGS, V6, P1067; Cullum N, 2004, COCHRANE LIB; Eming SA, 2004, EXPERT OPIN BIOL TH, V4, P1373, DOI 10.1517/14712598.4.9.1373; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Mustoe T, 2004, AM J SURG, V187, p65S, DOI 10.1016/S0002-9610(03)00306-4; Severens Johan L, 2002, Adv Skin Wound Care, V15, P72, DOI 10.1097/00129334-200203000-00008; Tomic-Canic M, 2004, AM J SURG, V188, p67S, DOI 10.1016/S0002-9610(03)00293-9	8	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1388	1389		10.1016/S0140-6736(04)17240-1	http://dx.doi.org/10.1016/S0140-6736(04)17240-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488204				2022-12-01	WOS:000224485300009
J	Malasarn, D; Saltikov, W; Campbell, KM; Santini, JM; Hering, JG; Newman, DK				Malasarn, D; Saltikov, W; Campbell, KM; Santini, JM; Hering, JG; Newman, DK			arrA is a reliable marker for As(V) respiration	SCIENCE			English	Article									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia	California Institute of Technology; California Institute of Technology; California Institute of Technology; La Trobe University	Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu		Campbell, Kate/0000-0002-8715-5544				Akai J, 2004, APPL GEOCHEM, V19, P215, DOI 10.1016/j.apgeochem.2003.09.008; Harvey CF, 2002, SCIENCE, V298, P1602, DOI 10.1126/science.1076978; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kneebone PE, 2002, ENVIRON SCI TECHNOL, V36, P381, DOI 10.1021/es010922h; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093	7	190	198	9	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					455	455		10.1126/science.1102374	http://dx.doi.org/10.1126/science.1102374			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486292				2022-12-01	WOS:000224626500043
J	Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR				Mandal, M; Lee, M; Barrick, JE; Weinberg, Z; Emilsson, GM; Ruzzo, WL; Breaker, RR			A glycine-dependent riboswitch that uses cooperative binding to control gene expression	SCIENCE			English	Article							MESSENGER-RNA STRUCTURE; MECHANISM; TRANSCRIPTION	We identified a previously unknown riboswitch class in bacteria that is selectively triggered by glycine. A representative of these glycine-sensing RNAs from Bacillus subtilis operates as a rare genetic on switch for the gcvT operon, which codes for proteins that form the glycine cleavage system. Most glycine riboswitches integrate two ligand-binding domains that function cooperatively to more closely approximate a two-state genetic switch. This advanced form of riboswitch may have evolved to ensure that excess glycine is efficiently used to provide carbon flux through the citric acid cycle and maintain adequate amounts of the amino acid for protein synthesis. Thus, riboswitches perform key regulatory roles and exhibit complex performance characteristics that previously had been observed only with protein factors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Yale University; Yale University; University of Washington; University of Washington Seattle	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X; Weinberg, Zasha/0000-0002-6681-3624; Ruzzo, Walter L./0000-0002-6260-2926; Lee, Mark/0000-0002-9576-9589				ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Hill A, 1910, J PHYSIOL-LONDON, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Jose AM, 2001, NUCLEIC ACIDS RES, V29, P1631, DOI 10.1093/nar/29.7.1631; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KURGANOV BI, 1978, ALLOSTERIC ENZYMES; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M., UNPUB; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Ptashne M., 2002, GENES SIGNALS; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; SUDARSAN N, 1932, GENE DEV, V17, P2688; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; WEISSBLUTH M, 1974, MOL BIOL BIOCH BIOPH, V15, P27; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	28	391	432	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					275	279		10.1126/science.1100829	http://dx.doi.org/10.1126/science.1100829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472076				2022-12-01	WOS:000224419700040
J	Zhang, SF; Ma, C; Chalfie, M				Zhang, SF; Ma, C; Chalfie, M			Combinatorial marking of cells and organelles with reconstituted fluorescent proteins	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; MOTOR-NEURONS; SYNAPTIC-TRANSMISSION; GENE-EXPRESSION; COMPLEMENTATION; IDENTIFICATION; VISUALIZATION; HOMEOPROTEIN; SENSITIVITY	Expression of GFP and other fluorescent proteins depends on cis-regulatory elements. Because these elements rarely direct expression to specific cell types, GFP production cannot always be sufficiently limited. Here we show that reconstitution of GFP, YFP, and CFP previously split into two polypeptides yields fluorescent products when coexpressed in C. elegans. Because this reconstitution involves two components, it can confirm cellular coexpression and identify cells expressing a previously uncharacterized promoter. By choosing promoters whose expression patterns overlap for a single cell type, we can produce animals with fluorescence only in those cells. Furthermore, when one partial GFP polypeptide is fused with a subcellularly localized protein or peptide, this restricted expression leads to the fluorescent marking of cellular components in a subset of cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030997, GM30997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRENNER S, 1974, GENETICS, V77, P71; Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 2004, GREEN FLUORESCENT PR; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Doi N, 1999, FEBS LETT, V453, P305, DOI 10.1016/S0014-5793(99)00732-2; Du HP, 2001, GENETICS, V158, P197; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ozawa T, 2000, ANAL CHEM, V72, P5151, DOI 10.1021/ac000617z; Ozawa T, 2001, ANAL CHEM, V73, P5866, DOI 10.1021/ac010717k; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Umezawa Y, 2003, CHEM REC, V3, P22, DOI 10.1002/tcr.10049; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Wu J, 2001, GENE DEV, V15, P789, DOI 10.1101/gad.857401; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	34	109	169	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					137	+		10.1016/j.cell.2004.09.012	http://dx.doi.org/10.1016/j.cell.2004.09.012			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454087	Bronze			2022-12-01	WOS:000224292600015
J	Falkowski, PG; Davis, CS				Falkowski, PG; Davis, CS			Natural proportions	NATURE			English	Article									Rutgers State Univ, Inst Marine & Coastal Sci, Princeton, NJ 08540 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Princeton, NJ 08540 USA.							Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Hedin LO, 2004, P NATL ACAD SCI USA, V101, P10849, DOI 10.1073/pnas.0404222101; Redfield A. C., 1934, P176; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI 10.1515/9781400885695	4	42	46	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					131	131		10.1038/431131a	http://dx.doi.org/10.1038/431131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356609	Bronze			2022-12-01	WOS:000223746000019
J	Kalisz, S; Vogler, DW; Hanley, KM				Kalisz, S; Vogler, DW; Hanley, KM			Context-dependent autonomous self-fertilization yields reproductive assurance and mixed mating	NATURE			English	Article							INBREEDING DEPRESSION; CROSS-FERTILIZATION; EVOLUTION; PLANTS; POLLINATION; ECOLOGY; SYSTEMS; COST	The evolution of self-fertilization in hermaphrodites is opposed by costs that decrease the value of self progeny relative to that of outcross progeny1-3. However, self-fertilization is common in plants(4); 20% are highly selfing and 33% are intermediate between selfing and outcrossing(5). Darwin(6) proposed an adaptive benefit of self-pollination in providing reproductive assurance when outcrossing is impossible(6-9). Moreover, if outcross pollen receipt is inconsistent within or between years, these conditions likewise favour self-pollination(10), and this can result in a mixture of self and outcross seed production ( mixed mating). Despite wide acceptance, the reproductive assurance hypothesis has lacked the support of complete empirical evidence to show that variable pollination can create both the ecological and genetic conditions favouring self-pollination. We recently showed in Collinsia verna that during periods of infrequent pollinator visits, autonomous self-pollination boosted seed output per flower(11), the key ecological condition. Here we show low inbreeding depression and marker-based estimates of selfing, demonstrating that when the pollination environment in wild populations necessitates reproductive assurance, selfing rates increase. We provide a complete demonstration of reproductive assurance under variable pollination environments and mechanistically link reproductive assurance to intermediate selfing rates through mixed mating.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; SUNY Coll Oneonta, Dept Biol, Oneonta, NY 13820 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System	Kalisz, S (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	kalisz@pitt.edu						BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 1996, PHILOS T R SOC B, V351, P1271, DOI 10.1098/rstb.1996.0110; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Cruden R.W., 1989, EVOLUTIONARY ECOLOGY, P171; Darwin C. R., 1876, EFFECTS CROSS SELF F; Fausto JA, 2001, AM J BOT, V88, P1794, DOI 10.2307/3558355; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; HOLSINGER KE, 1991, AM NAT, V138, P606, DOI 10.1086/285237; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Husband BC, 1996, EVOLUTION, V50, P54, DOI 10.1111/j.1558-5646.1996.tb04472.x; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; Johnston MO, 1998, GENETICA, V102-3, P267, DOI 10.1023/A:1017039010191; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; Kalisz S, 2003, ECOLOGY, V84, P2928, DOI 10.1890/02-0519; Kalisz S, 1999, AM J BOT, V86, P1239, DOI 10.2307/2656771; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Ritland K., MULTILOCUS MATING SY; Schoen DJ, 1996, PHILOS T R SOC B, V351, P1281, DOI 10.1098/rstb.1996.0111; SCHOEN DJ, 1992, INT J PLANT SCI, V153, P381, DOI 10.1086/297042; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Stebbins G.L., 1974, FLOWERING PLANTS EVO; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x	30	325	347	4	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					884	887		10.1038/nature02776	http://dx.doi.org/10.1038/nature02776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318220				2022-12-01	WOS:000223369800040
J	Daley, GQ				Daley, GQ			Missed opportunities in embryonic stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.							COOK G, 2004, BOSTON GLOBE    0523, pA14; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330	2	27	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					627	628		10.1056/NEJMp048200	http://dx.doi.org/10.1056/NEJMp048200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15302910				2022-12-01	WOS:000223225500001
J	Hedwig, B; Poulet, JFA				Hedwig, B; Poulet, JFA			Complex auditory behaviour emerges from simple reactive steering	NATURE			English	Article							PATTERN-RECOGNITION; TEMPORAL PATTERN; FEMALE CRICKETS; CALLING SONG; ACOUSTIC COMMUNICATION; PHONOTACTIC BEHAVIOR; GRYLLUS-BIMACULATUS; FLYING CRICKETS; GRYLLIDAE; SYSTEM	The recognition and localization of sound signals is fundamental to acoustic communication(1,2). Complex neural mechanisms are thought to underlie the processing of species-specific sound patterns even in animals with simple auditory pathways(3,4). In female crickets, which orient towards the male's calling song, current models propose pattern recognition mechanisms based on the temporal structure of the song(5-7). Furthermore, it is thought that localization is achieved by comparing the output of the left and right recognition networks, which then directs the female to the pattern that most closely resembles the species-specific song(8-10). Here we show, using a highly sensitive method for measuring the movements of female crickets, that when walking and flying each sound pulse of the communication signal releases a rapid steering response. Thus auditory orientation emerges from reactive motor responses to individual sound pulses. Although the reactive motor responses are not based on the song structure, a pattern recognition process may modulate the gain of the responses on a longer timescale. These findings are relevant to concepts of insect auditory behaviour and to the development of biologically inspired robots performing cricket-like auditory orientation(11-13).	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hedwig, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	bh202@cam.ac.uk; jfap2@cam.ac.uk		Poulet, James/0000-0003-0296-5415	Biotechnology and Biological Sciences Research Council [S19133] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARKIN RC, 1998, BEHAV BASED ROBOTICS, P24302; Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; CADE WH, 1979, CAN ENTOMOL, V111, P741, DOI 10.4039/Ent111741-6; DOHERTY JA, 1985, J EXP BIOL, V114, P17; DOHERTY JA, 1991, J COMP PHYSIOL A, V168, P213, DOI 10.1007/BF00218413; GERHARD HC, 2002, ACOUSTIC COMMUNICATI, P24302; Hedwig B, 2000, J NEUROSCI METH, V100, P165, DOI 10.1016/S0165-0270(00)00255-7; Hennig RM, 2003, J COMP PHYSIOL A, V189, P589, DOI 10.1007/s00359-003-0438-7; HOY RR, 1978, FED PROC, V37, P2316; Huber F., 1990, Advances in the Study of Behavior, V19, P299, DOI 10.1016/S0065-3454(08)60206-5; MOISEFF A, 1978, P NATL ACAD SCI USA, V75, P4052, DOI 10.1073/pnas.75.8.4052; MURPHEY RK, 1972, J EXP BIOL, V56, P335; Nabatiyan A, 2003, J NEUROPHYSIOL, V90, P2484, DOI 10.1152/jn.00259.2003; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; POLLACK GS, 1986, J COMP PHYSIOL A, V158, P549, DOI 10.1007/BF00603799; Pollack GS, 2001, CURR OPIN NEUROBIOL, V11, P734, DOI 10.1016/S0959-4388(01)00277-X; POLLACK GS, 1981, J INSECT PHYSIOL, V27, P41, DOI 10.1016/0022-1910(81)90030-5; POPOV AV, 1977, J COMP PHYSIOL, V119, P111, DOI 10.1007/BF00655876; Schildberger K., 1989, P423; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; SCHMITZ B, 1982, J COMP PHYSIOL, V148, P431, DOI 10.1007/BF00619782; STABEL J, 1989, J COMP PHYSIOL A, V165, P165, DOI 10.1007/BF00619191; ULAGARAJ SM, 1973, SCIENCE, V182, P1278, DOI 10.1126/science.182.4118.1278; VONHELVERSEN D, 1995, J COMP PHYSIOL A, V177, P767, DOI 10.1007/BF00187635; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; Webb B, 2000, BIOL CYBERN, V82, P247, DOI 10.1007/s004220050024; WEBER T, 1988, J COMP PHYSIOL A, V163, P13, DOI 10.1007/BF00611992; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weber T., 1989, P310; WEBSTER DB, 1992, EVOLUTIONARY BIOL HE, P24302	30	84	85	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					781	785		10.1038/nature02787	http://dx.doi.org/10.1038/nature02787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306810				2022-12-01	WOS:000223233600042
J	Mimura, S; Seki, T; Tanaka, S; Diffley, JFX				Mimura, S; Seki, T; Tanaka, S; Diffley, JFX			Phosphorylation-dependent binding of mitotic cyclins to Cdc6 contributes to DNA replication control	NATURE			English	Article							S-PHASE; MOLECULAR-BASIS; PROTEIN; PROTEOLYSIS; DOMAIN; SPECIFICITY; COMPONENT; KINASES; TARGETS	Cyclin-dependent kinases (CDKs) limit the activation of DNA replication origins to once per cell cycle by preventing the assembly of pre-replicative complexes (pre-RCs) during S, G2 and M phases of the cell cycle in the budding yeast Saccharomyces cerevisiae(1,2). CDKs inhibit each pre-RC component (ORC, Cdc6, Cdt1/Mcm2-7) by different mechanisms. We show here that the mitotic CDK, Clb2/Cdc28, binds tightly to an amino-terminal domain (NTD) of Cdc6, and that Cdc6 in this complex is unable to assemble pre-RCs. We present evidence indicating that this Clb2-dependent mechanism contributes to preventing rereplication in vivo. CDK interaction with the NTD of Cdc6 is mediated by the cyclin subunit Clb2, and could be reconstituted with recombinant Clb2 protein and synthetic NTD peptides. Tight Clb2 binding occurred only when the NTD was phosphorylated on CDK consensus sites. Human CDKs containing cyclins A, B and E also bound specifically to phospho-NTD peptides. We propose that direct binding of cyclins to phosphopeptide motifs may be a widespread phenomenon contributing to the targeting of CDKs to substrates.	Canc Res UK London Res Inst, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	john.diffley@cancer.org.uk	Tanaka, Seiji/Q-8601-2019	Tanaka, Seiji/0000-0003-3882-3494; Diffley, John/0000-0001-5184-7680				Adams PD, 1999, MOL CELL BIOL, V19, P1068; Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; HALFORD KA, 2003, BIOCH ANAL YEAST PRE; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304	23	89	89	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1118	1123		10.1038/nature03024	http://dx.doi.org/10.1038/nature03024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15496876				2022-12-01	WOS:000224730800045
J	Currie, MP; Karwatowski, SP; Perera, J; Langford, EJ				Currie, MP; Karwatowski, SP; Perera, J; Langford, EJ			Introduction of nurse led DC cardioversion service in day surgery unit: prospective audit	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE PATIENTS; ATRIAL-FIBRILLATION; SUICIDAL IDEATION; AMERICAN-COLLEGE; TASK-FORCE; OLDER; DEPRESSION; BEHAVIOR; SOCIETY; PEOPLE	Problem Atrial fibrillation is the most common persistent arrhythmia in adults and carries an increased risk of thromboembolism and stroke. Electrical (DC) cardioversion is an effective treatment, but logistical difficulties in many institutions lead to problems providing a prompt service. This reduces the rate of long term success, delays relief of symptoms, and increases the burden on anticoagulation clinics. Design Prospective audit of introduction of a collaborative, nurse led DC cardioversion service in a day surgery unit. Setting Day surgery unit 5 km from an acute hospital in southeast London. Key measures for improvement Waiting times, success of procedures, and complication rates. Strategies for change Collaborative working across traditional specialty boundaries; empowerment of patients within the process; using a nurse consultant as a single point of reference to coordinate the service. Effects of change Sinus rhythm was restored in 131 (92%) of the first 143 patients treated. Three patients needed hospital admission; all were discharged uneventfully within 24 hours. No important complications occurred. Waiting times were reduced from 27 weeks to eight weeks for patients eligible for the service. Lessons learnt Elective DC cardioversion under general anaesthesia can be safely done by an appropriately trained nurse in a day surgery unit remote from an acute general hospital. This model of care is effective and can reduce waiting times and relieve pressure on acute beds and junior doctors.	Princess Royal Univ Hosp, Bromley Hosp NHS Trust, Dept Cardiol, Orpington BR6 8ND, Kent, England; Bromley Hosp NHS Trust, Dept Anaesthet, Day Surg Unit, Bromley, England		Currie, MP (corresponding author), Princess Royal Univ Hosp, Bromley Hosp NHS Trust, Dept Cardiol, Orpington BR6 8ND, Kent, England.	mary.currie@bromleyhospitals.nhs.uk						Alexopoulos GS, 1999, ARCH GEN PSYCHIAT, V56, P1048, DOI 10.1001/archpsyc.56.11.1048; Bartels SJ, 2002, AM J GERIAT PSYCHIAT, V10, P417, DOI 10.1176/appi.ajgp.10.4.417; Beautrais AL, 2002, SUICIDE LIFE-THREAT, V32, P1, DOI 10.1521/suli.32.1.1.22184; Callahan CM, 1996, J AM GERIATR SOC, V44, P1205, DOI 10.1111/j.1532-5415.1996.tb01370.x; CONWELL Y, 1990, J AM GERIATR SOC, V38, P640, DOI 10.1111/j.1532-5415.1990.tb01422.x; Cook JM, 2002, AM J GERIAT PSYCHIAT, V10, P437, DOI 10.1176/appi.ajgp.10.4.437; De Leo D, 2002, BRIT J PSYCHIAT, V181, P226, DOI 10.1192/bjp.181.3.226; De Leo D, 1990, DEPRESSION SUICIDE L; DEBEAUVOIR S, 1972, COMING AGE, P522; Department of Health, 2001, REF GUID CONS EX TRE; Duberstein PR, 2004, PSYCHOL MED, V34, P137, DOI 10.1017/S0033291703008584; Erlangsen A, 2003, J GERONTOL B-PSYCHOL, V58, pS314, DOI 10.1093/geronb/58.5.S314; FOSTER JR, 1984, HDB STUDIES PSYCHIAT, P265; Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983; Gallo JJ, 1994, J GERONTOL, V49, P251; HARRIS EC, 1994, MEDICINE, V73, P281, DOI 10.1097/00005792-199411000-00001; Harwood D, 2001, INT J GERIATR PSYCH, V16, P155, DOI 10.1002/1099-1166(200102)16:2<155::AID-GPS289>3.0.CO;2-0; Jackson A, 2002, NURS TIMES, V98, P34; JONES JS, 1990, AM J PSYCHIAT, V147, P1225; JORM AF, 1995, AGE AGEING, V24, P389, DOI 10.1093/ageing/24.5.389; Lykouras L, 2002, J AFFECT DISORDERS, V69, P225, DOI 10.1016/S0165-0327(00)00322-0; NAKRA B, 1990, VERWOERDTS CLIN GERO, P107; Quinn T, 1998, Nurs Crit Care, V3, P59; RAO R, 1998, BRIT MED J, V317, pB1016; Rubio A, 2001, BIOL PSYCHIAT, V49, P137, DOI 10.1016/S0006-3223(00)00952-5; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; Skoog I, 1996, AM J PSYCHIAT, V153, P1015; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Tracy CM, 2000, J AM COLL CARDIOL, V36, P1725, DOI 10.1016/S0735-1097(00)01085-8; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	30	15	15	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					892	895B		10.1136/bmj.329.7471.892	http://dx.doi.org/10.1136/bmj.329.7471.892			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863MU	15485966	Green Published			2022-12-01	WOS:000224566800018
J	Afshar, K; Willard, FS; Colombo, K; Johnston, CA; McCudden, CR; Siderovski, DP; Gonczy, P				Afshar, K; Willard, FS; Colombo, K; Johnston, CA; McCudden, CR; Siderovski, DP; Gonczy, P			RIC-8 is required for GPR-1/2-Dependent G alpha function during asymmetric division of C-elegans embryos	CELL			English	Article							CELL-DIVISION; GOLOCO MOTIF; G-PROTEINS; DROSOPHILA NEUROBLAST; GUANINE-NUCLEOTIDES; SPINDLE POSITION; DISTINCT ROLES; BETA-GAMMA; COMPLEX; ORIENTATION	Heterotrimeric G proteins are crucial for asymmetric cell division, but the mechanisms of signal activation remain poorly understood. Here, we establish that the evolutionarily conserved protein RIC-8 is required for proper asymmetric division of one-cell stage C. elegans embryos. Spindle severing experiments demonstrate that RIC-8 is required for generation of substantial pulling forces on astral microtubules. RIC-8 physically interacts with GOA-1 and GPA-16, two Galpha subunits that act in a partially redundant manner in one-cell stage embryos. RIC-8 preferentially binds to GDP bound GOA-1 and is a guanine nucleotide exchange factor (GEF) for GOA-1. Our analysis suggests that RIC-8 acts before the GoLoco protein GPR-1/2 in the sequence of events leading to Galpha activation. Furthermore, coimmunoprecipitation and in vivo epistasis demonstrate that inactivation of the Gbeta subunit GPB-1 alleviates the need for RIC-8 in one-cell stage embryos. Our findings suggest a mechanism in which RIC-8 favors generation of Galpha free from Gbetagamma and enables GPR-1/2 to mediate asymmetric cell division.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	Swiss Institute Experimental Cancer Research; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	pierre.gonczy@isrec.unil.ch	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; McCudden, Christopher/0000-0002-4172-4641; Gonczy, Pierre/0000-0002-6305-6883	NIGMS NIH HHS [GM62338, GM065533] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062338, P01GM065533] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oxford GS, 2004, METHOD ENZYMOL, V390, P437; Pichler S, 2000, DEVELOPMENT, V127, P2063; Praitis V, 2001, GENETICS, V157, P1217; Robatzek M, 2000, GENETICS, V156, P1069; Ross EM, 1999, CRC METH SIG TRANS, P123; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	38	148	155	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					219	230		10.1016/j.cell.2004.09.026	http://dx.doi.org/10.1016/j.cell.2004.09.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479639	Bronze, Green Published			2022-12-01	WOS:000224577200010
J	Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R				Fraidenraich, D; Stillwell, E; Romero, E; Wilkes, D; Manova, K; Basson, CT; Benezra, R			Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells	SCIENCE			English	Article							GROWTH-FACTOR-I; TRANSGENIC MICE; GENE; EXPRESSION; PROLIFERATION; MORPHOGENESIS; DIFFERENTIATION; OVEREXPRESSION; NEUROGENESIS; INDUCTION	We report that Id knockout mouse embryos display multiple cardiac defects, but mid-gestation lethality is rescued by the injection of 15 wild-type embryonic stem (ES) cells into mutant blastocysts. Myocardial markers altered in Id mutant cells are restored to normal throughout the chimeric myocardium. Intraperitoneal injection of ES cells into female mice before conception also partially rescues the cardiac phenotype with no incorporation of ES cells. Insulin-like growth factor 1, a long-range secreted factor, in combination with WNT5a, a locally secreted factor, likely account for complete reversion of the cardiac phenotype. Thus, ES cells have the potential to reverse congenital defects through Id-dependent local and long-range effects in a mammalian embryo.	Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Mol Cytol Core Facil, Weill Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cornell Univ, Mol Cardiol Lab, Weill Med Coll, Greenberg Cardiol Div,Dept Med, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Benezra, R (corresponding author), Cornell Univ, Canc Biol & Genet Program, Weill Med Coll, New York, NY 10021 USA.	r-benezra@ski.mskcc.org			NCI NIH HHS [R01 CA107429, R01CA107429] Funding Source: Medline; NHLBI NIH HHS [K01 HL076568, KO1HL076568] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL076568] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMO M, 1989, ENDOCRINOLOGY, V124, P2737, DOI 10.1210/endo-124-6-2737; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen J, 1998, DEVELOPMENT, V125, P1943; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Clouthier DE, 2003, DEV BIOL, V261, P506, DOI 10.1016/S0012-1606(03)00128-3; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Jen Y, 1996, DEV DYNAM, V207, P235; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Tran CM, 1998, DEVELOPMENT, V125, P1951; Wu H, 1999, DEVELOPMENT, V126, P3597; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	21	153	172	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					247	252		10.1126/science.1102612	http://dx.doi.org/10.1126/science.1102612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472070	Green Accepted			2022-12-01	WOS:000224419700031
J	Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL				Foster, KR; Shaulsky, G; Strassmann, JE; Queller, DC; Thompson, CRL			Pleiotropy as a mechanism to stabilize cooperation	NATURE			English	Article							AMEBA DICTYOSTELIUM-DISCOIDEUM; SOCIAL AMEBA; EVOLUTION; EXPRESSION; DIF-1	Most genes affect many traits(1-4). This phenomenon, known as pleiotropy, is a major constraint on evolution because adaptive change in one trait may be prevented because it would compromise other traits affected by the same genes(2,4). Here we show that pleiotropy can have an unexpected effect and benefit one of the most enigmatic of adaptations-cooperation. A spectacular act of cooperation occurs in the social amoeba Dictyostelium discoideum, in which some cells die to form a stalk that holds the other cells aloft as reproductive spores(5,6). We have identified a gene, dimA(7), in D. discoideum that has two contrasting effects. It is required to receive the signalling molecule DIF-1 that causes differentiation into prestalk cells. Ignoring DIF-1 and not becoming prestalk should allow cells to cheat by avoiding the stalk. However, we find that in aggregations containing the wildtype cells, lack of the dimA gene results in exclusion from spores. This pleiotropic linkage of stalk and spore formation limits the potential for cheating in D. discoideum because defecting on prestalk cell production results in an even greater reduction in spores. We propose that the evolution of pleiotropic links between cheating and personal costs can stabilize cooperative adaptations.	Rice Univ, Houston, TX 77005 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	Rice University; Baylor College of Medicine; University of Manchester	Foster, KR (corresponding author), Rice Univ, Houston, TX 77005 USA.	krfoster@rice.edu; christopher.thompson@man.ac.uk		Strassmann, Joan/0000-0003-0638-8440; Foster, Kevin/0000-0003-4687-6633; Shaulsky, Gad/0000-0002-0532-0551				Atzmony D, 1997, CURR SCI INDIA, V72, P142; BARTON NH, 1990, GENETICS, V124, P773; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Frank SA, 2003, EVOLUTION, V57, P693; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; JERMYN KA, 1991, DEVELOPMENT, V111, P779; Kay RR, 2001, DEVELOPMENT, V128, P4959; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Keller L, 1999, LEVELS SELECTION EVO; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; LEACH CK, 1973, J EMBRYOL EXP MORPH, V29, P647; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Nunney L, 1999, MG BEH ECOL, P238; Otto SP, 2004, P ROY SOC B-BIOL SCI, V271, P705, DOI 10.1098/rspb.2003.2635; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Thompson CRL, 2000, DEV BIOL, V227, P56, DOI 10.1006/dbio.2000.9877; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Travisano M, 2004, TRENDS MICROBIOL, V12, P72, DOI 10.1016/j.tim.2003.12.009; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Vulic M, 2001, GENETICS, V158, P519; Wright S., 1968, EVOLUTION GENETICS P, V1	30	193	198	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					693	696		10.1038/nature02894	http://dx.doi.org/10.1038/nature02894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470429				2022-12-01	WOS:000224299300041
J	Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ				Gunnarsson, TG; Gill, JA; Sigurbjornsson, T; Sutherland, WJ			Pair bonds - Arrival synchrony in migratory birds	NATURE			English	Editorial Material									Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; Langhus, IS-570 Fljot, Iceland	University of East Anglia; University of East Anglia	Gunnarsson, TG (corresponding author), Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	t.gunnarsson@uea.ac.uk	Gill, Jennifer A/A-7759-2008; Sutherland, William/B-1291-2013; Gunnarsson, Tomas G/L-9783-2015	Gunnarsson, Tomas Gretar/0000-0001-7692-0637; Sutherland, William/0000-0002-6498-0437				COULSON JC, 1980, P INT ORN C, V17, P823; Ens B.J., 1996, PARTNERSHIPS BIRDS S, P344; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; GUNNARSSON TG, IN PRESS BIRD STUDY; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Reynolds JD, 1997, BEHAV ECOL, V8, P126, DOI 10.1093/beheco/8.2.126	6	71	75	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					646	646		10.1038/431646a	http://dx.doi.org/10.1038/431646a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470417				2022-12-01	WOS:000224299300029
J	Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J				Frosh, A; Smith, LC; Jackson, CJ; Linehan, JM; Brandner, S; Wadsworth, JDF; Collinge, J			Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; ACCUMULATION; APPENDIX; SAMPLES	Variant Creutzfeldt-Jakob disease (CJD) is thought to be caused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions. The prevalence of preclinical or subclinical prion infection in the UK is currently unknown. Since clinical variant CJD is uniformly associated with tonsillar prion infection, we screened 2000 anonymous surgical tonsillectomy specimens for disease-associated prion protein. Analysis by both high sensitivity immunoblotting and immunohistochemistry detected no positive cases. However, this negative result cannot provide reassurance that relevant community infection is unlikely because of the fairly small sample size, demographic and age-related factors, and unknown test sensitivity during the prolonged incubation period. Nevertheless, our findings establish a protocol for prevalence screening on a national scale.	Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), Natl Hosp Neurol & Neurosurg, Inst Neurol, Univ Coll, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; FRASER H, 1992, PRION DIS HUMANS ANI; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	10	48	52	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1260	1262		10.1016/S0140-6736(04)17143-2	http://dx.doi.org/10.1016/S0140-6736(04)17143-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464187				2022-12-01	WOS:000224254200033
J	Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N				Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N			Pure red-cell aplasia and epoetin therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ANTIERYTHROPOIETIN ANTIBODIES	BACKGROUND: Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998 and 2000, 13 such cases were reported from France -- 12 in patients who had received the Eprex formulation of epoetin alfa and 1 in a patient who had received Neorecormon (a formulation of epoetin beta); both are products that are marketed outside the United States. METHODS: We obtained reports of epoetin-associated pure red-cell aplasia from the Food and Drug Administration and from the manufacturers of Eprex, Epogen (another formulation of epoetin alfa), and Neorecormon. The numbers of case reports and estimates of exposure-adjusted incidence were analyzed according to the product, the cause of anemia, the route of administration, the country in which pure red-cell aplasia was identified, and the date on which pure red-cell aplasia was reported. RESULTS: Between January 1998 and April 2004, 175 cases of epoetin-associated pure red-cell aplasia were reported for Eprex, 11 cases for Neorecormon, and 5 cases for Epogen. Over half these cases had occurred in France, Canada, the United Kingdom, and Spain. Between 2001 and 2003, the estimated exposure-adjusted incidence was 18 cases per 100,000 patient-years for the Eprex formulation without human serum albumin, 6 per 100,000 patient-years for the Eprex formulation with human serum albumin, 1 case per 100,000 patient-years for Neorecormon, and 0.2 case per 100,000 patient-years for Epogen. After procedures were adopted to ensure appropriate storage, handling, and administration of Eprex to patients with chronic kidney disease, the exposure-adjusted incidence decreased by 83 percent worldwide. CONCLUSIONS: After the peak incidence of Eprex-associated pure red-cell aplasia was reached in 2001, interventions designed in response to drug-monitoring programs worldwide resulted in a reduction of more than 80 percent in the incidence of pure red-cell aplasia due to Eprex.	Northwestern Univ, Feinberg Sch Med, Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; NW Mem Hosp, Dept Pharm, Chicago, IL 60611 USA; Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL USA; Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy; Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA USA; Univ New Mexico, Vet Affairs Cooperat Study Program Clin Res Pharm, Albuquerque, NM 87131 USA; A Manzoni Hosp, Dept Nephrol & Dialysis, Lecce, Italy; Univ Paris 06, Tenon Hosp, Dept Nephrol, Paris, France; Hop Hotel Dieu, Dept Hematol, Paris, France; INSERM, U352, Paris, France	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universita di Modena e Reggio Emilia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bennett, CL (corresponding author), Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv & Policy Res, 333 E Huron St,Suite 277, Chicago, IL 60611 USA.	cbenne@northwestern.edu	MCKOY, JUNE/GRJ-5660-2022; Bennett, Charles L/C-2050-2008; Luminari, Stefano/J-5916-2014	Luminari, Stefano/0000-0001-8446-2285; Evens, Andrew/0000-0002-6900-1824; Belknap, Steven/0000-0002-3670-7409	NATIONAL CANCER INSTITUTE [P30CA060553, R01CA102713] Funding Source: NIH RePORTER; NCI NIH HHS [P 30 CA60553, 1R01CA 102713-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG ESP MED, 2002, NOT INF EP ALF CONTR; *AG FRANC SEC SAN, 2002, LETT PRESCR EPR INF; *ARZN DTSCH ARZT, 2002, ART ANW NUR INTR APP; BERGREM H, 1993, ERYTHROPOIETIN, P265; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Gershon SK, 2002, NEW ENGL J MED, V346, P1584; Hynes DM, 2002, AM J MED, V112, P169, DOI 10.1016/S0002-9343(01)01103-2; Kaufman J S, 1998, Am J Kidney Dis, V32, pS147, DOI 10.1016/S0272-6386(98)70178-7; Kaufman JS, 1998, NEW ENGL J MED, V339, P578, DOI 10.1056/NEJM199808273390902; Knauss MD, 2002, AM J HEALTH-SYST PH, V59, P1783, DOI 10.1093/ajhp/59.18.1783; Ladewski, 2004, J CLIN ONCOL, V22, P1169, DOI 10.1200/JCO.2004.01.914; Ladewski LA, 2003, J CLIN ONCOL, V21, P3859, DOI 10.1200/JCO.2003.04.537; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Locatelli F, 2003, ARTIF ORGANS, V27, P755, DOI 10.1046/j.1525-1594.2003.00991.x; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P288, DOI 10.1093/ndt/gfg489; *MED CONTR AG, EPR EP ALF PUR RED C; *MIN SAL, 2002, NOT INF IMP EP ALF G; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Porter S, 2001, J PHARM SCI-US, V90, P1; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; *SWISSM, 2003, PUR RED CELL APL; *THER GOODS ADM, 2002, AUSTR ADV DRUG REACT, V21; *THER PROD DIR, IMP SAF INF EPR EP A; Verhelst D, 2004, LANCET, V363, P1768, DOI 10.1016/S0140-6736(04)16302-2; 2004, JOHNSON JOHNSON 0120; 2003, NEORECORMON EPOETIN; 2003, WHO PHARMACEUT NEWSL; 2002, JOHNSON JOHNSON 1202; 2004, INFORMATION HEALTHCA; 2003, PROCRIT EPOETIN ALFA	32	282	307	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1403	1408		10.1056/NEJMoa040528	http://dx.doi.org/10.1056/NEJMoa040528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459301				2022-12-01	WOS:000224153900008
J	Chesebro, B				Chesebro, B			Biomedicine - A fresh look at BSE	SCIENCE			English	Editorial Material							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN		NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chesebro, B (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.	bschesebro@nih.gov						Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Houston EF, 2002, J GEN VIROL, V83, P1247, DOI 10.1099/0022-1317-83-5-1247; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Weissmann C, 1997, CURR OPIN NEUROBIOL, V7, P695, DOI 10.1016/S0959-4388(97)80091-8; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	12	16	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1918	+		10.1126/science.1103581	http://dx.doi.org/10.1126/science.1103581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448258				2022-12-01	WOS:000224136000033
J	Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ				Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ			The genomic sequence of the accidental pathogen Legionella pneumophila	SCIENCE			English	Article							IV SECRETION SYSTEM; COXIELLA-BURNETII; LEGIONNAIRES-DISEASE; VIRULENCE SYSTEM; DOT/ICM SYSTEM	We present the genomic sequence of Legionella pneumophila, the bacteria[ agent of Legionnaires' disease, a potentially fatal pneumonia acquired from aerosolized contaminated fresh water. The genome includes a 45-kilobase pair element that can exist in chromosomal and episomal forms, selective expansions of important gene families, genes for unexpected metabolic pathways, and previously unknown candidate virulence determinants. We highlight the genes that may account for Legionella's ability to survive in protozoa, mammalian macrophages, and inhospitable environmental niches and that may define new therapeutic targets.	Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Inst Pasteur, Unite Biochim & Biol Mol Insectes, F-75015 Paris, France; Roswell Pk Canc Inst, BACPAC Resources Lab, Buffalo, NY 14263 USA; Columbia Univ, Fu Fdn Sch Engn & Appl Sci, Dept Chem Engn, New York, NY 10027 USA; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roswell Park Cancer Institute; Columbia University; Tel Aviv University; Columbia University	Russo, JJ (corresponding author), Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, 630 W 168th St, New York, NY 10032 USA.	jjr4@columbia.edu	Segal, Gil/H-7987-2019; rzhetsky, andrey/B-6118-2012; Morozov, Pavel/GQP-7206-2022	Segal, Gil/0000-0003-0392-253X; rzhetsky, andrey/0000-0001-6959-7405; Geringer-Sameth, Alex/0000-0002-1269-6047; Gomez, Shawn/0000-0002-8251-4552	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 1 AI 4437, AI 23549] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brassinga AKC, 2003, J BACTERIOL, V185, P4630, DOI 10.1128/JB.185.15.4630-4637.2003; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DEFELIPE KS, UNPUB; Fernandez-Leborans G, 2000, ECOTOX ENVIRON SAFE, V47, P266, DOI 10.1006/eesa.2000.1944; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	21	384	815	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1966	1968		10.1126/science.1099776	http://dx.doi.org/10.1126/science.1099776			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448271				2022-12-01	WOS:000224136000050
J	Heymann, DL; Aylward, RB				Heymann, DL; Aylward, RB			Global health - Eradicating polio	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland.							[Anonymous], 2003, Wkly Epidemiol Rec, V78, P241; [Anonymous], 1995, WHOEPIGEN956; Plotkin SA, 2001, CLIN INFECT DIS, V32, P1068, DOI 10.1086/319612; *WHO, IN PRESS REP WHO CON; World Health Organization, 2004, GEN DECL ER POL	5	37	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1275	1277		10.1056/NEJMp048204	http://dx.doi.org/10.1056/NEJMp048204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385650	Green Accepted			2022-12-01	WOS:000223997700001
J	Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC				Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC			Exogenous control of mammalian gene expression through modulation of RNA self-cleavage	NATURE			English	Article							HAMMERHEAD-RIBOZYME; IN-VITRO; SYSTEM; IDENTIFICATION; INHIBITION; CELLS	Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences(1-4). Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs(5) into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies(6), this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Div Mol Med, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Mulligan, RC (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA.	mulligan@receptor.med.harvard.edu	Gray, John T/D-2916-2016; Wilson, Matthew H/K-3193-2013	Gray, John T/0000-0002-1888-4612; 				ASZALOS A, 1966, J ANTIBIOT, V19, P285; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Cech TR, 2004, NATURE, V428, P263, DOI 10.1038/428263a; CECH TR, 1990, BIOSCIENCE REP, V10, P239, DOI 10.1007/BF01117241; CHOWRIRA BM, 1994, J BIOL CHEM, V269, P25856; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hermann T, 1998, J MOL BIOL, V276, P903, DOI 10.1006/jmbi.1997.1590; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Jenne A, 2001, NAT BIOTECHNOL, V19, P56, DOI 10.1038/83513; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Murray JB, 1996, BIOCHEM J, V317, P855, DOI 10.1042/bj3170855; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; STAGE TK, 1995, RNA, V1, P95; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zillmann M, 1997, RNA, V3, P734	30	200	226	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					471	476		10.1038/nature02844	http://dx.doi.org/10.1038/nature02844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386015				2022-12-01	WOS:000224000500045
J	Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H				Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H			Walking and dementia in physically capable elderly men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HONOLULU-HEART-PROGRAM; JAPANESE-AMERICAN MEN; ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; COGNITIVE DECLINE; APOLIPOPROTEIN-E; OLDER PERSONS; RISK-FACTORS; INCIDENT AD; HEALTH	Context Evidence suggests that physical activity may be related to the clinical expression of dementia. Whether the association includes low-intensity activity such as walking is not known. Objective To examine the association between walking and future risk of dementia in older men. Design Prospective cohort study. Setting and Participants Distance walked per day was assessed from 1991 to 1993 in 2257 physically capable men aged 71 to 93 years in the Honolulu-Asia Aging Study. Follow-up for incident dementia was based on neurological assessment at 2 repeat examinations (1994-1996 and 1997-1999). Main Outcome Measures Overall dementia, Alzheimer disease, and vascular dementia. Results During the course of follow-up, 158 cases of dementia were identified (15.6/ 1000 person-years). After adjusting for age, men who walked the least (<0.25 mile/d) experienced a 1.8-fold excess risk of dementia compared with those who walked more than 2 mile/d (17.8 vs 10.3/1000 person-years; relative hazard [RH], 1.77; 95% confidence interval [CI], 1.04-3.01). Compared with men who walked the most (>2 mile/d), an excess risk of dementia was also observed in those who walked 0.25 to 1 mile/d (17.6 vs 10.3/1000 person-years; RH, 1.71; 95% Cl, 1.02-2.86). These associations persisted after accounting for other factors, including the possibility that limited amounts of walking could be the result of a decline in physical function due to preclinical dementia. Conclusions Findings suggest that walking is associated with a reduced risk of dementia. Promoting active lifestyles in physically capable men could help late-life cognitive function.	Univ Virginia, Sch Med, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Dept Vet Affairs, Honolulu, HI USA; Kuakini Med Ctr, Honolulu Asia Aging Study, Honolulu, HI USA; Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA	University of Virginia; Pacific Health Research & Education Institute; University of Hawaii System; University of Hawaii System	Abbott, RD (corresponding author), Univ Virginia Hlth Syst, Dept Hlth Evaluat Sci, POB 800717, Charlottesville, VA 22908 USA.	rda3e@virginia.edu			NHLBI NIH HHS [N01-HC-05102] Funding Source: Medline; NIA NIH HHS [N01-AG-4-2149, 1-R01-AG17155-01A1] Funding Source: Medline; NINDS NIH HHS [1-R01-NS41265-01] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017155, N01AG042149] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABBOTT RD, 1985, AM J EPIDEMIOL, V121, P465, DOI 10.1093/oxfordjournals.aje.a114019; ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd; CHIU HC, 1992, NEUROLOGY, V42, P473; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COX DR, 1972, J R STAT SOC B, V34, P187; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; Havlik RJ, 2000, NEUROLOGY, V54, P1526, DOI 10.1212/WNL.54.7.1526; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scarmeas N, 2003, ARCH NEUROL-CHICAGO, V60, P359, DOI 10.1001/archneur.60.3.359; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	35	469	490	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1447	1453		10.1001/jama.292.12.1447	http://dx.doi.org/10.1001/jama.292.12.1447			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383515	Bronze			2022-12-01	WOS:000224031800026
J	Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM				Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM			A microtubule-binding myosin required for nuclear anchoring and spindle assembly	NATURE			English	Article							UNCONVENTIONAL MYOSIN; OOCYTE MATURATION; XENOPUS-OOCYTES; EGG CORTEX; IN-VITRO; F-ACTIN; MICROFILAMENTS; FERTILIZATION; MOVEMENT; PROTEIN	Proper spindle positioning and orientation are essential for asymmetric cell division and require microtubule-actin filament (F-actin) interactions in many systems(1,2). Such interactions are particularly important in meiosis(3), where they mediate nuclear anchoring(4-6), as well as meiotic spindle assembly and rotation(7,8), two processes required for asymmetric cell division. Myosin-10 proteins are phosphoinositide-binding(9), actin-based motors that contain carboxy-terminal MyTH4 and FERM domains of unknown function(10). Here we show that Xenopus laevis myosin-10 (Myo10) associates with microtubules in vitro and in vivo, and is concentrated at the point where the meiotic spindle contacts the F-actin-rich cortex. Microtubule association is mediated by the MyTH4-FERM domains, which bind directly to purified microtubules. Disruption of Myo10 function disrupts nuclear anchoring, spindle assembly and spindle-F-actin association. Thus, this myosin has a novel and critically important role during meiosis in integrating the F- actin and microtubule cytoskeletons.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Bement, WM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	wmbement@wisc.edu	Bement, William/AAA-5444-2021	Cheney, Richard/0000-0001-6565-7888; Berg, Jonathan/0000-0003-2360-2664	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003299] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALEXANDRE H, 1989, DEV BIOL, V136, P311, DOI 10.1016/0012-1606(89)90258-3; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Berg JS, 2000, J CELL SCI, V113, P3439; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; GARD DL, 1993, DEV BIOL, V159, P298, DOI 10.1006/dbio.1993.1242; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kim NH, 2000, ZYGOTE, V8, P25, DOI 10.1017/S0967199400000794; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; LESSMAN CA, 1987, CELL DIFFER DEV, V20, P239, DOI 10.1016/0045-6039(87)90469-6; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Narasimhulu SB, 1998, PLANT CELL, V10, P957, DOI 10.1105/tpc.10.6.957; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; SARDET C, 1992, DEVELOPMENT, V115, P221; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; SHIMIZU T, 1990, ANN NY ACAD SCI, V582, P260; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Weber KL, 2002, J CELL SCI, V115, P1373; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.0.CO;2-G; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175	30	192	198	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					325	329		10.1038/nature02834	http://dx.doi.org/10.1038/nature02834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372037				2022-12-01	WOS:000223864000045
J	Koh, LP; Dunn, RR; Sodhi, NS; Colwell, RK; Proctor, HC; Smith, VS				Koh, LP; Dunn, RR; Sodhi, NS; Colwell, RK; Proctor, HC; Smith, VS			Species coextinctions and the biodiversity crisis	SCIENCE			English	Article							EVOLUTIONARY HISTORY; EXTINCTION; PHILOPTERIDAE; CONSERVATION; PHTHIRAPTERA; BUTTERFLIES; SINGAPORE; TAXONOMY	To assess the coextinction of species (the loss of a species upon the loss of another), we present a probabilistic model, scaled with empirical data. The model examines the relationship between coextinction levels (proportion of species extinct) of affiliates and their hosts across a wide range of coevolved interspecific systems: pollinating Ficus wasps and Ficus, parasites and their hosts, butterflies and their larval host plants, and ant butterflies and their host ants. Applying a nomographic method based on mean host specificity (number of host species per affiliate species), we estimate that 6300 affiliate species are "coendangered" with host species currently listed as endangered. Current extinction estimates need to be recalibrated by taking species coextinctions into account.	Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Curtin Univ Technol, Dept Environm Biol, Perth, WA 6845, Australia; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	National University of Singapore; Curtin University; University of Connecticut; University of Alberta; University of Glasgow	Sodhi, NS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsns@nus.edu.sg	Koh, Lian Pin/A-5794-2010; Colwell, Robert K/C-7276-2015; Proctor, Heather C./A-2677-2014; Dunn, Robert/B-1360-2013; Smith, Vincent/AAK-7335-2020	Koh, Lian Pin/0000-0001-8152-3871; Proctor, Heather C./0000-0002-4920-9556; Smith, Vincent/0000-0001-5297-7452; Dunn, Robert/0000-0002-6030-4837				Amaral LAN, 1999, PHYS REV LETT, V82, P652, DOI 10.1103/PhysRevLett.82.652; Boswell GP, 1998, P ROY SOC B-BIOL SCI, V265, P1921, DOI 10.1098/rspb.1998.0521; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; Clayton DH, 1999, ANN ENTOMOL SOC AM, V92, P675, DOI 10.1093/aesa/92.5.675; COLWELL RK, IN PRESS ECOLOGY; Colwell RK, ESTIMATES STAT ESTIM; Colwell Robert K., 1994, P23; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Gotwald WH, 1995, CORNELL SERIES ARTHR; HILTONTAYLOR C, 2000, 2000 INT UNION CONSE; Koh LP, 2004, BIOTROPICA, V36, P272, DOI 10.1111/j.1744-7429.2004.tb00319.x; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Price RD, 2000, J PARASITOL, V86, P948, DOI 10.1645/0022-3395(2000)086[0948:PLDUTO]2.0.CO;2; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; STORK NE, 1993, NATURE, V366, P307, DOI 10.1038/366307a0; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; WINDSOR DA, 1995, CONSERV BIOL, V9, P1, DOI 10.1046/j.1523-1739.1995.09010001.x	20	373	388	8	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1632	1634		10.1126/science.1101101	http://dx.doi.org/10.1126/science.1101101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361627				2022-12-01	WOS:000223891200047
J	Skaar, EP; Humayun, M; Bae, T; DeBord, KL; Schneewind, O				Skaar, EP; Humayun, M; Bae, T; DeBord, KL; Schneewind, O			Iron-source preference of Staphylococcus aureus infections	SCIENCE			English	Article							MODEL HOST; TRANSPORT; PROTEIN; IDENTIFICATION; SIDEROPHORE; VIRULENCE; MEMBRANE; GENES; HEMIN	Although bacteria use different iron compounds in vitro, the possibility that microbes distinguish between these iron sources during infection has hitherto not been examined. We applied stable isotope labeling to detect source-specific iron by mass spectrometry and show that Staphylococcus aureus preferentially imports heme iron over transferrin iron. By combining this approach with computational genome analysis, we identified hts (heme transport system), a gene cluster that promotes preferred heme iron import by S. aureus. Heme iron scavenging by means of hts is required for staphylococcal pathogenesis in animal hosts, indicating that heme iron is the preferred iron source during the initiation of infection.	Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Comm Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Humayun, Munir/A-1247-2007	Bae, Taeok/0000-0002-0576-2851; Humayun, Munir/0000-0001-8516-9435	NIAID NIH HHS [AI52474] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBUS A, 1991, INFECT IMMUN, V59, P1008, DOI 10.1128/IAI.59.3.1008-1014.1991; ANBAR AD, 2004, FRONTIERS BOULDER, V217, P223; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; BERNHEIMER AW, 1968, J BACTERIOL, V96, P487, DOI 10.1128/JB.96.2.487-491.1968; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Bullen J. J., 1999, IRON INFECT MOL PHYS; CRICHTON R, 2001, INORGANIC BIOCH IRON, V2; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Heinrichs JH, 1999, J BACTERIOL, V181, P1436, DOI 10.1128/JB.181.5.1436-1443.1999; Kloek AP, 1996, J MOL EVOL, V43, P101, DOI 10.1007/BF02337354; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morrissey JA, 2000, INFECT IMMUN, V68, P6281, DOI 10.1128/IAI.68.11.6281-6288.2000; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; VONWACHENFELDT C, 1990, J BIOL CHEM, V265, P13939; Walczyk T, 2002, SCIENCE, V295, P2065, DOI 10.1126/science.1069389	26	321	336	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1626	1628		10.1126/science.1099930	http://dx.doi.org/10.1126/science.1099930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361626				2022-12-01	WOS:000223891200045
J	Bowers, S				Bowers, S			COPD is not a death sentence	LANCET			English	Article												sgbowers@fast.net							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					896	896		10.1016/S0140-6736(04)16985-7	http://dx.doi.org/10.1016/S0140-6736(04)16985-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351197				2022-12-01	WOS:000223685200036
J	Blanpain, C; Lowry, WE; Geoghegan, A; Polak, L; Fuchs, E				Blanpain, C; Lowry, WE; Geoghegan, A; Polak, L; Fuchs, E			Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche	CELL			English	Article							LABEL-RETAINING CELLS; HAIR FOLLICLE; MOUSE EPIDERMIS; IN-VIVO; GROWTH; SKIN; KERATINOCYTE; MULTIPLICATION; MORPHOGENESIS; INDUCTION	In adult skin, each hair follicle contains a reservoir of stem cells (the bulge), which can be mobilized to regenerate the new follicle with each hair cycle and to reepithelialize epidermis during wound repair. Here we report new methods that permit their clonal analyses and engraftment and demonstrate the two defining features of stem cells, namely self-renewal and multipotency. We also show that, within the bulge, there are two distinct populations, one of which maintains basal lamina contact and temporally precedes the other, which is suprabasal and arises only after the start of the first postnatal hair cycle. This spatial distinction endows them with discrete transcriptional programs, but surprisingly, both populations are growth inhibited in the niche but can self-renew in vitro and make epidermis and hair when grafted. These findings suggest that the niche microenvironment imposes intrinsic "stemness" features without restricting the establishment of epithelial polarity and changes in gene expression.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Blanpain, Cedric/ABD-8392-2021; Fuchs, Elaine/G-1565-2016		NIAMS NIH HHS [AR 31737, AR 050452, R01 AR050452-04] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Poblet E, 2003, J INVEST DERMATOL, V121, P1220, DOI 10.1046/j.1523-1747.2003.12550_2.x; POTTEN CS, 1988, J CELL SCI, P45; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; TURNBAR T, 2004, SCIENCE, V303, P359; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	1023	1090	2	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					635	648		10.1016/j.cell.2004.08.012	http://dx.doi.org/10.1016/j.cell.2004.08.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339667	Bronze			2022-12-01	WOS:000223730300013
J	Delprato, A; Merithew, E; Lambright, DG				Delprato, A; Merithew, E; Lambright, DG			Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5	CELL			English	Article							SMALL GTPASE RAB5; NUCLEOTIDE-EXCHANGE; CRYSTAL-STRUCTURE; SPASTIC PARALYSIS; BINDING PROTEIN; PH DOMAIN; EFFECTOR; EEA1; ACTIVATION; RABAPTIN-5	The Rab5 GTPase, an essential regulator of endocytosis and endosome biogenesis, is activated by guanine-nucleotide exchange factors (GEFs) that contain a Vps9 domain. Here, we show that the catalytic core of the Rab GEF Rabex-5 has a tandem architecture consisting of a Vps9 domain stabilized by an indispensable helical bundle. A family-wide analysis of Rab specificity demonstrates high selectivity for Rab5 subfamily GTPases. Conserved exchange determinants map to a common surface of the Vps9 domain, which recognizes invariant aromatic residues in the switch regions of Rab GTPases and selects for for the Rab5 subfamily by requiring a small nonacidic residue preceding a critical phenylalanine in the switch I region. These and other observations reveal unexpected similarity with the Arf exchange site in the Sec7 domain.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	david.lambright@umassmed.edu			NIDDK NIH HHS [DK60564] Funding Source: Medline; NIGMS NIH HHS [GM56324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Devon RS, 2003, CLIN GENET, V64, P210, DOI 10.1034/j.1399-0004.2003.00138.x; Dhaka A, 2003, J NEUROSCI, V23, P748; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kauppi M, 2002, J CELL SCI, V115, P899; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mesa R, 2001, J CELL SCI, V114, P4041; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nuoffer C, 1997, MOL BIOL CELL, V8, P1305, DOI 10.1091/mbc.8.7.1305; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2002, J BIOL CHEM, V277, P50893, DOI 10.1074/jbc.M208580200; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu ZY, 2001, BIOCHEMISTRY-US, V40, P3027, DOI 10.1021/bi002680o	63	128	132	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					607	617		10.1016/j.cell.2004.08.009	http://dx.doi.org/10.1016/j.cell.2004.08.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339665	Bronze			2022-12-01	WOS:000223730300011
J	Fyhn, M; Molden, S; Witter, MP; Moser, EI; Moser, MB				Fyhn, M; Molden, S; Witter, MP; Moser, EI; Moser, MB			Spatial representation in the entorhinal cortex	SCIENCE			English	Article							POSITIONAL FIRING PROPERTIES; HEAD-DIRECTION CELLS; FREELY-MOVING RATS; PARAHIPPOCAMPAL REGION; HIPPOCAMPAL-LESIONS; UNIT-ACTIVITY; PLACE CELLS; MEMORY; NEURONS; ORGANIZATION	As the interface between hippocampus and neocortex, the entorhinal cortex is likely to play a pivotal role in memory. To determine how information is represented in this area, we measured spatial modulation of neural activity in layers of medial entorhinal cortex projecting to the hippocampus. Close to the postrhinal-entorhinal border, entorhinal neurons had stable and discrete multipeaked place fields, predicting the rat's location as accurately as place cells in the hippocampus. Precise positional modulation was not observed more ventromedially in the entorhinal cortex or upstream in the postrhinal cortex, suggesting that sensory input is transformed into durable allocentric spatial representations internally in the dorsocaudal medial entorhinal cortex.	Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway; Vrije Univ Amsterdam Med Ctr, Dept Anat, Neurosci Res Inst, Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no						BARNES CA, 1990, PROG BRAIN RES, V83, P287; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Calton JL, 2003, J NEUROSCI, V23, P9719; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; JUNG MW, 1994, J NEUROSCI, V14, P7347; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LEE I, 2003, SOC NEUR ABSTR, V91, P11; LEUTGEB S, 2003, SOC NEUR ABSTR, V91, P5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.0.CO;2-D; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; vanHaeften T, 1997, J NEUROSCI, V17, P862; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	37	813	841	9	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1258	1264		10.1126/science.1099901	http://dx.doi.org/10.1126/science.1099901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333832				2022-12-01	WOS:000223624600032
J	Seckl, MJ; Gillmore, R; Foskett, M; Sebire, NJ; Rees, H; Newlands, ES				Seckl, MJ; Gillmore, R; Foskett, M; Sebire, NJ; Rees, H; Newlands, ES			Routine terminations of pregnancy - should we screen for gestational trophoblastic neoplasia?	LANCET			English	Article							METHOTREXATE; EPIDEMIOLOGY; TUMORS	After termination of pregnancy for non-medical reasons, the products of conception are often not routinely examined for gestational trophoblastic neoplasia. Between 1995 and 2001 we identified 15 women without and 36 women with a pathological diagnosis of gestational trophoblastic neoplasia at the time of their pregnancy termination. Women without a diagnosis were significantly more likely to have subsequent life-threatening complications of gestational trophoblastic neoplasia (four of 15 vs none of 36; p=0.003), and to require surgical intervention (15 of 15 vs one of 36; p<0.0001) and chemotherapy (nine of 15 vs two of 36; p<0.0001). All women should be screened for gestational trophoblastic neoplasia after termination of pregnancy.	Univ London Imperial Coll Sci Technol & Med, Gestat Trophoblast Dis Unit, Dept Med Oncol, London W6 8RF, England	Imperial College London	Seckl, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Gestat Trophoblast Dis Unit, Dept Med Oncol, Charing Cross & Hammersmith Hosp Campus,Fulham Pa, London W6 8RF, England.	m.seckl@imperial.co.uk	sebire, neil J/C-4960-2008	Sebire, Neil/0000-0001-5348-9063				JACOBS PA, 1982, BRIT J OBSTET GYNAEC, V89, P258, DOI 10.1111/j.1471-0528.1982.tb04693.x; McNeish IA, 2002, J CLIN ONCOL, V20, P1838, DOI 10.1200/JCO.2002.07.166; Papadopoulos AJ, 2002, J REPROD MED, V47, P460; Rustin GJS, 1996, J CLIN ONCOL, V14, P2769, DOI 10.1200/JCO.1996.14.10.2769; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6; Steigrad SJ, 2003, BEST PRACT RES CL OB, V17, P837, DOI 10.1016/S1521-6934(03)00049-X; THOMAS J, 2001, NATL AUDIT INDUCED A	7	31	33	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 21	2004	364	9435					705	707		10.1016/S0140-6736(04)16898-0	http://dx.doi.org/10.1016/S0140-6736(04)16898-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WO	15325836				2022-12-01	WOS:000223428900033
J	Prescher, JA; Dube, DH; Bertozzi, CR				Prescher, JA; Dube, DH; Bertozzi, CR			Chemical remodelling of cell surfaces in living animals	NATURE			English	Article							SIALIC-ACID; STAUDINGER LIGATION; GLYCOSYLATION; BIOSYNTHESIS; IDENTIFICATION; GLYCOPROTEINS; EXPRESSION; CHEMISTRY; PROTEINS; MOLECULE	Cell surfaces are endowed with biological functionality designed to mediate extracellular communication. The cell-surface repertoire can be expanded to include abiotic functionality through the biosynthetic introduction of unnatural sugars into cellular glycans, a process termed metabolic oligosaccharide engineering(1,2). This technique has been exploited in fundamental studies of glycan-dependent cell-cell and virus-cell interactions(3-5) and also provides an avenue for the chemical remodelling of living cells(6-8). Unique chemical functional groups can be delivered to cell-surface glycans by metabolism of the corresponding unnatural precursor sugars. These functional groups can then undergo covalent reaction with exogenous agents bearing complementary functionality. The exquisite chemical selectivity required of this process is supplied by the Staudinger ligation of azides and phosphines, a reaction that has been performed on cultured cells without detriment to their physiology(7,9). Here we demonstrate that the Staudinger ligation can be executed in living animals, enabling the chemical modification of cells within their native environment. The ability to tag cell-surface glycans in vivo may enable therapeutic targeting and noninvasive imaging of changes in glycosylation during disease progression.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu						Buttner B, 2002, J NEUROSCI, V22, P8869; Charter NW, 2002, J BIOL CHEM, V277, P9255, DOI 10.1074/jbc.M111619200; CODINGTON JF, 1979, BIOCHEMISTRY-US, V18, P2145, DOI 10.1021/bi00578a002; Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006; Fukuda M, 1996, CANCER RES, V56, P2237; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Jurisson SS, 1999, CHEM REV, V99, P2205, DOI 10.1021/cr980435t; Kavarana MJ, 1999, J MED CHEM, V42, P221, DOI 10.1021/jm9708036; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Luchansky SJ, 2003, METHOD ENZYMOL, V362, P249; LUCHANSKY SJ, IN PRESS BIOCHEMISTR; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Martin DC, 1999, J CELL BIOL, V146, P881, DOI 10.1083/jcb.146.4.881; Morton CL, 2000, CANCER RES, V60, P4206; Ovaa H, 2003, ANGEW CHEM INT EDIT, V42, P3626, DOI 10.1002/anie.200351314; REICHNER JS, 1988, J BIOL CHEM, V263, P16316; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SELL S, 1990, HUM PATHOL, V21, P1003, DOI 10.1016/0046-8177(90)90250-9; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; SOARES ER, 1979, BIOCHEM GENET, V17, P577, DOI 10.1007/BF00502119; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100	30	549	592	21	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					873	877		10.1038/nature02791	http://dx.doi.org/10.1038/nature02791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318217				2022-12-01	WOS:000223369800037
J	Pierard, LA; Lancellotti, P				Pierard, LA; Lancellotti, P			The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; EXERCISE-INDUCED CHANGES; CORONARY-ARTERY-DISEASE; HEART-FAILURE; DETERMINANTS; MECHANISM; HYPERTENSION; INSIGHTS	BACKGROUND: Acute mitral regurgitation may cause pulmonary edema, but the pathogenetic role of chronic ischemic mitral regurgitation, a dynamic condition, has not yet been characterized. METHODS: We prospectively studied 28 patients (mean [+/-SD] age, 65+/-11 years) with acute pulmonary edema and left ventricular systolic dysfunction and 46 patients without a history of acute pulmonary edema. The two groups were matched for all baseline characteristics. Patients underwent quantitative Doppler echocardiography during exercise. Exercise-induced changes in the left ventricular volume, the ejection fraction, the mitral regurgitant volume, the effective regurgitant orifice area, and the transtricuspid pressure gradient were compared in patients with and without acute pulmonary edema. RESULTS: The two groups had similar clinical and baseline echocardiographic characteristics. They also had similar exercise-induced changes in heart rate, systolic blood pressure, and left ventricular volumes. In the univariate analysis, patients with recent pulmonary edema had a much higher increase than did the patients without pulmonary edema in mitral regurgitant volume (26+/-14 ml vs. 5+/-14 ml, P<0.001), the effective regurgitant orifice area (16+/-10 mm(sup 2) vs. 2+/-9 mm(sup 2), P<0.001), and the transtricuspid pressure gradient (29+/-10 mm Hg vs. 13+/-11 mm Hg, P<0.001). In the multivariate analysis, exercise-induced changes in the effective regurgitant orifice area (P<0.001), in the transtricuspid pressure gradient (P=0.001), and in the left ventricular ejection fraction (P=0.02) were independently associated with a history of recent pulmonary edema. CONCLUSIONS: In patients with left ventricular systolic dysfunction, acute pulmonary edema is associated with the dynamic changes in ischemic mitral regurgitation and the resulting increase in pulmonary vascular pressure.	Univ Hosp Liege, Div Cardiol, Liege, Belgium	University of Liege	Pierard, LA (corresponding author), Univ Hosp Sart Tilman, Dept Cardiol, B-4000 Liege, Belgium.	lpierard@chu.ulg.ac.be						Agostoni P, 2003, CIRCULATION, V108, P2666, DOI 10.1161/01.CIR.0000097115.61309.59; Bentancur AG, 2002, AM J MED SCI, V323, P238, DOI 10.1097/00000441-200205000-00002; Cotter G, 1998, LANCET, V351, P389, DOI 10.1016/S0140-6736(97)08417-1; EnriquezSarano M, 1997, J AM COLL CARDIOL, V29, P153, DOI 10.1016/S0735-1097(96)00436-6; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; He SQ, 1997, CIRCULATION, V96, P1826, DOI 10.1161/01.CIR.96.6.1826; Hung J, 1999, J AM COLL CARDIOL, V33, P538, DOI 10.1016/S0735-1097(98)00570-1; Irvine T, 2002, HEART, V88, piv11; KEREN G, 1986, AM HEART J, V112, P517, DOI 10.1016/0002-8703(86)90516-8; Lancellotti P, 2003, CIRCULATION, V108, P1713, DOI 10.1161/01.CIR.0000087599.49332.05; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Lebrun F, 2001, J AM COLL CARDIOL, V38, P1685, DOI 10.1016/S0735-1097(01)01605-9; Levine RA, 2003, J AM COLL CARDIOL, V42, P1929, DOI 10.1016/j.jacc.2003.09.004; Otsuji Y, 1997, CIRCULATION, V96, P1999, DOI 10.1161/01.CIR.96.6.1999; STONE GW, 1991, AM J CARDIOL, V67, P37, DOI 10.1016/0002-9149(91)90095-3; TCHENG JE, 1992, ANN INTERN MED, V117, P18, DOI 10.7326/0003-4819-117-1-18; Yiu SF, 2000, CIRCULATION, V102, P1400, DOI 10.1161/01.CIR.102.12.1400	18	201	209	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1627	1634		10.1056/NEJMoa040532	http://dx.doi.org/10.1056/NEJMoa040532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483281	Bronze			2022-12-01	WOS:000224427300009
J	Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P				Keeling, L; Anderson, L; Schutz, KE; Kerje, S; Fredriksson, R; Carlborg, O; Cornwallis, CK; Pizzari, T; Jensen, P			Chicken genomics: Feather-pecking and victim pigmentation	NATURE			English	Editorial Material							QUANTITATIVE TRAIT LOCI; LAYING HENS; BEHAVIOR		Swedish Univ Agr Sci, Dept Anim Environm & Hlth, S-53223 Skara, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, S-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75124 Uppsala, Sweden; AgRes Anim Behav & Welf, Hamilton, New Zealand; Linkoping Univ, IFM, Dept Biol, S-58183 Linkoping, Sweden; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Leeds, Sch Biol, Evolut & Ecol Grp, Leeds LS2 9JT, W Yorkshire, England	Swedish University of Agricultural Sciences; Uppsala University; Swedish University of Agricultural Sciences; AgResearch - New Zealand; Linkoping University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Sheffield; University of Leeds	Keeling, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, POB 234, S-53223 Skara, Sweden.	per.jensen@ifm.liu.se	Cornwallis, Charlie/A-6276-2012; Fredriksson, Robert/AAH-3921-2019; Keeling, Linda J/K-6542-2012	Fredriksson, Robert/0000-0002-2810-3226; Keeling, Linda J/0000-0003-2629-0117; Carlborg, Orjan/0000-0002-2722-5264; Schutz, Karin/0000-0002-2893-3465				Blokhuis HJ, 1998, VET QUART, V20, P6, DOI 10.1080/01652176.1998.9694825; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1661, DOI 10.1093/ps/82.11.1661; Buitenhuis AJ, 2003, POULTRY SCI, V82, P1215, DOI 10.1093/ps/82.8.1215; JENSEN P, 2003, ISAE 2003 M JUN 24 2, P68; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; KERJE S, IN PRESS GENETICS; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; McAdie TM, 2002, APPL ANIM BEHAV SCI, V75, P147, DOI 10.1016/S0168-1591(01)00182-4; Savory CJ, 1999, BRIT POULTRY SCI, V40, P565, DOI 10.1080/00071669986918; Smyth J.R., 1996, POULTRY BREEDING GEN, P109	10	84	88	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					645	646		10.1038/431645a	http://dx.doi.org/10.1038/431645a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470416				2022-12-01	WOS:000224299300028
J	D'Souza, V; Summers, MF				D'Souza, V; Summers, MF			Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus	NATURE			English	Article							NUCLEOCAPSID PROTEIN; RETROVIRAL RNA; NMR STRUCTURE; ENCAPSIDATION SIGNAL; ZINC-FINGER; DIMERIZATION; RECOGNITION; ELEMENT; COMPLEX; VIRIONS	All retroviruses specifically package two copies of their genomes during virus assembly, a requirement for strand-transfer-mediated recombination during reverse transcription(1,2). Genomic RNA exists in virions as dimers, and the overlap of RNA elements that promote dimerization and encapsidation suggests that these processes may be coupled(3-5). Both processes are mediated by the nucleocapsid domain (NC) of the retroviral Gag polyprotein(3). Here we show that dimerization-induced register shifts in base pairing within the Psi-RNA packaging signal of Moloney murine leukaemia virus (MoMuLV) expose conserved UCUG elements that bind NC with high affinity ( dissociation constant = 75 +/- 12 nM). These elements are base-paired and do not bind NC in the monomeric RNA. The structure of the NC complex with a 101-nucleotide 'core encapsidation' segment of the MoMuLV Psi site(6) reveals a network of interactions that promote sequence- and structure-specific binding by NC's single CCHC zinc knuckle. Our findings support a structural RNA switch mechanism for genome encapsidation, in which protein binding sites are sequestered by base pairing in the monomeric RNA and become exposed upon dimerization to promote packaging of a diploid genome.	Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Summers, MF (corresponding author), Univ Maryland Baltimore Cty, Howard Hughes Med Inst, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	summers@hhmi.umbc.edu						Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; BENDER MA, 1987, J VIROL, V61, P1639, DOI 10.1128/JVI.61.5.1639-1646.1987; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; D'Souza V, 2001, J MOL BIOL, V314, P217, DOI 10.1006/jmbi.2001.5139; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; HIBBERT CS, IN PRESS J VIROL; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; LEVIN JG, 1974, J VIROL, V14, P152, DOI 10.1128/JVI.14.1.152-161.1974; Ly H, 2002, J VIROL, V76, P3135, DOI 10.1128/JVI.76.7.3135-3144.2002; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MERIC C, 1989, J VIROL, V63, P1558; Mougel M, 1997, J VIROL, V71, P8061, DOI 10.1128/JVI.71.10.8061-8065.1997; Oroudjev EM, 1999, J MOL BIOL, V291, P603, DOI 10.1006/jmbi.1999.2984; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PRATS AC, 1990, J VIROL, V64, P774, DOI 10.1128/JVI.64.2.774-783.1990; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; Sakuragi J, 2001, J VIROL, V75, P2557, DOI 10.1128/JVI.75.6.2557-2565.2001; Schuler W, 1999, BIOCHEMISTRY-US, V38, P12984, DOI 10.1021/bi990378d; TORRENT C, 1994, J MOL BIOL, V240, P434, DOI 10.1006/jmbi.1994.1459; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; VARMUS HE, 1982, SCIENCE, V216, P812, DOI 10.1126/science.6177038; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YANG SL, 1994, EMBO J, V13, P713, DOI 10.1002/j.1460-2075.1994.tb06311.x	30	169	171	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					586	590		10.1038/nature02944	http://dx.doi.org/10.1038/nature02944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457265				2022-12-01	WOS:000224156700051
J	Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR				Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR			Reaction discovery enabled by DNA-templated synthesis and in vitro selection	NATURE			English	Article							ORGANIC-SYNTHESIS; CATALYSTS; CYCLOADDITION; COMBINATORIAL; FLUORESCENCE; EVOLUTION; ENZYMES	Current approaches to reaction discovery focus on one particular transformation. Typically, researchers choose substrates based on their predicted ability to serve as precursors for the target structure, then evaluate reaction conditions(1-6) for their ability to effect product formation. This approach is ideal for addressing specific reactivity problems, but its focused nature might leave many areas of chemical reactivity unexplored. Here we report a reaction discovery approach that uses DNA-templated organic synthesis(7-10) and in vitro selection to simultaneously evaluate many combinations of different substrates for bond-forming reactions in a single solution. Watson - Crick base pairing controls the effective molarities of substrates tethered to DNA strands; bond-forming substrate combinations are then revealed using in vitro selection for bond formation, PCR amplification and DNA microarray analysis. Using this approach, we discovered an efficient and mild carbon - carbon bond-forming reaction that generates an enone from an alkyne and alkene using an inorganic palladium catalyst. Although this approach is restricted to conditions and catalysts that are at least partially compatible with DNA, we expect that its versatility and efficiency will enable the discovery of additional reactions between a wide range of substrates.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	liu@chemistry.harvard.edu	Sakurai, Kaori/AAJ-7405-2021; Liu, David R./HCH-3132-2022; Sakurai, Kaori/F-6238-2013	Sakurai, Kaori/0000-0002-1348-8530; Snyder, Thomas/0000-0001-7256-7821	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065865-02, R01 GM065865, R01 GM065865-01A2, R01 GM065865-04, R01 GM065865-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Calderone CT, 2002, ANGEW CHEM INT EDIT, V41, P4104, DOI 10.1002/1521-3773(20021104)41:21<4104::AID-ANIE4104>3.0.CO;2-O; Crabtree R. H., 2001, ORGANOMETALLIC CHEM; Evans CA, 2002, CURR OPIN CHEM BIOL, V6, P333, DOI 10.1016/S1367-5931(02)00324-1; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; HECK RF, 1982, ORG REACTIONS, V27, P345; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; KRAMER MF, 2001, CURRENT PROTOCOLS MO, V2; Li C., 1997, ORGANIC REACTIONS AQ; Li XY, 2003, J AM CHEM SOC, V125, P10188, DOI 10.1021/ja035379e; Lober O, 2001, J AM CHEM SOC, V123, P4366, DOI 10.1021/ja005881o; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Morgan, 1995, COMPREHENSIVE ORGANI, V5, P257; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.3.CO;2-E; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schultz PG, 2002, NATURE, V418, P485, DOI 10.1038/418485a; SMIDT J, 1962, ANGEW CHEM INT EDIT, V74, P93, DOI 10.1002/ange.19620740302; SMIDT J, 1959, ANGEW CHEM INT EDIT, V71, P176, DOI 10.1002/ange.19590710503; Stambuli JP, 2003, CURR OPIN CHEM BIOL, V7, P420, DOI 10.1016/S1367-5931(03)00056-5; Stambuli JP, 2001, J AM CHEM SOC, V123, P2677, DOI 10.1021/ja0058435; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Taylor SJ, 1998, SCIENCE, V280, P267, DOI 10.1126/science.280.5361.267; TSUJI J, 1995, PALALDIUM REAGENTS C; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611	30	212	269	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					545	549		10.1038/nature02920	http://dx.doi.org/10.1038/nature02920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	857YP	15457254	Green Accepted			2022-12-01	WOS:000224156700040
J	Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M				Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M			Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids	LANCET			English	Article							LARGE T-ANTIGEN; HUMAN PLEURAL MESOTHELIOMA; HUMAN BRAIN-TUMORS; HUMAN-MALIGNANT MESOTHELIOMA; NON-HODGKIN-LYMPHOMA; DNA-SEQUENCES; HUMAN CANCERS; CELL-LINES; POLIOVIRUS VACCINES; MAMMALIAN-CELLS	Background PCR-based evidence of infection by simian virus 40 (SV40) has been reported in varying proportions of pleural mesotheliomas and other tumours, but data are conflicting and reproducibility limited. During a study of SV40 in relation to homozygous deletion of CDKN2A in mesotheliomas, we became concerned by inconsistent results and therefore used several independent techniques to investigate SV40 in these tumours. Methods High-quality DNA and RNA were extracted from 71 frozen mesothelioma samples. DNA PCR was done with four sets of primers for the SV40 T-antigen gene. RNA transcripts were examined by RT-PCR. Findings The first two primer sets for DNA PCR gave positive results in proportions similar to those reported in positive studies (56-62%) but there were unusual reproducibility difficulties. These primers were in a region of the T-antigen gene (nucleotides 4100-4713) that is present in many common laboratory plasmids. In assays with PCR primers not included within that region, only four cases (6%) showed products but these were too faint to suggest clonal infection. Further PCR assays confirmed that the SV40 sequences in the tumour samples had a deletion found only in plasmids, not in native functional SV40. Review of previous studies showed a similar pattern of discrepancies between SV40 T-antigen DNA PCR results obtained with primers within and beyond the region 4100-4713. All 71 mesotheliomas were negative for T-antigen transcripts by RT-PCR, and lacked T-antigen-positive tumour cells by immunohistochemistry. Interpretation Our data based on three independent experimental approaches do not support a significant role for SV40 in human mesotheliomas. The risk of false-positive results due to contamination by common laboratory plasmids containing SV40 sequences has been underestimated. Studies of SV40 based on PCR methods require careful primer design to reduce this risk. Relevance to practice This paper presents several lines of evidence against the proposed link between SV40 infection and human mesotheliomas. Studies reporting a high prevalence of SV40 DNA in human tumours have been based on molecular assays prone to false-positive results. Because SV40 appears unlikely to have a major role, if any, in human mesotheliomas, clinicians should continue to consider asbestos exposure as the most likely and most thoroughly established aetiological factor in individuals with this cancer.	Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	ladanyim@mskcc.org	Ladanyi, Marc/AAG-8585-2019	Rusch, Valerie/0000-0003-2345-6900				AMBINDER RF, 1986, J CLIN MICROBIOL, V24, P16, DOI 10.1128/JCM.24.1.16-20.1986; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Brown F, 1998, DEV BIOL STAND, V94, P1; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Capello D, 2003, LANCET, V361, P88, DOI 10.1016/S0140-6736(03)12157-5; CARBONE M, 1994, ONCOGENE, V9, P1781; Carbone M, 2003, INT J CANCER, V106, P140, DOI 10.1002/ijc.11189; Carbone M, 1997, ONCOGENE, V15, P1877, DOI 10.1038/sj.onc.1201375; de Sanjose S, 2003, INT J CANCER, V104, P522, DOI 10.1002/ijc.10993; DeLuca A, 1997, NAT MED, V3, P913, DOI 10.1038/nm0897-913; Dhaene K, 1999, VIRCHOWS ARCH, V435, P1, DOI 10.1007/s004280050387; Dobbelstein M, 1998, J GEN VIROL, V79, P3079, DOI 10.1099/0022-1317-79-12-3079; Emri S, 2000, ANTICANCER RES, V20, P891; Engels EA, 2003, JNCI-J NATL CANCER I, V95, P532, DOI 10.1093/jnci/95.7.532; Engels EA, 2002, INT J CANCER, V101, P348, DOI 10.1002/ijc.10621; Galateau-Salle F, 1998, J PATHOL, V184, P252, DOI 10.1002/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R; Gazdar AF, 2002, NAT REV CANCER, V2, P957, DOI 10.1038/nrc947; Gordon GJ, 2002, ONCOL REP, V9, P631; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Griffiths DJ, 1998, DEV BIOL STAND, V94, P127; Hirvonen A, 1999, MOL CARCINOGEN, V26, P93, DOI 10.1002/(SICI)1098-2744(199910)26:2<93::AID-MC4>3.3.CO;2-Q; HOWELL MD, 1987, ANAL BIOCHEM, V161, P311, DOI 10.1016/0003-2697(87)90456-8; Hubner R, 2002, CANCER CAUSE CONTROL, V13, P121, DOI 10.1023/A:1014321729038; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jasani B, 2001, SEMIN CANCER BIOL, V11, P49, DOI 10.1006/scbi.2000.0346; Kim JYH, 2002, NEURO-ONCOLOGY, V4, P165, DOI 10.1093/neuonc/4.3.165; Klein G, 2002, ONCOGENE, V21, P1141, DOI 10.1038/sj.onc.1205173; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Leithner A, 2002, CANCER BIOL THER, V1, P375; Lin PP, 1999, CANCER RES, V59, P1428; MacKenzie J, 2003, J NATL CANCER I, V95, P1001, DOI 10.1093/jnci/95.13.1001; Martinelli M, 2002, AM J PATHOL, V161, P1127, DOI 10.1016/S0002-9440(10)64389-1; Martini F, 1996, CANCER RES, V56, P4820; Martini F, 2002, CANCER-AM CANCER SOC, V94, P1037, DOI 10.1002/cncr.10272; Mayall F, 2003, J CLIN PATHOL, V56, P728, DOI 10.1136/jcp.56.10.728; Mulatero C, 1999, THORAX, V54, P60, DOI 10.1136/thx.54.1.60; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; NERENBERG MI, 1991, BIOTECHNIQUES, V11, P332; Pass HI, 1998, J THORAC CARDIOV SUR, V116, P854, DOI 10.1016/S0022-5223(98)00438-3; Pilatte Y, 2000, AM J RESP CELL MOL, V23, P788, DOI 10.1165/ajrcmb.23.6.4251; Prins JB, 1998, INT J CANCER, V75, P649, DOI 10.1002/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.0.CO;2-2; Rollison DEM, 2003, CANCER EPIDEM BIOMAR, V12, P460; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; SAGER R, 1981, CELL, V23, P41, DOI 10.1016/0092-8674(81)90268-3; Salewski H, 1999, CANCER RES, V59, P1980; Shah KV, 2000, REV MED VIROL, V10, P31, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<31::AID-RMV260>3.0.CO;2-I; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Simsir A, 2001, DIAGN CYTOPATHOL, V25, P203, DOI 10.1002/dc.2039; Strickler HD, 1996, CANCER EPIDEM BIOMAR, V5, P473; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P38, DOI 10.1093/jnci/95.1.38; Strickler HD, 2001, CANCER EPIDEM BIOMAR, V10, P523; Strickler HD, 1998, JAMA-J AM MED ASSOC, V279, P292, DOI 10.1001/jama.279.4.292; Testa JR, 1998, CANCER RES, V58, P4505; Testa JR, 2001, SEMIN CANCER BIOL, V11, P31, DOI 10.1006/scbi.2000.0344; Tzeng YJ, 1998, ONCOGENE, V16, P2103, DOI 10.1038/sj.onc.1201733; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Vilchez RA, 2003, J NATL CANCER I, V95, P687, DOI 10.1093/jnci/95.9.687; Vilchez RA, 2003, LANCET ONCOL, V4, P188, DOI 10.1016/S1470-2045(03)01024-6; Vilchez RA, 2002, J ACQ IMMUN DEF SYND, V29, P109, DOI 10.1097/00042560-200202010-00001; Vivaldi A, 2003, J CLIN ENDOCR METAB, V88, P892, DOI 10.1210/jc.2002-020436; Volter C, 1998, DEV BIOL STAND, V94, P137; Waheed I, 1999, CANCER RES, V59, P6068; XIAO S, 1995, ONCOGENE, V11, P511; zur Hansen H, 2003, INT J CANCER, V107, P687, DOI 10.1002/ijc.11517	66	148	152	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1157	1166		10.1016/S0140-6736(04)17102-X	http://dx.doi.org/10.1016/S0140-6736(04)17102-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451223				2022-12-01	WOS:000224102400029
J	Aubret, F; Shine, R; Bonnet, X				Aubret, F; Shine, R; Bonnet, X			Adaptive developmental plasticity in snakes	NATURE			English	Editorial Material									CNRS, CEBC, F-79360 Villiers En Bois, France; Univ Poitiers, Conseil Gen Deux Sevres, F-79360 Villiers En Bois, France; Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; Univ Sydney, Sydney, NSW 2006, Australia	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; University of Western Australia; University of Sydney	Aubret, F (corresponding author), CNRS, CEBC, F-79360 Villiers En Bois, France.	rics@bio.usyd.edu.au	Shine, Richard/B-8711-2008	Bonnet, Xavier/0000-0001-6150-8199				AUBRET F, 2003, AMPHIBIA-REPTILIA, V25, P9; BOCK WJ, 1980, AM ZOOL, V20, P217; COGGER HG, 1992, REPTILES AMPHIBIANS; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Forsman A, 1997, BIOL J LINN SOC, V62, P209, DOI 10.1006/bijl.1997.0148; PIGLIUCCI M, 2001, SYN ECO EVO, pR13; SHINE R, 1987, HERPETOLOGICA, V43, P233	7	104	107	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					261	262		10.1038/431261a	http://dx.doi.org/10.1038/431261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372019				2022-12-01	WOS:000223864000027
J	Nalbant, P; Hodgson, L; Kraynov, V; Toutchkine, A; Hahn, KM				Nalbant, P; Hodgson, L; Kraynov, V; Toutchkine, A; Hahn, KM			Activation of endogenous Cdc42 visualized in living cells	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; RHO-GTPASES; COMPLEX; RAC; BINDING; WASP; FIBROBLASTS; NEUTROPHILS; FILOPODIA; POLARITY	Signaling proteins are tightly regulated spatially and temporally to perform multiple functions. For Cdc42 and other guanosine triphosphatases, the subcellular location of activation is a critical determinant of cell behavior. However, current approaches are limited in their ability to examine the dynamics of Cdc42 activity in living cells. We report the development of a biosensor capable of visualizing the changing activation of endogenous, unlabeled Cdc42 in living cells. With the use of a dye that reports protein interactions, the biosensor revealed localized activation in the trans-Golgi apparatus, microtubule-dependent Cdc42 activation at the cell periphery, and activation kinetics precisely coordinated with cell extension and retraction.	Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hahn, KM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	khahn@med.unc.edu	Toutchkine, Alexei/A-7600-2009; Krainov, Vladimir P./D-9224-2014	Hodgson, Louis/0000-0001-9188-7580; Hahn, Klaus/0000-0002-1970-7562	NIGMS NIH HHS [R01 GM057464, GM57464, GM64346] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM057464, R01GM057464, U54GM064346] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; MANDEVILLE JTH, 1995, BIOPHYS J, V68, P1207, DOI 10.1016/S0006-3495(95)80336-X; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Nabi IR, 1999, J CELL SCI, V112, P1803; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seth A, 2003, BIOCHEMISTRY-US, V42, P3997, DOI 10.1021/bi026881z; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585	32	300	309	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1615	1619		10.1126/science.1100367	http://dx.doi.org/10.1126/science.1100367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361624				2022-12-01	WOS:000223891200042
J	Eigenmann, PA; Haenggeli, CA				Eigenmann, PA; Haenggeli, CA			Food colourings and preservatives - allergy and hyperactivity	LANCET			English	Editorial Material							CHILDREN		Childrens Univ Hosp, CH-1211 Geneva 14, Switzerland	University of Geneva	Eigenmann, PA (corresponding author), Childrens Univ Hosp, CH-1211 Geneva 14, Switzerland.	Philippe.Eigenmann@hcuge.ch	Eigenmann, Philippe/A-6569-2017	Eigenmann, Philippe/0000-0003-1738-1826				Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; EGGER J, 1992, LANCET, V339, P1150, DOI 10.1016/0140-6736(92)90742-L; Feingold B F, 1975, Am J Nurs, V75, P797, DOI 10.2307/3423460; Homer CJ, 2000, PEDIATRICS, V105, P1158; POLLOCK I, 1990, ARCH DIS CHILD, V65, P74, DOI 10.1136/adc.65.1.74; Warner J O, 1993, Pediatr Allergy Immunol, V4, P112, DOI 10.1111/j.1399-3038.1993.tb00078.x	7	22	22	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					823	824		10.1016/S0140-6736(04)16996-1	http://dx.doi.org/10.1016/S0140-6736(04)16996-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351173				2022-12-01	WOS:000223685200007
J	Dormitzer, PR; Nason, EB; Prasad, BVV; Harrison, SC				Dormitzer, PR; Nason, EB; Prasad, BVV; Harrison, SC			Structural rearrangements in the membrane penetration protein of a non-enveloped virus	NATURE			English	Article							RHESUS ROTAVIRUS VP4; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE; CELL ENTRY; FUSION; HEMAGGLUTININ; RECONSTRUCTION; CLEAVAGE; BINDING; PERMEABILIZATION	Non-enveloped virus particles (those that lack a lipid-bilayer membrane) must breach the membrane of a target host cell to gain access to its cytoplasm. So far, the molecular mechanism of this membrane penetration step has resisted structural analysis. The spike protein VP4 is a principal component in the entry apparatus of rotavirus, a non-enveloped virus that causes gastroenteritis and kills 440,000 children each year(1). Trypsin cleavage of VP4 primes the virus for entry by triggering a rearrangement that rigidifies the VP4 spikes(2). We have determined the crystal structure, at 3.2 Angstrom resolution, of the main part of VP4 that projects from the virion. The crystal structure reveals a coiled-coil stabilized trimer. Comparison of this structure with the two-fold clustered VP4 spikes in a similar to12 Angstrom resolution image reconstruction from electron cryomicroscopy of trypsin-primed virions shows that VP4 also undergoes a second rearrangement, in which the oligomer reorganizes and each subunit folds back on itself, translocating a potential membrane-interaction peptide from one end of the spike to the other. This rearrangement resembles the conformational transitions of membrane fusion proteins of enveloped viruses(3-6).	Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Berna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Baylor College of Medicine	Dormitzer, PR (corresponding author), Harvard Univ, Sch Med, Dept Pediat, 320 Longwood Ave, Boston, MA 02115 USA.	dormitze@crystal.harvard.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053174] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053174-02, R01 AI053174-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arias CF, 1996, J VIROL, V70, P5832, DOI 10.1128/JVI.70.9.5832-5839.1996; Crawford SE, 2001, J VIROL, V75, P6052, DOI 10.1128/JVI.75.13.6052-6061.2001; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Dormitzer PR, 2001, J VIROL, V75, P7339, DOI 10.1128/JVI.75.16.7339-7350.2001; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gilbert JM, 1998, J VIROL, V72, P5323, DOI 10.1128/JVI.72.6.5323-5327.1998; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lawton JA, 1996, J STRUCT BIOL, V116, P209, DOI 10.1006/jsbi.1996.0032; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MACKOW ER, 1988, P NATL ACAD SCI USA, V85, P645, DOI 10.1073/pnas.85.3.645; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OFFIT PA, 1986, J VIROL, V58, P700, DOI 10.1128/JVI.58.2.700-703.1986; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; TANIGUCHI K, 1988, J VIROL, V62, P2421, DOI 10.1128/JVI.62.7.2421-2426.1988; Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133	30	164	178	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1053	1058		10.1038/nature02836	http://dx.doi.org/10.1038/nature02836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329727	Green Accepted, Bronze			2022-12-01	WOS:000223514900049
J	Lloyd, S				Lloyd, S			Going into reverse	NATURE			English	Editorial Material									MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Mech Engn, 3-160, Cambridge, MA 02139 USA.							Landauer R., 2003, MAXWELLS DEMON, VII	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					971	971		10.1038/430971a	http://dx.doi.org/10.1038/430971a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329700	Bronze			2022-12-01	WOS:000223514900022
J	Ahn, S; Joyner, AL				Ahn, S; Joyner, AL			Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning	CELL			English	Article							APICAL ECTODERMAL RIDGE; SONIC-HEDGEHOG; CUBITUS-INTERRUPTUS; SPINAL-CORD; INDIAN-HEDGEHOG; TRANSCRIPTIONAL ACTIVATOR; RECOMBINASE ACTIVITY; POLARIZING ACTIVITY; CRE RECOMBINASE; NEURAL-TUBE	In the vertebrate limb, the posteriorly located zone of polarizing activity (ZPA) regulates digit identity through the morphogen Sonic Hedgehog (Shh). By genetically marking Shh-responding cells in mice, we have addressed whether the cumulative influence of positive Shh signaling over time and space reflects a linear gradient of Shh responsiveness and whether Shh could play additional roles in limb patterning. Our results show that all posterior limb mesenchyme cells, as well as the ectoderm, respond to Shh from the ZPA and become the bone, muscle, and skin of the posterior limb. Further, the readout of Shh activator function integrated over time and space does not display a stable and linear gradient along the A-P axis, as in a classical morphogen view. Finally, by fate mapping Shh-responding cells in Gli2 and Gli3 mutant limbs, we demonstrate that a specific level of positive Hh signaling is not required to specify digit identities.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu						AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Duprez D, 1999, MECH DEVELOP, V82, P151, DOI 10.1016/S0925-4773(99)00040-4; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iwasaki M, 1997, MECH DEVELOP, V69, P197, DOI 10.1016/S0925-4773(97)00145-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kimmel RA, 2000, GENE DEV, V14, P1377; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; MATISE MP, 2001, GENE TARGETING, P101; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2001, DEVELOPMENT, V128, P733; Mo R, 1997, DEVELOPMENT, V124, P113; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Park HL, 2000, DEVELOPMENT, V127, P1593; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	50	375	389	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					505	516		10.1016/j.cell.2004.07.023	http://dx.doi.org/10.1016/j.cell.2004.07.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315762	Bronze			2022-12-01	WOS:000223650900012
J	Tang, SM; Wolf, R; Xu, SP; Heisenberg, M				Tang, SM; Wolf, R; Xu, SP; Heisenberg, M			Visual pattern recognition in Drosophila is invariant for retinal position	SCIENCE			English	Article							FLIGHT ORIENTATION; FINE-STRUCTURE; YAW TORQUE; HONEYBEES; TEMPLATE; BEHAVIOR; VISION; MEMORY	Vision relies on constancy mechanisms. Yet, these are little understood, because they are difficult to investigate in freely moving organisms. One such mechanism, translation invariance, enables organisms to recognize visual patterns independent of the region of their visual field where they had originally seen them. Tethered flies ( Drosophila melanogaster) in a flight simulator can recognize visual patterns. Because their eyes are fixed in space and patterns can be displayed in defined parts of their visual field, they can be tested for translation invariance. Here, we show that flies recognize patterns at retinal positions where the patterns had not been presented before.	Acad Sinica, Inst Biophys, Beijing 100101, Peoples R China; Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Wurzburg	Tang, SM (corresponding author), Acad Sinica, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	tang-shm@sohu.com; heisenberg@biozentrum.uni-wuerzburg.de						BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BUCHNER E, 1971, THESIS U TUBINGEN; DILL M, 1995, LEARN MEMORY, V2, P152, DOI 10.1101/lm.2.3-4.152; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; DILL M, 1992, THESIS U WURZBURG; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; HEISENBERG M, 1995, CURR OPIN NEUROBIOL, V5, P475, DOI 10.1016/0959-4388(95)80008-5; Heisenberg M., 1984, STUDIES BRAIN FUNCTI, V12; HENGSTENBERG R, 1971, KYBERNETIK, V9, P56, DOI 10.1007/BF00270852; Horridge GA, 1998, J INSECT PHYSIOL, V44, P343, DOI 10.1016/S0022-1910(97)00116-9; Hubel DH., 1988, EYE BRAIN VISION; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SCHUSTER S, 1996, THESIS U TUBINGEN; SRINIVASAN MV, 1993, NATURE, V362, P539, DOI 10.1038/362539a0; SRINIVASAN MV, 1994, PHILOS T R SOC B, V343, P199, DOI 10.1098/rstb.1994.0021; TANG SJ, UNPUB, P95311; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; WEHNER R, 1985, NATURE, V315, P228, DOI 10.1038/315228a0; WEHNER R, 1967, NATURE, V215, P1244, DOI 10.1038/2151244a0; WEHNER R, 1966, Z VERGL PHYSIOL, V52, P290, DOI 10.1007/BF02427714; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699	28	68	68	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1020	1022		10.1126/science.1099839	http://dx.doi.org/10.1126/science.1099839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310908				2022-12-01	WOS:000223250700053
J	Vanderschuren, LJMJ; Everitt, BJ				Vanderschuren, LJMJ; Everitt, BJ			Drug seeking becomes compulsive after prolonged cocaine self-administration	SCIENCE			English	Article							ADDICTION; BEHAVIOR; SUPPRESSION; STIMULI; CORTEX; ABUSE; RATS	Compulsive drug use in the face of adverse consequences is a hallmark feature of addiction, yet there is little preclinical evidence demonstrating the actual progression from casual to compulsive drug use. Presentation of an aversive conditioned stimulus suppressed drug seeking in rats with limited cocaine self-administration experience, but no longer did so after an extended cocaine-taking history. In contrast, after equivalent extended sucrose experience, sucrose seeking was still suppressed by an aversive conditioned stimulus. Persistent cocaine seeking in the presence of signals of environmental adversity after a prolonged cocaine-taking history was not due to impaired fear conditioning, nor to an increase in the incentive value of cocaine, and may reflect the establishment of compulsive behavior.	Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	Utrecht University; Utrecht University Medical Center; University of Cambridge	Vanderschuren, LJMJ (corresponding author), Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands.	l.j.m.j.vanderschuren@med.uu.nl	Vanderschuren, Louk/AAS-4391-2020	Vanderschuren, Louk/0000-0002-5379-0363; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; *AM PSYCH ASS WASH, 1994, DIAGN STAT MAN MENT; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kearns DN, 2002, DRUG ALCOHOL DEPEN, V65, P253, DOI 10.1016/S0376-8716(01)00167-3; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; LEDOUX JE, 1984, J NEUROSCI, V4, P683; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Olmstead MC, 2000, PSYCHOPHARMACOLOGY, V152, P123, DOI 10.1007/s002130000498; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	21	523	536	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					1017	1019		10.1126/science.1098975	http://dx.doi.org/10.1126/science.1098975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310907				2022-12-01	WOS:000223250700052
J	Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA				Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA			Self-assembly of amphiphilic dendritic dipeptides into helical pores	NATURE			English	Article							DENDRIMERS; CONDUCTION; POLYMERS; CHANNEL; SHAPE	Natural pore-forming proteins act as viral helical coats(1) and transmembrane channels(2-4), exhibit antibacterial activity(5) and are used in synthetic systems, such as for reversible encapsulation(6) or stochastic sensing(7). These diverse functions are intimately linked to protein structure(1-4). The close link between protein structure and protein function makes the design of synthetic mimics a formidable challenge, given that structure formation needs to be carefully controlled on all hierarchy levels, in solution and in the bulk. In fact, with few exceptions(8,9), synthetic pore structures capable of assembling into periodically ordered assemblies that are stable in solution and in the solid state(10-13) have not yet been realized. In the case of dendrimers, covalent(14) and non- covalent(15) coating and assembly of a range of different structures(15-17) has only yielded closed columns(18). Here we describe a library of amphiphilic dendritic dipeptides that self-assemble in solution and in bulk through a complex recognition process into helical pores. We find that the molecular recognition and self-assembly process is sufficiently robust to tolerate a range of modifications to the amphiphile structure, while preliminary proton transport measurements establish that the pores are functional. We expect that this class of self-assembling dendrimers will allow the design of a variety of biologically inspired systems with functional properties arising from their porous structure.	Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Digital Instruments, Veeco Metrol Grp, Santa Barbara, CA 93110 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; National Institute of Standards & Technology (NIST) - USA; University of Pennsylvania	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Hudson, Steven/AAB-2909-2019; Percec, Virgil/H-6316-2014; Hudson, Steven/W-3211-2019; Nummelin, Sami/P-4185-2019; Miura, Yoshiko/AAD-1166-2020; Nummelin, Sami J/O-5741-2015; Peterca, Mihai/C-9504-2009	Hudson, Steven/0000-0002-3203-4833; Percec, Virgil/0000-0001-5926-0489; Nummelin, Sami/0000-0003-2195-4818; Miura, Yoshiko/0000-0001-8590-6079; Nummelin, Sami J/0000-0003-2195-4818; Peterca, Mihai/0000-0002-7247-4008; Balagurusamy, Venkat/0000-0002-1994-2634; /0000-0002-1631-1781				Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Brunsveld L, 2000, J AM CHEM SOC, V122, P6175, DOI 10.1021/ja0005237; CHAN HS, 1995, PHILOS T R SOC B, V348, P61, DOI 10.1098/rstb.1995.0046; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emrick T, 1999, CURR OPIN COLLOID IN, V4, P15, DOI 10.1016/S1359-0294(99)00008-4; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Finikova O, 2003, J AM CHEM SOC, V125, P4882, DOI 10.1021/ja0341687; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; LEHN JM, 1995, SUPRAMOL CHEM, P118; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Percec V, 2002, CHEM-EUR J, V8, P2011, DOI 10.1002/1521-3765(20020503)8:9<2011::AID-CHEM2011>3.0.CO;2-3; Percec V, 2001, J AM CHEM SOC, V123, P1302, DOI 10.1021/ja0037771; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Sakai N, 2003, CHEM COMMUN, P2514, DOI 10.1039/b303649a; Schmitt JL, 2003, HELV CHIM ACTA, V86, P1598, DOI 10.1002/hlca.200390137; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	30	537	544	4	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					764	768		10.1038/nature02770	http://dx.doi.org/10.1038/nature02770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306805				2022-12-01	WOS:000223233600037
J	Spagnoli, LG; Mauriello, A; Sangiorgi, G; Fratoni, S; Bonanno, E; Schwartz, RS; Piepgras, DG; Pistolese, R; Ippoliti, A; Holmes, DR				Spagnoli, LG; Mauriello, A; Sangiorgi, G; Fratoni, S; Bonanno, E; Schwartz, RS; Piepgras, DG; Pistolese, R; Ippoliti, A; Holmes, DR			Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATHEROSCLEROTIC PLAQUES; INFLAMMATION; ENDARTERECTOMY; PATHOGENESIS; ULCERATION; THROMBOSIS; MORPHOLOGY; DISEASE; PROTEIN; LESIONS	Context Recent studies suggest that factors other than the degree of carotid stenosis are involved in ischemic stroke pathogenesis, especially modifications of plaque composition and related complications. Objective To examine the role of carotid plaque rupture and thrombosis in ischemic stroke pathogenesis in patients undergoing carotid endarterectomy, excluding those with possible cardiac embolization or with severe stenosis of the circle of Willis. Design, Setting, and Patients A total of 269 carotid plaques selected from an interinstitutional Carotid Tissue Bank were studied by histology after surgical endarterectomy between January 1995 and December 2002. A total of 96 plaques were from patients with ipsilateral major stroke, 91 plaques from patients with transient ischemic attack (TIA), and 82 plaques from patients without symptoms. Main Outcome Measures Differences in the frequency of thrombosis, cap rupture, cap erosion, inflammatory infiltrate, and major cardiovascular risk factors between study groups. Results A thrombotically active carotid plaque associated with high inflammatory infiltrate was observed in 71 (74.0%) of 96 patients with ipsilateral major stroke (and in all 32 plaques from patients operated within 2 months of symptom onset) compared with 32 (35.2%) of 91 patients with TIA (P<.001) or 12 (14.6%) of 82 patients who were without symptoms (P<.001). In addition, a fresh thrombus was observed in 53.8% of patients with stroke operated 13 to 24 months after the cerebrovascular event, An acute thrombus was associated with cap rupture in 64 (90.1%) of 71 thrombosed plaques from patients with stroke and with cap erosion in the remaining 7 cases (9.9%). Ruptured plaques of patients affected by stroke were characterized by the presence of a more severe inflammatory infiltrate, constituted by monocytes, macrophages, and T lymphocyte cells compared with that observed in the TIA and asymptomatic groups (P=.001). There was no significant difference between groups in major cardiovascular risk factors. Conclusion These results demonstrate a major role of carotid thrombosis and inflammation in ischemic stroke in patients affected by carotid atherosclerotic disease.	Univ Roma Tor Vergata, Dept Cardiovasc Dis, Div Vasc Surg, I-00133 Rome, Italy; Minneapolis Cardiovasc Res Inst, Minneapolis, MN USA; Mayo Clin & Mayo Fdn, Dept Neurol Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Cardiovasc Dis, Rochester, MN 55905 USA	University of Rome Tor Vergata; Mayo Clinic; Mayo Clinic; Mayo Clinic	Spagnoli, LG (corresponding author), Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Cattedra Anat & Istol Patol, Via Montpellier 1, I-00133 Rome, Italy.	spagnoli@uniroma2.it	Sangiorgi, Giuseppe M/H-5141-2019; MAURIELLO, ALESSANDRO/K-4705-2016	Sangiorgi, Giuseppe M/0000-0001-5862-1967; MAURIELLO, ALESSANDRO/0000-0002-7351-5676; Spagnoli, Luigi Giusto/0000-0002-0684-5501; IPPOLITI, ARNALDO/0000-0001-5311-8203; bonanno, elena/0000-0002-0222-0141; ippoliti, arnaldo/0000-0002-2804-0157				Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1978, NEUROLOGY, V28, P769; Bassiouny HS, 1997, J VASC SURG, V26, P585, DOI 10.1016/S0741-5214(97)70056-9; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Carr S, 1996, J VASC SURG, V23, P755, DOI 10.1016/S0741-5214(96)70237-9; Chamorro A, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000075297; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; ELIASZIW M, 1994, STROKE, V25, P304, DOI 10.1161/01.STR.25.2.304; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Fujii K, 2003, CIRCULATION, V108, P2473, DOI 10.1161/01.CIR.0000097121.95451.39; Goldstein LB, 2003, STROKE, V34, P2767, DOI 10.1161/01.STR.0000097803.90702.31; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; GOMEZ CR, 1990, STROKE, V21, P148, DOI 10.1161/01.STR.21.1.148; Gorelick PB, 2002, STROKE, V33, P862, DOI 10.1161/hs0302.103657; Hatsukami TS, 1997, STROKE, V28, P95, DOI 10.1161/01.STR.28.1.95; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Mauriello A, 2000, CIRCULATION, V101, P744, DOI 10.1161/01.CIR.101.7.744; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; SITZER M, 1995, STROKE, V26, P1231, DOI 10.1161/01.STR.26.7.1231; SPAGNOLI LG, 1994, ATHEROSCLEROSIS, V108, P39, DOI 10.1016/0021-9150(94)90036-1; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tilton RG, 2002, DRUG NEWS PERSPECT, V15, P351, DOI 10.1358/dnp.2002.15.6.701654; VANDAMME H, 1993, INT ANGIOL, V12, P299; Verheye S, 2002, CIRCULATION, V105, P1596, DOI 10.1161/01.CIR.0000012527.94843.BF; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; ZHENG Z, 2003, CURR MOL MED, V361, P372	38	335	364	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 20	2004	292	15					1845	1852		10.1001/jama.292.15.1845	http://dx.doi.org/10.1001/jama.292.15.1845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IV	15494582	Bronze			2022-12-01	WOS:000224485100023
J	Bianco, PR				Bianco, PR			Hepatitis CNS3 helicase unwinds RNA in leaps and bounds	LANCET			English	Editorial Material							C VIRUS; MACROMOLECULAR MACHINES; STEP-SIZE; MECHANISMS		SUNY Buffalo, Dept Microbiol & Immunol, Ctr Single Mol Biophys, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bianco, PR (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Ctr Single Mol Biophys, Buffalo, NY 14214 USA.	pbianco@buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066831] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66831-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; Borowski P, 2003, EUR J BIOCHEM, V270, P1645, DOI 10.1046/j.1432-1033.2003.03540.x; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dev Anouk, 2004, Curr Gastroenterol Rep, V6, P77, DOI 10.1007/s11894-004-0030-5; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88	14	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1385	1387		10.1016/S0140-6736(04)17238-3	http://dx.doi.org/10.1016/S0140-6736(04)17238-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488202				2022-12-01	WOS:000224485300007
J	Bossuyt, F; Meegaskumbura, M; Beenaerts, N; Gower, DJ; Pethiyagoda, R; Roelants, K; Mannaert, A; Wilkinson, M; Bahir, MM; Manamendra-Arachchi, K; Ng, PKL; Schneider, CJ; Oommen, OV; Milinkovitch, MC				Bossuyt, F; Meegaskumbura, M; Beenaerts, N; Gower, DJ; Pethiyagoda, R; Roelants, K; Mannaert, A; Wilkinson, M; Bahir, MM; Manamendra-Arachchi, K; Ng, PKL; Schneider, CJ; Oommen, OV; Milinkovitch, MC			Local endemism within the western Ghats-Sri Lanka biodiversity hotspot	SCIENCE			English	Article							EVOLUTION	The apparent biotic affinities between the mainland and the island in the Western Ghats-Sri Lanka biodiversity hotspot have been interpreted as the result of frequent migrations during recent periods of low sea level. We show, using molecular phylogenies of two invertebrate and four vertebrate groups, that biotic interchange between these areas has been much more limited than hitherto assumed. Despite several extended periods of land connection during the past 500,000 years, Sri Lanka has maintained a fauna that is largely distinct from that of the Indian mainland. Future conservation programs for the subcontinent should take into account such patterns of local endemism at the finest scale at which they may occur.	Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, B-1050 Brussels, Belgium; Free Univ Brussels, Inst Mol Biol & Med, Lab Evolutionary Genet, B-6041 Gosselies, Belgium; Boston Univ, Dept Biol, Boston, MA 02215 USA; Wildlife Heritage Trust, Colombo 8, Sri Lanka; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Univ Kerala, Dept Zool, Thiruvananthapuram 695581, Kerala, India	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Boston University; Natural History Museum London; National University of Singapore; University of Kerala	Bossuyt, F (corresponding author), Free Univ Brussels, Dept Biol, Unit Ecol & Systemat, Pleinlaan 2, B-1050 Brussels, Belgium.	fbossuyt@vub.ac.be	Wilkinson, Mark/J-2026-2014; Meegaskumbura, Madhava/F-8782-2013; Ng, Peter/J-7393-2012; Beenaerts, Natalie/AAC-5579-2021; Pethiyagoda, Rohan/C-2307-2009	Wilkinson, Mark/0000-0002-9459-8976; Meegaskumbura, Madhava/0000-0002-4599-6724; Milinkovitch, Michel/0000-0002-2553-0724; Beenaerts, Natalie/0000-0001-5655-5943; Pethiyagoda, Rohan/0000-0001-7215-9617; Roelants, Kim/0000-0001-5367-5958; Bossuyt, Franky/0000-0001-6804-9271				BOTT R, 1970, ARK ZOOL, V22, P627; BOTT R, 1970, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V526, P1; CADLE JE, 1990, BIOL J LINN SOC, V40, P293, DOI 10.1111/j.1095-8312.1990.tb00541.x; Daniels RJR, 2001, CURR SCI INDIA, V81, P240; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Erdelen W., 1990, VEGETATION EROSION, P491; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; INGER R F, 1984, Journal of the Bombay Natural History Society, V81, P551; KIRTISINGHE P, 1957, AMPHIBIAN FAUNA CEYL; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.2307/1796430; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Moritz Craig, 1997, P442; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng Peter K.L., 1995, Journal of South Asian Natural History, V1, P129; Ng Peter K. L., 2001, Zeylanica, V6, P113; Pan GB, 1997, CLIMATES S ASIA; Pethiyagoda R, 1991, FRESHWATER FISHES SR; Pethiyagoda R, 1998, OCC PAP WILDL HERITA, V2, P1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; SENANAYAKE FR, 1977, NATURE, V265, P351, DOI 10.1038/265351a0; SMITH MA, 1943, SERPENTES FAUNA BRIT, V3; Vaz GG, 2000, CURR SCI INDIA, V79, P228; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, p.; [No title captured]	27	246	272	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					479	481		10.1126/science.1100167	http://dx.doi.org/10.1126/science.1100167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486298				2022-12-01	WOS:000224626500051
J	Jetz, W; Carbone, C; Fulford, J; Brown, JH				Jetz, W; Carbone, C; Fulford, J; Brown, JH			The scaling of animal space use	SCIENCE			English	Article							HOME-RANGE SIZE; POPULATION ENERGY-USE; BODY-SIZE; MAMMALS; DENSITY; MASS; AREA; ABUNDANCE; ECOLOGY; BIRDS	Space used by animals increases with increasing body size. Energy requirements alone can explain how population density decreases, but not the steep rate at which home range area increases. We present a general mechanistic model that predicts the frequency of interaction, spatial overlap, and loss of resources to neighbors. Extensive empirical evidence supports the model, demonstrating that spatial constraints on defense cause exclusivity of home range use to decrease with increasing body size. In large mammals, over 90% of available resources may be lost to neighbors. Our model offers a general framework to understand animal space use and sociality.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Zool Soc London, Inst Zool, London NW1 4RY, England	Princeton University; University of New Mexico; Zoological Society of London	Jetz, W (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	wjetz@princeton.edu	Jetz, Walter/ABF-1517-2020	Jetz, Walter/0000-0002-1971-7277				Barrett L, 1998, FUNCT ECOL, V12, P857, DOI 10.1046/j.1365-2435.1998.00261.x; Blackburn TM, 1997, J ANIM ECOL, V66, P233, DOI 10.2307/6025; Blackburn TM, 1996, OIKOS, V75, P303, DOI 10.2307/3546254; Calder W. A, 1984, SIZE FUNCTION LIFE H; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CARBONE C, IN PRESS AM NAT; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Johnson CN, 1999, OIKOS, V85, P565, DOI 10.2307/3546706; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kirschfeld K., 1976, P354; LINDSTEDT SL, 1986, ECOLOGY, V67, P413, DOI 10.2307/1938584; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Marquet PA, 2002, SCIENCE, V295, P2229, DOI 10.1126/science.1070587; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Okubo A., 1980, DIFFUSION ECOLOGICAL; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Silva M, 2001, GLOBAL ECOL BIOGEOGR, V10, P469, DOI 10.1046/j.1466-822x.2001.00261.x; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231	31	380	390	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					266	268		10.1126/science.1102138	http://dx.doi.org/10.1126/science.1102138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472074				2022-12-01	WOS:000224419700037
J	Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM				Stuart, AJ; Kosintsev, PA; Higham, TFG; Lister, AM			Pleistocene to Holocene extinction dynamics in giant deer and woolly mammoth	NATURE			English	Article							MEGALOCEROS-GIGANTEUS BLUMENBACH; IRISH ELK; EUROPE; ISLAND	The extinction of the many well-known large mammals (megafauna) of the Late Pleistocene epoch has usually been attributed to 'overkill' by human hunters, climatic/vegetational changes or to a combination of both(1,2). An accurate knowledge of the geography and chronology of these extinctions is crucial for testing these hypotheses. Previous assumptions that the megafauna of northern Eurasia had disappeared by the Pleistocene/Holocene transition(2) were first challenged a decade ago by the discovery that the latest woolly mammoths on Wrangel Island, northeastern Siberia, were contemporaneous with ancient Egyptian civilization(3,4). Here we show that another spectacular megafaunal species, the giant deer or 'Irish elk', survived to around 6,900 radiocarbon yr BP (about 7,700 yr ago) in western Siberia-more than three millennia later than its previously accepted terminal date(2,5)-and therefore, that the reasons for its ultimate demise are to be sought in Holocene not Pleistocene events. Before their extinction, both giant deer and woolly mammoth underwent dramatic shifts in distribution, driven largely by climatic/vegetational changes. Their differing responses reflect major differences in ecology.	UCL, Dept Biol, London WC1E 6BT, England; Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3JQ, England	University of London; University College London; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Oxford	Stuart, AJ (corresponding author), UCL, Dept Biol, Mortimer St, London WC1E 6BT, England.	Tony@megafauna.freeserve.co.uk	Higham, Tom/Y-2707-2019	Higham, Tom/0000-0002-5949-598X; Lister, Adrian/0000-0002-7985-138X				Aaris-Sorensen K, 2004, BOREAS, V33, P61, DOI 10.1080/03009480310006970; BARNOSKY AD, 1986, QUATERNARY RES, V25, P128, DOI 10.1016/0033-5894(86)90049-9; BARNOSKY AD, 1985, SCIENCE, V228, P340, DOI 10.1126/science.228.4697.340; FORONOVA IV, 2001, UNITED I GEOLOGY T, V848, P243; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gonzalez S, 2000, NATURE, V405, P753, DOI 10.1038/35015668; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Guenther E., 1960, SCHRIFT NATURWISS VE, V30, P79; Guthrie RD, 2004, NATURE, V429, P746, DOI 10.1038/nature02612; Hoekstra R, 2001, PSYCHIAT RES, V103, P115, DOI 10.1016/S0165-1781(01)00282-7; Kahlke Ralf-Dietrich, 1994, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V546, P1; Kaiser K., 1999, EISZEITALTER GEGENWA, V49, P102; LISTER AM, 1994, ZOOL J LINN SOC-LOND, V112, P65, DOI 10.1006/zjls.1994.1034; Litt T, 2003, QUATERNARY SCI REV, V22, P7, DOI 10.1016/S0277-3791(02)00180-4; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Martin P. S., 1984, QUATERNARY EXTINCTIO, P364; MITCHELL G. F., 1949, PROC ROY IRISH ACAD SECT B, V52, P291; Moen RA, 1999, EVOL ECOL RES, V1, P235; Panova N, 1996, FOREST DEV PROCESS U, P26; PAVLOW M, 1906, MEM ACAD SCI ST PETE, V20, P1; SERIKOV YB, 2000, PALEOLITHIC MESOLITH, P351; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; Stuart AJ, 2002, QUATERNARY SCI REV, V21, P1559, DOI 10.1016/S0277-3791(02)00026-4; STUART AJ, IN PRESS QUAT INT; Tzedakis PC, 1995, QUATERNARY SCI REV, V14, P967, DOI 10.1016/0277-3791(95)00042-9; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; Vereshchagin N.K., 1984, P483; Woodman P, 1997, QUATERNARY SCI REV, V16, P129, DOI 10.1016/S0277-3791(96)00037-6; Woodman P. C, 1985, QUATERNARY HIST IREL, P251	29	222	245	1	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					684	689		10.1038/nature02890	http://dx.doi.org/10.1038/nature02890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470427				2022-12-01	WOS:000224299300039
J	Wills-Karp, M; Karp, CL				Wills-Karp, M; Karp, CL			Chitin checking - Novel insights into asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACIDIC MAMMALIAN CHITINASE		Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA; Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Wills-Karp, M (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA.			Karp, Christopher/0000-0002-0832-2659				Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Herrera-Estrella A, 1999, EXS, V87, P171; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	5	24	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1455	1457		10.1056/NEJMcibr041294	http://dx.doi.org/10.1056/NEJMcibr041294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459309				2022-12-01	WOS:000224153900017
J	Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M				Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M			Mis16 and Mis18 are required for CENP-A loading and histone deacetylation at centromeres	CELL			English	Article							BUDDING YEAST KINETOCHORE; CULTURED-MAMMALIAN-CELLS; FISSION YEAST; CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; OUTER KINETOCHORE; EQUAL SEGREGATION; PROTEIN; GENE	Centromeres contain specialized chromatin that includes the centromere-specific histone H3 variant, spCENP-A/Cnp1. Here we report identification of five fission yeast centromere proteins, Mis14-18. Mis14 is recruited to kinetochores independently of CENP-A, and, conversely, CENP-A does not require Mis14 to associate with centromeres. In contrast, Mis15, Mis16 (strong similarity with human RbAp48 and RbAp46), Mis17, and Mis18 are all part of the CENP-A recruitment pathway. Mis15 and Mis17form an evolutionarily conserved complex that also includes Mis6. Mis16 and Mis18 form a complex and maintain the deacetylated state of histones specifically in the central core of centromeres. Mis16 and Mis18 are the most upstream factors in kinetochore assembly as they can associate with kinetochores in all kinetochore mutants except for mis18 and mis16, respectively. RNAi knockdown in human cells shows that Mis16 function is conserved as RbAp48 and RbAp46 are both required for localization of human CENP-A.	Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp						ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Furuyama T, 2003, GENESIS, V35, P114, DOI 10.1002/gene.10173; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Harborth J, 2001, J CELL SCI, V114, P4557; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Henikoff S, 2003, NATURE, V423, P814, DOI 10.1038/423814a; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jin QW, 2002, MOL CELL BIOL, V22, P7168, DOI 10.1128/MCB.22.20.7168-7183.2002; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nabeshima K, 1997, METHOD ENZYMOL, V283, P459; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100	42	323	340	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					715	729		10.1016/j.cell.2004.09.002	http://dx.doi.org/10.1016/j.cell.2004.09.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369671	Bronze			2022-12-01	WOS:000223992400008
J	Burls, A; Jobanputra, P				Burls, A; Jobanputra, P			The trials of anakinra	LANCET			English	Editorial Material							RHEUMATOID-ARTHRITIS		Univ Birmingham, Dept Epidemiol & Publ Hlth, W Midlands Hlth Technol Assessment Collaborat, Birmingham B15 2TT, W Midlands, England; Univ Hosp Birmingham NHS Trust, Selly Oak Hosp, Dept Rheumatol, Birmingham, W Midlands, England	University of Birmingham	Burls, A (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, W Midlands Hlth Technol Assessment Collaborat, Birmingham B15 2TT, W Midlands, England.	A.J.Burls@bham.ac.uk	Burls, Amanda J.E./D-7641-2011; Jobanputra, Paresh/R-2311-2019	Jobanputra, Paresh/0000-0002-2712-667X; Burls, Amanda/0000-0001-9540-622X				Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Buch MH, 2004, ARTHRITIS RHEUM-US, V50, P725, DOI 10.1002/art.20115; CLARK W, 2004, HLTH TECH ASSESS, V8; Fleischmann RM, 2003, ARTHRITIS RHEUM-US, V48, P927, DOI 10.1002/art.10870; *FOOD DRUG ADM CTR, 103950 BLA STN FOOD; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; JOBANPUTRA P, 2002, HLTH TECH ASSESS, V6; NICE, 2002, GUID US ET INFL TREA; *NICE, 2003, AN RHEUM ARTHR; Parmar MKB, 1996, J NATL CANCER I, V88, P1645, DOI 10.1093/jnci/88.22.1645	10	14	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					827	828		10.1016/S0140-6736(04)16999-7	http://dx.doi.org/10.1016/S0140-6736(04)16999-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351176				2022-12-01	WOS:000223685200010
J	Hallam, SJ; Putnam, N; Preston, CM; Detter, JC; Rokhsar, D; Richardson, PM; DeLong, EF				Hallam, SJ; Putnam, N; Preston, CM; Detter, JC; Rokhsar, D; Richardson, PM; DeLong, EF			Reverse methanogenesis: Testing the hypothesis with environmental genomics	SCIENCE			English	Article							METHANE-OXIDIZING ARCHAEA; MARINE-SEDIMENTS; ANAEROBIC OXIDATION; CARBONATES; PATHWAYS; BACTERIA; GENES	Microbial methane consumption in anoxic sediments significantly impacts the global environment by reducing the flux of greenhouse gases from ocean to atmosphere. Despite its significance, the biological mechanisms controlling anaerobic methane oxidation are not well characterized. One current model suggests that relatives of methane-producing Archaea, developed the capacity to reverse methanogenesis and thereby to consume methane to produce cellular carbon and energy. We report here a test of the "reverse-methanogenesis" hypothesis by genomic analyses of methane-oxidizing Archaea, from deep-sea sediments. Our results show that nearly all genes typically associated with methane production are present in one specific group of archaeal methanotrophs. These genome-based observations support previous hypotheses and provide an informed foundation for metabolic modeling of anaerobic methane oxidation.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95064 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA	Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	DeLong, EF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu	Putnam, Nicholas/B-9968-2008	Putnam, Nicholas/0000-0002-1315-782X; Rokhsar, Daniel/0000-0002-8704-2224				Angelaccio S, 2003, J BIOL CHEM, V278, P41789, DOI 10.1074/jbc.M306747200; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borowski WS, 1999, MAR GEOL, V159, P131, DOI 10.1016/S0025-3227(99)00004-3; Chistoserdova L, 2000, MICROBIOL-SGM, V146, P233, DOI 10.1099/00221287-146-1-233; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hoehler TM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P326; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; KUHNER CH, 1993, J BACTERIOL, V175, P3195, DOI 10.1128/JB.175.10.3195-3203.1993; KULM LD, 1986, SCIENCE, V231, P561, DOI 10.1126/science.231.4738.561; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; PAULL CK, 1992, PALAIOS, V7; Reeburgh WS, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P334; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	24	470	513	14	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1457	1462		10.1126/science.1100025	http://dx.doi.org/10.1126/science.1100025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353801				2022-12-01	WOS:000223761900047
J	Wojtowicz, WM; Flanagan, JJ; Millard, SS; Zipursky, SL				Wojtowicz, WM; Flanagan, JJ; Millard, SS; Zipursky, SL			Alternative splicing of Drosophila Dscam generates axon guidance receptors that exhibit isoform-specific homophilic binding	CELL			English	Article							CELL-ADHESION MOLECULE; SUPERFAMILY; EXPRESSION; DIVERSITY; NEUREXINS; NEURONS; FAMILY; GROWTH; MEMBER	Dscam is an immunoglobulin (Ig) superfamily protein required for the formation of neuronal connections in Drosophila. Through alternative splicing, Dscam potentially gives rise to 19,008 different extracellular domains linked to one of two alternative transmembrane segments, resulting in 38,016 isoforms. All isoforms share the same domain structure but contain variable amino acid sequences within three Ig domains in the extracellular region. We demonstrate that different isoforms exhibit different binding specificity. Each isoform binds to itself but does not bind or binds poorly to other isoforms. The amino acid sequences of all three variable Ig domains determine binding specificity. Even closely related isoforms sharing nearly identical amino acid sequences exhibit isoform-specific binding. We propose that this preferential homophilic binding specificity regulates interactions between cells and contributes to the formation of complex patterns of neuronal connections.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu	Millard, Sean/A-8522-2013	Zipursky, Stephen/0000-0001-5630-7181; Millard, Sean/0000-0001-8573-4625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS044582, T32NS007101] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007185, GM07185] Funding Source: Medline; NINDS NIH HHS [F31NS044582, 5 T32 NS07101, F31 NS044582, T32 NS007101] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GRAVELEY BR, 2004, IN PRESS ORG EVOLUTI; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Higashijima S, 1996, DEVELOPMENT, V122, P527; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	31	235	242	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					619	633		10.1016/j.cell.2004.08.021	http://dx.doi.org/10.1016/j.cell.2004.08.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339666	Green Accepted, Bronze			2022-12-01	WOS:000223730300012
J	Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG				Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG			Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host	CELL			English	Article							BASEPLATE MORPHOGENESIS; CONTRACTILE TAIL; GENETIC-CONTROL; ELECTRON MICROSCOPE; T4 BACTERIOPHAGES; ESCHERICHIA COLI; SHEATH PROTEIN; PRODUCT; DNA; EVOLUTION	The contractile tail of bacteriophage T4 undergoes major structural transitions when the virus attaches to the host cell surface. The baseplate at the distal end of the tail changes from a hexagonal to a star shape. This causes the sheath around the tail tube to contract and the tail tube to protrude from the baseplate and pierce the outer cell membrane and the cell wall before reaching the inner cell membrane for subsequent viral DNA injection. Analogously, the T4 tail can be contracted by treatment with 3 M urea. The structure of the T4 contracted tail, including the head-tail joining region, has been determined by cryo-electron microscopy to 17 Angstrom resolution. This 1200 Angstrom-long, 20 MDa structure has been interpreted in terms of multiple copies of its approximately 20 component proteins. A comparison with the metastable hexagonal baseplate of the mature virus shows that the baseplate proteins move as rigid bodies relative to each other during the structural change.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow 117997, Russia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Leiman, Petr G/E-5120-2010	Leiman, Petr G/0000-0002-9091-0918; Kostyuchenko, Victor/0000-0001-9751-307X; Chipman, Paul/0000-0003-3652-4087				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Arisaka F, 1981, Prog Clin Biol Res, V64, P365; ARISAKA F, 1990, BIOCHEMISTRY-US, V29, P5057, DOI 10.1021/bi00473a009; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Black Lindsay W., 1994, P218; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6; CRAWFORD JT, 1980, J MOL BIOL, V139, P679, DOI 10.1016/0022-2836(80)90054-6; CROWTHER RA, 1977, J MOL BIOL, V116, P489, DOI 10.1016/0022-2836(77)90081-X; Desplats C, 2003, RES MICROBIOL, V154, P259, DOI 10.1016/S0923-2508(03)00069-X; DRIEDONKS RA, 1981, J MOL BIOL, V152, P641, DOI 10.1016/0022-2836(81)90121-2; DUDA RL, 1985, P NATL ACAD SCI USA, V82, P5550, DOI 10.1073/pnas.82.16.5550; Eiserling Frederick A., 1994, P209; FOKINE A, IN PRESS P NATL ACAD; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kellenberger E, 1996, BIOPHYS CHEM, V59, P41, DOI 10.1016/0301-4622(95)00117-4; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIKUCHI Y, 1975, J SUPRAMOL STR CELL, V3, P24, DOI 10.1002/jss.400030104; KIKUCHI Y, 1975, J MOL BIOL, V99, P645, DOI 10.1016/S0022-2836(75)80178-1; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; KING J, 1971, J MOL BIOL, V58, P693, DOI 10.1016/0022-2836(71)90034-9; KING J, 1968, J MOL BIOL, V32, P231, DOI 10.1016/0022-2836(68)90007-7; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kostyuchenko VA, 1999, STRUCTURE, V7, P1213, DOI 10.1016/S0969-2126(00)80055-6; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989; Leiman PG, 2003, J MOL BIOL, V328, P821, DOI 10.1016/S0022-2836(03)00366-8; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; MOODY MF, 1981, J MOL BIOL, V150, P217, DOI 10.1016/0022-2836(81)90450-2; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; MOODY MF, 1973, J MOL BIOL, V80, P613, DOI 10.1016/0022-2836(73)90200-3; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; SIMON LD, 1967, VIROLOGY, V32, P298, DOI 10.1016/0042-6822(67)90278-4; SIMON LD, 1967, VIROLOGY, V32, P279, DOI 10.1016/0042-6822(67)90277-2; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; TAKEDA S, 1990, BIOCHEMISTRY-US, V29, P5050, DOI 10.1021/bi00473a008; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; Vianelli A, 2000, J BACTERIOL, V182, P680, DOI 10.1128/JB.182.3.680-688.2000; WATTS NR, 1990, J MOL BIOL, V216, P312; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	59	208	228	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					419	429		10.1016/j.cell.2004.07.022	http://dx.doi.org/10.1016/j.cell.2004.07.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315755	Bronze			2022-12-01	WOS:000223650900005
J	Snow, RW				Snow, RW			The invisible victims	NATURE			English	Article							MALARIA; FUTURE		Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya	Kenya Medical Research Institute	Snow, RW (corresponding author), Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya.		Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088				Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MONASCH R, IN PRESS AM J TROP M; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; SNOW RW, 2003, 11 DCPP; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; 2000, ABUJA DECLARATION RO	7	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					934	935		10.1038/430934a	http://dx.doi.org/10.1038/430934a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318234	Bronze			2022-12-01	WOS:000223369800057
J	Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C				Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C			Intranuclear biotin	LANCET			English	Editorial Material									Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin Univ St Luc, Dept Obstet, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Marbaix, E (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium.			Sempoux, Christine/0000-0003-1375-3979					0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					532	532		10.1016/S0140-6736(04)16813-X	http://dx.doi.org/10.1016/S0140-6736(04)16813-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302198				2022-12-01	WOS:000223132700034
J	Glotzer, SC				Glotzer, SC			Some assembly required	SCIENCE			English	Editorial Material							GOLD NANOPARTICLES; BUILDING-BLOCKS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, 2300 Hayward St, Ann Arbor, MI 48109 USA.	sgtolzer@umich.edu						Blum AS, 2004, NANO LETT, V4, P867, DOI 10.1021/nl0497474; Cardoen G, 2004, MACROMOLECULES, V37, P5123, DOI 10.1021/ma049769c; Gracias DH, 2002, APPL PHYS LETT, V80, P2802, DOI 10.1063/1.1470222; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Laine RM, 1998, APPL ORGANOMET CHEM, V12, P715, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<715::AID-AOC778>3.0.CO;2-0; Malikova N, 2002, LANGMUIR, V18, P3694, DOI 10.1021/la025563y; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Mokari T, 2004, SCIENCE, V304, P1787, DOI 10.1126/science.1097830; Nelson DR, 2002, NANO LETT, V2, P1125, DOI 10.1021/n10202096; Song T, 2003, POLYMER, V44, P2529, DOI [10.1016/S0032-3861(03)00107-1, 10.1016/s0032-3861(03)00107-1]; Wang SP, 2002, NANO LETT, V2, P817, DOI 10.1021/n10255193; Westenhoff S, 2002, J AM CHEM SOC, V124, P2448, DOI 10.1021/ja0173728; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zhang ZL, 2003, NANO LETT, V3, P1341, DOI 10.1021/nl034454g	16	328	339	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					419	420		10.1126/science.1099988	http://dx.doi.org/10.1126/science.1099988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486279				2022-12-01	WOS:000224626500031
J	Mechelli, A; Crinion, JT; Noppeney, U; O'Doherty, J; Ashburner, J; Frackowiak, RS; Price, CJ				Mechelli, A; Crinion, JT; Noppeney, U; O'Doherty, J; Ashburner, J; Frackowiak, RS; Price, CJ			Structural plasticity in the bilingual brain - Proficiency in a second language and age at acquisition affect grey-matter density.	NATURE			English	Editorial Material							PET		Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Fdn Santa Lucia, I-00179 Rome, Italy	University of London; University College London; IRCCS Santa Lucia	Mechelli, A (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	a.mechelli@fil.ion.ucl.ac.uk	Frackowiak, Richard S/I-1809-2013; Crinion, Jennifer/A-1992-2019; O'Doherty, John P/F-1204-2013; Frackowiak, Richard/H-4383-2011; Ashburner, John/I-3757-2013; Mechelli, Andrea/B-1114-2011	Crinion, Jennifer/0000-0001-8080-6562; Frackowiak, Richard/0000-0002-3151-822X; Ashburner, John/0000-0001-7605-2518; Price, Catherine/0000-0001-7448-4835; Noppeney, Uta/0000-0002-7697-2290	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Poline JB, 1996, NEUROIMAGE, V4, P34, DOI 10.1006/nimg.1996.0027; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159	8	578	600	8	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					757	757		10.1038/431757a	http://dx.doi.org/10.1038/431757a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483594	Bronze			2022-12-01	WOS:000224435500027
J	Yernool, D; Boudker, O; Jin, Y; Gouaux, E				Yernool, D; Boudker, O; Jin, Y; Gouaux, E			Structure of a glutamate transporter homologue from Pyrococcus horikoshii	NATURE			English	Article							SCANNING MUTAGENESIS REVEALS; AMINO-ACID TRANSPORTERS; MEMBRANE TOPOLOGY; BACILLUS-STEAROTHERMOPHILUS; CONFORMATIONAL-CHANGES; ANOMALOUS DIFFRACTION; PERMEATION PATHWAY; ESCHERICHIA-COLI; REENTRANT LOOP; PROTON CURRENT	Glutamate transporters are integral membrane proteins that catalyse the concentrative uptake of glutamate from the synapse to intracellular spaces by harnessing pre-existing ion gradients. In the central nervous system glutamate transporters are essential for normal development and function, and are implicated in stroke, epilepsy and neurodegenerative diseases. Here we present the crystal structure of a eukaryotic glutamate transporter homologue from Pyrococcus horikoshii. The transporter is a bowl-shaped trimer with a solvent-filled extracellular basin extending halfway across the membrane bilayer. At the bottom of the basin are three independent binding sites, each cradled by two helical hairpins, reaching from opposite sides of the membrane. We propose that transport of glutamate is achieved by movements of the hairpins that allow alternating access to either side of the membrane.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360				Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JORDING D, 1993, MOL GEN GENET, V241, P106, DOI 10.1007/BF00280207; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kanner BI, 2002, BBA-BIOENERGETICS, V1555, P92, DOI 10.1016/S0005-2728(02)00260-8; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Slotboom DJ, 2001, TRENDS BIOCHEM SCI, V26, P534, DOI 10.1016/S0968-0004(01)01925-9; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLNER B, 1995, MOL MICROBIOL, V18, P123, DOI 10.1111/j.1365-2958.1995.mmi_18010123.x; Tzingounis AV, 1998, J BIOL CHEM, V273, P17315, DOI 10.1074/jbc.273.28.17315; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; Wheal H.V., 1995, EXCITATORY AMINO ACI; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	50	633	643	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					811	818		10.1038/nature03018	http://dx.doi.org/10.1038/nature03018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483603	Bronze			2022-12-01	WOS:000224435500038
J	Crown, J				Crown, J			Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancer	LANCET			English	Editorial Material									St Vincents Univ Hosp, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital	Crown, J (corresponding author), St Vincents Univ Hosp, Elm Pk, Dublin 4, Ireland.	John.crown@icorg.ie	Crown, John/AAL-3367-2020	Crown, John/0000-0002-3125-7613				CROWN J, 2003, P AN M AM SOC CLIN, V22, pA23; DAVIDSON NE, 1992, J CLIN ONCOL, V10, P517, DOI 10.1200/JCO.1992.10.4.517; FARQUHAR C, 2003, COCHRANE LIB; Hortobagyi GN, 2004, J CLIN ONCOL, V22, P2263, DOI 10.1200/JCO.2004.02.927; NITZ UA, 2003, P AN M AM SOC CLIN, V22, pA832; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Weiss RB, 2001, J CLIN ONCOL, V19, P2771, DOI 10.1200/JCO.2001.19.11.2771; Zander AR, 2004, J CLIN ONCOL, V22, P2273, DOI 10.1200/JCO.2004.07.026	9	10	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1299	1300		10.1016/S0140-6736(04)17207-3	http://dx.doi.org/10.1016/S0140-6736(04)17207-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474123				2022-12-01	WOS:000224349700010
J	Villier, L; Korn, D				Villier, L; Korn, D			Morphological disparity of ammonoids and the mark of Permian mass extinctions	SCIENCE			English	Article							END	The taxonomic diversity of ammonoids, in terms of the number of taxa preserved, provides an incomplete picture of the extinction pattern during the Permian because of a strongly biased fossil record. The analysis of morphological disparity (the variety of shell shapes) is a powerful complementary tool for testing hypotheses about the selectivity of extinction and permits the recognition of three distinct patterns. First, a trend of decreasing disparity, ranging for about 30 million years, led to a minimum disparity immediately before the Permian-Triassic boundary. Second, the strongly selective Capitanian crisis fits a model of background extinction driven by standard environmental changes. Third, the end-Permian mass extinction operated as a random, nonselective sorting of morphologies, which is consistent with a catastrophic cause.	Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, F-13331 Marseille 3, France; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Villier, L (corresponding author), Univ Aix Marseille 1, Ctr Sedimentol Paleontol, FRE 2761, CNRS, 3 Pl Victor Hugo, F-13331 Marseille 3, France.	lvillier@up.univ-mrs.fr	Korn, Dieter/B-2963-2009	Korn, Dieter/0000-0003-1104-6939				Aberhan M, 2003, GEOLOGY, V31, P1077, DOI 10.1130/G19938.1; Benton M. J., 2003, LIFE NEARLY DIED GRE; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Erwin D. H., 1993, GREAT PALEOZOIC CRIS; Erwin DH, 2002, GEOL SOC AM SPEC PAP, V356, P363; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; GLENISTER BF, 1981, AMMONOIDEA, P49; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D, 2002, P NATL ACAD SCI USA, V99, P8139, DOI 10.1073/pnas.102163299; KULLMANN J, 2002, GONIAT VERSION 3 1 P; LEONOVA TB, 2002, PALEONTOL J S1, V36; Peters SE, 2002, NATURE, V416, P420, DOI 10.1038/416420a; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Raup David M., 1996, P419; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Saunders WB, 2004, PALEOBIOLOGY, V30, P19, DOI 10.1666/0094-8373(2004)030<0019:TEHOSG>2.0.CO;2; Saunders WB, 1999, SCIENCE, V286, P760, DOI 10.1126/science.286.5440.760; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; Wills M. A., 2001, FOSSILS PHYLOGENY FO, P55; ZHOU Z, 1996, PERMOPHILES, V29, P195	21	54	59	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					264	266		10.1126/science.1102127	http://dx.doi.org/10.1126/science.1102127			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472073				2022-12-01	WOS:000224419700036
J	Jeffery, WR; Strickler, AG; Yamamoto, Y				Jeffery, WR; Strickler, AG; Yamamoto, Y			Migratory neural crest-like cells form body pigmentation in a urochordate embryo	NATURE			English	Article							EVOLUTION; EXPRESSION; TUNICATE; PLACODES; PROTOCHORDATE; AMPHIOXUS; ORIGIN; PLATE; GENES	The neural crest, a source of many different cell types in vertebrate embryos, has not been identified in other chordates(1-3). Current opinion therefore holds that neural crest cells were a vertebrate innovation(4-7). Here we describe a migratory cell population resembling neural crest cells in the ascidian urochordate Ecteinascidia turbinata. Labelling of embryos and larvae with the vital lipophilic dye DiI enabled us to detect cells that emerge from the neural tube, migrate into the body wall and siphon primordia, and subsequently differentiate as pigment cells. These cells express HNK-1 antigen and Zic gene markers of vertebrate neural crest cells. The results suggest that migratory cells with some of the features of neural crest cells are present in the urochordates. Thus, we propose a hypothesis for neural crest evolution beginning with the release of migratory cells from the CNS to produce body pigmentation in the common ancestor of the urochordates and vertebrates. These cells may have gained additional functions or were joined by other cell types to generate the variety of derivatives typical of the vertebrate neural crest.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	jeffery@umd.edu		Yamamoto, Yoshiyuki/0000-0003-4830-5703				AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; ATOU Y, 2002, DEV GENES EVOL, V212, P87; Baker CVH, 1997, MECH DEVELOP, V69, P13, DOI 10.1016/S0925-4773(97)00129-9; Berrill NJ, 1935, PHILOS T ROY SOC B, V225, P255, DOI 10.1098/rstb.1935.0013; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Burighel P, 1998, J COMP NEUROL, V394, P230, DOI 10.1002/(SICI)1096-9861(19980504)394:2<230::AID-CNE7>3.0.CO;2-3; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gostling NJ, 2003, EVOL DEV, V5, P136, DOI 10.1046/j.1525-142X.2003.03020.x; Hall BK, 1999, NEURAL CREST DEV EVO; Hirata M, 1997, ZOOL SCI, V14, P305, DOI 10.2108/zsj.14.305; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.199.parts1-2.8.x; JEFFERY WR, 1992, BIOESSAYS, V14, P219, DOI 10.1002/bies.950140404; JUNGALWALA FB, 1992, J NEUROCHEM, V58, P1045, DOI 10.1111/j.1471-4159.1992.tb09360.x; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Le Douarin N.M., 1999, NEURAL CREST; LYERLA TA, 1975, BIOL BULL, V149, P178, DOI 10.2307/1540488; Manni L, 2001, EVOL DEV, V3, P297, DOI 10.1046/j.1525-142X.2001.01040.x; Manni L, 1999, J COMP NEUROL, V412, P527, DOI 10.1002/(SICI)1096-9861(19990927)412:3<527::AID-CNE11>3.0.CO;2-U; Nakata K, 1998, MECH DEVELOP, V75, P43, DOI 10.1016/S0925-4773(98)00073-2; Olsen CL, 1997, DEVELOPMENT, V124, P3609; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stone JR, 2004, EVOL DEV, V6, P123, DOI 10.1111/j.1525-142X.2004.04014.x; THIERY JP, 1982, DEV BIOL, V93, P324, DOI 10.1016/0012-1606(82)90121-X; THORNDYKE MC, 1979, CELL TISSUE RES, V203, P301; Wada H, 1998, DEVELOPMENT, V125, P1113; Wada H, 2001, DEV GROWTH DIFFER, V43, P509	30	187	195	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2004	431	7009					696	699		10.1038/nature02975	http://dx.doi.org/10.1038/nature02975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470430				2022-12-01	WOS:000224299300042
J	Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A				Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A			Basis for structural diversity in homologous RNAs	SCIENCE			English	Article							RIBONUCLEASE-P RNA; CRYSTAL-STRUCTURE; FOLDING MOTIF; RIBOZYME; DOMAIN	Large RNA molecules, such as ribozymes, fold with well-defined tertiary structures that are important for their activity. There are many instances of ribozymes with identical function but differences in their secondary structures, suggesting alternative tertiary folds. Here, we report a crystal structure of the 161-nucleotide specificity domain of an A-type ribonuclease P that differs in secondary and tertiary structure from the specificity domain of a B-type molecule. Despite the differences, the cores of the domains have similar three-dimensional structure. Remarkably, the similar geometry of the cores is stabilized by a different set of interactions involving distinct auxiliary elements.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN JW, 1994, NUCLEIC ACIDS RES, V22, P3660, DOI 10.1093/nar/22.17.3660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024	21	117	126	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					104	107		10.1126/science.1101489	http://dx.doi.org/10.1126/science.1101489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459389				2022-12-01	WOS:000224304000046
J	Sesma, A; Osbourn, AE				Sesma, A; Osbourn, AE			The rice leaf blast pathogen undergoes developmental processes typical of root-infecting fungi	NATURE			English	Article							MAGNAPORTHE-GRISEA; SP-NOV; PENETRATION; GENE; RESISTANCE; BIOLOGY; PROTEIN	Pathogens have evolved different strategies to overcome the various barriers that they encounter during infection of their hosts(1). The rice blast fungus Magnaporthe grisea causes one of the most damaging diseases of cultivated rice and has emerged as a paradigm system for investigation of foliar pathogenicity. This fungus undergoes a series of well-defined developmental steps during leaf infection, including the formation of elaborate penetration structures (appressoria). This process has been studied in great detail(2), and over thirty M. grisea genes that condition leaf infection have been identified(3). Here we show a new facet of the M. grisea life cycle: this fungus can undergo a different ( and previously uncharacterized) set of programmed developmental events that are typical of root-infecting pathogens. We also show that root colonization can lead to systemic invasion and the development of classical disease symptoms on the aerial parts of the plant. Gene-for-gene type specific disease resistance that is effective against rice blast in leaves also operates in roots. These findings have significant implications for fungal development, epidemiology, plant breeding and disease control.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, AE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	annie.osbourn@sainsbury-laboratory.ac.uk	Sesma, Ane/AAF-4796-2021; Sesma, Ane/A-8883-2010	Sesma, Ane/0000-0003-3982-8932				Cannon P. F., 1994, Systema Ascomycetum, V13, P25; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Dufresne M, 2001, MOL PLANT MICROBE IN, V14, P300, DOI 10.1094/MPMI.2001.14.3.300; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; GANGOPADHYAY S, 1986, International Journal of Tropical Plant Diseases, V4, P187; HORNBY D, 1981, BIOL CONTROL TAKE AL; Hornby D, 1998, TAKE ALL DIS CEREALS; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; LANDSCHOOT PJ, 1989, MYCOL RES, V93, P59, DOI 10.1016/S0953-7562(89)80137-6; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Ou SH, 1985, RICE DIS; Resendes CM, 2001, NEW PHYTOL, V150, P563, DOI 10.1046/j.1469-8137.2001.00131.x; Rho HS, 2001, MOL CELLS, V12, P407; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Sambrook J., 1989, MOL CLONING LAB MANU; SCOTT DB, 1983, T BRIT MYCOL SOC, V81, P77, DOI 10.1016/S0007-1536(83)80206-X; Sosnowski M, 2001, PLANT PATHOL, V50, P808, DOI 10.1046/j.1365-3059.2001.00631.x; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; VALENT B, 1991, GENETICS, V127, P87; Vereijssen J, 2004, EUR J PLANT PATHOL, V110, P103, DOI 10.1023/B:EJPP.0000010130.38700.88; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187	29	247	272	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					582	586		10.1038/nature02880	http://dx.doi.org/10.1038/nature02880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457264				2022-12-01	WOS:000224156700050
J	Wallace, SC; Wang, XM				Wallace, SC; Wang, XM			Two new carnivores from an unusual late Tertiary forest biota in eastern North America	NATURE			English	Article							EARLY PLIOCENE; PLANTS	Late Cenozoic terrestrial fossil records of North America are biased by a predominance of mid-latitude deposits, mostly in the western half of the continent. Consequently, the biological history of eastern North America, including the eastern deciduous forest, remains largely hidden. Unfortunately, vertebrate fossil sites from this vast region are rare(1,2), and few pertain to the critically important late Tertiary period, during which intensified global climatic changes took place(3,4). Moreover, strong phylogenetic affinities between the flora of eastern North America and eastern Asia clearly demonstrate formerly contiguous connections, but disparity among shared genera ( eastern Asia - eastern North America disjunction) implies significant periods of separation since at least the Miocene epoch(1,2). Lacustrine sediments deposited within a former sinkhole in the southern Appalachian Mountains provide a rare example of a late Miocene to early Pliocene terrestrial biota from a forested ecosystem(5). Here we show that the vertebrate remains contained within this deposit represent a unique combination of North American and Eurasian taxa. A new genus and species of the red ( lesser) panda ( Pristinailurus bristoli), the earliest and most primitive so far known, was recovered. Also among the fauna are a new species of Eurasian badger (Arctomeles dimolodontus) and the largest concentration of fossil tapirs ever recorded. Cladistical analyses of the two new carnivores strongly suggest immigration events that were earlier than and distinct from previous records(6,7), and that the close faunal affinities between eastern North America and eastern Asia in the late Tertiary period are consistent with the contemporaneous botanical record(8,9).	Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; E Tennessee State Univ, Dept Phys Astron & Geol, Johnson City, TN 37614 USA	East Tennessee State University	Wang, XM (corresponding author), Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	xwang@nhm.org	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840				[Anonymous], [No title captured]; BOYDDAWKINS W, 1888, Q J GEOL SOC LOND, V44, P228; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; EMRY RJ, 1998, GEOLOGY PALEONTOLOGY, P153; Farlow JO, 2001, AM MIDL NAT, V145, P367, DOI 10.1674/0003-0031(2001)145[0367:TPCSBA]2.0.CO;2; Ginsburg Leonard, 2001, Geodiversitas, V23, P81; HULBERT RCJ, IN PRESS B FLA MUS N; HUNT RM, 1998, EVOLUTION TERTIARY M, V1, P174; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; KORMOS TH, 1935, MITTEILUNGEN JB KONI, V30, P1; Kundrat M., 1997, Journal of Vertebrate Paleontology, V17, p58A; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; MacFadden BJ, 1998, PALEOBIOLOGY, V24, P274; Morlo Michael, 2001, Palaeontologische Zeitschrift, V75, P163; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Parmalee PW, 2002, ANN CARNEGIE MUS, V71, P233; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Schlosser M., 1899, MITTHEILUNGEN JB KON, V13, P66; SCHMIDTKITTLER N, 1995, VERTEBRATE LOCALITY, P75; Stach J., 1951, Acta Geologica Polonica, V2, P129; Tedford RH, 2003, NATURE, V425, P388, DOI 10.1038/nature01892; TEDFORD RH, 1977, NATURE, V265, P621, DOI 10.1038/265621a0; Tedford RH, 2001, J VERTEBR PALEONTOL, V21, P311, DOI 10.1671/0272-4634(2001)021[0311:PATBUC]2.0.CO;2; Tedford Richard H., 2004, P169; VOORHIES MR, 1979, SCIENCE, V206, P331, DOI 10.1126/science.206.4416.331; WALLACE SC, 2002, J VERT PALEONTOL, V22, P117; Wang XM, 1997, J VERTEBR PALEONTOL, V17, P184, DOI 10.1080/02724634.1997.10010963; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Zdansky O., 1924, Palaeontologia Sinica Series C, V2, P1; [No title captured]	30	70	72	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					556	559		10.1038/nature02819	http://dx.doi.org/10.1038/nature02819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457257				2022-12-01	WOS:000224156700043
J	McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME				McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME			Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONJUGATE VACCINE; IMMUNITY; DISEASE; IMPACT; HIB; COLONIZATION; EPIGLOTTITIS; CARRIAGE; CHILDREN	Objective To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003. Design Prospective, laboratory based surveillance of invasive Hib infections and cross sectional seroprevalence study. Setting England and Wales. Participants Cases were confirmed by isolation of H influenzae from a normally sterile site, or from a non-sterile site in cases with a diagnosis of epiglottitis. Excess serum samples collected from English 30-39 year olds as part of a national serosurvey were identified for the years 1990, 1994, 1997, 2000, and 2002. Main outcome measures The number of invasive Hib infections from 1991 to 2003. Population immunity to H influenzae type b in English adults was also measured. Results After routine infant immunisation was introduced in October 1992, adult Hib infections decreased initially but then rose from a low in 1998 to reach prevaccine levels in 2003. An associated fall in median Hib antibody concentrations occurred, from 1.29 mug/ml (95% confidence interval 0.90 to 1.64) in 1991 to 0.70 mug/ml (0.57 to 0.89) in 1994 (P=0.006), with no significant change observed thereafter. Conclusions Although immunisation of infants resulted in an initial decline in Hib infections in adults, a resurgence in reported cases occurred in 2002-3. This rise was associated with an increase in cases in children and evidence of reduced immunity in older unimmunised cohorts. Childhood immunisation programmes may have unanticipated effects on the epidemiology of disease in older age groups, and surveillance strategies must be targeted at entire populations.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Stat Modelling & Econ Dept, London NW9 5EQ, England; John Radcliffe Hosp, Hlth Protect Agcy Specialist & Reference Microbio, Haemophilus Reference Unit, Oxford OX3 9DU, England	Health Protection Agency; Health Protection Agency; University of Oxford	Ramsay, ME (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	mary.ramsay@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; McVernon, Jodie/0000-0001-9774-1961; Trotter, Caroline/0000-0003-4000-2708				BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; BOISVERT PL, 1948, AM J DIS CHILD, V75, P427; *DEP HLTH, 2003, BOOST VACC OFF FOLL; European Union Invasive Bacterial Infections Surveillance Network, 2006, INV HAEM INFL EUR 20; GLODE MP, 1984, PEDIATR INFECT DIS J, V3, P548, DOI 10.1097/00006454-198411000-00013; *HLTH PROT AG, Q COMM DIS REP COVER; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Leino T, 2000, EPIDEMIOL INFECT, V125, P583, DOI 10.1017/S0950268800004799; McVernon J, 2004, EPIDEMIOL INFECT, V132, P765, DOI 10.1017/S0950268804002122; McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6; MICHAELS RH, 1977, J INFECT DIS, V136, P222, DOI 10.1093/infdis/136.2.222; *NAT STAT ONL, BIRTH STAT BIRTHS PA; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Rijkers GT, 2003, LANCET, V361, P1563, DOI 10.1016/S0140-6736(03)13201-1; Sarangi J, 2000, EPIDEMIOL INFECT, V124, P441, DOI 10.1017/S0950268899003611; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Trotter C L, 2003, Commun Dis Public Health, V6, P55; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	22	51	54	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					655	658		10.1136/bmj.329.7467.655	http://dx.doi.org/10.1136/bmj.329.7467.655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374916	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000224042300019
J	Sacchini, V; Borgen, PI				Sacchini, V; Borgen, PI			Can radiation therapy for breast cancer be avoided?	LANCET			English	Editorial Material							CONSERVING SURGERY; RADIOTHERAPY; IMPACT		Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sacchini, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA.	sacchinv@mskcc.org						Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Mor V, 2000, SURGERY, V128, P847, DOI 10.1067/msy.2000.109530; Veronesi Umberto, 2003, Breast J, V9, P106, DOI 10.1046/j.1524-4741.2003.09208.x; Vinh-Hung V, 2004, JNCI-J NATL CANCER I, V96, P115, DOI 10.1093/jnci/djh013; Vinh-Hung V, 2003, RADIOTHER ONCOL, V67, P147, DOI 10.1016/S0167-8140(03)00002-1; Vinh-Hung V, 2002, RADIOTHER ONCOL, V64, P281, DOI 10.1016/S0167-8140(02)00105-6	7	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					916	917		10.1016/S0140-6736(04)17037-2	http://dx.doi.org/10.1016/S0140-6736(04)17037-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364173				2022-12-01	WOS:000223831000006
J	Gauderman, WJ; Avol, E; Gilliland, F; Vora, H; Thomas, D; Berhane, K; McConnell, R; Kuenzli, N; Lurmann, F; Rappaport, E; Margolis, H; Bates, D; Peters, J				Gauderman, WJ; Avol, E; Gilliland, F; Vora, H; Thomas, D; Berhane, K; McConnell, R; Kuenzli, N; Lurmann, F; Rappaport, E; Margolis, H; Bates, D; Peters, J			The effect of air pollution on lung development from 10 to 18 years of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; OBSTRUCTIVE RESPIRATORY-DISEASE; PULMONARY-FUNCTION; FUNCTION GROWTH; CHRONIC EXPOSURE; UCLA POPULATION; PREADOLESCENT CHILDREN; PARTICULATE MATTER; DIFFERING LEVELS; FOLLOW-UP	Background: Whether exposure to air pollution adversely affects the growth of lung function during the period of rapid lung development that occurs between the ages of 10 and 18 years is unknown. Methods: In this prospective study, we recruited 1759 children (average age, 10 years) from schools in 12 southern California communities and measured lung function annually for eight years. The rate of attrition was approximately 10 percent per year. The communities represented a wide range of ambient exposures to ozone, acid vapor, nitrogen dioxide, and particulate matter. Linear regression was used to examine the relationship of air pollution to the forced expiratory volume in one second (FEV1) and other spirometric measures. Results: Over the eight-year period, deficits in the growth of FEV1 were associated with exposure to nitrogen dioxide (P=0.005), acid vapor (P=0.004), particulate matter with an aerodynamic diameter of less than 2.5 microm (PM2.5) (P=0.04), and elemental carbon (P=0.007), even after adjustment for several potential confounders and effect modifiers. Associations were also observed for other spirometric measures. Exposure to pollutants was associated with clinically and statistically significant deficits in the FEV1 attained at the age of 18 years. For example, the estimated proportion of 18-year-old subjects with a low FEV1 (defined as a ratio of observed to expected FEV1 of less than 80 percent) was 4.9 times as great at the highest level of exposure to PM2.5 as at the lowest level of exposure (7.9 percent vs. 1.6 percent, P=0.002). Conclusions: The results of this study indicate that current levels of air pollution have chronic, adverse effects on lung development in children from the age of 10 to 18 years, leading to clinically significant deficits in attained FEV1 as children reach adulthood.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Sonoma Technol, Petaluma, CA USA; State Calif, Air Resouces Board, Sacramento, CA USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Southern California; University of British Columbia	Gauderman, WJ (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90089 USA.	jimg@usc.edu	Fahimifar, Sepideh/M-5303-2019; Kuenzli, Nino/F-7195-2014	Kuenzli, Nino/0000-0001-8360-080X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048] Funding Source: NIH RePORTER; NIEHS NIH HHS [1P01ES11627, 5P30ES07048] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Avol E.L., 1998, RES REP HLTH EFF I, V82, P1; Avol EL, 2001, AM J RESP CRIT CARE, V164, P2067, DOI 10.1164/ajrccm.164.11.2102005; Bascom R, 1996, AM J RESP CRIT CARE, V153, P477, DOI 10.1164/ajrccm.153.2.8564086; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Churg A, 2003, ENVIRON HEALTH PERSP, V111, P714, DOI 10.1289/ehp.6042; DETELS R, 1991, AM J PUBLIC HEALTH, V81, P350, DOI 10.2105/AJPH.81.3.350; DETELS R, 1987, CHEST, V92, P594, DOI 10.1378/chest.92.4.594; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; *ENV PROT AG, 2003, 454K03001 ENV PROT A; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Frischer T, 1999, AM J RESP CRIT CARE, V160, P390, DOI 10.1164/ajrccm.160.2.9809075; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Hole DJ, 1996, BRIT MED J, V313, P711; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; Jedrychowski W, 1999, ENVIRON HEALTH PERSP, V107, P669, DOI 10.2307/3434460; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Mckean MC, 2001, EUR RESPIR J, V18, P23, DOI 10.1183/09031936.01.00073101; NIOSH, 1999, 5040 NIOSH; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Raizenne M, 1996, ENVIRON HEALTH PERSP, V104, P506, DOI 10.2307/3432991; Sarnat JA, 2001, ENVIRON HEALTH PERSP, V109, P1053, DOI 10.2307/3454961; SAS Institute, 2002, SAS STAT US GUID VER; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; SCHWARTZ J, 1989, ENVIRON RES, V50, P309, DOI 10.1016/S0013-9351(89)80012-X; Sherwin RP, 2000, VIRCHOWS ARCH, V437, P422, DOI 10.1007/s004280000262; TAGER IB, 1985, AM REV RESPIR DIS, V131, P752; Tager IB, 1999, AM J RESP CRIT CARE, V160, P387; TAGER IB, 1983, NEW ENGL J MED, V309, P699, DOI 10.1056/NEJM198309223091204; TASHKIN DP, 1994, AM J RESP CRIT CARE, V149, P1209, DOI 10.1164/ajrccm.149.5.8173761; Tolocka MP, 2001, AEROSOL SCI TECH, V34, P88; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502; WANG XB, 1994, AM J RESP CRIT CARE, V149, P1420, DOI 10.1164/ajrccm.149.6.8004293; WARE JH, 1986, AM REV RESPIR DIS, V133, P834	39	893	920	4	179	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1057	1067		10.1056/NEJMoa040610	http://dx.doi.org/10.1056/NEJMoa040610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CX	15356303				2022-12-01	WOS:000223733900005
J	Hsu, GW; Ober, M; Carell, T; Beese, LS				Hsu, GW; Ober, M; Carell, T; Beese, LS			Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase	NATURE			English	Article							STEADY-STATE; INSERTION; MUTATIONS; KINETICS; CRYSTAL; EXO(-); SITE; 8-OXO-7,8-DIHYDROGUANINE; RESOLUTION; FRAGMENT	Aerobic respiration generates reactive oxygen species that can damage guanine residues and lead to the production of 8-oxoguanine (8oxoG), the major mutagenic oxidative lesion in the genome(1). Oxidative damage is implicated in ageing(2) and cancer, and its prevalence presents a constant challenge to DNA polymerases that ensure accurate transmission of genomic information. When these polymerases encounter 8oxoG, they frequently catalyse misincorporation of adenine in preference to accurate incorporation of cytosine(3). This results in the propagation of G to T transversions, which are commonly observed somatic mutations associated with human cancers(4,5). Here, we present sequential snapshots of a high-fidelity DNA polymerase during both accurate and mutagenic replication of 8oxoG. Comparison of these crystal structures reveals that 8oxoG induces an inversion of the mismatch recognition mechanisms that normally proofread DNA, such that the 8oxoG.adenine mismatch mimics a cognate base pair whereas the 8oxoG.cytosine base pair behaves as a mismatch. These studies reveal a fundamental mechanism of error-prone replication and show how 8oxoG, and DNA lesions in general, can form mismatches that evade polymerase error-detection mechanisms, potentially leading to the stable incorporation of lethal mutations.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	Duke University; University of Munich	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lsb@biochem.duke.edu	beese, lorena/G-4993-2010; Carell, Thomas/G-4799-2012	Carell, Thomas/0000-0001-7898-2831				BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CULP SJ, 1989, CHEM RES TOXICOL, V2, P416, DOI 10.1021/tx00012a010; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; OTWINOWSKI Z, 1997, ENZYMOLOGY MACROMO A; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047	27	251	257	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					217	221		10.1038/nature02908	http://dx.doi.org/10.1038/nature02908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15322558				2022-12-01	WOS:000223746000051
J	Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M				Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M			Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NORTH-KARELIA; AVERAGE VOLUME; E GENOTYPE; CONSUMPTION; COMMUNITY; SMOKING; PERFORMANCE; PATTERNS	Objective To evaluate the relation between midlife alcohol consumption and mild cognitive impairment and dementia in old age, and the possible modification of this relation by apolipoprotein E. Design Prospective, population based study. Setting Populations of Kuopio and Joensuu, eastern Finland. Participants Of 1464 men and women aged 65-79 years randomly selected from population based samples studied in 1972 or 1977,1018 (70%) were re-examined in 1998 (after an average follow up of 23 years). Main outcome measures Mild cognitive impairment and dementia in old age. Results Participants who drank no alcohol at midlife and those who drank alcohol frequently were both twice as likely to have mild cognitive impairment in old age as those participants who drank alcohol infrequently. The risk of dementia related to alcohol drinking was modified by the presence of the apolipoprotein e4 allele. ne carriers of apolipoprotein e4 had an increased risk of dementia with increasing alcohol consumption: compared with non-carriers who never drank, the odds ratio for carriers who never drank was 0.6, for infrequent drinkers it was 2.3, and for frequent drinkers was 3.6 (die overall interaction term "drinking frequency*apolipoprotein e4" was significant (P = 0.04), as were the interactions "infrequent drinking*apolipoprotein c4" (P = 0.02) and "frequent drinking*apolipoprotein e4" (P = 0.03)). Non-carriers of apolipoprotein e4 had similar odds ratios for dementia irrespective of alcohol consumption. Conclusion Alcohol drinking in middle age showed a U shaped relation with risk of mild cognitive impairment in old age. Risk of dementia increased with increasing alcohol consumption only in those individuals carrying the apolipoprotein e4 allele.	Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, S-11382 Stockholm, Sweden; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Karolinska Univ Hosp, Karolinska Inst, Neurotec, Div Geriatr Med, S-14186 Huddinge, Sweden; Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland	Karolinska Institutet; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, Box 6401, S-11382 Stockholm, Sweden.	Miia.Kivipelto@uku.fi	Kivipelto, Miia/AAS-3557-2021; Viitanen, Matti/AAY-5163-2020	Kivipelto, Miia/0000-0003-0992-3875				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galanis DJ, 2000, AM J PUBLIC HEALTH, V90, P1254, DOI 10.2105/AJPH.90.8.1254; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS48, DOI 10.1093/ije/20.Supplement_2.S48; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; HEBERT LE, 1993, AM J EPIDEMIOL, V137, P881, DOI 10.1093/oxfordjournals.aje.a116749; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Kauhanen J, 1999, ARTERIOSCL THROM VAS, V19, P3001, DOI 10.1161/01.ATV.19.12.3001; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Launer LJ, 1996, AM J EPIDEMIOL, V143, P219; Leroi I, 2002, AM J EPIDEMIOL, V156, P747, DOI 10.1093/aje/kwf107; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; The 1999 ESPAD Report, 2000, 1999 ESPAD REPORT AL; Thomas VS, 2001, J AM GERIATR SOC, V49, P415, DOI 10.1046/j.1532-5415.2001.49085.x; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	39	187	198	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2004	329	7465					539	542A		10.1136/bmj.38181.418958.BE	http://dx.doi.org/10.1136/bmj.38181.418958.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	853DE	15304383	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000223805800018
J	Roth, GS; Mattison, JA; Ottinger, MA; Chachich, ME; Lane, MA; Ingram, DK				Roth, GS; Mattison, JA; Ottinger, MA; Chachich, ME; Lane, MA; Ingram, DK			Aging in rhesus monkeys: Relevance to human health interventions	SCIENCE			English	Editorial Material							NONHUMAN PRIMATE MODELS; AGE-RELATED DECLINE; CALORIC RESTRICTION; DIETARY RESTRICTION; CYTOKINE PRODUCTION; METABOLIC SYNDROME; BRAIN; LONGEVITY; MENOPAUSE; RATS	Progress in gerontologicat research has been promoted through the use of numerous animal models, which have helped identify possible mechanisms of aging and age-related chronic diseases and evaluate possible interventions with potential relevance to human aging and disease. Further development of nonhuman primate models, particularly rhesus monkeys, could accelerate this progress, because their closer genetic relationship to humans produces a highly similar aging phenotype. Because the relatively tong lives of primates increase the administrative and economic demands on research involving them, new emphasis has emerged on increasing the efficient use of these valuable resources through cooperative, interdisciplinary research.	NIA, Lab Expt Gerontol, Intramural Res Program, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA; Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland College Park	Ingram, DK (corresponding author), NIA, Lab Expt Gerontol, Intramural Res Program, Gerontol Res Ctr,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	ingramd@grc.nia.nih.gov			NATIONAL INSTITUTE ON AGING [Z01AG000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASKERVILLE A, 1992, J COMP PATHOL, V107, P49, DOI 10.1016/0021-9975(92)90095-C; Bellino FL, 2003, BIOL REPROD, V68, P10, DOI 10.1095/biolreprod.102.005215; Black A, 2001, BONE, V28, P295, DOI 10.1016/S8756-3282(00)00452-X; Bodkin NL, 2003, HORM METAB RES, V35, P617, DOI 10.1055/s-2003-43510; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; Brewer M, 2001, COMPARATIVE MED, V51, P424; Calhoun ME, 2004, J COMP NEUROL, V475, P238, DOI 10.1002/cne.20181; CHAKRABORTY M, 1995, CANCER RES, V55, P1525; CLARKSON TB, 1994, JAMA-J AM MED ASSOC, V271, P317; Colman RJ, 1999, METHODS AGING RES, P249; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; Dunbar CE, 2001, J INTERN MED, V249, P329, DOI 10.1046/j.1365-2796.2001.00805.x; Dunnett SB, 2001, TRENDS PHARMACOL SCI, V22, P211, DOI 10.1016/S0165-6147(00)01707-7; FANTON JW, 1991, RADIAT RES, V126, P141, DOI 10.2307/3577812; Gilardi KVK, 1997, BIOL REPROD, V57, P335, DOI 10.1095/biolreprod57.2.335; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; HEILBRONN L, 2004, 33 ANN M AM AG ASS S; Herndon JG, 1998, NEUROBIOL AGING, V19, P267, DOI 10.1016/S0197-4580(98)00054-2; HUBBARD GB, 1985, VET PATHOL, V22, P88, DOI 10.1177/030098588502200116; KALER LW, 1986, ENDOCRINOLOGY, V119, P566, DOI 10.1210/endo-119-2-566; KAUFMAN PL, 1982, EXP EYE RES, V34, P287, DOI 10.1016/0014-4835(82)90061-6; Keuker JIH, 2003, NEUROBIOL AGING, V24, P157, DOI 10.1016/S0197-4580(02)00062-3; Kim JJ, 2001, CLIN CANCER RES, V7, p882S; Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Kramer PA, 2002, J ORTHOP RES, V20, P399, DOI 10.1016/S0736-0266(01)00122-X; Lane MA, 1997, J CLIN ENDOCR METAB, V82, P2093, DOI 10.1210/jc.82.7.2093; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Mascarucci P, 2001, AGING-CLIN EXP RES, V13, P85, DOI 10.1007/BF03351530; Matochik JA, 2000, NEUROBIOL AGING, V21, P591, DOI 10.1016/S0197-4580(00)00134-2; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; MATTISON JA, IN PRESS NEUROBIOL A; Morris ED, 1999, J CEREBR BLOOD F MET, V19, P218, DOI 10.1097/00004647-199902000-00013; Moscrip TD, 2000, J GERONTOL A-BIOL, V55, pB373, DOI 10.1093/gerona/55.8.B373; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Peters A, 2002, PROG BRAIN RES, V136, P455; Price DL, 1991, BRAIN PATHOL, V1, P287, DOI 10.1111/j.1750-3639.1991.tb00672.x; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rapp PR, 2003, J NEUROSCI, V23, P5708; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Roth GS, 1997, J GERONTOL A-BIOL, V52, pB98, DOI 10.1093/gerona/52A.2.B98; ROTH GS, 1995, NAT MED, V1, P414, DOI 10.1038/nm0595-414; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; Roth GS, 2001, J CLIN ENDOCR METAB, V86, P3292, DOI 10.1210/jc.86.7.3292; SCHWARTZ SM, 1992, AM J PHYS ANTHROPOL, V89, P109, DOI 10.1002/ajpa.1330890110; Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485; SEPEHR S, 2003, ACTA NEUROPATHOL, V105, P145; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893; Smucny DA, 2004, J MED PRIMATOL, V33, P48, DOI 10.1111/j.1600-0684.2003.00052.x; Steinbaum SR, 2004, PROG CARDIOVASC DIS, V46, P321, DOI 10.1016/j.pcad.2003.08.005; Torre P, 2000, HEARING RES, V142, P131, DOI 10.1016/S0378-5955(00)00025-3; Uno H, 1996, NEUROBIOL AGING, V17, P275, DOI 10.1016/0197-4580(95)02063-2; Valverde CR, 2000, COMPARATIVE MED, V50, P540; Voytko ML, 2001, SYNAPSE, V39, P95, DOI 10.1002/1098-2396(20010101)39:1<95::AID-SYN12>3.0.CO;2-2; Voytko ML, 1999, NEUROBIOL AGING, V20, P617, DOI 10.1016/S0197-4580(99)00097-4; Weindruch R., 1988, RETARDATION AGING DI; Winegar DA, 2001, J LIPID RES, V42, P1543; Wise PM, 2002, RECENT PROG HORM RES, V57, P235, DOI 10.1210/rp.57.1.235; Zhang ZM, 2000, J GERONTOL A-BIOL, V55, pB473, DOI 10.1093/gerona/55.10.B473	61	242	249	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1423	1426		10.1126/science.1102541	http://dx.doi.org/10.1126/science.1102541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353793				2022-12-01	WOS:000223761900036
J	Escher, M; Perneger, TV; Chevrolet, JC				Escher, M; Perneger, TV; Chevrolet, JC			National questionnaire survey on what influences doctors' decisions about admission to intensive care	BRITISH MEDICAL JOURNAL			English	Article							ILL PATIENTS; UNIT; TRIAGE; PHYSICIANS; RESUSCITATION; CANCER; ALLOCATION; RESOURCES; JUDGMENT; SUPPORT	Objectives To determine what influences doctors' decisions about admission of patients to intensive care. Design National questionnaire survey using eight clinical vignettes involving hypothetical patients. Setting Switzerland. Participants 402 Swiss doctors specialising in intensive care. Main outcome measures Rating of factors influencing decisions on admission and response to eight hypothetical clinical scenarios. Results Of 381 doctors agreeing to participate, 232 (61%) returned questionnaires. Most rated as important or very important the prognosis of the underlying disease (82%) and of the acute illness (81%) and the patients' wishes (71%). Few considered the important socioeconomic circumstances of the patient (20%), religious beliefs (3%) and emotional state (6%). In the vignettes, underlying disease (cancer versus non-cancerous disease) was not associated with admission to intensive care, but four other factors were: patients' wishes (odds ratio 3.0, 95% confidence interval 2.0 to 4.6), upbeat personality (2.9, 1.9 to 4.4), younger age (1.5, 1.1 to 2.2), and a greater number of beds available in intensive care (1.8, 1.2 to 2.5). Conclusions Doctors' decisions to admit patients to intensive care are influenced by patients' wishes and ethically problematic non-medical factors such as a patient's personality or availability of beds. Patients with cancer are not discriminated against.	Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Qual Care Unit, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Med Intens Care Div, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva; University of Geneva	Escher, M (corresponding author), Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland.	monica.escher@hcuge.ch						Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Coppola KM, 2001, ARCH INTERN MED, V161, P431, DOI 10.1001/archinte.161.3.431; Egol A, 1999, CRIT CARE MED, V27, P633; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; ELY JW, 1992, J AM GERIATR SOC, V40, P471, DOI 10.1111/j.1532-5415.1992.tb02013.x; Furnham A, 2000, J SOC BEHAV PERS, V15, P185; Ghusn HF, 1997, J AM GERIATR SOC, V45, P1118, DOI 10.1111/j.1532-5415.1997.tb05977.x; Hanson LC, 1996, ARCH INTERN MED, V156, P785, DOI 10.1001/archinte.156.7.785; JACOBS P, 1990, CRIT CARE MED, V18, P1282, DOI 10.1097/00003246-199011000-00020; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; KOHLENBERGER C, 1994, JAMA-J AM MED ASSOC, V271, P1200; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; LAWRENCE VA, 1987, ARCH INTERN MED, V147, P1637, DOI 10.1001/archinte.147.9.1637; NUCKTON TJ, 1995, ARCH INTERN MED, V155, P1087, DOI 10.1001/archinte.155.10.1087; Redelmeier DA, 2001, CAN MED ASSOC J, V164, P358; Sprung CL, 1997, INTENS CARE MED, V23, P1011, DOI 10.1007/s001340050449; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Tanvetyanon T, 2003, CRIT CARE MED, V31, P60, DOI 10.1097/00003246-200301000-00009; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Vincent JL, 1998, INTENS CARE MED, V24, P1251, DOI 10.1007/s001340050758; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525	23	80	84	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					425	428		10.1136/bmj.329.7463.425	http://dx.doi.org/10.1136/bmj.329.7463.425			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15321898	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000223520300015
J	Pedersen, TH; Nielsen, OB; Lamb, GD; Stephenson, DG				Pedersen, TH; Nielsen, OB; Lamb, GD; Stephenson, DG			Intracellular acidosis enhances the excitability of working muscle	SCIENCE			English	Article							FROG SKELETAL-MUSCLE; CHLORIDE CONDUCTANCE; LACTIC-ACID; FIBERS; RAT; POTASSIUM; CHANNELS; FATIGUE; TWITCH; PH	Intracellular acidification of skeletal muscles is commonly thought to contribute to muscle fatigue. However, intracellular acidosis also acts to preserve muscle excitability when muscles become depolarized, which occurs with working muscles. Here, we show that this process may be mediated by decreased chloride permeability, which enables action potentials to still be propagated along the internal network of tubules in a muscle fiber (the T system) despite muscle depolarization. These results implicate chloride ion channels in muscle function and emphasize that intracellular acidosis of muscle has protective effects during muscle fatigue.	La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; Univ Aarhus, Dept Physiol, DK-8000 Aarhus, Denmark	La Trobe University; Aarhus University	Stephenson, DG (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	G.Stephenson@zoo.latrobe.edu.au		Nielsen, Ole Baekgaard/0000-0003-3535-7862; Holm Pedersen, Thomas/0000-0002-1060-4989				Balog EM, 2001, J APPL PHYSIOL, V90, P228, DOI 10.1152/jappl.2001.90.1.228; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Coonan JR, 1998, J PHYSIOL-LONDON, V509, P551, DOI 10.1111/j.1469-7793.1998.551bn.x; DULHUNTY AF, 1979, J MEMBRANE BIOL, V45, P293, DOI 10.1007/BF01869290; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Hille B., 2001, ION CHANNELS EXCITAB, V3; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; HUTTER OF, 1967, J PHYSIOL-LONDON, V189, P403, DOI 10.1113/jphysiol.1967.sp008176; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LAMB GD, 1994, J PHYSIOL-LONDON, V478, P331, DOI 10.1113/jphysiol.1994.sp020253; Launikonis BS, 2004, J GEN PHYSIOL, V123, P231, DOI 10.1085/jgp.200308946; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Ortenblad N, 2003, J PHYSIOL-LONDON, V548, P139, DOI 10.1113/jphysiol.2002.036657; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Posterino GS, 2001, PFLUG ARCH EUR J PHY, V442, P197, DOI 10.1007/s004240100528; Ruff RL, 1996, ACTA PHYSIOL SCAND, V156, P159, DOI 10.1046/j.1365-201X.1996.189000.x; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Sjogaard G, 1990, Acta Physiol Scand Suppl, V593, P1; Stephenson DG, 1998, ACTA PHYSIOL SCAND, V162, P229, DOI 10.1046/j.1365-201X.1998.0304f.x; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17	21	224	231	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1144	1147		10.1126/science.1101141	http://dx.doi.org/10.1126/science.1101141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326352				2022-12-01	WOS:000223557400045
J	Roper, C; Pearce, R; Nair, S; Sharp, B; Nosten, F; Anderson, T				Roper, C; Pearce, R; Nair, S; Sharp, B; Nosten, F; Anderson, T			Intercontinental spread of pyrimethamine-resistant malaria	SCIENCE			English	Article							ANTIMALARIAL-DRUG-RESISTANCE; PLASMODIUM-FALCIPARUM; MUTATIONS		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; SW Fdn Biomed Res, San Antonio, TX 78284 USA; MRC, Durban, South Africa; Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand	University of London; London School of Hygiene & Tropical Medicine; Texas Biomedical Research Institute; Mahidol University	Roper, C (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	cally.roper@lshtm.ac.uk	Nosten, Francois/AAC-5509-2019; Roper, Cally/K-2989-2013	Nosten, Francois/0000-0002-7951-0745; Roper, Cally/0000-0002-6545-309X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Ryan ET, 2000, NEW ENGL J MED, V342, P1716, DOI 10.1056/NEJM200006083422306; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	9	374	378	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1124	1124		10.1126/science.1098876	http://dx.doi.org/10.1126/science.1098876			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326348				2022-12-01	WOS:000223557400037
J	Edwards, M; Richardson, AJ				Edwards, M; Richardson, AJ			Impact of climate change on marine pelagic phenology and trophic mismatch	NATURE			English	Article							NORTH-SEA; PHYTOPLANKTON BLOOMS; CONSEQUENCES; TEMPERATURE; COPEPODS; GROWTH	Phenology, the study of annually recurring life cycle events such as the timing of migrations and flowering, can provide particularly sensitive indicators of climate change(1). Changes in phenology may be important to ecosystem function because the level of response to climate change may vary across functional groups and multiple trophic levels. The decoupling of phenological relationships will have important ramifications for trophic interactions, altering food-web structures and leading to eventual ecosystem-level changes. Temperate marine environments may be particularly vulnerable to these changes because the recruitment success of higher trophic levels is highly dependent on synchronization with pulsed planktonic production(2,3). Using long-term data of 66 plankton taxa during the period from 1958 to 2002, we investigated whether climate warming signals(4) are emergent across all trophic levels and functional groups within an ecological community. Here we show that not only is the marine pelagic community responding to climate changes, but also that the level of response differs throughout the community and the seasonal cycle, leading to a mismatch between trophic levels and functional groups.	The Lab, Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England		Edwards, M (corresponding author), The Lab, Sir Alister Hardy Fdn Ocean Sci, Citadel Hill, Plymouth PL1 2PB, Devon, England.	maed@sahfos.ac.uk	Richardson, Anthony J/B-3649-2010	Richardson, Anthony J/0000-0002-9289-7366; Edwards, Martin/0000-0002-5716-4714				Beaugrand G, 2003, PROG OCEANOGR, V58, P235, DOI 10.1016/j.pocean.2003.08.006; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Colebrook J. M., 1965, Bulletin of Marine Ecology, V6, P123; COLEBROOK JM, 1979, MAR BIOL, V51, P23, DOI 10.1007/BF00389027; Cushing D. H., 1990, ADV MAR BIOL, P250, DOI DOI 10.1016/S0065-2881(08)60202-3); Eilertsen HC, 2000, S AFR J MARINE SCI, V22, P323, DOI 10.2989/025776100784125717; EILERTSEN HC, 1995, MAR ECOL PROG SER, V116, P303, DOI 10.3354/meps116303; Greve W, 1996, ICES J MAR SCI, V53, P951, DOI 10.1006/jmsc.1996.0117; Greve W., 2004, PHENOLOGY INTEGRATIV, P385; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Lindley JA, 1998, INVERTEBR REPROD DEV, V33, P209, DOI 10.1080/07924259.1998.9652633; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schiermeier Q, 2004, NATURE, V428, P4, DOI 10.1038/428004a; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Sverdrup H.U., 1953, J CONS CONS PERM INT, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; van Haren H, 1998, J MAR RES, V56, P655, DOI 10.1357/002224098765213621; VANBEUSEKOM JEE, 1994, 6471 DAN ENV PROT AG; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918	29	1486	1532	12	945	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					881	884		10.1038/nature02808	http://dx.doi.org/10.1038/nature02808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318219				2022-12-01	WOS:000223369800039
J	Steinbrook, R				Steinbrook, R			Antiretroviral medications - From Thailand to Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					739	739		10.1056/NEJMp048201	http://dx.doi.org/10.1056/NEJMp048201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317884				2022-12-01	WOS:000223367900003
J	Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J				Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J			Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection	SCIENCE			English	Article							EXPRESSION CLONING; MUCOUS CELLS; GLYCOSYLATION; AUTOIMMUNITY; ADHESIN; FORMS	Helicobacter pylori infects the stomachs of nearly a half the human population, yet most infected individuals remain asymptomatic, which suggests that there is a host defense against this bacterium. Because H. pylori is rarely found in deeper portions of the gastric mucosa, where O-glycans are expressed that have terminal alpha1,4-linked N-acetylglucosamine, we tested whether these O-glycans might affect H. pylori growth. Here, we report that these O-glycans have antimicrobial activity against H. pylori, inhibiting its biosynthesis of cholesteryl-alpha-D-glucopyranoside, a major cell wall component. Thus, the unique O-glycans in gastric mucin appeared to function as a natural antibiotic, protecting the host from H. pylori infection.	Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan; Burnham Inst, Canc Res Ctr, Glycobiol Program, La Jolla, CA 92037 USA	Shinshu University; Shinshu University; Shinshu University; Sanford Burnham Prebys Medical Discovery Institute	Nakayama, J (corresponding author), Shinshu Univ, Sch Med, Dept Pathol, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	jun@hsp.md.shinshu-u.ac.jp		KAWAKUBO, MASATOMO/0000-0001-5106-5742	NCI NIH HHS [CA 33000, CA 71932] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA033000, R01CA033000, P01CA071932] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Cave D R, 2001, Semin Gastrointest Dis, V12, P196; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x; Finlay J, 2003, J ANTIMICROB CHEMOTH, V52, P18, DOI 10.1093/jac/dkg286; Hidaka E, 2001, GUT, V49, P474, DOI 10.1136/gut.49.4.474; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; Horii T, 2002, HELICOBACTER, V7, P39, DOI 10.1046/j.1523-5378.2002.00054.x; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; INAMOTO Y, 1993, J CLIN GASTROENTEROL, V17, pS136, DOI 10.1097/00004836-199312001-00024; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; ITO Y, UNPUB; KAWAKUBO M, UNPUB; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nakayama J, 1996, J BIOL CHEM, V271, P3684; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	26	256	272	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1003	1006		10.1126/science.1099250	http://dx.doi.org/10.1126/science.1099250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310903				2022-12-01	WOS:000223250700048
J	Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S				Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S			Fetal loss associated with excess thyroid hormone exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-BETA; RESISTANCE; PREGNANCY; HYPERTHYROIDISM; MUTATIONS; ABORTION; DISEASE; WOMEN; RISK; GENE	Context Maternal hypothyroidism and hyperthyroidism have deleterious effects on the outcome of pregnancy. While the effects of thyroid hormone (TH) deprivation on the fetus, independently from that on the mother, can be studied in infants with congenital hypothyroidism, this is not the case in those with fetal thyrotoxicosis. Objective To study the effects of TH excess on fetuses carried by mothers with resistance to TH (RTH) who are euthyroid despite high TH levels but who may carry normal fetuses that are exposed to high maternal hormone levels. Design, Setting, and Participants Retrospective study of 167 members of an Azorean family with RTH. Affected individuals had the RTH phenotype (high serum concentration of free thyroxine and triiodothyronine without suppressed thyrotropin) confirmed by genotyping to identify the Arg243-->Gln mutation in the TH receptor p gene. Main Outcome Measures Pregnancy outcome of affected mothers vs that of unaffected mothers carrying fetuses conceived by affected fathers, as well as that of unaffected first-degree relatives and outcomes from the general island population. Comparison of birth weights and blood concentrations of thyrotropin (TSH) obtained during routine neonatal screening of infants born to these 3 groups. Results Thirty-six couples with complete information belonged to 1 of 3 groups: affected mothers (n=9), affected fathers (n=9), and unaffected relatives (n=18). Mean miscarriage rates were 22.9%, 2.0%, and 4.4%, respectively (chi(2)=8.66, P=.01). Affected mothers had an increased rate of miscarriage (z=3.10, P=.002, by Wilcoxon rank-sum test). They had marginally higher than expected numbers of affected offspring, ie, 20 affected and 11 unaffected children (P=.07), while affected fathers had 15 affected and 12 unaffected children (P=.35). Unaffected infants born to affected mothers were significantly smaller than affected infants, having a mean SD score for gestational age of -1.79 (SD, 0.86) vs -0.06 (SD, 1.11) to -0.22 (SD, 0.70) for all other groups (P<.001). Only unaffected infants born to affected mothers had undetectable blood levels of TSH. Conclusion There was a higher rate of miscarriage in mothers affected by RTH that may have involved predominantly unaffected fetuses. The lower birth weight and suppressed levels of TSH in unaffected infants born to affected mothers indicates that the high maternal TH levels produce fetal thyrotoxicosis. These data indicate a direct toxic effect of TH excess on the fetus.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Hosp Espirito Santo, Endocrinol Unit, Ponta Delgada, Azores, Portugal; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Univ Chicago, Comm Nutr Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Cao, Dingcai/E-8404-2010; Refetoff, Samuel/ABB-1263-2021	Refetoff, Samuel/0000-0003-0164-8231	NCRR NIH HHS [RR18372, RR00055] Funding Source: Medline; NIDDK NIH HHS [DK58258, DK17050] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018372] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abramson J, 2001, THYROID, V11, P57, DOI 10.1089/10507250150500676; Anselmo J, 2001, J CLIN ENDOCR METAB, V86, P4273, DOI 10.1210/jc.86.9.4273; BECKS GP, 1991, MED CLIN N AM, V75, P121, DOI 10.1016/S0025-7125(16)30475-8; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Galton VA, 1999, J CLIN INVEST, V103, P979, DOI 10.1172/JCI6073; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; HARAKAWA S, 1989, ACTA ENDOCRINOL-COP, V121, P739, DOI 10.1530/acta.0.1210739; KOPP P, 1995, NEW ENGL J MED, V332, P150, DOI 10.1056/NEJM199501193320304; Mestman JH, 1997, CLIN OBSTET GYNECOL, V40, P45, DOI 10.1097/00003081-199703000-00007; Mestman JH, 1998, ENDOCRIN METAB CLIN, V27, P127, DOI 10.1016/S0889-8529(05)70303-0; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; MORREALE DE, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI DOI 10.1210/JCEM.85.11.6961; Muller AF, 1999, FERTIL STERIL, V71, P30, DOI 10.1016/S0015-0282(98)00394-X; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; Refetoff S, 2001, METABOLIC MOL BASES, P4029; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; WEISS RE, 1993, J CLIN INVEST, V91, P2408, DOI 10.1172/JCI116474; Yagi H, 1997, J CLIN ENDOCR METAB, V82, P1608, DOI 10.1210/jc.82.5.1608	23	170	177	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					691	695		10.1001/jama.292.6.691	http://dx.doi.org/10.1001/jama.292.6.691			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304465				2022-12-01	WOS:000223177300022
J	Hess, HA; Roper, JC; Grill, SW; Koelle, MR				Hess, HA; Roper, JC; Grill, SW; Koelle, MR			RGS-7 completes a receptor-independent heterotrimeric G protein regulate mitotic spindle positioning in C-elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; G-ALPHA; POLARITY CUES; ORIENTATION; ASSOCIATION; MECHANISMS; SYNEMBRYN; DIVISIONS; G(O)ALPHA; PARTNER	Heterotrimeric G proteins promote microtubule forces that position mitotic spindles during asymmetric cell division in C. elegans embryos. While all previously studied G protein functions require activation by seven-transmembrane receptors, this function appears to be receptor independent. We found that mutating a regulator of G protein signaling, RGS-7, resulted in hyperasymmetric spindle movements due to decreased force on one spindle pole. RGS-7 is localized at the cell cortex, and its effects require two redundant Galpha(o)-related G proteins and their nonreceptor activators RIC-8 and GPR-1/2. Using recombinant proteins, we found that RIC-8 stimulates GTP binding by Galpha(o) and that the FIGS domain of RGS-7 stimulates GTP hydrolysis by Galpha(o), demonstrating that Galpha(o) passes through the GTP bound state during its activity cycle. While GTPase activators typically inactivate G proteins, RGS-7 instead appears to promote G protein function asymmetrically in the cell, perhaps acting as a G protein effector.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Max Planck Society; Yale University; Yale University	Koelle, MR (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.	michael.koelle@yale.edu	Grill, Stephan/D-9427-2012					Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; CARTY DJ, 1994, METHOD ENZYMOL, V237, P38; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dong MQ, 2000, GENE DEV, V14, P2003; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Edgley M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf051; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Honda A, 2002, J BIOL CHEM, V277, P20234, DOI 10.1074/jbc.M112080200; Kehrl JH, 2002, GENOMICS, V79, P860, DOI 10.1006/geno.2002.6773; Kelly WG, 1997, GENETICS, V146, P227; Knust E, 2001, CELL, V107, P125, DOI 10.1016/S0092-8674(01)00534-7; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Miller KG, 2000, GENETICS, V156, P1649; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Rose LS, 1998, DEVELOPMENT, V125, P1337; Sato M, 2003, LIFE SCI, V73, P917, DOI 10.1016/S0024-3205(03)00355-2; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tsou MFB, 2003, DEVELOPMENT, V130, P5717, DOI 10.1242/dev.00790; Tsou MFB, 2002, DEVELOPMENT, V129, P4469; WU HC, 1994, LAB INVEST, V71, P175; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	38	84	87	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					209	218		10.1016/j.cell.2004.09.025	http://dx.doi.org/10.1016/j.cell.2004.09.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479638	Bronze			2022-12-01	WOS:000224577200009
J	Newman, TB				Newman, TB			Treating depression in children: A black-box warning for antidressants in children?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Newman, TB (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	2	61	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1595	1598						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483275				2022-12-01	WOS:000224427300003
J	Stoleru, D; Peng, Y; Agosto, J; Rosbash, M				Stoleru, D; Peng, Y; Agosto, J; Rosbash, M			Coupled oscillators control morning and evening locomotor behaviour of Drosophila	NATURE			English	Article							SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; PACEMAKER NEURONS; CLOCK GENES; PERIOD; BRAIN; MELANOGASTER; NEUROPEPTIDE; LIGHT; PROJECTIONS	Daily rhythms of physiology and behaviour are precisely timed by an endogenous circadian clock(1,2). These include separate bouts of morning and evening activity, characteristic of Drosophila melanogaster and many other taxa, including mammals(3-5). Whereas multiple oscillators have long been proposed to orchestrate such complex behavioural programmes(6), their nature and interplay have remained elusive. By using cell-specific ablation, we show that the timing of morning and evening activity in Drosophila derives from two distinct groups of circadian neurons: morning activity from the ventral lateral neurons that express the neuropeptide PDF, and evening activity from another group of cells, including the dorsal lateral neurons. Although the two oscillators can function autonomously, cell-specific rescue experiments with circadian clock mutants indicate that they are functionally coupled.	Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA.	rosbash@brandeis.edu			NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; HALLIBURTON IW, 1980, J GEN VIROL, V48, P1, DOI 10.1099/0022-1317-48-1-1; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Rao S, 2001, J NEUROBIOL, V49, P159, DOI 10.1002/neu.1072; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	30	504	514	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					862	868		10.1038/nature02926	http://dx.doi.org/10.1038/nature02926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483615				2022-12-01	WOS:000224435500051
J	Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC				Vaniman, DT; Bish, DL; Chipera, SJ; Fialips, CI; Carey, JW; Feldman, WC			Magnesium sulphate salts and the history of water on Mars	NATURE			English	Article							MINERALS; ROCKS	Recent reports of similar to30 wt% of sulphate within saline sediments onMars(1,2)-probably occurring in hydrated form(3)-suggest a role for sulphates in accounting for equatorial H2O observed in a global survey by the Odyssey spacecraft(4). Among salt hydrates likely to be present(3), those of the MgSO4.nH(2)O series have many hydration states. Here we report the exposure of several of these phases to varied temperature, pressure and humidity to constrain their possible H2O contents under martian surface conditions. We found that crystalline structure and H2O content are dependent on temperature-pressure history, that an amorphous hydrated phase with slow dehydration kinetics forms at <1% relative humidity, and that equilibrium calculations may not reflect the true H2O-bearing potential of martian soils. Mg sulphate salts can retain sufficient H2O to explain a portion of the Odyssey observations(5). Because phases in the MgSO4 center dot nH(2)O system are sensitive to temperature and humidity, they can reveal much about the history of water on Mars. However, their ease of transformation implies that salt hydrates collected on Mars will not be returned to Earth unmodified, and that accurate in situ analysis is imperative.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Indiana Univ, Bloomington, IN 47405 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Indiana University System; Indiana University Bloomington	Vaniman, DT (corresponding author), Los Alamos Natl Lab, MS D462, Los Alamos, NM 87545 USA.	vaniman@lanl.gov	Carey, James/B-4421-2011; Bish, David/AAY-7618-2020					Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bish D. L., 2003, 6 INT C MARS; Bish DL, 2003, ICARUS, V164, P96, DOI 10.1016/S0019-1035(03)00140-4; BRUECKNER J, 2004, EOS S, V85; Chipera S.J., 1997, ADV X-RAY ANAL, V39, P713, DOI [10.1154/S0376030800023168, DOI 10.1154/S0376030800023168]; Chou IM, 2003, ASTROBIOLOGY, V3, P619, DOI 10.1089/153110703322610708; CHRISTENSEN PR, 1982, J GEOPHYS RES, V87, P9985, DOI 10.1029/JB087iB12p09985; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1978, ICARUS, V34, P645, DOI 10.1016/0019-1035(78)90052-0; CLARK BC, 1976, SCIENCE, V194, P1283, DOI 10.1126/science.194.4271.1283; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Feldman WC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020181; FELDMAN WC, 2004, J GEOPHYS RES-PLANET, V109, DOI DOI 10.1029/2003JE002160; FOLEY CN, 2003, J GEOPHYS RES, V108, DOI DOI 10.1019/2002JE002019; Gounelle M, 2001, METEORIT PLANET SCI, V36, P1321, DOI 10.1111/j.1945-5100.2001.tb01827.x; Hawthorne FC, 2000, REV MINERAL GEOCHEM, V40, P1, DOI 10.2138/rmg.2000.40.1; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; SAVIJARVI H, 1995, ICARUS, V117, P120, DOI 10.1006/icar.1995.1146; TAYLOR LA, 1973, P LUNAR PLANET SCI C, P829; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; [No title captured]	23	239	243	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					663	665		10.1038/nature02973	http://dx.doi.org/10.1038/nature02973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470421				2022-12-01	WOS:000224299300033
J	Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH				Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH			PHYTOCHROME-INTERACTING FACTOR 1 is a critical bHLH regulator of chlorophyll biosynthesis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; LIGHT; ARABIDOPSIS; PIF3; PROTEIN; PROMOTER; PLANTS	Photosynthetic organisms must achieve a delicate balance between the light energy absorbed by chlorophyll and their capacity to channel that energy into productive photochemical reactions. Release of excess absorbed energy in the cell can cause lethal photooxidative damage. We identified a basic helix-toop-helix (bHLH) transcription factor, designated PHYTOCHROME-INTERACTING FACTOR 1 (PIF1), that negatively regulates chlorophyll biosynthesis. pif1 mutant seedlings accumulate excess free protochlorophyllide when grown in the dark, with consequent lethal bleaching upon exposure to light. PIF1 interacts specifically with the photoactivated conformer of phytochromes A and B, suggesting a signaling pathway by which chlorophyll biosynthetic rates are tightly controlled during the critical initial emergence of seedlings from subterranean darkness into sunlight.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Texas, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol Biol, Austin, TX 78712 USA; ARS, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Agriculture (USDA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quait@nature.berkeley.edu	Kim, Chanhong/G-5506-2012; Hudson, Matthew E/A-4438-2008; Kim, Chanhong/AAL-4930-2021	Hudson, Matthew E/0000-0002-4737-0936; Kim, Chanhong/0000-0003-4133-9070; Al-Sady, Bassem/0000-0002-8996-7941; Huq, Enamul/0000-0001-7692-5139	NIGMS NIH HHS [GM47475] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047475] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Fairchild CD, 2000, GENE DEV, V14, P2377; Halliday KJ, 1999, P NATL ACAD SCI USA, V96, P5832, DOI 10.1073/pnas.96.10.5832; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; HUQ E, UNPUB; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; MONTE E, UNPUB; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; WANG H, 2004, ARABIDOPSIS BOOK; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	22	350	394	3	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1937	1941		10.1126/science.1099728	http://dx.doi.org/10.1126/science.1099728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448264				2022-12-01	WOS:000224136000040
J	Wilson, JF				Wilson, JF			Frailty - and its dangerous effects - Might be preventable	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM INTERLEUKIN-6; FUNCTIONAL DECLINE; GERIATRIC SYNDROME; PROGRAM					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021; Keysor JJ, 2001, J GERONTOL A-BIOL, V56, pM412, DOI 10.1093/gerona/56.7.M412; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2004, AGING CLIN EXP RES, V16, P153; LIPSITZ LA, 2004, SCI AGING KNWOLEDGE, DOI DOI 10.1126/SAGEKE.2004.16PE16; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WALSTON J, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.4.PE4	11	37	40	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					489	492		10.7326/0003-4819-141-6-200409210-00035	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381535				2022-12-01	WOS:000224067900026
J	Aitken, CM; Jones, DM; Larter, SR				Aitken, CM; Jones, DM; Larter, SR			Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs	NATURE			English	Article							PETROLEUM RESERVOIRS; AROMATIC-HYDROCARBONS; CRUDE-OIL; IN-SITU; DEGRADATION; NAPHTHALENE; MICROBIOLOGY; METABOLITES; OXIDATION; BACTERIA	Biodegradation of crude oil in subsurface petroleum reservoirs is an important alteration process with major economic consequences(1). Aerobic degradation of petroleum hydrocarbons at the surface is well documented(2) and it has long been thought that the flow of oxygen- and nutrient-bearing meteoric waters into reservoirs was necessary for in-reservoir petroleum biodegradation(3). The occurrence of biodegraded oils in reservoirs where aerobic conditions are unlikely(4), together with the identification of several anaerobic microorganisms in oil fields(5) and the discovery of anaerobic hydrocarbon biodegradation mechanisms(6,7), suggests that anaerobic degradation processes could also be responsible. The extent of anaerobic hydrocarbon degradation processes in the world's deep petroleum reservoirs, however, remains strongly contested. Moreover, no organism has yet been isolated that has been shown to degrade hydrocarbons under the conditions found in deep petroleum reservoirs(8). Here we report the isolation of metabolites indicative of anaerobic hydrocarbon degradation from a large fraction of 77 degraded oil samples from both marine and lacustrine sources from around the world, including the volumetrically important Canadian tar sands. Our results therefore suggest that anaerobic hydrocarbon degradation is a common process in biodegraded subsurface oil reservoirs.	Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada	Newcastle University - UK; University of Calgary	Jones, DM (corresponding author), Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.jones@ncl.ac.uk		Larter, Stephen/0000-0001-7195-1477				Aitken C.M., 2004, THESIS U NEWCASTLE U; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; ATLAS RM, 1992, ADV MICROB ECOL, V12, P287; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; BENNETT PC, 1993, APPL GEOCHEM, V8, P529, DOI 10.1016/0883-2927(93)90012-6; Boll M, 2002, CURR OPIN CHEM BIOL, V6, P604, DOI 10.1016/S1367-5931(02)00375-7; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; Elshahed MS, 2001, ENVIRON SCI TECHNOL, V35, P682, DOI 10.1021/es001571u; EVANS CR, 1971, CHEM GEOL, V8, P147, DOI 10.1016/0009-2541(71)90002-7; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; HORSTAD I, 1992, ORG GEOCHEM, V19, P107, DOI 10.1016/0146-6380(92)90030-2; Jones DM, 2001, ANAL CHEM, V73, P703, DOI 10.1021/ac000621a; Kartsev AA, 1959, GEOCHEMICAL METHODS; Larter S, 2003, ORG GEOCHEM, V34, P601, DOI 10.1016/S0146-6380(02)00240-1; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; MAGOT M, 1994, RECHERCHE, V25, P936; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Palmer S.E., 1993, ORG GEOCHEM, P511, DOI 10.1007/978-1-4615-2890-6_23; Peters K.E., 1993, BIOMARKER GUIDE, V1st; Phelps CD, 2002, ENVIRON MICROBIOL, V4, P532, DOI 10.1046/j.1462-2920.2002.00330.x; Rios-Hernandez LA, 2003, APPL ENVIRON MICROB, V69, P434, DOI 10.1128/AEM.69.1.434-443.2003; Roling WFM, 2003, RES MICROBIOL, V154, P321, DOI 10.1016/S0923-2508(03)00086-X; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Van Der LINDEN A. C, 1965, ADVANCE ENZYMOLADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS OF BIOCHEMISTRY, V27, P469; WATSON JS, 1999, THESIS U NEWCASTLE U; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhang XM, 2000, BIODEGRADATION, V11, P117, DOI 10.1023/A:1011128109670	30	274	297	8	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					291	294		10.1038/nature02922	http://dx.doi.org/10.1038/nature02922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372028				2022-12-01	WOS:000223864000036
J	Bacci, A; Huguenard, JR; Prince, DA				Bacci, A; Huguenard, JR; Prince, DA			Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids	NATURE			English	Article							ENDOGENOUS CANNABINOIDS; VISUAL-CORTEX; PYRAMIDAL NEURONS; CELLS; SYNAPSES; SUPPRESSION; ANANDAMIDE; RECORDINGS; CHANNELS; NETWORKS	Neocortical GABA-containing interneurons form complex functional networks responsible for feedforward and feedback inhibition and for the generation of cortical oscillations associated with several behavioural functions(1,2). We previously reported that fast-spiking (FS), but not low-threshold-spiking (LTS), neocortical interneurons from rats generate a fast and precise self-inhibition mediated by inhibitory autaptic transmission(3). Here we show that LTS cells possess a different form of self-inhibition. LTS, but not FS, interneurons undergo a prominent hyperpolarization mediated by an increased K+-channel conductance. This self-induced inhibition lasts for many minutes, is dependent on an increase in intracellular [Ca2+] and is blocked by the cannabinoid receptor antagonist AM251, indicating that it is mediated by the autocrine release of endogenous cannabinoids. Endocannabinoid-mediated slow self-inhibition represents a powerful and long-lasting mechanism that alters the intrinsic excitability of LTS neurons, which selectively target the major site of excitatory connections onto pyramidal neurons; that is, their dendrites(4-7). Thus, modulation of LTS networks after their sustained firing will lead to long-lasting changes of glutamate-mediated synaptic strength in pyramidal neurons, with consequences during normal and pathophysiological cortical network activities.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Prince, DA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	daprince@stanford.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bacci, Alberto/0000-0002-3355-5892				Bacci A, 2003, J NEUROSCI, V23, P9664; Bacci A, 2003, J NEUROSCI, V23, P859; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Diana MA, 2003, J NEUROSCI, V23, P5906; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; MACKIE K, 1995, J NEUROSCI, V15, P6552; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pouzat C, 1999, J NEUROSCI, V19, P1675; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Yamada M, 1998, PHARMACOL REV, V50, P723	30	212	217	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					312	316		10.1038/nature02913	http://dx.doi.org/10.1038/nature02913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372034				2022-12-01	WOS:000223864000042
J	Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R				Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R			Pilus chaperones represent a new type of protein-folding catalyst	NATURE			English	Article							DRIVES FIBER FORMATION; ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOGENESIS; FIMC; PAPD; MECHANISM; SUBUNITS; BACTERIA; PATHWAY	Adhesive type 1 pili from uropathogenic Escherichia coli strains have a crucial role during infection by mediating the attachment to and potentially the invasion of host tissue. These filamentous, highly oligomeric protein complexes are assembled by the 'chaperone-usher' pathway(1), in which the individual pilus subunits fold in the bacterial periplasm and form stoichiometric complexes with a periplasmic chaperone molecule that is essential for pilus assembly(2-4). The chaperone subsequently delivers the subunits to an assembly platform (usher) in the outer membrane, which mediates subunit assembly and translocation to the cell surface(5-8). Here we show that the periplasmic type 1 pilus chaperone FimC binds non-native pilus subunits and accelerates folding of the subunit FimG by 100-fold. Moreover, we find that the FimC FimG complex is formed quantitatively and very rapidly when folding of FimG is initiated in the presence of both FimC and the assembly-competent subunit FimF, even though the FimC-FimG complex is thermodynamically less stable than the FimF-FimG complex. FimC thus represents a previously unknown type of protein-folding catalyst, and simultaneously acts as a kinetic trap preventing spontaneous subunit assembly in the periplasm.	ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Glockshuber, R (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch		Weber-Ban, Eilika/0000-0002-5773-9274; Spirig, Thomas/0000-0001-8936-238X				BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALBACH J, 2000, FRONTIERS MOL BIOL; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hermanns U, 2000, BIOCHEMISTRY-US, V39, P11564, DOI 10.1021/bi000549a; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; KLEMM P, 1990, MOL GEN GENET, V220, P334; KUEHN MJ, 1991, P NATL ACAD SCI USA, V88, P10586, DOI 10.1073/pnas.88.23.10586; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sauer FG, 2000, CURR OPIN STRUC BIOL, V10, P548, DOI 10.1016/S0959-440X(00)00129-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zavialov AV, 2002, MOL MICROBIOL, V45, P983, DOI 10.1046/j.1365-2958.2002.03066.x	28	90	95	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					329	332		10.1038/nature02891	http://dx.doi.org/10.1038/nature02891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372038				2022-12-01	WOS:000223864000046
J	Khademi, S; O'Connell, J; Remis, J; Robles-Colmenares, Y; Miericke, LJW; Stroud, RM				Khademi, S; O'Connell, J; Remis, J; Robles-Colmenares, Y; Miericke, LJW; Stroud, RM			Mechanism of ammonia transport by Amt/MEP/Rh: Structure of AmtB at 1.3.5 angstrom	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; ESCHERICHIA-COLI; PHYLOGENETIC CHARACTERIZATION; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GREEN-ALGA; FAMILY; GLNK; NH4+	The first structure of an ammonia channel from the Amt/MEP/Rh protein superfamily, determined to 1.35 angstrom resolution, shows it to be a channel that spans the membrane 11 times. Two structurally similar halves span the membrane with opposite polarity. Structures with and without ammonia or methyl ammonia show a vestibule that recruits NH4+/NH3, a binding site for NH4+, and a 20 angstrom-long hydrophobic channel that lowers the NH4+ pK(a) to below 6 and conducts NH3. Favorable interactions for NH3 are seen within the channel and use conserved histidines. Reconstitution of AmtB into vesicles shows that AmtB conducts uncharged NH3.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, S412C Genentech Hall,600 16th St, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda/0000-0001-5242-8015	NIGMS NIH HHS [GM24485] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024485, R01GM024485] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HACKETTE SL, 1970, J BIOL CHEM, V245, P4241; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KHADEMI S, UNPUB; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; LUDEWIG U, IN PRESS J PHYSL LON; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002; Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799; Tate R, 1998, MOL PLANT MICROBE IN, V11, P188, DOI 10.1094/MPMI.1998.11.3.188; Thomas GH, 2000, MOL MICROBIOL, V37, P331, DOI 10.1046/j.1365-2958.2000.01994.x; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Westhoff CM, 2004, J BIOL CHEM, V279, P17443, DOI 10.1074/jbc.M311853200; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200	36	515	527	7	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1587	1594		10.1126/science.1101952	http://dx.doi.org/10.1126/science.1101952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361618				2022-12-01	WOS:000223891200035
J	Li, SR; Zhou, DY; Lu, MM; Morrisey, EE				Li, SR; Zhou, DY; Lu, MM; Morrisey, EE			Advanced cardiac morphogenesis does not require heart tube fusion	SCIENCE			English	Article							VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; ZEBRAFISH; CELLS; ASYMMETRY; ENDODERM; GATA4; MESP1; GENES; MICE	The bilateral cardiac mesoderm migrates from the lateral region of the embryo to the ventral midline, where it fuses to form the primitive heart tube. It is generally accepted that migration and fusion are essential for subsequent stages of cardiac morphogenesis. We present evidence that, in Foxp4 mutant embryonic mice, each bilateral heart-forming region is capable of developing into a highly differentiated four-chambered mammalian heart in the absence of midline fusion. These data demonstrate that left-right chamber specification, cardiac looping, septation, cardiac myocyte differentiation, and endocardial cushion formation are preprogrammed in the precardiac mesoderm and do not require midline positional identity or heart tube fusion.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			NHLBI NIH HHS [HL71589] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071589] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 2001, AM J MED GENET, V101, P315, DOI 10.1002/ajmg.1180; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Li S., UNPUB; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MM, 2002, MECH DEVELOP, V119, pS197, DOI 10.1016/S0925-4773(03)00116-3; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1998, MECH DEVELOP, V75, P53, DOI 10.1016/S0925-4773(98)00077-X; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Yelon D, 1999, SEMIN CELL DEV BIOL, V10, P93, DOI 10.1006/scdb.1998.0278	23	73	76	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1619	1622		10.1126/science.1098674	http://dx.doi.org/10.1126/science.1098674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361625				2022-12-01	WOS:000223891200043
J	Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G				Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G			Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity	NATURE			English	Article							SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1; AMINO-ACID; CELL SIZE; RESISTANCE; PHOSPHORYLATION; KINASE; GENES; ACTIVATION; GLUCOSE	Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes(1). Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals(2), were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass(3). However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin(3), raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance(4,5). Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Genopole Strasbourg, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG, CH-4057 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis	Thomas, G (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Joaquin, Manel/O-6533-2019; Thomas, George/K-9235-2014; Auwerx, Johan/ABE-9307-2021; FUMAGALLI, Stefano/C-2914-2019; Joaquin, Manel/E-2216-2015	Joaquin, Manel/0000-0001-8973-5916; Thomas, George/0000-0003-3518-8149; Joaquin, Manel/0000-0001-8973-5916; , Stefano/0000-0001-5832-8680; Auwerx, Johan/0000-0002-5065-5393				Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Doty FD, 1999, J MAGN RESON, V138, P144, DOI 10.1006/jmre.1998.1703; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Le Marchand-Brustel Y, 2003, BIOCHEM SOC T, V31, P1152; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; MARETTE A, 1991, INT J OBESITY, V15, P823; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Patti ME, 1999, ANN NY ACAD SCI, V892, P187, DOI 10.1111/j.1749-6632.1999.tb07796.x; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Proietto J, 1999, MOL CELL ENDOCRINOL, V151, P143, DOI 10.1016/S0303-7207(99)00050-7; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tremblay F, 2001, J BIOL CHEM, V276, P38052; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)81297-6	30	1306	1369	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					200	205		10.1038/nature02866	http://dx.doi.org/10.1038/nature02866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15306821				2022-12-01	WOS:000223746000048
J	Stott, L; Cannariato, K; Thunell, R; Haug, GH; Koutavas, A; Lund, S				Stott, L; Cannariato, K; Thunell, R; Haug, GH; Koutavas, A; Lund, S			Decline of surface temperature and salinity in the western tropical Pacific Ocean in the Holocene epoch	NATURE			English	Article							EL-NINO; EQUATORIAL PACIFIC; SEA-LEVEL; CLIMATE; VARIABILITY; BALANCE	In the present-day climate, surface water salinities are low in the western tropical Pacific Ocean and increase towards the eastern part of the basin(1). The salinity of surface waters in the tropical Pacific Ocean is thought to be controlled by a combination of atmospheric convection, precipitation, evaporation and ocean dynamics(2), and on interannual timescales significant variability is associated with the El Nino/Southern Oscillation cycles. However, little is known about the variability of the coupled ocean atmosphere system on timescales of centuries to millennia. Here we combine oxygen isotope and Mg/Ca data from foraminifers retrieved from three sediment cores in the western tropical Pacific Ocean to reconstruct Holocene sea surface temperatures and salinities in the region. We find a decrease in sea surface temperatures of similar to0.5 degreesC over the past 10,000 yr, whereas sea surface salinities decreased by similar to1.5 practical salinity units. Our data imply either that the Pacific basin as a whole has become progressively less salty or that the present salinity gradient along the Equator has developed relatively recently.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Southern California; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Massachusetts Institute of Technology (MIT)	Stott, L (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	stott@usc.edu						Aggarwal PK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019911; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cronin MF, 1998, J GEOPHYS RES-OCEANS, V103, P27567, DOI 10.1029/98JC02605; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Morimoto M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013521; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Oppo DW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000260; PRELL WL, 1986, NATURE, V323, P526, DOI 10.1038/323526a0; Schmittner A, 2000, GEOPHYS RES LETT, V27, P1163, DOI 10.1029/1999GL011048; Sun DZ, 1998, GEOPHYS RES LETT, V25, P2659, DOI 10.1029/98GL01813; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	19	349	387	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					56	59		10.1038/nature02903	http://dx.doi.org/10.1038/nature02903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343330	Green Submitted			2022-12-01	WOS:000223641500039
J	Klausner, R; Alonso, P				Klausner, R; Alonso, P			An attack on all fronts	NATURE			English	Article							PLACEBO-CONTROLLED TRIAL; GLOBAL FUND; MALARIA		Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Ctr Invest Saude Manhica, Manhica, Mozambique; Univ Barcelona, IDIBAPS, Hosp Clin, Ctr Int Hlth, E-08007 Barcelona, Spain	Bill & Melinda Gates Foundation; Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Klausner, R (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.		Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; [Anonymous], 2003, AFR MAL REP 2003; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; BOYD MARK F., 1939, AMER JOUR TROP MED, V19, P1; Butler D, 2004, NATURE, V429, P588, DOI 10.1038/429588a; Lengeler C., 2004, COCHRANE DB SYST REV, V2; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8	8	13	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					930	931		10.1038/430930a	http://dx.doi.org/10.1038/430930a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318232	Bronze			2022-12-01	WOS:000223369800055
J	Stramer, SL; Glynn, SA; Kleinman, SH; Strong, DM; Caglioti, S; Wright, DJ; Dodd, RY; Busch, MP				Stramer, SL; Glynn, SA; Kleinman, SH; Strong, DM; Caglioti, S; Wright, DJ; Dodd, RY; Busch, MP		Natl Heart Lung Blood Inst Nucleic	Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; UNITED-STATES; COST-EFFECTIVENESS; RNA; RISK; NAT; TRANSMISSION; TRANSFUSION; SAFETY	BACKGROUND Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United States as an investigational screening test in mid-1999 to identify donations made during the window period before seroconversion. METHODS We analyzed all antibody-nonreactive donations that were confirmed to be positive for HIV-1 and HCV RNA on nucleic acid - amplification testing of "minipools" ( pools of 16 to 24 donations) by the main blood-collection programs in the United States during the first three years of nucleic acid screening. RESULTS Among 37,164,054 units screened, 12 were confirmed to be positive for HIV-1 RNA or 1 in 3.1 million donations - only 2 of which were detected by HIV-1 p24 antigen testing. For HCV, of 39,721,404 units screened, 170 were confirmed to be positive for HCV RNA, or 1 in 230,000 donations ( or 1 in 270,000 on the basis of 139 donations confirmed to be positive for HCV RNA with the use of a more sensitive HCV-antibody test). The respective rates of positive HCV and HIV-1 nucleic acid - amplification tests were 3.3 and 4.1 times as high among first-time donors as among donors who gave blood repeatedly. Follow-up studies of 67 HCV RNA - positive donors demonstrated that seroconversion occurred a median of 35 days after the index donation, followed by a low rate of resolution of viremia; three cases of long-term immunologically silent HCV infection were documented. CONCLUSIONS Minipool nucleic acid - amplification testing has helped prevent the transmission of approximately 5 HIV-1 infections and 56 HCV infections annually and has reduced the residual risk of transfusion-transmitted HIV-1 and HCV to approximately 1 in 2 million blood units.	Amer Red Cross, Natl Testing & Reference Labs, Gaithersburg, MD 20877 USA; Amer Red Cross, Rockville, MD USA; WESTAT Corp, Rockville, MD 20850 USA; Univ British Columbia, Victoria, BC, Canada; Puget Sound Blood Ctr, Seattle, WA 98104 USA; Blood Syst Lab, Tempe, AZ USA; Blood Syst Res Inst, Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	American Red Cross; American Red Cross; Westat; University of British Columbia; Puget Sound Blood Center; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Stramer, SL (corresponding author), Amer Red Cross, Natl Testing & Reference Labs, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.	stramers@usa.redcross.org	Abrams, William R/A-5782-2008		NHLBI NIH HHS [N01-HB-97080, N01-HB-97078, N01-HB-97082, N01-HB-97081, N01-HB-97079, N01-HB-47114, N01-HB-97077] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097080, N01HB097082, N01HB097078, N01HB097077, N01HB047114, N01HB097081, N01HB097079] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Beld M, 1999, BLOOD, V94, P1183, DOI 10.1182/blood.V94.4.1183.416k15_1183_1191; Busch MP, 2000, TRANSFUSION, V40, P1157, DOI 10.1046/j.1537-2995.2000.40101157.x; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Busch MP, 1998, INFUSIONSTHERAPIE, V25, P194; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Busch MP, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P33; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; Delwart EL, 2004, VOX SANG, V86, P171, DOI 10.1111/j.0042-9007.2004.00416.x; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Galel SA, 2002, TRANSFUSION, V42, P1507, DOI 10.1046/j.1537-2995.2002.00236.x; Giachetti C, 2002, J CLIN MICROBIOL, V40, P2408, DOI 10.1128/JCM.40.7.2408-2419.2002; Grant PR, 2002, TRANSFUSION MED, V12, P229, DOI 10.1046/j.1365-3148.2002.00382.x; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; LEHMANN EL, 1959, TESTING STATISTICAL, P140; MAPLE PAC, 1994, J MED VIROL, V44, P43, DOI 10.1002/jmv.1890440109; Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x; McCullough J, 2000, TRANSFUSION, V40, P143; *NAT BLOOD DAT RES, 2003, 2002 NAT BLOOD COLL; Notari EP, 2001, TRANSFUSION, V41, P751, DOI 10.1046/j.1537-2995.2001.41060751.x; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Orton SL, 2004, TRANSFUSION, V44, P275, DOI 10.1111/j.1537-2995.2004.00623.x; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Peoples BG, 2000, TRANSFUSION, V40, P1280, DOI 10.1046/j.1537-2995.2000.40101280.x; PRATT JW, 1981, CONCEPTS NONPARAMETR, P41; Schmidt WN, 1997, J INFECT DIS, V176, P27, DOI 10.1086/514033; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Schreiber GB, 2002, TRANSFUSION, V42, P414, DOI 10.1046/j.1525-1438.2002.00084.x; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Stramer SL, 2001, TRANSFUSION, V41, P1079; Stramer SL, 1999, TRANSFUSION, V39, p2S; Tobler LH, 1997, CLIN CHEM, V43, P1487; Tobler LH, 2003, TRANSFUSION, V43, P1452, DOI 10.1046/j.1537-2995.2003.00521.x; 2004, MMWR MORB MORTAL WKL, V53, P281	37	368	402	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					760	768		10.1056/NEJMoa040085	http://dx.doi.org/10.1056/NEJMoa040085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317889				2022-12-01	WOS:000223367900008
J	Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R				Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R			Potential funding crisis for the Radiation Effects Research Foundation	LANCET			English	Editorial Material							ATOMIC-BOMB SURVIVORS; NONCANCER DISEASE INCIDENCE; CANCER		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England.	mark.little@imperial.ac.uk	Cardis, Elisabeth/C-3904-2017; de Vathaire, Florent/L-2983-2016; Wakeford, Richard/I-1978-2019	Cardis, Elisabeth/0000-0003-0999-6839; Wakeford, Richard/0000-0002-2934-0987; Shore, Roy/0000-0002-6842-2248; Muirhead, Colin/0000-0001-5394-1267; Little, Mark/0000-0003-0980-7567; de Vathaire, Florent/0000-0002-8374-9281; Grosche, Bernd/0000-0003-2024-3555				Adelstein SJ, 2004, RADIAT RES, V161, P621, DOI 10.1667/0033-7587(2004)161[0621:ASMADM]2.0.CO;2; CULLINGS HM, 2003, RERF UPDATE, V14, P17; HYUBER T, 2003, RADIAT ENVIRON BIOPH, V42, P27; ICRP, 1991, ANN ICRP, V21, P1; Malakoff D, 2004, SCIENCE, V304, P33; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 1994, RADIAT RES, V137, P68; ROESSLER G, 2003, HLTH PHYS NEWS, V31, P4; Straume T, 2003, NATURE, V424, P539, DOI 10.1038/nature01815; THOMPSON DE, 1994, RAD RES S, V137, P17; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, VII; *US NAT AC SCI, 1990, HLTH EFF EXP LOW LEV; WONG FL, 1993, RADIAT RES, V135, P418, DOI 10.2307/3578884; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; 2004, JAPAN TIMES     0403	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					557	558		10.1016/S0140-6736(04)16861-X	http://dx.doi.org/10.1016/S0140-6736(04)16861-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313337				2022-12-01	WOS:000223275100003
J	Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K				Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K			Eocene evolution of whale hearing	NATURE			English	Article							CETACEA; ORIGIN	The origin of whales ( order Cetacea) is one of the best-documented examples of macroevolutionary change in vertebrates(1-3). As the earliest whales became obligately marine, all of their organ systems adapted to the new environment. The fossil record indicates that this evolutionary transition took less than 15 million years, and that different organ systems followed different evolutionary trajectories. Here we document the evolutionary changes that took place in the sound transmission mechanism of the outer and middle ear in early whales. Sound transmission mechanisms change early on in whale evolution and pass through a stage ( in pakicetids) in which hearing in both air and water is unsophisticated. This intermediate stage is soon abandoned and is replaced ( in remingtonocetids and protocetids) by a sound transmission mechanism similar to that in modern toothed whales. The mechanism of these fossil whales lacks sophistication, and still retains some of the key elements that land mammals use to hear airborne sound.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Indian Inst Technol, Dept Earth Sci, Roorkee 427667, Uttaranchel, India; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India	Northeast Ohio Medical University (NEOMED); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Howard University; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG)	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu	Bajpai, Sunil/E-8416-2010; KUMAR, Kishor/H-7232-2013	KUMAR, Kishor/0000-0003-0875-9735; Thewissen, J. G. M./0000-0002-0973-4137				BERTA A, 1994, SCIENCE, V263, P180, DOI 10.1126/science.263.5144.180; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Hemila S, 2001, HEARING RES, V151, P221, DOI 10.1016/S0378-5955(00)00232-X; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; Lombard R. Eric, 1993, P241; Luo Z.-X., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Mason MJ, 2001, J ZOOL, V255, P467; Moller A. R., 1974, HDB SENSORY PHYSL AU, VV, P491; Norris K. S., 1964, P317; Nummela S, 1999, HEARING RES, V133, P61, DOI 10.1016/S0378-5955(99)00053-2; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; NUMMELA S, 1995, HEARING RES, V85, P18, DOI 10.1016/0378-5955(95)00030-8; OELSCHLAGER HA, 1990, NATO ADV SCI I A-LIF, V196, P137; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; Thewissen JGM, 1996, NATURE, V381, P379, DOI 10.1038/381379b0; Tonndorf J., 1968, ARCH OTOLARYNGOL, V87, P49; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Wagner GP, 2000, EVOL BIOL, V31, P155; Wyss AR, 1987, AM MUS NAT HIST NOVI, V2871, P1	30	66	70	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					776	778		10.1038/nature02720	http://dx.doi.org/10.1038/nature02720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306808				2022-12-01	WOS:000223233600040
J	Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA				Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA			Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics	NATURE			English	Article							GLYCOPROTEIN-IIB-IIIA; INSIDE-OUT ACTIVATION; LIGAND-BINDING; CRYSTAL-STRUCTURE; A-DOMAIN; EXTRACELLULAR SEGMENT; SIGNAL-TRANSDUCTION; BETA(3) SUBUNIT; HYBRID DOMAIN; GPIIB-IIIA	Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin alpha and beta subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen- mimetic therapeutics bind to platelet integrin alpha(IIb)beta(3). Allostery in the beta(3)I domain alters three metal binding sites, associated loops and alpha1- and alpha7-helices. Piston-like displacement of the alpha7-helix causes a 62degrees reorientation between the beta(3)I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin ( PSI) domain in the upper beta(3) leg causes a 70 Angstrom separation between the knees of the alpha and beta legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springer@cbr.med.harvard.edu	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X	NHLBI NIH HHS [P01 HL048675] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; ARTONI A, 2004, IN PRESS P NATL ACAD; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; CHEN JF, IN PRESS J BIOL CHEM; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KUNICKI TJ, 1995, BLOOD CELL MOL DIS, V21, P131, DOI 10.1006/bcmd.1995.0015; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, J BIOL CHEM, V278, P17185, DOI 10.1074/jbc.M301516200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; SPRINGER TA, 2004, CELL SURFACE RECEPTO; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Watkins NA, 2002, BLOOD, V99, P1833, DOI 10.1182/blood.V99.5.1833; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; ZAVORTINK M, 1993, CELL ADHES COMMUN, V1, P251, DOI 10.3109/15419069309097258	50	628	650	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					59	67		10.1038/nature02976	http://dx.doi.org/10.1038/nature02976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15378069	Green Accepted			2022-12-01	WOS:000224854900038
J	Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P				Daviglus, ML; Stamler, J; Pirzada, A; Yan, LJL; Garside, DB; Liu, K; Wang, RW; Dyer, AR; Lloyd-Jones, DM; Greenland, P			Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MIDDLE-AGE; OLDER AGE; PREVALENCE; OBESITY; TRENDS; LIFE; COHORTS	Content For women, impact of cardiovascular risk factors measured in young adulthood, particularly favorable (low-risk) profile, on mortality has been difficult to assess due to low short-term death rates. Objective To assess the relationship of baseline coronary risk factor status to mortality from coronary heart disease (CHD), cardiovascular diseases (CVDs), and all causes in young women. Design Prospective cohort study. Setting and Participants A total of 7302 women aged 18 to 39 years without prior CHID or major electrocardiographic abnormalities screened between 1967 and 1973 for the Chicago Heart Association Detection Project in Industry. Risk groups were defined using national guidelines for values of systolic and diastolic blood pressure, serum cholesterol level, body mass index, presence of diabetes, and smoking status. Participants were divided into 4 groups: low risk, 0 risk factors high but 1 or more unfavorable, 1 only risk factor high, and 2 or more risk factors high. Main Outcome Measures All-cause mortality, CHD mortality, and CVD mortality; hazard ratio of outcome measures comparing low-risk group with other groups. Results Only 20% met low-risk criteria; 59% had high levels of 1 or more risk factors. During an average follow-up of 31 years, there were 47 CHID deaths, 94 CVD deaths, and 469 deaths from all causes. The age-adjusted CVD death rate per 10000 person-years was lowest for low-risk women and increased with the number of risk factors, ie, 1.5, 1.7, 5.0, and 9.1 for low-risk; 0, 1, and 2 or more risk factors high, respectively. Multivariate-adjusted CVD mortality hazard ratio for low-risk women was 0.19 (95% confidence interval, 0.08-0.45) compared with women with 2 or more risk factors high. Similar patterns were observed for CHD and all-cause mortality and for both blacks and whites. Conclusion For women with favorable levels for all 5 major risk factors at younger ages, CHID and CVD are rare; long-term and all-cause mortality are much lower compared with others.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Daviglus, ML (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	daviglus@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009; Greenland, Philip/ABD-5528-2021; Pirzada, Amber/ABG-6028-2021	Pirzada, Amber/0000-0003-0526-3611; Lloyd-Jones, Donald/0000-0003-0847-6110	NHLBI NIH HHS [R01 HL21010] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Daviglus ML, 2003, ARCH INTERN MED, V163, P2460, DOI 10.1001/archinte.163.20.2460; Daviglus ML, 2004, AM J CARDIOL, V94, P367, DOI 10.1016/j.amjcard.2004.04.038; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Rosengren A, 2001, EUR HEART J, V22, P136, DOI 10.1053/euhj.2000.2179; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; *US DEP HHS, 1980, DHHS PUBL PHS, V1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 1967, INT CLASS DIS 8 REV; Yan LJL, 2003, CIRCULATION, V107, pE7037	17	175	181	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1588	1592		10.1001/jama.292.13.1588	http://dx.doi.org/10.1001/jama.292.13.1588			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467061	Bronze			2022-12-01	WOS:000224254600026
J	Fiser, J; Chiu, CY; Weliky, M				Fiser, J; Chiu, CY; Weliky, M			Small modulation of ongoing cortical dynamics by sensory input during natural vision	NATURE			English	Article							RESPONSE VARIABILITY; VISUAL-CORTEX; NEURONS; INFORMATION; MECHANISMS; DISCHARGE; SCENES; CELLS	During vision, it is believed that neural activity in the primary visual cortex is predominantly driven by sensory input from the environment. However, visual cortical neurons respond to repeated presentations of the same stimulus with a high degree of variability(1-4). Although this variability has been considered to be noise owing to random spontaneous activity within the cortex(5-7), recent studies show that spontaneous activity has a highly coherent spatio-temporal structure(8-13). This raises the possibility that the pattern of this spontaneous activity may shape neural responses during natural viewing conditions to a larger extent than previously thought. Here, we examine the relationship between spontaneous activity and the response of primary visual cortical neurons to dynamic natural-scene and random-noise film images in awake, freely viewing ferrets from the time of eye opening to maturity. The correspondence between evoked neural activity and the structure of the input signal was weak in young animals, but systematically improved with age. This improvement was linked to a shift in the dynamics of spontaneous activity. At all ages including the mature animal, correlations in spontaneous neural firing were only slightly modified by visual stimulation, irrespective of the sensory input. These results suggest that in both the developing and mature visual cortex, sensory evoked neural activity represents the modulation and triggering of ongoing circuit dynamics by input signals, rather than directly reflecting the structure of the input signal itself.	Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; Univ Rochester, Interdepartmental Program Neruosci, Rochester, NY 14627 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Weliky, M (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu	Fiser, József/A-2877-2009	Fiser, Jozsef/0000-0002-7064-0690; Chiu, Chiayu/0000-0001-5809-6306				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 1999, J NEUROSCI, V19, P2209; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Gallant JL, 1998, NEUROREPORT, V9, P1673, DOI 10.1097/00001756-199805110-00075; Gao WJ, 1999, J COMP NEUROL, V409, P261, DOI 10.1002/(SICI)1096-9861(19990628)409:2<261::AID-CNE7>3.0.CO;2-R; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; SCHILLER PH, 1976, BRAIN RES, V105, P347, DOI 10.1016/0006-8993(76)90432-7; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, J NEUROSCI, V23, P10388; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	301	302	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					573	578		10.1038/nature02907	http://dx.doi.org/10.1038/nature02907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457262				2022-12-01	WOS:000224156700048
J	Fenton, L				Fenton, L			Preventing HIV/AIDS through poverty reduction: the only sustainable solution?	LANCET			English	Editorial Material									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Fenton, L (corresponding author), UCL, Int Hlth & Med Educ Ctr, Archway Campus, London N19 5LW, England.	lynda.fenton@doctors.org.uk						Ainsworth M., 1998, CONFRONTING AIDS EVI; Bloom D. E., 2002, HLTH WEALTH AIDS POV; COHEN D, 2000, SEPED C PAPER SERIES, V2; Collins J., 2000, 4 UNRISDUNAIDS; Horton R, 2000, LANCET, V356, P225; Stillwaggon E, 2002, J DEV STUD, V38, P1, DOI 10.1080/00220380412331322561; 2003, LANCET, V362, P9383	7	86	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1186	1187		10.1016/S0140-6736(04)17109-2	http://dx.doi.org/10.1016/S0140-6736(04)17109-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451230				2022-12-01	WOS:000224102400036
J	Aide, TM; Grau, HR				Aide, TM; Grau, HR			Ecology - Globalization, migration, and Latin American ecosystems	SCIENCE			English	Editorial Material									Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA; Univ Nacl Tucuman, Lab Invest Ecol Yungas, RA-4107 San Miguel De Tucuman, Argentina	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Nacional de Tucuman	Aide, TM (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA.	tmaide@yahoo.com; chilograu@yahoo.com.ar						Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; GRAU HR, UNPUB ENV CONSERV; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Janzen DH, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 2, P559; JANZEN DH, COMMUNICATION; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; PRESTON D, 1996, LATIN AM DEV GEOGRAP, P165; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x	13	352	378	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1915	1916		10.1126/science.1103179	http://dx.doi.org/10.1126/science.1103179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448256				2022-12-01	WOS:000224136000031
J	Anderson, DG; Burdick, JA; Langer, R				Anderson, DG; Burdick, JA; Langer, R			Materials science - Smart biomaterials	SCIENCE			English	Editorial Material							EXTRACELLULAR MATRICES; DRUG-DELIVERY; MICROCHIP; RELEASE; CELLS		MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	rlanger@mit.edu						Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee KY, 2000, NATURE, V408, P998, DOI 10.1038/35050141; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744; Santini JT, 1999, NATURE, V397, P335, DOI 10.1038/16898; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	16	238	250	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1923	1924		10.1126/science.1099987	http://dx.doi.org/10.1126/science.1099987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448260				2022-12-01	WOS:000224136000036
J	Karlawish, JH; Bonnie, RJ; Appelbaum, PS; Lyketsos, C; James, B; Knopman, D; Patusky, C; Kane, RA; Karlan, PS				Karlawish, JH; Bonnie, RJ; Appelbaum, PS; Lyketsos, C; James, B; Knopman, D; Patusky, C; Kane, RA; Karlan, PS			Addressing the ethical, legal, and social issues raised by voting by persons with dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE	This article addresses an emerging policy problem in the United States: participation in the electoral process by citizens with dementia. At present, health care professionals, family caregivers, and long-term care staff lack adequate guidance to decide whether individuals with dementia should be precluded from or assisted in casting a ballot. Voting by persons with dementia raises a series of important questions about the autonomy of individuals with dementia, the integrity of the electoral process, and the prevention of fraud. Three subsidiary issues warrant special attention: development of a method to assess capacity to vote; identification of appropriate kinds of assistance to enable persons with cognitive impairment to vote; and formulation of uniform and workable policies for voting in long-term care settings. In some instances, extrapolation from existing policies and research permits reasonable recommendations to guide policy and practice. However, in other instances, additional research is necessary.	Univ Penn, Inst Aging, Dept Med, Ctr Bioeth, Philadelphia, PA 19104 USA; Univ Penn, Fels Inst Govt, Philadelphia, PA 19104 USA; Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Univ Virginia, Inst Law Psychiat & Publ Policy, Charlottesville, VA USA; Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA; Mayo Clin, Dept Neurol, Alzheimers Dis Res Ctr, Rochester, MN USA; Univ Minnesota, Sch Publ Hlth, Long Term Care Resources Ctr, Minneapolis, MN USA; Stanford Univ, Sch Law, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Virginia; University of Virginia; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Karlawish, JH (corresponding author), Univ Penn, Inst Aging, Dept Med, Ctr Bioeth, 3615 Chestnut St, Philadelphia, PA 19104 USA.	jasonkar@mail.med.upenn.edu		James, Bryan/0000-0003-1932-151X	NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER; NIA NIH HHS [U19 AG010483] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ADM AG, OLD AM MONTH; ALVAREZ M, 2003, ABSENTEE VOTES COUNT; Appelbaum PS, 2000, MACARTHUR COMPETENCE; Buchanan AE., 1989, DECIDING OTHERS ETHI; *FED EL COMM, NAT REG FORM; *FED EL COMM, FED EL 2000 EL RES U; Goffman E., 1961, ASYLUMS; Grisso T., 1998, MACARTHUR COMPETENCE; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HISCHMAN KB, 2004, J GERIATR PSYCHIA NE, V17, P55; ISSACHAROFF S, 2001, LAW DEMOCRACY LEGAL; Karlawish JHT, 2002, NEUROLOGY, V58, P1100, DOI 10.1212/WNL.58.7.1100; Karlawish JHT, 2001, NEUROLOGY, V56, P789, DOI 10.1212/WNL.56.6.789; Keyssar Alexander, 2009, RIGHT VOTE CONTESTED; Magaziner J, 2000, GERONTOLOGIST, V40, P663, DOI 10.1093/geront/40.6.663; OSULLIVAN JL, 2002, J HLTH CARE LAW POLI, V4, P325; Ott BR, 2003, NEUROLOGY, V60, P1546, DOI 10.1212/01.WNL.0000061481.46191.75; PRESLEY SA, 2000, WASHINGTON POST 0103, pA1; risso T, 2002, EVALUATING COMPETENC, P309; ROSENBLATT A, IN PRESS J AM GERIAT; SALES BD, 1982, DISABLED PERSONS LAW, V1, P99; SHERMAN J, 2004, LONDON TIMES    0611, P11; *TASK FORC NAT COM, 2001, TASK FORC REP ACC RE; TATE A, 2000, CHICAGO REPORTER NOV, V29, P10; *U PENNS ALZH DIS, DEV PRACT GUID VOT P; 2000, ALZHEIMER PAGE; 2001, FED REG, V66, P512; 2001, NEWSDAY         0812, pA22	28	45	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1345	1350		10.1001/jama.292.11.1345	http://dx.doi.org/10.1001/jama.292.11.1345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367557	Green Submitted			2022-12-01	WOS:000223866800027
J	Smith, GCS; Wood, AM; Pell, JP; White, IR; Crossley, JA; Dobbie, R				Smith, GCS; Wood, AM; Pell, JP; White, IR; Crossley, JA; Dobbie, R			Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCOTLAND; WEIGHT; BIRTH; FETAL	BACKGROUND: Unexplained stillbirth and the sudden infant death syndrome (SIDS) share some features. A raised maternal serum level of alpha-fetoprotein during the second trimester of pregnancy is a marker of placental dysfunction and a strong predictor of the risk of unexplained stillbirth. It is unknown whether alpha-fetoprotein levels also predict the risk of SIDS. METHODS: We linked a prenatal-screening database for women in western Scotland with databases of maternity, perinatal death, and birth and death certifications to assess the association between second-trimester levels of maternal serum alpha-fetoprotein and the subsequent risk of SIDS. RESULTS: Among 214,532 women with singleton births, there were 114 cases of SIDS (incidence, 2.7 per 10,000 births among women with alpha-fetoprotein levels in the lowest quintile and 7.5 per 10,000 births among those with levels in the highest quintile). When the lowest quintile was used as a referent, the unadjusted odds ratios for SIDS for the second through fifth quintiles were 1.7 (95 percent confidence interval, 0.8 to 3.5), 1.8 (95 percent confidence interval, 0.9 to 3.7), 2.5 (95 percent confidence interval, 1.3 to 4.8), and 2.8 (95 percent confidence interval, 1.4 to 5.4), respectively (P for trend = 0.001). The risk of SIDS varied inversely with the birth-weight percentile and the gestational age at delivery; after adjustment for these factors, the odds ratios for SIDS were 1.7 (95 percent confidence interval, 0.8 to 3.5), 1.7 (95 percent confidence interval, 0.8 to 3.5), 2.2 (95 percent confidence interval, 1.1 to 4.4), and 2.2 (95 percent confidence interval, 1.1 to 4.3), respectively (P for trend = 0.01). CONCLUSIONS: There is a direct association between second-trimester maternal serum alpha-fetoprotein levels and the risk of SIDS, which may be mediated in part through impaired fetal growth and preterm birth.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Yorkhill Natl Hlth Serv Trust, Inst Med Genet, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Glasgow	Smith, GCS (corresponding author), Univ Cambridge, Rosie Matern Hosp, Dept Obstet & Gynaecol, Robinson Way, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Wood, Angela/GZA-5762-2022; Smith, Gordon/A-8070-2008	Wood, Angela/0000-0002-7937-304X; Smith, Gordon/0000-0003-2124-0997; White, Ian/0000-0002-6718-7661; Pell, Jill/0000-0002-8898-7035				Alm B, 2001, ARCH DIS CHILD, V84, P24, DOI 10.1136/adc.84.1.24; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; CAMPBELL S, 1993, ULTRASOUND OBST GYN, P1431; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Crossley J A, 1994, J Med Screen, V1, P180; *CROWN OFF, 1998, DEATH PROC FISC; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; EVANS E, 1990, CLIN APPL ULTRASONIC; Fifer WP, 2002, SEMIN PERINATOL, V26, P89, DOI 10.1053/sper.2002.29854; HANSON M, 1994, ADV EXP MED BIOL, V360, P99; *INF STAT DIV NHS, 2001, SCOTT PER INF MORT R; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Shinozuka N, 2000, AM J PHYSIOL-HEART C, V278, pH41, DOI 10.1152/ajpheart.2000.278.1.H41; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Sullivan FM, 2002, PAEDIATR PERINAT EP, V16, P96; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; WALLER DK, 1993, EPIDEMIOLOGY, V4, P471, DOI 10.1097/00001648-199309000-00014; Waller DK, 1996, OBSTET GYNECOL, V88, P816; WALSH S, 1995, MED HYPOTHESES, V45, P73, DOI 10.1016/0306-9877(95)90206-6	23	29	32	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2004	351	10					978	986		10.1056/NEJMoa040963	http://dx.doi.org/10.1056/NEJMoa040963			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	850UB	15342806				2022-12-01	WOS:000223637400008
J	Montoya, JP; Holl, CM; Zehr, JP; Hansen, A; Villareal, TA; Capone, DG				Montoya, JP; Holl, CM; Zehr, JP; Hansen, A; Villareal, TA; Capone, DG			High rates of N-2 fixation by unicellular diazotrophs in the oligotrophic Pacific Ocean	NATURE			English	Article							NORTH-ATLANTIC OCEAN; CYANOBACTERIUM TRICHODESMIUM-THIEBAUTII; NITROGEN-FIXATION; MARINE CYANOBACTERIUM; EXTENSIVE BLOOM; SITU RATES; DENITRIFICATION; SPP.; GENE	The availability of nitrogen is important in regulating biological productivity in marine environments. Deepwater nitrate has long been considered the major source of new nitrogen supporting primary production in oligotrophic regions of the open ocean, but recent studies have showed that biological N-2 fixation has a critical role in supporting oceanic new production(1-7). Large colonial cyanobacteria in the genus Trichodesmium and the heterocystous endosymbiont Richelia have traditionally been considered the dominant marine N-2 fixers, but unicellular diazotrophic cyanobacteria and bacterioplankton have recently been found in the picoplankton and nanoplankton community of the North Pacific central gyre, and a variety of molecular and isotopic evidence suggests that these unicells could make a major contribution to the oceanic N budget(8). Here we report rates of N-2 fixation by these small, previously overlooked diazotrophs that, although spatially variable, can equal or exceed the rate of N-2 fixation reported for larger, more obvious organisms. Direct measurements of N-15(2) fixation by small diazotrophs in various parts of the Pacific Ocean, including the waters off Hawaii where the unicellular diazotrophs were first characterized, show that N-2 fixation by unicellular diazotrophs can support a significant fraction of total new production in oligotrophic waters.	Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Univ Texas, Inst Marine Sci, Port Aransas, TX 78373 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Hawaii System; University of Texas System; University of Southern California; University of Southern California	Montoya, JP (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	j.montoya@biology.gatech.edu	Villareal, Tracy A/I-9462-2012; Zehr, Jonathan P/B-3513-2014; Montoya, Joseph/C-3115-2013	Villareal, Tracy A/0000-0002-5717-8163; Zehr, Jonathan P/0000-0002-5691-5408; Montoya, Joseph/0000-0001-7197-4660				Allen CB, 1996, DEEP-SEA RES PT I, V43, P917, DOI 10.1016/0967-0637(96)00022-2; Aufdenkampe AK, 2002, DEEP-SEA RES PT II, V49, P2619, DOI 10.1016/S0967-0645(02)00051-6; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 1998, MAR ECOL PROG SER, V172, P281, DOI 10.3354/meps172281; CAPONE DG, 1990, APPL ENVIRON MICROB, V56, P3532, DOI 10.1128/AEM.56.11.3532-3536.1990; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CARPENTER EJ, 1977, LIMNOL OCEANOGR, V22, P739, DOI 10.4319/lo.1977.22.4.0739; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; GOERING JJ, 1966, LIMNOL OCEANOGR, V11, P614, DOI 10.4319/lo.1966.11.4.0614; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; GUNDERSEN KR, 1976, PAC SCI, V30, P45; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Lee K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014198; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Saino T, 1977, BIOL NITROGEN FIXATI; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; Wessel P., 1998, EOS T AGU, V79, P579, DOI [DOI 10.1029/98E000426, 10.1029/98EO00426]; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	29	443	465	5	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1027	1031		10.1038/nature02824	http://dx.doi.org/10.1038/nature02824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329721				2022-12-01	WOS:000223514900043
J	Greenwood, B				Greenwood, B			Between hope and a hard place	NATURE			English	Article							MALARIA; MORTALITY		London Sch Hyg & Trop Med, Malaria Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Malaria Ctr, London, England.							[Anonymous], 2003, AFR MAL REP 2003; Coleman PG, 2004, TROP MED INT HEALTH, V9, P433, DOI 10.1111/j.1365-3156.2004.01225.x; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a	5	19	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					926	927		10.1038/430926a	http://dx.doi.org/10.1038/430926a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318230				2022-12-01	WOS:000223369800053
J	She, XW; Horvath, JE; Jiang, ZS; Liu, G; Furey, TS; Christ, L; Clark, R; Graves, T; Gulden, CL; Alkan, C; Bailey, JA; Sahinalp, C; Rocchi, M; Haussler, D; Wilson, RK; Miller, W; Schwartz, S; Eichler, EE				She, XW; Horvath, JE; Jiang, ZS; Liu, G; Furey, TS; Christ, L; Clark, R; Graves, T; Gulden, CL; Alkan, C; Bailey, JA; Sahinalp, C; Rocchi, M; Haussler, D; Wilson, RK; Miller, W; Schwartz, S; Eichler, EE			The structure and evolution of centromeric transition regions within the human genome	NATURE			English	Article							RECENT SEGMENTAL DUPLICATIONS; ALPHA-SATELLITE DNA; GENETIC DEFINITION; SEQUENCE; EXPANSION; PRIMATES; REPEAT; ORIGIN	An understanding of how centromeric transition regions are organized is a critical aspect of chromosome structure and function; however, the sequence context of these regions has been difficult to resolve on the basis of the draft genome sequence. We present a detailed analysis of the structure and assembly of all human pericentromeric regions (5 megabases). Most chromosome arms ( 35 out of 43) show a gradient of dwindling transcriptional diversity accompanied by an increasing number of interchromosomal duplications in proximity to the centromere. At least 30% of the centromeric transition region structure originates from euchromatic gene-containing segments of DNA that were duplicatively transposed towards pericentromeric regions at a rate of six-seven events per million years during primate evolution. This process has led to the formation of a minimum of 28 new transcripts by exon exaptation and exon shuffling, many of which are primarily expressed in the testis. The distribution of these duplicated segments is nonrandom among pericentromeric regions, suggesting that some regions have served as preferential acceptors of euchromatic DNA.	Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, UCSC Genome Bioinformat Grp, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; Univ Bari, DAPEG, Sez Genet, I-70126 Bari, Italy; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Washington University (WUSTL); Simon Fraser University; Universita degli Studi di Bari Aldo Moro; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA.	eee@gs.washington.edu	Alkan, Can/D-2982-2009; Sahinalp, Suleyman Cenk/X-7843-2018; Wilson, Richard K./AAF-4139-2019	Alkan, Can/0000-0002-5443-0706; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Wilson, Richard K./0000-0002-1992-1358; Furey, Terry/0000-0001-5546-9672; Rocchi, Mariano/0000-0002-9451-5616	Telethon [E.0672] Funding Source: Medline	Telethon(Fondazione Telethon)		Alexandrov I, 2001, CHROMOSOMA, V110, P253, DOI 10.1007/s004120100146; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BALDINI A, 1993, HUM GENET, V90, P577; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Courseaux A, 2003, GENOME RES, V13, P369, DOI 10.1101/gr.490303; Crosier M, 2002, GENOME RES, V12, P67, DOI 10.1101/gr.213702; Eder V, 2003, MOL BIOL EVOL, V20, P1506, DOI 10.1093/molbev/msg165; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; *INT SYST HUM CYT, 1981, CYTOGENET CELL GENET, V31, P1; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jackson M, 2003, CURR OPIN GENET DEV, V13, P629, DOI 10.1016/j.gde.2003.10.011; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; LOCKE DP, IN PRESS CYTOGENET G; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; RUDD MK, IN PRES TRENDS GENET; SCHNEIDER M, 1979, MATURITAS, V1, P153, DOI 10.1016/0378-5122(79)90002-1; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Thomas JW, 2003, GENOME RES, V13, P55, DOI 10.1101/gr.791403; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; WILLARD HF, 1987, J MOL EVOL, V25, P207, DOI 10.1007/BF02100014; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	40	151	155	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					857	864		10.1038/nature02806	http://dx.doi.org/10.1038/nature02806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318213				2022-12-01	WOS:000223369800033
J	Howe, GR				Howe, GR			Studies of nuclear workers: the pros and cons	LANCET			English	Editorial Material							ATOMIC-ENERGY-AUTHORITY; MORTALITY; EMPLOYEES; CANCER		Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Howe, GR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.	gh68@columbia.edu						Armitage P., 1987, STAT METHODS MED RES; Atkinson WD, 2004, OCCUP ENVIRON MED, V61, P577, DOI 10.1136/oem.2003.012443; BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; CARDIS E, 1994, LANCET, V344, P1039; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Muirhead C. R., 1999, Journal of Radiological Protection, V19, P3, DOI 10.1088/0952-4746/19/1/002; PERSTON DL, 2003, RADIAT RES, V160, P381; ROONEY C, 1993, BRIT MED J, V307, P1391, DOI 10.1136/bmj.307.6916.1391; *UNSCEAR, 2000, GEN ASS SCI ANN EFF, V2	9	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1199	1200		10.1016/S0140-6736(04)17157-2	http://dx.doi.org/10.1016/S0140-6736(04)17157-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464167				2022-12-01	WOS:000224254200007
J	Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM				Zhang, LX; Zhou, H; Su, Y; Sun, ZH; Zhang, HW; Zhang, L; Zhang, Y; Ning, YH; Chen, YG; Meng, AM			Zebrafish Dpr2 inhibits mesoderm induction by promoting degradation of nodal receptors	SCIENCE			English	Article							TGF-BETA RECEPTOR; ONE-EYED-PINHEAD; WNT SIGNALS; GASTRULATION; INTERNALIZATION; ENDOCYTOSIS; ANTAGONIST; INTERACTS; ANTIVIN; SMAD2	Nodal proteins, members of the transforming growth factor-beta (TGFbeta) superfamily, have been identified as key endogenous mesoderm inducers in vertebrates. Precise control of Nodal signaling is essential for normal development of embryos. Here, we report that zebrafish dapper2 (dpr2) is expressed in mesoderm precursors during early embryogenesis and is positively regulated by Nodal signals. In vivo functional studies in zebrafish suggest that Dpr2 suppresses mesoderm induction activities of Nodal signaling. Dpr2 is localized in late endosomes, binds to the TGFbeta receptors ALK5 and ALK4, and accelerates lysosomal degradation of these receptors.	Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Mol Cell Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, YG (corresponding author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Lab,Lab Dev Biol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@mail.tsinghua.edu.cn; mengam@mail.tsinghua.edu.cn	Zhang, Yu/F-6583-2016; Su, Ying/M-5825-2013; Meng, Anming/A-4785-2012; Chen, Ye-Guang/L-6998-2019; Su, Ying/ABA-8545-2021; Zhang, Long/AAT-6571-2021	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Zhang, Long/0000-0001-8139-0474; Meng, Anming/0000-0001-7228-3431; Zhang, Yu/0000-0001-5512-9272				Agathon A, 2001, GENESIS, V30, P178, DOI 10.1002/gene.1059; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Iratni R, 2002, SCIENCE, V298, P1996, DOI 10.1126/science.1073405; Katoh M, 2003, INT J ONCOL, V22, P907; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Osada SI, 2000, DEVELOPMENT, V127, P2503; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Thisse C, 1999, DEVELOPMENT, V126, P229; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang L., UNPUB; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	25	110	122	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					114	117		10.1126/science.1100569	http://dx.doi.org/10.1126/science.1100569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459392				2022-12-01	WOS:000224304000049
J	Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A				Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A			alpha-synuclein locus duplication as a cause of familial Parkinson's disease	LANCET			English	Article								Genomic triplication of the alpha-synuclein gene (SNCA) has been reported to cause hereditary early-onset parkinsonism with dementia. These findings prompted us to screen for multiplication of the SNCA locus in nine families in whom parkinsonism segregates as an autosomal dominant trait. One kindred was identified with SNCA duplication by semiquantitative PCR and confirmed by fluorescent in-situ hybridisation analysis in peripheral leucocytes. By contrast with SNCA triplication families, the clinical phenotype of SNCA duplication closely resembles idiopathic Parkinson's disease, which has a late age-of-onset, progresses slowly, and in which neither cognitive decline nor dementia are prominent. These findings suggest a direct relation between SNCA gene dosage and disease progression.	Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; INSERM, U508, F-59019 Lille, France; INSERM, U524, F-59045 Lille, France; CHU Lille, EA MENRT 2683, Dept Neurol, Movement Disorder Clin, Lille, France	Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Farrer, M (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu	LICEND, CEMND/F-1296-2015; Chartier-Harlin, Marie-Christine/L-4527-2018	Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Farrer, Matthew/0000-0003-1159-5321; Amouyel, Philippe/0000-0001-9088-234X; Levecque, Clotilde/0000-0002-0519-337X				Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Golbe LI, 2004, ANN NEUROL, V55, P153, DOI 10.1002/ana.20036; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278	5	1458	1506	4	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1167	1169		10.1016/S0140-6736(04)17103-1	http://dx.doi.org/10.1016/S0140-6736(04)17103-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451224				2022-12-01	WOS:000224102400030
J	Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C				Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C			A critical role for eosinophils in allergic airways remodeling	SCIENCE			English	Article							SUBEPITHELIAL FIBROSIS; BRONCHIAL-ASTHMA; INFLAMMATION; EXPRESSION; HYPERREACTIVITY; BIOPSIES; GATA-1; MOUSE; LEADS	Features of chronic asthma include airway hyperresponsiveness, inflammatory infiltrates, and structural changes in the airways, termed remodeling. The contribution of eosinophils, cells associated with asthma and allergy, remains to be established. We show that in mice with a total ablation of the eosinophil lineage, increases in airway hyperresponsiveness and mucus secretion were similar to those observed in wild-type mice, but eosinophil-deficient mice were significantly protected from peribronchiolar collagen deposition and increases in airway smooth muscle. These data suggest that eosinophils contribute substantially to airway remodeling but are not obligatory for allergen-induced lung dysfunction, and support an important role for eosinophil-targeted therapies in chronic asthma.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02111 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Humbles, AA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA.	alison.humbles@childrens.harvard.edu; c.lloyd@imperial.ac.uk	Xanthou, Georgina/AAH-8682-2019	Lloyd, Clare/0000-0001-8977-6726; Yu, Channing/0000-0002-3231-2565	Wellcome Trust [087618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bandeira-Melo C, 2003, PROSTAG LEUKOTR ESS, V69, P135, DOI 10.1016/S0952-3278(03)00074-7; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HUMBLES AA, UNPUB; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; LENDRUM AC, 1962, J CLIN PATHOL, V15, P401, DOI 10.1136/jcp.15.5.401; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; MCMILLAN S, 2004, CLIN EXP ALLERGY, V34, P1; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Moir LM, 2003, AM J PHYSIOL-LUNG C, V284, pL148, DOI 10.1152/ajplung.00105.2002; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WANNER A, 1990, CHEST, V97, pS11; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	29	683	720	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1776	1779		10.1126/science.1100283	http://dx.doi.org/10.1126/science.1100283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375268				2022-12-01	WOS:000224039500042
J	Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP				Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP			Neuroprotection in ischemia: Blocking calcium-permeable acid-sensing ion channels	CELL			English	Article							NMDA RECEPTOR ACTIVATION; D-ASPARTATE RECEPTORS; GATED NA+ CHANNEL; CATION CHANNEL; GLUTAMATE NEUROTOXICITY; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; NEURONAL INJURY; SENSORY NEURONS; CELL-CULTURE	Ca2+ toxicity remains the central focus of ischemic brain injury. The mechanism by which toxic Ca2+ loading of cells occurs in the ischemic brain has become less clear as multiple human trials of glutamate antagonists have failed to show effective neuroprotection in stroke. Acidosis is a common feature of ischemia and is assumed to play a critical role in brain injury; however, the mechanism(s) remain ill defined. Here, we show that acidosis activates Ca2+-permeable acid-sensing ion channels (ASICs), inducing glutamate receptor-independent, Ca2+-dependent, neuronal injury inhibited by ASIC blockers. Cells lacking endogenous ASICs are resistant to acid injury, while transfection of Ca2+-permeable ASIC1a establishes sensitivity. In focal ischemia, intracerebroventricular injection of ASIC1 a blockers or knockout of the ASIC1 a gene protects the brain from ischemic injury and does so more potently than glutamate antagonism. Thus, acidosis injures the brain via membrane receptor-based mechanisms with resultant toxicity of [Ca2+](i), disclosing new potential therapeutic targets for stroke.	Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Oregon Hlth & Sci Univ, Dept Neurol Physiol & Pharmacol, Portland, OR 97239 USA	University of Toronto; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Oregon Health & Science University	Xiong, ZG (corresponding author), Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA.	zxiong@downeurobiology.org	Minami, Manabu/H-8540-2016	Welsh, Michael/0000-0002-1646-6206; Chu, Xiang-Ping/0000-0002-6781-0468; Wemmie, John/0000-0001-7531-9065				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Dingledine R, 1999, PHARMACOL REV, V51, P7; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LITT L, 1985, J CEREBR BLOOD F MET, V5, P537, DOI 10.1038/jcbfm.1985.81; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; McDonald JW, 1998, J NEUROSCI, V18, P6290; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; MELDRUM BS, 1995, ANN NY ACAD SCI, V757, P492, DOI 10.1111/j.1749-6632.1995.tb17509.x; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Pearigen P, 1996, BRAIN RES, V725, P184; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMON RP, 1985, J PHARMACOL EXP THER, V234, P830; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WESTERGAARD E, 1969, ACTA ANAT, V74, P405; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	70	788	853	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					687	698		10.1016/j.cell.2004.08.026	http://dx.doi.org/10.1016/j.cell.2004.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369669	Bronze			2022-12-01	WOS:000223992400006
J	Priori, SG; Napolitano, C; Schwartz, PJ; Grillo, M; Bloise, R; Ronchetti, E; Moncalvo, C; Tulipani, C; Veia, A; Bottelli, G; Nastoli, J				Priori, SG; Napolitano, C; Schwartz, PJ; Grillo, M; Bloise, R; Ronchetti, E; Moncalvo, C; Tulipani, C; Veia, A; Bottelli, G; Nastoli, J			Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARRHYTHMIAS	Context Data on the efficacy of beta-blockers in the 3 most common genetic long QT syndrome (LQTS) loci are limited. Objective To describe and assess outcome in a large systematically genotyped population of beta-blocker-treated LQTS patients. Design, Setting, and Patients Consecutive LQTS-genotyped patients (n=335) in Italy treated with beta-blockers for an average of 5 years. Main Outcome Measures Cardiac events (syncope, ventricular tachycardia/torsades de pointes, cardiac arrest, and sudden cardiac death) while patients received beta-blocker therapy according to genotype. Results Cardiac events among patients receiving beta-blocker therapy occurred in 19 of 187 (10%) LQT1 patients, 27 of 120 (23%) LQT2 patients, and 9 of 28 (32%) LQT3 patients (P<.001). The risk of cardiac events was higher among LQT2 (adjusted relative risk, 2.81; 95% confidence interval [CI], 1.50-5.27; P=.001) and LQT3 (adjusted relative risk, 4.00; 95% CI, 2.45-8.03; P<.001) patients than among LQT1 patients, suggesting inadequate protection from beta-blocker therapy. Other important predictors of risk were a QT interval corrected for heart rate that was more than 500 ms in patients receiving therapy (adjusted relative risk, 2.01; 95% CI, 1.16-3.51; P=.01) and occurrence of a first cardiac event before the age of 7 years (adjusted RR, 4.34; 95% CI, 2.35-8.03; P<.001). Conclusion Among patients with genetic LQTS treated with &beta;-blockers, there is a high rate of cardiac events, particularly among patients with LQT2 and LQT3 genotypes.	Univ Pavia, Maugeri Fdn, IRCCS, I-27100 Pavia, Italy; Policlin San Matteo, IRCCS, Dept Cardiol, I-27100 Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Priori, SG (corresponding author), Univ Pavia, Maugeri Fdn, IRCCS, Via Ferrata 8, I-27100 Pavia, Italy.	spriori@fsm.it	Napolitano, Carlo/K-4760-2016; bloise, raffaella/AAC-2922-2020; Priori, Silvia G G/A-6116-2014; Priori, Silvia G/ABH-6894-2020; napolitano, carlo/ABI-4608-2020; Schwartz, Peter J/J-4267-2016	Napolitano, Carlo/0000-0002-7643-4628; bloise, raffaella/0000-0003-3485-9596; Priori, Silvia G G/0000-0001-6877-0288; Priori, Silvia G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; Schwartz, Peter J/0000-0003-0367-1048; Nastoli, janni/0000-0002-5888-5951; ronchetti, elena/0000-0002-9185-7848	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Groh WJ, 1996, AM J CARDIOL, V78, P703, DOI 10.1016/S0002-9149(96)00403-3; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; SCHWARTZ PJ, 2000, CARDIAC ELECTROPHYSI, P597; WARD O C, 1964, J Ir Med Assoc, V54, P103	10	416	431	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1341	1344		10.1001/jama.292.11.1341	http://dx.doi.org/10.1001/jama.292.11.1341			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367556	Bronze			2022-12-01	WOS:000223866800026
J	Abzhanov, A; Protas, M; Grant, BR; Grant, PR; Tabin, CJ				Abzhanov, A; Protas, M; Grant, BR; Grant, PR; Tabin, CJ			Bmp4 and morphological variation of beaks in Darwin's finches	SCIENCE			English	Article								Darwin's finches are a classic example of species diversification by natural selection. Their impressive variation in beak morphology is associated with the exploitation of a variety of ecological niches, but its developmental basis is unknown. We performed a comparative analysis of expression patterns of various growth factors in species comprising the genus Geospiza. We found that expression of Bmp4 in the mesenchyme of the upper beaks strongly correlated with deep and broad beak morphology. When misexpressed in chicken embryos, Bmp4 caused morphological transformations paralleling the beak morphology of the large ground finch G. magnirostris.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Harvard University; Harvard Medical School; Princeton University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK56246] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; Darwin C, 1988, VOYAGE BEAGLE; Freeman S., 2003, EVOLUTIONARY ANAL; Futuyma D.J., 1998, EVOL BIOL; Grant P.R., 1999, ECOLOGY EVOLUTION DA; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Lack D., 1947, DARWINS FINCHES; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; PRICE TD, 1985, AM NAT, V125, P169, DOI 10.1086/284336; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Schneider RA, 2001, DEVELOPMENT, V128, P2755	13	540	561	3	338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2004	305	5689					1462	1465		10.1126/science.1098095	http://dx.doi.org/10.1126/science.1098095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353802				2022-12-01	WOS:000223761900048
J	Griffin, AS; West, SA; Buckling, A				Griffin, AS; West, SA; Buckling, A			Cooperation and competition in pathogenic bacteria	NATURE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; VISCOUS POPULATIONS; EVOLUTION; VIRULENCE; ALTRUISM; CONFLICT; RELATEDNESS; PARASITES; INFECTION	Explaining altruistic cooperation is one of the greatest challenges for evolutionary biology(1-3). One solution to this problem is if costly cooperative behaviours are directed towards relatives(4,5). This idea of kin selection has been hugely influential and applied widely from microorganisms to vertebrates(2-10). However, a problem arises if there is local competition for resources, because this leads to competition between relatives, reducing selection for cooperation(3,11-14). Here we use an experimental evolution approach to test the effect of the scale of competition, and how it interacts with relatedness. The cooperative trait that we examine is the production of siderophores, iron-scavenging agents, in the pathogenic bacterium Pseudomonas aeruginosa(15-17). As expected, our results show that higher levels of cooperative siderophore production evolve in the higher relatedness treatments. However, our results also show that more local competition selects for lower levels of siderophore production and that there is a significant interaction between relatedness and the scale of competition, with relatedness having less effect when the scale of competition is more local. More generally, the scale of competition is likely to be of particular importance for the evolution of cooperation in microorganisms, and also the virulence of pathogenic microorganisms, because cooperative traits such as siderophore production have an important role in determining virulence(6,9,17-19).	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Edinburgh; University of Bath	Griffin, AS (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	a.griffin@ed.ac.uk	Griffin, Ashleigh/C-6244-2014; West, Stuart A/M-3608-2014	Griffin, Ashleigh/0000-0001-7674-9825; West, Stuart A/0000-0003-2152-3153; Buckling, Angus/0000-0003-1170-4604				Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, P62; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HAMILTON WD, 1996, NARROW ROADS GENE LA, V1; HOOGKAMPKORSTANJE JAA, 1995, J CLIN MICROBIOL, V33, P572, DOI 10.1128/JCM.33.3.572-575.1995; KELLER L, 2002, ENCY EVOLUTION, P595; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Pepper JW, 2000, J THEOR BIOL, V206, P355, DOI 10.1006/jtbi.2000.2132; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	30	675	689	8	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1024	1027		10.1038/nature02744	http://dx.doi.org/10.1038/nature02744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329720	Green Published			2022-12-01	WOS:000223514900042
J	Nagao, K; Adachi, Y; Yanagida, M				Nagao, K; Adachi, Y; Yanagida, M			Separase-mediated cleavage of cohesin at interphase is required for DNA repair	NATURE			English	Article							SISTER-CHROMATID SEPARATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINT; CUT2 PROTEOLYSIS; EXCISION-REPAIR; BUDDING YEAST; ANAPHASE	Sister chromatids are held together by cohesins(1). At anaphase, separase is activated by degradation of its inhibitory partner, securin(2,3). Separase then cleaves cohesins(4-6), thus allowing sister chromatid separation. Fission yeast securin (Cut2) has destruction boxes and a separase (Cut1) interaction site in the amino and carboxyl terminus, respectively(7,8). Here we show that securin is essential for separase stability and also for proper repair of DNA damaged by ultraviolet, X-ray and g-ray irradiation. The cut2(EA2) mutant is defective in the repair of ultraviolet damage lesions, although the DNA damage checkpoint is activated normally. In double mutant analysis of ultraviolet sensitivity, checkpoint kinase chk1 (ref. 9) and excision repair rad13 (ref. 10) mutants were additive with cut2(EA2), whereas recombination repair rhp51 (ref. 11) and cohesin subunit rad21 (ref. 12) mutants were not. Cohesin was hyper-modified on ultraviolet irradiation in a Rad3 kinase-dependent way(13). Experiments using either mutant cohesin that cannot be cleaved by separase or a protease-dead separase provide evidence that this DNA repair function of securin-separase acts through the cleavage of cohesin. We propose that the securin-separase complex might aid DNA repair by removing local cohesin in interphase cells.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan; Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan	Kyoto University; Kyoto University; Okinawa Institute of Science & Technology Graduate University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp		Nagao, Koji/0000-0003-1418-6988				Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; CARR AM, 1993, NUCLEIC ACIDS RES, V21, P1345, DOI 10.1093/nar/21.6.1345; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Jager H, 2001, GENE DEV, V15, P2572, DOI 10.1101/gad.207301; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Nakamura T, 2002, GENES CELLS, V7, P1113, DOI 10.1046/j.1365-2443.2002.00586.x; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; UZAWA S, 1990, CELL, V62, P913, DOI 10.1016/0092-8674(90)90266-H; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	29	108	110	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1044	1048		10.1038/nature02803	http://dx.doi.org/10.1038/nature02803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329725				2022-12-01	WOS:000223514900047
J	Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J				Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J			Cryo-EM visualization of a viral internal ribosome entry site bound to human ribosomes: The IRES functions as an RNA-Based translation factor	CELL			English	Article							CRICKET PARALYSIS VIRUS; COLI 70S RIBOSOME; METHIONINE-INDEPENDENT INITIATION; 80 S RIBOSOME; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; EXPANSION SEGMENTS; CRYOELECTRON MICROSCOPY	Internal initiation of protein synthesis in eukaryotes is accomplished by recruitment of ribosomes to structured internal ribosome entry sites (IRESs), which are located in certain viral and cellular messenger RNAs. An IRES element in cricket paralysis virus (CrPV) can directly assemble 80S ribosomes in the absence of canonical initiation factors and initiator tRNA. Here we present cryo-EM structures of the CrPV IRES bound to the human ribosomal 40S subunit and to the 80S ribosome. The CrPV IRES adopts a defined, elongate structure within the ribosomal intersubunit space and forms specific contacts with components of the ribosomal A, P, and E sites. Conformational changes in the ribosome as well as within the IRES itself show that CrPV IRES actively manipulates the ribosome. CrPV-Iike IRES elements seem to act as RNA-based translation factors.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 10012 USA; Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Purdue Univ, Dept Biol, W Lafayette, IN 47906 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Frank, J (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org	Jan, Eric/O-1923-2019	Sarnow, Peter/0000-0002-2043-2770	NCRR NIH HHS [P41 RR01219] Funding Source: Medline; NIGMS NIH HHS [R037 GM29169, R01 GM55440, GM55979] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM055440, R37GM029169, R01GM055979] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alkemar G, 2004, RNA, V10, P403, DOI 10.1261/rna.5135204; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	50	209	217	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					465	475		10.1016/j.cell.2004.08.001	http://dx.doi.org/10.1016/j.cell.2004.08.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315759	Bronze			2022-12-01	WOS:000223650900009
J	Zucchero, TM; Cooper, ME; Maher, BS; Daack-Hirsch, S; Nepomuceno, B; Ribeiro, L; Caprau, D; Christensen, K; Suzuki, Y; Machida, J; Natsume, N; Yoshiura, KI; Vieira, AR; Orioli, IM; Castilla, EE; Moreno, L; Arcos-Burgos, M; Lidral, AC; Field, LL; Liu, YE; Ray, A; Goldstein, TH; Schultz, RE; Shi, M; Johnson, MK; Kondo, S; Schutte, BC; Marazita, ML; Murray, JC				Zucchero, TM; Cooper, ME; Maher, BS; Daack-Hirsch, S; Nepomuceno, B; Ribeiro, L; Caprau, D; Christensen, K; Suzuki, Y; Machida, J; Natsume, N; Yoshiura, KI; Vieira, AR; Orioli, IM; Castilla, EE; Moreno, L; Arcos-Burgos, M; Lidral, AC; Field, LL; Liu, YE; Ray, A; Goldstein, TH; Schultz, RE; Shi, M; Johnson, MK; Kondo, S; Schutte, BC; Marazita, ML; Murray, JC			Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL MAJOR LOCUS; FAMILY-BASED TESTS; LINKAGE ANALYSIS; UNIFIED APPROACH; CLINICAL-TRIALS; ASSOCIATION; MSX1; METAANALYSIS; FREQUENCIES; REGIONS	BACKGROUND: Cleft lip or palate (or the two in combination) is a common birth defect that results from a mixture of genetic and environmental factors. We searched for a specific genetic factor contributing to this complex trait by examining large numbers of affected patients and families and evaluating a specific candidate gene. METHODS: We identified the gene that encodes interferon regulatory factor 6 (IRF6) as a candidate gene on the basis of its involvement in an autosomal dominant form of cleft lip and palate, Van der Woude's syndrome. A single-nucleotide polymorphism in this gene results in either a valine or an isoleucine at amino acid position 274 (V274I). We carried out transmission-disequilibrium testing for V274I in 8003 individual subjects in 1968 families derived from 10 populations with ancestry in Asia, Europe, and South America, haplotype and linkage analyses, and case-control analyses, and determined the risk of cleft lip or palate that is associated with genetic variation in IRF6. RESULTS: Strong evidence of overtransmission of the valine (V) allele was found in the entire population data set (P<10(sup -9)); moreover, the results for some individual populations from South America and Asia were highly significant. Variation at IRF6 was responsible for 12 percent of the genetic contribution to cleft lip or palate and tripled the risk of recurrence in families that had already had one affected child. CONCLUSIONS: DNA-sequence variants associated with IRF6 are major contributors to cleft lip, with or without cleft palate. The contribution of variants in single genes to cleft lip or palate is an important consideration in genetic counseling.	Univ Iowa, Coll Dent, Iowa City, IA 52242 USA; Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA; HOPE Fdn, Bacolod City, Philippines; Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Sao Paulo, Brazil; Univ So Denmark, Inst Publ Hlth, Odense, Denmark; Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 464, Japan; Nagasaki Univ, Sch Med, Nagasaki 852, Japan; Univ Fed Rio de Janeiro, Estudio Collaborat Latino Amer Malformac Congenit, Rio De Janeiro, Brazil; Oswaldo Cruz Fdn, ECLAMC, Rio De Janeiro, Brazil; Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; Univ Antioquia, Inst Biol, Medellin, Colombia; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Zhabei Genet Inst, Shanghai, Peoples R China	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade de Sao Paulo; University of Southern Denmark; Aichi Gakuin University; Nagasaki University; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Antioquia; University of British Columbia	Murray, JC (corresponding author), Univ Iowa, Coll Dent, S Grand Ave,2182 ML, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Bicudo, Lucilene/ABA-5679-2020; Maher, Brion S/F-9185-2010; Cooper, Mark/AAC-5326-2020; Christensen, Kaare/C-2360-2009; Arcos-Burgos, Mauricio/H-1326-2017	Christensen, Kaare/0000-0002-5429-5292; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Daack-Hirsch, Sandra/0000-0003-1192-7154	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559, R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013076, R01DE013513, R01DE011948, K02DE015291, R01DE014667, R01DE009886, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE016148, DE13513, R01 DE014667-01, P60 DE13076, R01 DE014667-07, K02 DE015291-04, DE08559, R01 DE014667-02, K02 DE015291-01, R01 DE014667-03, R01 DE014667-05, R01 DE014667, R01 DE014667-06, DE11948, DE09886, K02 DE015291-03, K02 DE015291, K02 DE015291-05, R01 DE014667-04, R01 DE014667-08, DE14667, K02 DE015291-02] Funding Source: Medline; NIEHS NIH HHS [ES10876] Funding Source: Medline; NIGMS NIH HHS [GM08629] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; Cann HM, 2002, SCIENCE, V296, P261; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Field L. Leigh, 1994, European Journal of Human Genetics, V2, P159; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Houdayer C, 2001, AM J MED GENET, V104, P86, DOI 10.1002/1096-8628(20011115)104:1<86::AID-AJMG10053>3.0.CO;2-E; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Marazita ML, 2002, CLEFT PALATE-CRAN J, V39, P149, DOI 10.1597/1545-1569(2002)039<0149:NCLWOW>2.0.CO;2; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; Mossey P.A., 2002, CLEFT LIP PALATE, P127; Murray JC, 1997, CLEFT PALATE-CRAN J, V34, P7, DOI 10.1597/1545-1569(1997)034<0007:CAESOC>2.3.CO;2; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RAY AK, 1993, AM J HUM GENET, V52, P1006; Romitti PA, 1999, TERATOLOGY, V59, P39, DOI 10.1002/(SICI)1096-9926(199901)59:1<39::AID-TERA9>3.0.CO;2-7; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Scott L, 2000, GENET EPIDEMIOL, V19, P381, DOI 10.1002/1098-2272(200012)19:4<381::AID-GEPI9>3.0.CO;2-B; Shi M, 2003, BIRTH DEFECTS RES A, V67, P545, DOI 10.1002/bdra.10076; Sobel E, 1996, AM J HUM GENET, V58, P1323; Terwilliger J., 1994, HDB HUMAN GENETIC LI; van den Boogaard MJH, 2000, NAT GENET, V25, P125; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vieira AR, 2003, J DENT RES, V82, P289, DOI 10.1177/154405910308200409; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	38	434	466	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					769	780		10.1056/NEJMoa032909	http://dx.doi.org/10.1056/NEJMoa032909			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317890	Green Accepted			2022-12-01	WOS:000223367900009
J	FitzGerald, GA				FitzGerald, GA			Coxibs and cardiovascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THERAPEUTIC ARTHRITIS RESEARCH; RANDOMIZED CONTROLLED-TRIAL; LUMIRACOXIB; IBUPROFEN; NAPROXEN; TARGET; COX-2		Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.		FitzGerald, Garret A/A-4222-2010					Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1	5	676	719	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1709	1711		10.1056/NEJMp048288	http://dx.doi.org/10.1056/NEJMp048288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15470192				2022-12-01	WOS:000224585200002
J	Yamamoto, KR				Yamamoto, KR			Bankrolling stem-cell research with California dollars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1711	1713		10.1056/NEJMp048224	http://dx.doi.org/10.1056/NEJMp048224			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863TH	15496617				2022-12-01	WOS:000224585200003
J	Martin, MD				Martin, MD			Shower time	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											Martin, MD (corresponding author), 2901 Montopolis Dr, Austin, TX 78741 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2004	141	8					647	647		10.7326/0003-4819-141-8-200410190-00017	http://dx.doi.org/10.7326/0003-4819-141-8-200410190-00017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	864SD	15492347				2022-12-01	WOS:000224652300011
J	Grima, B; Chelot, E; Xia, RH; Rouyer, F				Grima, B; Chelot, E; Xia, RH; Rouyer, F			Morning and evening peaks of activity rely on different clock neurons of the Drosophila brain	NATURE			English	Article							CIRCADIAN PACEMAKER CELLS; BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; PERIOD; GENE; MELANOGASTER; OSCILLATIONS; NEUROPEPTIDE; PROJECTIONS; MUTATION	In Drosophila, a 'clock' situated in the brain controls circadian rhythms of locomotor activity. This clock relies on several groups of neurons that express the Period ( PER) protein, including the ventral lateral neurons (LN(v)s), which express the Pigment-dispersing factor (PDF) neuropeptide, and the PDF-negative dorsal lateral neurons (LN(d)s)(1). In normal cycles of day and night, adult flies exhibit morning and evening peaks of activity(1,2); however, the contribution of the different clock neurons to the rest activity pattern remains unknown. Here, we have used targeted expression of PER to restore the clock function of specific subsets of lateral neurons in arrhythmic per 0 mutant flies. We show that PER expression restricted to the LNvs only restores the morning activity, whereas expression of PER in both the LNvs and LNds also restores the evening activity. This provides the first neuronal bases for 'morning' and 'evening' oscillators in the Drosophila brain. Furthermore, we show that the LNvs alone can generate 24 h activity rhythms in constant darkness, indicating that the morning oscillator is sufficient to drive the circadian system.	CNRS, UPR 2216, NGI, Inst Neurobiol Alfred Fessard, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Rouyer, F (corresponding author), CNRS, UPR 2216, NGI, Inst Neurobiol Alfred Fessard, Av Terrasse, F-91198 Gif Sur Yvette, France.	rouyer@iaf.cnrs-gif.fr	Rouyer, François/L-9043-2018	Rouyer, François/0000-0001-5641-397X				Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Cheng YZ, 1998, J NEUROSCI, V18, P741; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; HALLIBURTON IW, 1980, J GEN VIROL, V48, P1, DOI 10.1099/0022-1317-48-1-1; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Klarsfeld A, 2003, BEHAV PROCESS, V64, P161, DOI 10.1016/S0376-6357(03)00133-5; Malpel S, 2002, DEVELOPMENT, V129, P1443; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011	21	479	490	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					869	873		10.1038/nature02935	http://dx.doi.org/10.1038/nature02935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483616				2022-12-01	WOS:000224435500052
J	Heekeren, HR; Marrett, S; Bandettini, PA; Ungerleider, LG				Heekeren, HR; Marrett, S; Bandettini, PA; Ungerleider, LG			A general mechanism for perceptual decision-making in the human brain	NATURE			English	Article							HUMAN EXTRASTRIATE CORTEX; PREFRONTAL CORTEX; NEURAL BASIS; REPRESENTATION; ATTENTION; OBJECTS; MICROSTIMULATION; MEMORY; FACES; AREA	Findings from single-cell recording studies suggest that a comparison of the outputs of different pools of selectively tuned lower-level sensory neurons may be a general mechanism by which higher-level brain regions compute perceptual decisions. For example, when monkeys must decide whether a noisy field of dots is moving upward or downward, a decision can be formed by computing the difference in responses between lower-level neurons sensitive to upward motion and those sensitive to downward motion(1-4). Here we use functional magnetic resonance imaging and a categorization task in which subjects decide whether an image presented is a face or a house to test whether a similar mechanism is also at work for more complex decisions in the human brain and, if so, where in the brain this computation might be performed. Activity within the left dorsolateral prefrontal cortex is greater during easy decisions than during difficult decisions, covaries with the difference signal between face- and house-selective regions in the ventral temporal cortex, and predicts behavioural performance in the categorization task. These findings show that even for complex object categories, the comparison of the outputs of different pools of selectively tuned neurons could be a general mechanism by which the human brain computes perceptual decisions.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; NIMH, Funct MRI Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Heekeren, HR (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	hauke@nih.gov	Heekeren, Hauke/B-7739-2008; Bandettini, Peter A./F-5871-2012	Heekeren, Hauke/0000-0001-7912-6826; Marrett, Sean/0000-0001-8179-6511	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002035, ZIAMH002783, Z01MH002783, Z01MH002035] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEEKEREN HR, 2002, SOC NEUR ABSTR; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pessoa L, 2003, J NEUROSCI, V23, P3990; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Sharma J, 2003, SCIENCE, V300, P1758, DOI 10.1126/science.1081721; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	31	505	511	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					859	862		10.1038/nature02966	http://dx.doi.org/10.1038/nature02966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483614				2022-12-01	WOS:000224435500050
J	Kuiken, T; Rimmelzwaan, G; van Riel, D; van Amerongen, G; Baars, M; Fouchier, R; Osterhaus, A				Kuiken, T; Rimmelzwaan, G; van Riel, D; van Amerongen, G; Baars, M; Fouchier, R; Osterhaus, A			Avian H5N1 influenza in cats	SCIENCE			English	Article							VIRUSES		Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; van Riel, Debby/0000-0001-9753-3564; Osterhaus, Albert/0000-0002-6074-1172				HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; *WHO, 2004, CONF HUM CAS AV INFL; [No title captured]	6	302	348	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					241	241		10.1126/science.1102287	http://dx.doi.org/10.1126/science.1102287			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15345779				2022-12-01	WOS:000224419700029
J	Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS				Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS			Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen	CELL			English	Article							LARGE T-ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN; BOVINE MITOCHONDRIAL F-1-ATPASE; SIMIAN VIRUS-40 DNA; IN-VITRO; CRYSTAL-STRUCTURE; SIMIAN-VIRUS-40 ORIGIN; SEQUENTIAL HYDROLYSIS; ESCHERICHIA-COLI; ATP SYNTHASE	The large tumor antigen (LTag) of simian virus 40, an AAA(+) protein, is a hexameric helicase essential for viral DNA replication in eukaryotic cells. LTag functions as an efficient molecular machine powered by ATP binding and hydrolysis for origin DNA melting and replication fork unwinding. To understand how ATP binding and hydrolysis are coupled to conformational changes, we have determined high-resolution structures (similar to1.9 Angstrom) of LTag hexamers in distinct nucleotide binding states. The structural differences of LTag in various nucleotide states detail the molecular mechanisms of conformational changes triggered by ATP binding/hydrolysis and reveal a potential mechanism of concerted nucleotide binding and hydrolysis. During these conformational changes, the angles and orientations between domains of a monomer alter, creating an "iris"-like motion in the hexamer. Additionally, six unique P hairpins on the channel surface move longitudinally along the central channel, possibly serving as a motor for pulling DNA into the LTag double hexamer for unwinding.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Southern California	Chen, XS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.	xiaojiang.chen@usc.edu	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; finkielstein, carla/0000-0002-8417-4643	PHS HHS [NIH-R01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARTHUR AK, 1988, J VIROL, V62, P1999, DOI 10.1128/JVI.62.6.1999-2006.1988; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1991, J VIROL, V65, P1228, DOI 10.1128/JVI.65.3.1228-1235.1991; BRUNGER AT, 1998, CRYSTALLOGRAPHY NMR; Brush GS, 1995, METHOD ENZYMOL, V262, P522; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Menz RI, 2001, FEBS LETT, V494, P11, DOI 10.1016/S0014-5793(01)02302-X; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Rittinger K, 1998, NATURE, V392, P448, DOI 10.1038/33043; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smelkova NV, 1998, J VIROL, V72, P8676, DOI 10.1128/JVI.72.11.8676-8681.1998; STILLMAN B, 1985, EMBO J, V4, P2933, DOI 10.1002/j.1460-2075.1985.tb04026.x; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wittinghofer A, 1998, BIOL CHEM, V379, P933; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834	48	253	260	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					47	60		10.1016/j.cell.2004.09.017	http://dx.doi.org/10.1016/j.cell.2004.09.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454080	Bronze			2022-12-01	WOS:000224292600008
J	Fernandes, CC; Podos, J; Lundberg, JG				Fernandes, CC; Podos, J; Lundberg, JG			Amazonian ecology: Tributaries enhance the diversity of electric fishes	SCIENCE			English	Article							RIVER-BASIN; GYMNOTIFORMES; ORGANIZATION; CHANNEL	Neotropical rivers support a diverse array of endemic taxa, including electric fishes of the order Gymnotiformes. A comprehensive survey of the main channels of the Amazon River and its major tributaries (>2000-kilometer transect) yielded 43 electric fish species. Biogeographical analyses suggest that local mainstem electric fish diversity is enhanced by tributaries. Mainstem species richness tends to increase downstream of tributary confluences, and species composition is most similar between tributaries and adjacent downstream mainstem locations. These findings support a "nodal" or heterogeneous model of riverine community organization across a particularly extensive and diverse geographical region.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; Inst Nacl de Pesquisas da Amazonia, BR-69083 Manaus, Amazonas, Brazil; Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Institute Nacional de Pesquisas da Amazonia; Drexel University	Fernandes, CC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	cristina@bio.umass.edu	Podos, Jeff/I-3843-2019; Fernandes, Cristina/B-4343-2019	Fernandes, Cristina/0000-0002-9670-8198; Podos, Jeffrey/0000-0002-2546-7999				AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; CAPPARELLA AP, 1991, ACTA C INT ORNITHOL, V20, P307; Fernandes CC, 1997, ECOL FRESHW FISH, V6, P36, DOI 10.1111/j.1600-0633.1997.tb00140.x; Fernandes CC, 2002, COPEIA, P52, DOI 10.1643/0045-8511(2002)002[0052:LOAEFS]2.0.CO;2; Fernandes CC, 1998, COPEIA, P730; GORMAN OT, 1986, AM NAT, V128, P611, DOI 10.1086/284592; Goulding M., 1988, RIO NEGRO RICH LIFE; HOPKINS CD, 1988, ANNU REV NEUROSCI, V11, P497, DOI 10.1146/annurev.ne.11.030188.002433; IBARRA M, 1989, COPEIA, P364; KULLANDER S, 2003, CHECK LIST FRESH WAT; Lowe-McConnell R.H., 1987, ECOLOGICAL STUDIES T; LUNDBERG JG, 1987, SCIENCE, V237, P81, DOI 10.1126/science.237.4810.81; Lundberg JG, 1996, COPEIA, P657; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Lundberg John G., 1998, P13; Mago-Leccia F., 1994, ELECT FISHES CONTINE; Matthews W.J., 1998, PATTERNS FRESHWATER; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; PYDANIEL LR, UNPUB; Rice SP, 2001, CAN J FISH AQUAT SCI, V58, P824, DOI 10.1139/cjfas-58-4-824; RICHEY JE, 1991, BIOGEOCHEMISTRY MAJO, P51; SIOLI H, 1975, COUPLING LAND WATER, P199; STEWART DJ, 1987, POLITECNICA B, V1, P9; WALLACE AR, 1876, P ZOOL SOC LOND, V20, P107	28	137	150	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1960	1962		10.1126/science.1101240	http://dx.doi.org/10.1126/science.1101240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448270				2022-12-01	WOS:000224136000048
J	Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P				Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P			Impaired PtdIns(4,5)P-2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking	NATURE			English	Article							TRANSMITTER RELEASE; MEMBRANE; POOL; ENDOCYTOSIS; CLATHRIN; TRANSMISSION; DOMAIN; ARF6; PHOSPHOINOSITIDES; SYNAPTOJANIN	Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5) P-2) has an important function in cell regulation both as a precursor of second messenger molecules and by means of its direct interactions with cytosolic and membrane proteins. Biochemical studies have suggested a role for PtdIns(4,5) P-2 in clathrin coat dynamics, and defects in its dephosphorylation at the synapse produce an accumulation of coated endocytic intermediates. However, the involvement of PtdIns(4,5) P-2 in synaptic vesicle exocytosis remains unclear. Here, we show that decreased levels of PtdIns(4,5) P-2 in the brain and an impairment of its depolarization-dependent synthesis in nerve terminals lead to early postnatal lethality and synaptic defects in mice. These include decreased frequency of miniature currents, enhanced synaptic depression, a smaller readily releasable pool of vesicles, delayed endocytosis and slower recycling kinetics. Our results demonstrate a critical role for PtdIns(4,5) P-2 synthesis in the regulation of multiple steps of the synaptic vesicle cycle.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Ryan, Timothy/AAO-8286-2020; Wenk, Markus Rene/D-1441-2014	Ryan, Timothy/0000-0003-2533-9548; Fitzsimonds, Reiko/0000-0002-0576-9885	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036942] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; Fesce R, 1999, NAT CELL BIOL, V1, pE3, DOI 10.1038/8950; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Kashani AH, 2001, J PHYSIOL-LONDON, V530, P243, DOI 10.1111/j.1469-7793.2001.0243l.x; Khvotchev M, 1998, J BIOL CHEM, V273, P21451, DOI 10.1074/jbc.273.34.21451; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neeb A, 1999, EUR J CELL BIOL, V78, P533, DOI 10.1016/S0171-9335(99)80018-1; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Valtorta Flavia, 1994, Seminars in Cell Biology, V5, P211, DOI 10.1006/scel.1994.1027; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wiedemann C, 1998, J NEUROSCI, V18, P5594	48	278	288	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					415	422		10.1038/nature02896	http://dx.doi.org/10.1038/nature02896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386003				2022-12-01	WOS:000224000500031
J	Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF				Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF			Tropism switching in Bordetella bacteriophage defines a family of diversity-generating retroelements	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; PERTUSSIS; DNA; RETROTRANSPOSITION; RETROVIRUSES; INTEGRATION; EXPRESSION; MECHANISMS; EVOLUTION; PEPTIDES	Bordetella bacteriophages generate diversity in a gene that specifies host tropism(1). This microevolutionary adaptation is produced by a genetic element that combines the basic retroelement life cycle of transcription, reverse transcription and integration with site-directed, adenine-specific mutagenesis. Central to this process is a reverse transcriptase-mediated exchange between two repeats; one serving as a donor template (TR) and the other as a recipient of variable sequence information (VR)(1). Here we describe the genetic basis for diversity generation. The directionality of information transfer is determined by a 21-base-pair sequence present at the 3' end of VR. On the basis of patterns of marker transfer in response to variant selective pressures, we propose that a TR reverse transcript is mutagenized, integrated into VR as a single non-coding strand, and then partially converted to the parental VR sequence. This allows the diversity-generating system to minimize variability to the subset of bases under selection. Using the Bordetella phage cassette as a signature, we have identified numerous related elements in diverse bacteria. These elements constitute a new family of retroelements with the potential to confer selective advantages to their host genomes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Calgary	Miller, JF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jfmiller@ucla.edu						Adams MH., 1959, N Y, V74, P164; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; COTTER PA, 2000, PRINCIPLES BACTERIAL, P619; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; KING JC, 1985, PRECISION FREQUENCY, V1, P147; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pena CEA, 2000, P NATL ACAD SCI USA, V97, P7760, DOI 10.1073/pnas.140014297; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	27	127	135	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					476	481		10.1038/nature02833	http://dx.doi.org/10.1038/nature02833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386016				2022-12-01	WOS:000224000500046
J	Mecklenbrauker, I; Kalled, SL; Leitges, M; Mackay, F; Tarakhovsky, A				Mecklenbrauker, I; Kalled, SL; Leitges, M; Mackay, F; Tarakhovsky, A			Regulation of B-cell survival by BAFF-dependent PKC delta-mediated nuclear signalling	NATURE			English	Article							KINASE-C-DELTA; REACTIVE LYMPHOCYTES-B; HISTONE H2B; PROTEOLYTIC ACTIVATION; AUTOIMMUNE-DISEASE; APOPTOTIC CELLS; TRANSGENIC MICE; PHOSPHORYLATION; IDENTIFICATION; NF-KAPPA-B2	Approximately 65% of B cells generated in human bone marrow are potentially harmful autoreactive B cells(1). Most of these cells are clonally deleted in the bone marrow, while those autoreactive B cells that escape to the periphery are anergized or perish before becoming mature B cells(2-5). Escape of self-reactive B cells from tolerance permits production of pathogenic auto-antibodies(6); recent studies suggest that extended B lymphocyte survival is a cause of autoimmune disease in mice and humans(7). Here we report a mechanism for the regulation of peripheral B-cell survival by serine/threonine protein kinase Cdelta (PKCdelta): spontaneous death of resting B cells is regulated by nuclear localization of PKCdelta that contributes to phosphorylation of histone H2B at serine 14 (S14-H2B). We show that treatment of B cells with the potent B-cell survival factor BAFF ('B-cell-activating factor belonging to the TNF family') prevents nuclear accumulation of PKCdelta. Our data suggest the existence of a previously unknown BAFF-induced and PKCdelta-mediated nuclear signalling pathway which regulates B-cell survival.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Biogen Idec Inc, Cambridge, MA 02142 USA; Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany; St Vincent Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Rockefeller University; Biogen; Max Planck Society; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@mail.rockefeller.edu	Leitges, Michael/AAN-1953-2021; Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693				Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Woodland RT, 1996, J IMMUNOL, V156, P2143; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X	30	121	128	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					456	461		10.1038/nature02955	http://dx.doi.org/10.1038/nature02955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15361883				2022-12-01	WOS:000224000500042
J	Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K				Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K			A linear, O-coordinated eta(1)-CO2 bound to uranium	SCIENCE			English	Article							CARBON-DIOXIDE; TRIVALENT URANIUM; COMPLEXES; CO2; REACTIVITY; TRIAZACYCLONONANE; DINITROGEN; CHEMISTRY; MONOXIDE	The electron-rich, six-coordinate tris-aryloxide uranium(III) complex [(((ArO)-Ar-Ad)(3)tacn)U-III] [where ((ArOH)-Ar-Ad)(3)tacn = 1,4,7-tris(3-adamantyl-5-tert-butyl-2-hydroxybenzyl)-1,4,7-triazacyclononane] reacts rapidly with CO, to yield [(((ArO)-Ar-Ad)(3)tacn)U-IV(CO2)], a complex in which the CO2 ligand is linearly coordinated to the metal through its oxygen atom (eta(1)-OCO). The latter complex has been crystallographically and spectroscopically characterized. The inequivalent O-C-O bond lengths [1.122 angstroms (Angstrom) for the O-C bond adjacent to uranium and 1.277 Angstrom for the other], considered together with magnetization data and electronic and vibrational-spectra, support the following bonding model: U-IV=O=C-.-O- H <----> U-IV-O=C-O-. In these charge-separated resonance structures, the uranium center is oxidized to uranium(IV) and the CO2 ligand reduced by one electron.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Meyer, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,MC 0358, La Jolla, CA 92093 USA.	kmeyer@ucsd.edu	Meyer, Karsten/G-2570-2012; Rheingold, Arnold/U-4735-2019	Meyer, Karsten/0000-0002-7844-2998; Rheingold, Arnold/0000-0003-4472-8127; Nakai, Hidetaka/0000-0002-8548-1987	NIDDK NIH HHS [3 T32 DK07233-2651] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews L, 2000, J AM CHEM SOC, V122, P11440, DOI 10.1021/ja0016699; ARESTA M, 1975, J CHEM SOC CHEM COMM, P636, DOI 10.1039/c39750000636; ARESTA M, 1977, J CHEM SOC DALTON, P708, DOI 10.1039/dt9770000708; BRENNAN JG, 1986, J AM CHEM SOC, V108, P335, DOI 10.1021/ja00262a046; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Castro-Rodriguez I, 2002, CHEM COMMUN, P2764, DOI 10.1039/b208473b; Clark D. L., 1997, INORG SYNTH, V31, P307; Conejo MD, 1999, CHEM-EUR J, V5, P3000; Diaconescu PL, 2000, J AM CHEM SOC, V122, P6108, DOI 10.1021/ja994484e; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FREUND HJ, 1986, SURF SCI, V172, P1, DOI 10.1016/0039-6028(86)90580-7; Gibson DH, 1999, COORDIN CHEM REV, V185-6, P335, DOI 10.1016/S0010-8545(99)00021-1; Gibson DH, 1996, CHEM REV, V96, P2063, DOI 10.1021/cr940212c; HERSKOVITZ T, 1977, J AM CHEM SOC, V99, P2391, DOI 10.1021/ja00449a087; Katz J., 1980, CHEM ACTINIDE ELEMEN; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; Mauser H, 2001, J AM CHEM SOC, V123, P10821, DOI 10.1021/ja011362p; Nakai H, 2004, INORG CHEM, V43, P855, DOI 10.1021/ic035142j; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; Roussel P, 1998, J AM CHEM SOC, V120, P1070, DOI 10.1021/ja972933+; Souter PF, 1997, J AM CHEM SOC, V119, P7350, DOI 10.1021/ja971038n	22	284	289	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1757	1759		10.1126/science.1102602	http://dx.doi.org/10.1126/science.1102602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15375263				2022-12-01	WOS:000224039500036
J	Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P				Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P			Ultraviolet reflectance by the skin of nestlings	NATURE			English	Editorial Material							COLOR; VISION		Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; Univ Neuchatel, Dept Zool, CH-2007 Neuchatel, Switzerland; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Lausanne; University of Neuchatel; University of Bristol	Jourdie, V (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	philipp.heeb@ie-zea.unil.ch	Bennett, Andrew T.D. T.D./P-2670-2016; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Bennett, Andrew T.D. T.D./0000-0001-8512-2805; 				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Hunt S, 2003, P R SOC LOND S, V270, P25; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0	10	78	78	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					262	262		10.1038/431262a	http://dx.doi.org/10.1038/431262a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372020	Bronze			2022-12-01	WOS:000223864000028
J	Watson, JT; Pertel, PE; Jones, RC; Siston, AM; Paul, WS; Austin, CC; Gerber, SI				Watson, JT; Pertel, PE; Jones, RC; Siston, AM; Paul, WS; Austin, CC; Gerber, SI			Clinical characteristics and functional outcomes of West Nile fever	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; NEW-YORK; OUTBREAK; ENCEPHALITIS; EPIDEMIC	Background: West Nile fever, considered a nonsevere manifestation of West Nile virus infection, has not been clinically well described in the United States. In 2002, Illinois had 884 documented cases of West Nile virus infection with 66 associated deaths. Objective: To describe the symptoms and functional outcomes of West Nile fever. Design: Case series. Setting: Illinois. Patients: 98 community-dwelling patients with laboratory evidence of West Nile virus infection but no history of clinical evidence of meningitis, encephalitis, or acute flaccid paralysis. Intervention: Outpatient interviews. Measurements: Presence and duration of patient-reported symptoms of infection, symptom-associated absenteeism, health care use, and impact on daily activities. Results: Of 98 patients, 96% had fatigue for a median of 36 days, 81% had fever for a median of 5 days, 71% had headache for a median of 10 days, 61% had muscle weakness for a median of 28 days, and 53% had difficulty concentrating for a median of 14 days. Thirty respondents reported hospitalization, with a median stay of 5 days. At 30 days after onset, 63% of respondents continued to have symptoms. Duration did not vary significantly with increased age. Among the 72 patients who normally attended work or school, 57 (79%) could not attend because of illness (median absence, 10 days). Limitations: Recall bias could have been introduced by the delay between illness onset and interview and by self-reporting of illness information. Conclusions: West Nile fever is a more severe illness than has previously been documented. Mandatory reporting of West Nile fever cases in addition to West Nile meningoencephalitis cases could allow more accurate and timely recognition of the geographic distribution of West Nile virus infections and could inform public health interventions.	Chicago Dept Publ Hlth, Chicago, IL 60612 USA; Illinois Dept Publ Hlth, Springfield, IL 62761 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Chicago Department of Public Health; Centers for Disease Control & Prevention - USA	Watson, JT (corresponding author), Chicago Dept Publ Hlth, 2160 W Ogden, Chicago, IL 60612 USA.	watson_john@cdph.org						*CDCP, ENC MEN ARB 2001 CAS; *CDCP, 2004, W NIL VIR 2002 CAS C; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; *SER W NIL VIR INF, 2001, MMWR-MORBID MORTAL W, V50, P37; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; 2000, MMWR MORB MORTAL WKL, V49, P1044; 2002, MMWR MORB MORTAL WKL, V51, P1072; 2002, MMWR MORB MORTAL WKL, V51, P497	19	134	147	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					360	365		10.7326/0003-4819-141-5-200409070-00010	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353427				2022-12-01	WOS:000223733800004
J	Opdal, SH; Rognum, TO				Opdal, SH; Rognum, TO			New insight into sudden infant-death syndrome	LANCET			English	Editorial Material							SEROTONIN TRANSPORTER GENE; RISK		Rikshosp Univ Hosp, Inst Forens Med, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Opdal, SH (corresponding author), Rikshosp Univ Hosp, Inst Forens Med, N-0027 Oslo, Norway.	siriop@ulrik.uio.no						Blackwell CC, 1999, FEMS IMMUNOL MED MIC, V25, P1, DOI 10.1111/j.1574-695X.1999.tb01320.x; Guntheroth WG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e64; Heininger U, 2004, PEDIATRICS, V114, pE9, DOI 10.1542/peds.114.1.e9; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Lindgren C, 1997, EUR J PEDIATR, V156, P405, DOI 10.1007/s004310050626; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; Opdal SH, 2003, HUM IMMUNOL, V64, P1183, DOI 10.1016/j.humimm.2003.08.359; Opdal SH, 1999, EUR J PEDIATR, V158, P210, DOI 10.1007/s004310051051; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; ROGNUM TO, 1993, ACTA PAEDIATR, V82, P82, DOI 10.1111/j.1651-2227.1993.tb12886.x; Vege A, 1999, FEMS IMMUNOL MED MIC, V25, P67, DOI 10.1111/j.1574-695X.1999.tb01328.x; VEGE A, 1995, ACTA PAEDIATR, V84, P193, DOI 10.1111/j.1651-2227.1995.tb13608.x; Weese-Mayer DE, 2004, PEDIATR RES, V56, P391, DOI 10.1203/01.PDR.0000136285.91048.4A; Weese-Mayer DE, 2003, AM J MED GENET A, V117A, P268, DOI 10.1002/ajmg.a.20005	16	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					825	826		10.1016/S0140-6736(04)16998-5	http://dx.doi.org/10.1016/S0140-6736(04)16998-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351175				2022-12-01	WOS:000223685200009
J	Fortney, JJ				Fortney, JJ			Looking into the giant planets	SCIENCE			English	Editorial Material							EQUATION-OF-STATE; PHASE-SEPARATION; HELIUM; JUPITER; SATURN; DEUTERIUM; EVOLUTION; HYDROGEN		NASA, Planetary Syst Branch, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Fortney, JJ (corresponding author), NASA, Planetary Syst Branch, Ames Res Ctr, Moffett Field, CA 94035 USA.	jfortney@arc.nasa.gov	Fortney, Jonathan/F-8813-2014	Fortney, Jonathan/0000-0002-9843-4354				CASTILLO JF, COMMUNICATION; Collins GW, 1998, SCIENCE, V281, P1178, DOI 10.1126/science.281.5380.1178; Conrath BJ, 2000, ICARUS, V144, P124, DOI 10.1006/icar.1999.6265; FLASAR FM, COMMUNICATION; Fortney JJ, 2004, ASTROPHYS J, V608, P1039, DOI 10.1086/420765; Fortney JJ, 2003, ICARUS, V164, P228, DOI 10.1016/S0019-1035(03)00130-1; Hubbard WB, 1999, PLANET SPACE SCI, V47, P1175, DOI 10.1016/S0032-0633(99)00042-2; Knudson MD, 2003, J PHYS A-MATH GEN, V36, P6149, DOI 10.1088/0305-4470/36/22/342; PFAFFENZELLER O, 1995, PHYS REV LETT, V74, P2599, DOI 10.1103/PhysRevLett.74.2599; SALPETER EE, 1973, ASTROPHYS J, V181, pL83, DOI 10.1086/181190; Saumon D, 2004, ASTROPHYS J, V609, P1170, DOI 10.1086/421257; SMOLUCHO.R, 1967, NATURE, V215, P691, DOI 10.1038/215691a0; STEVENSON DJ, 1975, PHYS REV B, V12, P3999, DOI 10.1103/PhysRevB.12.3999; STEVENSON DJ, 1977, ASTROPHYS J SUPPL S, V35, P239, DOI 10.1086/190479; von Zahn U, 1998, J GEOPHYS RES-PLANET, V103, P22815, DOI 10.1029/98JE00695	15	15	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2004	305	5689					1414	1415		10.1126/science.1101352	http://dx.doi.org/10.1126/science.1101352			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353790	Green Published			2022-12-01	WOS:000223761900033
J	Casali, A; Struhl, G				Casali, A; Struhl, G			Reading the Hedgehog morphogen gradient by measuring the ratio of bound to unbound Patched protein	NATURE			English	Article							CUBITUS INTERRUPTUS; DROSOPHILA EMBRYOS; MEMBRANE-PROTEIN; SONIC HEDGEHOG; GENE ENCODES; POLARITY; RECEPTOR; PATTERN; SIGNAL; FORMS	Morphogens are 'form-generating' substances that spread from localized sites of production and specify distinct cellular outcomes at different concentrations. A cell's perception of morphogen concentration is thought to be determined by the number of active receptors, with inactive receptors making little if any contribution(1). Patched (Ptc)(2-5), the receptor for the morphogen Hedgehog (Hh)(6-12), is active in the absence of ligand and blocks the expression of target genes by inhibiting Smoothened (Smo), an essential transducer of the Hh signal(3,13-16). Hh binding to Ptc abrogates the ability of Ptc to inhibit Smo, thereby unleashing Smo activity and inducing target gene expression(2,3,12-16). Here, we show that a cell's measure of ambient Hh concentration is not determined solely by the number of active (unliganded) Ptc molecules. Instead, we find that Hh-bound Ptc can titrate the inhibitory action of unbound Ptc. Furthermore, we demonstrate that this effect is sufficient to allow normal reading of the Hh gradient in the presence of a form of Ptc that cannot bind the ligand(12) but retains its ability to inhibit Smo. These results support a model in which the ratio of bound to unbound Ptc molecules determines the cellular response to Hh.	Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Struhl, G (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA.	gs20@columbia.edu	Casali, Andreu/Z-5620-2019; Casali, Andreu/ABD-5226-2021	Casali, Andreu/0000-0003-1738-869X				Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hepker J, 1997, DEVELOPMENT, V124, P549; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; Struhl G, 1997, DEVELOPMENT, V124, P2143; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1	30	94	95	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					76	80		10.1038/nature02835	http://dx.doi.org/10.1038/nature02835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15300262				2022-12-01	WOS:000223641500044
J	Malumbres, M; Sotillo, R; Santamaria, D; Galan, J; Cerezo, A; Ortega, S; Dubus, P; Barbacid, M				Malumbres, M; Sotillo, R; Santamaria, D; Galan, J; Cerezo, A; Ortega, S; Dubus, P; Barbacid, M			Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6	CELL			English	Article							PROTEIN-KINASES; MICE; PROGRESSION; CANCER; G(1); IDENTIFICATION; PROLIFERATION; ONCOGENESIS; REGULATORS; DISRUPTION	Cdk4 and Cdk6 are thought to be essential for initiation of the cell cycle in response to mitogenic stimuli. Previous studies have shown that Cdk4 is dispensable for proliferation in most cell types, an observation attributed to a putative a compensatory role by Cdk6. Cdk6-null mice are viable and develop normally although hematopoiesis is slightly impaired. Embryos defective for Cdk4 and CdK6 die during the late stages of embryonic development due to severe anemia. However, these embryos display normal organogenesis and most cell types proliferate normally. In vitro, embryonic fibroblasts lacking Cdk4 and Cdk6 proliferate and become immortal upon serial passage. Moreover, quiescent Cdk4/Cdk6-null cells respond to serum stimulation and enter S phase with normal kinetics although with lower efficiency. These results indicate that D-type cyclin-dependent kinases are not essential for cell cycle entry and suggest the existence of alternative mechanisms to initiate cell proliferation upon mitogenic stimulation.	CNIO, Mol Oncol Program, E-28029 Madrid, Spain; Univ Bordeaux 2, EA2406, F-33076 Bordeaux, France	Centro Nacional de Investigaciones Oncologicas (CNIO); UDICE-French Research Universities; Universite de Bordeaux	Malumbres, M (corresponding author), CNIO, Mol Oncol Program, E-28029 Madrid, Spain.	malumbres@cnio.es; barbacid@cnio.es	Holt, Janet E/B-2415-2013; Malumbres, Marcos/E-8834-2011; Santamaria, David/D-3930-2011; Cerezo, Ana/F-4403-2011	Malumbres, Marcos/0000-0002-0829-6315; Santamaria, David/0000-0002-4711-3569; Cerezo Montemayor, Ana/0000-0003-0275-0844; Sotillo, Rocio/0000-0002-0855-7917; Dubus, Pierre/0000-0003-1803-4711; Galan, Javier/0000-0002-1160-8279				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amanatullah DF, 2001, METHOD ENZYMOL, V333, P116; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LUKAS J, 1995, ONCOGENE, V10, P2125; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moons DS, 2002, ENDOCRINOLOGY, V143, P3001, DOI 10.1210/en.143.8.3001; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Park M, 1999, DEVELOPMENT, V126, P4849; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Stacey D, 2002, CURR OPIN GENET DEV, V12, P44, DOI 10.1016/S0959-437X(01)00262-3; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sweeney KJ, 1997, ONCOGENE, V14, P1329, DOI 10.1038/sj.onc.1200951; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198	42	594	612	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					493	504		10.1016/j.cell.2004.08.002	http://dx.doi.org/10.1016/j.cell.2004.08.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315761	Bronze			2022-12-01	WOS:000223650900011
J	Hemingway, J				Hemingway, J			Taking aim at mosquitoes	NATURE			English	Article							INSECTICIDE RESISTANCE; GENOME SEQUENCE; PLASMODIUM		Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Hemingway, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.			Hemingway, Janet/0000-0002-3200-7173				Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200	9	16	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					936	936		10.1038/430936a	http://dx.doi.org/10.1038/430936a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318236	Green Accepted			2022-12-01	WOS:000223369800059
J	Mandavilli, A				Mandavilli, A			Struggling to make an impact	NATURE			English	Editorial Material																		2002, NATURE, V419, P422; 2004, NATURE, V429, P588	2	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					935	935		10.1038/430935a	http://dx.doi.org/10.1038/430935a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318235	Bronze			2022-12-01	WOS:000223369800058
J	Mocumbi, P				Mocumbi, P			Plague of my people	NATURE			English	Editorial Material																			0	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					925	925		10.1038/430925a	http://dx.doi.org/10.1038/430925a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318229	Bronze			2022-12-01	WOS:000223369800052
J	Zou, SM; Dodd, RY; Stramer, SL; Strong, DM				Zou, SM; Dodd, RY; Stramer, SL; Strong, DM		Tissue Safety Study Grp	Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-DONORS; VIRAL-INFECTIONS; PREVALENCE; RISK; NAT; MARKERS; TIME	BACKGROUND: Tissue-banking organizations in the United States have introduced various review and testing procedures to reduce the risk of the transmission of viral infections from tissue grafts. We estimated the current probability of undetected viremia with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-lymphotropic virus (HTLV) among tissue donors. METHODS: Rates of prevalence of hepatitis B surface antigen (HBsAg) and antibodies against HIV (anti-HIV), HCV (anti-HCV), and HTLV (anti-HTLV) were determined among 11,391 donors to five tissue banks in the United States. The data were compared with those of first-time blood donors in order to generate estimated incidence rates among tissue donors. The probability of viremia undetected by screening at the time of tissue donation was estimated on the basis of the incidence estimates and the window periods for these infections. RESULTS: The prevalence of confirmed positive tests among tissue donors was 0.093 percent for anti-HIV, 0.229 percent for HBsAg, 1.091 percent for anti-HCV, and 0.068 percent for anti-HTLV. The incidence rates were estimated to be 30.118, 18.325, 12.380, and 5.586 per 100,000 person-years, respectively. The estimated probability of viremia at the time of donation was 1 in 55,000, 1 in 34,000, 1 in 42,000, and 1 in 128,000, respectively. CONCLUSIONS: The prevalence rates of HBV, HCV, HIV, and HTLV infections are lower among tissue donors than in the general population. However, the estimated probability of undetected viremia at the time of tissue donation is higher among tissue donors than among first-time blood donors. The addition of nucleic acid-amplification testing to the screening of tissue donors should reduce the risk of these infections among recipients of donated tissues.	Amer Red Cross, Transmissible Dis Dept, Rockville, MD 20855 USA; Puget Sound Blood Ctr, NW Tissue Ctr, Seattle, WA 98104 USA	American Red Cross; Puget Sound Blood Center	Zou, SM (corresponding author), Amer Red Cross, Transmissible Dis Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.	zous@usa.redcross.org	Abrams, William R/A-5782-2008					Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; *AM ASS TISS BANKS, 2002, 2002 ANN REG SURV AC; [Anonymous], 2002, STAND TISS BANK; Busch MP, 2004, TRANSFUS CLIN BIOL, V11, P26, DOI 10.1016/j.tracli.2003.12.003; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Dodd R Y, 2000, Dev Biol (Basel), V102, P19; Dodd RY, 2000, ANN MED, V32, P469, DOI 10.3109/07853890009002022; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Eastlund T., 2004, ADV TISSUE BANKING, V7, P51, DOI DOI 10.1142/9789812796646_0003; Glynn SA, 2000, JAMA-J AM MED ASSOC, V284, P229, DOI 10.1001/jama.284.2.229; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; JOYCE MJ, 2004, AM AC ORTH SURG 71 A; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Korelitz JJ, 1997, TRANSFUSION, V37, P634, DOI 10.1046/j.1537-2995.1997.37697335159.x; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; PETERSEN LR, 1994, TRANSFUSION, V34, P283, DOI 10.1046/j.1537-2995.1994.34494233574.x; Scardino MK, 2002, CORNEA, V21, P798, DOI 10.1097/00003226-200211000-00014; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Stramer SL, 2001, TRANSFUSION, V41, P1079; 2003, MMWR MORB MORTAL WKL, V52, P273; 2000, CRYSTAL BALL SOFTWAR	24	143	151	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					751	759		10.1056/NEJMoa032510	http://dx.doi.org/10.1056/NEJMoa032510			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317888				2022-12-01	WOS:000223367900007
J	Isbister, GK				Isbister, GK			Necrotic arachnidism: the mythology of a modern plague	LANCET			English	Editorial Material							WHITE-TAILED SPIDER; DISGUST SENSITIVITY; CLINICAL TOXINOLOGY; LAMPONA-CYLINDRATA; MISS-MUFFET; BITE; ETIOLOGY; LOXOSCELES; DIAGNOSIS; PHOBIAS		Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia	Calvary Mater Newcastle Hospital; University of Newcastle	Isbister, GK (corresponding author), Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia.	gsbite@femtree.com	Isbister, Geoffrey K/G-8052-2015	Isbister, Geoffrey K/0000-0003-1519-7419				ATKINSON RK, 1991, COMP BIOCHEM PHYS C, V98, P441, DOI 10.1016/0742-8413(91)90230-Q; *AUSTR TRANSP SAF, 2002, ROAD CRASH DAT RAT A; Bettini S, 1978, ARTHROPOD VENOMS, P103; DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x; DAVEY GCL, 1994, SOC ANIM, V2, P17, DOI 10.1163/156853094X00045; DAVEY GCL, 1993, BEHAV RES THER, V31, P41, DOI 10.1016/0005-7967(93)90041-R; Davey GCL, 1991, ANXIETY RES, V4, P299, DOI [10.1080/08917779208248798, DOI 10.1080/08917779208248798]; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; GRAY M, 1989, MED J AUSTRALIA, V151, P114, DOI 10.5694/j.1326-5377.1989.tb101182.x; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; Isbister GK, 2003, MED J AUSTRALIA, V179, P199, DOI 10.5694/j.1326-5377.2003.tb05499.x; Isbister GK, 2002, QJM-INT J MED, V95, P723, DOI 10.1093/qjmed/95.11.723; Isbister GK, 2002, J TOXICOL-CLIN TOXIC, V40, P231, DOI 10.1081/CLT-120005493; KEMP DR, 1990, MED J AUSTRALIA, V152, P669, DOI 10.5694/j.1326-5377.1990.tb125430.x; MARETIC Z, 1979, OTHER EUROPEAN ARANE, P172; MCGAIN F, 2000, BEE WASP STING RELAT; MENZIES RG, 1995, CLIN PSYCHOL REV, V15, P23, DOI 10.1016/0272-7358(94)00039-5; Merckelbach H, 1997, BEHAV RES THER, V35, P1031, DOI 10.1016/S0005-7967(97)00054-5; MORFORD MPO, CLASSICAL MYTHOLOGY, pCH8; RAVEN RJ, 1991, MED J AUSTRALIA, V154, P208; RIBEIRO LA, 1990, TOXICON, V28, P715, DOI 10.1016/0041-0101(90)90260-E; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9; SOUTHCOTT RV, 1976, MED J AUSTRALIA, V1, P406, DOI 10.5694/j.1326-5377.1976.tb140704.x; SPRING WJ, 1987, MED J AUSTRALIA, V147, P605, DOI 10.5694/j.1326-5377.1987.tb133700.x; STGEORGE I, 1991, NEW ZEAL MED J, V104, P207; Sutherland S, 2001, AUSTR ANIMAL TOXINS; SUTHERLAND SK, 1987, MED J AUSTRALIA, V147, P531, DOI 10.5694/j.1326-5377.1987.tb133672.x; SUTHERLAND SK, 1982, TOXICON S1, V20, P59; VEST DK, 1987, TOXICON, V25, P175, DOI 10.1016/0041-0101(87)90239-X; Vetter RS, 2002, ANN EMERG MED, V39, P544, DOI 10.1067/mem.2002.123594; White J, 2003, MED J AUSTRALIA, V179, P180, DOI 10.5694/j.1326-5377.2003.tb05493.x; White J, 2003, J TOXICOL-CLIN TOXIC, V41, P263, DOI 10.1081/CLT-120021112; WHITE J, 1989, MED J AUSTRALIA, V150, P401, DOI 10.5694/j.1326-5377.1989.tb136536.x; 1996, ADVERSE DRUG REACT T, V15, P199	35	26	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					549	553		10.1016/S0140-6736(04)16816-5	http://dx.doi.org/10.1016/S0140-6736(04)16816-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302201				2022-12-01	WOS:000223132700037
J	Majeed, A; Williams, S; Jarman, B; Aylin, P				Majeed, A; Williams, S; Jarman, B; Aylin, P			Prescribing of antibiotics and admissions for respiratory tract infections in England	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Majeed, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Majeed, Azeem/0000-0002-2357-9858; Aylin, Paul/0000-0003-4589-1743					0	22	23	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 16	2004	329	7471					879	879		10.1136/bmj.329.7471.879	http://dx.doi.org/10.1136/bmj.329.7471.879			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863MU	15485964	Green Published			2022-12-01	WOS:000224566800013
J	Chen, HT; Hahn, S				Chen, HT; Hahn, S			Mapping the location of TFIIB within the RNA polymerase II transcription preinitiation complex: A model for the structure of PIC	CELL			English	Article							N-TERMINAL DOMAIN; TATA-BOX; ZINC RIBBON; PROMOTER DNA; START SITE; INITIATION; BINDING; PROTEIN; IDENTIFICATION; HOLOENZYME	Biochemical probes positioned on the surface of the general transcription factor TFIIB were used to probe the architecture of the RNA polymerase II (Pol II) transcription preinitiation complex (PIC). In PICs, the TFIIB linker and core domains are positioned over the central cleft and wall of Pol II. This positioning is not observed in the smaller Pol II-TFIIB complex. These results lead to a new model for the structure of the PIC, which agrees with most previously documented protein-DNA interactions within Pol II and archaea PICs. Specific interaction of the TFIIB core domain with Pol II positions and orients the promoter DNA over the Pol II central cleft, and TBP-DNA bending leads to bending of the promoter around the surface of Pol II. The TFIIF subunit Tfg1 was found in close proximity to the TFIIB B finger, linker, and core domains, suggesting that these two factors closely cooperate during initiation.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	shahn@fhcrc.org	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382; Hahn, Steven/0000-0001-7240-2533	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053451-07, R01 GM053451-09, R01 GM053451-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bell SD, 1998, COLD SPRING HARB SYM, V63, P41, DOI 10.1101/sqb.1998.63.41; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen HT, 2000, PROTEIN SCI, V9, P1743, DOI 10.1110/ps.9.9.1743; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; CHEN Y, 1994, SCIENCE, V265, P90, DOI 10.1126/science.8016656; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Craighead JL, 2002, STRUCTURE, V10, P1117, DOI 10.1016/S0969-2126(02)00813-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Datwyler SA, 2000, TRENDS BIOCHEM SCI, V25, P408, DOI 10.1016/S0968-0004(00)01652-2; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Douziech M, 2000, MOL CELL BIOL, V20, P8168, DOI 10.1128/MCB.20.21.8168-8177.2000; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2000, GENE DEV, V14, P719; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; MARTINEZ E, 1995, P NATL ACAD SCI USA, V92, P11864, DOI 10.1073/pnas.92.25.11864; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	49	105	110	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					169	180		10.1016/j.cell.2004.09.028	http://dx.doi.org/10.1016/j.cell.2004.09.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479635	Bronze			2022-12-01	WOS:000224577200006
J	Hayashi, T; Carthew, RW				Hayashi, T; Carthew, RW			Surface mechanics mediate pattern formation in the developing retina	NATURE			English	Article							CELL-ADHESION; DROSOPHILA; CADHERIN; EYE; GENE; SPECIFICATION; EXPRESSION; ARMADILLO; TENSIONS; TISSUES	Pattern formation of biological structures involves organizing different types of cells into a spatial configuration. In this study, we investigate the physical basis of biological patterning of the Drosophila retina in vivo. We demonstrate that E- and N-cadherins mediate apical adhesion between retina epithelial cells. Differential expression of N-cadherin within a sub-group of retinal cells (cone cells) causes them to form an overall shape that minimizes their surface contact with surrounding cells. The cells within this group, in both normal and experimentally manipulated conditions, pack together in the same way as soap bubbles do. The shaping of the cone cell group and packing of its components precisely imitate the physical tendency for surfaces to be minimized. Thus, simple patterned expression of N-cadherin results in a complex spatial pattern of cells owing to cellular surface mechanics.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	Northwestern University; University of Tokyo	Hayashi, T (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	t-hayashi@northwestern.edu; r-carthew@northwestern.edu	Hayashi, Takashi/D-5466-2016					BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLOCHLINGER K, 1993, DEVELOPMENT, V117, P441; Bloor JW, 2002, DEVELOPMENT, V129, P3173; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chanut F, 2002, GENETICS, V160, P623; CHICHILNISKY EJ, 1986, J THEOR BIOL, V123, P81, DOI 10.1016/S0022-5193(86)80237-5; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foty RA, 1996, DEVELOPMENT, V122, P1611; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Morgan T.H., 1927, EXPT EMBRYOLOGY; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Pignoni F, 1997, DEVELOPMENT, V124, P271; Plateau J., 1873, STATIQUE EXPT THEORI; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; TAYLOR JE, 1976, ANN MATH, V103, P489, DOI 10.2307/1970949; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thompson DW., 1917, GROWTH FORM, DOI [10.5962/bhl.title.11332, DOI 10.5962/BHL.TITLE.11332]; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; Wolff Tanya, 1993, P1277; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	40	242	247	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					647	652		10.1038/nature02952	http://dx.doi.org/10.1038/nature02952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470418				2022-12-01	WOS:000224299300030
J	Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM				Rao, SV; Jollis, JG; Harrington, RA; Granger, CB; Newby, LK; Armstrong, PW; Moliterno, DJ; Lindblad, L; Pieper, K; Topol, EJ; Stamler, JS; Califf, RM			Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL TRANSFUSION; TRIAL; STRATEGIES; SURVIVAL; IMPACT	Context It is unclear if blood transfusion in anemic patients with acute coronary syndromes is associated with improved survival. Objective To determine the association between blood transfusion and mortality among patients with acute coronary syndromes who develop bleeding, anemia, or both during their hospital course. Design, Setting, and Patients We analyzed 24112 enrollees in 3 large international trials of patients with acute coronary syndromes (the GUSTO IIb, PURSUIT, and PARAGON B trials). Patients were grouped according to whether they received a blood transfusion during the hospitalization. The association between transfusion and outcome was assessed using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate and the propensity to receive blood, and a landmark analysis. Main Outcome Measure Thirty-day mortality. Results Of the patients included, 2401 (10.0%) underwent at least 1 blood transfusion during their hospitalization. Patients who underwent transfusion were older and had more comorbid illness at presentation and also had a significantly higher unadjusted rate of 30-day death (8.00% vs 3.08%; P<.001), myocardial infarction (MI) (25.16% vs 8.16%; P<.001), and death/Ml (29.24% vs 10.02%; P<.001) compared with patients who did not undergo transfusion. Using Cox proportional hazards modeling that incorporated transfusion as a time-dependent covariate, transfusion was associated with an increased hazard for 30-day death (adjusted hazard ratio [HR], 3.94; 95% confidence interval [CI], 3.26-4.75) and 30-day death/Ml (HR, 2.92; 95% Cl, 2.55-3.35). In the landmark analysis that included procedures and bleeding events, transfusion was associated with a trend toward increased mortality. The predicted probability of 30-day death was higher with transfusion at nadir hematocrit values above 25%. Conclusions Blood transfusion in the setting of acute coronary syndromes is associated with higher mortality, and this relationship persists after adjustment for other predictive factors and timing of events. Given the limitations of post hoc analysis of clinical trials data, a randomized trial of transfusion strategies is warranted to resolve the disparity in results between our study and other observational studies. We suggest caution regarding the routine use of blood transfusion to maintain arbitrary hematocrit levels in stable patients with ischemic heart disease.	Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Univ Alberta, Dept Cardiol, Edmonton, AB, Canada; Univ Kentucky, Div Cardiol, Lexington, KY USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; University of Alberta; University of Kentucky; Cleveland Clinic Foundation	Rao, SV (corresponding author), Duke Clin Res Inst, POB 17969,2400 Pratt St, Durham, NC 27715 USA.	sunil.rao@duke.edu	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291; Topol, Eric/0000-0002-1478-4729; Armstrong, Paul/0000-0002-0460-3445; Stamler, Jonathan/0000-0002-6866-1572				ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; ANDERSON JR, 1985, CANCER TREAT REP, V69, P1139; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; Casutt M, 1999, CRIT CARE MED, V27, P2194, DOI 10.1097/00003246-199910000-00021; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; DIETRICH KA, 1990, CRIT CARE MED, V18, P940, DOI 10.1097/00003246-199009000-00007; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; Fransen E, 1999, CHEST, V116, P1233, DOI 10.1378/chest.116.5.1233; GOODNOUGH LT, 1993, AM J MED, V94, P509, DOI 10.1016/0002-9343(93)90086-5; Greenburg AG, 1995, AM J SURG, V170, pS44, DOI 10.1016/S0002-9610(99)80058-0; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 2001, CMAJ S11, V156, pS27; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; PARAGON B, 2002, CIRCULATION, V105, P316; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1996, NEW ENGL J MED, V335, P775; WELCH HG, 1992, ANN INTERN MED, V116, P393, DOI 10.7326/0003-4819-116-5-393; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615	23	787	817	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1555	1562		10.1001/jama.292.13.1555	http://dx.doi.org/10.1001/jama.292.13.1555			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467057	Bronze			2022-12-01	WOS:000224254600022
J	Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N				Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N			Association of hemoglobin A(1c) with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; GLYCATED HEMOGLOBIN; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; FASTING GLYCEMIA; PLASMA-GLUCOSE; LIFE-STYLE; PREVENTION; CLASSIFICATION	Background: increasing evidence suggests a continuous relationship between blood glucose concentrations and cardiovascular risk, even below diagnostic threshold levels for diabetes. Objective: To examine the relationship between hemoglobin A(1c), cardiovascular disease, and total mortality. Design: Prospective population study. Setting: Norfolk, United Kingdom. Participants: 4662 men and 5570 women who were 45 to 79 years of age and were residents of Norfolk. Measurements: Hemoglobin A(1c) and cardiovascular disease risk factors were assessed from 1995 to 1997, and cardiovascular disease events and mortality were assessed during the follow-up period to 2003. Results: In men and women, the relationship between hemoglobin A(1c) and cardiovascular disease (806 events) and between hemoglobin A(1c) and all-cause mortality (521 deaths) was continuous and significant throughout the whole distribution. The relationship was apparent in persons without known diabetes. Persons with hemoglobin A(1c) concentrations less than 5% had the lowest rates of cardiovascular disease and mortality. An increase in hemoglobin A(1c) of 1 percentage point was associated with a relative risk for death from any cause of 1.24 (95% Cl, 1.14 to 1.34; P < 0.001) in men and with a relative risk of 1.28 (Cl, 1.06 to 1.32; P < 0.001) in women. These relative risks were independent of age, body mass index, waist-to-hip ratio, systolic blood pressure, serum cholesterol concentration, cigarette smoking, and history of cardiovascular disease. When persons with known diabetes, hemoglobin Ale concentrations of 7% or greater, or a history of cardiovascular disease were excluded, the result was similar (adjusted relative risk, 1.26 [Cl, 1.04 to 1.52]; P = 0.02). Fifteen percent (68 of 521) of the deaths in the sample occurred in persons with diabetes (4% of the sample), but 72% (375 of 521) occurred in persons with HbA(1c) concentrations between 5% and 6.9%. Limitations: Whether HbA(1c) concentrations and cardiovascular disease are causally related cannot be concluded from an observational study; intervention studies are needed to determine whether decreasing HbA(1c) concentrations would reduce cardiovascular disease. Conclusions: The risk for cardiovascular disease and total mortality associated with hemoglobin A(1c) concentrations increased continuously through the sample distribution. Most of the events in the sample occurred in persons with moderately elevated HbA(1c) concentrations. These findings support the need for randomized trials of interventions to reduce hemoglobin A(1c) concentrations in persons without diabetes.	Univ Cambridge, Epidemiol Unit, MRC, Cambridge CB2 2AH, England; MRC, Dunn Nutr Unit, Cambridge CB4 1XJ, England	University of Cambridge	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Welch, Ailsa Ann/A-4850-2008; Khaw, Kay-Tee/AAZ-3209-2021; Luben, Robert N/H-5519-2015	Welch, Ailsa Ann/0000-0002-6702-3704; Luben, Robert N/0000-0002-5088-6343				Alberti KGMM, 1998, DIABETIC MED, V15, P535, DOI 10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.3.CO;2-H; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Day N, 1999, BRIT J CANCER, V80, P95; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; FULLER JH, 1979, J CHRON DIS, V32, P721, DOI 10.1016/0021-9681(79)90051-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harding AH, 2001, DIABETES CARE, V24, P1911, DOI 10.2337/diacare.24.11.1911; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PYORALA K, 1979, J CHRON DIS, V32, P729, DOI 10.1016/0021-9681(79)90052-3; PYORALA K, 1994, EUR HEART J, V15, P1300; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; SCHEIDTNAVE C, 1991, AM J EPIDEMIOL, V133, P565, DOI 10.1093/oxfordjournals.aje.a115928; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vinicor F, 2003, LANCET, V361, P544, DOI 10.1016/S0140-6736(03)12561-5; Wood D, 1998, HEART, V80, pS1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	32	739	787	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					413	420		10.7326/0003-4819-141-6-200409210-00006	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381514				2022-12-01	WOS:000224067900001
J	Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F				Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F			JunD reduces tumor angiogenesis by protecting cells from oxidative stress	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR; ENDOTHELIAL GROWTH-FACTOR; MITOCHONDRIAL RESPIRATORY-CHAIN; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTIONAL RESPONSE; PARAMAGNETIC-RESONANCE; PROLYL HYDROXYLATION; CYCLE PROGRESSION; MESSENGER-RNA	Reactive oxygen species (ROS) are implicated in the pathophysiology of various diseases, including cancer. In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS. Using junD-deficient cells, we demonstrate that JunD regulates genes involved in antioxidant defense, H2O2 production, and angiogenesis. The accumulation of H2O2 in junD(-/-) cells decreases the availability of Fell and reduces the activity of HIF prolyl hydroxylases (PHDs) that target hypoxia-inducible factors-alpha (HIF(alpha) for degradation. Subsequently, HIF-alpha proteins accumulate and enhance the transcription of VEGF-A, a potent proangiogenic factor. Our study uncovers the mechanism by which JunD protects cells from oxidative stress and exerts an antiangiogenic effect. Furthermore, we provide new insights into the regulation of PHD activity, allowing immediate reactive adaptation to changes in O-2 or iron levels in the cell.	Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, F-75724 Paris 15, France; CNRS, Inst Signaling Dev Biol & Canc Res, UMR 6543, Ctr Antoine Lacassagne, F-06189 Nice, France; Univ Paris 05, Lab Chim Biochim Pharmacol & Toxicol, CNRS, UMR 8601, F-75270 Paris 06, France; Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Stanford University	Mechta-Grigoriou, F (corresponding author), Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, 25 Rue Docteur Roux, F-75724 Paris 15, France.	fmechta@pasteur.fr	MECHTA-GRIGORIOU, Fatima/C-5253-2017; Chan, Doris/O-1227-2014; Berra, Edurne/F-9692-2011	MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; Chan, Doris/0000-0002-4990-986X; Berra, Edurne/0000-0002-3820-5744; Yves-Michel, FRAPART/0000-0003-3854-3580				Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BOS JL, 1989, CANCER RES, V49, P4682; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CAMMACK R, 1993, METHOD ENZYMOL, V227, P353, DOI 10.1016/0076-6879(93)27014-8; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fandrey J, 2000, ADV EXP MED BIOL, V475, P153; Feger F, 2001, CANCER RES, V61, P5289; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Knowles HJ, 2003, CANCER RES, V63, P1764; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Richard DE, 2000, J BIOL CHEM, V275, P26765; ROSCHE B, 1995, BIOCHIM BIOPHYS ACTA, V1252, P117; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TISCHER E, 1991, J BIOL CHEM, V266, P11947; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	58	451	468	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					781	794		10.1016/j.cell.2004.08.025	http://dx.doi.org/10.1016/j.cell.2004.08.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369676	Bronze			2022-12-01	WOS:000223992400013
J	Pelkmans, L; Burli, T; Zerial, M; Helenius, A				Pelkmans, L; Burli, T; Zerial, M; Helenius, A			Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic	CELL			English	Article							CHOLERA-TOXIN; IN-VIVO; GOLGI; INTERNALIZATION; SIMIAN-VIRUS-40; ENDOSOME; PATHWAY; RAB5; INHIBITION; CELLS	Endocytosis comprises several routes of internalization. An outstanding question is whether the caveolar and endosomal pathways intersect. Following transport of the caveolar protein Caveolin-1 and two cargo complexes, Simian Virus 40 and Cholera toxin, in live cells, we uncovered a Rab5-dependent pathway in which caveolar vesicles are targeted to early endosomes and form distinct and stable membrane domains. In endosomes, the low pH selectively allowed the toxin to diffuse out of the caveolar domains into the surrounding membrane, while the virus remained trapped. Thus, we conclude that, unlike cyclic assembly and disassembly of coat proteins in vesicular transport, oligomeric complexes of caveolin-1 confer permanent structural stability to caveolar vesicles that transiently interact with endosomes to form subdomains and release cargo selectively by compartment-specific cues.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	pelkmans@mpi-cbg.de		Pelkmans, Lucas/0000-0002-6754-9730				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Benmerah A, 1999, J CELL SCI, V112, P1303; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; JANICOT M, 1991, J BIOL CHEM, V266, P12858; Kaiser RD, 1998, BBA-BIOMEMBRANES, V1375, P13, DOI 10.1016/S0005-2736(98)00127-8; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McCann JA, 1997, BIOCHEMISTRY-US, V36, P9169, DOI 10.1021/bi962996p; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; UPCROFT P, 1987, J GEN VIROL, V68, P2477, DOI 10.1099/0022-1317-68-9-2477; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	400	413	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					767	780		10.1016/j.cell.2004.09.003	http://dx.doi.org/10.1016/j.cell.2004.09.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369675	Bronze			2022-12-01	WOS:000223992400012
J	Rassenti, LZ; Huynh, L; Toy, TL; Chen, L; Keating, MJ; Gribben, JG; Neuberg, DS; Flinn, IW; Rai, KR; Byrd, JC; Kay, NE; Greaves, A; Weiss, A; Kipps, TJ				Rassenti, LZ; Huynh, L; Toy, TL; Chen, L; Keating, MJ; Gribben, JG; Neuberg, DS; Flinn, IW; Rai, KR; Byrd, JC; Kay, NE; Greaves, A; Weiss, A; Kipps, TJ			ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VARIABLE-REGION MUTATIONS; V-H GENES; CD38 EXPRESSION; B-CELLS; PHENOTYPE	BACKGROUND: The course of chronic lymphocytic leukemia (CLL) is variable. In aggressive disease, the CLL cells usually express an unmutated immunoglobulin heavy-chain variable-region gene (IgV(sub H)) and the 70-kD zeta-associated protein (ZAP-70), whereas in indolent disease, the CLL cells usually express mutated IgV(sub H) but lack expression of ZAP-70. METHODS: We evaluated the CLL B cells from 307 patients with CLL for ZAP-70 and mutations in the rearranged IgV(sub H) gene. We then investigated the association between the results and the time from diagnosis to initial therapy. RESULTS: We found that ZAP-70 was expressed above a defined threshold level in 117 of the 164 patients with an unmutated IgV(sub H) gene (71 percent), but in only 24 of the 143 patients with a mutated IgV(sub H) gene (17 percent, P<0.001). Among the patients with ZAP-70-positive CLL cells, the median time from diagnosis to initial therapy in those who had an unmutated IgV(sub H) gene (2.8 years) was not significantly different from the median time in those who had a mutated IgV(sub H) gene (4.2 years, P=0.07). However, the median time from diagnosis to initial treatment in each of these groups was significantly shorter than the time in patients with ZAP-70-negative CLL cells who had either mutated or unmutated IgV(sub H) genes (P<0.001). The median time from diagnosis to initial therapy among patients who did not have ZAP-70 was 11.0 years in those with a mutated IgV(sub H) gene and 7.1 years in those with an unmutated IgV(sub H) gene (P<0.001). CONCLUSIONS: Although the presence of an unmutated IgV(sub H) gene is strongly associated with the expression of ZAP-70, ZAP-70 is a stronger predictor of the need for treatment in B-cell CLL.	Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Chron Lymphocyt Leukemia Res Consortium, La Jolla, CA USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Johns Hopkins, Kimmel Canc Ctr, Baltimore, MD USA; Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA; Ohio State Univ, Columbus, OH 43210 USA; Mayo Clin, Rochester, MN USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Northwell Health; University System of Ohio; Ohio State University; Mayo Clinic; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kipps, TJ (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tkipps@ucsd.edu	Jones, Jeffrey A/E-9827-2013	Flinn, Ian/0000-0001-6724-290X	NCI NIH HHS [P01-CA81534] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dighiero G, 1998, NEW ENGL J MED, V338, P1506, DOI 10.1056/NEJM199805213382104; Dighiero G, 2000, NEW ENGL J MED, V343, P1799, DOI 10.1056/NEJM200012143432410; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; KIPPS TJ, 2001, WILLIAMS HEMATOLOGY, P1163; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Lin K, 2002, BLOOD, V100, P2291; Maloum K, 2000, BLOOD, V96, P377, DOI 10.1182/blood.V96.1.377.013k56f_377_379; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; RAI KR, 2000, HEMATOLOGY BASIC PRI, P1350; Rassenti LZ, 1997, J EXP MED, V185, P1435, DOI 10.1084/jem.185.8.1435; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306	27	702	759	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2004	351	9					893	901		10.1056/NEJMoa040857	http://dx.doi.org/10.1056/NEJMoa040857			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849BM	15329427				2022-12-01	WOS:000223512500011
J	West, MA; Wallin, RPA; Matthews, SP; Svensson, HG; Zaru, R; Ljunggren, HG; Prescott, AR; Watts, C				West, MA; Wallin, RPA; Matthews, SP; Svensson, HG; Zaru, R; Ljunggren, HG; Prescott, AR; Watts, C			Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling	SCIENCE			English	Article							CLASS-I; MACROPINOCYTOSIS; MATURATION; PODOSOMES; CYTOSKELETON	Microbial products are sensed through Toll-like receptors (TLRs) and trigger a program of dendritic cell (DC) maturation that enables DCs to activate T cells. Although an accepted hallmark of this response is eventual down-regulation of DC endocytic capacity, we show that TLR ligands first acutely stimulate antigen macropinocytosis, leading to enhanced presentation on class I and class 11 major histocompatibility complex molecules. Simultaneously, actin-rich podosomes disappear, which suggests a coordinated redeployment of actin to fuel endocytosis. These reciprocal changes are transient and require p38 and extracellular signal-regulated kinase activation. Thus, the DC actin cytoskeleton can be rapidly mobilized in response to innate immune stimuli to enhance antigen capture and presentation.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Karolinska Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden	University of Dundee; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk	Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Watts, Colin/0000-0001-6183-2087; Matthews, Stephen/0000-0003-3556-962X; Zaru, Rossana/0000-0002-3358-4423	Medical Research Council [G0100536] Funding Source: Medline; MRC [G0100536] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.3.CO;2-0; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.3.CO;2-1; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9	30	395	415	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1153	1157		10.1126/science.1099153	http://dx.doi.org/10.1126/science.1099153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326355				2022-12-01	WOS:000223557400048
J	Butler, D				Butler, D			Power to the people	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					928	929		10.1038/430928a	http://dx.doi.org/10.1038/430928a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318231	Bronze			2022-12-01	WOS:000223369800054
J	Doms, RW				Doms, RW			Viral entry denied	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEIN; FUSION		Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Doms, RW (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.							Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101	3	6	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					743	744		10.1056/NEJMp048058	http://dx.doi.org/10.1056/NEJMp048058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317885				2022-12-01	WOS:000223367900004
J	Vennerstrom, JL; Arbe-Barnes, S; Brun, R; Charman, SA; Chiu, FCK; Chollet, J; Dong, YX; Dorn, A; Hunziker, D; Matile, H; McIntosh, K; Padmanilayam, M; Tomas, JS; Scheurer, C; Scorneaux, B; Tang, YQ; Urwyler, H; Wittlin, S; Charman, WN				Vennerstrom, JL; Arbe-Barnes, S; Brun, R; Charman, SA; Chiu, FCK; Chollet, J; Dong, YX; Dorn, A; Hunziker, D; Matile, H; McIntosh, K; Padmanilayam, M; Tomas, JS; Scheurer, C; Scorneaux, B; Tang, YQ; Urwyler, H; Wittlin, S; Charman, WN			Identification of an antimalarial synthetic trioxolane drug development candidate	NATURE			English	Article							PLASMODIUM-FALCIPARUM; QINGHAOSU ARTEMISININ; OZONIDES; PHARMACOKINETICS; ABSORPTION; RESISTANCE; PEROXIDES; DISCOVERY; INVITRO; DESIGN	The discovery of artemisinin more than 30 years ago provided a completely new antimalarial structural prototype; that is, a molecule with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle(1). Available evidence(2-4) suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by haem, released as a result of haemoglobin digestion by the malaria-causing parasite. This irreversible redox reaction produces carbon-centred free radicals, leading to alkylation of haem(5) and proteins ( enzymes) 6, one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be critical to parasite survival. Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs(8). The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indices and provide for successful treatment outcomes(9). However, as a drug class, the artemisinins suffer from chemical(10) ( semisynthetic availability, purity and cost), biopharmaceutical(11) (poor bioavailability and limiting pharmacokinetics) and treatment(8,11) (non-compliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential. Here we describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.	Univ Nebraska, Med Ctr, Coll Pharm, Omaha, NE 68198 USA; Swiss Trop Inst, Hemel Hempstead HP1 1JY, Herts, England; Monash Univ, Victorian Coll Pharm, Parkville, Vic 3052, Australia; F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland; Basilea Pharmaceut Ltd, CH-4058 Basel, Switzerland	University of Nebraska System; University of Nebraska Medical Center; Monash University; Roche Holding; Basilea Pharmaceutica Ltd.	Vennerstrom, JL (corresponding author), Univ Nebraska, Med Ctr, Coll Pharm, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	jvenners@unmc.edu	Charman, Susan A/E-2221-2011	Charman, Susan A/0000-0003-1753-8213; Charman, William/0000-0002-7051-2023				Abe M, 1999, J AM CHEM SOC, V121, P6556, DOI 10.1021/ja990807v; AVERY MA, 1992, J AM CHEM SOC, V114, P974, DOI 10.1021/ja00029a028; CHAWIRA AN, 1987, J TROP MED HYG, V90, P1; Crespi CL, 1997, ANAL BIOCHEM, V248, P188, DOI 10.1006/abio.1997.2145; CUMMING JN, 1997, ADV PHARMACOL, V37, P254; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Gordi T, 2004, TOXICOL LETT, V147, P99, DOI 10.1016/j.toxlet.2003.12.009; Griesbaum K, 1997, LIEBIGS ANN-RECL, P1381; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; KEUL H, 1975, CHEM BER-RECL, V108, P1207, DOI 10.1002/cber.19751080427; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; LI AG, 1998, J PHARM PHARMACOL, V50, P173; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Palm K, 1997, PHARMACEUT RES, V14, P568, DOI 10.1023/A:1012188625088; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Ridley RG, 1997, ANTIMICROB AGENTS CH, V41, P677, DOI 10.1128/AAC.41.3.677; Robert A, 2002, CHEM COMMUN, P414, DOI 10.1039/b110817b; Smith DA, 1996, MED RES REV, V16, P243; Tang YQ, 2004, MED RES REV, V24, P425, DOI 10.1002/med.10066; van de Waterbeemd H, 2001, J MED CHEM, V44, P1313, DOI 10.1021/jm000407e; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vennerstrom J. L., 2002, Patent No. [US6486- 199B1, 6486199]; VENNERSTROM JL, 2002, Patent No. 0219767; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; Wu YK, 2002, ACCOUNTS CHEM RES, V35, P255, DOI 10.1021/ar000080b	30	537	575	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					900	904		10.1038/nature02779	http://dx.doi.org/10.1038/nature02779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	847DA	15318224				2022-12-01	WOS:000223369800044
J	Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW				Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW			Corals' adaptive response to climate change	NATURE			English	Editorial Material							REEF CORALS; FLEXIBILITY; HYPOTHESIS; MORTALITY; DIVERSITY; PATTERNS; ECOLOGY		Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA; Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Wildlife Conservation Society; Columbia University; Columbia University; University of Miami	Baker, AC (corresponding author), Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA.	abaker@wcs.org	McClanahan, Tim/K-4998-2019	Starger, Craig/0000-0003-2444-6632; Baker, Andrew/0000-0002-7866-2587; McClanahan, Timothy/0000-0001-5821-3584				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Glynn PW, 2001, B MAR SCI, V69, P79; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4; Wilkinson C.R., 2002, STATUS CORAL REEFS W	13	564	591	6	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					741	741		10.1038/430741a	http://dx.doi.org/10.1038/430741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306799	Bronze			2022-12-01	WOS:000223233600030
J	Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE				Sprague, AL; Boynton, WV; Kerry, KE; Janes, DM; Hunten, DM; Kim, KJ; Reedy, RC; Metzger, AE			Mars' south polar Ar enhancement: A tracer for south polar seasonal meridional mixing	SCIENCE			English	Article							GENERAL-CIRCULATION; MARTIAN ATMOSPHERE; SURFACE	The gamma ray spectrometer on the Mars Odyssey spacecraft measured an enhancement of atmospheric argon over southern high latitudes during autumn followed by dissipation during winter and spring. Argon does not freeze at temperatures normal for southern winter (similar to145 kelvin) and is left in the atmosphere, enriched relative to carbon dioxide (CO2), as the southern seasonal cap of CO2 frost accumulates. Calculations of seasonal transport of argon into and out of southern high latitudes point to meridional (north-south) mixing throughout southern winter and spring.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Arizona; University of New Mexico; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sprague, AL (corresponding author), Univ Arizona, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	sprague@lpl.arizona.edu		Reedy, Robert/0000-0002-2189-1303; Kim, Kyeong J/0000-0001-6220-8411				Banfield D, 2003, ICARUS, V161, P319, DOI 10.1016/S0019-1035(02)00044-1; Boynton WV, 2004, SPACE SCI REV, V110, P37, DOI 10.1023/B:SPAC.0000021007.76126.15; Chamberlain J. W., 1987, THEORY PLANETARY ATM; Colaprete A, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002053; Feldman WC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002101; HABERLE RM, COMMUNICATION; HESS SL, 1979, J GEOPHYS RES, V84, P2969, DOI 10.1029/JB084iB06p02969; KELLY N, 2003, 6 INT C MARS, V3244; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1976, SCIENCE, V193, P780, DOI 10.1126/science.193.4255.780; Litvak ML, 2004, SOLAR SYST RES+, V38, P167, DOI 10.1023/B:SOLS.0000030856.83622.17; MCCONNOCHIE TH, 2003, AAS DIVISION PLANETA, P14; MCCONNOCHIE TH, 2003, 6 INT C MARS, V3249; METZGER AE, 1990, J GEOPHYS RES-SOLID, V95, P14695, DOI 10.1029/JB095iB09p14695; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P1447, DOI 10.1029/JB095iB02p01447; Prettyman TH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002139; PRETTYMAN TH, 2004, 35 LUN PLAN SCI C, V1878; SCHOEBERL MR, 1991, SCIENCE, V251, P46, DOI 10.1126/science.251.4989.46; Wilson RJ, 1997, GEOPHYS RES LETT, V24, P123, DOI 10.1029/96GL03814	20	57	57	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1364	1367		10.1126/science.1098496	http://dx.doi.org/10.1126/science.1098496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15472041				2022-12-01	WOS:000225301600049
J	Lohrer, AM; Thrush, SF; Gibbs, MM				Lohrer, AM; Thrush, SF; Gibbs, MM			Bioturbators enhance ecosystem function through complex biogeochemical interactions	NATURE			English	Article							BIODIVERSITY; DISTURBANCE; PRODUCTIVITY; DIVERSITY; BIOMASS; IMPACTS; TERM	Predicting the consequences of species loss is critically important, given present threats to biological diversity such as habitat destruction, overharvesting and climate change(1). Several empirical studies have reported decreased ecosystem performance ( for example, primary productivity) coincident with decreased biodiversity(2-4), although the relative influence of biotic effects and confounding abiotic factors has been vigorously debated(5-7). Whereas several investigations focused on single trophic levels ( for example, grassland plants)(8,9), studies of whole systems have revealed multiple layers of feedbacks, hidden drivers and emergent properties(10,11), making the consequences of species loss more difficult to predict(12). Here we report functionally important organisms and considerable biocomplexity in a sedimentary seafloor habitat, one of Earth's most widespread ecosystems. Experimental field measurements demonstrate how the abundance of spatangoid urchins - infaunal ( in seafloor sediment) grazers / deposit feeders - is positively related to primary production, as their activities change nutrient fluxes and improve conditions for production by microphytobenthos (sedimentatry microbes and unicellular algae). Declines of spatangoid urchins after trawling are well documented(13,14), and our research linking these bioturbators to important benthic - pelagic fluxes highlights potential ramifications for productivity in coastal oceans.	Natl Inst Water & Atmospher Res, Hamilton, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Lohrer, AM (corresponding author), Natl Inst Water & Atmospher Res, POB 11-115, Hamilton, New Zealand.	d.lohrer@niwa.co.nz	Ross, Donald J/F-7607-2012	Ross, Donald J/0000-0002-8659-3833; Thrush, Simon/0000-0002-4005-3882				Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; CLARK KR, 2001, PRIMER VERSION 5; Daan R, 1996, ICES J MAR SCI, V53, P1036, DOI 10.1006/jmsc.1996.0129; FALKOWSKI P, 1985, J PLANKTON RES, V7, P715, DOI 10.1093/plankt/7.5.715; Ghiold J., 1989, BIOL OCEANOGRAPHY, V6, P79, DOI DOI 10.1080/01965581.1988.10749524; Grasshoff K., 1999, METHODS SEAWATER ANA, DOI DOI 10.1002/ANGE.19770890738; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Hector A, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P36; Hector A, 2002, SCIENCE, V295, P639, DOI 10.1126/science.1064815; Herman PMJ, 1999, ADV ECOL RES, V29, P195; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Jennings S, 2001, MAR ECOL PROG SER, V213, P127, DOI 10.3354/meps213127; LOHRER AM, UNPUB J EXP MAR BIOL; Long BG, 1995, MAR ECOL PROG SER, V129, P127, DOI 10.3354/meps129127; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Raffaelli D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P147; Sartory D.P., 1982, SPECTROPHOTOMETRIC A; Snelgrove P, 1997, AMBIO, V26, P578; Thompson Bruce, 1993, Bulletin Southern California Academy of Sciences, V92, P25; THRUSH S, UNPUB ECOLOGY; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.1890/1051-0761(1998)008[0866:DOTMBH]2.0.CO;2; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valiela I., 1995, MARINE ECOLOGICAL PR, V3	30	409	429	11	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1092	1095		10.1038/nature03042	http://dx.doi.org/10.1038/nature03042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15470385				2022-12-01	WOS:000224730800039
J	Tso, A; Harris, L; Littlewood, T				Tso, A; Harris, L; Littlewood, T			Acceptability to a general haematology clinic of written responses to referrals: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England	University of Oxford	Littlewood, T (corresponding author), John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England.	tim.littlewood@orh.nhs.uk						Wright D, 1992, Health Trends, V24, P145	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					946	947		10.1136/bmj.38253.703553.F7	http://dx.doi.org/10.1136/bmj.38253.703553.F7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15465846	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000224773200016
J	Berggren, PO; Yang, SN; Murakami, M; Efanov, AM; Uhles, S; Kohler, M; Moede, T; Fernstrom, A; Appelskog, LB; Aspinwall, CA; Zaitsev, SV; Larsson, O; de Vargas, LM; Fecher-Trost, C; Weissgerber, P; Ludwig, A; Leibiger, B; Juntti-Berggren, L; Barker, CJ; Gromada, J; Freichel, M; Leibiger, IB; Flockerzi, V				Berggren, PO; Yang, SN; Murakami, M; Efanov, AM; Uhles, S; Kohler, M; Moede, T; Fernstrom, A; Appelskog, LB; Aspinwall, CA; Zaitsev, SV; Larsson, O; de Vargas, LM; Fecher-Trost, C; Weissgerber, P; Ludwig, A; Leibiger, B; Juntti-Berggren, L; Barker, CJ; Gromada, J; Freichel, M; Leibiger, IB; Flockerzi, V			Removal of Ca2+ channel beta(3) Subunit enhances Ca2+ oscillation frequency and insulin exocytosis	CELL			English	Article							PANCREATIC BETA-CELLS; GATED CALCIUM-CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; FUNCTIONAL EXPRESSION; SUBUNIT; COMPLEX; GLUCOSE; TRANSCRIPTION; MODULATION; ACTIVATION	An oscillatory increase in pancreatic beta cell cytoplasmic free Ca2+ concentration, [Ca2+](i), is a key feature in glucose-induced insulin release. The role of the voltage-gated Ca2+ channel beta(3) subunit in the molecular regulation of these [Ca2+](i) oscillations has now been clarified by using beta(3) subunit-deficient beta cells. beta(3) knockout mice showed a more efficient glucose homeostasis compared to wild-type mice due to increased glucose-stimulated insulin secretion. This resulted from an increased glucose-induced [Ca2+](i) oscillation frequency in beta cells lacking the beta(3) subunit, an effect accounted for by enhanced formation of inositol 1,4,5-trisphosphate (InsP(3)) and increased Ca2+ mobilization from intracellular stores. Hence, the beta(3) subunit negatively modulated InsP(3)-induced Ca2+ release, which is not paralleled by any effect on the voltage-gated L type Ca2+ channel. Since the increase in insulin release was manifested only at high glucose concentrations, blocking the beta(3) subunit in the beta cell may constitute the basis for a novel diabetes therapy.	Karolinska Univ Hosp SOlna, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-17176 Stockholm, Sweden; Univ Saarland, D-66421 Homburg, Germany; Lilly Res Labs, D-22419 Hamburg, Germany; Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia; Boston Univ, Sch Med, Evans BIomed Res Ctr, Boston, MA 02118 USA; Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Karolinska Institutet; Karolinska University Hospital; Saarland University; Eli Lilly; Lilly Deutschland GmbH; Lomonosov Moscow State University; Boston University; Technical University of Munich	Berggren, PO (corresponding author), Karolinska Univ Hosp SOlna, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-17176 Stockholm, Sweden.	per-olof.berggren@molmed.ki.se	Tuluc, Petronel/C-2527-2011; Efanov, Alexander/R-3630-2019	Efanov, Alexander/0000-0002-8630-1503; Kohler, Martin/0000-0001-6487-4303; Uhles, Sabine/0000-0002-2836-8726; Moede, Tilo/0000-0002-2045-9244; Berggren, Per-Olof/0000-0001-8991-413X; Aspinwall, Craig/0000-0002-4359-5812	NIDDK NIH HHS [DK58508] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058508] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BARKER CJ, 1995, BIOCHEM J, V306, P557, DOI 10.1042/bj3060557; BARKER CJ, 1994, BIOCHEM J, V297, P265, DOI 10.1042/bj2970265; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; IHARA Y, 1995, MOL ENDOCRINOL, V9, P121, DOI 10.1210/me.9.1.121; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; ROE MW, 1993, J BIOL CHEM, V268, P9953; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; STADDON JM, 1991, J BIOL CHEM, V266, P4840; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; Yu J, 2003, J BIOL CHEM, V278, P46210, DOI 10.1074/jbc.M303743200; Zaitsev SV, 2001, DIABETES, V50, pS70, DOI 10.2337/diabetes.50.2007.S70	34	89	97	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 15	2004	119	2					273	284		10.1016/j.cell.2004.09.033	http://dx.doi.org/10.1016/j.cell.2004.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479643	Bronze			2022-12-01	WOS:000224577200014
J	Ozcan, U; Cao, Q; Yilmaz, E; Lee, AH; Iwakoshi, NN; Ozdelen, E; Tuncman, G; Gorgun, C; Glimcher, LH; Hotamisligil, GS				Ozcan, U; Cao, Q; Yilmaz, E; Lee, AH; Iwakoshi, NN; Ozdelen, E; Tuncman, G; Gorgun, C; Glimcher, LH; Hotamisligil, GS			Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTOR; MESSENGER-RNA; ER STRESS; KINASE; RESISTANCE; XBP-1; IRE1; JNK	Obesity contributes to the development of type 2 diabetes, but the underlying mechanisms are poorly understood. Using cell culture and mouse models, we show that obesity causes endoplasmic reticulum (ER) stress. This stress in turn leads to suppression of insulin receptor signaling through hyperactivation of c-Jun N-terminal kinase (JNK) and subsequent serine phosphorylation of insulin receptor substrate-1 (IRS-1). Mice deficient in X-box-binding protein-1 (XBP-1), a transcription factor that modulates the ER stress response, develop insulin resistance. These findings demonstrate that ER stress is a central feature of peripheral insulin resistance and type 2 diabetes at the molecular, cellular, and organismal levels. Pharmacologic manipulation of this pathway may offer novel opportunities for treating these common diseases.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	YILMAZ, ERKAN/O-1592-2014; Longo, Kenneth A/A-5631-2010	YILMAZ, ERKAN/0000-0001-7355-3878; 	NCI NIH HHS [P05-CA100707] Funding Source: Medline; NIAID NIH HHS [AI32412] Funding Source: Medline; NIDDK NIH HHS [T32-DK07703, DK52539] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, T32DK007703] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligin G. S., 2003, DIABETES MELLITUS, P953; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; KHARROUBI I, 2004, ENDOCRINOLOGY   0805, DOI DOI 10.1210/EN.2004-0478; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; OZCAN U, UNPUB; Reimold AM, 2000, GENE DEV, V14, P152; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	26	2802	2964	11	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					457	461		10.1126/science.1103160	http://dx.doi.org/10.1126/science.1103160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486293				2022-12-01	WOS:000224626500044
J	Metcalf, B; Voss, L; Jeffery, A; Perkins, J; Wilkin, T				Metcalf, B; Voss, L; Jeffery, A; Perkins, J; Wilkin, T			Physical activity cost of the school run: impact on schoolchildren of being driven to school (EarlyBird 22)	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Med, Peninsula Med Sch, Derriford Hosp, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Wilkin, T (corresponding author), Univ Med, Peninsula Med Sch, Derriford Hosp, Plymouth PL6 8DH, Devon, England.	T.Wilkin@pms.ac.uk		Jeffery, Alison/0000-0001-7539-5957				Cooper AR, 2003, AM J PREV MED, V25, P273, DOI 10.1016/S0749-3797(03)00205-8; *DEP ENV TRANSP RE, 2000, 199799 DEP ENV TRANS; Department for Education and Skills, 2003, TRAV SCH GOOD PRACT; Metcalf BS, 2002, MED SCI SPORT EXER, V34, P1533, DOI 10.1097/00005768-200209000-00022; Voss LD, 2003, J PEDIATR ENDOCR MET, V16, P1211	5	87	88	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					832	833		10.1136/bmj.38169.688102.F71	http://dx.doi.org/10.1136/bmj.38169.688102.F71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15317729	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000224472800019
J	Potter, BK				Potter, BK			The prince and the professor - With respect, professor, the Prince of Wales is not so wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Asda Hulme, Manchester M15, England; Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Potter, BK (corresponding author), Asda Hulme, Manchester M15, England.	ldyxrkp@nottingham.ac.uk						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					858	859		10.1136/bmj.329.7470.858-b	http://dx.doi.org/10.1136/bmj.329.7470.858-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472281	Green Published			2022-12-01	WOS:000224472800041
J	Qi, Y; Gregory, MA; Li, ZL; Brousal, JP; West, K; Hann, SR				Qi, Y; Gregory, MA; Li, ZL; Brousal, JP; West, K; Hann, SR			p19(ARF) directly and differentially controls the functions of c-Myc independently of p53	NATURE			English	Article							CELL-CYCLE PROGRESSION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; P53-INDEPENDENT APOPTOSIS; FIBROBLASTS; INDUCTION; PROTEOLYSIS; EXPRESSION; INK4A/ARF; TARGET	Increased expression of the oncogenic transcription factor c-Myc causes unregulated cell cycle progression(1). c-Myc can also cause apoptosis, but it is not known whether the activation and/or repression of c-Myc target genes mediates these diverse functions of c-Myc. Because unchecked cell cycle progression leads to hyperproliferation and tumorigenesis, it is essential for tumour suppressors, such as p53 and p19(ARF) (ARF), to curb cell cycle progression in response to increased c-Myc (refs 2, 3). Increased c-Myc has previously been shown to induce ARF expression, which leads to cell cycle arrest or apoptosis through the activation of p53 (ref. 4). Here we show that ARF can inhibit c-Myc by a unique and direct mechanism that is independent of p53. When c-Myc increases, ARF binds with c-Myc and dramatically blocks c-Myc's ability to activate transcription and induce hyperproliferation and transformation. In contrast, c-Myc's ability to repress transcription is unaffected by ARF and c-Myc-mediated apoptosis is enhanced. These differential effects of ARF on c-Myc function suggest that separate molecular mechanisms mediate c-Myc-induced hyperproliferation and apoptosis. This direct feedback mechanism represents a p53-independent checkpoint to prevent c-Myc-mediated tumorigenesis.	Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Hann, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	steve.hann@vanderbilt.edu						Amanullah A, 2000, ONCOGENE, V19, P2967, DOI 10.1038/sj.onc.1203638; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fukatsu K, 1997, SEN-I GAKKAISHI, V53, P15, DOI 10.2115/fiber.53.15; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Haviernik P, 2003, ONCOGENE, V22, P1600, DOI 10.1038/sj.onc.1206268; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Lenahan MK, 1996, ONCOGENE, V12, P1847; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Sakamuro D, 1995, ONCOGENE, V11, P2411; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Soucek L, 2002, CANCER RES, V62, P3507; Trudel M, 1997, J EXP MED, V186, P1873, DOI 10.1084/jem.186.11.1873; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	30	178	190	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					712	717		10.1038/nature02958	http://dx.doi.org/10.1038/nature02958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15361884				2022-12-01	WOS:000224299300046
J	Remondes, M; Schuman, EM				Remondes, M; Schuman, EM			Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory	NATURE			English	Article							SLOW-WAVE SLEEP; PLACE; PLASTICITY; LESIONS; AMNESIA; CELLS	A dialogue between the hippocampus and the neocortex is thought to underlie the formation, consolidation and retrieval of episodic memories(1-4), although the nature of this corticohippocampal communication is poorly understood. Using selective electrolytic lesions in rats, here we examined the role of the direct entorhinal projection (temporoammonic, TA) to the hippocampal area CA1 in short-term (24 hours) and long-term (four weeks) spatial memory in the Morris water maze. When short-term memory was examined, both sham- and TA-lesioned animals showed a significant preference for the target quadrant. When re-tested four weeks later, sham- lesioned animals exhibited long-term memory; in contrast, the TA-lesioned animals no longer showed target quadrant preference. Many long-lasting memories require a process called consolidation, which involves the exchange of information between the cortex and hippocampus(3,5,6). The disruption of long-term memory by the TA lesion could reflect a requirement for TA input during either the acquisition or consolidation of long-term memory. To distinguish between these possibilities, we trained animals, verified their spatial memory 24 hours later, and then subjected trained animals to TA lesions. TA-lesioned animals still exhibited a deficit in long-term memory, indicating a disruption of consolidation. Animals in which the TA lesion was delayed by three weeks, however, showed a significant preference for the target quadrant, indicating that the memory had already been adequately consolidated at the time of the delayed lesion. These results indicate that, after learning, ongoing cortical input conveyed by the TA path is required to consolidate long-term spatial memory.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 114-96, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	Remondes, Miguel/0000-0001-9321-3985				Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; El-Ghundi M, 1999, EUR J PHARMACOL, V383, P95, DOI 10.1016/S0014-2999(99)00573-7; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; JARRARD LE, 1983, BEHAV NEUROSCI, V97, P873, DOI 10.1037/0735-7044.97.6.873; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SKELTON RW, 1992, HIPPOCAMPUS, V2, P73, DOI 10.1002/hipo.450020110; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	27	281	290	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					699	703		10.1038/nature02965	http://dx.doi.org/10.1038/nature02965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470431				2022-12-01	WOS:000224299300043
J	Bateman, JM; McNeill, H				Bateman, JM; McNeill, H			Temporal control of differentiation by the insulin receptor/Tor pathway in Drosophila	CELL			English	Article							CONTROLS PLANAR POLARITY; TOP MESSENGER-RNAS; CELL-GROWTH; TUMOR-SUPPRESSOR; EYE DEVELOPMENT; DIRECT TARGET; TRANSCRIPTION FACTORS; RHEB; KINASE; TSC1	Multicellular organisms must integrate growth and differentiation precisely to pattern complex tissues. Despite great progress in understanding how different cell fates are induced, it is poorly understood how differentiation decisions are temporally regulated. In a screen for patterning mutants, we isolated alleles of tsc1, a component of the insulin receptor (InR) growth control pathway. We find that loss of tsc1 disrupts patterning due to a loss of temporal control of differentiation. tsc1 controls the timing of differentiation downstream or in parallel to the RAS/MAPK pathway. Examination of InR, PI3K, PTEN, Tor, Rheb, and S6 kinase mutants demonstrates that increased InR signaling leads to precocious differentiation while decreased signaling leads to delays in differentiation. Importantly, cell fates are unchanged, but tissue organization is lost upon loss of developmental timing controls. These data suggest that intricate developmental decisions are coordinated with nutritional status and tissue growth by the InR signaling pathway.	Canc Res UK, London WC2A 3PX, England	Cancer Research UK	McNeill, H (corresponding author), Canc Res UK, 44 Lincolns Inn Fields, London WC2A 3PX, England.	helen.mcneill@cancer.org.uk	Bateman, Joseph M/F-3625-2011; McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154; Bateman, Joseph/0000-0003-0754-1785				Behan KJ, 2002, DEV GENES EVOL, V212, P267, DOI 10.1007/s00427-002-0241-4; BOHMANN D, 1994, CELL, V78, P973, DOI 10.1016/0092-8674(94)90273-9; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JAN YN, 1985, J NEUROSCI, V5, P2453; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers Sally J., 2004, VVolume 42, P167; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; McConnell S K, 1992, Curr Opin Neurobiol, V2, P23, DOI 10.1016/0959-4388(92)90156-F; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Sparagana Steven P., 2000, Current Opinion in Neurology, V13, P115, DOI 10.1097/00019052-200004000-00001; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4; Wolff Tanya, 1993, P1277; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	54	86	90	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					87	96		10.1016/j.cell.2004.08.028	http://dx.doi.org/10.1016/j.cell.2004.08.028			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454083	Bronze			2022-12-01	WOS:000224292600011
J	Collins, S; Bell, G				Collins, S; Bell, G			Phenotypic consequences of 1,000 generations of selection at elevated CO2 in a green alga	NATURE			English	Article							CHLAMYDOMONAS-REINHARDTII; ESCHERICHIA-COLI; DIVERSITY; RESPONSES; ENVIRONMENTS; MECHANISMS; RADIATION	Estimates of the effect of increasing atmospheric CO2 concentrations on future global plant production rely on the physiological response of individual plants or plant communities when exposed to high CO2 (refs 1 - 6). Plant populations may adapt to the changing atmosphere, however, such that the evolved plant communities of the next century are likely to be genetically different from contemporary communities(7-12). The properties of these future communities are unknown, introducing a bias of unknown sign and magnitude into projections of global carbon pool dynamics. Here we report a long-term selection experiment to investigate the phenotypic consequences of selection for growth at elevated CO2 concentrations. After about 1,000 generations, selection lines of the unicellular green alga Chlamydomonas failed to evolve specific adaptation to a CO2 concentration of 1,050 parts per million. Some lines, however, evolved a syndrome involving high rates of photosynthesis and respiration, combined with higher chlorophyll content and reduced cell size. These lines also grew poorly at ambient concentrations of CO2. We tentatively attribute this outcome to the accumulation of conditionally neutral mutations in genes affecting the carbon concentration mechanism.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	graham.bell@mcgill.ca	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				Andalo C, 2001, ECOLOGY, V82, P157, DOI 10.1890/0012-9658(2001)082[0157:IAICUE]2.0.CO;2; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BAZZAZ FA, 1995, P NATL ACAD SCI USA, V92, P8161, DOI 10.1073/pnas.92.18.8161; Colman B, 2002, FUNCT PLANT BIOL, V29, P261, DOI 10.1071/PP01184; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Potvin C, 1996, OECOLOGIA, V108, P683, DOI 10.1007/BF00329043; Raven JA, 2001, J PHYCOL, V37, P943, DOI 10.1046/j.1529-8817.2001.01079.x; RUBAN O, 2003, PHOTOSYNTHETICA, V41, P9; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Spalding MH, 2002, FUNCT PLANT BIOL, V29, P221, DOI 10.1071/PP01182; Sultemeyer D, 1998, CAN J BOT, V76, P962; SUZUKI K, 1989, PLANT PHYSIOL, V90, P1195, DOI 10.1104/pp.90.3.1195; Thyssen C, 2003, PLANTA, V217, P102, DOI 10.1007/s00425-002-0961-8; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Travisano M, 1996, GENETICS, V143, P15; Turner PE, 2000, GENETICS, V156, P1465; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005; Yedid G, 2002, NATURE, V420, P810, DOI 10.1038/nature01151	29	246	255	5	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					566	569		10.1038/nature02945	http://dx.doi.org/10.1038/nature02945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457260				2022-12-01	WOS:000224156700046
J	Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR			Pack-MULE transposable elements mediate gene evolution in plants	NATURE			English	Article							DRAFT SEQUENCE; RICE; GENOME; IDENTIFICATION; DIVERSITY	Mutator-like transposable elements (MULEs) are found in many eukaryotic genomes and are especially prevalent in higher plants(1-3). In maize, rice and Arabidopsis a few MULEs were shown to carry fragments of cellular genes(4-6). These chimaeric elements are called Pack-MULEs in this study. The abundance of MULEs in rice and the availability of most of the genome sequence permitted a systematic analysis of the prevalence and nature of Pack-MULEs in an entire genome. Here we report that there are over 3,000 Pack-MULEs in rice containing fragments derived from more than 1,000 cellular genes. Pack-MULEs frequently contain fragments from multiple chromosomal loci that are fused to form new open reading frames, some of which are expressed as chimaeric transcripts. About 5% of the Pack-MULEs are represented in collections of complementary DNA. Functional analysis of amino acid sequences and proteomic data indicate that some captured gene fragments might be functional. Comparison of the cellular genes and Pack-MULE counterparts indicates that fragments of genomic DNA have been captured, rearranged and amplified over millions of years. Given the abundance of Pack-MULEs in rice and the widespread occurrence of MULEs in all characterized plant genomes, gene fragment acquisition by Pack-MULEs might represent an important new mechanism for the evolution of genes in higher plants.	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Howard Hughes Med Inst, St Louis, MO 63108 USA; Washington Univ, Dept Genet, St Louis, MO 63108 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	suew@plantbio.uga.edu	Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; BENNETZEN JL, 1994, THEOR APPL GENET, V87, P657, DOI 10.1007/BF00222890; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; CRESSE AD, 1995, GENETICS, V140, P315; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hanley S, 2000, PLANT J, V23, P557, DOI 10.1046/j.1365-313x.2000.00830.x; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koller A, 2002, P NATL ACAD SCI USA, V99, P11969, DOI 10.1073/pnas.172183199; Kumar S., 2001, MEGA2 MOL EVOLUTIONA; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; LEVY AA, 1991, MOL GEN GENET, V229, P147, DOI 10.1007/BF00264223; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Normile D, 2002, SCIENCE, V296, P32, DOI 10.1126/science.296.5565.32; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; TALBERT LE, 1988, MOL BIOL EVOL, V5, P519; TAYLOR LP, 1985, EMBO J, V4, P869, DOI 10.1002/j.1460-2075.1985.tb03712.x; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; Walbot Virginia, 2002, P533; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Yu ZH, 2000, GENETICS, V156, P2019	24	378	409	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					569	573		10.1038/nature02953	http://dx.doi.org/10.1038/nature02953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457261				2022-12-01	WOS:000224156700047
J	Rohde, DLT; Olson, S; Chang, JT				Rohde, DLT; Olson, S; Chang, JT			Modelling the recent common ancestry of all living humans	NATURE			English	Article							POPULATION; GENEALOGY	If a common ancestor of all living humans is defined as an individual who is a genealogical ancestor of all present-day people, the most recent common ancestor (MRCA) for a randomly mating population would have lived in the very recent past(1-3). However, the random mating model ignores essential aspects of population substructure, such as the tendency of individuals to choose mates from the same social group, and the relative isolation of geographically separated groups. Here we show that recent common ancestors also emerge from two models incorporating substantial population substructure. One model, designed for simplicity and theoretical insight, yields explicit mathematical results through a probabilistic analysis. A more elaborate second model, designed to capture historical population dynamics in a more realistic way, is analysed computationally through Monte Carlo simulations. These analyses suggest that the genealogies of all living humans overlap in remarkable ways in the recent past. In particular, the MRCA of all present-day humans lived just a few thousand years ago in these models. Moreover, among all individuals living more than just a few thousand years earlier than the MRCA, each present-day human has exactly the same set of genealogical ancestors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Dept Stat, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Yale University	Rohde, DLT (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dr@tedlab.mit.edu						Bonne-Tamir B, 2003, ANN HUM GENET, V67, P153, DOI 10.1046/j.1469-1809.2003.00024.x; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; Derrida B, 2000, PHYSICA A, V281, P1, DOI 10.1016/S0378-4371(00)00031-5; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Fitzhugh W., 1988, CROSSROADS CONTINENT; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hoerder Dirk, 2002, CULTURES CONTACT WOR; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; MORTON NE, 1971, AM J HUM GENET, V23, P339; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Ohno S, 1996, P NATL ACAD SCI USA, V93, P15276, DOI 10.1073/pnas.93.26.15276; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Stannard D.E., 1992, AM HOLOCAUST COLUMBU; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; *US NAT OFF VIT ST, 1956, VIT STAT SPEC REP, V43; Wachter K. W., 1980, GENEALOGICAL DEMOGRA, P85; WARD RH, 1970, AM J HUM GENET, V22, P538; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106; Wilkinson-Herbots HM, 1998, J MATH BIOL, V37, P535, DOI 10.1007/s002850050140; Wiuf C, 1997, GENETICS, V147, P1459; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	24	74	76	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					562	566		10.1038/nature02842	http://dx.doi.org/10.1038/nature02842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457259	Green Submitted			2022-12-01	WOS:000224156700045
J	Schroeder, SA				Schroeder, SA			The tobacco buyout and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1377	1380		10.1056/NEJMp048218	http://dx.doi.org/10.1056/NEJMp048218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459295				2022-12-01	WOS:000224153900002
J	Ghosh, AK; Ghosh, K				Ghosh, AK; Ghosh, K			Misinterpretation of numbers: a potential source of physician's error	LANCET			English	Editorial Material							MEDICINE; TREAT		Mayo Clin Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Ghosh, AK (corresponding author), Mayo Clin Coll Med, Div Gen Internal Med, W 17-B, Rochester, MN 55905 USA.	ghosh.amit@mayo.edu						Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Ghosh AK, 2004, J GEN INTERN MED, V19, P184; Ghosh AK, 2004, J LAB CLIN MED, V144, P60, DOI 10.1016/j.lab.2004.05.013; Ghosh AK, 2004, QJM-INT J MED, V97, P53, DOI 10.1093/qjmed/hch010; GHOSH AK, 2002, J INVEST MED, V50, P243; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Kohn L, 2000, ERR IS HUMAN BUILDIN; Kristiansen IS, 2002, J CLIN EPIDEMIOL, V55, P888, DOI 10.1016/S0895-4356(02)00432-8; Noguchi Y, 2002, J GEN INTERN MED, V17, P848, DOI 10.1046/j.1525-1497.2002.20139.x; Wheeler DW, 2004, J ROY SOC MED, V97, P380, DOI 10.1258/jrsm.97.8.380	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1108	1110		10.1016/S0140-6736(04)17119-5	http://dx.doi.org/10.1016/S0140-6736(04)17119-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451207				2022-12-01	WOS:000224102400008
J	He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM				He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM			Nitric oxide represses the Arabidopsis floral transition	SCIENCE			English	Article							FLOWERING-TIME; CIRCADIAN CLOCK; GENE-EXPRESSION; PLANTS; PROTEIN; REGULATOR; ENCODES	The correct timing of flowering is essential for plants to maximize reproductive success and is controlled by environmental and endogenous signals. We report that nitric oxide (NO) repressed the floral transition in Arabidopsis thaliana. Plants treated with NO, as well as a mutant overproducing NO (nox1), flowered late, whereas a mutant producing less NO (nos1) flowered early. NO suppressed CONSTANS and GIGANTEA gene expression and enhanced FLOWERING LOCUS C expression, which indicated that NO regulates the photoperiod and autonomous pathways. Because NO is induced by environmental stimuli and constitutively produced, it may integrate both external and internal cues into the floral decision.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Capital Normal Univ, Dept Biol, Beijing 100037, Peoples R China; Duke Univ, Med Ctr, Mass Spectrometry Lab, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Orthopaed Res Lab, Durham, NC 27710 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Duke University; Capital Normal University; Duke University; Duke University; University of California System; University of California San Diego	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Fiorani, Fabio/F-4171-2011	Fiorani, Fabio/0000-0001-8775-1541; Jackson, Robert/0000-0001-8846-7147; Pei, Zhen-Ming/0000-0003-1473-696X; Guo, Fang-Qing/0000-0001-6889-394X; Tang, Ruhang/0000-0003-4918-3525				Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HE Y, UNPUB; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Leshem YY, 1996, J PLANT PHYSIOL, V148, P258, DOI 10.1016/S0176-1617(96)80251-3; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Morot-Gaudry-Talarmain Y, 2002, PLANTA, V215, P708, DOI 10.1007/s00425-002-0816-3; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Streatfield SJ, 1999, PLANT CELL, V11, P1609, DOI 10.1105/tpc.11.9.1609; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	416	470	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1968	1971		10.1126/science.1098837	http://dx.doi.org/10.1126/science.1098837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448272				2022-12-01	WOS:000224136000051
J	delBarco-Trillo, J; Ferkin, MH				delBarco-Trillo, J; Ferkin, MH			Male mammals respond to a risk of sperm competition conveyed by odours of conspecific males	NATURE			English	Article							COPULATORY-BEHAVIOR; MEADOW VOLES; EJACULATE; SCENT; GAMES	Sperm competition occurs when a female copulates with two or more males and the sperm of those males compete within the female's reproductive tract to fertilize her eggs(1,2). The frequent occurrence of sperm competition has forced males of many species to develop different strategies to overcome the sperm of competing males(1,3). A prevalent strategy is for males to increase their sperm investment ( total number of sperm allocated by a male to a particular female) after detecting a risk of sperm competition(1,3,4). It has been shown that the proportion of sperm that one male contributes to the sperm pool of a female is correlated with the proportion of offspring sired by that male(5,6). Therefore, by increasing his sperm investment a male may bias a potential spermcompetition in his favour(5,7,8). Here we show that male meadow voles, Microtus pennsylvanicus, increase their sperm investment when they mate in the presence of another male's odours. Such an increase in sperm investment does not occur by augmenting the frequency of ejaculations, but by increasing the amount of sperm in a similar number of ejaculations.	Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Memphis	delBarco-Trillo, J (corresponding author), Univ Memphis, Dept Biol, Ellington Hall, Memphis, TN 38152 USA.	jtrillo@memphis.edu	Ferkin, Michael H/A-3968-2009; delBarco-Trillo, Javier/F-6728-2010	delBarco-Trillo, Javier/0000-0002-9948-6674				[Anonymous], 1998, SPERM COMPETITION SE; [Anonymous], [No title captured]; BAKER RR, 1995, HUMAN SPERM COMPETIT, P203; BELLIS MA, 1990, J MAMMAL, V71, P479, DOI 10.2307/1381968; Birkhead TR., 1992, SPERM COMPETITION BI; BOONSTRA R, 1993, BEHAV ECOL, V4, P83, DOI 10.1093/beheco/4.1.83; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1; Dewsbury D.A., 1984, P547; DEWSBURY DA, 1975, SCIENCE, V190, P947, DOI 10.1126/science.1188377; DEWSBURY DA, 1981, BEHAV ECOL SOCIOBIOL, V9, P121, DOI 10.1007/BF00293583; DEWSBURY DA, 1972, Q REV BIOL, V47, P1, DOI 10.1086/407097; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Ferkin MH, 2004, ETHOLOGY, V110, P257, DOI 10.1111/j.1439-0310.2004.00961.x; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; GRAY GD, 1975, ANIM BEHAV, V23, P261, DOI 10.1016/0003-3472(75)90074-3; Johnston R.E., 1983, P3; Lezama V, 2001, APPL ANIM BEHAV SCI, V75, P55, DOI 10.1016/S0168-1591(01)00187-3; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pound N, 1999, P ROY SOC B-BIOL SCI, V266, P1755, DOI 10.1098/rspb.1999.0842; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; SCHWAGMEYER PL, 1990, ANIM BEHAV, V39, P156, DOI 10.1016/S0003-3472(05)80735-3; Simmons L.W., 2001, MG BEH ECOL; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	30	135	139	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					446	449		10.1038/nature02845	http://dx.doi.org/10.1038/nature02845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386011				2022-12-01	WOS:000224000500039
J	Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW				Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW			C-elegans LIN-18 is a Ryk ortholog in parallel to LIN-17/frizzled in Wnt and functions signaling	CELL			English	Article							ASYMMETRIC CELL DIVISIONS; CAENORHABDITIS-ELEGANS; VULVAR DEVELOPMENT; GENE-EXPRESSION; RECEPTOR; PROTEIN; ENCODES; MUTATIONS; LINEAGES; HOMOLOG	Wnt proteins are intercellular signals that regulate various aspects of animal development. In Caenorhabditis elegans, mutations in lin-17, a Frizzled-class Wnt receptor, and in lin-18 affect cell fate patterning in the P7.p vulval lineage. We found that lin-18 encodes a member of the Ryk/Derailed family of tyrosine kinase-related receptors, recently found to function as Wnt receptors. Members of this family have nonactive kinase domains. The LIN-18 kinase domain is dispensable for LIN-18 function, while the Wnt binding WIF domain is required. We also found that Wnt proteins LIN-44, MOM-2, and CWN-2 redundantly regulate P7.p patterning. Genetic interactions indicate that LIN-17 and LIN-18 function independently of each other in parallel pathways, and different ligands display different receptor specificities. Thus, two independent Wnt signaling pathways, one employing a Ryk receptor and the other a Frizzled receptor, function in parallel to regulate cell fate patterning in the C. elegans vulva.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Kentucky, Coll Med, Dept Biochem, Lexington, KY 40536 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Rush Univ, Dept Med, Ctr Med, Chicago, IL 60612 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Kentucky; University System of Ohio; Ohio State University; Rush University	Sternberg, PW (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu		Katz, Wendy/0000-0003-3038-6314				Burdine RD, 1998, DEVELOPMENT, V125, P1083; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHAMBERLIN HM, 1995, DEV BIOL, V170, P679, DOI 10.1006/dbio.1995.1246; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Katso RM, 1999, MOL CELL BIOL, V19, P6427; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.0.CO;2-K; MADURO M, 1995, GENETICS, V141, P977; Maloof JN, 1999, DEVELOPMENT, V126, P37; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Natarajan L, 2001, GENETICS, V159, P159; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SHACKLEFORD GM, 1993, ONCOGENE, V8, P1857; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	57	141	153	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					795	806		10.1016/j.cell.2004.09.001	http://dx.doi.org/10.1016/j.cell.2004.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369677	Bronze			2022-12-01	WOS:000223992400014
J	Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI				Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI			Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation	CELL			English	Article							NUCLEOSIDE TRIPHOSPHATASE P4; BLUETONGUE VIRUS CORE; T7 DNA HELICASE; BACTERIOPHAGE PHI-6; CRYSTAL-STRUCTURE; REPLICATIVE HELICASE; POLYMERASE COMPLEX; CATALYTIC SITES; PROTEIN; MECHANISM	Many viruses package their genome into preformed capsids using packaging motors powered by the hydrolysis of ATP. The hexameric ATPase P4 of dsRNA bacteriophage phi12, located at the vertices of the ico-sahedral capsid, is such a packaging motor. We have captured crystallographic structures of P4 for all the key points along the catalytic pathway, including apo, substrate analog bound, and product bound. Substrate and product binding have been observed as both binary complexes and ternary complexes with divalent cations. These structures reveal large movements of the putative RNA binding loop, which are coupled with nucleotide binding and hydrolysis, indicating how ATP hydrolysis drives RNA translocation through cooperative conformational changes. Two distinct conformations of bound nucleotide triphosphate suggest how hydrolysis is activated by RNA binding. This provides a model for chemomechanical coupling for a prototype of the large family of hexameric helicases and oligonucleotide translocating enzymes.	Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England; Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Fac Biosci, Viikki Bioctr, Helsinki 00014, Finland	University of Oxford; University of Helsinki; University of Helsinki	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk	Tuma, Roman/AAL-4436-2020; Kainov, Denis/I-5526-2019; Mancini, Erika J/J-9880-2013	Tuma, Roman/0000-0003-0047-0013; Kainov, Denis/0000-0001-7716-6955; Mancini, Erika J/0000-0001-9591-7898; Bamford, Dennis/0000-0002-6438-8118; Grimes, Jonathan Mark/0000-0001-9698-0389; Stuart, David/0000-0002-3426-4210				Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cassetti MC, 1998, J VIROL, V72, P5769, DOI 10.1128/JVI.72.7.5769-5780.1998; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paatero AO, 1998, J VIROL, V72, P10058, DOI 10.1128/JVI.72.12.10058-10065.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pirttimaa MJ, 2002, J VIROL, V76, P10122, DOI 10.1128/JVI.76.20.10122-10127.2002; Qiao J, 2003, J BACTERIOL, V185, P4572, DOI 10.1128/JB.185.15.4572-4577.2003; Qiao XY, 2003, J BACTERIOL, V185, P6409, DOI 10.1128/JB.185.21.6409-6414.2003; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Roizman B, 1996, FIELDS VIROLOGY, P2231; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEBER J, 1993, J BIOL CHEM, V268, P20126	55	140	143	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					743	755		10.1016/j.cell.2004.09.007	http://dx.doi.org/10.1016/j.cell.2004.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369673	Bronze			2022-12-01	WOS:000223992400010
J	Thompson, WW; Shay, DK; Weintraub, E; Brammer, I; Bridges, CB; Cox, NJ; Fukuda, K				Thompson, WW; Shay, DK; Weintraub, E; Brammer, I; Bridges, CB; Cox, NJ; Fukuda, K			Influenza-associated hospitalizations in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PANDEMIC INFLUENZA; OUTPATIENT VISITS; IMPACT; VACCINATION; EPIDEMICS; MORTALITY; CHILDREN; INFECTIONS; PNEUMONIA	Context Respiratory viral infections are responsible for a large number of hospitalizations in the United States each year. Objective To estimate annual influenza-associated hospitalizations in the United States by hospital discharge category, discharge type, and age group. Design, Setting, and Participants National Hospital Discharge Survey (NHDS) data and World Health Organization Collaborating Laboratories influenza surveillance data were used to estimate annual average numbers of hospitalizations associated with the circulation of influenza viruses from the 1979-1980 through the 2000-2001 seasons in the United States using age-specific Poisson regression models. Main Outcome Measures We estimated influenza-associated hospitalizations for primary and any listed pneumonia and influenza and respiratory and circulatory hospitalizations. Results Annual averages of 94735 (range, 18908-193561) primary and 133 900 (range, 30757-271529) any listed pneumonia and influenza hospitalizations were associated with influenza virus infections. Annual averages of 226 054 (range, 54523-430960) primary and 294128 (range, 86494-544909) any listed respiratory and circulatory hospitalizations were associated with influenza virus infections. Persons 85 years or older had the highest rates of influenza-associated primary respiratory and circulatory hospitalizations (1194.9 per 100000 persons). Children younger than 5 years (107.9 primary respiratory and circulatory hospitalizations per 100000 persons) had rates similar to persons aged 50 through 64 years. Estimated rates of influenza-associated hospitalizations were highest during seasons in which A(H3N2) viruses predominated, followed by B and A(H1N1) seasons. After adjusting for the length of each influenza season, influenza-associated primary pneumonia and influenza hospitalizations increased over time among the elderly. There were no significant increases in influenza-associated primary respiratory and circulatory hospitalizations after adjusting for the length of the influenza season. Conclusions Significant numbers of influenza-associated hospitalizations in the United States occur among the elderly, and the numbers of these hospitalizations have increased substantially over the last 2 decades due in part to the aging of the population. Children younger than 5 years had rates of influenza-associated hospitalizations similar to those among individuals aged 50 through 64 years. These findings highlight the need for improved influenza prevention efforts for both young and older US residents.	Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,MS E61, Atlanta, GA 30333 USA.	wct2@cdc.gov		Fukuda, Keiji/0000-0002-9598-9565; Shay, David/0000-0001-9619-4820				BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Dennison C, 2000, Vital Health Stat 1, P1; *EDW BROTH, 1978, INT CLASS DIS 9 REV, V1; FRANK AL, 1983, AM J EPIDEMIOL, V118, P313, DOI 10.1093/oxfordjournals.aje.a113638; Fukuda K, 2000, INT J CLIN PRACT, P37; Gensheimer KF, 2002, VACCINE, V20, pS63, DOI 10.1016/S0264-410X(02)00135-4; Gillum B.S., 1998, VITAL HLTH STAT 13, V133, p[i, 1]; Glezen WP, 2000, NEW ENGL J MED, V342, P1752; GLEZEN WP, 1980, AM J EPIDEMIOL, V111, P13, DOI 10.1093/oxfordjournals.aje.a112865; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; GRAVES EJ, 1997, VITAL HLTH STAT 13, V128, P1; Hall Margaret J, 2002, Adv Data, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HAUPT BJ, 1992, VITAL HLTH STAT 13, V111, P1; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KOZAK LJ, 2002, VITAL HLTH STAT 13, V153, P1; LAWRENCE L, 1999, ADV DATA, V308, P1; McBean AM, 2004, INT J INFECT DIS, V8, P227, DOI 10.1016/j.ijid.2004.04.013; MCBEAN AM, 1993, ARCH INTERN MED, V153, P2105, DOI 10.1001/archinte.153.18.2105; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Meyer KC, 2001, RESP PHYSIOL, V128, P23, DOI 10.1016/S0034-5687(01)00261-4; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichols G, 1999, J ASIAN EARTH SCI, V17, P47, DOI 10.1016/S0743-9547(98)00034-8; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *US BUR CENS, 1990, INT EST POP AG SEX R; *US DEP HHS, 1999, 991232 PHS US DEP HH; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5	41	1681	1780	2	163	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1333	1340		10.1001/jama.292.11.1333	http://dx.doi.org/10.1001/jama.292.11.1333			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367555				2022-12-01	WOS:000223866800025
J	Hruska, AJ				Hruska, AJ			The Global Fund's principal recipients ... or neglected partners	LANCET			English	Editorial Material											Hruska, AJ (corresponding author), Arrayan 2702,Dpto 304, Santiago, Chile.	ajhruska@umich.edu	Hruska, Allan/AAV-7547-2020	Hruska, Allan/0000-0003-0984-3816				RIVERS R, 2004, NEWSLETTER      0607; 2003, GLOBAL FUND FIGHT AI; 2004, AGUA BUENA ASOCIACIO	3	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					918	920		10.1016/S0140-6736(04)17039-6	http://dx.doi.org/10.1016/S0140-6736(04)17039-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364175				2022-12-01	WOS:000223831000008
J	Ray, WA; Murray, KT; Meredith, S; Narasimhulu, SS; Hall, K; Stein, CM				Ray, WA; Murray, KT; Meredith, S; Narasimhulu, SS; Hall, K; Stein, CM			Oral erythromycin and the risk of sudden death from cardiac causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADES-DE-POINTES; PROLONGATION; ITRACONAZOLE; TERFENADINE; CISAPRIDE; MIDAZOLAM; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; CLARITHROMYCIN; KETOCONAZOLE	Background: Oral erythromycin prolongs cardiac repolarization and is associated with case reports of torsades de pointes. Because erythromycin is extensively metabolized by cytochrome P-450 3A (CYP3A) isozymes, commonly used medications that inhibit the effects of CYP3A may increase plasma erythromycin concentrations, thereby increasing the risk of ventricular arrhythmias and sudden death. We studied the association between the use of erythromycin and the risk of sudden death from cardiac causes and whether this risk was increased with the concurrent use of strong inhibitors of CYP3A. Methods: We studied a previously identified Tennessee Medicaid cohort that included 1,249,943 person-years of follow-up and 1476 cases of confirmed sudden death from cardiac causes. The CYP3A inhibitors used in the study were nitroimidazole antifungal agents, diltiazem, verapamil, and troleandomycin; each doubles, at least, the area under the time-concentration curve for a CYP3A substrate. Amoxicillin, an antimicrobial agent with similar indications but which does not prolong cardiac repolarization, and former use of erythromycin also were studied, to assess possible confounding by indication. Results: The multivariate adjusted rate of sudden death from cardiac causes among patients currently using erythromycin was twice as high (incidence-rate ratio, 2.01; 95 percent confidence interval, 1.08 to 3.75; P=0.03) as that among those who had not used any of the study antibiotic medications. There was no significant increase in the risk of sudden death among former users of erythromycin (incidence-rate ratio, 0.89; 95 percent confidence interval, 0.72 to 1.09; P=0.26) or among those who were currently using amoxicillin (incidence-rate ratio, 1.18; 95 percent confidence interval, 0.59 to 2.36; P=0.65). The adjusted rate of sudden death from cardiac causes was five times as high (incidence-rate ratio, 5.35; 95 percent confidence interval, 1.72 to 16.64; P=0.004) among those who concurrently used CYP3A inhibitors and erythromycin as that among those who had used neither CYP3A inhibitors nor any of the study antibiotic medications. In contrast, there was no increase in the risk of sudden death among those who concurrently used amoxicillin and CYP3A inhibitors or those currently using any of the study antibiotic medications who had formerly used CYP3A inhibitors. Conclusions: The concurrent use of erythromycin and strong inhibitors of CYP3A should be avoided.	Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; Nashville Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031304] Funding Source: NIH RePORTER; AHRQ HHS [HS1-0384] Funding Source: Medline; NIGMS NIH HHS [GM-31304] Funding Source: Medline; FDA HHS [FD-U-001641] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS		Abernethy DR, 2001, CLIN PHARMACOL THER, V69, P96, DOI 10.1067/mcp.2001.114230; Ahonen J, 1997, EUR J CLIN PHARMACOL, V51, P415, DOI 10.1007/s002280050223; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Curtis LH, 2003, AM J MED, V114, P135, DOI 10.1016/S0002-9343(02)01455-9; Damkier P, 1999, BRIT J CLIN PHARMACO, V48, P829, DOI 10.1046/j.1365-2125.1999.00099.x; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; Desta Z, 1998, J PHARMACOL EXP THER, V285, P428; Drici MD, 1998, JAMA-J AM MED ASSOC, V280, P1774, DOI 10.1001/jama.280.20.1774; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Gil M, 2003, AM J CARDIOL, V92, P995, DOI 10.1016/S0002-9149(03)00906-8; Goldschmidt N, 2001, ANN PHARMACOTHER, V35, P1396; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; HOFER CA, 1993, AM J MED, V95, P431, DOI 10.1016/0002-9343(93)90314-F; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KIRCH W, 1989, THER DRUG MONIT, V11, P411; Kivisto KT, 1997, CLIN PHARMACOL THER, V62, P348, DOI 10.1016/S0009-9236(97)90038-2; Koh TW, 2001, PACE, V24, P1575, DOI 10.1046/j.1460-9592.2001.01575.x; Lam YWF, 2003, J CLIN PHARMACOL, V43, P1274, DOI 10.1177/0091270003259216; Lamberg TS, 1998, CLIN PHARMACOL THER, V63, P640, DOI 10.1016/S0009-9236(98)90087-X; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; LEISTER KA, 1981, MED CARE, V19, P658, DOI 10.1097/00005650-198106000-00008; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; Matsumoto S, 2001, BRIT J CLIN PHARMACO, V51, P133, DOI 10.1111/j.1365-2125.2001.01292.x; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; MURRAY KT, 2004, CARDIOLOGY, P765; NICOLAU DP, 1992, J HEART LUNG TRANSPL, V11, P564; OLKKOLA KT, 1994, CLIN PHARMACOL THER, V55, P481, DOI 10.1038/clpt.1994.60; Ouellet D, 1998, CLIN PHARMACOL THER, V64, P355, DOI 10.1016/S0009-9236(98)90065-0; Paine MF, 2002, CLIN PHARMACOL THER, V72, P524, DOI 10.1067/mcp.2002.128387; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Simard C, 2001, EUR J CLIN PHARMACOL, V57, P229, DOI 10.1007/s002280100298; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Stanat SJC, 2003, MOL CELL BIOCHEM, V254, P1, DOI 10.1023/A:1027309703313; STROM BL, 1990, EPIDEMIOL REV, V12, P87, DOI 10.1093/oxfordjournals.epirev.a036064; Tschida SJ, 1996, PHARMACOTHERAPY, V16, P663; Varis T, 2000, CLIN PHARMACOL THER, V67, P215, DOI 10.1067/mcp.2000.104611; Vogt AW, 1997, ANESTH ANALG, V85, P1011, DOI 10.1097/00000539-199711000-00010; WAROT D, 1987, EUR J CLIN PHARMACOL, V32, P389, DOI 10.1007/BF00543975; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; WISEMAN LR, 1994, DRUGS, V47, P116, DOI 10.2165/00003495-199447010-00008	45	331	349	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1089	1096		10.1056/NEJMoa040582	http://dx.doi.org/10.1056/NEJMoa040582			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CX	15356306				2022-12-01	WOS:000223733900008
J	Siok, WT; Perfetti, CA; Jin, Z; Tan, LH				Siok, WT; Perfetti, CA; Jin, Z; Tan, LH			Biological abnormality of impaired reading is constrained by culture	NATURE			English	Article							LEFT PREFRONTAL CORTEX; HUMAN FRONTAL-CORTEX; WORKING-MEMORY; BRAIN ACTIVATION; NATIVE LANGUAGE; NEURAL SYSTEMS; FUNCTIONAL MRI; WORD FORM; DYSLEXIA; CHINESE	Developmental dyslexia is characterized by a severe reading problem in people who have normal intelligence and schooling(1-3). Impaired reading of alphabetic scripts is associated with dysfunction of left temporoparietal brain regions(2-5). These regions perform phonemic analysis and conversion of written symbols to phonological units of speech (grapheme-to-phoneme conversion); two central cognitive processes that mediate reading acquisition(6-7). Furthermore, it has been assumed that, in contrast to cultural diversities, dyslexia in different languages has a universal biological origin(1,8). Here we show using functional magnetic resonance imaging with reading-impaired Chinese children and associated controls, that functional disruption of the left middle frontal gyrus is associated with impaired reading of the Chinese language ( a logographic rather than alphabetic writing system). Reading impairment in Chinese is manifested by two deficits: one relating to the conversion of graphic form ( orthography) to syllable, and the other concerning orthography-to-semantics mapping. Both of these processes are critically mediated by the left middle frontal gyrus, which functions as a centre for fluent Chinese reading(9-11) that coordinates and integrates various information about written characters in verbal and spatial working memory. This finding provides an insight into the fundamental pathophysiology of dyslexia by suggesting that rather than having a universal origin, the biological abnormality of impaired reading is dependent on culture.	Univ Hong Kong, Dept Linguist, Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China; Univ Pittsburgh, Ctr Learning Res & Dev, Pittsburgh, PA 15260 USA; Beijing 306 Hosp, MRI Div, Beijing 100101, Peoples R China; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA	University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, LH (corresponding author), Univ Hong Kong, Dept Linguist, Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China.	lihaitan@intra.nimh.nih.gov	Siok, Wai Ting/A-8392-2010	Siok, Wai Ting/0000-0002-2154-5996				Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; Fiez JA, 2000, NAT NEUROSCI, V3, P3, DOI 10.1038/71078; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Mattingly I, 1972, LANGUAGE EAR EYE, P133; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perfetti CA, 1999, READING CHINESE SCRIPT, P115; PERFETTI CA, IN PRESS PSYCHOL REV; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; WANG WSY, 1973, SCI AM, V228, P50, DOI 10.1038/scientificamerican0273-50	31	329	368	9	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					71	76		10.1038/nature02865	http://dx.doi.org/10.1038/nature02865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343334				2022-12-01	WOS:000223641500043
J	Banks, E; Reeves, G; Beral, V; Bull, D; Crossley, B; Simmonds, M; Hilton, E; Bailey, S; Barrett, N; Briers, P; English, R; Jackson, A; Kutt, E; Lavelle, J; Rockall, L; Wallis, MG; Wilson, M; Patnick, J				Banks, E; Reeves, G; Beral, V; Bull, D; Crossley, B; Simmonds, M; Hilton, E; Bailey, S; Barrett, N; Briers, P; English, R; Jackson, A; Kutt, E; Lavelle, J; Rockall, L; Wallis, MG; Wilson, M; Patnick, J			Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE REPLACEMENT THERAPY; BREAST DENSITY; PARENCHYMAL PATTERNS; SCREENING-PROGRAM; CANCER; INTERVAL; ESTROGEN; AGE; PREDICTORS; PROGESTIN	Objectives To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography. Methods Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 12355 women aged 50-64 years were followed for outcome of screening and incident breast cancer in the next 12 months. Sensitivity and specificity were calculated by using standard definitions, with adjustment for potential confounding factors. Results Breast cancer was diagnosed in 726 (0.6%) women, 629 in screen positive and 97 in screen negative women; 3885 (3.2%) were screen positive but had no subsequent diagnosis of breast cancer. Overall sensitivity was 86.6% and specificity was 96.8%. Three factors had an adverse effect on both measures: use of hormone replacement therapy (sensitivity: 83.0% (95% confidence interval 77.4% to 87.6%), 84.7% (73.9% to 91.6%), and 92.1% (87.6% to 95.0%); specificity: 96.8% (96.6% to 97.0%), 97.8% (97.5% to 98.0%), and 98.1% (98.0% to 98.2%), respectively, for current, past, and never use); previous breast surgery v no previous breast surgery (sensitivity: 83.5% (75.7% to 89.1%) v 89.4% (86.5% to 91.8%); specificity: 96.2% (95.8% to 96.5%) v 97.4% (97.3% to 97.5%), respectively); and body mass index <25 v >= 25 (sensitivity: 85.7% (81.2% to 89.3%) v 91.0% (87.5% to 93.6%); specificity: 97.2% (97.0% to 97.3%) v 97.4% (97.3% to 97.6%), respectively). Neither sensitivity nor specificity varied significantly according to age, family history of breast cancer, parity, past oral contraceptive use, tubal ligation, physical activity, smoking, or alcohol consumption. Conclusions The efficiency, and possibly the effectiveness, of mammographic screening is lower in users of hormone replacement therapy, in women with previous breast surgery, and in thin women compared with other women.	Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Oxford OX2 6HE, England; Princess Wales Community Hosp, Breast Screening Serv, Bromsgrove B61 0BB, Worcs, England; Charing Cross Hosp, W London Breast Screening Serv, London W6 8RF, England; Gloucestershire Breast Screening Serv, Cheltenham GL53 7AS, Glos, England; Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Breast Care Unit, Oxford OX3 7JH, England; Queen Alexandra Hosp, Patricia Massey Breast Screening Unit, Portsmouth PO6 3LY, Hants, England; Cent Hlth Clin, Avon Breast Screening, Bristol BS2 0JD, Avon, England; Royal Lancaster Infirm, N Lancashire Breast Screening Serv, Lancaster LA1 4GG, England; Worthing Dist Hosp, W Sussex Breast Screening Serv, Worthing BN11 2DH, W Sussex, England; Coventry & Warwick Hosp, Breast Screening Unit, Coventry CV1 4FH, W Midlands, England; Withington Hosp, Greater Manchester Breast Screening Serv, Nightingale Ctr, Manchester M20 0PT, Lancs, England; NHS Breast Screening Programme, Sheffield S11 9PS, S Yorkshire, England	Cancer Research UK; Radcliffe Infirmary; Imperial College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Banks, E (corresponding author), Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Gibson Bldg, Oxford OX2 6HE, England.	emily.banks@anu.edu.au		Banks, Emily/0000-0002-4617-1302				Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319; Banks E, 2004, BMJ-BRIT MED J, V328, P1291, DOI 10.1136/bmj.328.7451.1291; Banks E, 2002, J MED SCREEN, V9, P74, DOI 10.1136/jms.9.2.74; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BERAL V, IN PRESS MENOPAUSE H; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Crane CEB, 2002, BREAST, V11, P131, DOI 10.1054/brst.2001.0371; DESTAVOLA BL, 1990, INT J EPIDEMIOL, V19, P247, DOI 10.1093/ije/19.2.247; Fisher MD, 2001, CLIN LYMPHOMA, V2, P84, DOI 10.1016/S1526-9655(11)70134-8; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; Sala E, 1998, J MED SCREEN, V5, P207, DOI 10.1136/jms.5.4.207; Schouten LJ, 1997, LANCET, V349, P1104, DOI 10.1016/S0140-6736(05)62329-X; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Wang HG, 2001, INT J CANCER, V94, P594, DOI 10.1002/ijc.1511	23	77	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					477	479		10.1136/bmj.329.7464.477	http://dx.doi.org/10.1136/bmj.329.7464.477			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331472	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000223684600011
J	Warnke, PH; Springer, ING; Wiltfang, J; Acil, Y; Eufinger, H; Wehmoller, M; Russo, PAJ; Bolte, H; Sherry, E; Behrens, E; Terheyden, H				Warnke, PH; Springer, ING; Wiltfang, J; Acil, Y; Eufinger, H; Wehmoller, M; Russo, PAJ; Bolte, H; Sherry, E; Behrens, E; Terheyden, H			Growth and transplantation of a custom vascularised bone graft in a man	LANCET			English	Article							HUMAN OSTEOGENIC PROTEIN-1; MANDIBULAR RECONSTRUCTION; MORPHOGENETIC PROTEIN-7; MINIATURE PIGS; RHOP-1; TISSUE	Background A major goal of research in bone transplantation is the ability to avoid creation of secondary bone defects. We aimed to repair an extended mandibular discontinuity defect by growth of a custom bone transplant inside the latissimus dorsi muscle of an adult male patient. Methods Three-dimensional computed tomography (CT) scanning and computer-aided design techniques were used to produce an ideal virtual replacement for the mandibular defect. These data were used to create a titanium mesh cage that was filled with bone mineral blocks and infiltrated with 7 mg recombinant human bone morphogenetic protein 7 and 20 mL of the patient's bone marrow. Thus prepared, the transplant was implanted into the latissimus dorsi muscle and 7 weeks later transplanted as a free bone-muscle flap to repair the mandibular defect. Findings In-vivo skeletal scintigraphy showed bone remodelling and mineralisation inside the mandibular transplant both before and after transplantation. CT provided radiological evidence of new bone formation. Postoperatively, the patient had an improved degree of mastication and was satisfied with the aesthetic outcome of the procedure. Interpretation Heterotopic bone induction to form a mandibular replacement inside the latissimus dorsi muscle in a human being is possible. This technique allows for a lower operative burden compared with conventional techniques by avoiding creation of a secondary bone defect. It also provides a good three-dimensional outcome.	Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany; Knappschaftskrankenhaus, Dept Oral & Maxillofacial Surg, Recklinghausen, Germany; Australian Natl Univ, Dept Rheumatol, Canberra, ACT, Australia; Univ Kiel, Dept Diagnost Radiol, Kiel, Germany; Univ Sydney, Dept Orthopaed Surg, Penrith, Australia	University of Kiel; Australian National University; University of Kiel; University of Sydney	Warnke, PH (corresponding author), Univ Kiel, Dept Oral & Maxillofacial Surg, Arnold Heller Str 16, D-24105 Kiel, Germany.	warnke@mkg.uni-kiel.de	Terheyden, Hendrik/HDM-7610-2022; Cruz e Silva, Odete/AAH-5595-2020; Wiltfang, Jörg/B-1767-2010	Terheyden, Hendrik/0000-0002-0709-114X; 				Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Springer ING, 2002, BONE, V31, P230, DOI 10.1016/S8756-3282(02)00809-8; Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032; Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1054/ijom.2003.0500; Terheyden H, 2003, INT J ORAL MAX SURG, V32, P528, DOI 10.1054/ijom.2002.0408; Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008; Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1034/j.1399-0020.1999.280613.x; Vacanti JP, 2003, J GASTROINTEST SURG, V7, P831, DOI 10.1016/S1091-255X(03)00135-5; Vacanti JP, 1999, LANCET S1, V354, pSI32; Wang HM, 2004, J BIOMED MATER RES A, V68A, P219, DOI 10.1002/jbm.a.10129; Warnke PH, 2003, PLAST RECONSTR SURG, V111, P2471, DOI 10.1097/01.PRS.0000063110.10932.9B	12	505	535	0	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					766	770		10.1016/S0140-6736(04)16935-3	http://dx.doi.org/10.1016/S0140-6736(04)16935-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337402				2022-12-01	WOS:000223569600027
J	Clark, JM; Xu, X; Forster, CA; Wang, Y				Clark, JM; Xu, X; Forster, CA; Wang, Y			A Middle Jurassic 'sphenosuchian' from China and the origin of the crocodylian skull	NATURE			English	Article							BASAL CROCODYLOMORPH ARCHOSAURS; EVOLUTION; ONTOGENY	The skull of living crocodylians is highly solidified and the jaw closing muscles are enlarged(1), allowing for prey capture by prolonged crushing between the jaws. Living species are all semi-aquatic, with sprawling limbs and a broad body that moves mainly from side-to-side(2); however, fossils indicate that they evolved from terrestrial forms. The most cursorial of these fossils(3-6) are small, gracile forms often grouped together as the Sphenosuchia, with fully erect, slender limbs; their relationships, however, are poorly understood(5,7-10). A new crocodylomorph from deposits in northwestern China of the poorly known Middle Jurassic epoch possesses a skull with several adaptations typical of living crocodylians. Postcranially it is similar to sphenosuchians but with even greater adaptations for cursoriality in the forelimb. Here we show, through phylogenetic analysis, that it is the closest relative of the large group Crocodyliformes, including living crocodylians. Thus, important features of the modern crocodylian skull evolved during a phase when the postcranial skeleton was evolving towards greater cursoriality, rather than towards their current semi-aquatic habitus.	George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	George Washington University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Clark, JM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jclark@gwu.edu						AGUE JJ, 1995, AM J SCI, V295, P1, DOI 10.2475/ajs.295.1.1; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Benton MJ, 2002, ZOOL J LINN SOC-LOND, V136, P25, DOI 10.1046/j.1096-3642.2002.00024.x; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Chen Pei-ji, 1996, Museum of Northern Arizona Bulletin, V60, P395; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; CLARK JM, 2001, DINOSAURS XINJIANG; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Goslow, 2001, ANAL VERTEBRATE STRU; Iordansky N.N., 1973, P201; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Lucas S.G., 2002, CHINESE FOSSIL VERTE; MULLER GB, 1990, J MORPHOL, V203, P151, DOI 10.1002/jmor.1052030204; Osmolska H, 1997, ACTA PALAEONTOL POL, V42, P257; PARRISH JM, 1987, PALEOBIOLOGY, V13, P396; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Sereno P.C., 1992, Journal of Vertebrate Paleontology, V12, P435; Sues HD, 2003, J VERTEBR PALEONTOL, V23, P329, DOI 10.1671/0272-4634(2003)023[0329:ANCAFT]2.0.CO;2; SWOFFORD DL, 2003, PAUP BETA 10 SOFTWAR; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58	23	87	92	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1021	1024		10.1038/nature02802	http://dx.doi.org/10.1038/nature02802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329719				2022-12-01	WOS:000223514900041
J	Douma, S; van Laar, T; Zevenhoven, J; Meuwissen, R; van Garderen, E; Peeper, DS				Douma, S; van Laar, T; Zevenhoven, J; Meuwissen, R; van Garderen, E; Peeper, DS			Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB	NATURE			English	Article							HUMAN NEUROBLASTOMAS; SIGNAL-TRANSDUCTION; KINASE RECEPTOR; EXPRESSION; APOPTOSIS; SURVIVAL; PATHWAY; ACTIVATION; MECHANISMS; INTEGRINS	Metastasis is a major factor in the malignancy of cancers, and is often responsible for the failure of cancer treatment. Anoikis ( apoptosis resulting from loss of cell-matrix interactions) has been suggested to act as a physiological barrier to metastasis; resistance to anoikis may allow survival of cancer cells during systemic circulation, thereby facilitating secondary tumour formation in distant organs(1-3). In an attempt to identify metastasis-associated oncogenes, we designed an unbiased, genome-wide functional screen solely on the basis of anoikis suppression. Here, we report the identification of TrkB, a neurotrophic tyrosine kinase receptor(4,5), as a potent and specific suppressor of caspase-associated anoikis of non-malignant epithelial cells. By activating the phosphatidylinositol-3-OH kinase/protein kinase B pathway, TrkB induced the formation of large cellular aggregates that survive and proliferate in suspension. In mice, these cells formed rapidly growing tumours that infiltrated lymphatics and blood vessels to colonize distant organs. Consistent with the ability of TrkB to suppress anoikis, metastases-whether small vessel infiltrates or large tumour nodules-contained very few apoptotic cells. These observations demonstrate the potent oncogenic effects of TrkB and uncover a specific pro-survival function that may contribute to its metastatic capacity, providing a possible explanation for the aggressive nature of human tumours that overexpress TrkB.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	van Laar, Theo/0000-0002-0990-6234				Aoyama M, 2001, CANCER LETT, V164, P51, DOI 10.1016/S0304-3835(00)00715-1; Banks GB, 2002, INT J DEV BIOL, V46, P551; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ho R, 2002, CANCER RES, V62, P6462; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaboin J, 2003, CANCER LETT, V193, P109, DOI 10.1016/S0304-3835(02)00723-1; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ruggeri BA, 1999, CURR MED CHEM, V6, P845; Ruoslahti E, 1997, CURR OPIN CELL BIOL, V9, P605, DOI 10.1016/S0955-0674(97)80112-3; Schmidt M, 2002, BRIT J CANCER, V87, P924, DOI 10.1038/sj.bjc.6600566; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Vooijs M, 2002, CANCER RES, V62, P1862; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533	30	437	494	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1034	1040		10.1038/nature02765	http://dx.doi.org/10.1038/nature02765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329723	Bronze			2022-12-01	WOS:000223514900045
J	Malinina, L; Malakhova, ML; Teplov, A; Brown, RE; Patel, DJ				Malinina, L; Malakhova, ML; Teplov, A; Brown, RE; Patel, DJ			Structural basis for glycosphingolipid transfer specificity	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEINS; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; PIG BRAIN; PURIFICATION; RECOGNITION; REFINEMENT; ANGSTROM; COMPLEX	Lipid transfer proteins are important in membrane vesicle biogenesis and trafficking, signal transduction and immunological presentation processes(1-3). The conserved and ubiquitous mammalian glycolipid transfer proteins (GLTPs) serve as potential regulators of cell processes mediated by glycosphingolipids, ranging from differentiation and proliferation to invasive adhesion, neurodegeneration and apoptosis(4,5). Here we report crystal structures of apo-GLTP (1.65 Angstrom resolution) and lactosylceramide-bound (1.95 Angstrom) GLTP, in which the bound glycosphingolipid is sandwiched, after adaptive recognition, within a previously unknown two-layer all-alpha-helical topology. Glycosphingolipid binding specificity is achieved through recognition and anchoring of the sugar-amide headgroup to the GLTPlipid recognition centre and within the hydrophobic tunnel support a framework for understanding how GLTPs acquire and release glycosphingolipids during lipid intermembrane transfer and presentation processes.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	University of Minnesota System; Memorial Sloan Kettering Cancer Center	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu; pateld@mskcc.org	Malinina, Lucy/B-8161-2013	Malinina, Lucy/0000-0001-7973-1831; Brown, Rhoderick/0000-0002-7337-3604; Teplov, Alexei/0000-0003-4826-4518	NIGMS NIH HHS [R01 GM045928-13, R01 GM045928-08, R01 GM045928, R01 GM045928-11, R01 GM045928-10, R01 GM045928-12, R01 GM045928-07, R01 GM045928-09, R01 GM045928-14A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE A, 1985, J BIOL CHEM, V260, P1231; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li XM, 2002, BIOPHYS J, V83, P1535, DOI 10.1016/S0006-3495(02)73923-4; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; METZ RJ, 1982, J BIOL CHEM, V257, P2901; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Rogers DP, 2000, INT REV CYTOL, V197, P35, DOI 10.1016/S0074-7696(00)97002-5; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; YAMADA K, 1985, J BIOL CHEM, V260, P4615; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	30	102	103	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1048	1053		10.1038/nature02856	http://dx.doi.org/10.1038/nature02856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329726	Green Accepted			2022-12-01	WOS:000223514900048
J	Diggs, C; Ewart, S; Moree, M				Diggs, C; Ewart, S; Moree, M			Strength in unity	NATURE			English	Article									USAID Malaria Vaccine Dev Program, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Diggs, C (corresponding author), USAID Malaria Vaccine Dev Program, Washington, DC 20523 USA.								0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					938	939		10.1038/430938a	http://dx.doi.org/10.1038/430938a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318238	Bronze			2022-12-01	WOS:000223369800061
J	Wood, C; Clauss, M				Wood, C; Clauss, M			Panda phlebotomies? The need for comparative screening for haemochromatosis	LANCET			English	Editorial Material							IRON; LEMURS; STORES		Inst Anim Physiol, D-5764 Oberschleissheim, Germany; Zhejiang Univ, Coll Life Sci, Hangzhou 310027, Zhejiang, Peoples R China; Zhejiang Univ, Minist Educ, Key Lab Conservat Genet & Reprod Biol Endangered, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Clauss, M (corresponding author), Inst Anim Physiol, D-5764 Oberschleissheim, Germany.	clauss@tiph.vetmed.uni-muenchen.de	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Wood, Christopher/0000-0002-5517-9496				BENIRSCHKE K, 1985, ADV VET SCI COMP MED, V30, P167; Clauss M., 2002, P EUROPEAN ASS ZOO W, V4, P123; Dutton CJ, 2003, J ZOO WILDLIFE MED, V34, P16, DOI 10.1638/1042-7260(2003)34[0016:BEOFRL]2.0.CO;2; GONZALES J, 1984, ZOO BIOL, V3, P255, DOI 10.1002/zoo.1430030308; Lowenstine Linda J., 1999, P260; Mazzaro LM, 2004, ZOO BIOL, V23, P205, DOI 10.1002/zoo.10126; O'Toole D, 2001, VET PATHOL, V38, P372, DOI 10.1354/vp.38-4-372; Paglia DE, 1999, P AM ASS ZOO VET ANN, P163; Paglia DE, 2000, P AM ASS ZOO VET, P124; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; WEEKS BR, 1989, AM J VET RES, V50, P198; Wood C, 2003, AM J PRIMATOL, V61, P101, DOI 10.1002/ajp.10113; ZHANG H, 1993, INT S PROT GIANT PAN, P351	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1384	1385		10.1016/S0140-6736(04)17237-1	http://dx.doi.org/10.1016/S0140-6736(04)17237-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488201				2022-12-01	WOS:000224485300006
J	Cuello, LG; Cortes, DM; Perozo, E				Cuello, LG; Cortes, DM; Perozo, E			Molecular architecture of the KvAP voltage-dependent K+ channel in a lipid bilayer	SCIENCE			English	Article							GATED SODIUM-CHANNELS; POTASSIUM CHANNEL; TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; CHARGE MOVEMENT; SHAKER; S4; CONDUCTION; MECHANISM; SENSOR	We have analyzed the local structure and dynamics of the prokaryotic voltage-dependent K+ channel (KvAP) at 0 millivolts, using site-directed spin labeling and electron paramagnetic resonance spectroscopy. We show that the S4 segment is located at the protein/lipid interface, with most of its charges protected from the lipid environment. Structurally, S4 is highly dynamic and is separated into two short helices by a flexible linker. Accessibility and dynamics data indicate that the S1 segment is surrounded by other parts of the protein. We propose that S1 is at the contact interface between the voltage-sensing and pore domains. These results establish the general principles of voltage-dependent channel structure in a biological membrane.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA	University of Virginia	Perozo, E (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA.	eperozo@virginia.edu						Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Goldstein SAN, 1996, NEURON, V16, P717, DOI 10.1016/S0896-6273(00)80092-6; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Huang C C, 2000, Pac Symp Biocomput, P230; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; MCHAOURAB HS, 2000, DISTANCE MEASUREMENT; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Steinhoff HJ, 2003, METHODS, V29, P188, DOI 10.1016/S1046-2023(02)00309-2; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	33	190	195	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					491	495		10.1126/science.1101373	http://dx.doi.org/10.1126/science.1101373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486302				2022-12-01	WOS:000224626500055
J	Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S				Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S			Mrf4 determines skeletal muscle identity in Myf5 : Myod double-mutant mice	NATURE			English	Article							PROGENITOR CELLS; GENE-EXPRESSION; MYF-5; MYOD; MOUSE; SPECIFICATION; ACTIVATION; DISRUPTION; MYOGENESIS; MARKER	In vertebrates, skeletal muscle is a model for the acquisition of cell fate from stem cells(1). Two determination factors of the basic helix - loop - helixmyogenic regulatory factor (MRF) family, Myf5 and Myod, are thought to direct this transition because double-mutant mice totally lack skeletal muscle fibres and myoblasts(2-4). In the absence of these factors, progenitor cells remain multipotent and can change their fate(5,6). Gene targeting studies have revealed hierarchical relationships between these and the other MRF genes, Mrf4 and myogenin, where the latter are regarded as differentiation genes(7). Here we show, using an allelic series of three Myf5 mutants that differentially affect the expression of the genetically linked Mrf4 gene, that skeletal muscle is present in the new Myf5: Myod double- null mice only when Mrf4 expression is not compromised. This finding contradicts the widely held view thatmyogenic identity is conferred solely byMyf5 and Myod, and identifies Mrf4 as a determination gene. We revise the epistatic relationship of the MRFs, in which both Myf5 and Mrf4 act upstream of Myod to direct embryonic multipotent cells into the myogenic lineage.	CNRS, URA 2578, Dept Dev Biol, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Tajbakhsh, S (corresponding author), CNRS, URA 2578, Dept Dev Biol, 25 Rue Dr Roux, F-75724 Paris 15, France.	shaht@pasteur.fr		Gayraud-Morel, Barbara/0000-0002-1168-8504; Shinin, Vasily/0000-0002-4285-6515				Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; Daubas P, 2000, DEVELOPMENT, V127, P319; Hadchouel J, 2000, DEVELOPMENT, V127, P4455; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Moran JL, 1999, NATURE, V399, P742, DOI 10.1038/21560; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Rawls A, 1998, DEVELOPMENT, V125, P2349; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Summerbell D, 2002, MECH DEVELOP, V117, P331, DOI 10.1016/S0925-4773(02)00208-3; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1995, DEVELOPMENT, V121, P4077; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Wang YK, 1997, DEVELOPMENT, V124, P2507; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704	29	455	483	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					466	471		10.1038/nature02876	http://dx.doi.org/10.1038/nature02876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386014				2022-12-01	WOS:000224000500044
J	Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U				Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U			A frequency-dependent switch from inhibition to excitation in a hippocampal unitary circuit	NATURE			English	Article							MOSSY FIBER SYNAPSES; RAT HIPPOCAMPUS; SLICE CULTURES; SYNAPTIC CONNECTIONS; PYRAMIDAL CELLS; CA3 NEURONS; ORGANIZATION; CONDUCTANCE; DEPRESSION; INVITRO	The hippocampus, a brain structure essential for memory and cognition, is classically represented as a trisynaptic excitatory circuit. Recent findings challenge this view, particularly with regard to the mossy fibre input to CA3, the second synapse in the trisynaptic pathway(1). Thus, the powerful mossy fibre input to CA3 pyramidal cells might mediate both synaptic excitation and inhibition(2,3). Here we show, by recording from connected cell pairs in rat entorhinal - hippocampal slice cultures, that single action potentials in a dentate granule cell evoke a net inhibitory signal in a pyramidal cell. The hyperpolarization is due to disynaptic feedforward inhibition, which overwhelms monosynaptic excitation. Interestingly, this net inhibitory synaptic response changes to an excitatory signal when the frequency of presynaptic action potentials increases. The process responsible for this switch involves the facilitation of monosynaptic excitatory transmission coupled with rapid depression of inhibitory circuits. This ability to immediately switch the polarity of synaptic responses constitutes a novel synaptic mechanism, which might be crucial to the state-dependent processing of information in associative hippocampal networks.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Zurich	Mori, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	mori@hifo.unizh.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FROTSCHER M, 1988, NEUROSCIENCE, V24, P541, DOI 10.1016/0306-4522(88)90348-X; FROTSCHER M, 1989, EXP BRAIN RES, V75, P441; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; SCHWARTZKROIN PA, 1990, PROG BRAIN RES, V83, P269; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Spruston N, 1997, J COMP NEUROL, V385, P427; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Varela JA, 1999, J NEUROSCI, V19, P4293; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	30	138	139	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					453	456		10.1038/nature02854	http://dx.doi.org/10.1038/nature02854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386013				2022-12-01	WOS:000224000500041
J	Rauch, EM; Bar-Yam, Y				Rauch, EM; Bar-Yam, Y			Theory predicts the uneven distribution of genetic diversity within species	NATURE			English	Article							GEOGRAPHIC BARRIERS; BIODIVERSITY; POPULATIONS; GENEALOGIES; COALESCENT; DISPERSAL; HOTSPOTS; SIZE	Global efforts to conserve species have been strongly influenced by the heterogeneous distribution of species diversity across the Earth. This is manifest in conservation efforts focused on diversity hotspots(1-3). The conservation of genetic diversity within an individual species(4,5) is an important factor in its survival in the face of environmental changes and disease(6,7). Here we show that diversity within species is also distributed unevenly. Using simple genealogical models, we show that genetic distinctiveness has a scale-free power law distribution. This property implies that a disproportionate fraction of the diversity is concentrated in small sub-populations, even when the population is well-mixed. Small groups are of such importance to overall population diversity that even without extrinsic perturbations, there are large fluctuations in diversity owing to extinctions of these small groups. We also show that diversity can be geographically non-uniform potentially including sharp boundaries between distantly related organisms - without extrinsic causes such as barriers to gene flow or past migration events. We obtained these results by studying the fundamental scaling properties of genealogical trees. Our theoretical results agree with field data from global samples of Pseudomonas bacteria. Contrary to previous studies(8), our results imply that diversity loss owing to severe extinction events is high, and focusing conservation efforts on highly distinctive groups can save much of the diversity.	MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; New England Complex Syst Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT)	Rauch, EM (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 32 Vassar St, Cambridge, MA 02139 USA.	rauch@necsi.org						Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fisher R., 1930, P ROY SOC EDINB, V50, P205; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Irwin DE, 2002, EVOLUTION, V56, P2383; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nei M., 1987, MOL EVOLUTIONARY GEN; Notohara M, 2001, J APPL PROBAB, V38, P1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WATTERSON GA, 1982, ADV APPL PROBAB, V14, P206, DOI 10.2307/1426517; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Wilkins JF, 2002, GENETICS, V161, P873; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wright S, 1943, GENETICS, V28, P114	28	44	45	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					449	452		10.1038/nature02745	http://dx.doi.org/10.1038/nature02745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386012				2022-12-01	WOS:000224000500040
J	Rolett, B; Diamond, J				Rolett, B; Diamond, J			Environmental predictors of pre-European deforestation on Pacific islands	NATURE			English	Article								Some Pacific island societies, such as those of Easter Island and Mangareva, inadvertently contributed to their own collapse by causing massive deforestation(1-7). Others retained forest cover and survived(3,8,9). How can those fateful differences be explained? Although the answers undoubtedly involve both different cultural responses of peoples and different susceptibilities of environments, how can one determine which environmental factors predispose towards deforestation and which towards replacement of native trees with useful introduced tree species? Here we code European-contact conditions and nine environmental variables for 81 sites on 69 Pacific islands from Yap in the west to Easter in the east, and from Hawaii in the north to New Zealand in the south. We thereby detect statistical decreases in deforestation and/or forest replacement with island rainfall, elevation, area, volcanic ash fallout, Asian dust transport and makatea terrain ( uplifted reef), and increases with latitude, age and isolation. Comparative analyses of deforestation therefore lend themselves to much more detailed interpretations than previously possible. These results might be relevant to similar deforestation-associated collapses ( for example, Fertile Crescent, Maya and Anasazi) or the lack thereof ( Japan and highland New Guinea) elsewhere in the world.	Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of Hawaii System; University of California System; University of California Los Angeles	Rolett, B (corresponding author), Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA.	rolett@hawaii.edu						Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BARRAU J, 1958, BISHOP MUS B, V219; Bellwood P.S., 1987, POLYNESIANS PREHISTO; BETANCOURT JL, 1981, SCIENCE, V214, P656, DOI 10.1126/science.214.4521.656; Brieman L, 1984, CLASSIFICATION REGRE; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Flenley J, 2002, ENIGMAS EASTER ISLAN; Ginoux P, 2001, J GEOPHYS RES-ATMOS, V106, P20255, DOI 10.1029/2000JD000053; Haberle S.G., 1998, AUST ARCHAEOL, V47, P1, DOI DOI 10.1080/03122417.1998.11681610; JENNRICH R, 1995, INTRO COMPUTATIONAL, pCH9; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30; Mieth A, 2003, RAPA NUI J, V17, P34; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Spriggs M., 1997, ISLAND MELANESIANS; Totman C.D., 1989, GREEN ARCHIPELAGO FO; Vinton Kirch P., 2017, ROAD WINDS; Webster D., 2002, FALL ANCIENT MAYA	17	107	110	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					443	446		10.1038/nature02801	http://dx.doi.org/10.1038/nature02801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386010				2022-12-01	WOS:000224000500038
J	Yoda, K; Tomonaga, T				Yoda, K; Tomonaga, T			Centromere identity originates in the structure of CENP-A/H4 tetramer itself: a mechanism for aneuploidy	LANCET			English	Editorial Material							CENP-A; HISTONE H3; CHROMATIN		Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan	Nagoya University; Chiba University	Yoda, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	i45156a@nucc.cc.nagoya-u.ac.jp						Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; RAJAGOPALAN H, 2003, NAT REV CANCER, V3, P3511; SART D, 1997, NAT GENET, V16, P144; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tomonaga T, 2003, CANCER RES, V63, P3511; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1022	1024		10.1016/S0140-6736(04)17077-3	http://dx.doi.org/10.1016/S0140-6736(04)17077-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380953				2022-12-01	WOS:000223959300009
J	Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A				Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A			Post-mating clutch piracy in an amphibian	NATURE			English	Article							MULTIPLE PATERNITY; RANA-TEMPORARIA; BOREAL POPULATION; COMMON FROGS; BODY-SIZE; SELECTION; SUCCESS; SYSTEMS	Female multiple mating and alternative mating systems can decrease the opportunity for sexual selection(1-3). Sperm competition is often the outcome of females mating with multiple males and has been observed in many animals(1,4-7), and alternative reproductive systems are widespread among species with external fertilization and parental care(3,8-10). Multiple paternity without associated complex behaviour related to mating or parental care is also seen in simultaneously spawning amphibians(11-15) and fishes(16) that release gametes into water. Here we report 'clutch piracy' in a montane population of the common frog Rana temporaria, a reproductive behaviour previously unknown in vertebrates with external fertilization. Males of this species clasp the females and the pair deposits one spherical clutch of eggs. No parental care is provided. 'Pirate' males search for freshly laid clutches, clasp them as they would do a female and fertilize the eggs that were left unfertilized by the 'parental' male. This behaviour does not seem to be size-dependent, and some males mate with a female and perform clutch piracy in the same season. Piracy affected 84% of the clutches and in some cases increased the proportion of eggs fertilized, providing direct fitness benefits both for the pirate males and the females(17). Sexual selection probably caused by a strong male-biased sex ratio-occurs in this population, as indicated by size-assortative mating; however, clutch piracy may reduce its impact. This provides a good model to explore how alternative mating strategies can affect the intensity of sexual selection.	Univ Vigo, Fac Ciencias Biol, Dept Ecol & Biol Anim, Lab Anat Anim, Vigo 36201, Spain; Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78457 Constance, Germany; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Amsterdam, Museum Zool, NL-1092 AD Amsterdam, Netherlands	Universidade de Vigo; University of Konstanz; University of Amsterdam; University of Amsterdam	Vieites, DR (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	vieites@berkeley.edu	Vences, Miguel/E-5573-2010; Barluenga, Marta/ABA-4194-2020; Vieites, David/B-4481-2009; Soler, Antonio Palanca/B-4206-2010; Meyer, Axel/C-9826-2009	Barluenga, Marta/0000-0003-1514-0586; Vieites, David/0000-0001-5551-7419; Meyer, Axel/0000-0002-0888-8193; Vences, Miguel/0000-0003-0747-0817				Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Birkhead Timothy R., 1997, P121; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Byrne PG, 1999, P ROY SOC B-BIOL SCI, V266, P717, DOI 10.1098/rspb.1999.0695; Clutton-Brock T. H., 1991, MONOGRAPHS BEHAV ECO; DORGEIX CA, 1995, MOL ECOL, V4, P505, DOI 10.1111/j.1365-294X.1995.tb00245.x; Duellman WE, 1986, BIOL AMPHIBIANS, P1; ELMBERG J, 1987, HOLARCTIC ECOL, V10, P193; ELMBERG J, 1990, CAN J ZOOL, V68, P121, DOI 10.1139/z90-017; ELMBERG J, 1991, BEHAV ECOL SOCIOBIOL, V28, P125; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Garner TWJ, 2003, P ROY SOC B-BIOL SCI, V270, P619, DOI 10.1098/rspb.2002.2284; GIBBONS MM, 1986, J ZOOL, V209, P579, DOI 10.1111/j.1469-7998.1986.tb03613.x; Grossenbacher K., 1997, ATLAS AMPHIBIANS REP, P158; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 1998, EVOLUTION, V52, P848, DOI [10.2307/2411279, 10.1111/j.1558-5646.1998.tb03709.x]; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Laurila A, 1998, BIOL J LINN SOC, V63, P221; Lode T, 2004, NATURWISSENSCHAFTEN, V91, P44, DOI 10.1007/s00114-003-0491-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Neff BD, 2002, J FISH BIOL, V61, P739, DOI [10.1006/jfbi.2002.2101, 10.1111/j.1095-8649.2002.tb00908.x]; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Rico C, 1992, MOL ECOL, V1, P79, DOI 10.1111/j.1365-294X.1992.tb00159.x; Roberts JD, 1999, ANIM BEHAV, V57, P721, DOI 10.1006/anbe.1998.1019; Shuster S. M., 2003, MATING SYSTEMS STRAT, DOI [10.2307/j.ctvs32sqk, DOI 10.2307/J.CTVS32SQK]; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Vos CC, 2001, HEREDITY, V86, P598, DOI 10.1046/j.1365-2540.2001.00865.x	30	93	102	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					305	308		10.1038/nature02879	http://dx.doi.org/10.1038/nature02879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372032	Green Submitted			2022-12-01	WOS:000223864000040
J	Rao, BL; Basu, A; Wairagkar, NS; Gore, MM; Arankalle, VA; Thakare, JP; Jadi, RS; Rao, KA; Mishra, AC				Rao, BL; Basu, A; Wairagkar, NS; Gore, MM; Arankalle, VA; Thakare, JP; Jadi, RS; Rao, KA; Mishra, AC			A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus	LANCET			English	Article							FEBRILE ILLNESS; ASSAY; TRANSMISSION; ANIMALS; PCR	Background An outbreak of acute encephalitis of unknown origin with high case fatality (183 of 329 cases) was reported in children from Andhra Pradesh state in southern India during 2003. We investigated the causative agent. Methods Cell lines and peripheral blood lymphocyte co-cultures were used to isolate the causative agent from clinical samples. Identity of the agent was established by electron microscopy and serological and molecular assays. Findings Clinical samples tested negative for IgM antibodies to Japanese encephalitis, West Nile, dengue, and measles viruses, and for RNA of coronavirus, paramyxovirus, enterovirus, and influenza viruses. Virus was isolated from six patients with encephalitis and was identified as Chandipura virus by electron microscopy, complement fixation, and neutralisation tests. Chandipura virus RNA was detected in clinical samples from nine patients. Sequencing of five of these RNA samples showed 96.7-97.5% identity with the reference strain of 1965. Chandipura viral antigen and RNA were detected in brain tissue of a deceased child by immunofluorescent antibody test and PCR. Neutralising, IgG, and IgM antibodies to Chandipura virus were present in some patients' serum samples. Serum samples obtained after 4 days of illness were more frequently positive for IgM to Chandipura virus than were those obtained earlier (p<0.001). A similar trend was noted for neutralising antibodies. Interpretation Our findings suggest that this outbreak of acute encephalitis in Andhra Pradesh was associated with Chandipura virus, adding to the evidence suggesting that this virus should be considered as an important emerging pathogen.	Natl Inst Virol, Pune 411001, Maharashtra, India; Karimnagar Dist Hosp, Karimnagar, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mishra, AC (corresponding author), Natl Inst Virol, 20A Dr Ambedkar Rd, Pune 411001, Maharashtra, India.	acm1750@rediffmail.com	Jadi, Ramesh/AAV-2059-2020	Jadi, Ramesh/0000-0002-5710-4893; Arankalle, Vidya/0000-0002-9940-3437				BANERJEE K, 1984, VIRUS ECOLOGY, P109; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; de Mattos C, 2001, FIELDS VIROLOGY, P1245; DHANDA V, 1970, INDIAN J MED RES, V58, P179; GORE MM, 1985, INDIAN J MED RES, V81, P343; ILKAL MA, 1991, ACTA VIROL, V35, P27, DOI 10.1016/0166-0934(91)90082-B; John T Jacob, 2003, Indian Pediatr, V40, P863; KELKAR SD, 1976, INDIAN J MED RES, V64, P814; KEMP GE, 1975, B WORLD HEALTH ORGAN, V52, P615; KUMAR S, 2001, MEGA2 1 MOL EVOLUTIO; NAJIB KHAN, 1954, Indian Journal of Medical Sciences, V8, P597; NERURKAR LS, 1984, J CLIN MICROBIOL, V20, P109, DOI 10.1128/JCM.20.1.109-114.1984; Poddar SK, 2002, J CLIN LAB ANAL, V16, P163, DOI 10.1002/jcla.10036; RAO TR, 1967, INDIAN J MED RES, V55, P1306; Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999; RODRIGUE.FM, 1972, B WORLD HEALTH ORGAN, V46, P173; RODRIGUES FM, 1984, INDIAN J MED RES S, P1; RODRIGUES JJ, 1983, INDIAN J MED RES, V77, P303; SEVER JL, 1962, J IMMUNOL, V88, P320; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; TESH RB, 1993, AM J TROP MED HYG, V32, P621; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480	23	131	142	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					869	874		10.1016/S0140-6736(04)16982-1	http://dx.doi.org/10.1016/S0140-6736(04)16982-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351194	Bronze, Green Published			2022-12-01	WOS:000223685200033
J	Jaffe, H				Jaffe, H			Whatever happened to the US AIDS epidemic?	SCIENCE			English	Editorial Material							HIV; MEN		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Jaffe, H (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; BOZZETTE SA, 2003, NEW ENGL J MED, V344, P817; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2002, CAS HIV INF AIDS US; *CDCP, FACT SHEET PUBLIC HL; Centers for Disease Control and Prevention, UNPUB; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1229; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1013; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; FLEMING PL, 2002, 9 C RETR OPP INF SEA; *KAIS FAM FDN, 2004, SURV AM HIV AIDS 1; KAMIMOTO L, 2004, 11 C RETR OPP INF SA; LYTER DW, 1987, PUBLIC HEALTH REP, V102, P468; MECKLER L, 2002, WASHINGTON POST 0123, pA15; Montgomery JP, 2003, AIDS CARE, V15, P829, DOI 10.1080/09540120310001618676; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Urbina A, 2004, CLIN INFECT DIS, V38, P890, DOI 10.1086/381975; *US BUR JUST, US DEP JUST BUR JUST; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; *WASH POST KAIS FA, 2002, NAT SURV PUBL ATT HI; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115	23	25	26	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1243	1244		10.1126/science.1101136	http://dx.doi.org/10.1126/science.1101136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333825				2022-12-01	WOS:000223624600025
J	Leonard, MB; Feldman, HI; Shults, J; Zemel, BS; Foster, BJ; Stallings, VA				Leonard, MB; Feldman, HI; Shults, J; Zemel, BS; Foster, BJ; Stallings, VA			Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							X-RAY ABSORPTIOMETRY; GLOMERULAR-FILTRATION RATE; CHILDREN; DENSITY; DISEASE; OSTEOPENIA; FRACTURES; GROWTH; RISK; OSTEOPOROSIS	BACKGROUND: Glucocorticoids suppress bone formation, impair growth, and induce obesity. We determined the effects of long-term treatment with glucocorticoids on bone mineral content in children with glucocorticoid-sensitive nephrotic syndrome, a disorder with minimal known independent effects on bone. METHODS: We performed dual-energy x-ray absorptiometry of the whole body and spine in 60 children and adolescents with the nephrotic syndrome and 195 control subjects. We used linear regression analysis of log-transformed values to compare the bone mineral content in patients with that in controls. RESULTS: Patients had received an average of 23,000 mg of glucocorticoids and were shorter (P=0.008) and had a greater body-mass index (P<0.001) than controls. The bone mineral content of the spine, adjusted for bone area, age, sex, degree of maturation (Tanner stage), and race, did not differ significantly between patients and controls (ratio, 0.99; 95 percent confidence interval, 0.96 to 1.02; P=0.51). After adjustment for the z score for body-mass index, the bone mineral content of the spine was significantly lower in patients than in controls (0.96; 95 percent confidence interval, 0.92 to 0.99; P=0.01). Whole-body bone mineral content, adjusted for height, age, sex, degree of maturation, and race, was significantly higher in patients than in controls (ratio, 1.11; 95 percent confidence interval, 1.05 to 1.18; P<0.001); however, the addition of the z score for body-mass index to the model eliminated the association with the nephrotic syndrome (ratio, 0.99; 95 percent confidence interval, 0.94 to 1.03; P=0.55). CONCLUSIONS: Intermittent treatment with high-dose glucocorticoids during growth does not appear to be associated with deficits in the bone mineral content of the spine or whole body relative to age, bone size, sex, and degree of maturation. Glucocorticoid-induced increases in body-mass index were associated with increased whole-body bone mineral content and maintenance of the bone mineral content of the spine.	Childrens Hosp Philadelphia, Dept Pediat, CHOP N, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Leonard, MB (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, CHOP N, Rm 1564, Philadelphia, PA 19104 USA.	leonard@email.chop.edu	Zemel, Babette S./D-1117-2009	Zemel, Babette S./0000-0002-6164-7348	NCRR NIH HHS [M01RR00240] Funding Source: Medline; NIDDK NIH HHS [1-R03-DK058200, T32 DK007785, K08-DK02523] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007785, K08DK002523, R03DK058200] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhudhikanok GS, 1996, PEDIATRICS, V97, P103; Boot AM, 1998, GUT, V42, P188, DOI 10.1136/gut.42.2.188; BRODEHL J, 1991, EUR J PEDIATR, V150, P380, DOI 10.1007/BF02093714; Canalis E, 2002, J PEDIATR ENDOCR MET, V15, P1341; CARTER DR, 1992, J BONE MINER RES, V7, P137; Daniel V, 1997, CLIN NEPHROL, V47, P289; Ellis KJ, 2001, J BONE MINER RES, V16, P1658, DOI 10.1359/jbmr.2001.16.9.1658; Ferraris JR, 2000, PEDIATR NEPHROL, V14, P682, DOI 10.1007/s004670000337; Freundlich M, 2004, PEDIATR NEPHROL, V19, P400, DOI 10.1007/s00467-003-1378-8; FREUNDLICH M, 1985, PEDIATRICS, V76, P280; Gafni RI, 2004, J PEDIATR-US, V144, P253, DOI 10.1016/j.jpeds.2003.08.054; Gafni RI, 2002, FASEB J, V16, P736, DOI 10.1096/fj.01-0640fje; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359/jbmr.1998.13.1.143; GRYMONPREZ A, 1995, PEDIATR NEPHROL, V9, P278, DOI 10.1007/BF02254183; Gulati S, 2003, AM J KIDNEY DIS, V41, P1163, DOI 10.1016/S0272-6386(03)00348-2; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; LAAN RF, 1994, ANN INTERN MED, V119, P963; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Leonard MB, 1998, J BONE MINER RES, V13, P1687, DOI 10.1359/jbmr.1998.13.11.1687; Leonard MB, 2004, BONE, V34, P1044, DOI 10.1016/j.bone.2003.12.003; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Leonard MB, 2002, PEDIATR CLIN N AM, V49, P143, DOI 10.1016/S0031-3955(03)00113-5; Leonard MB, 1999, J PEDIATR-US, V135, P182, DOI 10.1016/S0022-3476(99)70020-X; Lien G, 2003, ARTHRITIS RHEUM-US, V48, P2214, DOI 10.1002/art.11097; Ma DQ, 2003, J BONE MINER RES, V18, P1970, DOI 10.1359/jbmr.2003.18.11.1970; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Petit MA, 2002, J BONE MINER RES, V17, P363, DOI 10.1359/jbmr.2002.17.3.363; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; SCHWARTZ GJ, 1984, J PEDIATR-US, V104, P849, DOI 10.1016/S0022-3476(84)80479-5; Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509; Stewart WA, 2003, ARTHRITIS RHEUM, V48, P2294, DOI 10.1002/art.11211; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Taylor A, 1997, J BONE MINER RES, V12, P652, DOI 10.1359/jbmr.1997.12.4.652; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Van Staa TP, 2003, J BONE MINER RES, V18, P913, DOI 10.1359/jbmr.2003.18.5.913; 1981, J PEDIAT, V98, P561	39	144	152	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2004	351	9					868	875		10.1056/NEJMoa040367	http://dx.doi.org/10.1056/NEJMoa040367			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849BM	15329424				2022-12-01	WOS:000223512500008
J	Gregory, R				Gregory, R			The blind leading the sighted	NATURE			English	Editorial Material									Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol	Gregory, R (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England.								0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					836	836		10.1038/430836a	http://dx.doi.org/10.1038/430836a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318199	Bronze			2022-12-01	WOS:000223369800021
J	Loh, AN; Bauer, JE; Druffel, ERM				Loh, AN; Bauer, JE; Druffel, ERM			Variable ageing and storage of dissolved organic components in the open ocean	NATURE			English	Article							PACIFIC-OCEAN; BLACK CARBON; MATTER; RADIOCARBON; SEDIMENTS; WATER; SEA; ENVIRONMENTS; FRACTIONS	Seawater dissolved organic matter (DOM) is the largest reservoir of exchangeable organic carbon in the ocean, comparable in quantity to atmospheric carbon dioxide(1,2). The composition, turnover times and fate of all but a few planktonic constituents of this material are, however, largely unknown(3,4). Models of ocean carbon cycling are thus limited by the need for information on temporal scales of carbon storage in DOM subcomponents, produced via the 'biological pump', relative to their recycling by bacteria(3,4). Here we show that carbohydrate- and protein-like substances in the open Atlantic and Pacific oceans, though often significantly aged, comprise younger fractions of the DOM, whereas dissolved lipophilic material exhibits up to similar to90 per cent fossil character. In contrast to the millennial mean ages of DOM observed throughout the water column, weighted mean turnover times of DOM in the surface ocean are only decadal in magnitude. An observed size-age continuum further demonstrates that small dissolved molecules are the most highly aged forms of organic matter, cycling much more slowly than larger, younger dissolved and particulate precursors, and directly links oceanic organic matter age and size with reactivity(3,5).	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Coll William & Mary, Sch Marine Sci, Gloucester Point, VA 23062 USA	University of California System; University of California Irvine; William & Mary	Loh, AN (corresponding author), Florida Gulf Coast Univ, Coll Arts & Sci, Div Ecol Studies, 10501 FGCU Blvd S, Ft Myers, FL 33965 USA.	anloh@fgcu.edu						Aluwihare LI, 2002, DEEP-SEA RES PT II, V49, P4421, DOI 10.1016/S0967-0645(02)00124-8; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Benner R., 2002, BIOGEOCHEMISTRY MARI, P59, DOI [10.1016/B978-012323841-2/50005-1, DOI 10.1016/B978-012323841-2/50005-1]; Carlson C. A., 2002, BIOGEOCHEMISTRY MARI, V805, P91, DOI [10.1016/b978-012323841-2/50006-3, DOI 10.1016/B978-012323841-2/50006-3]; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Druffel ERM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017423; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; Eglinton TI, 1997, SCIENCE, V277, P796, DOI 10.1126/science.277.5327.796; Eglinton TI, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000269; GOERICKE R, 1994, STABLE ISOTOPES ECOL, P181; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Hwang JS, 2003, SCIENCE, V299, P881, DOI 10.1126/science.1078508; LOH AN, 2002, THESIS COLL WILLIAM; Masiello CA, 1998, SCIENCE, V280, P1911, DOI 10.1126/science.280.5371.1911; Masiello CA, 2002, GEOCHIM COSMOCHIM AC, V66, P1025, DOI 10.1016/S0016-7037(01)00831-6; SANTSCHI PH, 1995, GEOCHIM COSMOCHIM AC, V59, P625, DOI 10.1016/0016-7037(94)00378-Y; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trumbore SE, 1995, DAHL WS ENV, V16, P7; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; Wakeham SG, 1997, DEEP-SEA RES PT II, V44, P2131, DOI 10.1016/S0967-0645(97)00035-0; Wang XC, 2001, GEOPHYS RES LETT, V28, P3313, DOI 10.1029/2001GL013430; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X; Whelan J.K., 1993, ORG GEOCHEM, P289; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	30	134	140	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					877	881		10.1038/nature02780	http://dx.doi.org/10.1038/nature02780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318218	Green Published			2022-12-01	WOS:000223369800038
J	Piffanelli, P; Ramsay, L; Waugh, R; Benabdelmouna, A; D'Hont, A; Hollricher, K; Jorgensen, JH; Schulze-Lefert, P; Panstruga, R				Piffanelli, P; Ramsay, L; Waugh, R; Benabdelmouna, A; D'Hont, A; Hollricher, K; Jorgensen, JH; Schulze-Lefert, P; Panstruga, R			A barley cultivation-associated polymorphism conveys resistance to powdery mildew	NATURE			English	Article							MLO FAMILY; DIVERSITY; GENE; DEFENSE; PROTEIN; GENOME; PLANTS	Barley ( Hordeum vulgare) has played a pivotal role in Old World agriculture since its domestication about 10,000 yr ago(1). Barley plants carrying loss-of-function alleles (mlo) of the Mlo locus are resistant against all known isolates of the widespread powdery mildew fungus(2). The sole mlo resistance allele recovered so far from a natural habitat, mlo-11, was originally retrieved from Ethiopian landraces and nowadays controls mildew resistance in the majority of cultivated European spring barley elite varieties(2). Here we use haplotype analysis to show that the mlo-11 allele probably arose once after barley domestication. Resistance in mlo-11 plants is linked to a complex tandem repeat array inserted upstream of the wild-type gene. The repeat units consist of a truncated Mlo gene comprising 3.5 kilobases (kb) of 50-regulatory sequence plus 1.1 kb of coding sequence. These generate aberrant transcripts that impair the accumulation of both Mlo wild-type transcript and protein. We exploited the meiotic instability of mlo-11 resistance and recovered susceptible revertants in which restoration of Mlo function was accompanied by excision of the repeat array. We infer cis-dependent perturbation of transcription machinery assembly by transcriptional interference in mlo-11 plants as a likely mechanism leading to disease resistance.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Scottish Crop Res Inst, Genome Unit, Dundee DD2 5DA, Scotland; CIRAD, F-34398 Montpellier 5, France; Max Planck Inst Zuchtungsforsch, Dept Plant Breeding & Yield Physiol, D-50829 Cologne, Germany; Riso Natl Lab, Res Dept, DK-4000 Roskilde, Denmark; Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; James Hutton Institute; CIRAD; Max Planck Society; Technical University of Denmark; Max Planck Society	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Bruening, Stefan/B-8505-2011; DHONT, Angélique/AAL-8074-2021; Schulze-Lefert, Paul/A-7746-2008; Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957; Benabdelmouna, Abdellah/0000-0003-1910-219X				Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chopra S, 2003, GENETICS, V163, P1135; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; GIESSEN J. E., 1956, Zeitschrift fur Pflanzenzuchtung, V35, P377; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; JORGENSEN JH, 1976, BARLEY GENET, V3, P446; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Matus IA, 2002, GENOME, V45, P1095, DOI [10.1139/g02-071, 10.1139/G02-071]; NEGASSA M, 1985, HEREDITAS, V102, P113, DOI 10.1111/j.1601-5223.1985.tb00472.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Pakniyat H, 1997, GENOME, V40, P332, DOI 10.1139/g97-046; Panstruga R, 2003, MICROBES INFECT, V5, P429, DOI 10.1016/S1286-4579(03)00053-4; Panstruga R, 1998, NUCLEIC ACIDS RES, V26, P1056, DOI 10.1093/nar/26.4.1056; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Simons G, 1997, GENOMICS, V44, P61, DOI 10.1006/geno.1997.4844; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Thomas WTB, 1998, MOL BREEDING, V4, P381, DOI 10.1023/A:1009646115967	27	125	142	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					887	891		10.1038/nature02781	http://dx.doi.org/10.1038/nature02781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318221	Green Published			2022-12-01	WOS:000223369800041
J	Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF				Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF			Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER-SOCIETY GUIDELINES; SCREENING COLONOSCOPY; ASYMPTOMATIC ADULTS; CLINICAL GUIDELINES; PRACTICE PATTERNS; POLYP GUIDELINE; UNITED-STATES; RISK; UPDATE; CARE	Background: increasing use of colonoscopy for colorectal cancer screening and surveillance of colorectal adenomas after polypectomy has given rise to concerns about the availability of endoscopic resources in the United States. Guidelines recommend surveillance after polypectomy at 3 to 5 years for a small adenoma, and follow-up is not advised for hyperplastic polyps. The intensity of physicians' surveillance is largely unstudied. Objective: To survey practicing gastroenterologists and general surgeons about their perceived need for the frequency of surveillance after polypectomy, to compare survey responses to practice guidelines, and to identify factors influencing their recommendations for surveillance. Design: Survey study conducted by the National Cancer Institute. Setting: A nationally representative study of physicians in the United States. Participants: 349 gastroenterologists and 316 general surgeons. Measurements: Questionnaires mailed in 1999 and 2000 assessed physicians' recommendations for surveillance after polypectomy in asymptomatic, average-risk patients. Results: Response rates were 83%. Among gastroenterologists (317 of 349) and surgeons (125 of 316) who perform screening colonoscopy, 24% (95% Cl, 19.3% to 28.7%) of gastroenterologists and 54% (Cl, 44.9% to 62.5%) of surgeons recommend surveillance for a hyperplastic polyp. For a small adenoma, most physicians recommended surveillance colonoscopy and more than 50% recommended examinations every 3 years or more often. Physicians indicated that published evidence was very influential in their practice (83% [Cl, 78.8% to 87.2%] of gastroenterologists and 78% [Cl, 72.5% to 86.8%] of surgeons). By contrast, only half of respondents reported that guidelines were very influential. Limitations: The study was based on physicians' self-reported practice patterns. Results may overestimate or underestimate the performance of surveillance colonoscopy. Conclusions: Some surveillance colonoscopy seems to be inappropriately performed and in excess of guidelines, particularly for hyperplastic polyps and low-risk lesions such as a small adenoma. These results suggest unnecessary demand for endoscopic resources.	NCI, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Brown, ML (corresponding author), NCI, Executive Plaza N 4005,6130 Executive Blvd, Bethesda, MD 20892 USA.	mb53o@nih.gov			NCI NIH HHS [N01-PC-85169] Funding Source: Medline; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC085169] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences)		*AM SOC GASTR END, 1997, COL SCREEN SURV IND, V1030; *AM SOC GASTR END, 1997, COL SCREEN SURV IND; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BOND JH, 1993, ANN INTERN MED, V119, P836, DOI 10.7326/0003-4819-119-8-199310150-00010; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CANNONALBRIGHT LA, 1994, AM J GASTROENTEROL, V89, P827; Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601; Cruz-Correa M, 2001, ARCH INTERN MED, V161, P2588, DOI 10.1001/archinte.161.21.2588; *CTR MED MED SERV, MED INF RES; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HEDBERG CA, 2002, LETT HLTH INSURANCE; HILLMAN AL, 1991, HEALTH AFFAIR, V10, P138, DOI 10.1377/hlthaff.10.4.138; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KODNER IJ, 1999, PRINCIPLES SURG, P1342; KOLATA G, 2003, NY TIMES        1208, pA23; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MAGUIRE PO, 2002, ACP OBSERVER, V1, P16; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ransohoff DF, 2002, GASTROENTEROL CLIN N, V31, P1031, DOI 10.1016/S0889-8553(02)00059-6; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; Rosson RS, 2003, ANN INTERN MED, V138, P356, DOI 10.7326/0003-4819-138-4-200302180-00022; Simmang CL, 1999, DIS COLON RECTUM, V42, P1123, DOI 10.1007/BF02238562; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; WAYE JD, 1982, ENDOSCOPY, V14, P79, DOI 10.1055/s-2007-1021585; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82821-8	45	262	266	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					264	271		10.7326/0003-4819-141-4-200408170-00006	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313742				2022-12-01	WOS:000223290900003
J	Orach, CG; De Brouwere, V				Orach, CG; De Brouwere, V			Postemergency health services for refugee and host populations in Uganda, 1999-2002	LANCET			English	Article								Since 1990, Uganda has hosted an estimated 200000 refugees in postemergency settlements interspersed within host communities. We investigated the extent to which obstetric needs were met in the refugee and host populations during 1999-2002. Between September and December, 2000, we retrospectively collected data from 1999 and 2000 on major obstetric interventions for absolute maternal indications from all five hospitals in Arua, Adjumani, and Moyo districts, Uganda. The same data were collected prospectively for 2001. We did community-based maternal mortality surveys on refugee and host populations in Adjumani district in 2002. Rates of major obstetric interventions were significantly higher for refugees than for the host population who live in the same rural areas as refugees (1.01% [95% CI 0.77-1.25] vs 0.45% [0.38-0.52]; p<0.0001). Rates of major obstetric interventions were also significantly higher for refugees than for the host population who live in rural areas without refugees (1.01% [0.77-1.25] vs 0.40% [0.36-0.441; p<0.0001). Maternal mortality was 2.5 times higher in the host population than in refugees in the Adjumani district (322 per 100000 births [247-396] vs 130 [81-179]. Refugees had better access to health services than did the rural host population in the northern Ugandan communities that we surveyed.	Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Free Univ Brussels, B-1050 Brussels, Belgium; Inst Trop Med, B-2000 Antwerp, Belgium	Makerere University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM)	Orach, CG (corresponding author), Makerere Univ, Inst Publ Hlth, POB 7072, Kampala, Uganda.	cgorach@iph.ac.ug						*CDCP, 1992, MMWR-MORBID MORTAL W, V41; *GOU UNHCR, 1999, SELF REL REF HOST AR; Goyens P., 1996, Journal of Refugee Studies, V9, P268, DOI 10.1093/jrs/9.3.268; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8	5	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					611	612		10.1016/S0140-6736(04)16854-2	http://dx.doi.org/10.1016/S0140-6736(04)16854-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313362				2022-12-01	WOS:000223275100034
J	Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK				Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK			Optical sectioning deep inside live embryos by selective plane illumination microscopy	SCIENCE			English	Article							GENE-EXPRESSION; FLUORESCENCE MICROSCOPY; THETA MICROSCOPY; CELL; AXIS; TOMOGRAPHY; RESOLUTION; SPECIMENS; MEDAKA; TOOL	Large, living biological specimens present challenges to existing optical imaging techniques because of their absorptive and scattering properties. We developed selective plane illumination microscopy (SPIM) to generate multidimensional images of samples up to a few millimeters in size. The system combines two-dimensional illumination with orthogonal camera-based detection to achieve high-resolution, optically sectioned imaging throughout the sample, with minimal photodamage and at speeds capable of capturing transient biological phenomena. We used SPIM to visualize all muscles in vivo in the transgenic Medaka line Arnie, which expresses green fluorescent protein in muscle tissue. We also demonstrate that SPIM can be applied to visualize the embryogenesis of the relatively opaque Drosophila melanogaster in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Huisken, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	huisken@embl.de; stelzer@embl.de	del bene, filippo/D-1245-2010; Swoger, Jim/H-7651-2015; Stelzer, Ernst H K/A-7648-2011; Wittbrodt, Joachim/D-4735-2014; Huisken, Jan/B-2472-2009	del bene, filippo/0000-0001-8551-2846; Swoger, Jim/0000-0003-3805-0073; Stelzer, Ernst H K/0000-0003-1545-0736; Wittbrodt, Joachim/0000-0001-8550-7377; Huisken, Jan/0000-0001-7250-3756				Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Kikuchi S, 1997, OPT COMMUN, V138, P21, DOI 10.1016/S0030-4018(97)00054-0; Lindek S, 1999, J MOD OPTIC, V46, P843, DOI 10.1080/095003499149575; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; PAWLEY JB, 1995, HDB BIOL CONFOCAL MI; Ruffins SW, 2002, CURR OPIN NEUROBIOL, V12, P580, DOI 10.1016/S0959-4388(02)00366-5; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SHAW PJ, 1990, J MICROSC-OXFORD, V158, P165, DOI 10.1111/j.1365-2818.1990.tb02989.x; STELZER EHK, 1994, OPT COMMUN, V111, P536, DOI 10.1016/0030-4018(94)90533-9; STELZER EHK, 1995, J MICROSC-OXFORD, V179, P1, DOI 10.1111/j.1365-2818.1995.tb03608.x; Swoger J, 2003, OPT LETT, V28, P1654, DOI 10.1364/OL.28.001654; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	21	1502	1585	29	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1007	1009		10.1126/science.1100035	http://dx.doi.org/10.1126/science.1100035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310904				2022-12-01	WOS:000223250700049
J	Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H				Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H			Anabaena sensory rhodopsin: A photochromic color 0 sensor at 2.0 angstrom	SCIENCE			English	Article							LIGHT; BACTERIORHODOPSIN	Microbial sensory rhodopsins are a family of membrane-embedded photoreceptors in prokaryotic and eukaryotic organisms. Structures of archaeal rhodopsins, which function as light-driven ion pumps or photosensors, have been reported. We present the structure of a eubacterial rhodopsin, which differs from those of previously characterized archaeal rhodopsins in its chromophore and cytoplasmic-side portions. Anabaena sensory rhodopsin exhibits light-induced interconversion between stable 13-cis and all-trans states of the retinylidene protein. The ratio of its cis and trans chromophore forms depends on the wavelength of illumination, thus providing a mechanism for a single protein to signal the color of light, for example, to regulate color-sensitive processes such as chromatic adaptation in photosynthesis. Its cytoplasmic half channel, highly hydrophobic in the archaeal rhodopsins, contains numerous hydrophilic residues networked by water molecules, providing a connection from the photoactive site to the cytoplasmic surface believed to interact with the receptor's soluble 14-kilodalton transducer.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92697 USA	University of Texas System; University of Texas System; Lomonosov Moscow State University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Spudich, JL (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu; hudel@uci.edu	Luecke, Hartmut/F-4712-2012	Luecke, Hartmut/0000-0002-4938-0775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067808, R01GM059970, R37GM027750] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Cartailler JP, 2004, STRUCTURE, V12, P133, DOI 10.1016/j.str.2003.12.001; Gartner W., 2000, HDB BIOL PHYS, V3, P297; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SINESHCHEKOV OA, UNPUB; Singh B, 2001, CURR MICROBIOL, V43, P265, DOI 10.1007/s002840010299; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SPUDICH JL, IN PRESS HDB PHOTOSE; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WAGNER G, 2001, ESP REV SERIES PHOTO, P421; Wang H.S.., 2002, ARABIDOPSIS BOOK, P1	23	184	189	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1390	1393		10.1126/science.1103943	http://dx.doi.org/10.1126/science.1103943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15459346	Green Accepted			2022-12-01	WOS:000225301600057
J	Bulte, E; Damania, R; Gillson, L; Lindsay, K				Bulte, E; Damania, R; Gillson, L; Lindsay, K			Space - The final frontier for economists and elephants	SCIENCE			English	Editorial Material							BIODIVERSITY; SERENGETI		Tilburg Univ, Dept Econ, NL-5000 LE Tilburg, Netherlands; Univ Adelaide, Sch Econ, Adelaide, SA 5005, Australia; Univ Oxford, Dept Zool, Environm Change Inst, Biodivers Res Grp, Oxford OX1 3PS, England; Amboseli Trust Elephants, Amboseli Elephant Res Project, Nairobi 00519, Kenya	Tilburg University; University of Adelaide; University of Oxford	Bulte, E (corresponding author), Tilburg Univ, Dept Econ, POB 90153, NL-5000 LE Tilburg, Netherlands.		Gillson, Lindsey/AAR-6531-2020	Gillson, Lindsey/0000-0001-9607-6760; Bulte, Erwin/0000-0001-9491-5268				Barbier E.B., 1990, ELEPHANTS EC IVORY; BARNES J, 1990, FUTURE BOTSWANAS ELE, P60; Barrett CB, 1998, LAND ECON, V74, P449, DOI 10.2307/3146878; BRANDER J, 1997, CAN J ECON, V50, P526; Bulte EH, 1999, AM J AGR ECON, V81, P453, DOI 10.2307/1244594; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Finnoff D, 2003, J ENVIRON ECON MANAG, V45, P589, DOI 10.1016/S0095-0696(02)00025-6; Fischer C, 2004, J ENVIRON ECON MANAG, V48, P926, DOI 10.1016/j.jeem.2003.12.003; Rogers KH., 2003, KRUGER EXPERIENCE EC, P41; Ross M.L., 2001, TIMBER BOOMS I BREAK; Sanchirico JN, 1999, J ENVIRON ECON MANAG, V37, P129, DOI 10.1006/jeem.1998.1060; Saphores JD, 2003, J ECON DYN CONTROL, V28, P509, DOI 10.1016/S0165-1889(03)00033-2; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; SWANSON TM, 1994, OXFORD ECON PAP, V46, P800, DOI 10.1093/oep/46.Supplement_1.800; 2004, CONT INT TRAD END SP	15	12	13	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					420	421		10.1126/science.1105392	http://dx.doi.org/10.1126/science.1105392			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	864IF	15486280				2022-12-01	WOS:000224626500032
J	Kah, LC; Lyons, TW; Frank, TD				Kah, LC; Lyons, TW; Frank, TD			Low marine sulphate and protracted oxygenation of the proterozoic biosphere	NATURE			English	Article							SULFUR ISOTOPIC COMPOSITION; OCEAN CHEMISTRY; SEAWATER; BASIN; GEOCHEMISTRY; RISE	Progressive oxygenation of the Earth's early biosphere is thought to have resulted in increased sulphide oxidation during continental weathering, leading to a corresponding increase in marine sulphate concentration(1). Accurate reconstruction of marine sulphate reservoir size is therefore important for interpreting the oxygenation history of early Earth environments. Few data, however, specifically constrain how sulphate concentrations may have changed during the Proterozoic era (2.5 - 0.54 Gyr ago). Prior to 2.2 Gyr ago, when oxygen began to accumulate in the Earth's atmosphere(2,3), sulphate concentrations are inferred to have been <1 mM and possibly < 200 muM, on the basis of limited isotopic variability preserved in sedimentary sulphides(4) and experimental data showing suppressed isotopic fractionation at extremely low sulphate concentrations(1,5). By 0.8 Gyr ago, oxygen and thus sulphate levels may have risen significantly(6,7). Here we report large stratigraphic variations in the sulphur isotope composition of marine carbonate-associated sulphate, and use a rate-dependent model for sulphur isotope change that allows us to track changes in marine sulphate concentrations throughout the Proterozoic. Our calculations indicate sulphate levels between 1.5 and 4.5 mM, or 5 - 15 per cent of modern values, for more than 1 Gyr after initial oxygenation of the Earth's biosphere. Persistence of low oceanic sulphate demonstrates the protracted nature of Earth's oxygenation. It links biospheric evolution to temporal patterns in the depositional behaviour of marine iron- and sulphur-bearing minerals(4), biological cycling of redox-sensitive elements(6) and availability of trace metals essential to eukaryotic development(8).	Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Univ Missouri, Dept Geol Sci, Columbia, MO 65211 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA	University of Tennessee System; University of Tennessee Knoxville; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Kah, LC (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	lckah@utk.edu	Kah, Linda C/J-3754-2019	Kah, Linda C/0000-0001-7172-2033; Frank, Tracy/0000-0002-8422-7389				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Azmy K, 2001, PRECAMBRIAN RES, V112, P303, DOI 10.1016/S0301-9268(01)00194-2; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BOSSCHER H, 1993, J GEOL, V101, P345, DOI 10.1086/648228; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; BURDETT JW, 1989, EARTH PLANET SC LETT, V94, P189, DOI 10.1016/0012-821X(89)90138-6; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Frank TD, 2003, GEOL MAG, V140, P397, DOI 10.1017/S0016756803007830; GELLATLY AM, IN PRESS GEOCHIM COS; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Kampschulte A, 2001, CHEM GEOL, V175, P149, DOI 10.1016/S0009-2541(00)00367-3; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; Kump LR, 1999, CHEM GEOL, V161, P181, DOI 10.1016/S0009-2541(99)00086-8; Luepke JJ, 2001, PRECAMBRIAN RES, V111, P79, DOI 10.1016/S0301-9268(01)00157-7; Lyons TW, 2000, GEOCHIM COSMOCHIM AC, V64, P427, DOI 10.1016/S0016-7037(99)00323-3; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; Staudt WJ, 1995, ACS SYM SER, V612, P332; Strauss H, 1997, PALAEOGEOGR PALAEOCL, V132, P97, DOI 10.1016/S0031-0182(97)00067-9; WHELAN JF, 1990, AM J SCI, V290, P396, DOI 10.2475/ajs.290.4.396	30	345	364	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					834	838		10.1038/nature02974	http://dx.doi.org/10.1038/nature02974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483609	Green Published			2022-12-01	WOS:000224435500044
J	Gally, C; Eimer, S; Richmond, JE; Bessereau, JL				Gally, C; Eimer, S; Richmond, JE; Bessereau, JL			A transmembrane protein required for acetylcholine receptor clustering in Caenorhabditis elegans	NATURE			English	Article							LEVAMISOLE RESISTANCE; AMPA RECEPTORS; CUB-DOMAIN; GENE; GABA; MUTANTS; SYNAPSE; MODULE	Clustering neurotransmitter receptors at the synapse is crucial for efficient neurotransmission. Here we identify a Caenorhabditis elegans locus, lev-10, required for postsynaptic aggregation of ionotropic acetylcholine receptors (AChRs). lev-10 mutants were identified on the basis of weak resistance to the anthelminthic drug levamisole, a nematode-specific cholinergic agonist that activates AChRs present at neuromuscular junctions (NMJs) resulting in muscle hypercontraction and death at high concentrations(1-3). In lev-10 mutants, the density of levamisole-sensitive AChRs at NMJs is markedly reduced, yet the number of functional AChRs present at the muscle cell surface remains unchanged. LEV-10 is a transmembrane protein localized to cholinergic NMJs and required in body-wall muscles for AChR clustering. We also show that the LEV-10 extracellular region, containing five predicted CUB domains and one LDLa domain, is sufficient to rescue AChR aggregation in lev-10 mutants. This suggests a mechanism for AChR clustering that relies on extracellular protein - protein interactions. Such a mechanism is likely to be evolutionarily conserved because CUB/LDL transmembrane proteins similar to LEV-10, but lacking any assigned function, are expressed in the mammalian nervous system and might be used to cluster ionotropic receptors in vertebrates.	Ecole Normale Super, INSERM, U497, F-75005 Paris, France; Univ Illinois, Chicago, IL 60607 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, INSERM, U497, 46 Rue Ulm, F-75005 Paris, France.	jlbesse@wotan.ens.fr	Eimer, Stefan/B-1865-2013; Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621	NINDS NIH HHS [R01 NS041477-02, R01 NS041477, R01NS41477-03, R01 NS041477-03, R01 NS041477-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Fleming JT, 1997, J NEUROSCI, V17, P5843; Gally C, 2003, J NEUROSCI, V23, P2591; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LEWIS JA, 1987, J NEUROSCI, V7, P3059; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Miller T, 2000, J AGING PHYS ACTIV, V8, P289; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OKKEMA PG, 1993, GENETICS, V135, P385; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; RAIZEN DM, 1995, GENETICS, V141, P1365; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Yochem J, 1998, GENETICS, V149, P1323; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	28	111	115	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					578	582		10.1038/nature02893	http://dx.doi.org/10.1038/nature02893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457263	Green Accepted			2022-12-01	WOS:000224156700049
J	Smeeth, L; Cook, C; Fombonne, E; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ				Smeeth, L; Cook, C; Fombonne, E; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ			MMR vaccination and pervasive developmental disorders: a case-control study	LANCET			English	Article							MUMPS-RUBELLA VACCINATION; PRACTICE RESEARCH DATABASE; EPIDEMIOLOGIC EVIDENCE; CAUSAL ASSOCIATION; NO EVIDENCE; MEASLES; AUTISM; CHILDREN; POPULATION; IMMUNIZATION	Background Concern that measles-mumps-rubella (MMR) vaccination might cause autism has led to a fall in vaccine coverage. We investigated whether MMR vaccination is associated with an increased risk of autism or other pervasive developmental disorders. Methods We did a matched case-control study using the UK General Practice Research Database. Cases were people born in 1973 or later who had first recorded diagnosis of pervasive developmental disorder while registered with a contributing general practice between 1987 and 2001. Controls were matched on age, sex, and general practice. Findings 1294 cases and 4469 controls were included. 1010 cases (78.1%) had MMR vaccination recorded before diagnosis, compared with 3671 controls (82.1%) before the age at which their matched case was diagnosed. After adjustment for age at joining the database, the odds ratio for association between MMR and pervasive developmental disorder was 0 . 86 (95% CI 0 . 68-1.09). Findings were similar when restricted to children with a diagnosis of autism, to those vaccinated with MMR before the third birthday, or to the period before media coverage of the hypothesis linking MMR with autism. Interpretation Our findings suggest that MMR vaccination is not associated with an increased risk of pervasive developmental disorders.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; McGill Univ, Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3A 2T5, Canada; Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; McGill University; University of London; King's College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, Keppel St, London WC1E 7HT, England.	autism@lshtm.ac.uk	Fombonne, Eric/M-4893-2018; RODRIGUES, LAURA CUNHA/AAO-4130-2021; smith, peter/ABH-9627-2020; Smeeth, Liam/X-5862-2018	Fombonne, Eric/0000-0002-8605-3538; smith, peter/0000-0003-0080-7560; Rodrigues, Laura Cunha/0000-0001-9008-660X; Smeeth, Liam/0000-0002-9168-6022	Medical Research Council [G108/492] Funding Source: Medline; MRC [G108/492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BURTON D, 2000, OPENING STATEMENT CH; Chen W, 2004, PSYCHOL MED, V34, P543, DOI 10.1017/S0033291703001259; CLAYTON D, 1993, CONDITIONAL LOGISTIC, P290; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; *DEP HLTH, 2002, DEPT HLTH STAT B; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeStefano F, 2004, PEDIATRICS, V113, P259, DOI 10.1542/peds.113.2.259; DeStefano Frank, 2004, Expert Rev Vaccines, V3, P19, DOI 10.1586/14760584.3.1.19; DeWilde S, 2001, BRIT J GEN PRACT, V51, P226; *DIR PUBL HLTH, 2002, MEASL LOND INC CURR; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Fombonne E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-5; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Geier DA, 2004, MED SCI MONITOR, V10, pPI33; GILLBERG C, 1998, AUTISM, V2, P423; Hollowell J, 1997, Popul Trends, P36; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jefferson T, 2003, VACCINE, V21, P3954, DOI 10.1016/S0264-410X(03)00271-8; Jick H, 2003, PHARMACOTHERAPY, V23, P1524, DOI 10.1592/phco.23.15.1524.31955; Jick H, 2003, EPIDEMIOLOGY, V14, P630, DOI 10.1097/01.EDE.0000082044.88833.c4; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Loff B, 1998, LANCET, V352, P1368, DOI 10.1016/S0140-6736(05)60771-4; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miller Elizabeth, 2003, Semin Pediatr Infect Dis, V14, P199, DOI 10.1016/S1045-1870(03)00034-7; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; *OFF NAT STAT, 1998, SER OFF NAT STAT MB6, V1; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Ramsay ME, 2002, BRIT J GEN PRACT, V52, P912; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; SALISBURY D, 1996, IMMUNISATION INFECT; Smeeth L, 2002, LANCET, V359, P2112, DOI 10.1016/S0140-6736(02)08918-3; Smeeth L, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-2; Spitzer WO, 2003, NEW ENGL J MED, V348, P951; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wilson K, 2003, ARCH PEDIAT ADOL MED, V157, P628, DOI 10.1001/archpedi.157.7.628; 2003, DRUG THER B, V41, P25	47	129	134	1	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					963	969		10.1016/S0140-6736(04)17020-7	http://dx.doi.org/10.1016/S0140-6736(04)17020-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364187				2022-12-01	WOS:000223831000026
J	Kunde, VG; Flasar, FM; Jennings, DE; Bezard, B; Strobel, DF; Conrath, BJ; Nixon, CA; Bjoraker, GL; Romani, PN; Achterberg, RK; Simon-Miller, AA; Irwin, P; Brasunas, JC; Pearl, JC; Smith, MD; Orton, GS; Gierasch, PJ; Spilker, LJ; Carlson, RC; Mamoutkine, AA; Calcutt, SB; Read, PL; Taylor, FW; Fouchet, T; Parrish, P; Barucci, A; Courtin, R; Coustenis, A; Gautier, D; Lellouch, E; Marten, A; Prange, R; Biraud, Y; Ferrari, C; Owen, TC; Abbas, MM; Samuelson, RE; Raulin, F; Ade, P; Cesarsky, CJ; Grossman, KU; Coradini, A				Kunde, VG; Flasar, FM; Jennings, DE; Bezard, B; Strobel, DF; Conrath, BJ; Nixon, CA; Bjoraker, GL; Romani, PN; Achterberg, RK; Simon-Miller, AA; Irwin, P; Brasunas, JC; Pearl, JC; Smith, MD; Orton, GS; Gierasch, PJ; Spilker, LJ; Carlson, RC; Mamoutkine, AA; Calcutt, SB; Read, PL; Taylor, FW; Fouchet, T; Parrish, P; Barucci, A; Courtin, R; Coustenis, A; Gautier, D; Lellouch, E; Marten, A; Prange, R; Biraud, Y; Ferrari, C; Owen, TC; Abbas, MM; Samuelson, RE; Raulin, F; Ade, P; Cesarsky, CJ; Grossman, KU; Coradini, A			Jupiter's atmospheric composition from the Cassini thermal infrared spectroscopy experiment	SCIENCE			English	Article							COMET SHOEMAKER-LEVY-9; JOVIAN SYSTEM; HCN; STRATOSPHERE; PRECIPITATION; EXCITATION; VOYAGER-1; EVOLUTION; IMPACTS; IO	The Composite Infrared Spectrometer observed Jupiter in the thermal infrared during the swing-by of the Cassini spacecraft. Results include the detection of two new stratospheric species, the methyl radical and diacetylene, gaseous species present in the north and south auroral infrared hot spots; determination of the variations with latitude of acetylene and ethane, the latter a tracer of atmospheric motion; observations of unexpected spatial distributions of carbon dioxide and hydrogen cyanide, both considered to be products of comet Shoemaker-Levy 9 impacts; characterization of the morphology of the auroral infrared hot spot acetylene emission; and a new evaluation of the energetics of the northern auroral infrared hot spot.	Univ Maryland, Dept Astron, College Pk, MD 20742 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Observ Paris, LESIA, CNRS, UMR8109, F-91925 Meudon, France; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Space Sci & Applicat Inc, Lanham, MD 20706 USA; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; CEA Saclay, Serv Astrophys, F-91191 Gif Sur Yvette, France; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Univ Paris 07, LISA, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 12, LISA, CNRS, UMR 7583, F-94010 Creteil, France; Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; European So Observ, D-85748 Garching, Germany; Gesamthsch Wuppertal, Dept Phys, D-5600 Wuppertal 1, Germany; CNR, Inst Astrophys Spatiale, Area Recerca Tor Vergata, I-00133 Rome, Italy	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Johns Hopkins University; Cornell University; University of Oxford; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; European Southern Observatory; University of Wuppertal; Consiglio Nazionale delle Ricerche (CNR)	Kunde, VG (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	Virgil.G.Kunde.1@gsfc.nasa.gov	Smith, Michael/C-8875-2012; Romani, Paul N/D-2729-2012; Fouchet, Thierry/C-6374-2017; brasunas, john/I-2798-2013; Nixon, Conor A/A-8531-2009; Bjoraker, Gordon L/D-5032-2012; Simon, Amy/C-8020-2012; Strobel, Darrell5/AAO-6643-2021; Orton, Glenn/AAD-9862-2020; Elbaz, David/AAB-4141-2020; Jennings, Donald/D-7978-2012; Ferrari, Cécile/P-9735-2016; Flasar, F Michael/C-8509-2012	Fouchet, Thierry/0000-0001-9040-8285; Nixon, Conor A/0000-0001-9540-9121; Simon, Amy/0000-0003-4641-6186; Strobel, Darrell5/0000-0002-0944-8675; Elbaz, David/0000-0002-7631-647X; Ferrari, Cécile/0000-0001-5962-7439; Ade, Peter/0000-0002-5127-0401; Calcutt, Simon/0000-0002-0102-3170; Taylor, Fred/0000-0002-0675-9769; Achterberg, Richard/0000-0002-7643-7626; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Bezard, Bruno/0000-0002-5433-5661				ANICICH VG, 1986, ASTROPHYS J SUPPL S, V62, P553, DOI 10.1086/191151; Banaszkiewicz M, 2000, ICARUS, V147, P386, DOI 10.1006/icar.2000.6448; Bezard B, 1997, ICARUS, V125, P94, DOI 10.1006/icar.1996.5610; BUNCE EW, 2004, IN PRESS J GEOPHYS R; CALDWELL J, 1980, ICARUS, V44, P667, DOI 10.1016/0019-1035(80)90135-9; Clarke JT, 2002, NATURE, V415, P997, DOI 10.1038/415997a; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Coustenis A, 1999, PLANET SPACE SCI, V47, P1305, DOI 10.1016/S0032-0633(99)00053-7; DROSSART P, 1993, J GEOPHYS RES-PLANET, V98, P18803, DOI 10.1029/93JE01801; Flasar FM, 2004, NATURE, V427, P132, DOI 10.1038/nature02142; GEHRELS N, 1983, J GEOPHYS RES-SPACE, V88, P5537, DOI 10.1029/JA088iA07p05537; Gladstone GR, 1996, ICARUS, V119, P1, DOI 10.1006/icar.1996.0001; Gladstone GR, 2002, NATURE, V415, P1000, DOI 10.1038/4151000a; Griffith CA, 2004, ICARUS, V170, P58, DOI 10.1016/j.icarus.2004.02.006; HANEL R, 1979, SCIENCE, V204, P972, DOI 10.1126/science.204.4396.972-a; HANEL R, 1979, SCIENCE, V206, P952, DOI 10.1126/science.206.4421.952; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Ingersoll AP, 1998, ICARUS, V135, P251, DOI 10.1006/icar.1998.5971; KIM SJ, 1985, ICARUS, V64, P233, DOI 10.1016/0019-1035(85)90088-0; Kunde V, 1996, P SOC PHOTO-OPT INS, V2803, P162, DOI 10.1117/12.253416; LELLOUCH E, 1995, NATURE, V373, P592, DOI 10.1038/373592a0; Lellouch E, 2002, ICARUS, V159, P112, DOI 10.1006/icar.2002.6929; MARTEN A, 1995, GEOPHYS RES LETT, V22, P1589, DOI 10.1029/95GL00949; Moreno R, 2003, PLANET SPACE SCI, V51, P591, DOI 10.1016/S0032-0633(03)00072-2; Moses J. I., 1996, COLLISION COMET SHOE; MOSES JI, IN PRESS JUPITER PLA; NOLL KS, 1996, COLLISION COMET SHOE; ORTON G, 2003, B AM ASTRON SOC, V35; ORTON GS, 1991, SCIENCE, V252, P537, DOI 10.1126/science.252.5005.537; Pallier L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018041; Pallier L, 2001, PLANET SPACE SCI, V49, P1159, DOI 10.1016/S0032-0633(01)00023-X; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; PRANGE R, 2003, AM GEOPH UN FALL M; REGO D, 1994, J GEOPHYS RES-PLANET, V99, P17075, DOI 10.1029/93JE03432; SCHOEBERL MR, 1992, J GEOPHYS RES-ATMOS, V97, P7859, DOI 10.1029/91JD02168; STROBEL DF, 1983, INT REV PHYS CHEM, V3, P145; WAITE JH, 1983, J GEOPHYS RES-SPACE, V88, P6143, DOI 10.1029/JA088iA08p06143	38	53	53	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2004	305	5690					1582	1586		10.1126/science.1100240	http://dx.doi.org/10.1126/science.1100240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15319491				2022-12-01	WOS:000223891200034
J	Sininger, YS; Cone-Wesson, B				Sininger, YS; Cone-Wesson, B			Asymmetric cochlear processing mimics hemispheric specialization	SCIENCE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; NEONATAL HEARING IMPAIRMENT; OLIVOCOCHLEAR SYSTEM; PERINATAL-PERIOD; IDENTIFICATION; MECHANISMS		Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg, Ctr Hlth Sci 62 132, Los Angeles, CA 90095 USA; Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Arizona	Sininger, YS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg, Ctr Hlth Sci 62 132, Los Angeles, CA 90095 USA.	ysininger@mednet.ucla.edu						Aidan D, 1997, ACTA OTO-LARYNGOL, V117, P25, DOI 10.3109/00016489709117986; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P449, DOI 10.1162/089892900562264; Gorga MP, 2000, EAR HEARING, V21, P400, DOI 10.1097/00003446-200010000-00007; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIMURA D, 1964, Q J EXP PSYCHOL, V16, P355, DOI 10.1080/17470216408416391; Moore JK, 1999, AUDIOL NEURO-OTOL, V4, P311, DOI 10.1159/000013855; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; MORLET T, 1993, ACTA OTO-LARYNGOL, V113, P271, DOI 10.3109/00016489309135808; Norton SJ, 2000, EAR HEARING, V21, P425, DOI 10.1097/00003446-200010000-00008; Shera CA, 2004, EAR HEARING, V25, P86, DOI 10.1097/01.AUD.0000121200.90211.83; VEUILLET E, 1991, J NEUROPHYSIOL, V65, P724, DOI 10.1152/jn.1991.65.3.724; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	12	73	80	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1581	1581		10.1126/science.1100646	http://dx.doi.org/10.1126/science.1100646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361617				2022-12-01	WOS:000223891200033
J	Chen, IA; Roberts, RW; Szostak, JW				Chen, IA; Roberts, RW; Szostak, JW			The emergence of competition between model protocells	SCIENCE			English	Article							VESICLES; GROWTH	The transition from independent molecular entities to cellular structures with integrated behaviors was a crucial aspect of the origin of life. We show that simple physical principles can mediate a coordinated interaction between genome and compartment boundary, independent of any genomic functions beyond self-replication. RNA, encapsulated in fatty acid vesicles, exerts an osmotic pressure on the vesicle membrane that drives the uptake of additional membrane components, leading to membrane growth at the expense of relaxed vesicles, which shrink. Thus, more efficient RNA replication could cause faster cell growth, leading to the emergence of Darwinian evolution at the cellular level.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; California Institute of Technology	Szostak, JW (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Chen, Irene/0000-0001-6040-7927	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; FERRELL JE, 1985, BIOCHEMISTRY-US, V24, P2857, DOI 10.1021/bi00333a007; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Jin AJ, 1999, EUR BIOPHYS J BIOPHY, V28, P187, DOI 10.1007/s002490050199; JONES JD, 1989, BIOCHEMISTRY-US, V28, P129, DOI 10.1021/bi00427a019; Landweber LF, 1998, BIOSCIENCE, V48, P94, DOI 10.2307/1313134; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; Monnard PA, 2002, ASTROBIOLOGY, V2, P139, DOI 10.1089/15311070260192237; Morowitz H.J., 1992, BEGINNINGS CELLULAR; MUI BLS, 1993, BIOPHYS J, V64, P443, DOI 10.1016/S0006-3495(93)81385-7; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; WALDE P, 1994, J AM CHEM SOC, V116, P11649, DOI 10.1021/ja00105a004; Watson J. D., 1965, MOL BIOL GENE; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	20	296	310	2	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1474	1476		10.1126/science.1100757	http://dx.doi.org/10.1126/science.1100757			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353806	Green Accepted			2022-12-01	WOS:000223761900052
J	Mazelin, L; Bernet, A; Bonod-Bidaud, C; Pays, L; Arnaud, S; Gespach, C; Bredesen, DE; Scoazec, JY; Mehlen, P				Mazelin, L; Bernet, A; Bonod-Bidaud, C; Pays, L; Arnaud, S; Gespach, C; Bredesen, DE; Scoazec, JY; Mehlen, P			Netrin-1 controls colorectal tumorigenesis by regulating apoptosis	NATURE			English	Article							CANCER DCC; RECEPTORS UNC5H; GENE; SUPPRESSOR; DEPENDENCE; MECHANISM; TUMORS; MICE	The expression of the protein DCC ( deleted in colorectal cancer) is lost or markedly reduced in numerous cancers and in the majority of colorectal cancers due to loss of heterozygosity in chromosome 18q, and has therefore been proposed to be a tumour suppressor(1). However, the rarity of mutations found in DCC, the lack of cancer predisposition of DCC mutant mice, and the presence of other tumour suppressor genes in 18q have raised doubts about the function of DCC as a tumour suppressor(2). Unlike classical tumour suppressors, DCC has been shown to induce apoptosis conditionally: by functioning as a dependence receptor, DCC induces apoptosis unless DCC is engaged by its ligand, netrin-1 (ref. 3). Here we show that inhibition of cell death by enforced expression of netrin-1 in mouse gastrointestinal tract leads to the spontaneous formation of hyperplastic and neoplastic lesions. Moreover, in the adenomatous polyposis coli mutant background associated with adenoma formation, enforced expression of netrin-1 engenders aggressive adenocarcinomatous malignancies. These data demonstrate that netrin-1 can promote intestinal tumour development, probably by regulating cell survival. Thus, a netrin-1 receptor or receptors function as conditional tumour suppressors.	Univ Lyon, CNRS,UMR 5534, Apoptosis Differentiat Lab, Eqiuipe Labellisee La Ligue Mol & Cellular Genet, F-69622 Villeurbanne, France; Hop St Antoine, INSERM, U482, F-75571 Paris, France; Buck Inst Age Res, Novato, CA 94945 USA; INSERM, U45, F-69437 Lyon, France; ANIPATH, F-69437 Lyon, France; Ctr Leon Berard, F-69373 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Buck Institute for Research on Aging; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Mehlen, P (corresponding author), Univ Lyon, CNRS,UMR 5534, Apoptosis Differentiat Lab, Eqiuipe Labellisee La Ligue Mol & Cellular Genet, F-69622 Villeurbanne, France.	mehlen@univ-lyon1.fr	Mazelin, Laetitia/AAD-9319-2020; bonod-bidaud, christelle/AAN-9236-2021; Bernet, Agnes/GSN-2702-2022	Mazelin, Laetitia/0000-0002-4001-2132; Pays, Laurent/0000-0003-0720-2273				Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Hsu Y H, 2001, Kaohsiung J Med Sci, V17, P351; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KLINGELHUTZ AJ, 1993, ONCOGENE, V8, P95; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Simon TC, 1997, J BIOL CHEM, V272, P10652; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100	22	234	251	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					80	84		10.1038/nature02788	http://dx.doi.org/10.1038/nature02788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343335				2022-12-01	WOS:000223641500045
J	Kim, H; Rogers, MJ; Richmond, JE; McIntire, SL				Kim, H; Rogers, MJ; Richmond, JE; McIntire, SL			SNF-6 is an acetylcholine transporter interacting with the dystrophin complex in Caenorhabditis elegans	NATURE			English	Article							NEUROMUSCULAR-JUNCTION; GLYCOPROTEIN COMPLEX; GENETIC-EVIDENCE; MUSCLE-FIBERS; TIME-COURSE; MUTATIONS; DYSTROBREVIN; PHENOTYPES; MUTANTS; CALCIUM	Muscular dystrophies are among the most common human genetic diseases and are characterized by progressive muscle degeneration. Muscular dystrophies result from genetic defects in components of the dystrophin-glycoprotein complex (DGC), a multimeric complex found in the muscle cell plasma membrane(1). The DGC links the intracellular cytoskeleton to the extracellular matrix and is thought to be important for maintaining the mechanical integrity of muscles(2) and organizing signalling molecules(3). The exact role of the DGC in the pathogenesis of disease has, however, remained uncertain(4). Mutations in Caenorhabditis elegans DGC genes lead to specific defects in coordinated movement and can also cause muscle degeneration(5-7). Here we show that mutations in the gene snf-6 result in phenotypes indistinguishable from those of the DGC mutants, and that snf-6 encodes a novel acetylcholine/choline transporter. SNF-6 mediates the uptake of acetylcholine at neuromuscular junctions during periods of increased synaptic activity. SNF-6 also interacts with the DGC, and mutations in DGC genes cause a loss of SNF-6 at neuromuscular junctions. Improper clearing of acetylcholine and prolonged excitation of muscles might contribute to the pathogenesis of muscular dystrophies.	Univ Calif San Francisco, Dept Neurol, Program Neurosci, Ernest Gallo & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Program Biomed Sci, Ernest Gallo & Res Ctr, Emeryville, CA 94608 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McIntire, SL (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, Ernest Gallo & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	slm@itsa.ucsf.edu		Kim, Hongkyun/0000-0002-4879-7122; Rogers, Matthew/0000-0001-5908-7962	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041477-03, R01 NS041477-02, R01 NS041477, R01 NS041477-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; BRENNER S, 1974, GENETICS, V77, P71; Burton EA, 2001, CONT NEUROS, P239; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Froehner SC, 1997, SOC GEN PHY, V52, P197; Gieseler K, 1999, FEBS LETT, V461, P59, DOI 10.1016/S0014-5793(99)01421-0; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Giugia JB, 1999, FEBS LETT, V463, P270, DOI 10.1016/S0014-5793(99)01651-8; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; JACKSON MJ, 1985, CLIN CHIM ACTA, V147, P215, DOI 10.1016/0009-8981(85)90202-5; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; Kramarcy NR, 2000, MOL CELL NEUROSCI, V15, P262, DOI 10.1006/mcne.1999.0823; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; MCARDLE A, 1994, MUSCLE NERVE, V17, P1378, DOI 10.1002/mus.880171206; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; POTTER LT, 1970, J PHYSIOL-LONDON, V206, P145, DOI 10.1113/jphysiol.1970.sp009003; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; SAELENS JK, 1965, J PHARMACOL EXP THER, V147, P336; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; Shioi G, 2001, GENETICS, V157, P1611; WATERSTON RH, 1984, J MOL BIOL, V180, P473, DOI 10.1016/0022-2836(84)90023-8; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	28	39	52	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					891	896		10.1038/nature02798	http://dx.doi.org/10.1038/nature02798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318222				2022-12-01	WOS:000223369800042
J	Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP				Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP			Pinyon jays use transitive inference to predict social dominance	NATURE			English	Article							VOCAL RECOGNITION; INFORMATION; EVOLUTION	Living in large, stable social groups is often considered to favour the evolution of enhanced cognitive abilities, such as recognizing group members, tracking their social status and inferring relationships among them(1-4). An individual's place in the social order can be learned through direct interactions with others, but conflicts can be time-consuming and even injurious. Because the number of possible pairwise interactions increases rapidly with group size, members of large social groups will benefit if they can make judgments about relationships on the basis of indirect evidence(5). Transitive reasoning should therefore be particularly important for social individuals, allowing assessment of relationships from observations of interactions among others. Although a variety of studies have suggested that transitive inference may be used in social settings(6-10), the phenomenon has not been demonstrated under controlled conditions in animals. Here we show that highly social pinyon jays (Gymnorhinus cyanocephalus) draw sophisticated inferences about their own dominance status relative to that of strangers that they have observed interacting with known individuals. These results directly demonstrate that animals use transitive inference in social settings and imply that such cognitive capabilities are widespread among social species.	Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Northern Arizona University	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA.	abond@unl.edu; akamil@unl.edu		Paz-y-Mino-C, Guillermo/0000-0003-4040-140X				Balda Russell P., 1996, Current Ornithology, V13, P33; Balda Russell P., 2002, Birds of North America, V605, P1; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; Hogue ME, 1996, BEHAV PROCESS, V38, P241, DOI 10.1016/S0376-6357(96)00035-6; Holekamp KE, 1999, ANIM BEHAV, V58, P383, DOI 10.1006/anbe.1999.1157; Humphrey N.K., 1976, GROWING POINTS ETHOL, P303, DOI DOI 10.2307/375925; Huntingford F.A., 1987, ANIMAL CONFLICT; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Kummer H., 1997, HUMAN NATURE BIOL SO, P157; Marzluff J. M., 1992, PINYON JAY; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; ROHWER S, 1982, AM ZOOL, V22, P531; *SAS I INC, 2000, SAS V8; Seyfarth RM, 2003, ANIMAL SOCIAL COMPLEXITY, P207; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522	20	228	234	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					778	781		10.1038/nature02723	http://dx.doi.org/10.1038/nature02723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306809	Green Published			2022-12-01	WOS:000223233600041
J	Ango, F; di Cristo, G; Higashiyama, H; Bennett, V; Wu, P; Huang, ZJ				Ango, F; di Cristo, G; Higashiyama, H; Bennett, V; Wu, P; Huang, ZJ			Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at Purkinje axon initial segment	CELL			English	Article							ADHESION MOLECULES; TRANSGENIC MICE; INTERNEURONS; L1; SPECTRIN; HIPPOCAMPUS; INHIBITION; CORTEX; DIVERSITY; GUIDANCE	Distinct classes of GABAergic synapses are segregated into subcellular domains (i.e., dendrite, soma, and axon initial segment-AIS), thereby differentially regulating the input, integration, and output of principal neurons. In cerebellum, for example, basket interneurons make exquisitely precise "pinceau synapses" on AIS of Purkinje neurons, but the underlying mechanism is unknown. Using BAC transgenic reporter mice, we found that basket axons always contacted Purkinje soma before innervating AIS. This synapse targeting process followed the establishment of a subcellular gradient of neurofascin186 (NF186), an L1 family immunoglobulin cell adhesion molecule (L1 CAM), along the Purkinje AIS-soma axis. This gradient was dependent on ankyrinG, an AIS-restricted membrane adaptor protein that recruits NF186. In the absence of neurofascin gradient, basket axons lost directional growth along Purkinje neurons and precisely followed NF186 to ectopic locations. Disruption of NF186-ankyrinG interactions at AIS reduced pinceau synapse formation. These results implicate ankyrin-based localization of L1CAMs in subcellular organization of GABAergic synapses.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem & Cell Biol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Duke University; Howard Hughes Medical Institute	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu		Huang, Z. Josh/0000-0003-0592-028X; Ango, Fabrice/0000-0002-5548-209X				BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; CAJAL SRY, 1911, MALOINE, P1909; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS JQ, 1984, J BIOL CHEM, V259, P1874; DICRISTO G, 2004, IN PRESS NAT NEUROSC; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Palay S.L., 1974, CEREBELLAR CORTEX; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RATHJEN FG, 1987, CELL, V51, P841, DOI 10.1016/0092-8674(87)90107-3; Rosina A, 1999, NEUROREPORT, V10, P1613, DOI 10.1097/00001756-199905140-00041; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	49	271	277	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					257	272		10.1016/j.cell.2004.10.004	http://dx.doi.org/10.1016/j.cell.2004.10.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479642	Bronze			2022-12-01	WOS:000224577200013
J	Emoto, K; He, Y; Ye, B; Grueber, WB; Adler, PN; Jan, LY; Jan, YN				Emoto, K; He, Y; Ye, B; Grueber, WB; Adler, PN; Jan, LY; Jan, YN			Control of dendritic branching and tiling by the tricornered-kinase/furry signaling pathway in Drosophila sensory neurons	CELL			English	Article							RETINAL GANGLION-CELLS; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; PERIPHERAL NEURONS; SMALL GTPASES; RHO-GTPASES; MORPHOGENESIS; GENE; GROWTH	To cover the receptive field completely but without redundancy, neurons of certain functional groups exhibit tiling of their dendrites via dendritic repulsion. Here we show that two evolutionarily conserved proteins, the Tricornered (Trc) kinase and Furry (Fry), are essential for tiling and branching control of Drosophila sensory neuron dendrites. Dendrites of fry and trc mutants display excessive terminal branching and fail to avoid homologous dendritic branches, resulting in significant overlap of the dendritic fields. Trc control of dendritic branching involves regulation of RacGTPase, a pathway distinct from the action of Trc in tiling. Time-lapse analysis further reveals a specific loss of the ability of growing dendrites to turn away from nearby dendritic branches in fry mutants, suggestive of a defect in like-repels-like avoidance. Thus, the Trc/ Fry signaling pathway plays a key role in patterning dendritic fields by promoting avoidance between homologous dendrites as well as by limiting dendritic branching.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, San Francisco, CA 94143 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Univ Virginia, Ctr Canc, Charlottesville, VA 22903 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Virginia; University of Virginia	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol & Biochem, 1550 4th St, San Francisco, CA 94143 USA.	ynjan@itsa.ucsf.edu	Ye, Bing/V-1306-2018; He, Ying/B-3952-2010; EMOTO, KAZUO/G-4992-2014	Ye, Bing/0000-0002-8828-4065; He, Ying/0000-0002-2052-8350; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Grueber, Wesley/0000-0001-6751-256X	NIGMS NIH HHS [R01 GM053498] Funding Source: Medline; NINDS NIH HHS [R01NS40929, F32 NS046847-03, F32 NS046847-01, F32 NS046847, F32 NS046847-02] Funding Source: Medline; PHS HHS [R0153498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046847, R01NS040929] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cong JL, 2001, DEVELOPMENT, V128, P2793; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Gallegos ME, 2004, NEURON, V44, P239, DOI 10.1016/j.neuron.2004.09.021; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Geng W, 2000, GENETICS, V156, P1817; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2001, J COMP NEUROL, V440, P271, DOI 10.1002/cne.1385; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hirata D, 2002, EMBO J, V21, P4863, DOI 10.1093/emboj/cdf495; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lohmann C, 2001, J NEUROBIOL, V48, P150, DOI 10.1002/neu.1048; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; PERRY VH, 1982, NATURE, V297, P683, DOI 10.1038/297683a0; PURPURA DP, 1975, ADV NEUROL, V12, P91; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Sugimura K, 2003, J NEUROSCI, V23, P3752; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	51	176	179	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					245	256		10.1016/j.cell.2004.09.036	http://dx.doi.org/10.1016/j.cell.2004.09.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479641	Bronze			2022-12-01	WOS:000224577200012
J	Rao, JVRP; Ganguly, NK; Mehendale, SM; Bollinger, RC				Rao, JVRP; Ganguly, NK; Mehendale, SM; Bollinger, RC			India's response to the HIV epidemic	LANCET			English	Editorial Material									Govt India, Minist Hlth & Family Welf, New Delhi 110011, India; Indian Council Med Res, New Delhi, India; Natl AIDS Res Inst, Pune, Maharashtra, India; Johns Hopkins Univ, Baltimore, MD USA	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Johns Hopkins University	Rao, JVRP (corresponding author), Govt India, Minist Hlth & Family Welf, New Delhi 110011, India.	secyhlth@hub.nic.in		Bollinger, Robert/0000-0002-6798-6834				BECKER N E, 1986, Health and Social Work, V11, P26; Celentano D, 2004, 15 INT AIDS C BANGK; MAHAPATRA, 2004, SEATTLE POST IN 0916; *NAT AIDS CONTR OR, 2001, NAT BAS GEN POP BEH; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; *UNAIDS WHO, S AFR EP FACT SHEET; *UNAIDS WHO, IND EP FACT SHEET HI; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013	8	32	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1296	1297		10.1016/S0140-6736(04)17205-X	http://dx.doi.org/10.1016/S0140-6736(04)17205-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474121				2022-12-01	WOS:000224349700008
J	Gebelein, B; McKay, DJ; Mann, RS				Gebelein, B; McKay, DJ; Mann, RS			Direct integration of Hox and segmentation gene inputs during Drosophila development	NATURE			English	Article							BITHORAX COMPLEX; HOMEODOMAIN PROTEIN; LIMB DEVELOPMENT; ULTRABITHORAX PROTEINS; TARGET GENES; DISTAL-LESS; REPRESSION; EXPRESSION; EXTRADENTICLE; EMBRYO	During Drosophila embryogenesis, segments, each with an anterior and posterior compartment, are generated by the segmentation genes while the Hox genes provide each segment with a unique identity. These two processes have been thought to occur independently. Here we show that abdominal Hox proteins work directly with two different segmentation proteins, Sloppy paired and Engrailed, to repress the Hox target gene Distalless in anterior and posterior compartments, respectively. These results suggest that segmentation proteins can function as Hox cofactors and reveal a previously unanticipated use of compartments for gene regulation by Hox proteins. Our results suggest that these two classes of proteins may collaborate to directly control gene expression at many downstream target genes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	rsm10@columbia.edu	Nakafuku, Masato/J-3068-2013		NIGMS NIH HHS [R01 GM054510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; Andrioli LPM, 2002, DEVELOPMENT, V129, P4931; Aspland SE, 1997, DEVELOPMENT, V124, P741; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; CASANOVA J, 1987, EMBO J, V6, P3103, DOI 10.1002/j.1460-2075.1987.tb02619.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Ferretti E, 2000, DEVELOPMENT, V127, P155; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Galant R, 2002, DEVELOPMENT, V129, P3115; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MANN RS, 1994, DEVELOPMENT, V120, P3205; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; Mann RS, 1996, NATURE, V383, P630, DOI 10.1038/383630a0; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nasiadka A., 2002, AD DEV BIOL, V12, P155; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C	47	117	117	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					653	659		10.1038/nature02946	http://dx.doi.org/10.1038/nature02946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470419				2022-12-01	WOS:000224299300031
J	Benamouzig, R; Chaussade, S				Benamouzig, R; Chaussade, S			Calcium supplementation for preventing colorectal cancer: where do we stand?	LANCET			English	Editorial Material							VITAMIN-D; ADENOMAS; RISK; RECURRENCE; TRIAL		Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France; Cochin Hosp, Dept Gastroenterol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Benamouzig, R (corresponding author), Univ Paris 13, AP HP, Avicenne Hosp, Dept Gastroenterol, F-93009 Bobigny, France.	apacc@club-internet.fr	Coriat, Romain/O-7902-2017; BENAMOUZIG, Robert/W-8067-2019	BENAMOUZIG, ROBERT/0000-0003-1952-6830				Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; BergsmaKadijk JA, 1996, EPIDEMIOLOGY, V7, P590, DOI 10.1097/00001648-199611000-00005; Boyapati SM, 2003, CANCER EPIDEM BIOMAR, V12, P631; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; WALLACE K, 2004, J NATL CANCER I, V96, P21; WEINGARTEN MA, 2004, COCHRANE LIB	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2004	364	9441					1197	1199		10.1016/S0140-6736(04)17156-0	http://dx.doi.org/10.1016/S0140-6736(04)17156-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464166				2022-12-01	WOS:000224254200006
J	Bonsall, MB; Jansen, VAA; Hassell, MP				Bonsall, MB; Jansen, VAA; Hassell, MP			Life history trade-offs assemble ecological guilds	SCIENCE			English	Article							LIMITING SIMILARITY; COMPETITION; DYNAMICS; HOST; COEXISTENCE	Ecological theory predicts that competition for a limiting resource will lead to the exclusion of species unless the within-species effects outweigh the between-species effects. Understanding how multiple competitors might coexist on a single resource has focused on the prescriptive formalism of a necessary niche width and limiting similarity. Here, we show how continuously varying life histories and trade-offs in these characteristics can allow multiple competitors to coexist, and we reveal how limiting similarity emerges and is shaped by the ecological and evolutionary characteristics of competitors. In this way, we illustrate how the interplay of ecological and evolutionary processes acts to shape ecological communities in a unique way. This leads us to argue that evolutionary processes (life-history trait trade-offs) are fundamental to the understanding of the structure of ecological communities.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England; Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Imperial College London; University of London; Royal Holloway University London	Bonsall, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	m.bonsall@imperial.ac.uk	Jansen, Vincent A A/C-8353-2009	Jansen, Vincent A.A./0000-0002-6518-2090; Bonsall, Michael/0000-0003-0250-0423				ABRAMS P, 1975, THEOR POPUL BIOL, V8, P356, DOI 10.1016/0040-5809(75)90052-0; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bonsall MB, 2004, P ROY SOC B-BIOL SCI, V271, P1143, DOI 10.1098/rspb.2004.2722; Bonsall MB, 2002, ECOLOGY, V83, P925, DOI 10.1890/0012-9658(2002)083[0925:ETORPA]2.0.CO;2; BRIGGS CJ, 1993, AM NAT, V141, P372, DOI 10.1086/285479; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; HAIGH J, 1972, THEOR POPUL BIOL, V3, P290, DOI 10.1016/0040-5809(72)90005-6; Hassell MP, 1978, DYNAMICS ARTHROPOD P; HASSELL MP, 2000, TEMPORAL SPATIAL DYN; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jansen VAA, 1999, ECOL LETT, V2, P379; Lack D., 1947, DARWINS FINCHES; LEVIN BR, 1971, EVOLUTION, V25, P249, DOI 10.1111/j.1558-5646.1971.tb01878.x; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MAY RM, 1981, AM NAT, V117, P234, DOI 10.1086/283704; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Morin P., 1999, COMMUNITY ECOL; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Roff Derek A., 1992; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Stearns S.C., 1992, pi; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi	32	106	112	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					111	114		10.1126/science.1100680	http://dx.doi.org/10.1126/science.1100680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459391				2022-12-01	WOS:000224304000048
J	Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE				Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE			Maintained cardiac pumping in anoxic crucian carp	SCIENCE			English	Article							CARDIOVASCULAR-RESPONSES; 5-DEGREES-C; 22-DEGREES; HYPOXIA; TURTLE; OXYGEN		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; Univ Oslo, Dept Mol Biosci, Physiol Programme, N-0316 Oslo, Norway	Simon Fraser University; University of Oslo	Stecyk, JAW (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jstecyk@interchange.ubc.ca	Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013; Nilsson, Göran Erik/Q-6129-2019	Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Stenslokken, Kare-Olav/0000-0003-2962-4143				AXELSSON M, 1990, J EXP BIOL, V151, P297; Hicks JMT, 2000, J EXP BIOL, V203, P3775; Hicks JMT, 2000, J EXP BIOL, V203, P3765; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; JACKSON DC, 1968, J APPL PHYSIOL, V24, P503, DOI 10.1152/jappl.1968.24.4.503; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; Stecyk JAW, 2002, J EXP BIOL, V205, P759	7	94	97	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					77	77		10.1126/science.1100763	http://dx.doi.org/10.1126/science.1100763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459381				2022-12-01	WOS:000224304000038
J	Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G				Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G			Talking about death with children who have severe malignant disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINALLY-ILL CHILDREN; SIOP WORKING COMMITTEE; PSYCHOSOCIAL ISSUES; OF-LIFE; CANCER; ASSISTANCE; GUIDELINES; CARE	Background: One of the questions faced by the parents of a child who is terminally ill with a malignant disease is whether or not they should talk about death with their child. Methods: In 2001, we attempted to contact all parents in Sweden who had lost a child to cancer between 1992 and 1997. Among 561 eligible parents, 449 answered a questionnaire, and 429 stated whether or not they had talked about death with their child. Results: None of the 147 parents who talked with their child about death regretted it. In contrast, 69 of 258 parents (27 percent) who did not talk with their child about death regretted not having done so. Parents who sensed that their child was aware of his or her imminent death were more likely to regret not having talked about it (47 percent, as compared with 13 percent of parents who did not sense this awareness in their child; relative risk, 3.7; 95 percent confidence interval, 2.3 to 6.0). The same variable was related to having talked about death (50 percent vs. 13 percent; relative risk, 3.8; 95 percent confidence interval, 2.6 to 5.6), as was being religious (42 percent vs. 25 percent; relative risk, 1.7; 95 percent confidence interval, 1.2 to 2.3). The child's age was related to both having talked about death and the parents' regretting not having talked about it. Conclusions: Parents who sense that their child is aware of his or her imminent death more often later regret not having talked with their child than do parents who do not sense this awareness in their child; overall, no parent in this cohort later regretted having talked with his or her child about death.	Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden; Karolinska Inst, Childhood Canc Res Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Steineck, G (corresponding author), Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden.	gunnar.steineck@onkpat.ki.se	Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969; Henter, Jan-Inge/0000-0002-0629-2126; Valdimarsdottir, Unnur/0000-0001-5382-946X				Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; Bluebond-Langner M, 1978, TERMINALLY ILL CHILD, P166; GOLDMAN A, 1993, PEDIATR HEMAT ONCOL, V10, P223, DOI 10.3109/08880019309029488; Henningsohn L, 2001, EUR UROL, V40, P151, DOI 10.1159/000049766; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hilden JM, 2000, J CLIN ONCOL, V18, P3193, DOI 10.1200/JCO.2000.18.17.3193; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; KREICHBERGS U, 2004, PSYCHOL MED, V34, P1; Masera G, 1999, MED PEDIATR ONCOL, V32, P44, DOI 10.1002/(SICI)1096-911X(199901)32:1<44::AID-MPO9>3.0.CO;2-P; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P268; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P271, DOI 10.1002/(SICI)1096-911X(200004)34:4<271::AID-MPO10>3.0.CO;2-0; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; RAIMBAULT G, 1981, ACTA PAEDIATR SCAND, V70, P179, DOI 10.1111/j.1651-2227.1981.tb05538.x; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P271; *SAS I INC, 1999, SAS STAT US GUID VER, P1365; SPINETTA J J, 1981, Journal of Pediatric Psychology, V6, P251, DOI 10.1093/jpepsy/6.3.251; SPINETTA JJ, 1973, PEDIATRICS, V52, P841; SPINETTA JJ, 1974, PSYCHOL BULL, V81, P256, DOI 10.1037/h0036229; Steineck G, 1998, ACTA ONCOL, V37, P15, DOI 10.1080/028418698423131; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; VALDIMARSDOTTIR U, 2003, THESIS KAROLINSKA I	23	291	292	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1175	1186		10.1056/NEJMoa040366	http://dx.doi.org/10.1056/NEJMoa040366			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371575				2022-12-01	WOS:000223861300006
J	Richardson, AJ; Schoeman, DS				Richardson, AJ; Schoeman, DS			Climate impact on plankton ecosystems in the Northeast Atlantic	SCIENCE			English	Article							MARINE-PHYTOPLANKTON; PATTERNS; BIODIVERSITY; TEMPERATURE; RECRUITMENT; OSCILLATION; INDICATOR; FISHERIES; TRENDS	It is now widely accepted that global warming is occurring, yet its effects on the world's largest ecosystem, the marine pelagic realm, are largely unknown. We show that sea surface warming in the Northeast Atlantic is accompanied by increasing phytoplankton abundance in cooler regions and decreasing phytoplankton abundance in warmer regions. This impact propagates up the food web (bottom-up control) through copepod herbivores to zooplankton carnivores because of tight trophic coupling. Future warming is therefore likely to alter the spatial distribution of primary and secondary pelagic production, affecting ecosystem services and placing additional stress on already-depleted fish and mammal populations.	Sir Alister Hardy Fdn Ocean Sci Lab, Plymouth PL1 2PB, Devon, England; Univ Port Elizabeth, Dept Zool, Port Elizabeth, South Africa	Nelson Mandela University	Richardson, AJ (corresponding author), Sir Alister Hardy Fdn Ocean Sci Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	anr@sahfos.ac.uk	Richardson, Anthony J/B-3649-2010	Richardson, Anthony J/0000-0002-9289-7366; Schoeman, David/0000-0003-1258-0885				AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bouman HA, 2003, MAR ECOL PROG SER, V258, P19, DOI 10.3354/meps258019; Carder KL, 1999, J GEOPHYS RES-OCEANS, V104, P5403, DOI 10.1029/1998JC900082; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P143; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Parsons LS, 2001, PROG OCEANOGR, V49, P167, DOI 10.1016/S0079-6611(01)00021-0; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Sathyendranath S, 2001, INT J REMOTE SENS, V22, P249, DOI 10.1080/014311601449925; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	26	543	575	4	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1609	1612		10.1126/science.1100958	http://dx.doi.org/10.1126/science.1100958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361622				2022-12-01	WOS:000223891200040
J	Joensuu, H; Lehtimaki, T; Holli, K; Elomaa, L; Turpeenniemi-Hujanen, T; Kataja, V; Anttila, A; Lundin, M; Isola, J; Lundin, J				Joensuu, H; Lehtimaki, T; Holli, K; Elomaa, L; Turpeenniemi-Hujanen, T; Kataja, V; Anttila, A; Lundin, M; Isola, J; Lundin, J			Risk for distant recurrence of breast cancer detected by mammography screening or other methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVAL CARCINOMAS; PROGNOSTIC-FACTORS; SURVIVAL; PROGRAM; DISEASE; COHORT; WOMEN; NATIONWIDE; FEATURES; TRIAL	Context Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods. Objective To compare the risk of recurrence and survival among women with cancerous tumors detected by mammography screening compared with other methods (outside of screening). Design, Setting, and Patients Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n=2842). The median follow-up time was 9.5 years. Cancer biological variables were analyzed from tumor tissue microarrays using immunohistochemistry or in situ hybridization and included ERBB2, TP53, and MK167 expression and ERBB2 amplification data. Main Outcome Measures Univariate and multivariate analyses of potential risk factors for distant recurrence of breast cancer and 10-year survival. Results Of the 1983 women with unilateral invasive breast cancer, data on tumor diameter were available for 1918 women. Women with cancerous tumors detected by mammography screening had better estimated 10-year distant disease-free survival than women with tumors found outside of screening (tumor size of less than or equal to 10 mm [n=386] 92% vs 85% [P=.04]; 11-20 mm [n=808] 88% vs 76% [P<.001]; 21-30 mm [n=409] 86% vs 63% [P=.008]; >30 mm [n=315] 68% vs 50% [P=.12], respectively). In a Cox multivariate model that included cancer biological factors, the relative hazard ratio for distant recurrence among women with tumors detected outside of screening (HR, 1.90; 95% confidence interval, 1.15-3.11) was significantly higher than among women with tumors detected by mammography screening (P=.01). Breast cancer diagnosis by mammography screening was an independent prognostic variable reducing the relative HR for distant recurrence. This effect was equal to or greater than the effect of 1-cm decrease in tumor diameter (HR, 1.20; 95% confidence interval, 1.10-1.31). Conclusions Cancerous tumors detected by mammography screening are associated with a better prognosis than tumors of similar size found outside of screening. The risk of distant metastases is overestimated for women diagnosed as having cancer by mammography screening unless the method of detection is taken into account in risk estimations.	Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Tampere Univ Hosp, Dept Pallliat Med, Tampere, Finland; Tampere Univ Hosp, Dept Oncol, Tampere, Finland; Univ Turku, Cent Hosp, Dept Oncol, FIN-20520 Turku, Finland; Oulu Univ, Cent Hosp, Dept Radiotherapy & Oncol, SF-90220 Oulu, Finland; Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Tampere Univ, Inst Med Technol, Tampere, Finland; Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; University of Turku; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Finnish Cancer Registry; Tampere University; Folkhalsan Research Center	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4,POB 180, FIN-00029 Helsinki, Finland.	heikki.joensuu@hus.fi	Lundin, Johan/AAC-8510-2020; Lehtimäki, Terho/AAD-1094-2022; Lundin, Johan/I-1843-2018	Lundin, Johan/0000-0002-2681-4139; Lehtimäki, Terho/0000-0002-2555-4427; Lundin, Johan/0000-0002-2681-4139; Kataja, Vesa/0000-0003-4846-4843; Joensuu, Heikki/0000-0003-0281-2507				[Anonymous], 1981, HIST TYP BREAST TUM; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Burrell HC, 1996, RADIOLOGY, V199, P811, DOI 10.1148/radiology.199.3.8638010; Colacurci N, 2001, MATURITAS, V40, P159, DOI 10.1016/S0378-5122(01)00232-8; COX DR, 1972, J R STAT SOC B, V34, P187; Crosier M, 1999, CLIN CANCER RES, V5, P2682; DALAND E. M., 1927, Surgery, Gynecology and Obstetrics, V44, P264; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FRISELL J, 1992, BREAST CANCER RES TR, V24, P11, DOI 10.1007/BF01832353; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Groenendijk RPR, 2000, BRIT J CANCER, V82, P381; Hakama M, 1997, BRIT MED J, V314, P864; HOLFORD TR, 1991, J CLIN EPIDEMIOL, V44, P29, DOI 10.1016/0895-4356(91)90198-I; HOLMBERG LH, 1986, LANCET, V2, P27; IKEDA DM, 1992, AM J ROENTGENOL, V159, P287, DOI 10.2214/ajr.159.2.1632342; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Klemi PJ, 2003, BREAST, V12, P308, DOI 10.1016/S0960-9776(03)00096-1; KLEMI PJ, 1992, BRIT MED J, V304, P467, DOI 10.1136/bmj.304.6825.467; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee AKC, 1997, CANCER-AM CANCER SOC, V79, P761, DOI 10.1002/(SICI)1097-0142(19970215)79:4<761::AID-CNCR13>3.3.CO;2-K; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28; Magee B, 1999, CLIN ONCOL-UK, V11, P40, DOI 10.1053/clon.1999.9007; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moody-Ayers SY, 2000, ARCH INTERN MED, V160, P1109, DOI 10.1001/archinte.160.8.1109; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; Nielsen M, 1989, APMIS Suppl, V10, P1; PEETERS PHM, 1989, BRIT J CANCER, V59, P929, DOI 10.1038/bjc.1989.196; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114; Schroen AA, 1996, J SURG ONCOL, V63, P141, DOI 10.1002/(SICI)1096-9098(199611)63:3<141::AID-JSO2>3.0.CO;2-D; SENIE RT, 1994, CANCER-AM CANCER SOC, V73, P1666, DOI 10.1002/1097-0142(19940315)73:6<1666::AID-CNCR2820730619>3.0.CO;2-E; Tabar L, 2000, LANCET, V355, P429; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Vitak B, 1998, EUR RADIOL, V8, P639, DOI 10.1007/s003300050452; VONROSEN A, 1985, BREAST CANCER RES TR, V6, P221, DOI 10.1007/BF01806772; WADE P, 1946, BRIT J RADIOL, V19, P272, DOI 10.1259/0007-1285-19-223-272; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Yassin M M, 2003, Asian J Surg, V26, P101, DOI 10.1016/S1015-9584(09)60229-3; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	40	148	151	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2004	292	9					1064	1073		10.1001/jama.292.9.1064	http://dx.doi.org/10.1001/jama.292.9.1064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VH	15339900	Bronze			2022-12-01	WOS:000223568700022
J	Cuervo, AM; Stefanis, L; Fredenburg, R; Lansbury, PT; Sulzer, D				Cuervo, AM; Stefanis, L; Fredenburg, R; Lansbury, PT; Sulzer, D			Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy	SCIENCE			English	Article							RAT-LIVER LYSOSOMES; PARKINSONS-DISEASE; CYTOSOLIC PROTEINS; SELECTIVE UPTAKE; PROTEASOME; NEURONS; SYSTEM; AGGREGATION; MECHANISMS; PATHWAY	Aberrant alpha-synuclein degradation is implicated in Parkinson's disease pathogenesis because the protein accumulates in the Lewy inclusion bodies associated with the disease. Little is known, however, about the pathways by which wild-type alpha-synuclein is normally degraded. We found that wild-type alpha-synuclein was selectively translocated into lysosomes for degradation by the chaperone-mediated autophagy pathway. The pathogenic A53T and A30P alpha-synuctein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degradation and that of other substrates. These findings may underlie the toxic gain-of-function by the mutants.	Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Acad Athens, Fdn Biomed Res, Neurobiol Lab, Athens 11527, Greece; Columbia Univ, Dept Neurol & Pathol, New York, NY 10032 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Cambridge, MA 02139 USA; Columbia Univ, Dept Neurosci, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Neurosci, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA	Yeshiva University; Albert Einstein College of Medicine; Academy of Athens; Columbia University; Harvard University; Brigham & Women's Hospital; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	amcuervo@aecom.yu.edu	Stefanis, Leonidas/AAD-7192-2019	Cuervo, Ana Maria/0000-0002-0771-700X	NIA NIH HHS [AG021904] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021904] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dice J. F., 2000, LYSOSOMAL PATHWAYS P; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Massey A., UNPUB; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Salvador N, 2000, J BIOL CHEM, V275, P27447; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061	28	1460	1504	3	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2004	305	5688					1292	1295		10.1126/science.1101738	http://dx.doi.org/10.1126/science.1101738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333840				2022-12-01	WOS:000223624600042
J	Begum, NA; Kinoshita, K; Kakazu, N; Muramatsu, M; Nagaoka, H; Shinkura, R; Biniszkiewicz, D; Boyer, LA; Jaenisch, R; Honjo, T				Begum, NA; Kinoshita, K; Kakazu, N; Muramatsu, M; Nagaoka, H; Shinkura, R; Biniszkiewicz, D; Boyer, LA; Jaenisch, R; Honjo, T			Uracil DNA glycosylase activity is dispensable for immunloglobulin class switch	SCIENCE			English	Article							SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; CRYSTAL-STRUCTURE; HISTONE H2AX; RECOMBINATION; ENZYME; MICE; REPLICATION; MUTATIONS	Activation-induced cytidine deaminase (AID) is required for the DNA cleavage step in immunoglobulin class switch recombination (CSR). AID is proposed to deaminate cytosine to generate uracil (U) in either mRNA or DNA. In the second instance, DNA cleavage depends on uracil DNA glycosylase (UNG) for removal of U. Using phosphorylated histone gamma-H2AX focus formation as a marker of DNA cleavage, we found that the UNG inhibitor Ugi did not inhibit DNA cleavage in immunoglobulin heavy chain (IgH) locus during CSR, even though Ugi blocked UNG binding to DNA and strongly inhibited CSR. Strikingly, UNG mutants that had lost the capability of removing U rescued CSR in UNG(-/-) B cells. These results indicate that UNG is involved in the repair step of CSR yet by an unknown mechanism. The dispensability of U removal in the DNA cleavage step of CSR requires a reconsideration of the model of DNA deamination by AID.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto 6028566, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Kyoto University; Kyoto Prefectural University of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Begum, Nasim/0000-0001-7177-188X				Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464	29	91	91	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1160	1163		10.1126/science.1098444	http://dx.doi.org/10.1126/science.1098444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326357				2022-12-01	WOS:000223557400050
J	Rowan, R				Rowan, R			Coral bleaching - Thermal adaptation in reef coral symbionts	NATURE			English	Editorial Material							CLIMATE-CHANGE; PHOTOINHIBITION; PHOTOSYNTHESIS		Univ Guam, Marine Lab, Mangilao, GU 96923 USA	University of Guam	Rowan, R (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	rrowan@uog9.uog.edu						Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, UNPUB ECOLOGY; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Werner C, 2001, PLANT CELL ENVIRON, V24, P27, DOI 10.1046/j.1365-3040.2001.00651.x	12	465	489	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					742	742		10.1038/430742a	http://dx.doi.org/10.1038/430742a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306800	Bronze			2022-12-01	WOS:000223233600031
J	Sachs, JD				Sachs, JD			Seeking a global solution	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, 535 W 116th St, New York, NY 10027 USA.								0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					725	726		10.1038/430725a	http://dx.doi.org/10.1038/430725a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306785				2022-12-01	WOS:000223233600017
J	Corey, DP; Garcia-Anoveros, J; Holt, JR; Kwan, KY; Lin, SY; Vollrath, MA; Amalfitano, A; Cheung, ELM; Derfler, BH; Duggan, A; Geleoc, GSG; Gray, PA; Hoffman, MP; Rehm, HL; Tamasauskas, D; Zhang, DS				Corey, DP; Garcia-Anoveros, J; Holt, JR; Kwan, KY; Lin, SY; Vollrath, MA; Amalfitano, A; Cheung, ELM; Derfler, BH; Duggan, A; Geleoc, GSG; Gray, PA; Hoffman, MP; Rehm, HL; Tamasauskas, D; Zhang, DS			TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells	NATURE			English	Article							ION CHANNELS; INNER-EAR; MECHANOELECTRICAL TRANSDUCTION; MECHANOTRANSDUCER CHANNEL; TIP LINKS; ADAPTATION; MUTATIONS; GENE; CADHERIN-23; ADENOVIRUS	Mechanical deflection of the sensory hair bundles of receptor cells in the inner ear causes ion channels located at the tips of the bundle to open, thereby initiating the perception of sound. Although some protein constituents of the transduction apparatus are known, the mechanically gated transduction channels have not been identified in higher vertebrates. Here, we investigate TRP ( transient receptor potential) ion channels as candidates and find one, TRPA1 ( also known as ANKTM1), that meets criteria for the transduction channel. The appearance of TRPA1 messenger RNA expression in hair cell epithelia coincides developmentally with the onset of mechanosensitivity. Antibodies to TRPA1 label hair bundles, especially at their tips, and tip labelling disappears when the transduction apparatus is chemically disrupted. Inhibition of TRPA1 protein expression in zebrafish and mouse inner ears inhibits receptor cell function, as assessed with electrical recording and with accumulation of a channel-permeant fluorescent dye. TRPA1 is probably a component of the transduction channel itself.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Northwestern Univ, Inst Neurosci, Dept Anesthesiol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Inst Neurosci, Dept Physiol, Chicago, IL 60611 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Partners Genome Ctr, Mol Med Lab, Cambridge, MA 02139 USA; Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27705 USA; NIDCR, Matrix & Morphogenesis Unit, CDBRB, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Northwestern University; Northwestern University; Northwestern University; University of Virginia; University of Virginia; Massachusetts Institute of Technology (MIT); Harvard University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Corey, DP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dcorey@hms.harvard.edu		Corey, David/0000-0003-4497-6016; Rehm, Heidi L./0000-0002-6025-0015; Kwan, Kelvin/0000-0002-8617-5543; Garcia-Anoveros, Jaime/0000-0001-6561-9048	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000707] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Duggan A, 2000, CURR BIOL, V10, pR384, DOI 10.1016/S0960-9822(00)00478-4; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hodges BL, 2000, J GENE MED, V2, P250, DOI 10.1002/1521-2254(200007/08)2:4<250::AID-JGM113>3.0.CO;2-3; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; Holt JR, 2002, AUDIOL NEURO-OTOL, V7, P157, DOI 10.1159/000058302; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Luebke AE, 2001, GENE THER, V8, P789, DOI 10.1038/sj.gt.3301445; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Starr CJ, 2004, P NATL ACAD SCI USA, V101, P2572, DOI 10.1073/pnas.0308474100; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUKHAREV S, 2004, SCI STKE, pRE4; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	42	497	559	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 9	2004	432	7018					723	730		10.1038/nature03066	http://dx.doi.org/10.1038/nature03066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	877UE	15483558				2022-12-01	WOS:000225597200040
J	Shachaf, CM; Kopelman, AM; Arvanitis, C; Karlsson, A; Beer, S; Mandl, S; Bachmann, MH; Borowsky, AD; Ruebner, B; Cardiff, RD; Yang, QW; Bishop, JM; Contag, CH; Felsher, DW				Shachaf, CM; Kopelman, AM; Arvanitis, C; Karlsson, A; Beer, S; Mandl, S; Bachmann, MH; Borowsky, AD; Ruebner, B; Cardiff, RD; Yang, QW; Bishop, JM; Contag, CH; Felsher, DW			MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer	NATURE			English	Article							LIVER-REGENERATION; STEM-CELLS; GROWTH; TUMORIGENESIS; ONCOGENES; NEOPLASIA	Hepatocellular carcinoma is generally refractory to clinical treatment(1). Here, we report that inactivation of the MYC oncogene is sufficient to induce sustained regression of invasive liver cancers. MYC inactivation resulted en masse in tumour cells differentiating into hepatocytes and biliary cells forming bile duct structures, and this was associated with rapid loss of expression of the tumour marker alpha-fetoprotein, the increase in expression of liver cell markers cytokeratin 8 and carcinoembryonic antigen, and in some cells the liver stem cell marker cytokeratin 19. Using in vivo bioluminescence imaging we found that many of these tumour cells remained dormant as long as MYC remain inactivated; however, MYC reactivation immediately restored their neoplastic features. Using array comparative genomic hybridization we confirmed that these dormant liver cells and the restored tumour retained the identical molecular signature and hence were clonally derived from the tumour cells. Our results show how oncogene inactivation may reverse tumorigenesis in the most clinically difficult cancers. Oncogene inactivation uncovers the pluripotent capacity of tumours to differentiate into normal cellular lineages and tissue structures, while retaining their latent potential to become cancerous, and hence existing in a state of tumour dormancy.	Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Univ Calif Davis, Med Ctr, Dept Pathol, Davis, CA 95616 USA; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco	Felsher, DW (corresponding author), Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Arvanitis, Constadina/C-5975-2013; Bachmann, Michael/N-9339-2016; Borowsky, Alexander D/S-5404-2017	Bachmann, Michael/0000-0002-0204-3720; Contag, Christopher/0000-0002-1011-8278; Arvanitis, Constadina/0000-0002-6311-0974				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Fausto N, 1990, CURR OPIN CELL BIOL, V2, P1036, DOI 10.1016/0955-0674(90)90153-6; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Felsher DW, 2003, NAT REV CANCER, V3, P375, DOI 10.1038/nrc1070; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Hardy J, 2001, EXP HEMATOL, V29, P1353, DOI 10.1016/S0301-472X(01)00756-1; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LEFFERT KS, 1984, CELL CULTURE METHODS, P43; Lotem J, 2002, SEMIN CANCER BIOL, V12, P339, DOI 10.1016/S1044-579X(02)00054-8; MURAKAMI H, 1993, CANCER RES, V53, P1719; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; SANDGREN EP, 1989, ONCOGENE, V4, P715; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; UHR JW, 1991, CANCER RES, V51, pS5045; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Venook A P, 2000, Curr Treat Options Oncol, V1, P407, DOI 10.1007/s11864-000-0068-z; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu YF, 2002, ONCOGENE, V21, P1518, DOI 10.1038/sj.onc.1205208	30	670	709	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2004	431	7012					1112	1117		10.1038/nature03043	http://dx.doi.org/10.1038/nature03043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865VB	15475948				2022-12-01	WOS:000224730800044
J	Bird, SM				Bird, SM			Prescribing sentence: time for evidence-based justice	LANCET			English	Editorial Material							MANDATORY DRUGS TESTS; PRISONS; SCOTLAND; DEATHS; NEED		MRC, Biostat Unit, Cambridge CB2 2SR, England; Univ Strathclyde, Dept Stat & Modeling Sci, Glasgow, Lanark, Scotland	MRC Biostatistics Unit; University of Strathclyde	Bird, SM (corresponding author), MRC, Biostat Unit, Cambridge CB2 2SR, England.	Sheila.bird@mrc-bsu.cam.ac.uk						Bird SM, 2003, DRUG-EDUC PREV POLIC, V10, P396, DOI 10.1080/0968763031000111626-131; Bird SM, 2003, LANCET, V362, P941, DOI 10.1016/S0140-6736(03)14362-0; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; BIRD SM, 2004, HERALD          0217, P15; BIRD SM, 2004, HERALD GLASGOW  0226, P19; Blunkett D., 2004, REDUCING CRIME CHANG; Bourn J., 2004, DRUG TREATMENT TESTI; Carter P., 2004, MANAGING OFFENDERS R; Committee on Data and Research for Policy on Illegal Drugs, 2001, INF AM POL ILL DRUGS; ELERY S, 2002, DRUG TREATMENT TESTI; Fitz-Gibbon C, 2004, J R STAT SOC A STAT, V167, P1, DOI 10.1046/j.0964-1998.2003.02047.x; GOGGINS P, 2004, POLICY REV       MAR, P10; Gore SM, 1998, BRIT MED J, V316, P1256, DOI 10.1136/bmj.316.7140.1256; Gore SM, 1996, BRIT MED J, V312, P1411; Gore SM, 1996, LANCET, V348, P1124, DOI 10.1016/S0140-6736(96)06318-0; GORE SM, 1995, BRIT MED J, V310, P595, DOI 10.1136/bmj.310.6979.595; *HOM OFF, 2004, ON CHARG DRUG TEST E; Hough M, 2003, IMPACT DRUG TREATMEN; KAY J, 2004, POLICY REV MAG   MAR, P14; NAYSMITH S, 2004, SUNDAY HERALD G 0229, P16; *ROYAL STAT SOC WO, PERF IND GOOD BAD UG; Singleton N., 2003, DRUG RELATED MORTALI; Smith AFM, 1996, J ROY STAT SOC A STA, V159, P367, DOI 10.2307/2983324; Turnbull PJ, 2000, DRUG TREATMENT TESTI	24	13	13	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1457	1459		10.1016/S0140-6736(04)17230-9	http://dx.doi.org/10.1016/S0140-6736(04)17230-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488223				2022-12-01	WOS:000224485300034
J	Schaub, B; von Mutius, E				Schaub, B; von Mutius, E			The marketing of asthma and allergies	LANCET			English	Editorial Material							HOUSE-DUST MITE; CLINICAL MANAGEMENT; CHILDHOOD ASTHMA; SOLUBLE CD14; EXPOSURE; CHILDREN; PREVENTION; POLYMORPHISM; AVOIDANCE; ENCASINGS		Univ Childrens Hosp, D-80337 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Schaub, B (corresponding author), Univ Childrens Hosp, D-80337 Munich, Germany.	bianca.schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515				*AM CAT FANC ASS, SPHINX CAT; Arshad SH, 2004, CURR OPIN ALLERGY CL, V4, P119, DOI [10.1097/00130832-200404000-00009, 10.1097/01.all.0000123971.96233.65]; Asher I, 2004, INT ARCH ALLERGY IMM, V135, P83, DOI 10.1159/000080524; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P936, DOI 10.1067/mai.2003.1475; Bergquist P, 2001, EUR RESPIR J, V18, P248, DOI 10.1183/09031936.01.00239601; Bukstein DA, 2003, ANN ALLERG ASTHMA IM, V90, P543, DOI 10.1016/S1081-1206(10)61848-0; Cabana MD, 2004, J ALLERGY CLIN IMMUN, V114, P352, DOI 10.1016/j.jaci.2004.04.047; Capristo C, 2004, ALLERGY, V59, P53, DOI 10.1111/j.1398-9995.2004.00652.x; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Cullinan P, 2004, THORAX, V59, P855, DOI 10.1136/thx.2003.019877; Halken S, 2003, J ALLERGY CLIN IMMUN, V111, P169, DOI 10.1067/mai.2003.5; Horak F, 2004, CLIN EXP ALLERGY, V34, P1220, DOI 10.1111/j.1365-2222.2004.02024.x; Juniper EF, 2003, CURR OPIN PULM MED, V9, pS8, DOI 10.1097/00063198-200304001-00003; Kabesch M, 2004, ALLERGY, V59, P520, DOI 10.1111/j.1398-9995.2004.00439.x; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Maziak W, 2002, EUR RESPIR J, V20, P1476, DOI 10.1183/09031936.02.00281102; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Robinson AR, 2004, ARCH INTERN MED, V164, P427, DOI 10.1001/archinte.164.4.427; Terreehorst I, 2003, NEW ENGL J MED, V349, P237, DOI 10.1056/NEJMoa023171; Vercelli D, 2003, CLIN EXP ALLERGY, V33, P153, DOI 10.1046/j.1365-2222.2003.01606.x	22	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1389	1390		10.1016/S0140-6736(04)17241-3	http://dx.doi.org/10.1016/S0140-6736(04)17241-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488205				2022-12-01	WOS:000224485300010
J	Marcus, GF				Marcus, GF			Before the word - Language evolution: evolutionary vestiges may provide clues to the ultimate origins of human language.	NATURE			English	Editorial Material									NYU, Dept Psychol, New York, NY 10003 USA	New York University	Marcus, GF (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.							Christiansen MH., 2003, LANGUAGE EVOLUTION; GOULD SJ, 1980, PANDAS THUMB; Jackendoff Ray, 2002, FDN LANGUAGE BRAIN M; Marcus G., 2004, BIRTH MIND; McElree B, 2003, J MEM LANG, V48, P67, DOI 10.1016/S0749-596X(02)00515-6	5	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2004	431	7010					745	745		10.1038/431745a	http://dx.doi.org/10.1038/431745a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483585				2022-12-01	WOS:000224435500020
J	Alexander, LN; Seward, JF; Santibanez, TA; Pallansch, MA; Kew, OM; Prevots, DR; Strebel, PM; Cono, J; Wharton, M; Orenstein, WA; Sutter, RW				Alexander, LN; Seward, JF; Santibanez, TA; Pallansch, MA; Kew, OM; Prevots, DR; Strebel, PM; Cono, J; Wharton, M; Orenstein, WA; Sutter, RW			Vaccine policy changes and epidemiology of poliomyelitis in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INACTIVATED POLIOVIRUS VACCINE; PARALYTIC POLIOMYELITIS; IMPACT; IDENTIFICATION; SCHEDULE	Context The last case of poliomyelitis in the United States due to indigenously acquired wild poliovirus occurred in 1979; however, as a consequence of oral poliovirus vaccine (OPV) use that began in 1961, an average of 9 cases of vaccine-associated paralytic poliomyelitis (VAPP) were confirmed each year from 1961 through 1989. To reduce the VAPP burden, national vaccination policy changed in 1997 from reliance on OPV to options for a sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. In 2000, an exclusive IPV schedule was adopted. Objective To review the epidemiology of paralytic poliomyelitis and document the association between the vaccine schedule changes and VAPP in the United States. Design and Setting Review of national surveillance data from 1990 through 2003 for cases of confirmed paralytic poliomyelitis. Main Outcome Measures Number of confirmed paralytic poliomyelitis cases, including VAPP, and ratio of VAPP cases to number of doses of OPV distributed that occurred before, during, and after implementation of policy changes. Results From 1990 through 1999, 61 cases of paralytic poliomyelitis were reported; 59 (97%) of these were VAPP (1 case per 2.9 million OPV doses distributed), 1 case was imported, and 1 case was indeterminate. Thirteen cases occurred during the 19971999 transitional policy period and were associated with the all-OPV schedule; none occurred with the IPV-OPV schedule. No cases occurred after the United States implemented the all-IPV policy in 2000. The last imported poliomyelitis case occurred in 1993 and the last case of VAPP occurred in 1999. Conclusion The change in polio vaccination policy from OPV to exclusive use of IPV was successfully implemented; this change led to the elimination of VAPP in the United States.	Ctr Dis Control & Prevent, Natl Immunizat Program, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Alexander, LN (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, Natl Ctr Infect Dis, 1600 Clifton Rd,MS E-61, Atlanta, GA 30333 USA.	lalexander@cdc.gov		Prevots, D Rebecca/0000-0003-0339-9873; Santibanez, Tammy A./0000-0002-5784-7427				Abramson JS, 1999, PEDIATRICS, V104, P1404, DOI 10.1542/peds.104.6.1404; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; CDC, 1981, CDC ANN SUMM REP MOR; Centers for Disease Control and Prevention, NAT IMM SURV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P107; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1017; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P180; DE L, 1995, J CLIN MICROBIOL, V33, P562, DOI 10.1128/JCM.33.3.562-571.1995; ESTEVES K, 1988, B WORLD HEALTH ORGAN, V66, P739; Halsey NA, 1999, PEDIATRICS, V103, P171, DOI 10.1542/peds.103.1.171; Halsey NA, 1997, PEDIATRICS, V99, P300, DOI 10.1542/peds.99.2.300; HENDERSON DA, 1964, JAMA-J AM MED ASSOC, V190, P41; *I MED, 1996, VACC SAF FOR OPT POL; *I MED, 1977, EV POL VACC, P75; *I MED, 1988, EV POL VACC POL VACC; JOCE R, 1992, BRIT MED J, V305, P79, DOI 10.1136/bmj.305.6845.79; KOHBERGER RC, 1995, I MED POL WORKSH JUN; Kolasa MS, 2001, PUBLIC HEALTH REP, V116, P282, DOI 10.1093/phr/116.4.282; Lindegren Mary Lou, 2004, Morbidity and Mortality Weekly Report, V53, P1; LUTHER T, 1962, ASS CASES POLIOMYELI, P1; Marwick C, 1996, JAMA-J AM MED ASSOC, V275, P827, DOI 10.1001/jama.275.11.827; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; NOTTAY BK, 1981, VIROLOGY, V108, P405, DOI 10.1016/0042-6822(81)90448-7; Polich T., 1997, J CLIN GEROPSYCHOLOG, V3, P1; PREVOTS DR, 1994, ARCH PEDIAT ADOL MED, V148, P479, DOI 10.1001/archpedi.1994.02170050037007; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE, V6th, P51; Schonberger L B, 1978, Adv Neurol, V19, P217; SCHONBERGER LB, 1976, AM J EPIDEMIOL, V104, P202, DOI 10.1093/oxfordjournals.aje.a112290; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; Sutter R. W. C. S., 1999, VACCINES, P364; SUTTER RW, 1989, AM J PUBLIC HEALTH, V79, P495, DOI 10.2105/AJPH.79.4.495; SUTTER RW, 1994, INFECT MED, V11, P429; Sutter RW, 1994, INFECT MED, V11, P426; SUTTER RW, 1994, INFECT MED, V11, P435; Taylor JA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e90; VARUGHESE PV, 1989, CAN J PUBLIC HEALTH, V80, P363; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Wattigney WA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e83; Weibel RE, 1996, AM J PUBLIC HEALTH, V86, P734, DOI 10.2105/AJPH.86.5.734; YANG CF, 1991, VIRUS RES, V20, P159; Zimmerman RK, 1999, AM FAM PHYSICIAN, V59, P113; 1998, MMWR MORB MORTAL WKL, V46, P79	44	149	168	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2004	292	14					1696	1701		10.1001/jama.292.14.1696	http://dx.doi.org/10.1001/jama.292.14.1696			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861JS	15479934	Bronze			2022-12-01	WOS:000224413400028
J	Shahmanesh, M; Wayal, S				Shahmanesh, M; Wayal, S			Targeting commercial sex-workers in Goa, India: time for a strategic rethink?	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED-DISEASES; CONDOM PROMOTION; HIV; PREVENTION; PREVALENCE; INFECTION; DECLINE; IMPACT		UCL Royal Free & Univ Coll Med Sch, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England; Posit People, Panaji, Goa, India	University of London; University College London; UCL Medical School	Shahmanesh, M (corresponding author), UCL Royal Free & Univ Coll Med Sch, Ctr Sexual Hlth & HIV Res, London WC1E 6AU, England.	bamaryjoon@yahoo.co.uk		Shahmanesh, Maryam/0000-0001-7129-8535; Wayal, Sonali/0000-0002-5878-7665				Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; BHAVE G, 1995, AIDS, V9, pS21; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Egger M, 2000, LANCET, V355, P2101, DOI 10.1016/S0140-6736(00)02376-X; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Jana S, 1998, AIDS, V12 Suppl B, pS101; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; SHARMA R, 2004, FRONTLINE       0717; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001	13	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2004	364	9442					1297	1299		10.1016/S0140-6736(04)17206-1	http://dx.doi.org/10.1016/S0140-6736(04)17206-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860NG	15474122				2022-12-01	WOS:000224349700009
J	Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL				Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL			Toroidal triblock copolymer assemblies	SCIENCE			English	Article							DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; MULTIPLE MORPHOLOGIES; SHAPED MORPHOLOGY; DILUTE-SOLUTION; DNA COMPLEXES; F-ACTIN; MICELLES; VESICLES; SURFACTANT	A stable phase of toroidal, or ringlike, supramolecular assemblies was formed by combining dilute solution characteristics critical for both bundling of like-charged biopolymers and block copolymer micelle formation. The key to toroid versus classic cylinder micelle formation is the interaction of the negatively charged hydrophilic block of an amphiphilic triblock copolymer with a positively charged divalent organic counterion. This produces a self-attraction of cylindrical micelles that leads to toroid formation, a mechanism akin to the toroidal bundling of semiflexible charged biopolymers such as DNA. The toroids can be kinetically trapped or chemically cross-linked. insight into the mechanism of toroid formation can be gained by observation of intermediate structures kinetically trapped during film casting.	Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	University of Delaware; Washington University (WUSTL); Washington University (WUSTL)	Pochan, DJ (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.		Qi, Kai/C-2558-2018; Cui, Honggang/C-6550-2008; Wooley, Karen/AAX-2259-2020; Wooley, Karen L/D-4399-2015; Cui, Honggang/E-8012-2010	Qi, Kai/0000-0002-4166-7421; Wooley, Karen/0000-0003-4086-384X; Wooley, Karen L/0000-0003-4086-384X; 				Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l; Bernheim-Groswasser A, 2000, J PHYS CHEM B, V104, P4005, DOI 10.1021/jp994301a; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bottcher C, 1998, J AM CHEM SOC, V120, P12, DOI 10.1021/ja971047w; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Dalhaimer P, 2004, J POLYM SCI POL PHYS, V42, P168, DOI 10.1002/polb.10709; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Ewert K, 2004, CURR MED CHEM, V11, P133, DOI 10.2174/0929867043456160; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; In M, 1999, J PHYS CHEM B, V103, P7747, DOI 10.1021/jp9919922; Jain S, 2004, MACROMOLECULES, V37, P1511, DOI 10.1021/ma035467j; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Prochazka K, 1996, MACROMOLECULES, V29, P6518, DOI 10.1021/ma960630e; Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h; Riegel IC, 2002, LANGMUIR, V18, P3358, DOI 10.1021/la015592t; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 2001, EUR BIOPHYS J BIOPHY, V30, P477, DOI 10.1007/s002490100178; van der Schoot P, 1999, MACROMOL THEOR SIMUL, V8, P428; Vriezema DM, 2004, MACROMOLECULES, V37, P4736, DOI 10.1021/ma035789n; Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035; Yu K, 1996, LANGMUIR, V12, P5980, DOI 10.1021/la960894u; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang LF, 1997, PHYS REV LETT, V79, P5034, DOI 10.1103/PhysRevLett.79.5034; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; Zhu JT, 2004, LANGMUIR, V20, P3809, DOI 10.1021/la0361565	29	675	683	4	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					94	97		10.1126/science.1102866	http://dx.doi.org/10.1126/science.1102866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459386				2022-12-01	WOS:000224304000043
J	Renault, AD; Sigal, YJ; Morris, AJ; Lehmann, R				Renault, AD; Sigal, YJ; Morris, AJ; Lehmann, R			Soma-germ line competition for lipid phosphate uptake regulates germ cell migration and survival	SCIENCE			English	Article							LYSOPHOSPHATIDIC ACID; DROSOPHILA; PLATELETS; RECEPTORS	Lipid phosphates can act as signaling molecules to influence cell division, apoptosis, and migration. wunen and wunen2 encode Drosophila lipid phosphate phosphohydrolases, integral membrane enzymes that dephosphorylate extracellular lipid phosphates. wun and wun2 act redundantly in somatic tissues to repel migrating germ cells, although the mechanism by which germ cells respond is unclear. Here, we report that wun2 also functions in germ cells, enabling them to perceive the wun/wun2-related signal from the soma. Upon Wun2 expression, cultured insect cells dephosphorylate and internalize exogenously supplied lipid phosphate. We propose that Drosophila germ cell migration and survival are controlled by competition for hydrolysis of a lipid phosphate between germ cells and soma.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill	Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Morris, Andrew/B-7869-2010	Renault, Andrew/0000-0003-4313-9726; Lehmann, Ruth/0000-0002-8454-5651	NICHD NIH HHS [HD421900 RO1] Funding Source: Medline; NIGMS NIH HHS [GM54388] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Hooks SB, 2001, J BIOL CHEM, V276, P4611, DOI 10.1074/jbc.M007782200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Renault AD, 2002, MECH DEVELOP, V119, pS293, DOI 10.1016/S0925-4773(03)00131-X; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Siess W, 2002, BBA-MOL CELL BIOL L, V1582, P204, DOI 10.1016/S1388-1981(02)00173-7; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Van Doren M, 1998, CURR BIOL, V8, P243; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; WYLIE CR, COMMUNICATION; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	19	69	70	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1963	1966		10.1126/science.1102421	http://dx.doi.org/10.1126/science.1102421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15331773				2022-12-01	WOS:000224136000049
J	Aaby, P				Aaby, P			Being wrong in the right direction?	LANCET			English	Editorial Material									Danish Epidemiol Sci Ctr, Bandim Hlth Project, Bissau, Guinea Bissau	Aarhus University	Aaby, P (corresponding author), Danish Epidemiol Sci Ctr, Bandim Hlth Project, Apartado 861, Bissau, Guinea Bissau.	psb@mail.gtelecom.gw		Aaby, Peter/0000-0001-8331-1389					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					984	984		10.1016/S0140-6736(04)17024-4	http://dx.doi.org/10.1016/S0140-6736(04)17024-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364191				2022-12-01	WOS:000223831000030
J	Watanabe, KN; Taeb, M; Okusu, H				Watanabe, KN; Taeb, M; Okusu, H			Japanese controversies over transgenic crop regulation	SCIENCE			English	Editorial Material									Univ Tsukuba, Ctr Gene Res, Tsukuba 3058572, Japan; Int Plant Genet Resources Inst, Rome, Italy; United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa 2200012, Japan	University of Tsukuba; Alliance; Bioversity International; United Nations University	Watanabe, KN (corresponding author), Univ Tsukuba, Ctr Gene Res, Tsukuba 3058572, Japan.	nabechan@gene.tsukuba.ac.jp		WATANABE, KAZUO/0000-0003-1499-9989				Barru N., 2003, GLOBAL STATUS COMMER; *DEP ENV FOOD RUR, GEN MOD; *JAP BIOIND ASS, BIOT Q A; Kapuscinski AR, 2003, NAT BIOTECHNOL, V21, P599, DOI 10.1038/nbt0603-599; MENON P, 2002, FRONTLINE, V19; Watanabe K.N., 2004, INTELLECTUAL PROPERT, P187; Watanabe KN, 2004, NAT BIOTECHNOL, V22, P943, DOI 10.1038/nbt0804-943a; Watanabe KN, 2003, NATURE, V421, P689, DOI 10.1038/421689a; 2004, KYOTO SHIMBUN N 0611; 2004, GUIDELINE PLANTING G	10	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1572	1572		10.1126/science.1100734	http://dx.doi.org/10.1126/science.1100734			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361611				2022-12-01	WOS:000223891200027
J	Bai, YF; Han, XG; Wu, JG; Chen, ZZ; Li, LH				Bai, YF; Han, XG; Wu, JG; Chen, ZZ; Li, LH			Ecosystem stability and compensatory effects in the Inner Mongolia grassland	NATURE			English	Article							BIODIVERSITY; DIVERSITY; DYNAMICS; ECOLOGY	Numerous studies have suggested that biodiversity reduces variability in ecosystem productivity through compensatory effects(1-6); that is, a species increases in its abundance in response to the reduction of another in a fluctuating environment(1,7). But this view has been challenged on several grounds(8-10). Because most studies have been based on artificially constructed grasslands with short duration, long-term studies of natural ecosystems are needed. On the basis of a 24-year study of the Inner Mongolia grassland, here we present three key findings. First, that January-July precipitation is the primary climatic factor causing fluctuations in community biomass production; second, that ecosystem stability (conversely related to variability in community biomass production) increases progressively along the hierarchy of organizational levels (that is, from species to functional group to whole community); and finally, that the community-level stability seems to arise from compensatory interactions among major components at both species and functional group levels. From a hierarchical perspective, our results corroborate some previous findings of compensatory effects(1,4,7,11). Undisturbed mature steppe ecosystems seem to culminate with high biodiversity, productivity and ecosystem stability concurrently. Because these relationships are correlational, further studies are necessary to verify the causation among these factors. Our study provides new insights for better management and restoration of the rapidly degrading Inner Mongolia grassland.	Chinese Acad Sci, Inst Bot, Lab Quantitat Vegetat Ecol, Beijing 100093, Peoples R China; Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe	Wu, JG (corresponding author), Chinese Acad Sci, Inst Bot, Lab Quantitat Vegetat Ecol, Beijing 100093, Peoples R China.	Jingle.Wu@asu.edu	Han, Xingguo/K-7552-2016; Wu, Jianguo/G-6267-2010; Han, Xingguo/B-3980-2012	Han, Xingguo/0000-0002-1836-975X; Wu, Jianguo/0000-0002-1182-3024; 				Bai Y.F., 1999, ACTA PHYTOECOL SIN, V23, P155; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Chen S.H., 2001, ROOT SYSTEMS GRASSLA; Chen Z., 2000, TYPICAL STEPPE ECOSY; CHEN ZZ, 1985, RES GRASSLAND ECOSYS, V1, P112; GIVNISH TJ, 1994, NATURE, V371, P113, DOI 10.1038/371113b0; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JIANG S, 1985, RES GRASSLAND ECOSYS, V1; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; LI B, 1988, RES GRASSLAND ECOSYS, V3, P84; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; WU JG, 1994, ECOL MONOGR, V64, P447, DOI 10.2307/2937145; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Wu Jianguo, 1992, P67; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	30	832	1119	75	959	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					181	184		10.1038/nature02850	http://dx.doi.org/10.1038/nature02850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356630				2022-12-01	WOS:000223746000043
J	Goldenberg, NA; Knapp-Clevenger, R; Manco-Johnson, MJ				Goldenberg, NA; Knapp-Clevenger, R; Manco-Johnson, MJ		Mt States Regional Thrombophilia G	Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	45th Annual Meeting and Exhibition of the American-Society-of-Hematology	DEC 06-09, 2003	San Diego, CA	Amer Soc Hematol			RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; POSTTHROMBOTIC SYNDROME; RISK-FACTORS; THROMBOPHILIA; ANTICOAGULATION; CHILDHOOD; REGISTRY; THERAPY; DISEASE	Background: Elevated levels of plasma factor VIII and D-dimer predict recurrent venous thromboembolism in adults. We sought to determine whether an elevation of factor VIII, D-dimer, or both at diagnosis and persistence of the laboratory abnormality after three to six months of anticoagulant therapy correlate with poor outcomes of thrombosis in children. Methods: We evaluated levels of factor VIII and D-dimer and additional components of an extensive laboratory thrombophilia (i.e., hypercoagulability) panel at the time of diagnosis in 144 children with a radiologically confirmed acute thrombotic event. All patients were treated initially with heparin and then with either warfarin or low-molecular-weight heparin for at least three to six months, according to the current standard of care. Patients were examined at follow-up visits 3, 6, and 12 months after diagnosis and then annually, at which times testing was repeated in children with previously abnormal factor VIII and D-dimer test results and a uniform evaluation for the post-thrombotic syndrome was performed. Results: Among 82 children for whom complete data were available regarding laboratory test results at diagnosis and thrombotic outcomes during follow-up, 67 percent had factor VIII levels above the cutoff value of 150 IU per deciliter, D-dimer levels above 500 ng per milliliter, or both at diagnosis, and at least one of the two laboratory values was persistently elevated in 43 percent of the 75 patients in whom testing was performed after three to six months of anticoagulant therapy. Fifty-one percent of the 82 patients had a poor outcome (i.e., a lack of thrombus resolution, recurrent thrombosis, or the post-thrombotic syndrome) during a median follow-up of 12 months (range, 3 months to 5 years). Elevated levels of factor VIII, D-dimer, or both at diagnosis were highly predictive of a poor outcome (odds ratio, 6.1; P=0.008), as was the persistence of at least one laboratory abnormality at three to six months (odds ratio, 4.7; P=0.002). The combination of a factor VIII level above 150 IU per deciliter and a D-dimer level above 500 ng per milliliter at diagnosis was 91 percent specific for a poor outcome, and after three to six months of standard anticoagulation, the combination was 88 percent specific. Conclusions: Elevated levels of plasma factor VIII, D-dimer, or both at diagnosis and a persistent elevation of at least one of these factors after standard-duration anticoagulant therapy predict a poor outcome in children with thrombosis.	Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, Denver, CO 80218 USA; Childrens Hosp, Denver, CO 80218 USA; Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado	Goldenberg, NA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, 1056 E 19th Ave,B-115, Denver, CO 80218 USA.	neil.goldenberg@uchsc.edu			PHS HHS [M01-R00069] Funding Source: Medline; ODCDC CDC HHS [UR6/CCU820552-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ODCDC CDC HHS		Bick RL, 2003, HEMATOL ONCOL CLIN N, V17, P9, DOI 10.1016/S0889-8588(02)00101-6; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Kahn SR, 2003, BLOOD, V102, p57A; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Male C, 1999, J PEDIATR-US, V134, P199, DOI 10.1016/S0022-3476(99)70416-6; Manco-Johnson MJ, 2003, BLOOD, V102, p553A; Manco-Johnson MJ, 2000, J PEDIATR-US, V136, P446, DOI 10.1016/S0022-3476(00)90006-4; Manco-Johnson MJ, 2002, THROMB HAEMOSTASIS, V88, P155; MANCOJOHNSON MJ, 1995, AM J HEMATOL, V48, P240, DOI 10.1002/ajh.2830480407; MARZINOTTO V, 2001, THROMB HAEMOST S2, V78, pOC962; Mathew P, 2003, BLOOD, V102, p548A; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; MEISSNER MH, 1993, J VASC SURG, V18, P596, DOI 10.1016/0741-5214(93)90069-X; Monagle P, 2000, PEDIATR RES, V47, P763, DOI 10.1203/00006450-200006000-00013; Monagle P, 2001, CHEST, V119, p344S, DOI 10.1378/chest.119.1_suppl.344S; Nowak-Gottl U, 2001, BLOOD, V97, P858, DOI 10.1182/blood.V97.4.858; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Van Ommen CH, 2003, J THROMB HAEMOST, V1, P2516, DOI 10.1046/j.1538-7836.2003.00465.x; van Ommen CH, 2001, J PEDIATR-US, V139, P676, DOI 10.1067/mpd.2001.118192; Vlieg AV, 2000, BLOOD, V95, P3678; Wong D L, 1988, Pediatr Nurs, V14, P9	26	164	168	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1081	1088		10.1056/NEJMoa040161	http://dx.doi.org/10.1056/NEJMoa040161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	852CX	15356305	Bronze			2022-12-01	WOS:000223733900007
J	Hynek, BM				Hynek, BM			Implications for hydrologic processes on Mars from extensive bedrock outcrops throughout Terra Meridiani	NATURE			English	Article								Grey haematite was recently detected in the Terra Meridiani region of Mars(1,2) by the Thermal Emission Spectrometer onboard the Mars Global Surveyor spacecraft. The formation of haematite on Earth often requires liquid water to be present for long periods of time, making this an important target for deciphering the history of water on Mars. The Mars Exploration Rover Opportunity landed in Meridiani early in 2004 and has since discovered light-toned bedrock outcrops rich in chemical and textural signatures of long-term water interaction locally at the landing site(3). Here I use remote sensing data to show that the light-toned outcrops at the landing site are not a local phenomenon. Instead, they are observable throughout the haematite-bearing plains in both visible and thermal infrared remote sensing data. Moreover, the light-toned material outcrops around much of the margin and is mappable for hundreds of kilometres to the north, east and west of the plains. I infer that 3 x 10(5) km(2) of this material is exposed over 20degrees of longitude, indicating the extended presence of surface or near-surface water over a large region of Mars.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Hynek, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	brian.hynek@lasp.colorado.edu						Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, 2004, LUNAR PLANET SCI C, V35, P2186; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; HYNEK BM, 2004, LUNAR PLANET SCI C, V35, P1899; JAKOSKY BM, 2004, UNPUB J GEOPHYS RES; Lane MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017183; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; PUTZIG NE, 2004, LUN PLAN SCI C, V35, P1863; Squyres S. W., 2004, LUNAR PLANET SCI C, VXXXV, P2187; Tanaka KL, 2000, ICARUS, V144, P254, DOI 10.1006/icar.1999.6297	17	72	73	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					156	159		10.1038/nature02902	http://dx.doi.org/10.1038/nature02902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356623				2022-12-01	WOS:000223746000036
J	Nichol, G; Kaul, P; Huszti, E; Bridges, JFP				Nichol, G; Kaul, P; Huszti, E; Bridges, JFP			Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure	ANNALS OF INTERNAL MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CONVENIENT APPROXIMATION; SECONDARY PREVENTION; LIFE EXPECTANCY; CLINICAL-TRIALS; CONDUCTION; UNCERTAINTY; MORBIDITY; DEALE	Background: Heart failure is a common, costly, and debilitating illness. Resynchronization of ventricular contraction in patients with heart failure improves ejection fraction. The long-term morbidity and costs associated with such cardiac resynchronization therapy remain unclear. Objective: To assess the incremental cost-effectiveness of cardiac resynchronization therapy. Design: Markov model with Monte Carlo simulation. Future costs and effects were discounted at 3%. Data Sources: Effects data were obtained from a concurrent systematic review. Health-related quality-of-life and cost data were obtained from publicly available data or from surveys. Target Population: Patients with reduced ventricular function and prolonged QRS. Time Horizon: Lifetime. Perspective: U.S. health care system. Interventions: Cardiac resynchronization therapy versus medical therapy. Outcome Measures: Quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness. Results of Base-Case Analysis: Medical therapy yielded a median of 2.64 (interquartile range, 2.47 to 2.82) discounted QALYs and a median discounted lifetime cost of $34400 (interquartile range, $31100 to $37700). Cardiac resynchronization therapy was associated with a median incremental cost of $107800 (interquartile range, $79800 to $156500) per additional QALY. Results of Sensitivity Analysis: Results were sensitive to changes in several variables, including the relative risk for death or hospitalization. Limitations: These results apply to patients who meet the inclusion criteria of the currently completed trials. Conclusions: The incremental cost per QALY for cardiac resynchronization is similar to that of other commonly used interventions but is sensitive to changes in several key variables. Resynchronization therapy should not be considered in patients with comorbid illness that shortens life expectancy.	Univ Washington, Harborview Prehosp Emergency Care Res & Training, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; Univ Alberta, Edmonton, AB, Canada; Case Western Reserve Univ, Cleveland, OH 44106 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; Case Western Reserve University	Nichol, G (corresponding author), Univ Washington, Harborview Prehosp Emergency Care Res & Training, Harborview Med Ctr, 325 9th Ave,Box 359747, Seattle, WA 98104 USA.	nichol@u.washington.edu	Nichol, Graham/Z-4996-2019	Kaul, Padma/0000-0003-2239-3944				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; *ALB EV BAS PRACT, 2003, SYST REV BIV PAC HEA; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.0.CO;2-O; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHRISTENSEN R, 1989, DATA DISTRIBUTIONS S; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Ezekowitz JA, 2003, ANN INTERN MED, V138, P445, DOI 10.7326/0003-4819-138-6-200303180-00007; *FDA, 2002, P010012 FDA; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P585, DOI 10.1016/0895-4356(89)90155-8; Furlong W, 1990, WORKING PAPER SERIES, V90-9; Garrigue S, 2002, HEART, V87, P529, DOI 10.1136/heart.87.6.529; Gold MR., 1996, COST EFFECTIVENESS H; Gold MR, 1996, COST EFFECTIVENESS H, P425; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Kaul P, 2003, J AM COLL CARDIOL, V41, p535A; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Llewellyn-Thomas H. A., 2000, ADAPTATION CHANGING, P109; LlewellynThomas HA, 1996, MED CARE, V34, pDS109; Lloyd-Williams F, 2003, J CLIN EPIDEMIOL, V56, P1157, DOI 10.1016/S0895-4356(03)00205-1; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; MASON J, 1993, BRIT MED J, V306, P570, DOI 10.1136/bmj.306.6877.570; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Massie BM, 1998, LANCET, V352, P29; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; *N AM SOC PAC EL, CPT COD GUID; *NAT HEART LUNG BL, 2002, NHLBI FACT BOOK; Nichol G, 2003, CIRCULATION, V108, P697, DOI 10.1161/01.CIR.0000084545.65645.28; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; PORTER M, 1984, SOC SCI MED, V19, P1197, DOI 10.1016/0277-9536(84)90370-8; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Shamim W, 1999, INT J CARDIOL, V70, P171, DOI 10.1016/S0167-5273(99)00077-7; Sox HC, 1988, MED DECISION MAKING; Sutton A. J., 2000, METHODS METAANALYSIS; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TORRANCE GW, 1995, PHARMACOECONOMICS, V7, P503, DOI 10.2165/00019053-199507060-00005; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; *US DEP HHS, 2001, US DEC LIF TABL 1998; US Department of Labor. Bureau of Labor Statistics, CONS PRIC IND; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; VANNEUMANN J, 1994, THEORY GAMES EC BEHA; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; WINER BJ, 1971, LATIN SQUARES RELATE, P685; Xiao HB, 1996, INT J CARDIOL, V53, P163, DOI 10.1016/0167-5273(95)02502-2; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	59	83	83	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					343	351		10.7326/0003-4819-141-5-200409070-00102	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00102			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353425				2022-12-01	WOS:000223733800002
J	Foster				Foster			How often are adverse events reported in English hospital statistics?	BMJ-BRITISH MEDICAL JOURNAL			English	Article								About 850 000 medical errors occur in NHS hospitals every year, resulting in 40 000 deaths. In-wl the United Kingdom, the National Patient Safety Agency (NPSA) was created to learn from patient safety incidents occurring in the NHS.(w2) In February 2004, it launched a new patient reporting system, drawing together reports of patient safety errors and systems failures provided by health professionals across England and Wales.(w3) An adverse event can be defined as "an unintended injury caused by medical management rather than a disease process, resulting in death, life threatening illness, disability at the time of discharge, admission to hospital, or prolongation of hospital stay."(w4) A medical or surgical misadventure is an adverse event that might have been avoided if the patient had received ordinary standards of care. We took at four years of hospital episode statistics to examine patterns in the recording of adverse events within this routinely collected source of data and ask whether it could be of use in monitoring this problem.	Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Foster (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011				Australian Institute for Health and Welfare, 2001, REP ADV EV ROUT COLL; EMSLIE S, 2001, RISK MANAGEMENT NATL; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; Wolff AM, 1996, MED J AUSTRALIA, V164, P458, DOI 10.5694/j.1326-5377.1996.tb122120.x	5	26	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					369	+		10.1136/bmj.329.7462.369	http://dx.doi.org/10.1136/bmj.329.7462.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310606	Green Published			2022-12-01	WOS:000223433600013
J	Madara, J				Madara, J			Building an intestine - Architectural contributions of commensal bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Madara, J (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002	4	30	36	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1685	1686		10.1056/NEJMcibr042621	http://dx.doi.org/10.1056/NEJMcibr042621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483290				2022-12-01	WOS:000224427300019
J	Noskov, SY; Berneche, S; Roux, B				Noskov, SY; Berneche, S; Roux, B			Control of ion selectivity in potassium channels by electrostatic and dynamic properties of carbonyl ligands	NATURE			English	Article							K+ CHANNEL; CONDUCTION; PERMEATION; ENERGY; FILTER; NA+; SIMULATIONS; MUTATIONS; OCCUPANCY; PROTEINS	Potassium channels are essential for maintaining a normal ionic balance across cell membranes. Central to this function is the ability of such channels to support transmembrane ion conduction at nearly diffusion-limited rates while discriminating for K+ over Na+ by more than a thousand-fold. This selectivity arises because the transfer of the K+ ion into the channel pore is energetically favoured, a feature commonly attributed to a structurally precise fit between the K+ ion and carbonyl groups lining the rigid and narrow pore(1). But proteins are relatively flexible structures(2,3) that undergo rapid thermal atomic fluctuations larger than the small difference in ionic radius between K+ and Na+. Here we present molecular dynamics simulations for the potassium channel KcsA, which show that the carbonyl groups coordinating the ion in the narrow pore are indeed very dynamic ('liquid-like') and that their intrinsic electrostatic properties control ion selectivity. This finding highlights the importance of the classical concept of field strength(4). Selectivity for K+ is seen to emerge as a robust feature of a flexible fluctuating pore lined by carbonyl groups.	Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, New York, NY 10021 USA; Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland	Cornell University; University of Basel	Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, 1300 York Ave, New York, NY 10021 USA.	benoit.roux@med.cornell.edu	Noskov, Sergei/B-3654-2010; Bernèche, Simon/L-6389-2013	Bernèche, Simon/0000-0002-6274-4094; Noskov, Sergei/0000-0001-7769-335X				Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420; ALLEN TW, IN PRESS J GEN PHYSL; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; AQVIST J, 1992, J PHYS CHEM-US, V96, P10019, DOI 10.1021/j100203a079; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; EISENMAN G, 1962, Biophys J, V2, P259; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Hille B., 2001, ION CHANNELS EXCITAB, V3; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Luzhkov VB, 2001, BBA-PROTEIN STRUCT M, V1548, P194, DOI 10.1016/S0167-4838(01)00213-8; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARRONE TJ, 1995, J AM CHEM SOC, V117, P779, DOI 10.1021/ja00107a022; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614; Pauling L., 1960, NATURE CHEM BOND; Shrivastava IH, 2002, BIOPHYS J, V83, P633, DOI 10.1016/S0006-3495(02)75197-7; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	32	425	435	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					830	834		10.1038/nature02943	http://dx.doi.org/10.1038/nature02943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483608				2022-12-01	WOS:000224435500043
J	Xu, X; Norell, MA				Xu, X; Norell, MA			A new troodontid dinosaur from China with avian-like sleeping posture	NATURE			English	Article							EVOLUTION; THEROPODA; SKULL	Discovering evidence of behaviour in fossilized vertebrates is rare. Even rarer is evidence of behaviour in non-avialan dinosaurs that directly relates to stereotypical behaviour seen in extant birds (avians) and not previously predicted in non-avialan dinosaurs(1,2). Here we report the discovery of a new troodontid taxon from the Early Cretaceous Yixian Formation of western Liaoning, China. Numerous other three-dimensionally preserved vertebrate fossils have been recovered recently at this locality, including some specimens preserving behavioural information(3). The new troodontid preserves several features that have been implicated in avialan origins. Notably, the specimen is preserved in the stereotypical sleeping or resting posture found in extant Aves(4). Evidence of this behaviour outside of the crown group Aves further demonstrates that many bird features occurred early in dinosaurian evolution(5,6).	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xu@amnh.org; xingxu@vip.sina.com						Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chang M.M., 2003, JEHOL BIOTA; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Clark James M., 1999, American Museum Novitates, V3265, P1; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Elzanowski Andrzej, 2002, P129; Guo ZF, 2003, SCI CHINA SER D, V46, P1261, DOI 10.1360/03yd0071; HILL RW, 1980, PHYSIOL ZOOL, V53, P305, DOI 10.1086/physzool.53.3.30155793; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Loope DB, 1998, GEOLOGY, V26, P27, DOI 10.1130/0091-7613(1998)026<0027:LADIAL>2.3.CO;2; Makovicky PJ, 2003, AM MUS NOVIT, P1; Marsh R.L., 1989, Advances in Comparative and Environmental Physiology, V4, P205; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1997, American Museum Novitates, V3215, P1; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Schweitzer MH, 2001, J EXP ZOOL, V291, P317, DOI 10.1002/jez.1132; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; WING LW, 1956, NATURAL HIST BIRDS; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD	30	163	180	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					838	841		10.1038/nature02898	http://dx.doi.org/10.1038/nature02898			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483610				2022-12-01	WOS:000224435500045
J	Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK				Xu, X; Norell, MA; Kuang, XW; Wang, XL; Zhao, Q; Jia, CK			Basal tyrannosauroids from China and evidence for protofeathers in tyrannosauroids	NATURE			English	Article							NORTH-AMERICA; DINOSAURIA; EVOLUTION; THEROPOD; INFORMATION; ANATOMY	Tyrannosauroids are one of the last and the most successful large-bodied predatory dinosaur groups(1-5), but their early history remains poorly understood. Here we report a new basal tyrannosauroid from the Early Cretaceous Yixian Formation of western Liaoning, China, which is small and gracile and has relatively long arms with three-fingered hands. The new taxon is the earliest known unquestionable tyrannosauroid found so far(6-9). It shows a mosaic of characters, including a derived cranial structure resembling that of derived tyrannosauroids(1-5) and a primitive postcranial skeleton similar to basal coelurosaurians. One of the specimens also preserves a filamentous integumentary covering similar to that of other coelurosaurian theropods from western Liaoning. This provides the first direct fossil evidence that tyrannosauroids had protofeathers.	Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	xu@amnh.org; norell@amnh.org						Brochu CA., 2003, J VERT PALEONTOL, V22, P1, DOI [DOI 10.2307/3889334, 10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947]; Buffetaut E, 1996, NATURE, V381, P689, DOI 10.1038/381689a0; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P227; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Currie PJ, 2001, CAN J EARTH SCI, V38, P1729, DOI 10.1139/e01-042; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Gauthier J., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz Thomas R. Jr, 2001, P64; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Manabe M, 1999, J PALEONTOL, V73, P1176, DOI 10.1017/S002233600003105X; Martin LD, 2000, AM ZOOL, V40, P687, DOI 10.1668/0003-1569(2000)040[0687:TFROFE]2.0.CO;2; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Spinage C.A., 1994, ELEPHANTS; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X., 2002, THESIS CHINESE ACAD	30	177	200	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					680	684		10.1038/nature02855	http://dx.doi.org/10.1038/nature02855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470426				2022-12-01	WOS:000224299300038
J	Dhar, G; Sanders, ER; Johnson, RC				Dhar, G; Sanders, ER; Johnson, RC			Architecture of the Hin synaptic complex during recombination: The recombinase subunits translocate with the DNA strands	CELL			English	Article							GAMMA-DELTA-RESOLVASE; SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; INVERSION; ENHANCER; EXCHANGE; MECHANISM; INVERTASOME; ACTIVATION	Most site-specific recombinases can be grouped into two mechanistically distinct families. Whereas tyrosine recombinases exchange DNA strands through a Holliday intermediate, serine recombinases such as Hin generate double-strand breaks in each recombining partner. Here, site-directed protein crosslinking is used to elucidate the configuration of protein subunits and DNA within the Hin synaptic complex and to follow the movement of protein subunits during DNA strand exchange. Our results show that the protein interface mediating synapsis is localized to a region within the catalytic domains, thereby positioning the DNA strands on the outside of the Hin tetrameric complex. Unexpected crosslinks between residues within the dimerization helices provide evidence for a conformational change that accompanies DNA cleavage. We demonstrate that the Hin subunits, which are linked to the cleaved DNA ends by serine-phosphodiester bonds translocate between synapsed dimers to exchange the DNA strands.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Johnson, RC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	rcjohnson@mednet.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038509, R37GM038509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burke ME, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03831.x; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chiu TK, 2002, EMBO J, V21, P801, DOI 10.1093/emboj/21.4.801; CRAIG NL, 2002, MOBILE DNA 2; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grindley NDF, 2002, MOBILE DNA, P272; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HAFFTER P, 1988, EMBO J, V7, P3991, DOI 10.1002/j.1460-2075.1988.tb03287.x; Haykinson MJ, 1996, CURR BIOL, V6, P163, DOI 10.1016/S0960-9822(02)00449-9; HEICHMAN KA, 1991, GENE DEV, V5, P1622, DOI 10.1101/gad.5.9.1622; HEICHMAN KA, 1990, SCIENCE, V249, P511, DOI 10.1126/science.2166334; HUGHES RE, 1993, EMBO J, V12, P1447, DOI 10.1002/j.1460-2075.1993.tb05788.x; Jayaram M., 2002, MOBILE DNA, P192; JOHNSON RC, 1985, CELL, V41, P781, DOI 10.1016/S0092-8674(85)80059-3; JOHNSON RC, 1987, NATURE, V329, P462, DOI 10.1038/329462a0; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; Johnson RC, 2002, MOBILE DNA, P230; KANAAR R, 1990, CELL, V62, P353, DOI 10.1016/0092-8674(90)90372-L; KANAAR R, 1988, P NATL ACAD SCI USA, V85, P752, DOI 10.1073/pnas.85.3.752; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Lee HJ, 2003, MOL CELLS, V16, P377; Leschziner AE, 2003, MOL CELL, V12, P775, DOI 10.1016/S1097-2765(03)00351-4; LIM HM, 1994, J BIOL CHEM, V269, P31134; Merickel SK, 2004, MOL MICROBIOL, V51, P1143, DOI 10.1046/j.1365-2958.2003.03890.x; Merickel SK, 1998, GENE DEV, V12, P2803, DOI 10.1101/gad.12.17.2803; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Pan B, 2001, J MOL BIOL, V310, P1089, DOI 10.1006/jmbi.2001.4821; Pan B, 1997, PROTEIN SCI, V6, P1237, DOI 10.1002/pro.5560060612; Rice P. A., 2002, MOBILE DNA, P219; RICE PA, 1994, STRUCTURE, V2, P371, DOI 10.1016/S0969-2126(00)00039-3; RICE PA, 1994, EMBO J, V13, P1514, DOI 10.1002/j.1460-2075.1994.tb06413.x; Sanders ER, 2004, J MOL BIOL, V340, P753, DOI 10.1016/j.jmb.2004.05.027; SANDERSON MR, 1990, CELL, V63, P1323, DOI 10.1016/0092-8674(90)90427-G; Sarkis GJ, 2001, MOL CELL, V8, P623, DOI 10.1016/S1097-2765(01)00334-3; SILVERMAN M, 1980, COLD SPRING HARB SYM, V45, P17, DOI 10.1101/SQB.1981.045.01.005; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STARK WM, 1991, EMBO J, V10, P3541, DOI 10.1002/j.1460-2075.1991.tb04918.x; Van Duyne G. D., 2002, MOBILE DNA, P93; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; ZIEG J, 1977, SCIENCE, V196, P170, DOI 10.1126/science.322276	40	33	35	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					33	45		10.1016/j.cell.2004.09.010	http://dx.doi.org/10.1016/j.cell.2004.09.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454079	Bronze			2022-12-01	WOS:000224292600007
J	Furness, C; Sharma, R; Harnden, A				Furness, C; Sharma, R; Harnden, A			10-minute consultation - Morbilliform rash	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford Green Coll, Oxford OX2 6HG, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Harnden, A (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HG, England.	anthony.harnden@dphpc.ox.ac.uk							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					719	719		10.1136/bmj.329.7468.719	http://dx.doi.org/10.1136/bmj.329.7468.719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388614	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000224210300019
J	Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA				Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA			The "duty to warn" a patient's family members about hereditary disease risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEOPLASIA TYPE 2A; ADENOMATOUS POLYPOSIS; GENETIC-DISEASE; CANCER; INFORMATION; MUTATIONS; RELATIVES; CARRIERS; BREAST; BRCA1	Genetic tests for adult-onset disorders, including common forms of cancer, are now commercially available, and tests for genetic polymorphisms that predict drug effects or toxicity after treatment are under development. For each of these circumstances, testing of 1 individual may imply an increased risk to his/her relative. The obligation, if any, to warn family members of the identification of a genetic mutation has generated concerns regarding the conflict between the physician's ethical obligations to respect the privacy of genetic information vs the potential liabilities resulting from the physician's failure to notify at-risk relatives. A duty to warn relatives about risks due to some infectious agents has been assumed by state and local health agencies, and the duty to breach confidentiality to warn of imminent harm has been the subject of case law. In general, the special nature of genetic tests has been viewed as a barrier to physicians' breaching the confidentiality of personal genetic information. However, the failure to warn family members about hereditary disease risks has already resulted in 3 lawsuits against physicians in the United States. While the findings of case law and the state and federal statutes that bear on the issue of "duty to warn" of inherited health risk are still being defined, we believe that health care professionals have a responsibility to encourage but not to coerce the sharing of genetic information in families, while respecting the boundaries imposed by the law and by the ethical practice of medicine.	Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Off Legal Affairs, New York, NY 10021 USA; Ropes & Gray LLP, Washington, DC 20037 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V7; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Burnett J W, 1999, Houst Law Rev, V36, P559; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; *COUNC ETH JUD AFF, 2A02 CEJA; Dugan RB, 2003, AM J MED GENET C, V119C, P27, DOI 10.1002/ajmg.c.10005; Falk MJ, 2003, AM J MED GENET A, V120A, P374, DOI 10.1002/ajmg.a.20227; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; *I MED COMM ASS GE, 1994, ASS GEN RISKS IMPL H; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Keeton WP, 1984, PROSSER KEETONS HORN; Knoppers BM, 1998, AM J HUM GENET, V62, P474; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; LINDEN AM, 1993, CANADIAN TORT LAW; LIPS CJM, 1994, NEW ENGL J MED, V331, P828, DOI 10.1056/NEJM199409293311302; MACKLIN R, 1992, GENE MAPPING USING L, P157; Offit K., 1998, CLIN CANC GENETICS R; OFFIT K, 2004, AM SOC CLIN ONCOLOGY; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1998, SCREEN COUNS GEN CON; Sankar P, 2003, ANNU REV MED, V54, P393, DOI 10.1146/annurev.med.54.101601.152131; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.20.5.1260; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Sudell A, 2001, J Contemp Health Law Policy, V18, P273; *US DEP HHS, OCR PRIV BRIEF SUMM; WELLS SA, 1994, ANN SURG, V220, P237, DOI 10.1097/00000658-199409000-00002	29	183	184	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1469	1473		10.1001/jama.292.12.1469	http://dx.doi.org/10.1001/jama.292.12.1469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383518				2022-12-01	WOS:000224031800029
J	Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN				Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN			Recent developments in diagnosis of pancreatic cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OF-THE-ART; DUCTAL ADENOCARCINOMA; COMPUTED-TOMOGRAPHY; TUMORS; NEOPLASMS; CT; ULTRASONOGRAPHY; RESECTABILITY; EXPRESSION; CARCINOMA		Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Dept Radiol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Lobo, DN (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England.	dileep.lobo@nottingham.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796				Adamek HE, 2000, LANCET, V356, P190, DOI 10.1016/S0140-6736(00)02479-X; Berberat P, 1999, WORLD J SURG, V23, P882, DOI 10.1007/s002689900593; Beyer T, 2000, J NUCL MED, V41, P1369; Brand R, 2001, CANCER J, V7, P287; Clarke DL, 2003, J AM COLL SURGEONS, V196, P119, DOI 10.1016/S1072-7515(02)01609-5; Conio M, 2001, CRIT REV ONCOL HEMAT, V37, P127, DOI 10.1016/S1040-8428(00)00108-6; Cooperman AM, 2000, J CLIN GASTROENTEROL, V31, P107, DOI 10.1097/00004836-200009000-00004; DiMagno EP, 1999, ANN ONCOL, V10, P140, DOI 10.1023/A:1008382029375; FUHRMAN GM, 1994, AM J SURG, V167, P104, DOI 10.1016/0002-9610(94)90060-4; GRAHAM RA, 1994, J SURG ONCOL, V55, P92, DOI 10.1002/jso.2930550206; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Hanbidge AE, 2002, CAN J GASTROENTEROL, V16, P101, DOI 10.1155/2002/184370; Haycox A, 1998, ALIMENT PHARM THER, V12, P937; Hosten N, 2000, LANCET, V356, P909, DOI 10.1016/S0140-6736(00)02683-0; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kalra MK, 2003, BRIT J RADIOL, V76, P857, DOI 10.1259/bjr/16642775; Kitano M, 2004, GUT, V53, P854, DOI 10.1136/gut.2003.029934; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Mertz HR, 2000, GASTROINTEST ENDOSC, V52, P367, DOI 10.1067/mge.2000.107727; Midwinter MJ, 1999, BRIT J SURG, V86, P189, DOI 10.1046/j.1365-2168.1999.01042.x; *NAT CANC GUID GRO, 2001, GUID COMM CANC SERV; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ozkan H, 2003, HEPATO-GASTROENTEROL, V50, P1669; Pisters PWT, 2001, BRIT J SURG, V88, P325, DOI 10.1046/j.1365-2168.2001.01695.x; Plebani M, 1995, INT J BIOL MARKER, V10, P189, DOI 10.1177/172460089501000401; Potter MW, 2000, SURG ONCOL, V9, P103, DOI 10.1016/S0960-7404(01)00005-6; Quinn M, 2001, CANC TRENDS ENGLAND; RICHTER JM, 1989, ARCH INTERN MED, V149, P2292, DOI 10.1001/archinte.149.10.2292; Rickes S, 2002, SCAND J GASTROENTERO, V37, P1313, DOI 10.1080/003655202761020605; Saruc M, 2003, PANCREAS, V26, P381, DOI 10.1097/00006676-200305000-00012; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/00000658-200207000-00005; STEINER E, 1989, AM J ROENTGENOL, V152, P487, DOI 10.2214/ajr.152.3.487; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Tamm EP, 2003, AM J ROENTGENOL, V180, P1311, DOI 10.2214/ajr.180.5.1801311; Vargas R, 2004, AM J ROENTGENOL, V182, P419, DOI 10.2214/ajr.182.2.1820419; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579	37	57	68	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					668	673		10.1136/bmj.329.7467.668	http://dx.doi.org/10.1136/bmj.329.7467.668			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374918	Green Published			2022-12-01	WOS:000224042300024
J	Northrup, AB; MacMillan, DWC				Northrup, AB; MacMillan, DWC			Two-step synthesis of carbohydrates by selective aldol reactions	SCIENCE			English	Article							DIELS-ALDER REACTION; ASYMMETRIC-SYNTHESIS; ALDEHYDES; HEXOSES; SUGARS; ROUTE	Studies of carbohydrates have been hampered by the lack of chemical strategies for the expeditious construction and coupling of differentially protected monosaccharides. Here, a synthetic route based on aldol coupling of three aldehydes is presented for the de novo production of polyol differentiated hexoses in only two chemical steps. The dimerization of alpha-oxyaldehydes, catalyzed by L-proline, is then followed by a tandem Mukaiyama aldol addition-cyclization step catalyzed by a Lewis acid. Differentially protected glucose, allose, and mannose stereoisomers can each be selected, in high yield and stereochemical purity, simply by changing the solvent and Lewis acid used. The reaction sequence also efficiently produces C-13-labeled analogs, as well as structural variants such as 2-amino- and 2-thio-substituted derivatives.	CALTECH, Dept Chem, Pasadena, CA 91125 USA	California Institute of Technology	MacMillan, DWC (corresponding author), CALTECH, Dept Chem, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dmacmill@caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066142] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066142, R01 GM66142-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bataille C, 2002, J ORG CHEM, V67, P8054, DOI 10.1021/jo0204193; BOGER DL, 1988, J ORG CHEM, V53, P5793, DOI 10.1021/jo00259a040; DANISHEFSKY S, 1985, J AM CHEM SOC, V107, P7761, DOI 10.1021/ja00311a089; Davies SG, 2002, SYNLETT, P1637, DOI 10.1055/s-2002-34215; Denmark SE, 2001, ANGEW CHEM INT EDIT, V40, P4759, DOI 10.1002/1521-3773(20011217)40:24<4759::AID-ANIE4759>3.0.CO;2-G; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; Ernst B., 2000, CARBOHYDRATES CHEM B; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; KO SY, 1983, SCIENCE, V220, P949, DOI 10.1126/science.220.4600.949; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; Nicolaou K. C., 1999, BIOORGANIC CHEM CARB, P134; Northrup AB, 2004, ANGEW CHEM INT EDIT, V43, P2152, DOI 10.1002/anie.200453716; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; Takeuchi M, 1999, SYNTHESIS-STUTTGART, P341; TIETZE LF, 1994, SYNLETT, P509; Vogel P., 2001, GLYCOSCIENCE, V2, P1023	18	345	354	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1752	1755		10.1126/science.1101710	http://dx.doi.org/10.1126/science.1101710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15308765				2022-12-01	WOS:000224039500034
J	Kim, SK; Rulifson, EJ				Kim, SK; Rulifson, EJ			Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells	NATURE			English	Article							ADIPOKINETIC HORMONE-RELEASE; SENSITIVE K+ CHANNELS; INSULIN-LIKE PEPTIDES; PANCREATIC A-CELLS; SULFONYLUREA RECEPTOR; CORPUS CARDIACUM; GLUCAGON; GROWTH; NEURONS; LOCUST	Antagonistic activities of glucagon and insulin control metabolism in mammals, and disruption of this balance underlies diabetes pathogenesis. Insulin-producing cells (IPCs) in the brain of insects such as Drosophila also regulate serum glucose(1,2), but it remains unclear whether insulin is the sole hormonal regulator of glucose homeostasis and whether mechanisms of glucose-sensing and response in IPCs resemble those in pancreatic islets. Here we show, by targeted cell ablation, that Drosophila corpora cardiaca (CC) cells(3-5) of the ring gland are also essential for larval glucose homeostasis. Unlike IPCs, CC cells express Drosophila cognates of sulphonylurea receptor (Sur) and potassium channel (Ir), proteins that comprise ATP-sensitive potassium channels regulating hormone secretion by islets and other mammalian glucose-sensing cells(6-8). They also produce adipokinetic hormone, a polypeptide with glucagon-like functions. Glucose regulation by CC cells is impaired by exposure to sulphonylureas, drugs that target the Sur subunit. Furthermore, ubiquitous expression of an akh transgene reverses the effect of CC ablation on serum glucose. Thus, Drosophila CC cells are crucial regulators of glucose homeostasis and they use glucose-sensing and response mechanisms similar to islet cells.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Dept Med,Oncol Div, Stanford, CA 94305 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Stanford University; Stanford University; University of Pennsylvania	Kim, SK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA.	seungkim@cmgm.stanford.edu		Kim, Seung/0000-0001-6135-7810				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; COPENHAVER PF, 1991, DEVELOPMENT, V113, P111; DEVELASCO B, IN PRESS DEV BIOL; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Hoy M, 2000, J PHYSIOL-LONDON, V527, P109, DOI 10.1111/j.1469-7793.2000.00109.x; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nasonkin I, 1999, J BIOL CHEM, V274, P29420, DOI 10.1074/jbc.274.41.29420; NOYES BE, 1995, MOL CELL ENDOCRINOL, V109, P133, DOI 10.1016/0303-7207(95)03492-P; ORCHARD I, 1981, J NEUROBIOL, V12, P143, DOI 10.1002/neu.480120204; Ostergard T, 2004, J CLIN ENDOCR METAB, V89, P297, DOI 10.1210/jc.2003-031011; PANNABECKER T, 1987, BRAIN RES, V423, P13, DOI 10.1016/0006-8993(87)90819-5; PANNABECKER T, 1989, BRAIN RES, V477, P38, DOI 10.1016/0006-8993(89)91392-9; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Passier PCCM, 1997, J ENDOCRINOL, V153, P299, DOI 10.1677/joe.0.1530299; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; STURGESS NC, 1985, LANCET, V2, P474; TOMANCAK P, BERKELEY DROSOPHILA; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; Yu DH, 2003, J NEUROSCI, V23, P64	30	318	326	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					316	320		10.1038/nature02897	http://dx.doi.org/10.1038/nature02897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372035				2022-12-01	WOS:000223864000043
J	van Halteren, HK; Bongaerts, GPA; Wagener, DJT				van Halteren, HK; Bongaerts, GPA; Wagener, DJT			Cancer and psychosocial distress: frequent companions	LANCET			English	Editorial Material									Oosterschelde Hosp, Dept Internal Med, Goes, Netherlands; Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; Univ Med Ctr, Dept Med Oncol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Halteren, HK (corresponding author), Oosterschelde Hosp, Dept Internal Med, Goes, Netherlands.	Hvanhalteren@soz.nl						Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Derogatis LR, 2001, BRIEF SYMPTOM INVENT; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID, pPA2019; Ross L, 2002, EUR J CANCER, V38, P1447, DOI 10.1016/S0959-8049(02)00126-0	4	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					824	825		10.1016/S0140-6736(04)16997-3	http://dx.doi.org/10.1016/S0140-6736(04)16997-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351174				2022-12-01	WOS:000223685200008
J	Ugalde, JA; Chang, BSW; Matz, MV				Ugalde, JA; Chang, BSW; Matz, MV			Evolution of coral pigments recreated	SCIENCE			English	Article							FEATURES		Univ Florida, Whitney Lab, Gainesville, FL 32611 USA; Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; Univ Chile, Lab Bioinformat & Gene Express, Santiago, Chile; Univ Toronto, Dept Zool, Toronto, ON, Canada	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad de Chile; University of Toronto	Matz, MV (corresponding author), Univ Florida, Whitney Lab, Gainesville, FL 32611 USA.	matz@whitney.ufl.edu	Ugalde, Juan Antonio/GLV-2034-2022; Matz, Mikhail V/K-4392-2017; Ugalde, Juan/E-7070-2010	Ugalde, Juan Antonio/0000-0001-6638-0817; Matz, Mikhail V/0000-0001-5453-9819; Ugalde, Juan/0000-0001-6638-0817				Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	5	96	99	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1433	1433		10.1126/science.1099597	http://dx.doi.org/10.1126/science.1099597			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353795				2022-12-01	WOS:000223761900038
J	Beatty, CD; Beirinckx, K; Sherratt, TN				Beatty, CD; Beirinckx, K; Sherratt, TN			The evolution of mullerian mimicry in multispecies communities	NATURE			English	Article							NATURAL-SELECTION; APOSEMATIC PREY; WARNING SIGNALS; COLOR	Prey species that are unprofitable to attack often share conspicuous colours and patterns with other coexisting defended species(1-6). This phenomenon, termed mullerian mimicry(2,3), has long been explained as a consequence of selection on defended prey to adopt a common way of advertising their unprofitability(7,8). However, studies using two unpalatable prey types have not always supported this theory(9-12). Here we show, using a system of humans hunting for computer-generated prey, that predators do not always generate strong selection for mimicry when there are two unprofitable prey types. By contrast, we demonstrate that when predators are faced with a range of different prey species, selection on unprofitable prey to resemble one another can be intense. Here the primary selective force is not one in which predators evaluate the profitabilities of distinct prey types independently, but one in which predators learn better to avoid unprofitable phenotypes that share traits distinguishing them from profitable prey(13,14). This need to simplify decision making readily facilitates the spread of imperfect mimetic forms from rarity, and suggests that mullerian mimicry is more likely to arise in multispecies communities.	Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University	Sherratt, TN (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	sherratt@ccs.carleton.ca	Beatty, Christopher/ABE-6438-2020	Beatty, Christopher/0000-0003-2641-0000				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; Bates HW, 1862, T LINN SOC LONDON, V23, P495, DOI [10.1111/j.1096-3642.1860.tb00146.x, DOI 10.1111/J.1096-3642.1860.TB00146.X]; BEATTY CD, UNPUB ANIM BEHAV; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Fisher R.A., 1930, GENETICAL THEORY NAT; Glanville PW, 1997, OIKOS, V80, P565, DOI 10.2307/3546630; Gotmark F, 1995, OIKOS, V74, P475, DOI 10.2307/3545993; GREENWOOD JJD, 1989, BIOL J LINN SOC, V36, P213, DOI 10.1111/j.1095-8312.1989.tb00491.x; GREENWOOD JJD, 1981, HEREDITY, V47, P27, DOI 10.1038/hdy.1981.56; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; MacDougall A, 1998, ANIM BEHAV, V55, P1281, DOI 10.1006/anbe.1997.0702; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 2001, P NATL ACAD SCI USA, V98, P8928, DOI 10.1073/pnas.171326298; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Mualler F., 1878, ZOOL ANZ, V1, P54; MULLER F, 1879, P ENTOMOL SOC LOND, pR20; PEARCE JM, 1994, ANIMAL LEARNING COGN, P110; Poulton E.B., 1890, COLOURS ANIMALS THEI; Rowe C, 2004, P ROY SOC B-BIOL SCI, V271, P407, DOI 10.1098/rspb.2003.2615; Ruxton GD, 1998, NATURE, V394, P833, DOI 10.1038/29652; SBORDONI V, 1979, ECOL ENTOMOL, V4, P83, DOI 10.1111/j.1365-2311.1979.tb00563.x; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Shettleworth, 2010, COGNITION EVOLUTION; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; TURNER JRG, 1984, BIOL BUTTERFLIES, P141	30	85	85	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					63	67		10.1038/nature02818	http://dx.doi.org/10.1038/nature02818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343332				2022-12-01	WOS:000223641500041
J	Harbison, CT; Gordon, DB; Lee, TI; Rinaldi, NJ; Macisaac, KD; Danford, TW; Hannett, NM; Tagne, JB; Reynolds, DB; Yoo, J; Jennings, EG; Zeitlinger, J; Pokholok, DK; Kellis, M; Rolfe, PA; Takusagawa, KT; Lander, ES; Gifford, DK; Fraenkel, E; Young, RA				Harbison, CT; Gordon, DB; Lee, TI; Rinaldi, NJ; Macisaac, KD; Danford, TW; Hannett, NM; Tagne, JB; Reynolds, DB; Yoo, J; Jennings, EG; Zeitlinger, J; Pokholok, DK; Kellis, M; Rolfe, PA; Takusagawa, KT; Lander, ES; Gifford, DK; Fraenkel, E; Young, RA			Transcriptional regulatory code of a eukaryotic genome	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; BINDING-SITES; SEQUENCES; GCN4; PROTEINS; DATABASE; MOTIFS; GENES	DNA-binding transcriptional regulators interpret the genome's regulatory code by binding to specific sequences to induce or repress gene expression(1). Comparative genomics has recently been used to identify potential cis-regulatory sequences within the yeast genome on the basis of phylogenetic conservation(2-6), but this information alone does not reveal if or when transcriptional regulators occupy these binding sites. We have constructed an initial map of yeast's transcriptional regulatory code by identifying the sequence elements that are bound by regulators under various conditions and that are conserved among Saccharomyces species. The organization of regulatory elements in promoters and the environment-dependent use of these elements by regulators are discussed. We find that environment-specific use of regulatory elements predicts mechanistic models for the function of a large population of yeast's transcriptional regulators.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Broad Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	efraenkel@wi.mit.edu; young@wi.mit.edu	Young, Richard A/F-6495-2012; Rinaldi, Nicola J/J-5858-2017; Kellis, Manolis/ABE-7385-2020	Young, Richard A/0000-0001-8855-8647; Rinaldi, Nicola J/0000-0002-0358-0747; Kellis, Manolis/0000-0001-7113-9630; Tagne, Jean-Bosco/0000-0003-1830-9156; Fraenkel, Ernest/0000-0001-9249-8181	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, R01HG004037] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002668, R01 HG002668-01, R01 HG004037] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIRKPATRICK CR, 1995, MOL CELL BIOL, V15, P4021; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Pritsker M, 2004, GENOME RES, V14, P99; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	30	1639	1690	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					99	104		10.1038/nature02800	http://dx.doi.org/10.1038/nature02800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343339	Green Accepted			2022-12-01	WOS:000223641500050
J	Zhang, JS; Kalkum, M; Yamamura, S; Chait, BT; Roeder, RG				Zhang, JS; Kalkum, M; Yamamura, S; Chait, BT; Roeder, RG			E protein silencing by the leukemogenic AML1-ETO fusion protein	SCIENCE			English	Article							LOOP-HELIX PROTEINS; TRANSLOCATION; EXPANSION; LEUKEMIA; TRANSCRIPTION; REGULATORS; EXPRESSION; PROMOTES; BINDING; MODEL	The AML1-ETO fusion protein, generated by the t(8;21) chromosomal translocation, is causally involved in nearly 15% of acute myeloid leukemia (AML) cases. This study shows that AML1-ETO, as well as ETO, inhibits transcriptional activation by E proteins through stable interactions that preclude recruitment of p300/CREB-binding protein (CBP) coactivators. These interactions are mediated by a conserved ETO TAF4 homology domain and a 17-amino acid p300/CBP and ETO target motif within AD1 activation domains of E proteins. In t(8;21) leukemic cells, very stable interactions between AML1-ETO and E proteins underlie a t(8;21) translocation-specific silencing of E protein function through an aberrant cofactor exchange mechanism. These studies identify E proteins as AML1-ETO targets whose dysregulation may be important for t(8;21) leukemogenesis, as well as an E protein silencing mechanism that is distinct from that associated with differentiation-inhibitory proteins.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@mail.rockefeller.edu		Kalkum, Markus/0000-0002-9506-671X; Zhang, Jinsong/0000-0002-8798-7316				Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Hug BA, 2002, CANCER RES, V62, P2906; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Pagliuca A, 2000, CANCER RES, V60, P1376; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Rhoades KL, 2000, BLOOD, V96, P2108; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Scandura JM, 2002, ONCOGENE, V21, P3422, DOI 10.1038/sj.onc.1205315; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Sjogren H, 2000, CANCER RES, V60, P6832; ZHANG J, UNPUB	24	163	170	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1286	1289		10.1126/science.1097937	http://dx.doi.org/10.1126/science.1097937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333839				2022-12-01	WOS:000223624600040
J	Schulze, MB; Manson, JE; Ludwig, DS; Colditz, GA; Stampfer, MJ; Willett, WC; Hu, FB				Schulze, MB; Manson, JE; Ludwig, DS; Colditz, GA; Stampfer, MJ; Willett, WC; Hu, FB			Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRUCTOSE CORN SYRUP; FOOD-FREQUENCY QUESTIONNAIRE; GLYCEMIC INDEX; BODY-WEIGHT; COFFEE CONSUMPTION; PHYSICAL-ACTIVITY; SOFT DRINK; MELLITUS; RISK; VALIDITY	Context Sugar-sweetened beverages like soft drinks and fruit punches contain large amounts of readily absorbable sugars and may contribute to weight gain and an increased risk of type 2 diabetes, but these relationships have been minimally addressed in adults. Objective To examine the association between consumption of sugar-sweetened beverages and weight change and risk of type 2 diabetes in women. Design, Setting, and Participants Prospective cohort analyses conducted from 1991 to 1999 among women in the Nurses' Health Study II. The diabetes analysis included 91249 women free of diabetes and other major chronic diseases at baseline in 1991. The weight change analysis included 51603 women for whom complete dietary information and body weight were ascertained in 1991, 1995, and 1999. We identified 741 incident cases of confirmed type 2 diabetes during 716300 person-years of follow-up. Main Outcome Measures Weight gain and incidence of type 2 diabetes. Results Those with stable consumption patterns had no difference in weight gain, but weight gain over a 4-year period was highest among women who increased their sugar-sweetened soft drink consumption from 1 or fewer drinks per week to 1 or more drinks per day (multivariate-adjusted means, 4.69 kg for 1991 to 1995 and 4.20 kg for 1995 to 1999) and was smallest among women who decreased their intake (1.34 and 0.15 kg for the 2 periods, respectively) after adjusting for lifestyle and dietary confounders. increased consumption of fruit punch was also associated with greater weight gain compared with decreased consumption. After adjustment for potential confounders, women consuming 1 or more sugar-sweetened soft drinks per day had a relative risk [RR] of type 2 diabetes of 1.83 (95% confidence interval [CI], 1.42-2.36; P<.001 for trend) compared with those who consumed less than 1 of these beverages per month. Similarly, consumption of fruit punch was associated with increased diabetes risk (RR for &GE;1 drink per day compared with <1 drink per month, 2.00; 95% Cl, 1.33-3.03; P=.001). Conclusion Higher consumption of sugar-sweetened beverages is associated with a greater magnitude of weight gain and an increased risk for development of type 2 diabetes in women, possibly by providing excessive calories and large amounts of rapidly absorbable sugars.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Schulze, MB (corresponding author), German Inst Human Nutr, Dept Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	mschulze@channing.harvard.edu	Colditz, Graham/A-3963-2009; Hu, Frank/C-1919-2013; Schulze, Matthias B/AAH-6906-2021	Colditz, Graham/0000-0002-7307-0291; Schulze, Matthias B/0000-0002-0830-5277; Ludwig, David/0000-0003-3307-8544	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NCI NIH HHS [CA50385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; AKGUN S, 1985, DIABETES CARE, V8, P279, DOI 10.2337/diacare.8.3.279; Almiron-Roig E, 2003, PHYSIOL BEHAV, V79, P767, DOI 10.1016/S0031-9384(03)00212-9; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Centre for Disease Control and Prevention, 2002, NAT DIAB FACT SHEET; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Janssens JP, 1999, EUR J CANCER PREV, V8, P289, DOI 10.1097/00008469-199908000-00004; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; PUTNAM JJ, STAT B FOOD RURAL EC, V965; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; SCLAFANI A, 1991, BRAIN RES BULL, V27, P383, DOI 10.1016/0361-9230(91)90129-8; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; *USDA, 1992, COMP FOODS RAW PROC; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	38	1071	1112	3	213	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					927	934		10.1001/jama.292.8.927	http://dx.doi.org/10.1001/jama.292.8.927			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WR	15328324				2022-12-01	WOS:000223429200017
J	Wilga, CD; Lauder, GV				Wilga, CD; Lauder, GV			Biomechanics - Hydrodynamic function of the shark's tail	NATURE			English	Editorial Material							CAUDAL FIN LOCOMOTION; HETEROCERCAL TAIL; WAKE DYNAMICS; FISHES		Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Rhode Island; Harvard University	Wilga, CD (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	cwilga@uri.edu						ALEXANDER RM, 1965, J EXP BIOL, V43, P131; Drucker EG, 1999, J EXP BIOL, V202, P2393; Ferry LA, 1996, J EXP BIOL, V199, P2253; GROVE A. J., 1936, ANN AND MAG NAT HIST, V17, P280; Lauder GV, 2000, AM ZOOL, V40, P101, DOI 10.1668/0003-1569(2000)040[0101:FOTCFD]2.0.CO;2; LAUDER GV, 1989, AM ZOOL, V29, P85; Nauen JC, 2002, J EXP BIOL, V205, P1709; THOMSON K S, 1976, Paleobiology, V2, P19; Webster DR, 1998, PHYS FLUIDS, V10, P400, DOI 10.1063/1.869531; Webster DR, 1997, PHYS FLUIDS, V9, P655, DOI 10.1063/1.869223; Wilga CD, 2002, J EXP BIOL, V205, P2365	11	78	80	9	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					850	850		10.1038/430850a	http://dx.doi.org/10.1038/430850a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318211	Bronze			2022-12-01	WOS:000223369800031
J	Wilson, JF				Wilson, JF			Searching for epilepsy solutions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					329	332		10.7326/0003-4819-141-4-200408170-00032	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313762				2022-12-01	WOS:000223290900025
J	Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B				Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B			The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels	NATURE			English	Article							CAPSAICIN-RECEPTOR; EVOKED ACTIVATION; ION-CHANNEL; VOLTAGE; MECHANISMS	The mammalian sensory system is capable of discriminating thermal stimuli ranging from noxious cold to noxious heat. Principal temperature sensors belong to the TRP cation channel family, but the mechanisms underlying the marked temperature sensitivity of opening and closing ('gating') of these channels are unknown. Here we show that temperature sensing is tightly linked to voltage-dependent gating in the cold-sensitive channel TRPM8 and the heat-sensitive channel TRPV1. Both channels are activated upon depolarization, and changes in temperature result in graded shifts of their voltage-dependent activation curves. The chemical agonists menthol ( TRPM8) and capsaicin ( TRPV1) function as gating modifiers, shifting activation curves towards physiological membrane potentials. Kinetic analysis of gating at different temperatures indicates that temperature sensitivity in TRPM8 and TRPV1 arises from a tenfold difference in the activation energies associated with voltage-dependent opening and closing. Our results suggest a simple unifying principle that explains both cold and heat sensitivity in TRP channels.	Katholieke Univ Leuven, Physiol Lab, B-3000 Louvain, Belgium; Univ Saarland, Fak Med, D-66421 Homburg, Germany	KU Leuven; Saarland University	Voets, T (corresponding author), Katholieke Univ Leuven, Physiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.	Thomas.Voets@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248				Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V525, P747, DOI 10.1111/j.1469-7793.2000.t01-1-00747.x; Hille B., 2001, ION CHANNELS EXCITAB, V3; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; MARSH D, 1991, CHEM PHYS LIPIDS, V57, P109, DOI 10.1016/0009-3084(91)90071-I; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tiwari JK, 1999, EUR BIOPHYS J BIOPHY, V28, P338, DOI 10.1007/s002490050216; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VANLUNTEREN E, 1993, J PHYSIOL-LONDON, V466, P81; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	31	726	774	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					748	754		10.1038/nature02732	http://dx.doi.org/10.1038/nature02732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306801	Green Published			2022-12-01	WOS:000223233600033
J	Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO				Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO			Contagiousness of varicella in vaccinated cases - A household contact study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; FAMILY CONTACTS; OUTBREAK; CHILDREN; SCHOOL; POSTLICENSURE; INFECTIONS; CHICKENPOX; AGE	Context Limited data are available on the contagiousness of vaccinated varicella cases Objectives To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness. Design, Setting, and Patients Population-based, active varicella surveillance project in a community of approximately 320000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected. Main Outcome Measures Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents. Results A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%. Conclusions Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov						ARBETER AM, 1986, PEDIATRICS, V78, P748; ASANO Y, 1977, PEDIATRICS, V59, P3; BALFOUR HH, 1990, J PEDIATR-US, V116, P633, DOI 10.1016/S0022-3476(05)81618-X; BERNSTEIN HH, 1993, PEDIATRICS, V92, P833; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P545; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gershon AA, 2002, NEW ENGL J MED, V347, P1962, DOI 10.1056/NEJMe020138; Hall S, 2002, PEDIATRICS, V109, P1068, DOI 10.1542/peds.109.6.1068; HOBBS F, 2002, CENSUS 2000 SPECIAL; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JUNKER AK, 1991, PEDIATR INFECT DIS J, V10, P569, DOI 10.1097/00006454-199108000-00004; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kleinbaum D.G., 1982, EPIDEMIOLOGIC RES PR, P1; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lieu TA, 1998, PEDIATR INFECT DIS J, V17, P120, DOI 10.1097/00006454-199802000-00008; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5	30	123	137	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					704	708		10.1001/jama.292.6.704	http://dx.doi.org/10.1001/jama.292.6.704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304467	Bronze			2022-12-01	WOS:000223177300024
J	Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH				Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH			Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells	NATURE			English	Article							IN-VIVO; TRANSGENIC MICE; DIFFERENTIATION; EXPANSION; CAPACITY; BMI-1; MYC	Haematopoietic stem cells (HSCs) sustain blood production throughout life. HSCs are capable of extensive proliferative expansion, as a single HSC may reconstitute lethally irradiated hosts(1). In steady-state, HSCs remain largely quiescent and self-renew at a constant low rate, forestalling their exhaustion during adult life(2,3). Whereas nuclear regulatory factors promoting proliferative programmes of HSCs in vivo and ex vivo have been identified(4-6), transcription factors restricting their cycling have remained elusive. Here we report that the zinc-finger repressor Gfi-1 (growth factor independent 1), a cooperating oncogene in lymphoid cells(7,8), unexpectedly restricts proliferation of HSCs. After loss of Gfi-1, HSCs display elevated proliferation rates as assessed by 5-bromodeoxyuridine incorporation and cell-cycle analysis. Gfi-1(-/-) HSCs are functionally compromised in competitive repopulation and serial transplantation assays, and are rapidly out-competed in the bone marrow of mouse chimaeras generated with Gfi-1(-/-) embryonic stem cells. Thus, Gfi-1 is essential to restrict HSC proliferation and to preserve HSC functional integrity.	Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; CHAN WY, 1998, TOP ENDOCRINOL, V8, P9; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	23	417	428	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					1002	1007		10.1038/nature02994	http://dx.doi.org/10.1038/nature02994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15457180				2022-12-01	WOS:000224585600048
J	Sampath, P; Mazumder, B; Seshadri, V; Gerber, CA; Chavatte, L; Kinter, M; Ting, SM; Dignam, JD; Kim, S; Driscoll, DM; Fox, PL				Sampath, P; Mazumder, B; Seshadri, V; Gerber, CA; Chavatte, L; Kinter, M; Ting, SM; Dignam, JD; Kim, S; Driscoll, DM; Fox, PL			Noncanonical function of glutamyl-prolyi-tRNA synthetase: Gene-specific silencing of translation	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; MESSENGER-RNA; GAMMA-INTERFERON; MACROMOLECULAR ASSEMBLAGE; MONOCYTIC CELLS; IFN-GAMMA; KINASE-C; COMPLEX; CERULOPLASMIN; IDENTIFICATION	Aminoacyl tRNA synthetases (ARS) catalyze the ligation of amino acids to cognate tRNAs. Chordate ARSs have evolved distinctive features absent from ancestral forms, including compartmentalization in a multisynthetase complex (MSC), noncatalytic peptide appendages, and ancillary functions unrelated to aminoacylation. Here, we show that glutamyl-prolyl-tRNA synthetase (GluProRS), a bifunctional ARS of the MSC, has a regulated, noncanonical activity that blocks synthesis of a specific protein. GluProRS was identified as a component of the interferon (IFN)gamma-activated inhibitor of translation (GAIT) complex by RNA affinity chromatography using the ceruloplasmin (Cp) GAIT element as ligand. In response to IFN-gamma, GluProRS is phosphorylated and released from the MSC, binds the Cp 3'-untranslated region in an mRNP containing three additional proteins, and silences Cp mRNA translation. Thus, GluProRS has divergent functions in protein synthesis: in the MSC, its aminoacylation activity supports global translation, but translocation of GluProRS to an inflammation-responsive mRNP causes gene-specific translational silencing.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol, Cleveland, OH 44115 USA; Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA; Seoul Natl Univ, Coll Pharm, Ctr ARS Network, Seoul 151742, South Korea	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Seoul National University (SNU)	Fox, PL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@ccf.org	Kim, Sunghoon/AAE-8314-2020	Mazumder, Barsanjit/0000-0003-3069-7833; Kinter, Michael/0000-0001-7409-8918; Chavatte, Laurent/0000-0001-7696-2431	NHLBI NIH HHS [HL29582, HL76491, HL67725] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067725, P01HL076491, P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; BERG BH, 1990, BIOCHIM BIOPHYS ACTA, V1038, P391, DOI 10.1016/0167-4838(90)90254-D; Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CLEMENS MJ, 1990, TRENDS BIOCHEM SCI, V15, P172, DOI 10.1016/0968-0004(90)90153-3; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; ELGLAYAR S, 2003, J IMMUNOL, V171, P4561; FETT R, 1991, J BIOL CHEM, V266, P1448; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Garcia GE, 2003, KIDNEY INT, V64, P160, DOI 10.1046/j.1523-1755.2003.00077.x; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Han JM, 2003, BIOCHEM BIOPH RES CO, V303, P985, DOI 10.1016/S0006-291X(03)00485-6; Harris CE, 1999, J VIROL, V73, P72, DOI 10.1128/JVI.73.1.72-80.1999; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; KLEBANOFF SJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P302, DOI 10.1016/0003-9861(92)90522-X; Ko YG, 2002, PROTEOMICS, V2, P1304, DOI 10.1002/1615-9861(200209)2:9<1304::AID-PROT1304>3.0.CO;2-E; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Mazumder B, 1997, J IMMUNOL, V159, P1938; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; MAZUMDER B, 2003, CELL, V28, P91; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Mukhopadhyay CK, 1997, P NATL ACAD SCI USA, V94, P11546, DOI 10.1073/pnas.94.21.11546; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; PENDERGAST AM, 1987, J BIOL CHEM, V262, P5939; PENDERGAST AM, 1985, J BIOL CHEM, V260, P1769; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SCHRAY B, 1991, NUCLEIC ACIDS RES, V19, P5307, DOI 10.1093/nar/19.19.5307; Shiba K, 2002, J MOL EVOL, V55, P727, DOI 10.1007/s00239-002-2368-3; STANDART N, 1994, BIOCHIMIE, V76, P867, DOI 10.1016/0300-9084(94)90189-9; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; TING SM, 1992, J BIOL CHEM, V267, P17701; VENEMA RC, 1991, J BIOL CHEM, V266, P5298; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wu H, 1995, BIOCHEMISTRY-US, V34, P16327, DOI 10.1021/bi00050a013; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	56	199	215	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					195	208		10.1016/j.cell.2004.09.030	http://dx.doi.org/10.1016/j.cell.2004.09.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479637	Bronze			2022-12-01	WOS:000224577200008
J	Madden, MEE; Bodnar, RJ; Rimstidt, JD				Madden, MEE; Bodnar, RJ; Rimstidt, JD			Jarosite as an indicator of water-limited chemical weathering on Mars	NATURE			English	Article							MARTIAN REGOLITH; METEORITES; CLIMATE; SOIL; CHEMISTRY; SULFUR; BASALT; SALTS; ROCKS	The Mars Exploration Rover Opportunity identified the ferric sulphate mineral jarosite and possible relicts of gypsum at the Meridiani Planum landing site(1). On Earth, jarosite has been found to form in acid mine drainage environments, during the oxidation of sulphide minerals(2), and during alteration of volcanic rocks by acidic, sulphur-rich fluids near volcanic vents(3). Jarosite formation is thus thought to require a wet, oxidizing and acidic environment. But jarosite on Earth only persists over geologically relevant time periods in arid environments because it rapidly decomposes to produce ferric oxyhydroxides in more humid climates(4). Here we present equilibrium thermodynamic reaction-path simulations that constrain the range of possible conditions under which such aqueous alteration phases are likely to have formed on Mars. These calculations simulate the chemical weathering of basalt at relevant martian conditions. We conclude that the presence of jarosite combined with residual basalt at Meridiani Planum indicates that the alteration process did not proceed to completion, and that following jarosite formation, arid conditions must have prevailed.	Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Madden, MEE (corresponding author), Virginia Tech, Dept Geosci, 4044 Derring Hall, Blacksburg, VA 24061 USA.	melwood@vt.edu	Rimstidt, James/N-8910-2013; Elwood Madden, Megan/C-3381-2009; Bodnar, Robert J/A-1916-2009	Elwood Madden, Megan/0000-0002-6735-4554; 				Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bethke C, 1996, GEOCHEMICAL REACTION; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; CLARK BC, 1981, ICARUS, V45, P370, DOI 10.1016/0019-1035(81)90041-5; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Fieldes M., 1975, Soil components. Volume 2. Inorganic components (Gieseking, J.E., Ed)., P351; Fulignati P, 2002, J VOLCANOL GEOTH RES, V115, P397, DOI 10.1016/S0377-0273(02)00209-3; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; GOODING JL, 1992, ICARUS, V99, P28, DOI 10.1016/0019-1035(92)90168-7; HEMLEY JJ, 1986, GEOLOGY, V14, P377, DOI 10.1130/0091-7613(1986)14<377:EOPOOM>2.0.CO;2; Herbert RB, 1997, CLAY CLAY MINER, V45, P261, DOI 10.1346/CCMN.1997.0450214; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Langmuir D., 1996, AQUEOUS ENV GEOCHEMI; Levine J.S., 1985, PHOTOCHEMISTRY ATMOS, P337; Linke W.F., 1958, SOLUBILITIES INORGAN, VI; Marion GM, 2003, GEOCHIM COSMOCHIM AC, V67, P4251, DOI 10.1016/S0016-7037(03)00372-7; McSween HY, 2000, GEOCHIM COSMOCHIM AC, V64, P2155, DOI 10.1016/S0016-7037(99)00401-9; MORRIS R, 2004, LUN PLAN SCI C, V35; Owen T., 1992, MARS, P818; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; ROSENBAUER RJ, 1983, ECON GEOL, V78, P1701, DOI 10.2113/gsecongeo.78.8.1701; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Sharp T. G., 2003, GEOPHYS RES LETT, V30; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Ziegler K, 2003, CHEM GEOL, V202, P461, DOI 10.1016/j.chemgeo.2002.06.001	30	212	217	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					821	823		10.1038/nature02971	http://dx.doi.org/10.1038/nature02971			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15483605				2022-12-01	WOS:000224435500040
J	Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y				Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y			Role of histone H2A ubiquitination in polycomb silencing	NATURE			English	Article							H3 LYSINE-27 METHYLATION; RING FINGER PROTEINS; TRANSCRIPTIONAL ACTIVATION; LIGASE ACTIVITY; RAD6; COMPLEX; CORE; UBIQUITYLATION; RECRUITMENT; DROSOPHILA	Covalent modification of histones is important in regulating chromatin dynamics and transcription(1,2). One example of such modification is ubiquitination, which mainly occurs on histones H2A and H2B(3). Although recent studies have uncovered the enzymes involved in histone H2B ubiquitination(4-6) and a 'cross-talk' between H2B ubiquitination and histone methylation(7,8), the responsible enzymes and the functions of H2A ubiquitination are unknown. Here we report the purification and functional characterization of an E3 ubiquitin ligase complex that is specific for histone H2A. The complex, termed hPRC1L ( human Polycomb repressive complex 1-like), is composed of several Polycomb-group proteins including Ring1, Ring2, Bmi1 and HPH2. hPRC1L monoubiquitinates nucleosomal histone H2A at lysine 119. Reducing the expression of Ring2 results in a dramatic decrease in the level of ubiquitinated H2A in HeLa cells. Chromatin immunoprecipitation analysis demonstrated colocalization of dRing with ubiquitinated H2A at the PRE and promoter regions of the Drosophila Ubx gene in wing imaginal discs. Removal of dRing in SL2 tissue culture cells by RNA interference resulted in loss of H2A ubiquitination concomitant with derepression of Ubx. Thus, our studies identify the H2A ubiquitin ligase, and link H2A ubiquitination to Polycomb silencing.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Ctr Invest Biol, Dept Desarrollo & Biol Celular, E-28040 Madrid, Spain	University of North Carolina; University of North Carolina Chapel Hill; Southern Methodist University; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	; Vidal, Miguel/M-8861-2016	Zhang, Yi/0000-0002-2789-0811; Vidal, Miguel/0000-0003-4374-6761; Wang, Hengbin/0000-0003-2414-0609; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; Gorfinkiel N, 2004, MECH DEVELOP, V121, P449, DOI 10.1016/j.mod.2004.03.019; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Lee SJ, 2001, FEBS LETT, V503, P61, DOI 10.1016/S0014-5793(01)02689-8; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P964, DOI 10.1021/bi00429a007; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	29	1235	1293	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					873	878		10.1038/nature02985	http://dx.doi.org/10.1038/nature02985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15386022				2022-12-01	WOS:000224435500053
J	Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC				Weng, AP; Ferrando, AA; Lee, W; Morris, JP; Silverman, LB; Sanchez-Irizarry, C; Blacklow, SC; Look, AT; Aster, JC			Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia	SCIENCE			English	Article							GAMMA-SECRETASE; TRANSCRIPTIONAL ACTIVATION; TRANSGENIC MICE; PROTEIN; COMPLEX; INACTIVATION; PRESENILIN; INDUCTION; RECEPTORS; DOMAINS	Very rare cases of human T cell acute lymphoblastic leukemia (T-ALL) harbor chromosomal translocations that involve NOTCH1, a gene encoding a transmembrane receptor that regulates normal T cell development. Here, we report that more than 50% of human T-ALLs, including tumors from all major molecular oncogenic subtypes, have activating mutations that involve the extracellular heterodimerization domain and/or the C-terminal PEST domain of NOTCH1. These findings greatly expand the role of activated NOTCH1 in the molecular pathogenesis of human T-ALL and provide a strong rationale for targeted therapies that interfere with NOTCH signaling.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Aster, JC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu	Weng, Andrew P/I-5015-2014; Ferrando, Adolfo A/Q-7026-2016	Weng, Andrew/0000-0001-7394-5425	NATIONAL CANCER INSTITUTE [K08CA098093, P01CA109901, P01CA068484, R01CA082308, R56CA094233, R01CA094233, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA68484, CA21765, CA98093, P01 CA109901, CA82308, CA94233, CA109901] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; ASTER J, UNPUB; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Berry LW, 1997, DEVELOPMENT, V124, P925; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Feldman BJ, 2000, BLOOD, V96, P1906, DOI 10.1182/blood.V96.5.1906.h8001906_1906_1913; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KRAMER H, 2000, SCI STKE, pPE1; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; SANCHEZIRIZARRY C, IN PRESS MOL CELL BI; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	25	2076	2224	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					269	271		10.1126/science.1102160	http://dx.doi.org/10.1126/science.1102160			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472075				2022-12-01	WOS:000224419700038
J	Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR				Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR		Canc Genome Project Collaborat Grp	Intragenic ERBB2 kinase mutations in tumours	NATURE			English	Article							LUNG-CANCER		Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore HA7 4LP, Middx, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Massachusetts Gen Hosp E, Mol Pathol Unit, Charlestown, MA 02129 USA; Erasmus MC Univ Med Ctr Rotterdam, Dr Daniel Den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Inst Nazl Tumori, Milan, Italy; Inst Mol Oncol, FIRC, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Royal Brompton Hosp, London SW3 6NP, England	Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of London; Institute of Cancer Research - UK; University of London; University College London; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Van Andel Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Pennsylvania; Royal Brompton Hospital	Stephens, P (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.		Chenevix-Trench, Georgia/AAV-2014-2020; Pierotti, Marco Alessandro/AAC-4728-2022; Leung, Suet Yi/C-4340-2009; Blow, Matthew/G-6369-2012; Yuen, Siu/K-6311-2014; Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/T-9620-2019	Chenevix-Trench, Georgia/0000-0002-1878-2587; Pierotti, Marco Alessandro/0000-0002-7431-8332; Blow, Matthew/0000-0002-8844-9149; Looijenga, Leendert/0000-0002-8146-1911; Flanagan, Adrienne/0000-0002-2832-1303; Yates, Andrew/0000-0002-8886-4772; Raine, Keiran/0000-0002-5634-1539; Hunter, Christopher/0000-0002-1335-0881; Knowles, Margaret/0000-0002-9363-8657; Gray, Kristian/0000-0002-7035-7107; Leung, Suet Yi/0000-0001-8614-4619; Edkins, Sarah/0000-0003-0717-1972				Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Klapper LN, 2000, ADV CANCER RES, V77, P25; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rosell R, 2004, J CLIN ONCOL, V22, P1171, DOI 10.1200/JCO.2004.01.904; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	8	602	631	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					525	526		10.1038/431525b	http://dx.doi.org/10.1038/431525b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457249				2022-12-01	WOS:000224156700034
J	Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE				Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE			Environmentally induced foregut remodeling by PHA-4/FoxA and DAF-12/NHR	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DNA-BINDING; DEVELOPMENTAL AGE; ENCODES; ISOFORMS; RECEPTOR; CEH-22	Growth and development of the Caenorhabditis elegans foregut (pharynx) depends on coordinated gene expression, mediated by pharynx defective (PHA)-4/FoxA in combination with additional, largely unidentified transcription factors. Here, we used whole genome analysis to establish clusters of genes expressed in different pharyngeal cell types. We created an expectation maximization algorithm to identify cis-regulatory elements that activate expression within the pharyngeal gene clusters. One of these elements mediates the response to environmental conditions within pharyngeal muscles and is recognized by the nuclear hormone receptor (NHR) DAF-12. Our data suggest that PHA-4 and DAF-12 endow the pharynx with transcriptional plasticity to respond to diverse developmental and physiological cues. Our combination of bioinformatics and in vivo analysis has provided a powerful means for genome-wide investigation of transcriptional control.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Genome Bioinformat Grp, Santa Cruz, CA 95064 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056264-08S1, R01 GM056264, R01-GM56264, R01 GM056264-08, R01 GM056264-07] Funding Source: Medline; PHS HHS [2P303A42014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; AO W, UNPUB; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beaster-Jones L, 2004, J MOL BIOL, V339, P695, DOI 10.1016/j.jmb.2004.04.030; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GAUDET J, IN PRESS PLOS BIOL; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Jia KL, 2002, DEVELOPMENT, V129, P221; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; LARSEN PL, 1995, GENETICS, V139, P1567; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Okkema PG, 1997, DEVELOPMENT, V124, P3965; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Snow MI, 2000, BBA-GENE STRUCT EXPR, V1494, P104, DOI 10.1016/S0167-4781(00)00224-4; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Vilimas T, 2004, DEV BIOL, V266, P388, DOI 10.1016/j.ydbio.2003.10.015; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0	32	135	145	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1743	1746		10.1126/science.1102216	http://dx.doi.org/10.1126/science.1102216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375261				2022-12-01	WOS:000224039500032
J	Zhou, RH; Huang, XH; Margulis, CJ; Berne, BJ				Zhou, RH; Huang, XH; Margulis, CJ; Berne, BJ			Hydrophobic collapse in multidomain protein folding	SCIENCE			English	Article							MOLECULAR-DYNAMICS; FREE-ENERGY; WATER; HYDRATION; DEPENDENCE; SIMULATION; SOLUTES	We performed molecular dynamics simulations of the collapse of a two-domain protein, the BphC enzyme, into a globular structure to examine how water molecules mediate hydrophobic collapse of proteins. in the interdomain region, liquid water persists with a density 10 to 15% lower than in the bulk, even at small domain separations. Water depletion and hydrophobic collapse occur on a nanosecond time scale, which is two orders of magnitude slower than that found in the collapse of idealized paraffin-like plates. When the electrostatic protein-water forces are turned off, a dewetting transition occurs in the interdomain region and the collapse speeds up by more than an order of magnitude. When attractive van der Waals forces are turned off as well, the dewetting in the interdomain region is more profound, and the collapse is even faster.	IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	International Business Machines (IBM); Columbia University	Zhou, RH (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	ruhongz@us.ibm.com; berne@chem.columbia.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Margulis, Claudio/0000-0003-1671-9784; Zhou, Ruhong/0000-0001-8624-5591	NIGMS NIH HHS [GM4330] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashbaugh HS, 2001, J AM CHEM SOC, V123, P10721, DOI 10.1021/ja016324k; Ball P, 2003, NATURE, V423, P25, DOI 10.1038/423025a; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Huang DM, 2002, J PHYS CHEM B, V106, P2047, DOI 10.1021/jp013289v; Huang X, 2003, P NATL ACAD SCI USA, V100, P11953, DOI 10.1073/pnas.1934837100; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Hummer G, 2000, CHEM PHYS, V258, P349, DOI 10.1016/S0301-0104(00)00115-4; Jensen TR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Leung K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.065502; Leung K, 2000, J CHEM PHYS, V113, P5845, DOI 10.1063/1.1290479; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1997, PHYS REV E, V56, pR6283, DOI 10.1103/PhysRevE.56.R6283; Lum K, 1998, INT J THERMOPHYS, V19, P845, DOI 10.1023/A:1022643006849; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Mountain RD, 2003, J AM CHEM SOC, V125, P1950, DOI 10.1021/ja020496f; PANGALI C, 1979, J CHEM PHYS, V71, P2982, DOI 10.1063/1.438702; Paulaitis ME, 2002, ADV PROTEIN CHEM, V62, P283; Pratt LR, 2002, ANNU REV PHYS CHEM, V53, P409, DOI 10.1146/annurev.physchem.53.090401.093500; Steitz R, 2003, LANGMUIR, V19, P2409, DOI 10.1021/la026731p; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; ten Wolde PR, 2002, P NATL ACAD SCI USA, V99, P6539, DOI 10.1073/pnas.052153299; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2885, DOI 10.1021/j100009a052; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; Zhou RH, 2003, PROTEINS, V52, P561, DOI 10.1002/prot.10419	27	469	478	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1605	1609		10.1126/science.1101176	http://dx.doi.org/10.1126/science.1101176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361621				2022-12-01	WOS:000223891200039
J	Seo, HC; Edvardsen, RB; Maeland, AD; Bjordal, M; Jensen, MF; Hansen, A; Flaat, M; Weissenbach, J; Lehrach, H; Wincker, P; Reinhardt, R; Chourrout, D				Seo, HC; Edvardsen, RB; Maeland, AD; Bjordal, M; Jensen, MF; Hansen, A; Flaat, M; Weissenbach, J; Lehrach, H; Wincker, P; Reinhardt, R; Chourrout, D			Hox cluster disintegration with persistent anteroposterior order of expression in Oikopleura dioica	NATURE			English	Article							CIONA-INTESTINALIS; CAENORHABDITIS-ELEGANS; GENE; GENOME; VERTEBRATES; PHYLOGENY; EVOLUTION; CHORDATE; EMBRYOS; ORIGINS	Tunicate embryos and larvae have small cell numbers and simple anatomical features in comparison with other chordates, including vertebrates. Although they branch near the base of chordate phylogenetic trees(1), their degree of divergence from the common chordate ancestor remains difficult to evaluate. Here we show that the tunicate Oikopleura dioica has a complement of nine Hox genes in which all central genes are lacking but a full vertebrate-like set of posterior genes is present. In contrast to all bilaterians studied so far, Hox genes are not clustered in the Oikopleura genome. Their expression occurs mostly in the tail, with some tissue preference, and a strong partition of expression domains in the nerve cord, in the notochord and in the muscle. In each tissue of the tail, the anteroposterior order of Hox gene expression evokes spatial collinearity, with several alterations. We propose a relationship between the Hox cluster breakdown, the separation of Hox expression domains, and a transition to a determinative mode of development.	Bergen High Technol Ctr, Sars Ctr Marine Mol Biol, N-5008 Bergen, Norway; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Genoscope Ctr Natl Sequencage, F-91000 Evry, France; CNRS, UMR 8030, F-91000 Evry, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Chourrout, D (corresponding author), Bergen High Technol Ctr, Sars Ctr Marine Mol Biol, Thormohlensgaten 55, N-5008 Bergen, Norway.	Daniel.Chourrout@sars.uib.no		Edvardsen, Rolf/0000-0001-8430-8042; Reinhardt, Richard/0000-0001-9376-2132				Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BURGLIN TR, 1993, CURR OPIN GENET DEV, V3, P615, DOI 10.1016/0959-437X(93)90097-9; Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Lacalli TC, 1999, BIOL REV, V74, P177, DOI 10.1017/S0006323199005319; Locascio A, 1999, DEVELOPMENT, V126, P4737; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Powers TP, 2004, CURR BIOL, V14, pR183, DOI 10.1016/j.cub.2004.02.015; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Spada F, 2001, J BIOL CHEM, V276, P20624, DOI 10.1074/jbc.M100438200; Spagnuolo A, 2003, GENE, V309, P71, DOI 10.1016/S0378-1119(03)00488-8; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; WELSCH U, 1969, Z ZELLFORSCH MIK ANA, V93, P547	28	243	252	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					67	71		10.1038/nature02709	http://dx.doi.org/10.1038/nature02709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343333				2022-12-01	WOS:000223641500042
J	Flore, O				Flore, O			Kaposi's sarcoma	LANCET			English	Editorial Material							EXPRESSION; CELLS; AIDS; INVITRO; GENE		NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA	New York University; New York University	Flore, O (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	ornella.flore@med.nyu.edu						ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; BABA M, 1987, ANTIVIR RES, V7, P99, DOI 10.1016/0166-3542(87)90025-8; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Jussila L, 1998, CANCER RES, V58, P1599; Kaposi M., 1872, ARCH DERMATOL SYPH-G, V4, P265, DOI 10.1007/BF01830024; NICKOLOFF BJ, 1989, AM J PATHOL, V135, P793; Roizman B, 1996, FIELDS VIROLOGY, P2221; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; RUTGERS JL, 1986, AM J PATHOL, V122, P493; Sturzl M, 1998, AIDS, V12, P1105; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384	11	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 28	2004	364	9436					740	741		10.1016/S0140-6736(04)16952-3	http://dx.doi.org/10.1016/S0140-6736(04)16952-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337387				2022-12-01	WOS:000223569600008
J	Rohling, EJ; Marsh, R; Wells, NC; Siddall, M; Edwards, NR				Rohling, EJ; Marsh, R; Wells, NC; Siddall, M; Edwards, NR			Similar meltwater contributions to glacial sea level changes from Antarctic and northern ice sheets	NATURE			English	Article							CLIMATE-CHANGE; GREENLAND; RECORD; CYCLE; INSTABILITY; MAXIMUM; EVENTS; PERIOD; MODEL; CORE	The period between 75,000 and 20,000 years ago was characterized by high variability in climate(1-12) and sea level(13,14). Southern Ocean records of ice-rafted debris(15) suggest a significant contribution to the sea level changes from melt water of Antarctic origin, in addition to likely contributions from northern ice sheets, but the relative volumes of melt water from northern and southern sources have yet to be established. Here we simulate the first-order impact of a range of relative meltwater releases from the two polar regions on the distribution of marine oxygen isotopes, using an intermediate complexity model. By comparing our simulations with oxygen isotope data from sediment cores, we infer that the contributions from Antarctica and the northern ice sheets to the documented sea level rises between 65,000 and 35,000 years ago(13) were approximately equal, each accounting for a rise of about 15 m. The reductions in Antarctic ice volume implied by our analysis are comparable to that inferred previously for the Antarctic contribution to meltwater pulse 1A (refs 16, 17), which occurred about 14,200 years ago, during the last deglaciation.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Bern, NCCR Climate, CH-3012 Bern, Switzerland	NERC National Oceanography Centre; University of Southampton; University of Bern	Rohling, EJ (corresponding author), Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	e.rohling@soc.soton.ac.uk	Marsh, Robert/G-4988-2013; Rohling, Eelco J/B-9736-2008	Rohling, Eelco J/0000-0001-5349-2158; Marsh, Robert/0000-0002-1051-8749	Natural Environment Research Council [NER/T/S/2002/00455] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; ANNAN JD, IN PRESS OCEAN MODEL; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Broecker WS, 2000, EARTH-SCI REV, V51, P137, DOI 10.1016/S0012-8252(00)00019-2; Clark PU, 2002, SCIENCE, V295, P2438; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Denton GH, 2002, QUATERNARY SCI REV, V21, P193, DOI 10.1016/S0277-3791(01)00090-7; EDWARDS NR, 2004, UNPUB CLIM DYN; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; LANGWAY CC, 1985, GEOPHYS MONOGR AM GE, V33; Leuschner DC, 2000, QUATERNARY SCI REV, V19, P243, DOI 10.1016/S0277-3791(99)00064-5; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; RAHMSTORF S, 1994, NATURE, V372, P82, DOI 10.1038/372082a0; Rahmstorf S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017115; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Stenni B, 2004, EARTH PLANET SC LETT, V217, P183, DOI 10.1016/S0012-821X(03)00574-0; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Voelker AHL, 2002, QUATERNARY SCI REV, V21, P1185, DOI 10.1016/S0277-3791(01)00139-1; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002	30	71	73	0	386	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1016	1021		10.1038/nature02859	http://dx.doi.org/10.1038/nature02859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329718				2022-12-01	WOS:000223514900040
J	Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC			AID is required for c-myc/IgH chromosome translocations in vivo	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; MYC ONCOGENE; SOMATIC HYPERMUTATION; B-CELLS; BURKITT-LYMPHOMA; CIRCULAR DNA; NEOPLASTIC DEVELOPMENT; MURINE PLASMACYTOMAS	Chromosome translocations between c-myc and immunoglobulin (Ig) are associated with Burkitt's lymphoma in humans and with pristane- and IL6-induced plasmacytomas in mice. These translocations frequently involve Ig switch regions, suggesting that they might be the result of aberrant Ig class switch recombination (CSR). However, a direct link between CSR and chromosome translocations has not been established. We have examined c-myc/IgH translocations in IL6 transgenic mice that are mutant for activation induced cytidine deaminase (AID), the enzyme that initiates CSR. Her a we report that AID is essential for the c-myc/IgH chromosome translocations induced by IL6.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Kyoto University	Ramiro, AR (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Muramatsu, Masamichi/C-4339-2015; Ramiro, Almudena R/H-6037-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Ramiro, Almudena R/0000-0002-7539-3844	NATIONAL CANCER INSTITUTE [Z01BC010283, ZIABC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ARMITAGE JO, 2001, HARRISONS PRINCIPLES, P715; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; GAUWERKY CE, 1993, SEMIN CANCER BIOL, V4, P333; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2000, LEUKEMIA, V14, P909, DOI 10.1038/sj.leu.2401676; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	59	347	357	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					431	438		10.1016/j.cell.2004.08.006	http://dx.doi.org/10.1016/j.cell.2004.08.006			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315756	Bronze			2022-12-01	WOS:000223650900006
J	Attaran, A				Attaran, A			Where did it all go wrong?	NATURE			English	Article							ROLL BACK MALARIA		Univ Ottawa, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Ottawa, ON K1N 6N5, Canada.							[Anonymous], 2003, AFR MAL REP 2003; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MCCARTHY FD, 2000, 2303 WORLD BANK; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; SPIELMAN A, 1993, J MED ENTOMOL, V30, P6, DOI 10.1093/jmedent/30.1.6; World Health Organization, 2001, MACROECONOMICS HLTH; Yamey G, 2004, BRIT MED J, V328, P1086, DOI 10.1136/bmj.328.7448.1086	8	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					932	933		10.1038/430932a	http://dx.doi.org/10.1038/430932a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318233				2022-12-01	WOS:000223369800056
J	Clayton, J; Butler, D; Hull, K				Clayton, J; Butler, D; Hull, K			The long and winding road	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					937	937		10.1038/430937a	http://dx.doi.org/10.1038/430937a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318237	Bronze			2022-12-01	WOS:000223369800060
J	Johnston, RE				Johnston, RE			A candidate vaccine for severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE		Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Johnston, RE (corresponding author), Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27514 USA.							[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; FLEMING JO, 1983, VIROLOGY, V131, P296, DOI 10.1016/0042-6822(83)90498-1; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; WILLIAMS RS, 1991, P NATL ACAD SCI USA, V88, P2726, DOI 10.1073/pnas.88.7.2726; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; 2003, MMWR MORB MORTAL WKL, V52, P284	6	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					827	828		10.1056/NEJMcibr041657	http://dx.doi.org/10.1056/NEJMcibr041657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317899				2022-12-01	WOS:000223367900019
J	Wood, MJ; Storz, G; Tjandra, N				Wood, MJ; Storz, G; Tjandra, N			Structural basis for redox regulation of Yap1 transcription factor localization	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; OXIDATIVE STRESS; RECEPTOR; DOMAIN; NMR; MACROMOLECULES; ACTIVATION; MECHANISM; TRANSPORT	The ability of organisms to alter their gene expression patterns in response to environmental changes is essential for viability. A central regulator of the response to oxidative stress in Saccharomyces cerevisiae is the Yap1 transcription factor. Upon activation by increased levels of reactive oxygen species, Yap1 rapidly redistributes to the nucleus where it regulates the expression of up to 70 genes(1-3). Here we identify a redox-regulated domain of Yap1 and determine its high-resolution solution structure. In the active oxidized form, a nuclear export signal (NES) in the carboxy-terminal cysteine-rich domain is masked by disulphide-bond-mediated interactions with a conserved amino-terminal alpha-helix. Point mutations that weaken the hydrophobic interactions between the N-terminal alpha-helix and the C-terminal NES-containing domain abolished redox-regulated changes in subcellular localization of Yap1. Upon reduction of the disulphide bonds, Yap1 undergoes a change to an unstructured conformation that exposes the NES and allows redistribution to the cytoplasm. These results reveal the structural basis of redox-dependent Yap1 localization and provide a previously unknown mechanism of transcription factor regulation by reversible intramolecular disulphide bond formation.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Storz, G (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	storzg@mail.nih.gov; nico@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001048, ZIAHL001048] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cavanagh J., 1995, PROTEIN NMR SPECTROS, V2nd; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SIKORSKI RS, 1989, GENETICS, V122, P19; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Wood MJ, 2003, BIOCHEMISTRY-US, V42, P11982, DOI 10.1021/bi035003d; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	29	130	134	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					917	921		10.1038/nature02790	http://dx.doi.org/10.1038/nature02790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318225				2022-12-01	WOS:000223369800048
J	Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW				Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW			Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; ACCUMULATION	We report a case of preclinical variant Creutzfeldt-Jakob disease (vCJD) in a patient who died from a nonneurological disorder 5 years after receiving a blood transfusion from a donor who subsequently developed vCJD. Protease-resistant prion protein (PrPres) was detected by western blot, paraffin-embedded tissue blot, and immunohistochemistry in the spleen, but not in the brain. Immunohistochemistry for prion protein was also positive in a cervical lymph node. The patient was a heterozygote at codon 129 of PRNP, suggesting that susceptibility to vCJD infection is not confined to the methionine homozygous PRNP genotype. These findings have major implications for future estimates and surveillance of vCJD in the UK.	Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	james.ironside@ed.ac.uk		Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108				Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X	5	674	695	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					527	529		10.1016/S0140-6736(04)16811-6	http://dx.doi.org/10.1016/S0140-6736(04)16811-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302196				2022-12-01	WOS:000223132700032
J	Joseph, SB; Bradley, MN; Castrillo, A; Bruhn, KW; Mak, PA; Pei, LM; Hogenesch, J; O'Connell, RM; Cheng, GH; Saez, E; Miller, JF; Tontonoz, P				Joseph, SB; Bradley, MN; Castrillo, A; Bruhn, KW; Mak, PA; Pei, LM; Hogenesch, J; O'Connell, RM; Cheng, GH; Saez, E; Miller, JF; Tontonoz, P			LXR-dependent gene expression is important for macrophage survival and the innate immune response	CELL			English	Article							CELL-BINDING CHARACTERISTICS; NUCLEAR RECEPTOR LXR; SCAVENGER RECEPTORS; MOLECULAR-CLONING; MICE LACKING; APOPTOSIS; CHOLESTEROL; LISTERIA; AIM; ATHEROSCLEROSIS	The liver X receptors (LXRs) are nuclear receptors with established roles in the regulation of lipid metabolism. We now show that LXR signaling not only regulates macrophage cholesterol metabolism but also impacts antimicrobial responses. Mice lacking LXRs are highly susceptible to infection with the intracellular bacteria Listeria monocytogenes (LM). Bone marrow transplant studies point to altered macrophage function as the major determinant of susceptibility. LXR-null macrophages undergo accelerated apoptosis when challenged with LM and exhibit defective bacterial clearance in vivo. These defects result, at least in part, from loss of regulation of the antiapoptotic factor SPalpha, a direct target for regulation by LXRalpha. Expression of LXRalpha or SPalpha in macrophages inhibits apoptosis in the setting of LM infection. Our results demonstrate that LXR-dependent gene expression plays an unexpected role in innate immunity and suggest that common nuclear receptor pathways mediate macrophage responses to modified lipoproteins and intracellular pathogens.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Novartis	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Bruhn, Kevin/F-9772-2013	Joseph, Sean/0000-0002-2602-8517	NATIONAL CANCER INSTITUTE [R01CA084008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL066088] Funding Source: NIH RePORTER; NCI NIH HHS [CA 84008] Funding Source: Medline; NHLBI NIH HHS [HL 66088, HL 30568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guzman CA, 1996, MOL MICROBIOL, V20, P119, DOI 10.1111/j.1365-2958.1996.tb02494.x; Haruta I, 2001, J BIOL CHEM, V276, P22910, DOI 10.1074/jbc.M100324200; Hilbi H, 1997, INFECT IMMUN, V65, P5165, DOI 10.1128/IAI.65.12.5165-5170.1997; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kuwata K, 2003, AM J PATHOL, V162, P837, DOI 10.1016/S0002-9440(10)63880-1; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; North RJ, 1997, IMMUNOL REV, V158, P27, DOI 10.1111/j.1600-065X.1997.tb00989.x; OCONNELL R, 2004, IN PRESS J EXP MED; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rojas M, 1997, J IMMUNOL, V159, P1352; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; van der Laan LJW, 1999, J IMMUNOL, V162, P939; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	35	431	453	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					299	309		10.1016/j.cell.2004.09.032	http://dx.doi.org/10.1016/j.cell.2004.09.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479645	Bronze			2022-12-01	WOS:000224577200016
J	Grotegut, CA				Grotegut, CA			Ureteral obstruction in pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Grotegut, CA (corresponding author), Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					E14	E14		10.1056/NEJMicm030958	http://dx.doi.org/10.1056/NEJMicm030958			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483272				2022-12-01	WOS:000224427300014
J	Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS				Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS			Ecosystem carbon storage in arctic tundra reduced by long-term nutrient fertilization	NATURE			English	Article							LITTER DECOMPOSITION; SOILS; TEMPERATURE; RESPONSES; NITROGEN; CLIMATE; MINERALIZATION; TURNOVER; BALANCE; BIOMASS	Global warming is predicted to be most pronounced at high latitudes, and observational evidence over the past 25 years suggests that this warming is already under way(1). One-third of the global soil carbon pool is stored in northern latitudes(2), so there is considerable interest in understanding how the carbon balance of northern ecosystems will respond to climate warming(3,4). Observations of controls over plant productivity in tundra and boreal ecosystems(5,6) have been used to build a conceptual model of response to warming, where warmer soils and increased decomposition of plant litter increase nutrient availability, which, in turn, stimulates plant production and increases ecosystem carbon storage(6,7). Here we present the results of a long-term fertilization experiment in Alaskan tundra, in which increased nutrient availability caused a net ecosystem loss of almost 2,000 grams of carbon per square meter over 20 years. We found that annual aboveground plant production doubled during the experiment. Losses of carbon and nitrogen from deep soil layers, however, were substantial and more than offset the increased carbon and nitrogen storage in plant biomass and litter. Our study suggests that projected release of soil nutrients associated with high-latitude warming may further amplify carbon release from soils, causing a net loss of ecosystem carbon and a positive feedback to climate warming.	Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks; Marine Biological Laboratory - Woods Hole	Mack, MC (corresponding author), Univ Florida, Dept Bot, Gainesville, FL 32611 USA.	mcmack@ufl.edu	Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910				Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bliss LC, 1992, ARCTIC ECOSYSTEMS CH; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Michaelson GJ, 1996, ARCTIC ALPINE RES, V28, P414, DOI 10.2307/1551852; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Nadelhoffer KJ, 2002, PLANT SOIL, V242, P107, DOI 10.1023/A:1019646124768; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; *SYSTAT INC, 1997, SYST WIND STAT VERS; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6	30	744	801	24	517	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					440	443		10.1038/nature02887	http://dx.doi.org/10.1038/nature02887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386009				2022-12-01	WOS:000224000500037
J	Naser, SA; Ghobrial, G; Romero, C; Valentine, JF				Naser, SA; Ghobrial, G; Romero, C; Valentine, JF			Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; LYMPH-NODES; TISSUE; IDENTIFICATION; MILK; SUSCEPTIBILITY; ASSOCIATION; MUTATION; BACILLI; COWS	Background Crohn's disease, a form of inflammatory bowel disease, resembles some aspects of tuberculosis, leprosy, and paratuberculosis. The role of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease is controversial. Methods We tested for MAP by PCR and culture in buffy coat preparations from 28 individuals with Crohn's disease, nine with ulcerative colitis, and 15 without inflammatory bowel disease. Findings MAP DNA in uncultured buffy coats was identified by PCR in 13 (46%) individuals with Crohn's disease, four (45%) with ulcerative colitis, and three (20%) without inflammatory bowel disease. Viable MAP was cultured from the blood of 14 (50%) patients with Crohn's disease, two (22%) with ulcerative colitis, and none of the individuals without inflammatory bowel disease. Current use of immunosuppressive medication did not correlate with a positive MAP culture. Sequencing of PCR products from MAP cultures confirmed the presence of the MAP-specific IS900 fragment. Among 11 MAP isolates assessed, we identified nine strains that were not identical. Interpretation We detected viable MAP in peripheral blood in a higher proportion of individuals with Crohn's disease than in controls. These data contribute to the evidence that MAP might be a cause of Crohn's disease.	Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Univ Cent Florida, Burnett Coll Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA; Univ Florida, Dept Med, Gainesville, FL USA; Gainesville VAMC, Gainesville, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Florida	Naser, SA (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	nasers@mail.ucf.edu	Valentine, John/L-6631-2019	Valentine, John/0000-0002-1894-9930	NIAID NIH HHS [R01-AI51251-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051251] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Chen GI, 2002, CAN J GASTROENTEROL, V16, P29, DOI 10.1155/2002/219187; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; DALZEIL TK, 1913, BRIT MED J, V2, P1068; DeFrancesco MA, 1996, EUR J CLIN MICROBIOL, V15, P551, DOI 10.1007/BF01709362; Grant IR, 2002, APPL ENVIRON MICROB, V68, P2428, DOI 10.1128/AEM.68.5.2428-2435.2002; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Gwozdz JM, 2000, AUST VET J, V78, P622, DOI 10.1111/j.1751-0813.2000.tb11938.x; HAAGSMA J, 1989, SCAND J GASTROENTERO, V24, pS158; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HARVEY RF, 1980, LANCET, V1, P514; Hermon-Taylor J, 1998, BRIT MED J, V316, P449, DOI 10.1136/bmj.316.7129.449; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; LISBY G, 1994, SCAND J GASTROENTERO, V29, P923, DOI 10.3109/00365529409094864; MARKESICH DC, 1988, J CLIN MICROBIOL, V26, P1600, DOI 10.1128/JCM.26.8.1600-1603.1988; MCFADDEN JJ, 1987, J CLIN MICROBIOL, V25, P796, DOI 10.1128/JCM.25.5.796-801.1987; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Naser SA, 2002, MOL CELL PROBE, V16, P41, DOI 10.1006/mcpr.2001.0395; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; SANDERSON JD, 1992, GUT, V33, P890, DOI 10.1136/gut.33.7.890; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; SAXEGAARD F, 1985, J CLIN MICROBIOL, V22, P312, DOI 10.1128/JCM.22.2.312-313.1985; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Shafran I, 2002, DIGEST LIVER DIS, V34, P22, DOI 10.1016/S1590-8658(02)80055-X; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	31	483	493	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1039	1044		10.1016/S0140-6736(04)17058-X	http://dx.doi.org/10.1016/S0140-6736(04)17058-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380962				2022-12-01	WOS:000223959300022
J	Kim, HJ; Graham, DW; DiSpirito, AA; Alterman, MA; Galeva, N; Larive, CK; Asunskis, D; Sherwood, PMA				Kim, HJ; Graham, DW; DiSpirito, AA; Alterman, MA; Galeva, N; Larive, CK; Asunskis, D; Sherwood, PMA			Methanobactin, a copper-acquisition compound from methane-oxidizing bacteria	SCIENCE			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; METHYLOCOCCUS-CAPSULATUS BATH; FORMALDEHYDE DEHYDROGENASE; MONOOXYGENASE ACTIVITY; SIDEROPHORE; EXPRESSION; PROTEIN; IONS	Siderophores are extracellular iron-binding compounds that mediate iron transport into many cells. We present evidence of analogous molecules for copper transport from methane-oxidizing bacteria, represented here by a small fluorescent chromopeptide (C45N12O14H62Cu, 1216 daltons) produced by Methylosinus trichosporium OB3b. The crystal structure of this compound, methanobactin, was resolved to 1.15 angstroms. It is composed of a tetrapeptide, a tripeptide, and several unusual moieties, including two 4-thionyl-5-hydroxy-imidazole chromophores that coordinate the copper, a pyrrolidine that confers a bend in the overall chain, and an amino-terminal isopropylester group. The copper coordination environment includes a dual nitrogen- and sulfur-donating system derived from the thionyl imidazolate moieties. Structural elucidation of this molecule has broad implications in terms of organo-copper chemistry, biological methane oxidation, and global carbon cycling.	Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA; Univ Kansas, Biochem Res Serv Lab, Lawrence, KS 66045 USA; Univ Kansas, Mass Spectrometry Lab, Lawrence, KS 66045 USA; Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas; Iowa State University; Kansas State University	Graham, DW (corresponding author), Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA.	dwgraham@ku.edu	Larive, Cynthia K/E-4640-2012	Graham, David W/0000-0002-9753-496X; Sherwood, Peter/0000-0001-6487-0724; Larive, Cynthia/0000-0003-3458-0771				BERSON O, 1998, ENVIRON SCI TECHNOL, V30, P802; Brantner CA, 1997, CAN J MICROBIOL, V43, P672, DOI 10.1139/m97-095; Bruckner C, 2000, INORG CHEM, V39, P6100, DOI 10.1021/ic0004636; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Claycomb GD, 2002, J VAC SCI TECHNOL A, V20, P1230, DOI 10.1116/1.1479357; Dalton H, 1984, MICROBIAL GROWTH C C, P1; DEMANGE P, 1988, BIOCHEMISTRY-US, V27, P2745, DOI 10.1021/bi00408a014; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; DISPIRITO AA, 2004, Patent No. 60434873; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FITCH MW, 1993, APPL ENVIRON MICROB, V59, P2771, DOI 10.1128/AEM.59.9.2771-2776.1993; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Kim H.-J., UNPUB; Kim HJ, 2001, FEMS MICROBIOL LETT, V201, P133, DOI 10.1016/S0378-1097(01)00257-9; KIM HJ, 2003, THESIS U KANSAS; KNOSP O, 1984, J BACTERIOL, V159, P341, DOI 10.1128/JB.159.1.341-347.1984; Lontoh S, 1998, APPL ENVIRON MICROB, V64, P1106; NGUYEN HHT, 1994, J BIOL CHEM, V269, P14995; PELTOLA P, 1993, ARCH MICROBIOL, V159, P521, DOI 10.1007/BF00249029; PRIOR SD, 1985, J GEN MICROBIOL, V131, P155; Puig S, 2002, STRUCTURE, V10, P1292, DOI 10.1016/S0969-2126(02)00863-8; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Selmer T, 2000, J BIOL CHEM, V275, P3755, DOI 10.1074/jbc.275.6.3755; Sheldrick G. M., 1994, SHELXTL VERSION 5 RE; Stafford GP, 2003, MICROBIOL-SGM, V149, P1771, DOI 10.1099/mic.0.26060-0; Tate S, 1999, MICROBIOL-UK, V145, P159, DOI 10.1099/13500872-145-1-159; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996; Zahn JA, 2001, J BACTERIOL, V183, P6832, DOI 10.1128/JB.183.23.6832-6840.2001	34	246	261	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1612	1615		10.1126/science.1098322	http://dx.doi.org/10.1126/science.1098322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	854GV	15361623				2022-12-01	WOS:000223891200041
J	Rivera, MC; Lake, JA				Rivera, MC; Lake, JA			The ring of life provides evidence for a genome fusion origin of eukaryotes	NATURE			English	Article							EVOLUTIONARY TREES; GENE-TRANSFER; PHYLOGENY; SEQUENCES; ARCHAEA; ARCHAEBACTERIA; NUCLEUS; RECONSTRUCTION; PROKARYOTES; EUBACTERIA	Genomes hold within them the record of the evolution of life on Earth. But genome fusions and horizontal gene transfer seem to have obscured sufficiently the gene sequence record such that it is difficult to reconstruct the phylogenetic tree of life. Here we determine the general outline of the tree using complete genome data from representative prokaryotes and eukaryotes and a new genome analysis method that makes it possible to reconstruct ancient genome fusions and phylogenetic trees. Our analyses indicate that the eukaryotic genome resulted from a fusion of two diverse prokaryotic genomes, and therefore at the deepest levels linking prokaryotes and eukaryotes, the tree of life is actually a ring of life. One fusion partner branches from deep within an ancient photosynthetic clade, and the other is related to the archaeal prokaryotes. The eubacterial organism is either a proteobacterium, or a member of a larger photosynthetic clade that includes the Cyanobacteria and the Proteobacteria.	Univ Calif Los Angeles, MCD Biol, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Astrobiol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, MCD Biol, Inst Mol Biol, Los Angeles, CA 90095 USA.	lake@mbi.ucla.edu	Rivera, Maria/GYU-2150-2022					Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Campbell AM, 2000, THEOR POPUL BIOL, V57, P71, DOI 10.1006/tpbi.2000.1454; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; DICKERSON RE, 1980, DIFFRACTION RELATED, P227; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; ESSER C, 2004, MOL BIOL EVOL; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Gogarten JP, 1997, ASM NEWS, V63, P404; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; GUPTA RS, 1994, P NATL ACAD SCI USA, V91, P2895, DOI 10.1073/pnas.91.8.2895; Horiike T, 2001, NAT CELL BIOL, V3, P210, DOI 10.1038/35055129; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; LAKE JA, 1995, P NATL ACAD SCI USA, V92, P9662, DOI 10.1073/pnas.92.21.9662; Lake JA, 1998, MOL BIOL EVOL, V15, P1224, DOI 10.1093/oxfordjournals.molbev.a026030; LAKE JA, 1982, P NATL ACAD SCI-BIOL, V79, P5948, DOI 10.1073/pnas.79.19.5948; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P2880, DOI 10.1073/pnas.91.8.2880; LAKE JA, 1974, RIBOSOMES, P543; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 1996, PLANT MOL BIOL, V32, P485, DOI 10.1007/BF00019100; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Ochman H, 2000, EMBO J, V19, P6637, DOI 10.1093/emboj/19.24.6637; PACE NR, 1986, CELL, V45, P325, DOI 10.1016/0092-8674(86)90315-6; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Tekaia F, 1999, GENOME RES, V9, P550; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1981, SCI AM, V244, P98, DOI 10.1038/scientificamerican0681-98; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	49	329	356	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					152	155		10.1038/nature02848	http://dx.doi.org/10.1038/nature02848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356622				2022-12-01	WOS:000223746000035
J	True, HL; Berlin, I; Lindquist, SL				True, HL; Berlin, I; Lindquist, SL			Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRION; PHENOTYPIC PLASTICITY; TERMINATION CODONS; SPECIES BARRIER; SUP35 PROTEIN; EVOLUTION; READTHROUGH; MECHANISM; CAPACITOR	Phenotypic plasticity and the exposure of hidden genetic variation both affect the survival and evolution of new traits(1-3), but their contributing molecular mechanisms are largely unknown. A single factor, the yeast prion [PSI+], may exert a profound effect on both(4). [PSI+] is a conserved, protein-based genetic element that is formed by a change in the conformation and function of the translation termination factor Sup35p(5), and is transmitted from mother to progeny. Curing cells of [PSI+] alters their survival in different growth conditions and produces a spectrum of phenotypes in different genetic backgrounds(4). Here we show, by examining three plausible explanations for this phenotypic diversity, that all traits tested involved [PSI+]-mediated read-through of nonsense codons. Notably, the phenotypes analysed were genetically complex, and genetic re-assortment frequently converted [PSI+]-dependent phenotypes to stable traits that persisted in the absence of [PSI+]. Thus, [PSI+] provides a temporary survival advantage under diverse conditions, increasing the likelihood that new traits will become fixed by subsequent genetic change. As an epigenetic mechanism that globally affects the relationship between genotype and phenotype, [PSI+] expands the conceptual framework for phenotypic plasticity, provides a one-step mechanism for the acquisition of complex traits and affords a route to the genetic assimilation of initially transient epigenetic traits.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, SL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	True, Heather/D-2979-2012					Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Behera N, 2004, J THEOR BIOL, V226, P177, DOI 10.1016/j.jtbi.2003.08.011; Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1996, P NATL ACAD SCI USA, V93, P2517, DOI 10.1073/pnas.93.6.2517; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guthrie C, 1991, GUIDE YEAST GENETICS; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Masel J, 2003, EVOLUTION, V57, P1498; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Pigliucci M, 2003, EVOLUTION, V57, P1455; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603	30	262	280	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					184	187		10.1038/nature02885	http://dx.doi.org/10.1038/nature02885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15311209				2022-12-01	WOS:000223746000044
J	Gilbert, N; Boyle, S; Fiegler, H; Woodfine, K; Carter, NP; Bickmore, WA				Gilbert, N; Boyle, S; Fiegler, H; Woodfine, K; Carter, NP; Bickmore, WA			Chromatin architecture of the human genome: Gene-rich domains are enriched in open chromatin fibers	CELL			English	Article							HIGHER-ORDER STRUCTURE; HUMAN TRANSCRIPTOME MAP; BETA-GLOBIN GENE; INTERPHASE NUCLEI; EXPRESSED GENES; ACTIVE GENES; CHROMOSOMES; HYBRIDIZATION; LOCALIZATION; SEQUENCE	We present an analysis of chromatin fiber structure across the human genome. Compact and open chromatin fiber structures were separated by sucrose sedimentation and their distributions analyzed by hybridization to metaphase chromosomes and genomic microarrays. We show that compact chromatin fibers originate from some sites of heterochromatin (C-bands), and G-bands (euchromatin). Open chromatin fibers correlate with regions of highest gene density, but not with gene expression since inactive genes can be in domains of open chromatin, and active genes in regions of low gene density can be embedded in compact chromatin fibers. Moreover, we show that chromatin fiber structure impacts on further levels of chromatin condensation. Regions of open chromatin fibers are cytologically decondensed and have a distinctive nuclear organization. We suggest that domains of open chromatin may create an environment that facilitates transcriptional activation and could provide an evolutionary constraint to maintain clusters of genes together along chromosomes.	MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Edinburgh; Wellcome Trust Sanger Institute	Bickmore, WA (corresponding author), MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	w.bickmore@hgu.mrc.ac.uk	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Gilbert, Nick/0000-0003-0505-6081				BELLARD M, 1977, COLD SPRING HARB SYM, V42, P779, DOI 10.1101/SQB.1978.042.01.078; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; CAPLAN A, 1987, J MOL BIOL, V193, P57, DOI 10.1016/0022-2836(87)90626-7; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FANTES JA, 1992, AM J HUM GENET, V51, P1286; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FISHER EA, 1986, BIOCHEMISTRY-US, V25, P8010, DOI 10.1021/bi00372a033; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; GREULICH KO, 1987, J MOL BIOL, V193, P709, DOI 10.1016/0022-2836(87)90353-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Kim Y, 2002, P NATL ACAD SCI USA, V99, P15381, DOI 10.1073/pnas.242536699; KIMURA T, 1983, NATURE, V306, P709, DOI 10.1038/306709a0; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; NOLL H, 1989, METHOD ENZYMOL, V170, P55; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shiels C, 1997, GENOMICS, V44, P35, DOI 10.1006/geno.1997.4817; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; TAGARRO I, 1994, HUM GENET, V93, P383; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Volpi EV, 2000, J CELL SCI, V113, P1565; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wolffe AP., 1998, CHROMATIN STRUCTURE; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203	54	372	383	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					555	566		10.1016/j.cell.2004.08.011	http://dx.doi.org/10.1016/j.cell.2004.08.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339661	Bronze			2022-12-01	WOS:000223730300007
J	Cowan, CR; Hyman, AA				Cowan, CR; Hyman, AA			Centrosomes direct cell polarity independently of microtubule assembly in C-elegans embryos	NATURE			English	Article							CAENORHABDITIS-ELEGANS; ANTEROPOSTERIOR AXIS; PROTEIN SPD-2; GAMMA-TUBULIN; SPINDLE; POLARIZATION; MATURATION; ESTABLISHMENT; DUPLICATION; DOMAINS	Polarity establishment requires a symmetry-breaking event, resulting in an axis along which determinants are segregated. In Caenorhabditis elegans, oocytes are apolar and are triggered to polarize rapidly along one axis after fertilization. The establishment of this first polarity axis is revealed by the asymmetric distribution of PAR proteins and cortical activity in the one-celled embryo. Current evidence suggests that the centrosome pronucleus complex contributed by the sperm is involved in defining the polarization axis(1-6). Here we directly assess the contribution of the centrosome to polarity establishment by laser ablating the centrosome before and during polarization. We find that the centrosome is required to initiate polarity but not to maintain it. Initiation of polarity coincides with the proximity of the centrosome to the cortex and the assembly of pericentriolar material on the immature sperm centrosome. Depletion of microtubules or the microtubule nucleator gamma-tubulin did not affect polarity establishment. These results demonstrate that the centrosome provides an initiating signal that polarizes C. elegans embryos and indicate that this signalling event might be independent of the role of the centrosome as a microtubule nucleator.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Cowan, CR (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	cowan@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Cowan, Carrie/0000-0002-2867-1733				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Boyd L, 1996, DEVELOPMENT, V122, P3075; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hung TJ, 1999, DEVELOPMENT, V126, P127; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pichler S, 2000, DEVELOPMENT, V127, P2063; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Praitis V, 2001, GENETICS, V157, P1217; Sadler PL, 2000, DEVELOPMENT, V127, P355; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562	24	162	168	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					92	96		10.1038/nature02825	http://dx.doi.org/10.1038/nature02825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343338				2022-12-01	WOS:000223641500048
J	Holman, H				Holman, H			Chronic disease - The need for a new clinical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF-MANAGEMENT; CHRONIC ILLNESS; REGIONAL-VARIATIONS; CARE; OUTCOMES		Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Stanford University	Holman, H (corresponding author), Stanford Univ, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.	Holman@stanford.edu						*AM HEALTHW, 2004, DEF PAT PHYS REL 21; Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; Cuff N., 2004, IMPROVING MEDICAL ED; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gerteis M., 1993, PATIENTS EYES UNDERS; Glasgow Russell E, 2003, Jt Comm J Qual Saf, V29, P563; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; *I MED, 2003, HLTH PROF ED BRIDG Q; Institute of Medicine, 2003, PRIOR AR NAT ACT TRA; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Ludmerer KM, 1999, TIME HEAL AM MED ED; PAWLSON LG, 1994, JOINT COMM J QUAL IM, V20, P33, DOI 10.1016/S1070-3241(16)30051-7; Pham HH, 2004, ACAD MED, V79, P32, DOI 10.1097/00001888-200401000-00009; Scott J, 1998, GERIATRICS, V53, P68; Starr PE., 2017, SOCIAL TRANSFORMATIO; Stewart M, 2000, J FAM PRACTICE, V49, P796; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788	26	99	101	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2004	292	9					1057	1059		10.1001/jama.292.9.1057	http://dx.doi.org/10.1001/jama.292.9.1057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VH	15339897				2022-12-01	WOS:000223568700019
J	Dietzschold, B; Koprowski, H				Dietzschold, B; Koprowski, H			Rabies transmission from organ transplants in the USA	LANCET			English	Editorial Material							BAT RABIES		Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Dietzschold, B (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	b_dietzschold@mail.jci.tju.edu						*CDCP, 2004, MMWR-MORBID MORTAL W, V53, P586; Dietzschold B, 2000, J HUMAN VIROL, V3, P50; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; MURPHY FA, 1973, LAB INVEST, V28, P361; RAY NB, 1995, J VIROL, V69, P764, DOI 10.1128/JVI.69.2.764-772.1995; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; WARRELL MJ, 1995, LANCET, V346, P65, DOI 10.1016/S0140-6736(95)92106-0	7	25	27	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 21	2004	364	9435					648	649		10.1016/S0140-6736(04)16912-2	http://dx.doi.org/10.1016/S0140-6736(04)16912-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WO	15325815				2022-12-01	WOS:000223428900009
J	Steinbrook, R				Steinbrook, R			After Bangkok - Expanding the global response to AIDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Joint United Nations Program on HIV/AIDS, 2004, 2004 REP GLOB AIDS E; *US AID UNAIDS WHO, 2004, COV SEL SERV HIV AID; *WHO, 2004, WHO HIV AIDS PLAN JA; *WHO, 2004, 3 5 PROGR REP DEC 20	4	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					738	+		10.1056/NEJMp048186	http://dx.doi.org/10.1056/NEJMp048186			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317883				2022-12-01	WOS:000223367900002
J	Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G				Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G			Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism	NATURE			English	Article							ESCHERICHIA-COLI MOEA; CRYSTAL-STRUCTURE; SULFITE OXIDASE; NITRATE REDUCTASE; SULFUR METABOLISM; MOLECULAR-BASIS; PROTEIN; COFACTOR; INSIGHTS; ENZYMES	The molybdenum cofactor is part of the active site of all molybdenum-dependent enzymes(1), except nitrogenase. The molybdenum cofactor consists of molybdopterin, a phosphorylated pyranopterin(2), with an ene-dithiolate coordinating molybdenum. The same pyranopterin-based cofactor is involved in metal coordination of the homologous tungsten-containing enzymes found in archea(3). The molybdenum cofactor is synthesized by a highly conserved biosynthetic pathway(4). In plants, the multidomain protein Cnx1 catalyses the insertion of molybdenum into molybdopterin. The Cnx1 G domain (Cnx1G), whose crystal structure has been determined in its apo form, binds molybdopterin with high affinity and participates in the catalysis of molybdenum insertion. Here we present two high-resolution crystal structures of Cnx1G in complex with molybdopterin and with adenylated molybdopterin ( molybdopterin - AMP), a mechanistically important intermediate. Molybdopterin - AMP is the reaction product of Cnx1G and is subsequently processed in a magnesium-dependent reaction by the amino-terminal E domain of Cnx1 to yield active molybdenum cofactor. The unexpected identification of copper bound to the molybdopterin dithiolate sulphurs in both structures, coupled with the observed copper inhibition of Cnx1G activity, provides a molecular link between molybdenum and copper metabolism.	Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schwarz, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.schwarz@tu-bs.de	Llamas, Angel/L-1638-2014; Schwarz, Guenter/ABE-9643-2021; Llamas, Angel/B-7104-2015	Llamas, Angel/0000-0001-6042-9472; Schwarz, Guenter/0000-0002-2118-9338; Llamas, Angel/0000-0001-6042-9472				Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; Kuper J, 2003, ARCH BIOCHEM BIOPHYS, V411, P36, DOI 10.1016/S0003-9861(02)00714-2; Kuper J, 2003, FEMS MICROBIOL LETT, V218, P187, DOI 10.1016/S0378-1097(02)01121-7; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; MASON J, 1986, TOXICOLOGY, V42, P99, DOI 10.1016/0300-483X(86)90001-6; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moorhead GBG, 2003, EUR J BIOCHEM, V270, P1356, DOI 10.1046/j.1432-1033.2003.03509.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; Stiefel EI, 1996, SCIENCE, V272, P1599, DOI 10.1126/science.272.5268.1599; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	30	152	159	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					803	806		10.1038/nature02681	http://dx.doi.org/10.1038/nature02681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306815				2022-12-01	WOS:000223233600047
J	Hultman, CM; Sparen, P				Hultman, CM; Sparen, P			Autism - prenatal insults or an epiphenomenon of a strongly genetic disorder?	LANCET			English	Editorial Material							PERINATAL RISK-FACTORS; SCHIZOPHRENIA		Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	Karolinska Institutet	Hultman, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	Christina.Hultman@meb.ki.se		Sparen, Par/0000-0002-5184-8971				Cnattingius S, 1999, ARCH GEN PSYCHIAT, V56, P634, DOI 10.1001/archpsyc.56.7.634; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; RODIER PM, 2004, CLIN MOL TERATOL, V70, P1	8	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					485	487		10.1016/S0140-6736(04)16825-6	http://dx.doi.org/10.1016/S0140-6736(04)16825-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302177				2022-12-01	WOS:000223132700008
J	Stomp, M; Huisman, J; de Jongh, F; Veraart, AJ; Gerla, D; Rijkeboer, M; Ibelings, BW; Wollenzien, UIA; Stal, LJ				Stomp, M; Huisman, J; de Jongh, F; Veraart, AJ; Gerla, D; Rijkeboer, M; Ibelings, BW; Wollenzien, UIA; Stal, LJ			Adaptive divergence in pigment composition promotes phytoplankton biodiversity	NATURE			English	Article							COMPETITION; MARINE; LIGHT; PHOTOTROPHY	The dazzling diversity of the phytoplankton has puzzled biologists for decades(1-5). The puzzle has been enlarged rather than solved by the progressive discovery of new phototrophic microorganisms in the oceans, including picocyanobacteria(6,7), pico-eukaryotes(8), and bacteriochlorophyll-based(9-11) and rhodopsin-based phototrophic bacteria(12,13). Physiological and genomic studies suggest that natural selection promotes niche differentiation among these phototrophic microorganisms, particularly with respect to their photosynthetic characteristics(14-16). We have analysed competition for light between two closely related picocyanobacteria of the Synechococcus group that we isolated from the Baltic Sea(17). One of these two has a red colour because it contains the pigment phycoerythrin, whereas the other is blue-green because it contains high contents of the pigment phycocyanin. Here we report theory and competition experiments that reveal stable coexistence of the two picocyanobacteria, owing to partitioning of the light spectrum. Further competition experiments with a third marine cyanobacterium, capable of adapting its pigment composition, show that this species persists by investing in the pigment that absorbs the colour not used by its competitors. These results demonstrate the adaptive significance of divergence in pigment composition of phototrophic microorganisms, which allows an efficient utilization of light energy and favours species coexistence.	Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; Netherlands Inst Ecol NIOO KNAW, Ctr Limnol, NL-3631 AC Nieuwersluis, Netherlands; Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, NL-4400 AC Yerseke, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Nieuwe Achtergracht 127, NL-1018 WS Amsterdam, Netherlands.	jef.huisman@science.uva.nl	Huisman, Jef/A-1089-2013; Ibelings, Bas W/B-4237-2011; Veraart, Annelies J/E-1927-2014; Gerla, Daan/A-4170-2009; Stal, Lucas J/B-3334-2011; Stomp, Maayke/J-1484-2012	Huisman, Jef/0000-0001-9598-3211; Ibelings, Bas W/0000-0002-7213-7407; Veraart, Annelies J/0000-0001-6286-7484; Gerla, Daan/0000-0002-2847-5273; 				Abrams PA, 1999, AM NAT, V153, P83, DOI 10.1086/303154; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Ernst A, 2003, MICROBIOL-SGM, V149, P217, DOI 10.1099/mic.0.25475-0; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.2307/176991; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Jonker RR, 1995, WATER SCI TECHNOL, V32, P177, DOI 10.1016/0273-1223(95)00696-6; Kirk JTO., 1994, LIGHT PHOTOSYNTHESIS, V2nd ed; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; OHKI K, 1985, PLANT PHYSIOL, V79, P943, DOI 10.1104/pp.79.4.943; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SATHYENDRANATH S, 1989, LIMNOL OCEANOGR, V34, P188, DOI 10.4319/lo.1989.34.1.0188; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Tilman D., 1982, Monographs in Population Biology, pi; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0	28	207	214	8	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 4	2004	432	7013					104	107		10.1038/nature03044	http://dx.doi.org/10.1038/nature03044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15475947				2022-12-01	WOS:000224854900049
J	Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR				Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR			Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2	SCIENCE			English	Article							CHROMOSOME SEGREGATION; PHOSPHORYLATION; COMPLEX; INCENP; INSTABILITY; PROGRESSION; METAPHASE; MUTATIONS; SPINDLE; REPAIR	Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.	Univ Cambridge, Canc Res UK, Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Canc Res UK, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Lee, MiYoung/G-3748-2014	Daniels, Matthew/0000-0002-9250-6214				Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Friedman LS, 1998, CANCER RES, V58, P1338; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Goggins M, 1996, CANCER RES, V56, P5360; Gretarsdottir S, 1998, CANCER RES, V58, P859; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; WANG Y, UNPUB; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Yu VPCC, 2000, GENE DEV, V14, P1400	19	237	243	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					876	879		10.1126/science.1102574	http://dx.doi.org/10.1126/science.1102574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15375219				2022-12-01	WOS:000224969400048
J	Brent, DA				Brent, DA			Treating depression in children: Antidepressants and pediatric depression the risk of doing nothing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUICIDE		Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Brent, DA (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA.							BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Martin A, 2004, ARCH PEDIAT ADOL MED, V158, P773, DOI 10.1001/archpedi.158.8.773; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; WEBSTER DW, 2004, JAMA-J AM MED ASSOC, V292, P1178	6	86	86	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1598	1601						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483276				2022-12-01	WOS:000224427300004
J	Wise, RP; Iskander, J; Pratt, RD; Campbell, S; Ball, R; Pless, RP; Braun, MM				Wise, RP; Iskander, J; Pratt, RD; Campbell, S; Ball, R; Pless, RP; Braun, MM			Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EVENT-REPORTING-SYSTEM; INFANT-DEATH-SYNDROME; ADVERSE EVENTS; IMMUNIZATION; RISK; PERTUSSIS; VAERS; EPIDEMIOLOGY; EFFICACY; PURPURA	Context Clinical trials evaluate a vaccine's safety before approval, but some risks may escape detection or adequate characterization until larger population exposures occur after licensure. Objective To summarize reports of events occurring after vaccination with 7-valent pneumococcal conjugate vaccine (PCV), including those that may warrant further investigation to assess possible causation by PCV. Design Descriptive epidemiology of reports submitted to the Vaccine Adverse Event Reporting System (VAERS), a national passive surveillance database. Setting and Patients United States during first 2 years after licensure of PCV (February 2000 through February 2002). Reports studied were for children younger than 18 years and vaccinated with PCV. Main Outcome Measures Numbers and proportional distributions of reports. Results A total of 4154 reports of events following PCV were submitted to VAERS, for a rate of 13.2 reports per 100000 doses distributed. Multiple vaccines were given in 74.3% of reports. The most frequently reported symptoms and signs included fever, injection site reactions, fussiness, rashes, and urticaria. Serious events were described in 14.6% of reports. There were 117 deaths, 23 reports of positive rechallenges, and 34 cases of invasive pneumococcal infections possibly representing vaccine failure. Immune-mediated events occurred in 31.3% of reports. All 14 patients with anaphylactic or anaphylactoid reactions survived. Thrombocytopenia developed in 14 patients and serum sickness in 6 others. Neurologic symptoms occurred in 38% of reports. Seizures described in 393 reports included 94 febrile seizures. Conclusions The majority of reports to VAERS in the first 2 years after licensure of PCV described generally minor adverse events previously identified in clinical trials. The proportion of reports portraying serious events was similar to that for other vaccines. Although there are important limitations in passive surveillance data, and caution in their interpretation is necessary, symptoms experienced by a few children more than once after successive PCV doses, including allergic reactions, prolonged or abnormal crying, fussiness, dyspnea, and gastrointestinal distress, warrant continued surveillance, as do reports of rare but potentially serious events, such as seizures, anaphylactic or anaphylactoid reactions, serum sickness, and thrombocytopenia.	US FDA, Ctr Biol Evaluat & Res, Div Epidemiol, Off Biostat & Epidemiol, Rockville, MD 20852 USA; US FDA, Ctr Biol Evaluat & Res, Div Vaccines & Related Prod Applicat, Off Vaccines Res & Review, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA USA; Ctr Infect Dis Prevent & Control Hlth Canada, Immunizat Safety Unit, Immunizat & Resp Infect Div, Ottawa, ON, Canada	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Wise, RP (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Epidemiol, Off Biostat & Epidemiol, HFM-225,1401 Rockville Pike, Rockville, MD 20852 USA.	R.P.Wise@cber.fda.gov						[Anonymous], 2002, IMMUNIZATION SAFETY; Ball Robert, 2002, Expert Rev Vaccines, V1, P161, DOI 10.1586/14760584.1.2.161; Beeler J, 1996, PEDIATR INFECT DIS J, V15, P88, DOI 10.1097/00006454-199601000-00020; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P568, DOI 10.1097/00006454-200206000-00018; Braun MM, 1997, J PEDIATR-US, V131, P529, DOI 10.1016/S0022-3476(97)70056-8; Byard RW, 1998, J PAEDIATR CHILD H, V34, P101; Byard RW, 1995, MED J AUSTRALIA, V163, P443, DOI 10.5694/j.1326-5377.1995.tb124675.x; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Cohen AD, 1996, J AUTOIMMUN, V9, P699, DOI 10.1006/jaut.1996.0091; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Ellenberg SS, 1997, PUBLIC HEALTH REP, V112, P10; *FDA PHS, 1995, COD COSTART SYMB THE; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; Halsey Neal A, 2002, Semin Pediatr Infect Dis, V13, P205, DOI 10.1053/spid.2002.125864; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; *I SAF MED PRACT, 2002, ISMP MED SAFETY ALER, V7, P2; Jefferson T, 1998, J EPIDEMIOL COMMUN H, V52, P674, DOI 10.1136/jech.52.10.674; Jonville-Bera AP, 2001, BRIT J CLIN PHARMACO, V51, P271, DOI 10.1046/j.1365-2125.2001.00341.x; Miller E, 2001, ARCH DIS CHILD, V84, P227, DOI 10.1136/adc.84.3.227; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; Shetty AK, 2000, ARCH FAM MED, V9, P553, DOI 10.1001/archfami.9.6.553; Silvers LE, 2001, PHARMACOEPIDEM DR S, V10, P279, DOI 10.1002/pds.619; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Stratton K., 2003, IMMUNIZATION SAFETY; STRATTON KR, 1994, JAMA-J AM MED ASSOC, V271, P1602, DOI 10.1001/jama.271.20.1602; Verstraeten T, 2001, AM J EPIDEMIOL, V154, P1006, DOI 10.1093/aje/154.11.1006; WEBER RE, 1984, MOL PHYSIOL, V6, P1; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; Wise RP, 1997, JAMA-J AM MED ASSOC, V278, P1176, DOI 10.1001/jama.278.14.1176; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1; 1994, FED REG, V59, P54042; 2001, MMWR WEEKLY     1221, V50, P1140	33	53	56	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2004	292	14					1702	1710		10.1001/jama.292.14.1702	http://dx.doi.org/10.1001/jama.292.14.1702			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861JS	15479935	Bronze			2022-12-01	WOS:000224413400029
J	Cottam, R				Cottam, R			Obesity and culture	LANCET			English	Editorial Material									Croydon Primary Care Trust, Surrey CR0 6SR, England		Cottam, R (corresponding author), Croydon Primary Care Trust, Surrey CR0 6SR, England.	rachelcottam@pink2.demon.co.uk						ATKINS R, 2003, ATKINS LIFE; *CAB OFF, 2004, ALC HARM RED STRAT E; Critser G., 2003, FAT LAND AM BECAME F; Furedi F., 2004, THERAPY CULTURE CULT; GROSSMAN M, 2004, EC OBESITY PUBLIC IN; MEEK J, 2002, GUARDIAN        1008; *NAT I CLIN EX, 2002, SELF HARM SHORT TERM; *NAT I CLIN EX, 2004, SCOP CONS DRAFT GUID; *NAT I CLIN EXC, FULL LIST STAK; National Institutes of Health, 2004, STRAT PLAN NIH OB RE; Packard V, 1957, HIDDEN PERSUADERS; SHAPIN S, 2004, LONDON REV BOOK 0805, P16; *UK PARL, 2004, 3 UK PARL SEL COMM H; 2004, GUARDIAN        0729	14	7	7	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 2	2004	364	9441					1202	1203		10.1016/S0140-6736(04)17159-6	http://dx.doi.org/10.1016/S0140-6736(04)17159-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HO	15464169				2022-12-01	WOS:000224254200009
J	Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M				Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M			The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector	CELL			English	Article							RENAL-TRANSPLANT RECIPIENTS; DEPENDENT PROTEIN-KINASE; SALT-INDUCIBLE KINASE; PANCREATIC BETA-CELL; TRANSCRIPTIONAL REGULATION; PHOSPHORYLATION; BINDING; IDENTIFICATION; ACTIVATION; LKB1	Elevations in circulating glucose and gut hormones during feeding promote pancreatic islet cell viability in part via the calcium- and cAMP-dependent activation of the transcription factor CREB. Here, we describe a signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator. This module consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which associate with TORC2. Under resting conditions, TORC2 is sequestered in the cytoplasm via a phosphorylation-dependent interaction with 14-3-3 proteins. Triggering of the calcium and cAMP second messenger pathways by glucose and gut hormones disrupts TORC2:14-3-3 complexes via complementary effects on TORC2 dephosphorylation; calcium influx increases calcineurin activity, whereas cAMP inhibits SIK2 kinase activity. Our results illustrate how a phosphatase/kinase module connects two signaling pathways in response to nutrient and hormonal cues.	Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Osaka University; Salk Institute; Scripps Research Institute	Takemori, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, H-1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mr-mb002@pop.med.osaka-u.ac.jp; montminy@salk.edu		Screaton, Robert/0000-0002-4917-9473; CANETTIERI, Gianluca/0000-0001-6694-2613				Al-Uzri A, 2001, TRANSPLANTATION, V72, P1020, DOI 10.1097/00007890-200109270-00007; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Filler G, 2000, NEPHROL DIAL TRANSPL, V15, P867, DOI 10.1093/ndt/15.6.867; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montclare JK, 2001, NUCLEIC ACIDS RES, V29, P3311, DOI 10.1093/nar/29.16.3311; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; RADHAKRISHNAN I, 1997, CELL, V91, P7411; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	35	488	519	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					61	74		10.1016/j.cell.2004.09.015	http://dx.doi.org/10.1016/j.cell.2004.09.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454081	Bronze, Green Published			2022-12-01	WOS:000224292600009
J	Steinbrook, R				Steinbrook, R			Medical marijuana, physician-assisted suicide, and the controlled substance act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Joy JE, 1999, MARIJUANA MED ASSESS; Kassirer JP, 1997, NEW ENGL J MED, V336, P366, DOI 10.1056/NEJM199701303360509; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	3	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1380	1383		10.1056/NEJMp048222	http://dx.doi.org/10.1056/NEJMp048222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857XT	15459296				2022-12-01	WOS:000224153900003
J	Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A				Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A		French Parkinson's Disease Genetic	Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease	LANCET			English	Article								The alpha-synuclein gene (SNCA) has been implicated in autosomal dominant forms,of Parkinson's disease. We screened 119 individuals from families with this rare form of the disease for SNCA duplications by 94 semiquantitative multiplex PCR. Two patients had duplications, which were confirmed by analysis of intragenic and flanking microsatellite markers. The phenotype in both patients was indistinguishable from idiopathic Parkinson's disease and no atypical features were present, by contrast with reports of families with triplication of the same gene. These results indicate that SNCA is more frequently associated with familial Parkinson's disease than previously thought, and that there is a clear dosage effect according to the number of supernumerary copies of this gene.	AP HP, Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; AP HP, Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75651 Paris 13, France; AP HP, CHU Pitie Salpetriere, Federat Neurol, F-75013 Paris, France; CHU Bordeaux, Hop Haut Leveque, Serv Neurol, Pessac, France; CHU Grenoble, Dept Neurol, F-38043 Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Brice, A (corresponding author), AP HP, Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.	brice@ccr.jussieu.fr	Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	brice, alexis/0000-0002-0941-3990				Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Vaughan JR, 1998, HUM MOL GENET, V7, P751, DOI 10.1093/hmg/7.4.751	5	784	805	2	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1169	1171		10.1016/S0140-6736(04)17104-3	http://dx.doi.org/10.1016/S0140-6736(04)17104-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451225				2022-12-01	WOS:000224102400031
J	Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ				Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ			Analgesia - Morphine-pathway block in top1 poppies	NATURE			English	Editorial Material							ALKALOID BIOSYNTHESIS; CELL		CSIRO Plant Ind, Canberra, ACT 2601, Australia; Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, D-06120 Halle Saale, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle Saale, Germany; Johnson & Johnson, Strawberry Hills, NSW 2012, Australia; Tasmanian Alkaloids, Westbury, Tas 7303, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Johnson & Johnson	Millgate, AG (corresponding author), CSIRO Plant Ind, Black Mt, Canberra, ACT 2601, Australia.	philip.larkin@csiro.au	Pogson, Barry J/C-9953-2009; Larkin, Philip J/A-9468-2008; Larkin, Philip/AAU-3195-2021; Wilson, Iain/D-4839-2009; Kutchan, Toni/L-4625-2013	Pogson, Barry J/0000-0003-1869-2423; Larkin, Philip J/0000-0002-2608-1924; Larkin, Philip/0000-0002-2608-1924; Wilson, Iain/0000-0002-4626-8059; 				Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Bock A, 2002, PLANTA, V216, P57, DOI 10.1007/s00425-002-0867-5; BROCHMANNHANSSEN E, 1984, PLANTA MED, V50, P343, DOI 10.1055/s-2007-969727; De Luca V, 2000, TRENDS PLANT SCI, V5, P168, DOI 10.1016/S1360-1385(00)01575-2; Kutchan TM, 1996, GENE, V179, P73, DOI 10.1016/S0378-1119(96)00426-X; KUTCHAN TM, IN PRESS ADV PLANT B; PARKER HI, 1972, J AM CHEM SOC, V94, P1276, DOI 10.1021/ja00759a039; Zenk M.H., 1995, ORGANIC REACTIVITY P, P89	8	76	87	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					413	414		10.1038/431413a	http://dx.doi.org/10.1038/431413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386001				2022-12-01	WOS:000224000500029
J	[Anonymous]				[Anonymous]			Prescribing of lipid regulating drugs and admissions for myocardial infarction in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article													Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743; Majeed, Azeem/0000-0002-2357-9858					0	3	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					645	+		10.1136/bmj.329.7467.645	http://dx.doi.org/10.1136/bmj.329.7467.645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374914	Green Published			2022-12-01	WOS:000224042300015
J	Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R				Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R			Choreography of the DNA damage response: Spatiotemporal relationships among checkpoint and repair proteins	CELL			English	Article							DOUBLE-STRAND BREAKS; STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; S-PHASE; RAD52 PROTEIN; MRE11 COMPLEX; NUCLEAR FOCI; HOMOLOGOUS RECOMBINATION; TELOMERE MAINTENANCE; SENSITIVE MUTANTS	DNA repair is an essential process for preserving genome integrity in all organisms. In eukaryotes, recombinational repair is choreographed by multiprotein complexes that are organized into centers (foci). Here, we analyze the cellular response to DNA double-strand breaks (DSBs) and replication stress in Saccharomyces cerevisiae. The Mre11 nuclease and the ATM-related Tell kinase are the first proteins detected at DSBs. Next, the Rfa1 single-strand DNA binding protein relocalizes to the break and recruits other key checkpoint proteins. Later and only in S and G2 phase, the homologous recombination machinery assembles at the site. Unlike the response to DSBs, Mre11 and recombination proteins are not recruited to hydroxyurea-stalled replication forks unless the forks collapse. The cellular response to DSBs and DNA replication stress is likely directed by the Mre11 complex detecting and processing DNA ends in conjunction with Sae2 and by RP-A recognizing single-stranded DNA and recruiting additional checkpoint and repair proteins.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University	Rothstein, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	rothstein@cancercenter.columbia.edu	Lisby, Michael/K-9814-2014	Lisby, Michael/0000-0002-4830-5247; Rothstein, Rodney/0000-0002-4107-9654				ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 1998, GENETICS, V148, P975; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0165-1218(74)90185-2; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Klein HL, 1997, GENETICS, V147, P1533; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Melo JA, 2001, GENE DEV, V15, P2809; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paulovich AG, 1997, GENETICS, V145, P45; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 1997, GENETICS, V147, P1545; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; TRUJILLO KM, 2003, J BIOL CHEM, V49, P48967; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	85	707	723	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					699	713		10.1016/j.cell.2004.08.015	http://dx.doi.org/10.1016/j.cell.2004.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369670	Bronze			2022-12-01	WOS:000223992400007
J	Senghas, A; Kita, S; Ozyurek, A				Senghas, A; Kita, S; Ozyurek, A			Children creating core properties of language: Evidence from an emerging sign language in Nicaragua	SCIENCE			English	Article							GESTURE	A new sign language has been created by deaf Nicaraguans over the past 25 years, providing an opportunity to observe the inception of universal hallmarks of language. We found that in their initial creation of the language, children analyzed complex events into basic elements and sequenced these elements into hierarchically structured expressions according to principles not observed in gestures accompanying speech in the surrounding language. Successive cohorts of learners extended this procedure, transforming Nicaraguan signing from its early gestural form into a linguistic system. We propose that this early segmentation and recombination reflect mechanisms with which children learn, and thereby perpetuate, language. Thus, children naturally possess learning abilities capable of giving language its fundamental structure.	Columbia Univ Barnard Coll, Dept Psychol, New York, NY 10027 USA; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England; Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Max Planck Inst Psycholinguist, NL-6525 XD Nijmegen, Netherlands; Koc Univ, Dept Psychol, TR-34450 Istanbul, Turkey	Columbia University; University of Bristol; Radboud University Nijmegen; Max Planck Society; Koc University	Senghas, A (corresponding author), Columbia Univ Barnard Coll, Dept Psychol, 3009 Broadway, New York, NY 10027 USA.	annie@alum.mit.edu	Galantucci, Bruno/E-5770-2010; ozyurek, asli/M-5366-2013; Kita, Sotaro/B-2860-2008	Kita, Sotaro/0000-0002-0088-3654	NIDCD NIH HHS [R01 DC05407, R01 DC00491, R01 DC005407] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005407, R01DC000491] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSEN RW, 1983, PIDGINISATION CREOLI, P1; BICKERTON D, 1984, BEHAV BRAIN SCI, V7, P173, DOI 10.1017/S0140525X00044149; Christiansen MH, 2003, TRENDS COGN SCI, V7, P300, DOI 10.1016/S1364-6613(03)00136-0; Coppola M., 2002, THESIS U ROCHESTER; DeGraff M., 1999, LANGUAGE CREATION LA; Goldin-Meadow S., 1982, LANG ACQUIS, P51; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hockett C. F., 1987, REFURBISHING OUR FDN; HOLM J, 1988, PIDGINS CREOLES, V1; Jackendoff R., 2002, FDN LANGUAGE BRAIN, DOI 10.1093/acprof:oso/9780198270126.001.0001; Kegl J, 1999, LEARN DEV CONCEP CH, P179; Kirby S., 1999, FUNCTION SELECTION I; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; Lenneberg E.H., 1967, HOSP PRACT, V2, P59, DOI [10.1080/21548331.1967.11707799, DOI 10.1080/21548331.1967.11707799]; McNeill D., 1992, HAND MIND WHAT GESTU; MEIER RP, 1987, J MEM LANG, V26, P362, DOI 10.1016/0749-596X(87)90119-7; Morford JP, 1996, LANG COMMUN, V16, P165, DOI 10.1016/0271-5309(96)00008-0; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; POLICH L, IN PRESS BUT SIGN LA; Sankoff Gillian, 1973, KIVUNG, V6, P32; Senghas A, 2003, COGNITIVE DEV, V18, P511, DOI 10.1016/j.cogdev.2003.09.006; Senghas A, 2001, PSYCHOL SCI, V12, P323, DOI 10.1111/1467-9280.00359; Senghas A., 1995, THESIS MIT; SENGHAS RJ, 1997, THESIS U ROCHESTER; Talmy Leonard., 1985, LANGUAGE TYPOLOGY SY, V3, P36, DOI DOI 10.1017/CB09780511618437; TOMASELLO M, 2003, LANGUAGE EVOLUTION, P94, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0006; [No title captured]	28	298	302	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1779	1782		10.1126/science.1100199	http://dx.doi.org/10.1126/science.1100199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	856IS	15375269	Green Published, Green Submitted			2022-12-01	WOS:000224039500043
J	Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH				Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH			Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C	NATURE			English	Article							EPITHELIAL TIGHT JUNCTION; JAM FAMILY; ROLES; APKC; ESTABLISHMENT; DYNAMICS; NECTIN-2; ACROSOME; CDC42; PAR-6	During spermatogenesis in the mammalian testis, stem cells (spermatogonia) differentiate into spermatocytes, which subsequently undergo two consecutive meiotic divisions to give rise to haploid spermatids. These cells are initially round but progressively elongate, condense their nuclei, acquire flagellar and acrosomal structures, and shed a significant amount of their cytoplasm to form spermatozoa (the sperm cells) in a developmental cascade termed spermiogenesis(1,2). Defects in these processes will lead to a lack of mature sperm cells ( azoospermia), which is a major cause of male infertility in the human population(3). Here we report that a cell-surface protein of the immunoglobulin superfamily, junctional adhesion molecule-C (JAM-C), is critically required for the differentiation of round spermatids into spermatozoa in mice. We found that Jam-C is essential for the polarization of round spermatids, a function that we attribute to its role in the assembly of a cell polarity complex.	Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; Univ Hosp Munster, Inst Cell Biol, ZMBE, D-48149 Munster, Germany; Univ Geneva, CMU, Dept Pathol, CH-1211 Geneva, Switzerland	Cancer Research UK; University of Geneva	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@cancer.org.uk	Ebnet, Klaus T/C-8314-2009; Adams, Ralf H/AAE-9274-2019; Aurrand-Lions, Michel/O-9953-2016	Ebnet, Klaus T/0000-0002-0417-7888; Aurrand-Lions, Michel/0000-0002-8361-3034				Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2002, VASC PHARMACOL, V39, P239, DOI 10.1016/S1537-1891(03)00012-0; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Chavakis T, 2003, THROMB HAEMOSTASIS, V89, P13; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Ezeh UIO, 2000, HUM REPROD, V15, P2356, DOI 10.1093/humrep/15.11.2356; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.e03-08-0620; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	30	199	212	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					320	324		10.1038/nature02877	http://dx.doi.org/10.1038/nature02877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372036				2022-12-01	WOS:000223864000044
J	Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L				Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L			Genetic evidence supports demic diffusion of Han culture	NATURE			English	Article							INFERRING ADMIXTURE PROPORTIONS; Y-CHROMOSOME; CHINESE POPULATIONS; MITOCHONDRIAL-DNA; PARENTAL POPULATIONS; HUMAN-EVOLUTION; MOLECULAR-DATA; FREQUENCIES; HAPLOTYPES; DISTANCES	The spread of culture and language in human populations is explained by two alternative models: the demic diffusion model, which involves mass movement of people; and the cultural diffusion model, which refers to cultural impact between populations and involves limited genetic exchange between them(1). The mechanism of the peopling of Europe has long been debated, a key issue being whether the diffusion of agriculture and language from the Near East was concomitant with a large movement of farmers(1-3). Here we show, by systematically analysing Y-chromosome and mitochondrial DNA variation in Han populations, that the pattern of the southward expansion of Han culture is consistent with the demic diffusion model, and that males played a larger role than females in this expansion. The Han people, who all share the same culture and language, exceed 1.16 billion (2000 census), and are by far the largest ethnic group in the world. The expansion process of Han culture is thus of great interest to researchers in many fields.	Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; Fudan Univ, Moragn Tan Inst Ctr Life Sci, Shanghai 200433, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45267 USA; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming 650223, Peoples R China	Fudan University; Fudan University; Fudan University; University System of Ohio; University of Cincinnati; Chinese Academy of Sciences; Kunming Institute of Zoology	Jin, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin@fudan.edu.cn	Zhang, Liang/F-8064-2013; Li, Hui/A-2014-2010; Zhang, Feng/C-7735-2009; mao, xianyun/B-4664-2014; Wen, Bo/P-5332-2019; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Zhang, Liang/0000-0002-7672-1168; Zhang, Feng/0000-0003-4556-8276; mao, xianyun/0000-0002-1236-4800; Wen, Bo/0000-0003-0394-7366; Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871				Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Du RF, 1997, SCI CHINA SER C, V40, P613, DOI 10.1007/BF02882691; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; FEI XT, 1999, PATTERN DIVERSITY UN; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; ROBERTS DF, 1965, HUM BIOL, V37, P38; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Schneider S., 2000, ARLEQUIN VER 2 000 S; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JL, 2003, GENETICS, V164, P747; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Xiao CJ, 2000, SCI CHINA SER C, V43, P472; XU YT, 2003, J CENTR U NATL, V30, P59; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	29	297	334	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					302	305		10.1038/nature02878	http://dx.doi.org/10.1038/nature02878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372031				2022-12-01	WOS:000223864000039
J	Court, FA; Sherman, DL; Pratt, T; Garry, EM; Ribchester, RR; Cottrell, DF; Fleetwood-Walker, SM; Brophy, PJ				Court, FA; Sherman, DL; Pratt, T; Garry, EM; Ribchester, RR; Cottrell, DF; Fleetwood-Walker, SM; Brophy, PJ			Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves	NATURE			English	Article							PROTEIN MESSENGER-RNA; MICE; OLIGODENDROCYTES; MICROTUBULES; EXPRESSION; JUNCTION; PERIAXIN; FIBERS	Nerve impulses are propagated at nodes of Ranvier in the myelinated nerves of vertebrates. Internodal distances have been proposed to affect the velocity of nerve impulse conduction(1); however, direct evidence is lacking, and the cellular mechanisms that might regulate the length of the myelinated segments are unknown. Ramon y Cajal described longitudinal and transverse bands of cytoplasm or trabeculae in internodal Schwann cells and suggested that they had a nutritive function(2). Here we show that internodal growth in wild-type nerves is precisely matched to nerve extension, but disruption of the cytoplasmic bands in Periaxin-null mice impairs Schwann cell elongation during nerve growth. By contrast, myelination proceeds normally. The capacity of wild-type and mutant Schwann cells to elongate is cell-autonomous, indicating that passive stretching can account for the lengthening of the internode during limb growth. As predicted on theoretical grounds, decreased internodal distances strikingly decrease conduction velocities and so affect motor function. We propose that microtubule-based transport in the longitudinal bands of Cajal permits internodal Schwann cells to lengthen in response to axonal growth, thus ensuring rapid nerve impulse transmission.	Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland.	peter.brophy@ed.ac.uk	Court, Felipe/C-5911-2015	Ribchester, Richard/0000-0003-2670-6995; Pratt, Thomas/0000-0002-7105-3527; Court, Felipe/0000-0002-9394-7601; Court, Felipe/0000-0002-1384-2552				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Anzini P, 1997, J NEUROSCI, V17, P4545; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Collinson JM, 1998, GLIA, V23, P11, DOI 10.1002/(SICI)1098-1136(199805)23:1<11::AID-GLIA2>3.0.CO;2-7; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Fernan M., 1933, HISTOLOGY; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; GRIFFITHS IR, 1989, J NEUROCYTOL, V18, P345, DOI 10.1007/BF01190837; HISCOE HB, 1947, ANAT REC, V99, P447, DOI 10.1002/ar.1090990404; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; HUXLEY AF, 1949, J PHYSIOL-LONDON, V108, P315, DOI 10.1113/jphysiol.1949.sp004335; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; RANVIER L, 1872, CR HEBD ACAD SCI, V75, P1129; SCHLAEPFER WW, 1973, J COMP NEUROL, V147, P255, DOI 10.1002/cne.901470207; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TRAPP BD, 1995, J NEUROSCI, V15, P1797, DOI 10.1523/JNEUROSCI.15-03-01797.1995	21	168	174	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					191	195		10.1038/nature02841	http://dx.doi.org/10.1038/nature02841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356632	Green Published			2022-12-01	WOS:000223746000046
J	Hierro, A; Sun, J; Rusnak, AS; Kim, J; Prag, G; Emr, SD; Hurley, JH				Hierro, A; Sun, J; Rusnak, AS; Kim, J; Prag, G; Emr, SD; Hurley, JH			Structure of the ESCRT-II endosomal trafficking complex	NATURE			English	Article							RECEPTOR DOWN-REGULATION; MULTIVESICULAR-BODY; UBIQUITIN LIGASE; PROTEIN; TSG101; MACHINERY; PATHWAY; SYSTEM; BODIES; DELTA	The multivesicular-body (MVB) pathway delivers transmembrane proteins and lipids to the lumen of the endosome. The multivesicular-body sorting pathway has crucial roles in growth-factor-receptor downregulation(1), developmental signalling(2-4), regulation of the immune response(5) and the budding of certain enveloped viruses such as human immunodeficiency virus(6). Ubiquitination is a signal for sorting into the MVB pathway(7,8), which also requires the functions of three protein complexes, termed ESCRT-I, -II and -III (endosomal sorting complex required for transport)(7,9,10). Here we report the crystal structure of the core of the yeast ESCRT-II complex, which contains one molecule of the Vps protein Vps22, the carboxy-terminal domain of Vps36 and two molecules of Vps25, and has the shape of a capital letter 'Y'. The amino-terminal coiled coil of Vps22 and the flexible linker leading to the ubiquitin-binding NZF domain of Vps36 both protrude from the tip of one branch of the 'Y'. Vps22 and Vps36 form nearly equivalent interactions with the two Vps25 molecules at the centre of the 'Y'. The structure suggests how ubiquitinated cargo could be passed between ESCRT components of the MVB pathway through the sequential transfer of ubiquitinated cargo from one complex to the next.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Hierro, Aitor/F-9998-2011	Hierro, Aitor/0000-0002-7721-1581	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; TEO H, IN PRESS J BIOL CHEM; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072	30	119	127	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					221	225		10.1038/nature02914	http://dx.doi.org/10.1038/nature02914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15329733	Green Published			2022-12-01	WOS:000223746000052
J	Cuthbert, GL; Daujat, S; Snowden, AW; Erdjument-Bromage, H; Hagiwara, T; Yamada, M; Schneider, R; Gregory, PD; Tempst, P; Bannister, AJ; Kouzarides, T				Cuthbert, GL; Daujat, S; Snowden, AW; Erdjument-Bromage, H; Hagiwara, T; Yamada, M; Schneider, R; Gregory, PD; Tempst, P; Bannister, AJ; Kouzarides, T			Histone deimination antagonizes arginine methylation	CELL			English	Article							IN-VIVO; GENE ACTIVATION; H3; RECEPTOR; PROMOTER; ACETYLATION; RESIDUES; H4	Methylation of arginine residues within histone H3 has been linked to active transcription. This modification appears on the estrogen-regulated pS2 promoter when the CARM1 methyltransferase is recruited during transcriptional activation. Here we describe a process, deimination, that converts histone arginine to citrulline and antagonizes arginine methylation. We show that peptidyl arginine deiminase 4 (PADI4) specifically deiminates, arginine residues R2, R8, R17, and R26 in the H3 tail. Deimination by PADI4 prevents arginine methylation by CARM1. Dimethylation of arginines prevents deimination by PADI4 although monomethylation still allows deimination to take place. In vivo targeting experiments on an endogenous promoter demonstrate that PADI4 can repress hormone receptor-mediated gene induction. Consistent with a repressive role for PADI4, this enzyme is recruited to the pS2 promoter following hormone induction when the gene is transcriptionally downregulated. The recruitment of PADI4 coincides with deimination of the histone H3 N-terminal tail. These results define deimination as a novel mechanism for antagonizing the transcriptional induction mediated by arginine methylation.	Univ Cambridge, Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; Sangamo Biosci Inc, Point Richmond Tech Ctr 2, Richmond, CA 94804 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Yokohama City Univ, Grad Sch Integrated Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan	University of Cambridge; University of Cambridge; Sangamo Therapeutics, Inc.; Memorial Sloan Kettering Cancer Center; Yokohama City University	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk	Daujat, Sylvain/A-6070-2017; zhang, shijun/K-3688-2013	Daujat, Sylvain/0000-0001-5107-119X; Gregory, Philip/0000-0001-9249-2468; Bannister, Andrew/0000-0002-6312-4436; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Kouzarides, Tony/0000-0002-8918-4162	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	21	606	637	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					545	553		10.1016/j.cell.2004.08.020	http://dx.doi.org/10.1016/j.cell.2004.08.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339660	Bronze			2022-12-01	WOS:000223730300006
J	Galik, K; Senut, B; Pickford, M; Gommery, D; Treil, J; Kuperavage, AJ; Eckhardt, RB				Galik, K; Senut, B; Pickford, M; Gommery, D; Treil, J; Kuperavage, AJ; Eckhardt, RB			External and internal morphology of the BAR 1002 ' 00 Orrorin tugenensis femur	SCIENCE			English	Article							CORTICAL BONE; FEMORAL-NECK; HOMINID; MIOCENE	Late Miocene fossils from the Lukeino Formation in Kenya's Tugen Hills are assigned to Orrorin tugenensis. Of 20 fossils recovered there to date, 3 are proximal femurs. One of these, BAR 1002'00, preserves an intact head connected to the proximal shaft by an elongated neck. Although this fossil is comparable in size to Pan troglodytes, computerized tomography scans of the neck-shaft junction of BAR 1002'00 reveal that the cortex is markedly thinner superiorly than inferiorly, differing from the approximately equal cortical thicknesses observed in extant African apes, approaching the condition in later hominids, and indicating that O. tugenensis was bipedal.	Penn State Univ, Dept Kinesiol, Lab Comparat Morphol & Mech, University Pk, PA 16802 USA; Allegheny Gen Hosp, Orthopaed Biomech Lab, Pittsburgh, PA 15212 USA; Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terr, F-75231 Paris 05, France; Coll France, Chaire Paleonanthropol & Prehist, F-75231 Paris 05, France; CNRS, UPR 2147, F-75014 Paris, France; CNRS, GDR 983, F-75005 Paris, France; CNRS, UMR 8555, Serv Radiol, F-31300 Toulouse, France; Clin Pasteur, Serv Radiol, F-31300 Toulouse, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Allegheny General Hospital; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Eckhardt, RB (corresponding author), Penn State Univ, Dept Kinesiol, Lab Comparat Morphol & Mech, University Pk, PA 16802 USA.	eyl@psu.edu						BEGUN D, 2004, SCIENCE, V303, P1503; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; Meijering EHW, 2001, MED IMAGE ANAL, V5, P111, DOI 10.1016/S1361-8415(00)00040-2; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Rafferty KL, 1998, J HUM EVOL, V34, P361, DOI 10.1006/jhev.1997.0202; Sawada Y, 2002, CR PALEVOL, V1, P293, DOI 10.1016/S1631-0683(02)00036-2; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405	11	91	98	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1450	1453		10.1126/science.1098807	http://dx.doi.org/10.1126/science.1098807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353798				2022-12-01	WOS:000223761900044
J	Rajkovic, A; Pangas, SA; Ballow, D; Suzumori, N; Matzuk, MM				Rajkovic, A; Pangas, SA; Ballow, D; Suzumori, N; Matzuk, MM			NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression	SCIENCE			English	Article							TRANSCRIPTION FACTOR; GERM-CELLS; C-KIT; MICE; DIFFERENTIATION; LOCUS; MSY2	Primordial ovarian follicles in mice form when somatic cells surround individual oocytes. We show that lack of Nobox, an oocyte-specific homeobox gene, accelerates postnatal oocyte loss and abolishes the transition from primordial to growing follicles in mice. Follicles are replaced by fibrous tissue in female mice lacking Nobox in a manner similar to nonsyndromic ovarian failure in women. Genes preferentially expressed in oocytes, including Oct4 and Gdf9, are down-regulated in Nobox(-/-) mice, whereas ubiquitous genes such as Bmp4, Kit, and Bax remain unaffected. Therefore, Nobox is critical for specifying an oocyte-restricted gene expression pattern essential for postnatal follicle development.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rajkovic, A (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	rajkovic@bcm.tmc.edu		Pangas, Stephanie/0000-0001-5748-5844; Suzumori, Nobuhiro/0000-0001-9003-1289	NICHD NIH HHS [HD33438, HD007165, HD01426, HD42500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033438] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001426, R01HD042500, R37HD033438] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bachvarova R, 1985, Dev Biol (N Y 1985), V1, P453; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; MANOVA K, 1991, DEV BIOL, V146, P312, DOI 10.1016/0012-1606(91)90233-S; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	15	379	412	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1157	1159		10.1126/science.1099755	http://dx.doi.org/10.1126/science.1099755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326356				2022-12-01	WOS:000223557400049
J	Bouzat, C; Gumilar, F; Spitzmaul, G; Wang, HL; Rayes, D; Hansen, SB; Taylor, P; Sine, SM				Bouzat, C; Gumilar, F; Spitzmaul, G; Wang, HL; Rayes, D; Hansen, SB; Taylor, P; Sine, SM			Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING; MOLECULAR DISSECTION; SUBUNIT INTERFACES; IDENTIFICATION; RESIDUES; KINETICS; REVEALS; DOMAIN	Neurotransmitter receptors from the Cys-loop superfamily couple the binding of agonist to the opening of an intrinsic ion pore in the final step in rapid synaptic transmission. Although atomic resolution structural data have recently emerged for individual binding(1) and pore domains(2), how they are linked into a functional unit remains unknown. Here we identify structural requirements for functionally coupling the two domains by combining acetylcholine (ACh)-binding protein, whose structure was determined at atomic resolution(1), with the pore domain from the serotonin type-3A (5-HT3A) receptor. Only when amino-acid sequences of three loops in ACh-binding protein are changed to their 5-HT3A counterparts does ACh bind with low affinity characteristic of activatable receptors, and trigger opening of the ion pore. Thus functional coupling requires structural compatibility at the interface of the binding and pore domains. Structural modelling reveals a network of interacting loops between binding and pore domains that mediates this allosteric coupling process.	Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; Univ Nacl Sur, CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Mayo Clinic; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; University of California System; University of California San Diego	Sine, SM (corresponding author), Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	sine@mayo.edu	, Diego/AAH-4523-2020; Spitzmaul, Guillermo/AAM-4785-2021	Spitzmaul, Guillermo/0000-0001-5123-8914; Gumilar, Fernanda/0000-0002-7789-2647				Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LEE BS, 1991, J BIOL CHEM, V266, P11448; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Spitzmaul G, 2001, MOL PHARMACOL, V60, P235, DOI 10.1124/mol.60.2.235; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326	27	230	234	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					896	900		10.1038/nature02753	http://dx.doi.org/10.1038/nature02753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318223				2022-12-01	WOS:000223369800043
J	Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA				Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA			Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; EVENTS; CARE	Objectives To characterise the incidence and nature of medication errors during paediatric resuscitations. Design A prospective observational study of simulated emergencies. Setting Emergency department of a tertiary paediatric hospital. Participants Teams that included a clinician who commonly leads "real" resuscitations, at least two assisting physicians, and two or three paediatric nurses. Interventions The teams conducted eight mock resuscitations, including ordering medications. Exercises were videotaped and drugs ordered and administered during the resuscitation were recorded. Syringes and drugs prepared during the resuscitation were collected and analysed for concentrations and actual amounts. Main outcome measures Number and type of drug errors. Results Participants gave 125 orders for medications. In 21 (17%) of the orders the exact dose was not specified. Nine dosing errors occur-red during the ordering phase. Of these errors, five were intercepted before the drug reached the patient. Four 10-fold errors were identified. In nine (16%) out of 58 syringes analysed, measured drug concentrations showed a deviation of at least 20% from the ordered dose. A large deviation (at least 50%) from the expected dose was found in four (7%) cases. Conclusions Medication errors commonly occur during all stages of paediatric resuscitation. Many errors could be detected only by analysing syringe content, suggesting that such errors may be a major source of morbidity and mortality in resuscitated children.	Hosp Sick Children, Div Paediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pharm, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Clin Biochem, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kozer, E (corresponding author), Assaf Harofeh Med Ctr, Paediat Emergency Serv, IL-70300 Zerifin, Israel.	erank@asaf.health.gov.il	Parshuram, Christopher/AAI-6669-2020; Koren, Gideon/AAG-7726-2019	Parshuram, Christopher/0000-0002-7744-481X; Koren, Gideon/0000-0002-9234-0875				Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; KOREN G, 1994, J CLIN PHARMACOL, V34, P1043, DOI 10.1002/j.1552-4604.1994.tb01978.x; Kozer E, 2002, PEDIATRICS, V110, P737, DOI 10.1542/peds.110.4.737; Kozer E, 2002, NEW ENGL J MED, V346, P1175, DOI 10.1056/NEJM200204113461518; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1998, ARCH PEDIAT ADOL MED, V152, P340; Parshuram CS, 2003, CRIT CARE MED, V31, P2483, DOI 10.1097/01.CCM.0000089638.83803.B2; Schindler MB, 1996, NEW ENGL J MED, V335, P1473, DOI 10.1056/NEJM199611143352001; Shah AN, 2003, ARCH PEDIAT ADOL MED, V157, P229, DOI 10.1001/archpedi.157.3.229; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857	11	86	89	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1321	1324		10.1136/bmj.38244.607083.55	http://dx.doi.org/10.1136/bmj.38244.607083.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15454495	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000225657800020
J	Dayan, L; Donovan, B				Dayan, L; Donovan, B			Chlamydia, gonorrhoea, and injectable progesterone	LANCET			English	Editorial Material							CONTRACEPTIVE USE; UNITED-STATES; DEPO-PROVERA; INFECTIONS; STORY		Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Royal N Shore Hosp, Sexual Hlth Serv, St Leonards, NSW 2065, Australia; Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	University of Sydney; Royal North Shore Hospital	Dayan, L (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	ldayan@doh.health.nsw.gov.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126				Cromer BA, 1998, J ADOLESCENT HEALTH, V23, P74, DOI 10.1016/S1054-139X(98)00030-5; Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415; KLITSCH M, 1993, FAM PLANN PERSPECT, V25, P37, DOI 10.2307/2135992; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Oddens BJ, 1997, J BIOSOC SCI, V29, P437, DOI 10.1017/S0021932097004379; RICHARD BW, 1987, ANN INTERN MED, V106, P886, DOI 10.7326/0003-4819-106-6-886; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726	7	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 16	2004	364	9443					1387	1388		10.1016/S0140-6736(04)17239-5	http://dx.doi.org/10.1016/S0140-6736(04)17239-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488203				2022-12-01	WOS:000224485300008
J	Friesema, ECH; Grueters, A; Biebermann, H; Krude, H; von Moers, A; Reeser, M; Barrett, TG; Mancilla, EE; Svensson, J; Kester, MHA; Kuiper, GGJM; Balkassmi, S; Uitterlinden, AG; Koehrle, J; Rodien, P; Halestrap, AP; Visser, T				Friesema, ECH; Grueters, A; Biebermann, H; Krude, H; von Moers, A; Reeser, M; Barrett, TG; Mancilla, EE; Svensson, J; Kester, MHA; Kuiper, GGJM; Balkassmi, S; Uitterlinden, AG; Koehrle, J; Rodien, P; Halestrap, AP; Visser, T			Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation	LANCET			English	Article								Monocarboxylate transporter 8 (MCT8) is a thyroid hormone transporter, the gene of which is located on the X chromosome. We tested whether mutations in MCT8 cause severe psychomotor retardation and high serum triiodothyronine (T,) concentrations in five unrelated young boys. The coding sequence of MCT8 was analysed by PCR and direct sequencing of its six exons. In two patients, gene deletions of 2.4 kb and 24 kb were recorded and in three patients missense mutations Ala150Va1, Arg171stop, and Leu397Pro were identified. We suggest that this novel syndrome of X-linked psychomotor retardation is due to a defect in T-3 entry into neurons through MCT8, resulting in impaired T-3 action and metabolism.	Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; Humboldt Univ, Dept Paediat Endocrinol, Charite Childrens Hosp, Berlin, Germany; Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands; Birmingham Childrens Hosp, Dept Endocrinol, Birmingham, W Midlands, England; Univ Chile, Inst Biomed Sci, Santiago, Chile; Malmo Univ Hosp, Dept Paediat, Malmo, Sweden; Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; CHU Angers, INSERM, U0018, EMI, Angers, France; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Birmingham; Universidad de Chile; Lund University; Skane University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Bristol	Visser, T (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	t.j.visser@erasmusmc.nl	Barrett, Timothy/F-1682-2010; Visser, Theo J/C-8059-2013; Halestrap, Andrew P/G-7275-2011; Rodien, Patrice/AAT-7909-2021; Köhrle, Josef/AAH-6438-2020	Barrett, Timothy/0000-0002-6873-0750; Visser, Theo J/0000-0002-6997-284X; Köhrle, Josef/0000-0002-9187-9078; Svensson, Johan/0000-0003-4313-1521; Biebermann, Heike/0000-0002-2024-7778; Halestrap, Andrew/0000-0001-5374-2778				Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; de Escobar GM, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI 10.1210/jc.85.11.3975; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Hennemann G, 2001, ENDOCR REV, V22, P451, DOI 10.1210/er.22.4.451; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0	7	469	483	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2004	364	9443					1435	1437		10.1016/S0140-6736(04)17226-7	http://dx.doi.org/10.1016/S0140-6736(04)17226-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862IX	15488219				2022-12-01	WOS:000224485300030
J	Goodman, MB				Goodman, MB			Deconstructing C-elegans sensory mechanotransduction	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SENSITIVITY; CHANNEL; NEURONS		Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Goodman, MB (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272				Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Brown A, UNPUB; *CDCP, 2004, NAT DIAB FACT SHEET; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hardie RC, 2001, J EXP BIOL, V204, P3403; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; MENDELSON M, 1964, SCIENCE, V144, P554, DOI 10.1126/science.144.3618.554; OHAGAN R, UNPUB; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015	14	1	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					427	428		10.1126/science.1105624	http://dx.doi.org/10.1126/science.1105624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486284				2022-12-01	WOS:000224626500036
J	Hall, DA; Zhu, H; Zhu, XW; Royce, T; Gerstein, M; Snyder, M				Hall, DA; Zhu, H; Zhu, XW; Royce, T; Gerstein, M; Snyder, M			Regulation of gene expression by a metabolic enzyme	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; BUDDING YEAST; COMPLEX; IDENTIFICATION; TRANSCRIPTION; PROMOTER; PROTEINS; PROTEOME; BINDING	Gene expression in eukaryotes is normally believed to be controlled by transcriptional regulators that activate genes encoding structural proteins and enzymes. To identify previously unrecognized DNA binding activities, a yeast proteome microarray was screened with DNA probes; Arg5,6, a well-characterized mitochondrial enzyme involved in arginine biosynthesis, was identified. Chromatin immunoprecipitation experiments revealed that Arg5,6 is associated with specific nuclear and mitochondrial loci in vivo, and Arg5,6 binds to specific fragments in vitro. Deletion of Arg5,6 causes altered transcript levels of both nuclear and mitochondrial target genes. These results indicate that metabolic enzymes can directly regulate eukaryotic gene expression.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	michael.snyder@yale.edu		Snyder, Michael/0000-0003-0784-7987; Zhu, Xiaowei/0000-0002-5731-3177				Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Bateman JM, 2002, GENETICS, V161, P1043; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Guillamon JM, 2001, FEMS YEAST RES, V1, P169, DOI 10.1111/j.1567-1364.2001.tb00031.x; HICKE BJ, 1989, EMBO J, V8, P3843, DOI 10.1002/j.1460-2075.1989.tb08562.x; Hirose Y, 2000, GENE DEV, V14, P1415; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; MacIver FH, 1997, CURR GENET, V31, P119, DOI 10.1007/s002940050184; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; SCHMIDT WM, 1994, J MOL BIOL, V243, P157, DOI 10.1006/jmbi.1994.1642; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Turner BM, 2003, NAT CELL BIOL, V5, P390, DOI 10.1038/ncb0503-390; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; [No title captured]	22	179	197	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2004	306	5695					482	484		10.1126/science.1096773	http://dx.doi.org/10.1126/science.1096773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486299				2022-12-01	WOS:000224626500052
J	Muni, NI; Gross, TP				Muni, NI; Gross, TP			Problems with drug-eluting coronary stents - The FDA perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Muni, NI (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.							*FOOD DRUG ADM, 2004, TAXUS EXPR 2 PACL EL; *FOOD DRUG ADM, 2003, CYPHER SIR EL COR ST	2	41	47	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1593	1595		10.1056/NEJMp048262	http://dx.doi.org/10.1056/NEJMp048262			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483274				2022-12-01	WOS:000224427300002
J	Hu, D; Hook, EW; Goldie, SJ				Hu, D; Hook, EW; Goldie, SJ			Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; SEXUALLY-TRANSMITTED-DISEASES; DIRECT MEDICAL COST; UNITED-STATES; ASYMPTOMATIC WOMEN; YOUNG-WOMEN; FOLLOW-UP; INFECTION; PREVALENCE; TESTS	Background: Clinical guidelines have traditionally advised annual Chlamydia trachomatis screening for women younger than 25 years of age. Objective: To assess the cost-effectiveness of recently proposed strategies for chlamyclia screening. Design: State transition simulation model; cost-effectiveness analysis. Data Sources: Published literature. Target Population: Sexually active U.S. women 15 to 29 years of age. Time Horizon: Lifetime. Perspective: Modified societal. Interventions: Four strategies targeted to 3 specific age groups (15 to 19 years, 15 to 24 years, and 15 to 29 years): 1) no screening, 2) annual screening for all women, 3) annual screening followed by 1 repeated test within 3 to 6 months after a positive test result, and 4) annual screening followed by selective semiannual screening for women with a history of infection. Outcome Measures: Clinical events (for example, pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility), lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection was the most effective and cost-effective strategy. It consistently had an incremental cost-effectiveness ratio less than $25 000 per quality-adjusted life-year (QALY) compared with the next most effective strategy. When the indirect transmission effects of a 10-year screening program on the probability of infection in uninfected women (that is, per-susceptible rate of infection) were considered, all strategies became more cost-effective. Results of Sensitivity Analysis: Results were sensitive to the annual incidence of chlamyclia, probability of persistent infection, screening test costs, and costs of treating long-term complications. Each variable was associated with threshold values beyond which screening became cost-saving. In probabilistic analysis, annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection had an incremental cost-effectiveness ratio less than $50 000 per QALY in 99% of simulations. Limitations: Uncertainty about the natural history of chlamydial infection and consideration of only the indirect transmission effects of C. trachomatis screening. Conclusions: Annual C. trachomatis screening for all women 15 to 29 years of age and selective targeting of those with a history of infection for semiannual screening is very cost-effective compared with other well-accepted clinical interventions.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Alabama Birmingham, Birmingham, AL USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Alabama System; University of Alabama Birmingham	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.							Abma J C, 1997, Vital Health Stat 23, P1; Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; ARAL SO, 1991, JAMA-J AM MED ASSOC, V266, P2570, DOI 10.1001/jama.266.18.2570; Bachmann LH, 2003, SEX TRANSM DIS, V30, P20, DOI 10.1097/00007435-200301000-00005; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; Black CM, 2002, J CLIN MICROBIOL, V40, P3757, DOI 10.1128/JCM.40.10.3757-3763.2002; BRIHMER C, 1989, EUR J OBSTET GYN R B, V30, P263, DOI 10.1016/0028-2243(89)90011-7; Britton T F, 1992, Am J Gynecol Health, V6, P80; BUHAUG H, 1990, BRIT J GEN PRACT, V40, P142; BUHAUG H, 1989, MED CARE, V27, P833, DOI 10.1097/00005650-198908000-00007; Burstein GR, 2001, SEX TRANSM INFECT, V77, P26, DOI 10.1136/sti.77.1.26; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; *CDCP, 2001, CHL PREV MON PROJ S; *CDCP, 2001, TRACK HIDD EP TRENDS; *CDCP, 1996, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2016, DEV WAT MAN PROGR RE; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Dean D, 1998, J CLIN MICROBIOL, V36, P94, DOI 10.1128/JCM.36.1.94-99.1998; Edmunds WJ, 1999, STAT MED, V18, P3263, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3263::AID-SIM315&gt;3.0.CO;2-3; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gift TL, 2002, SEX TRANSM DIS, V29, P542, DOI 10.1097/00007435-200209000-00009; Goeree R, 2001, SEX TRANSM DIS, V28, P701, DOI 10.1097/00007435-200112000-00007; Gold MR., 1996, COST EFFECTIVENESS H; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; GOLDSMITH MF, 1986, JAMA-J AM MED ASSOC, V255, P1665, DOI 10.1001/jama.255.13.1665; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; HALVORSEN L E, 1988, Tidsskrift for den Norske Laegeforening, V108, P2706; HAMMERSCHLAG MR, 1999, SEXUALLY TRANSMITTED, P1155; HILLIS SD, 1995, FAM PLANN PERSPECT, V27, P108, DOI 10.2307/2136107; HILLIS SD, 1994, AM J OBSTET GYNECOL, V170, P801, DOI 10.1016/S0002-9378(94)70286-1; HILLIS SD, 1995, 11 M INT SOC STD RES, V267, P156; *HLTH CAR FIN ADM, 2000, MED B; Howell MR, 1999, SEX TRANSM DIS, V26, P519, DOI 10.1097/00007435-199910000-00007; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lawrence RS., 2000, VACCINES 21 CENTURY, P149; Magid D, 1996, ANN INTERN MED, V124, P389, DOI 10.7326/0003-4819-124-4-199602150-00002; MARDH PA, 1977, NEW ENGL J MED, V296, P1377, DOI 10.1056/NEJM197706162962403; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; MCCORMACK WM, 1979, NEW ENGL J MED, V300, P123, DOI 10.1056/NEJM197901183000305; *MED EC, 2000, DRUG TOP RED BOOK; Mertz KJ, 2002, SEX TRANSM DIS, V29, P271, DOI 10.1097/00007435-200205000-00004; Mertz KJ, 2001, AM J PUBLIC HEALTH, V91, P1287, DOI 10.2105/AJPH.91.8.1287; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Nsuami M, 2000, SEX TRANSM DIS, V27, P473, DOI 10.1097/00007435-200009000-00010; Oh MK, 1996, J ADOLESCENT HEALTH, V18, P270, DOI 10.1016/1054-139X(95)00232-H; Ostergaard L, 1998, BRIT MED J, V317, P26, DOI 10.1136/bmj.317.7150.26; PAAVONEN J, 1985, AM J OBSTET GYNECOL, V152, P280, DOI 10.1016/S0002-9378(85)80210-6; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Richey CM, 1999, SEX TRANSM DIS, V26, P4, DOI 10.1097/00007435-199901000-00002; Rietmeijer CA, 2002, SEX TRANSM DIS, V29, P65, DOI 10.1097/00007435-200202000-00001; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Schwebke JR, 1997, SEX TRANSM DIS, V24, P181, DOI 10.1097/00007435-199704000-00001; Shafer MAB, 1999, ARCH PEDIAT ADOL MED, V153, P119; *SIG HLTH CAR INF, 1994, MED REG GEP GEG 1993; SMITH TW, 1991, FAM PLANN PERSPECT, V23, P102, DOI 10.2307/2135820; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; STAMM WE, 1999, SEXUALLY TRANSMITTED, P407; STEECE R, 1997, NATL PRICING CHLAMYD; Stephen EH, 2000, FAM PLANN PERSPECT, V32, P132, DOI 10.2307/2648162; Tao G, 2002, SEX TRANSM DIS, V29, P703, DOI 10.1097/00007435-200211000-00014; TEISALA K, 1987, OBSTET GYNECOL, V69, P343; *US CENS BUR, 2000, STAT ABSTR US  2000; *US DEP LAB BUR LA, 2003, 952 US DEP LAB BUR L; VISCIDI RP, 1993, J INFECT DIS, V168, P488, DOI 10.1093/infdis/168.2.488; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2565, DOI 10.1001/jama.266.18.2565; WASHINGTON AE, 1984, JAMA-J AM MED ASSOC, V251, P2529, DOI 10.1001/jama.251.19.2529; WASHINGTON AE, 1986, JAMA-J AM MED ASSOC, V255, P1735, DOI 10.1001/jama.255.13.1735; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WESTROM LV, 1994, SEX TRANSM DIS, V21, pS32; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; WOLNERHANSSEN P, 1983, OBSTET GYNECOL, V61, P702; Yeh JM, 2003, SEX TRANSM DIS, V30, P369, DOI 10.1097/00007435-200305000-00001; 1997, MMWR MORB MORTAL WKL, V46, P193	86	102	103	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					501	513		10.7326/0003-4819-141-7-200410050-00006	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466767				2022-12-01	WOS:000224467800002
J	Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B				Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B			The PLETHORA genes mediate patterning of the Arabidopsis root stem cell niche	CELL			English	Article							DEPENDENT AUXIN GRADIENTS; RADIAL ORGANIZATION; RESPONSE FACTORS; EMBRYO; MONOPTEROS; MERISTEM; TRANSCRIPTION; SCARECROW; MUTATION; THALIANA	A small organizing center, the quiescent center (QC), maintains stem cells in the Arabidopsis root and defines the stem cell niche. The phytohormone auxin influences the position of this niche by an unknown mechanism. Here, we identify the PLETHORA1 (PLT1) and PLT2 genes encoding AP2 class putative transcription factors, which are essential for QC specification and stem cell activity. The PLT genes are transcribed in response to auxin accumulation and are dependent on auxin response transcription factors. Distal PLT transcript accumulation creates an overlap with the radial expression domains of SHORT-ROOT and SCARECROW, providing positional information for the stem cell niche. Furthermore, the PLT genes are activated in the basal embryo region that gives rise to hypocotyl, root, and root stem cells and, when ectopically expressed, transform apical regions to these identities. Thus, the PLT genes are key effectors for establishment of the stem cell niche during embryonic pattern formation.	Univ Utrecht, Dept Mol Cell Biol, NL-3514 CH Utrecht, Netherlands; Univ Mediterranee, UMR 163 CNRS, CEA,DSVDEVM, LBDP, F-13108 St Paul Les Durance, France; Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA	Utrecht University; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Padualaan 8, NL-3514 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Aida, Mitsuhiro/AAW-7703-2020; NUSSAUME, Laurent/AAB-8312-2020; NUSSAUME, Laurent/AAA-5980-2022	Aida, Mitsuhiro/0000-0001-9000-7502; NUSSAUME, Laurent/0000-0002-9445-2563; Scheres, Ben/0000-0001-5400-9578; Beis, Dimitris/0000-0003-2579-7848; Blilou, Ikram/0000-0001-8003-3782				Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BERLETH T, 1993, DEVELOPMENT, V118, P575; BRAND AH, 1993, DEVELOPMENT, V118, P401; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hobbie L, 2000, DEVELOPMENT, V127, P23; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MORRISON JFJ, 1995, PCR 2 PRACTICAL APPR, P165; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Parinov S, 1999, PLANT CELL, V11, P2263, DOI 10.1105/tpc.11.12.2263; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Weijers D, 2001, DEVELOPMENT, V128, P4289; Willemsen V, 1998, DEVELOPMENT, V125, P521; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	45	771	836	4	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					109	+		10.1016/j.cell.2004.09.018	http://dx.doi.org/10.1016/j.cell.2004.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454085	Green Published, Bronze			2022-12-01	WOS:000224292600013
J	Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA				Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA			MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation	CELL			English	Article							CLASS-II TRANSACTIVATOR; N-COR; HISTONE DEACETYLASE; PLASMA-CELLS; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; GENE-EXPRESSION; POZ DOMAIN; BCL-6; SMRT	The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/ NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Div Hematopathol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Wade, PA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pwade@emory.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X; jaye, david/0000-0001-7977-6909	NIAID NIH HHS [AI34000] Funding Source: Medline; NIDDK NIH HHS [DK60647, DK065961] Funding Source: Medline; NIGMS NIH HHS [GM20675, GM47310] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034000, R56AI034000, R01AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065961, K08DK060647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABTS H, 1989, J IMMUNOL METHODS, V125, P19, DOI 10.1016/0022-1759(89)90073-2; ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GAZDAR AF, 1986, BLOOD, V67, P1542; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HARRIS NS, 1974, NATURE, V250, P507, DOI 10.1038/250507a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jaye DL, 2003, AM J PATHOL, V162, P1419, DOI 10.1016/S0002-9440(10)64275-7; Jaye DL, 2001, J IMMUNOL, V166, P7250, DOI 10.4049/jimmunol.166.12.7250; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Leon RP, 1998, P NATL ACAD SCI USA, V95, P13159, DOI 10.1073/pnas.95.22.13159; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Niu HF, 2002, HEMATOL ONCOL, V20, P155, DOI 10.1002/hon.689; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Urnov FD, 2000, EMBO J, V19, P4074, DOI 10.1093/emboj/19.15.4074; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; YE BHH, 1993, CANCER RES, V53, P2732; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8	54	258	275	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					75	86		10.1016/j.cell.2004.09.014	http://dx.doi.org/10.1016/j.cell.2004.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454082	Bronze			2022-12-01	WOS:000224292600010
J	Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA				Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA			High-resolution structure of a retroviral capsid hexameric amino-terminal domain	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION COMPLEXES; MURINE LEUKEMIA-VIRUS; CA PROTEIN; HIV-1; CORE; REPLICATION; INFECTION; FRAGMENT; EXCHANGE	Retroviruses are the aetiological agents of a range of human diseases including AIDS and T-cell leukaemias. They follow complex life cycles, which are still only partly understood at the molecular level. Maturation of newly formed retroviral particles is an essential step in production of infectious virions, and requires proteolytic cleavage of Gag polyproteins in the immature particle to form the matrix, capsid and nucleocapsid proteins present in the mature virion(1). Capsid proteins associate to form a dense viral core(2) that may be spherical, cylindrical or conical depending on the genus of the virus(3). Nonetheless, these assemblies all appear to be composed of a lattice formed from hexagonal rings, each containing six capsid monomers(2,4,5). Here, we describe the X-ray structure of an individual hexagonal assembly from N-tropic murine leukaemia virus (N-MLV). The interface between capsid monomers is generally polar, consistent with weak interactions within the hexamer. Similar architectures are probably crucial for the regulation of capsid assembly and disassembly in all retroviruses. Together, these observations provide new insights into retroviral uncoating and how cellular restriction factors may interfere with viral replication.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England; Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Taylor, IA (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	itaylor@nimr.mrc.ac.uk		Stoye, Jonathan/0000-0003-3377-323X; Smerdon, Stephen/0000-0001-5688-8465				Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; BOONE LR, 1983, J VIROL, V48, P110, DOI 10.1128/JVI.48.1.110-119.1983; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nandhagopal N, 2004, J MOL BIOL, V335, P275, DOI 10.1016/j.jmb.2003.10.034; Nermut MV, 1996, CURR TOP MICROBIOL, V214, P1; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swanstrom R, 1997, RETROVIRUSES; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; von Schwedler UK, 2000, EMBO J, V19, P2391, DOI 10.1038/sj.emboj.7593063; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555	31	161	162	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					481	485		10.1038/nature02915	http://dx.doi.org/10.1038/nature02915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386017				2022-12-01	WOS:000224000500047
J	Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG				Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG			Structural basis for allosteric control of the transcription regulator CcpA by the phosphoprotein HPr-Ser46-P	CELL			English	Article							CARBON CATABOLITE REPRESSION; GRAM-POSITIVE BACTERIA; CONTROL PROTEIN CCPA; BACILLUS-SUBTILIS; DNA-BINDING; HPR KINASE/PHOSPHORYLASE; PHOSPHOCARRIER PROTEIN; RESPONSIVE ELEMENTS; CRYSTAL-STRUCTURE; SENSOR ENZYME	Carbon catabolite repression (CCR) is one of the most fundamental environmental-sensing mechanisms in bacteria and imparts competitive advantage by establishing priorities in carbon metabolism. In gram-positive bacteria, the master transcription regulator of CCR is CcpA. CcpA is a Lacl-GaIR family member that employs, as an allosteric corepressor, the phosphoprotein HPr-Ser46-P, which is formed in glucose-replete conditions. Here we report structures of the Bacillus megaterium apoCcpA and a CcpA-(HPr-Ser46-P)-DNA complex. These structures reveal that HPr-Ser46-P mediates a novel two-component allosteric DNA binding activation mechanism that involves both rotation of the CcpA subdomains and relocation of pivot-point residue Thr61, which leads to juxtaposition of the DNA binding regions permitting "hinge" helix formation in the presence of cognate DNA. The structure of the CcpA-(HPr-Ser46-P)-cre complex also reveals the elegant mechanism by which CcpA family-specific interactions with HPr-Ser46-P residues Ser46-P and His15 partition the high-energy CCR and low-energy PTS pathways, the latter requiring HPr-His15-P.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, Inst Mikrobiol Biochem & Genet, D-91058 Erlangen, Germany	Oregon Health & Science University; University of Erlangen Nuremberg	Brennan, RG (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	brennanr@ohsu.edu		Brennan, Richard/0000-0001-7647-485X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593, T32AI007472] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07472, AI48593] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Audette GF, 2000, J MOL BIOL, V303, P545, DOI 10.1006/jmbi.2000.4166; Aung-Hilbrich LM, 2002, J MOL BIOL, V319, P77, DOI 10.1016/S0022-2836(02)00245-0; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chauvaux S, 1998, J BACTERIOL, V180, P491, DOI 10.1128/JB.180.3.491-497.1998; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; GALINIER A, 1997, P NATL ACAD SCI USA, V94, P8739; Gosseringer R, 1997, J MOL BIOL, V266, P665, DOI 10.1006/jmbi.1996.0820; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henkin TM, 1996, FEMS MICROBIOL LETT, V135, P9; Jones BE, 1997, PROTEIN SCI, V6, P2107; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim JH, 1998, P NATL ACAD SCI USA, V95, P9590, DOI 10.1073/pnas.95.16.9590; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Magasanik B, 1970, LACTOSE OPERON, P189; Miwa Y, 2001, J BACTERIOL, V183, P5877, DOI 10.1128/JB.183.20.5877-5884.2001; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1111/j.1365-2958.2001.02328.x; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Steinhauer K, 2002, ACTA CRYSTALLOGR D, V58, P515, DOI 10.1107/S090744490102145X; Stulke J, 2000, ANNU REV MICROBIOL, V54, P849, DOI 10.1146/annurev.micro.54.1.849; Stulke J, 1998, NATURWISSENSCHAFTEN, V85, P583, DOI 10.1007/s001140050555; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEICKERT MJ, 1990, P NATL ACAD SCI USA, V87, P6238, DOI 10.1073/pnas.87.16.6238; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Yuan YP, 1998, BIOINFORMATICS, V14, P285, DOI 10.1093/bioinformatics/14.3.285; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x; Zalieckas JM, 1999, J BACTERIOL, V181, P2883, DOI 10.1128/JB.181.9.2883-2888.1999	47	134	140	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					731	741		10.1016/j.cell.2004.08.027	http://dx.doi.org/10.1016/j.cell.2004.08.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369672	Bronze			2022-12-01	WOS:000223992400009
J	Christian, P; Khatry, SK; West, KP				Christian, P; Khatry, SK; West, KP			Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal	LANCET			English	Article							PREGNANT-WOMEN; SUPPLEMENTATION; THERAPY; ANEMIA; PLAINS; TRIAL	Anthelmintic treatment, which is recommended during pregnancy in areas where there is a high rate of anaemia, needs further investigation. We examined prospectively the association between anthelmintic treatment and maternal anaemia, birthweight, and infant mortality in a study of prenatal supplements, in which women received albendazole twice during pregnancy. Women given albendazole in the second trimester of pregnancy had a lower rate of severe anaemia during the third trimester. Birthweight of infants of women who had received two doses of albendazole rose by 59 g (95% CI 19-98), and infant mortality at 6 months fell by 41% (RR 0 . 59; 95% Cl 0 . 43-0.82). Antenatal anthelmintics could be effective in reducing maternal anaemia and improving birthweight and infant survival in hookworm-endemic regions.	Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Program Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; Ctr Human Nutr, Baltimore, MD USA; Soc Prevent Blindness, Nepal Nutr Intervent Project, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Christian, P (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Program Human Nutr, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	pchristi@jhsph.edu						ATUKORALA TMS, 1994, AM J CLIN NUTR, V60, P286, DOI 10.1093/ajcn/60.2.286; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Navitsky RC, 1998, J PARASITOL, V84, P647, DOI 10.2307/3284746; Stoltzfus RJ, 1998, GUIDELINES USE IRON	7	132	137	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					981	983		10.1016/S0140-6736(04)17023-2	http://dx.doi.org/10.1016/S0140-6736(04)17023-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364190				2022-12-01	WOS:000223831000029
J	Lin, HK; Bergmann, S; Pandolfi, PP				Lin, HK; Bergmann, S; Pandolfi, PP			Cytoplasmic PML function in TGF-beta signalling	NATURE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; MONOCYTIC DIFFERENTIATION; PREMATURE SENESCENCE; TUMOR SUPPRESSION; ANDROGEN RECEPTOR; PROTEIN ISOFORMS; ONCOGENIC RAS; CANCER-CELLS; GROWTH; ALPHA	Transforming growth factor beta (TGF-beta) is a pluripotent cytokine that controls key tumour suppressive functions(1-3), but cancer cells are often unresponsive to it(1,4). The promyelocytic leukaemia (PML) tumour suppressor of acute promyelocytic leukaemia (APL) accumulates in the PML nuclear body, but cytoplasmic PML isoforms of unknown function have also been described(5,6). Here we show that cytoplasmic Pml is an essential modulator of TGF-beta signalling. Pml-null primary cells are resistant to TGF-beta-dependent growth arrest, induction of cellular senescence and apoptosis. These cells also have impaired phosphorylation and nuclear translocation of the TGF-beta signalling proteins Smad2 and Smad3, as well as impaired induction of TGF-beta target genes. Expression of cytoplasmic Pml is induced by TGF-beta. Furthermore, cytoplasmic PML physically interacts with Smad2/3 and SARA (Smad anchor for receptor activation) and is required for association of Smad2/3 with SARA and for the accumulation of SARA and TGF-beta receptor in the early endosome. The PML-RARalpha oncoprotein of APL can antagonize cytoplasmic PML function and APL cells have defects in TGF-beta signalling similar to those observed in Pml-null cells. Our findings identify cytoplasmic PML as a critical TGF-beta regulator, and further implicate deregulated TGF-beta signalling in cancer pathogenesis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org						Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; ESCOLA JM, 1995, J CELL SCI, V108, P2337; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Ferbeyre G, 2000, GENE DEV, V14, P2015; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TESTA U, 1993, J IMMUNOL, V150, P2418; TESTA U, 1994, CANCER RES, V54, P4508; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, SCIENCE, V279, P1547; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	30	251	273	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					205	211		10.1038/nature02783	http://dx.doi.org/10.1038/nature02783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356634				2022-12-01	WOS:000223746000049
J	Painter, TM; Diaby, KL; Matia, DM; Lin, LS; Sibailly, TS; Kouassi, MK; Ekpini, ER; Roels, TH; Wiktor, SZ				Painter, TM; Diaby, KL; Matia, DM; Lin, LS; Sibailly, TS; Kouassi, MK; Ekpini, ER; Roels, TH; Wiktor, SZ			Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT-COURSE ZIDOVUDINE; COTE-DIVOIRE; PREGNANT-WOMEN; ORAL ZIDOVUDINE; BURKINA-FASO; ACCEPTABILITY; ABIDJAN; INTERVENTIONS; COHORT; RETURN	Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Cote d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; US Embasy, CDC HIV, Projet RETRO CI, Abidjan 1712 01, Cote Ivoire; WHO, Div HIV AIDS, CH-1211 Geneva 27, Switzerland; US Embassy, Ctr Dis Control & Prevent, Global AIDS Program, Kigali, Rwanda; BOTUSA Project, Global AIDS Program, Gaborone, Botswana	Centers for Disease Control & Prevention - USA; World Health Organization	Painter, TM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd NE,Mail Stop E-37, Atlanta, GA 30333 USA.	tcp2@cdc.gov		Roels, Thierry/0000-0002-0886-5645				Allen S., 1999, PREVENTING HIV DEV C, P87; Carr R, 1998, FASEB J, V12, pA1; Cartoux M, 1998, AIDS, V12, P2489, DOI 10.1097/00002030-199818000-00019; Cartoux M, 1998, AIDS, V12, P2337, DOI 10.1097/00002030-199817000-00016; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DEKONINCK M, 1997, RECHERCHES FEMINISTE, V10, P97; Ekouevi DK, 2004, JAIDS-J ACQ IMM DEF, V36, P755, DOI 10.1097/00126334-200406010-00014; EZOUA J, 2001, 12 INT C AIDS STD AF; Farquhar C., 2000, 13 INT AIDS C DURB S; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Issiaka S, 2001, AIDS CARE, V13, P123, DOI 10.1080/09540120020018224; Kiarie J, 2000, AIDS, V14, P1468, DOI 10.1097/00002030-200007070-00030; Ladner J, 1996, AIDS, V10, P69, DOI 10.1097/00002030-199601000-00010; Malonza IA, 2003, AIDS, V17, P113, DOI 10.1097/00002030-200301030-00015; McKenna SL, 1997, AIDS, V11, pS103; MOUZIN E, 2001, MTCT NEWS 2001, P2; Msellati P, 2001, B WORLD HEALTH ORGAN, V79, P641; MWAI C, 2001, 3 C GLOB STRAT PREV; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Prual A, 2000, HEALTH POLICY PLANN, V15, P11, DOI 10.1093/heapol/15.1.11; Seidel G, 2000, HEALTH POLICY PLANN, V15, P24, DOI 10.1093/heapol/15.1.24; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SIBAILLY TS, 2000, 13 INT AIDS C DURB S; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Wilkinson D, 1997, HEALTH POLICY PLANN, V12, P161, DOI 10.1093/heapol/12.2.161	29	76	77	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2004	329	7465					543	546		10.1136/bmj.329.7465.543	http://dx.doi.org/10.1136/bmj.329.7465.543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853DE	15345628	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000223805800019
J	Li, L; Thomas, RM; Suzuki, H; De Brabander, JK; Wang, XD; Harran, PG				Li, L; Thomas, RM; Suzuki, H; De Brabander, JK; Wang, XD; Harran, PG			A small molecule Smac mimic potentiates TRAIL- and TNF alpha-mediated cell death	SCIENCE			English	Article							APOPTOSIS PROTEIN; STRUCTURAL BASIS; INHIBITOR; SMAC/DIABLO; EXPRESSION; BINDING; IDENTIFICATION; SUPPRESSION; ACTIVATION; C-IAP2	We describe the synthesis and properties of a small molecule mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity. The compound binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (clAP-1), and cellular IAP 2 (clAP-2) and synergizes with both tumor necrosis factor alpha (TNFalpha.) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells. The molecule has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors. The compound is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.	Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	De Brabander, JK (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jdebra@biochem.swmed.edu; xwang@biochem.swmed.edu; pharra@biochem.swmed.edu			NCI NIH HHS [P01 CA95471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; BERSCHEID R, 1992, SYNTHESIS-STUTTGART, P58; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fox DA, 2000, ARCH INTERN MED, V160, P437, DOI 10.1001/archinte.160.4.437; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Imoto I, 2001, CANCER RES, V61, P6629; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang LL, 2003, CANCER RES, V63, P831	25	565	629	8	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1471	1474		10.1126/science.1098231	http://dx.doi.org/10.1126/science.1098231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	852NK	15353805				2022-12-01	WOS:000223761900051
J	Tzfira, T; Vaidya, M; Citovsky, V				Tzfira, T; Vaidya, M; Citovsky, V			Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium	NATURE			English	Article							T-DNA TRANSFER; NUCLEAR-LOCALIZATION SIGNAL; NOPALINE STRAINS; BINDING-PROTEIN; VIRULENCE GENE; A-TUMEFACIENS; VIRD2 PROTEIN; CELLS; HOST; VIRE2	Genetic transformation of plant cells by Agrobacterium represents a unique case of trans-kingdom DNA transfer(1). During this process, Agrobacterium exports its transferred ( T) DNA and several virulence (Vir) proteins into the host cell(2), within which T-DNA nuclear import is mediated by VirD2 (ref. 3) and VirE2 ( ref. 4) and their host cell interactors AtKAP-alpha(5) and VIP1 (ref. 6), whereas its integration is mediated mainly by host cell proteins(7-9). The factors involved in the uncoating of T-DNA from its cognate proteins, which occurs before integration into the host genome, are still unknown. Here, we report that VirF - one of the few known exported Vir proteins whose function in the host cell remains unknown - is involved in targeted proteolysis of VIP1 and VirE2. We show that VirF localizes to the plant cell nucleus and interacts with VIP1, a nuclear protein. VirF, which contains an F-box motif(10), significantly destabilizes both VIP1 and VirE2 in yeast cells. Destabilization of VIP1 in the presence of VirF was then confirmed in planta. These results suggest that VIP1 and its cognate VirE2 are specifically targeted by the VirF-containing Skp1-Cdc53-cullin-F-box complex for proteolysis. The critical role of proteasomal degradation in Agrobacterium-mediated genetic transformation was also evident from inhibition of T-DNA expression by a proteasomal inhibitor.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Tzfira, T (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	ttzfira@ms.cc.sunysb.edu		Citovsky, Vitaly/0000-0003-2024-6844				Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; del Pozo JC, 2000, PLANT MOL BIOL, V44, P123, DOI 10.1023/A:1006413007456; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; DOMMISSE EM, 1990, PLANT SCI, V69, P249, DOI 10.1016/0168-9452(90)90124-7; Gelvin SB, 2000, ANNU REV PLANT PHYS, V51, P223, DOI 10.1146/annurev.arplant.51.1.223; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; HOWARD EA, 1992, CELL, V68, P109, DOI 10.1016/0092-8674(92)90210-4; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JARCHOW E, 1991, P NATL ACAD SCI USA, V88, P10426, DOI 10.1073/pnas.88.23.10426; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; MELCHERS LS, 1990, PLANT MOL BIOL, V14, P249, DOI 10.1007/BF00018565; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; OTTEN L, 1984, MOL GEN GENET, V195, P159, DOI 10.1007/BF00332739; REGENSBURGTUINK AJG, 1993, NATURE, V363, P69, DOI 10.1038/363069a0; Schrammeijer B, 1998, MOL PLANT MICROBE IN, V11, P429, DOI 10.1094/MPMI.1998.11.5.429; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; STACHEL SE, 1989, NATURE, V340, P190, DOI 10.1038/340190a0; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	30	186	207	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					87	92		10.1038/nature02857	http://dx.doi.org/10.1038/nature02857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343337				2022-12-01	WOS:000223641500047
J	Pignone, M				Pignone, M			Faecal occult-blood screening in Burgundy	LANCET			English	Editorial Material							COLORECTAL-CANCER MORTALITY		Univ N Carolina, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27707 USA; Cecil Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27707 USA	University of North Carolina; University of North Carolina Chapel Hill	Pignone, M (corresponding author), Univ N Carolina, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27707 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342				Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Steele RJC, 2004, BMJ-BRIT MED J, V329, P133, DOI 10.1136/bmj.38153.491887.7C; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559	7	3	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 28	2004	364	9436					741	742		10.1016/S0140-6736(04)16953-5	http://dx.doi.org/10.1016/S0140-6736(04)16953-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337388				2022-12-01	WOS:000223569600009
J	Neumann, HPH; Pawlu, C; Peczkowska, M; Bausch, B; MeWhinney, SR; Muresan, M; Buchta, M; Franke, G; Klisch, J; Bley, TA; Hoegerle, S; Boedeker, CC; Opocher, G; Schipper, J; Januszewicz, A; Eng, C				Neumann, HPH; Pawlu, C; Peczkowska, M; Bausch, B; MeWhinney, SR; Muresan, M; Buchta, M; Franke, G; Klisch, J; Bley, TA; Hoegerle, S; Boedeker, CC; Opocher, G; Schipper, J; Januszewicz, A; Eng, C		European-Amer Paraganglioma Study Grp	Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOCRINE NEOPLASIA TYPE-2; GERM-LINE MUTATIONS; COMPLEX-II GENE; HEREDITARY PARAGANGLIOMAS; PHEOCHROMOCYTOMA; MULTIPLE; SUSCEPTIBILITY; DISEASE; SURGERY; PET	Context Germline mutations of the genes encoding succinate dehydrogenase subunits B (SDHB) and D. (SDHD) predispose to paraganglioma syndromes type 4 (PGL-4) and type 1 (PGL-1), respectively. In both syndromes, pheochromocytomas as well as head and neck paragangliomas occur; however, details for individual risks and other clinical characteristics are unknown. Objective To determine the differences in clinical features in carriers of SDHB mutations and SDHD mutations. Design, Setting, and Patients Population-based genetic screening for SDHB and SDHD germline mutations in 417 unrelated patients with adrenal or extra-adrenal abdominal or thoracic pheochromocytomas (n =334) or head and neck paragangliomas (n =83), but without syndromic features, from 2 registries based in Germany and central Poland, conducted from April 1, 2000, until May 15, 2004. Main Outcome Measures Demographic and clinical findings with respect to gene mutation in SDHB vs SDHD compared with nonmutation carriers. Results A total of 49 (12%) of 417 registrants carried SDHB or SDHD mutations. In addition, 28 SDHB and 23 SDHD mutation carriers were newly detected among relatives of these carriers. Comparison of 53 SDHB and 47 SDHD total mutation carriers showed similar ages at diagnosis but differences in penetrance and of tumor manifestations. Head and neck paragangliomas (10/32 vs 27/34, respectively, P<.001) and multifocal (9/32 vs 25/34, respectively, P<.001) tumors were more frequent in carriers of SDHD mutations. In contrast, SDHB mutation carriers have an increased frequency of malignant disease (11/32 vs 0/34, P<.001). Renal cell cancer was observed in 2 SDHB mutation carriers and papillary thyroid cancer in 1 SDHB mutation carrier and 1 SDHD mutation carrier. Conclusions In contrast with SDHD mutation carriers (PGL-1) who have more frequent multifocal paragangliomas, SDHB mutation carriers (PGL-4) are more likely to develop malignant disease and possibly extraparaganglial neoplasias, including renal cell and thyroid carcinomas. Appropriate and timely clinical screening is recommended in all patients with PGL-1 and PGL-4.	Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Neuroradiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Diagnost Radiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Nucl Med, D-79106 Freiburg, Germany; Univ Freiburg, Dept Otorhinolaryngol, D-79106 Freiburg, Germany; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Nancy, Hop Brabois, Dept Endocrinol, Nancy, France; Univ Padua, Dept Endocrinol, Padua, Italy	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Institute of Cardiology - Poland; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; CHU de Nancy; Universite de Lorraine; University of Padua	Neumann, HPH (corresponding author), Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany.	neumann@med1.ukl.uni-freiburg.de	Opocher, Giuseppe/F-3950-2014	Opocher, Giuseppe/0000-0002-9845-9623; Eng, Charis/0000-0002-3693-5145	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA16058] Funding Source: Medline; NICHD NIH HHS [R01HD39058-02, R01HD39058-02S1] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Badenhop RF, 2001, GENE CHROMOSOME CANC, V31, P255, DOI 10.1002/gcc.1142; Bauters C, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.6.e75; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; BAYSAL BE, IN PRESS J MED GENET; Cascon A, 2002, EUR J HUM GENET, V10, P457, DOI 10.1038/sj.ejhg.5200829; Eisenhofer G, 1999, NEW ENGL J MED, V340, P1872, DOI 10.1056/NEJM199906173402404; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Gimm O, 2000, CANCER RES, V60, P6822; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Hoegerle S, 2003, EUR J NUCL MED MOL I, V30, P689, DOI 10.1007/s00259-003-1115-3; Hoegerle S, 2002, RADIOLOGY, V222, P507, DOI 10.1148/radiol.2222010622; Janetschek G, 1998, J UROLOGY, V160, P330, DOI 10.1016/S0022-5347(01)62886-6; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; NEUMANN HPH, 1993, NEW ENGL J MED, V329, P1531, DOI 10.1056/NEJM199311183292103; Neumann HPH, 1999, BRIT J SURG, V86, P94, DOI 10.1046/j.1365-2168.1999.00974.x; Neumann HPH, 1999, J CLIN ENDOCR METAB, V84, P2608, DOI 10.1210/jc.84.8.2608; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Niemann S, 2003, HUM GENET, V113, P92, DOI 10.1007/s00439-003-0938-0; Pacak K, 2001, HYPERTENSION, V38, P6, DOI 10.1161/01.HYP.38.1.6; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P553, DOI 10.1210/jc.2002-021251; Taschner PEM, 2001, GENE CHROMOSOME CANC, V31, P274, DOI 10.1002/gcc.1144; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Walz MK, 2002, WORLD J SURG, V26, P1005, DOI 10.1007/s00268-002-6632-x	33	657	683	3	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					943	951		10.1001/jama.292.8.943	http://dx.doi.org/10.1001/jama.292.8.943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WR	15328326	Bronze			2022-12-01	WOS:000223429200019
J	Lewis, T				Lewis, T			10-minute consultation - Using the NO TEARS tool for medication review	BRITISH MEDICAL JOURNAL			English	Article									Carreg Wen Surg, Torfaen NP4 9AF, Wales		Lewis, T (corresponding author), Carreg Wen Surg, Torfaen NP4 9AF, Wales.	Tessa.Lewis@gp-w93015.wales.nhs.uk							0	30	30	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					434	434		10.1136/bmj.329.7463.434	http://dx.doi.org/10.1136/bmj.329.7463.434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15321901	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000223520300020
J	Araki, T; Sasaki, Y; Milbrandt, J				Araki, T; Sasaki, Y; Milbrandt, J			Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration	SCIENCE			English	Article							WALLERIAN DEGENERATION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; PROTEIN; DEACETYLASE; NEUROPROTECTION; INHIBITORS; LONGEVITY; FAMILY; YEAST	Axonal degeneration is an active program of self-destruction that is observed in many physiological and pathological settings. In Wallerian degeneration slow (wld(s)) mice, Wallerian degeneration in response to axonal injury is delayed because of a mutation that results in overexpression of a chimeric protein (Wld(s)) composed of the ubiquitin assembly protein Ufd2a and the nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme Nmnat1. We demonstrate that increased Nmnat activity is responsible for the axon-sparing activity of the Wlds protein. Furthermore, we demonstrate that SIRT1, a mammalian ortholog of Sir2, is the downstream effector of increased Nmnat activity that leads to axonal protection. These findings suggest that novel therapeutic strategies directed at increasing the supply of NAD and/or Sir2 activation may be effective for treatment of diseases characterized by axonopathy and neurodegeneration.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG013730] Funding Source: NIH RePORTER; NIA NIH HHS [AG05681, AG13730] Funding Source: Medline; NINDS NIH HHS [NS40745] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ARAKI T, UNPUB; Bruzzone S, 2001, FASEB J, V15, P10; Buck SW, 2004, J LEUKOCYTE BIOL, V75, P939, DOI 10.1189/jlb.0903424; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; COLEMAN MP, TRENDS NEUROSCI, V25, P532; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; SKAPER SD, 2003, ANN NY ACAD SCI, V993, P287; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	28	855	912	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1010	1013		10.1126/science.1098014	http://dx.doi.org/10.1126/science.1098014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310905				2022-12-01	WOS:000223250700050
J	Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE				Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE			Modulation of hematopoietic stem cell homing and engraftment by CD26	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; MYELOID PROGENITOR CELLS; BONE-MARROW; FACTOR-I; COMPETITIVE REPOPULATION; NOD/SCID MICE; CXCR4; TRANSPLANTATION; MOBILIZATION; ASSAY	Hematopoietic stem cell homing and engraftment are crucial to transplantation efficiency, and clinical engraftment is severely compromised when donor-cell numbers are limiting. The peptidase CD26 (DPPIV/dipeptidylpeptidase IV) removes dipeptides from the amino terminus of proteins. We present evidence that endogenous CD26 expression on donor cells negatively regulates homing and engraftment. By inhibition or deletion of CD26, it was possible to increase greatly the efficiency of transplantation. These results suggest that hematopoietic stem cell engraftment is not absolute, as previously suggested, and indicate that improvement of bone marrow transplant efficiency may be possible in the clinic.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46208 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067384, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519, R01DK053674] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL67384, R01 HL56416] Funding Source: Medline; NIDDK NIH HHS [T32 DK07519, R01 DK53674] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2002, BLOOD, V100, p609A; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BROXMEYER HE, 2004, THOMAS HEMATOPOIETIC, P550; Christopherson KW, 2003, EXP HEMATOL, V31, P1126, DOI 10.1016/j.exphem.2003.07.002; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Ema H, 2004, IMMUNITY, V20, P1, DOI 10.1016/S1074-7613(04)00002-0; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1980, BLOOD, V55, P77; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995	30	406	431	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1000	1003		10.1126/science.1097071	http://dx.doi.org/10.1126/science.1097071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310902				2022-12-01	WOS:000223250700047
J	Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG				Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG			Discovery of symbiotic nitrogen-fixing cyanobacteria in corals	SCIENCE			English	Article							FLUORESCENT PROTEINS; MARINE CYANOBACTERIUM; DIVERSITY; FIXATION; BACTERIA; PHOTOSYNTHESIS; PHYCOERYTHRIN; EMISSION; FAMILY; LIGHT	Colonies of the Caribbean coral Montastraea cavernosa exhibit a solar-stimulated orange-red fluorescence that is spectrally similar to a variety of fluorescent proteins expressed by corals. The source of this. uorescence is phycoerythrin in unicellular, nonheterocystis, symbiotic cyanobacteria within the host cells of the coral. The cyanobacteria coexist with the symbiotic dinoflagellates (zooxanthellae) of the coral and express the nitrogen. xing enzyme nitrogenase. The presence of this prokaryotic symbiont in a nitrogen-limited zooxanthellate coral suggests that nitrogen fixation may be an important source of this limiting element for the symbiotic association.	Univ New Hampshire, Dept Zool, Durham, NH 03824 USA; Univ New Hampshire, Ctr Marine Biol, Durham, NH 03824 USA; Phys Sci Inc, Andover, MA 01810 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Physical Sciences Inc.; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Lesser, MP (corresponding author), Univ New Hampshire, Dept Zool, Durham, NH 03824 USA.	mpl@cisunix.unh.edu						ADAMS DG, 2001, ECOLOGY CYANOBACTERI, P523; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dubinsky Z., 1994, Pacific Science, V48, P313; DUCKLOW HW, 1990, CORAL REEFS, P265; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; GLAZER AN, 1982, BIOCHEM SYST ECOL, V10, P203, DOI 10.1016/0305-1978(82)90031-X; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Litvaitis MK, 2002, HYDROBIOLOGIA, V468, P135, DOI 10.1023/A:1015262621848; Lokstein H, 1999, BBA-BIOENERGETICS, V1410, P97, DOI 10.1016/S0005-2728(98)00172-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Muscatine L, 1990, CORAL REEFS, P75; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Veron J. E. N., 1995, CORALS SPACE TIME; WIEBE WJ, 1975, SCIENCE, V188, P257, DOI 10.1126/science.188.4185.257; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818	28	327	341	7	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					997	1000		10.1126/science.1099128	http://dx.doi.org/10.1126/science.1099128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310901				2022-12-01	WOS:000223250700046
J	Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C				Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C			Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control	NATURE			English	Article							SISTER-CHROMATID SEPARATION; SPINDLE CHECKPOINT; CHROMOSOME INSTABILITY; MAMMALIAN-CELLS; BLADDER-CANCER; GENES; MAD2; E2F; DISRUPTION; PROTEINS	Advanced human cancers are invariably aneuploid, in that they harbour cells with abnormal chromosome numbers(1,2). However, the molecular defects underlying this trait, and whether they are a cause or a consequence of the malignant phenotype, are not clear. Mutations that disable the retinoblastoma (Rb) pathway are also common in human cancers(1). These mutations promote tumour development by deregulating the E2F family of transcription factors leading to uncontrolled cell cycle progression(3). We show that the mitotic checkpoint protein Mad2 is a direct E2F target and, as a consequence, is aberrantly expressed in cells with Rb pathway defects. Concordantly, Mad2 is overexpressed in several tumour types, where it correlates with high E2F activity and poor patient prognosis. Generation of Rb pathway lesions in normal and transformed cells produces aberrant Mad2 expression and mitotic defects leading to aneuploidy, such that elevated Mad2 contributes directly to these defects. These results demonstrate how chromosome instability can arise as a by-product of defects in cell cycle control that compromise the accuracy of mitosis, and suggest a new model to explain the frequent appearance of aneuploidy in human cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	ALAMINOS, MIGUEL/N-9960-2016; Díaz-Rodriguez, Elena/I-4784-2015	ALAMINOS, MIGUEL/0000-0003-4876-2672; Díaz-Rodriguez, Elena/0000-0002-6240-6327; Hernando, Eva/0000-0003-1023-0312	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alaminos M, 2003, CANCER RES, V63, P4538; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Arber N, 1997, CANCER RES, V57, P1569; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DALBAGNI G, 1993, LANCET, V342, P469, DOI 10.1016/0140-6736(93)91595-D; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernando E, 2001, INT J CANCER, V95, P223, DOI 10.1002/1097-0215(20010720)95:4<223::AID-IJC1038>3.0.CO;2-L; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lentini L, 2002, NEOPLASIA, V4, P380, DOI 10.1038/sj.neo.7900256; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Schuldiner O, 2001, ONCOGENE, V20, P4984, DOI 10.1038/sj.onc.1204459; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	432	450	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					797	802		10.1038/nature02820	http://dx.doi.org/10.1038/nature02820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306814	Bronze			2022-12-01	WOS:000223233600046
J	Kilner, RM; Madden, JR; Hauber, ME				Kilner, RM; Madden, JR; Hauber, ME			Brood parasitic cowbird nestlings use host young to procure resources	SCIENCE			English	Article							PARENT-OFFSPRING CONFLICT; SIBLING COMPETITION; MODELS; SELFISH; CHICKS; COST; NEST	Young brood parasites that tolerate the company of host offspring challenge the existing evolutionary view of family life. In theory, all parasitic nestlings should be ruthlessly self-interested and should kill host offspring soon after hatching. Yet many species allow host young to live, even though they are rivals for host resources. Here we show that the tolerance of host nestlings by the parasitic brown-headed cowbird Molothrus ater is adaptive. Host young procure the cowbird a higher provisioning rate, so it grows more rapidly. The cowbird's unexpected altruism toward host offspring simply promotes its selfish interests in exploiting host parents.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Cambridge; University of Auckland; University of California System; University of California Berkeley	Kilner, RM (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rmk1002@hermes.cam.ac.uk	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758				Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dearborn DC, 1996, CONDOR, V98, P645, DOI 10.2307/1369581; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; FORBES LS, 1993, AM NAT, V142, P82, DOI 10.1086/285530; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Haig D, 1996, J EVOLUTION BIOL, V9, P357, DOI 10.1046/j.1420-9101.1996.9030357.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauber Mark E., 2004, Etologia, V10, P1; Hauber ME, 2003, BEHAV ECOL, V14, P227, DOI 10.1093/beheco/14.2.227; Hosoi SA, 2000, ANIM BEHAV, V59, P823, DOI 10.1006/anbe.1999.1370; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kilner RM, 2003, ANIM BEHAV, V66, P569, DOI 10.1006/anbe.2003.2204; Kilpatrick AM, 2002, CAN J ZOOL, V80, P145, DOI 10.1139/Z01-217; Lichtenstein G, 1998, P ROY SOC B-BIOL SCI, V265, P249, DOI 10.1098/rspb.1998.0289; Lotem A, 1998, TRENDS ECOL EVOL, V13, P342, DOI 10.1016/S0169-5347(98)01401-3; MACNAIR MR, 1979, ANIM BEHAV, V27, P1202, DOI 10.1016/0003-3472(79)90067-8; MAY RM, 1985, AM NAT, V126, P475, DOI 10.1086/284433; Maynard Smith J., 1991, Animal Behaviour, V42, P1034; PARKER GA, 1989, AM NAT, V133, P846, DOI 10.1086/284956; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Reeve HK, 1999, MG BEH ECOL, P3; Rodriguez-Girones MA, 1999, P ROY SOC B-BIOL SCI, V266, P2399, DOI 10.1098/rspb.1999.0937; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilson DS, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P43, DOI 10.1007/0-306-47660-6_3; [No title captured]	30	133	143	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					877	879		10.1126/science.1098487	http://dx.doi.org/10.1126/science.1098487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297677				2022-12-01	WOS:000223104900053
J	Cumberland, P; Rahi, JS; Peckham, CS				Cumberland, P; Rahi, JS; Peckham, CS			Impact of congenital colour vision deficiency on education and unintentional injuries: findings from the 1958 British birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	j.rahi@ich.ucl.ac.uk	peckham, catherine s/I-6300-2013	Rahi, Jugnoo/0000-0002-5718-9209				ESSEN J, 1978, ED RES, V20, P300; *HLTH SAF EX, 1987, COL VIS, P1; Holroyd E, 1997, CHILD CARE HLTH DEV, V23, P391, DOI 10.1111/j.1365-2214.1997.tb00906.x; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; LAMPE JM, 1973, J SCHOOL HEALTH, V43, P309, DOI 10.1111/j.1746-1561.1973.tb03718.x	5	20	23	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2004	329	7474					1074	1075		10.1136/bmj.38176.685208.F7	http://dx.doi.org/10.1136/bmj.38176.685208.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	870PN	15465847	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000225070300020
J	Andersson, N; Ho-Foster, A; Matthis, J; Marokoane, N; Mashiane, V; Mhatre, S; Mitchell, S; Mokoena, T; Monasta, L; Ngxowa, N; Salcedo, MP; Sonnekus, H				Andersson, N; Ho-Foster, A; Matthis, J; Marokoane, N; Mashiane, V; Mhatre, S; Mitchell, S; Mokoena, T; Monasta, L; Ngxowa, N; Salcedo, MP; Sonnekus, H			National cross sectional study of views on sexual violence and risk of HIV infection and AIDS among South African school pupils	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENDER; WOMEN; PREVENTION; PREVALENCE; EDUCATION; BEHAVIOR; HEALTH; RAPE	Objective To investigate the views of school pupils on sexual violence and on the risk of HIV infection and AIDS and their experiences of sexual violence. Design National cross sectional study. Setting 5162 classes in 1418 South African schools. Participants 269 705 pupils aged 10-19 years in grades 6-11. Main outcome measure Answers to questions about sexual violence and about the risk of HIV infection and AIDS. Results Misconceptions about: sexual violence were common among both sexes, but more females held views that would put them at high risk of HIV infection. One third of the respondents thought they might be HIV positive. This was associated with misconceptions about sexual violence and about the risk of HIV infection and AIDS. Around 11% of males and 4% of females claimed to have forced someone else to have sex; 66% of these males and 71% of these females had themselves been forced to have sex. A history of forced sex was a powerful determinant of views on sexual violence and risk of HIV infection. Conclusions The views of South African youth on sexual violence and on the risk of HIV infection and AIDS were compatible with acceptance of sexual coercion and "adaptive" attitudes to survival in a violent society. Views differed little between the sexes.	Univ Autonoma Guerrero, CIET, Acapulco, Mexico; CIETafrica, ZA-2041 Houghton, South Africa		Andersson, N (corresponding author), Univ Autonoma Guerrero, CIET, Apdo Postal 182, Acapulco, Mexico.	neil@ciet.org	Ho-Foster, Ari/AAM-9225-2021; Monasta, Lorenzo/B-1388-2012; Andersson, Neil/G-2248-2011	Ho-Foster, Ari/0000-0001-9817-8090; Monasta, Lorenzo/0000-0001-7774-548X; 				Andersson N, 2002, CIETMAP FREE GIS EPI; ARMSTRONG S, 1993, WORLD AIDS, P27; Blumenthal S, 1999, CHILD ABUSE NEGLECT, V23, P129, DOI 10.1016/S0145-2134(98)00117-3; Bowley DM, 2002, SAMJ S AFR MED J, V92, P744; Buzi RS, 2003, J SCHOOL HEALTH, V73, P191, DOI 10.1111/j.1746-1561.2003.tb03602.x; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Garcia-Moreno C, 2000, AIDS, V14, pS253; Hartung TK, 2002, INT J STD AIDS, V13, P829, DOI 10.1258/095646202321020107; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Kim J, 2002, SOC SCI MED, V54, P1243, DOI 10.1016/S0277-9536(01)00093-4; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mitchell C, 2003, CULT HEALTH SEX, V5, P513, DOI 10.1080/13691050110149909; Peltzer K, 2000, PSYCHOL REP, V87, P593; Taylor M, 2003, J SCHOOL HEALTH, V73, P97, DOI 10.1111/j.1746-1561.2003.tb03580.x; Varga CA, 2003, STUD FAMILY PLANN, V34, P160, DOI 10.1111/j.1728-4465.2003.00160.x; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4	20	43	44	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2004	329	7472					952	954A		10.1136/bmj.38226.617454.7C	http://dx.doi.org/10.1136/bmj.38226.617454.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	866KU	15485935	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000224773200018
J	Gao, M; Labuda, T; Xia, Y; Gallagher, E; Fang, D; Liu, YC; Karin, M				Gao, M; Labuda, T; Xia, Y; Gallagher, E; Fang, D; Liu, YC; Karin, M			Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASES; N-TERMINAL KINASE; C-JUN; CELL DIFFERENTIATION; UBIQUITIN LIGASE; TRANSCRIPTION; EXPRESSION; APOPTOSIS; INHIBITOR	The turnover of Jun proteins, like that of other transcription factors, is regulated through ubiquitin-dependent proteolysis. Usually, such processes are regulated by extracellular stimuli through phosphorylation of the target protein, which allows recognition by F box-containing E3 ubiquitin ligases. In the case of c-Jun and JunB, we found that extracellular stimuli also modulate protein turnover by regulating the activity of an E3 ligase by means of its phosphorylation. Activation of the Jun amino-terminal kinase (JNK) mitogen-activated protein kinase cascade after T cell stimulation accelerated degradation of c-Jun and JunB through phosphorylation-dependent activation of the E3 ligase Itch. This pathway modulates cytokine production by effector T cells.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; Univ Copenhagen, Dept Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Inst Mol Biol, DK-2200 Copenhagen N, Denmark; La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of Copenhagen; University of Copenhagen; La Jolla Institute for Immunology	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; LIU, YUN-CAI/0000-0002-0996-7109	NIAID NIH HHS [AI43477, R21AI48542] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R21AI048542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376, R37ES004151, R01ES004151] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao M., UNPUB; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	26	328	341	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					271	275		10.1126/science.1099414	http://dx.doi.org/10.1126/science.1099414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15358865				2022-12-01	WOS:000224419700039
J	O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP				O'Dowd, CD; Facchini, MC; Cavalli, F; Ceburnis, D; Mircea, M; Decesari, S; Fuzzi, S; Yoon, YJ; Putaud, JP			Biogenically driven organic contribution to marine aerosol	NATURE			English	Article							SUBMICRON AEROSOL; CLOUD ALBEDO; SULFUR; FRACTIONATION; TRANSPORT; MATTER; MASS	Marine aerosol contributes significantly to the global aerosol load and consequently has an important impact on both the Earth's albedo and climate. So far, much of the focus on marine aerosol has centred on the production of aerosol from sea-salt(1) and non-sea-salt sulphates(2,3). Recent field experiments, however, have shown that known aerosol production processes for inorganic species cannot account for the entire aerosol mass that occurs in submicrometre sizes(4-6). Several experimental studies have pointed to the presence of significant concentrations of organic matter in marine aerosol(7-11). There is some information available about the composition of organic matter(12-14), but the contribution of organic matter to marine aerosol, as a function of aerosol size, as well as its characterization as hydrophilic or hydrophobic, has been lacking. Here we measure the physical and chemical characteristics of submicrometre marine aerosol over the North Atlantic Ocean during plankton blooms progressing from spring through to autumn. We find that during bloom periods, the organic fraction dominates and contributes 63% to the submicrometre aerosol mass (about 45% is water-insoluble and about 18% water-soluble). In winter, when biological activity is at its lowest, the organic fraction decreases to 15%. Our model simulations indicate that organic matter can enhance the cloud droplet concentration by 15% to more than 100% and is therefore an important component of the aerosol-cloud-climate feedback system involving marine biota.	CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy; Natl Univ Ireland, Dept Expt Phys, Galway, Ireland; Natl Univ Ireland, Environm Change Inst, Galway, Ireland; Inst Phys, Environm Phys & Chem Div, LT-2053 Vilnius, Lithuania; Commiss European Communities, Inst Environm & Sustainabil, Joint Res Ctr, I-21021 Ispra, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; European Commission Joint Research Centre; EC JRC ISPRA Site	Facchini, MC (corresponding author), CNR, Ist Sci Atmosfera & Clima, I-40129 Bologna, Italy.	mc.facchini@isac.cnr.it	Facchini, Maria Cristina/B-3369-2014; Facchini, Maria Cristina/AAA-1592-2019; O'Dowd, Colin D/K-8904-2012; Decesari, Stefano/B-9588-2015; Ceburnis, Darius/C-1293-2012; FACCHINI, MARIA CRISTINA/O-1230-2015; Fuzzi, Sandro/F-2675-2010	Facchini, Maria Cristina/0000-0003-4833-9305; Facchini, Maria Cristina/0000-0003-4833-9305; O'Dowd, Colin D/0000-0002-3068-2212; Decesari, Stefano/0000-0001-6486-3786; Ceburnis, Darius/0000-0003-0231-5324; FACCHINI, MARIA CRISTINA/0000-0003-4833-9305; Fuzzi, Sandro/0000-0002-5275-2381				Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; BLANCHARD DC, 1976, ADV CHEM SER, V145, P360; Cavalli F, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005137; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Facchini MC, 1999, NATURE, V401, P257, DOI 10.1038/45758; GAGOSIAN RB, 1981, NATURE, V291, P312, DOI 10.1038/291312a0; GEEVER M, 2003, J AER SCI, V1, pS637; GERSHEY RM, 1983, LIMNOL OCEANOGR, V28, P309, DOI 10.4319/lo.1983.28.2.0309; Gogou AI, 1998, J CHROMATOGR A, V799, P215, DOI 10.1016/S0021-9673(97)01106-0; HOFFMAN EJ, 1974, J GEOPHYS RES, V79, P4474, DOI 10.1029/JC079i030p04474; Huebert BJ, 1998, J GEOPHYS RES-ATMOS, V103, P16493, DOI 10.1029/98JD00770; KAWAMURA K, 1990, J ATMOS CHEM, V11, P107, DOI 10.1007/BF00053670; Kleefeld S, 2002, ATMOS ENVIRON, V36, P4479, DOI 10.1016/S1352-2310(02)00346-1; Martensson EM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002263; McInnes LM, 1996, ATMOS ENVIRON, V30, P869, DOI 10.1016/1352-2310(95)00354-1; Middlebrook AM, 1998, J GEOPHYS RES-ATMOS, V103, P16475, DOI 10.1029/97JD03719; Mochida M, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001278; Nenes A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015295; Novakov T, 1997, J GEOPHYS RES-ATMOS, V102, P21307, DOI 10.1029/97JD01487; ODowd CD, 1997, ATMOS ENVIRON, V31, P73, DOI 10.1016/S1352-2310(96)00106-9; Oppo C, 1999, MAR CHEM, V63, P235, DOI 10.1016/S0304-4203(98)00065-6; Putaud JP, 2000, TELLUS B, V52, P141, DOI 10.1034/j.1600-0889.2000.00056.x; Quinn PK, 2000, J GEOPHYS RES-ATMOS, V105, P6785, DOI 10.1029/1999JD901034; SHAW GE, 1983, CLIMATIC CHANGE, V5, P297, DOI 10.1007/BF02423524	24	678	688	10	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					676	680		10.1038/nature02959	http://dx.doi.org/10.1038/nature02959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15470425				2022-12-01	WOS:000224299300037
J	Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS				Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS			The genome of the diatom Thalassiosira pseudonana: Ecology, evolution, and metabolism	SCIENCE			English	Article							GENE-TRANSFER; OCEAN; SILICA; POLYAMINES; PROTEINS; NUCLEUS; FAMILY; LIGHT	Diatoms are unicellular algae with plastids acquired by secondary endosymbiosis. They are responsible for similar to20% of global carbon fixation. We report the 34 million-base pair draft nuclear genome of the marine diatom Thalassiosira pseudonana and its 129 thousand-base pair ptastid and 44 thousand-base pair mitochondrial genomes. Sequence and optical restriction mapping revealed 24 diploid nuclear chromosomes. We identified novel genes for silicic acid transport and formation of silica-based cell walls, high-affinity iron uptake, biosynthetic enzymes for several types of polyunsaturated fatty acids, use of a range of nitrogenous compounds, and a complete urea cycle, all attributes that allow diatoms to prosper in aquatic environments.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; Stn Zool, Plant Mol Biol Lab, I-80121 Naples, Italy; Ecole Normale Super, Dept Biol, F-75230 Paris, France; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08540 USA; Martek Biosci Corp, Columbia, MD 21045 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Sandia Natl Labs, Lockheed Martin Corp, Livermore, CA 94551 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany; Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Oak Ridge Natl Lab, Genome Anal Grp, Oak Ridge, TN 37831 USA; Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Melbourne; University of California System; University of California San Diego; Scripps Institution of Oceanography; Lockheed Martin; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Santa Cruz; University of Regensburg; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Hull; University of Massachusetts System; University of Massachusetts Worcester; Woods Hole Oceanographic Institution; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; California State University System; San Francisco State University; University of California System; University of California Berkeley	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu; dsrokhsar@lbl.gov	Bowler, Chris/AAC-6256-2019; Obornik, Miroslav/G-9350-2014; Palenik, Brian/AAA-1822-2020; Putnam, Nicholas/B-9968-2008; Allen, Andrew E/C-4896-2012; Zhou, Shiguo/B-3832-2011; Green, Beverley R./AAJ-5199-2021; Berges, John A/D-9520-2012; Saito, Mak/ADT-4986-2022; Valentin, Klaus/G-5862-2014	Palenik, Brian/0000-0002-3717-9046; Putnam, Nicholas/0000-0002-1315-782X; Allen, Andrew E/0000-0001-5911-6081; Zhou, Shiguo/0000-0001-7421-2506; Green, Beverley R./0000-0002-4021-9387; Berges, John A/0000-0002-3124-4783; Valentin, Klaus/0000-0001-7401-9423; Thamatrakoln, Kimberlee/0000-0002-8029-5026; Goodstein, David/0000-0001-6287-2697; Bowler, Chris/0000-0003-3835-6187; Lippmeier, J./0000-0002-8157-1491; Vardi, Assaf/0000-0002-7079-0234; Rokhsar, Daniel/0000-0002-8704-2224; Pazour, Gregory/0000-0002-6285-8796; Lane, Todd/0000-0002-5816-2649; Parker, Micaela/0000-0003-1007-4612				Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; CLINE K, 2003, LIGHT HARVESTING ANT, V13, P353; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Coffino P, 2000, P NATL ACAD SCI USA, V97, P4421, DOI 10.1073/pnas.97.9.4421; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Kroger N, 2000, PROTIST, V151, P263, DOI 10.1078/1434-4610-00024; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; Kroth PG, 2002, INT REV CYTOL, V221, P191; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; MCLACHLA.J, 1965, CAN J BOTANY, V43, P707, DOI 10.1139/b65-079; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; POULSEN N, IN PRESS J BIOL CHEM; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Round F.E., 1990, DIATOMS BIOL MORPHOL; Stewart V, 2003, J BACTERIOL, V185, P2104, DOI 10.1128/JB.185.7.2104-2111.2003; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Volcani B.E., 1981, SILICON SILICEOUS ST, P157; Walbot V, 2000, CURR OPIN PLANT BIOL, V3, P103, DOI 10.1016/S1369-5266(99)00051-5; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X	48	1455	1565	24	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					79	86		10.1126/science.1101156	http://dx.doi.org/10.1126/science.1101156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459382	Green Submitted			2022-12-01	WOS:000224304000039
J	Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J				Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J			Extinct Pu-244 in ancient zircons	SCIENCE			English	Article							XENON; AGES	We have found evidence, in the form of fissiogenic xenon isotopes, for in situ decay of Pu-244 in individual 4.1- to 4.2-billion-year-old zircons from the Jack Hills region of Western Australia. Because of its short half-life, 82 million years, Pu-244 was extinct within 600 million years of Earth's formation. Detrital zircons are the only known relics to have survived from this period, and a study of their Pu geochemistry will allow us to date ancient metamorphic events and determine the terrestrial Pu/U ratio for comparison with the solar ratio.	Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Colorado, Dept Geol Sci, Ctr Astrobiol, Boulder, CO 80309 USA	University of Manchester; Australian National University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder	Turner, G (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.	grenville.turner@man.ac.uk	Harrison, Timothy M/E-7443-2012; MOJZSIS, STEPHEN/AAU-9527-2020; Gilmour, Jamie/G-7515-2011	MOJZSIS, STEPHEN/0000-0003-0000-125X; Gilmour, Jamie/0000-0003-1990-8636				ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; CAMERON AGW, 1993, PHYS REP, V227, P283, DOI 10.1016/0370-1573(93)90073-M; CLAYTON DD, 1983, ASTROPHYS J, V268, P381, DOI 10.1086/160962; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; GILMOUR JD, 1994, REV SCI INSTRUM, V65, P617, DOI 10.1063/1.1145127; Goriely S, 2001, ASTRON ASTROPHYS, V379, P1113, DOI 10.1051/0004-6361:20011368; Harrison TM, 2003, GEOCHIM COSMOCHIM AC, V67, pA135; Honda M, 2003, EARTH PLANET SC LETT, V207, P69, DOI 10.1016/S0012-821X(02)01147-0; Hudson G.B., 1989, LUNAR PLANETARY SCI, V19, P547; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; LUGMAIR GW, 1977, EARTH PLANET SC LETT, V35, P273, DOI 10.1016/0012-821X(77)90131-5; Meyer BS, 2000, SPACE SCI REV, V92, P133, DOI 10.1023/A:1005282825778; Miura YN, 1998, GEOCHIM COSMOCHIM AC, V62, P2369, DOI 10.1016/S0016-7037(98)00118-5; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; ONIONS RK, 1994, EARTH PLANET SC LETT, V124, P131, DOI 10.1016/0012-821X(94)00070-0; Pellas P, 1997, GEOCHIM COSMOCHIM AC, V61, P3477, DOI 10.1016/S0016-7037(97)00167-1; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Shukolyukov A, 1996, GEOCHIM COSMOCHIM AC, V60, P2453, DOI 10.1016/0016-7037(96)00085-3; SHUKOLYUKOV YA, 1994, NOBLE GAS GEOCHEMIST, P125; STAUDACHER T, 1986, EARTH PLANET SC LETT, V60, P389; WASSERBURG GJ, 1996, APJ, V466, P109; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	24	53	53	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					89	91		10.1126/science.1101014	http://dx.doi.org/10.1126/science.1101014			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459384				2022-12-01	WOS:000224304000041
J	Li, C; Rieppel, O; LaBarbera, MC				Li, C; Rieppel, O; LaBarbera, MC			A Triassic aquatic protorosaur with an extremely long neck	SCIENCE			English	Article									Chinese Acad Sci, IVPP, Beijing 100044, Peoples R China; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Sciences; Field Museum of Natural History (Chicago); University of Chicago	Li, C (corresponding author), Chinese Acad Sci, IVPP, POB 643, Beijing 100044, Peoples R China.	lichun@pa.lvpp.ac.cn						Chun L, 2003, ACTA GEOL SIN-ENGL, V77, P419; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Rieppel Olivier, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P359; TAYLOR MA, 1989, NATURE, V341, P688, DOI 10.1038/341688a0; TSCHANZ K, 1988, PALAEONTOLOGY, V31, P997; Tschanz K., 1986, THESIS U ZURICH	6	44	56	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1931	1931		10.1126/science.1100498	http://dx.doi.org/10.1126/science.1100498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448262				2022-12-01	WOS:000224136000038
J	Stolow, A; Jonas, DM				Stolow, A; Jonas, DM			Multidimensional snapshots of chemical dynamics	SCIENCE			English	Editorial Material							RESOLVED PHOTOELECTRON-SPECTROSCOPY; MOLECULAR-DYNAMICS; CRYSTALLOGRAPHY; TRANSITION; PEPTIDE		Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	National Research Council Canada; University of Colorado System; University of Colorado Boulder	Stolow, A (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	albert.stolow@nrc.ca; david.jonas@colorado.edu	Stolow, Albert/AAN-5609-2020; Jonas, David M/A-7491-2008	Jonas, David M/0000-0002-1085-8161				Benesch F, 2004, OPT LETT, V29, P1028, DOI 10.1364/OL.29.001028; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; Bredenbeck J, 2003, J PHYS CHEM B, V107, P8654, DOI 10.1021/jp034552q; Davies JA, 2000, PHYS REV LETT, V84, P5983, DOI 10.1103/PhysRevLett.84.5983; DeCamp MF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.165502; Hanold KA, 1996, PHYS REV LETT, V77, P3335, DOI 10.1103/PhysRevLett.77.3335; Johnson SL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157403; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Jonas DM, 2003, SCIENCE, V300, P1515, DOI 10.1126/science.1085687; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lehr L, 1999, SCIENCE, V284, P635, DOI 10.1126/science.284.5414.635; Moffat K, 2003, FARADAY DISCUSS, V122, P65, DOI 10.1039/b201620f; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Ruan CY, 2004, P NATL ACAD SCI USA, V101, P1123, DOI 10.1073/pnas.0307302101; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; 2004, S EM ULTR SPEC CHEM	19	28	28	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2004	305	5690					1575	1577		10.1126/science.1103195	http://dx.doi.org/10.1126/science.1103195			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361614				2022-12-01	WOS:000223891200030
J	Elemans, CPH; Spierts, ILY; Muller, UK; van Leeuwen, JL; Goller, F				Elemans, CPH; Spierts, ILY; Muller, UK; van Leeuwen, JL; Goller, F			Superfast muscles control dove's trill	NATURE			English	Article							VOCALIZATIONS; SYRINX; SONG		Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Wageningen University & Research; Utah System of Higher Education; University of Utah	Elemans, CPH (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	coen.elemans@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X; Elemans, Coen/0000-0001-6306-5715				Beckers GJL, 2003, J EXP BIOL, V206, P1833, DOI 10.1242/jeb.00364; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; FLETCHER NH, 1988, J THEOR BIOL, V135, P455, DOI 10.1016/S0022-5193(88)80270-4; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Goller F, 1997, J EXP BIOL, V200, P2165; Goller F, 1998, NATURE, V395, P11, DOI 10.1038/25589; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; GREENWALT CH, 1968, BIRD SONG ACOUSTICS; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Larsen ON, 1999, P ROY SOC B-BIOL SCI, V266, P1609, DOI 10.1098/rspb.1999.0822; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Young IS, 2001, P ROY SOC B-BIOL SCI, V268, P1965, DOI 10.1098/rspb.2001.1731	12	52	55	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					146	146		10.1038/431146a	http://dx.doi.org/10.1038/431146a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356620	Bronze, Green Published			2022-12-01	WOS:000223746000033
J	Walensky, LD; Kung, AL; Escher, I; Malia, TJ; Barbuto, S; Wright, RD; Wagner, G; Verdine, GL; Korsmeyer, SJ				Walensky, LD; Kung, AL; Escher, I; Malia, TJ; Barbuto, S; Wright, RD; Wagner, G; Verdine, GL; Korsmeyer, SJ			Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix	SCIENCE			English	Article							CELL-PENETRATING PEPTIDES; CHROMOSOMAL BREAKPOINT; PROTEIN TRANSDUCTION; FOLLICULAR LYMPHOMA; NMR STRUCTURE; CYTOCHROME-C; DEATH; DOMAIN; BAK; MACROPINOCYTOSIS	BCL-2 family proteins constitute a critical control point for the regulation of apoptosis. Protein interaction between BCL-2 members is a prominent mechanism of control and is mediated through the amphipathic alpha-helical BH3 segment, an essential death domain. We used a chemical strategy, termed hydrocarbon stapling, to generate BH3 peptides with improved pharmacologic properties. The stapled peptides, called "stabilized alpha-helix of BCL-2 domains" (SAHBs), proved to be helical, protease-resistant, and cell-permeable molecules that bound with increased affinity to multidomain BCL-2 member pockets. A SAHB of the BH3 domain from the BID protein specifically activated the apoptotic pathway to kill leukemia cells. In addition, SAHB effectively inhibited the growth of human leukemia xenografts in vivo. Hydrocarbon stapling of native peptides may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways.	Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Childrens Hosp Boston, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Verdine, GL (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	verdine@chemistry.harvard.edu; stantey_korsmeyer@dfci.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	NCI NIH HHS [R37CA50239] Funding Source: Medline; NHLBI NIH HHS [K08HL074049, K08 HL074049] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074049] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; BRACKEN C, 1994, J AM CHEM SOC, V116, P6431, DOI 10.1021/ja00093a052; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LEUC A, 2003, P NATL ACAD SCI USA, V100, P11273; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Phelan JC, 1997, J AM CHEM SOC, V119, P455, DOI 10.1021/ja9611654; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schleiff E, 1997, J BIOL CHEM, V272, P17784, DOI 10.1074/jbc.272.28.17784; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WALENSKY LD, UNPUB; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; WILLIAMS RM, 1991, J AM CHEM SOC, V113, P9276, DOI 10.1021/ja00024a038; YAN B, 2004, BIOORG MED CHEM LETT, V14, P1403	31	1049	1231	9	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1466	1470		10.1126/science.1099191	http://dx.doi.org/10.1126/science.1099191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353804	Green Accepted			2022-12-01	WOS:000223761900050
J	Wang, YQ; Zhang, DX; Renner, SS; Chen, ZY				Wang, YQ; Zhang, DX; Renner, SS; Chen, ZY			A new self-pollination mechanism	NATURE			English	Editorial Material							ZINGIBERACEAE; POLLEN		Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China; Zhongkai Agrotech Coll, Guangzhou 510225, Peoples R China; Univ Munich, Dept Biol, D-80638 Munich, Germany	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Munich	Wang, YQ (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China.	dx-zhang@scib.ac.cn		Zhang, Dianxiang/0000-0001-6549-8872				Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; DOBSON HEM, 1988, AM J BOT, V75, P170, DOI 10.2307/2443884; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P1233, DOI 10.1093/oxfordjournals.aob.a085414; KRONESTEDT E, 1981, NORD J BOT, V1, P523; Larsen K, 2002, NORD J BOT, V22, P409, DOI 10.1111/j.1756-1051.2002.tb01392.x; LARSEN K, 1972, Notes from the Royal Botanic Garden Edinburgh, V31, P287; LARSEN KAI, 1964, BOT TIDSSKR, V60, P165; ROSE MJ, 1995, PLANT SYST EVOL, V195, P61, DOI 10.1007/BF00982315; Williams KJ, 2004, AM J BOT, V91, P100, DOI 10.3732/ajb.91.1.100	9	42	62	9	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					39	40		10.1038/431039b	http://dx.doi.org/10.1038/431039b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343325				2022-12-01	WOS:000223641500032
J	Tamura, K; Schimmel, P				Tamura, K; Schimmel, P			Chiral-selective aminoacylation of an RNA minihelix	SCIENCE			English	Article									Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Pizzarello S, 2004, SCIENCE, V303, P1151, DOI 10.1126/science.1093057; PROFY AT, 1984, J MOL EVOL, V20, P147, DOI 10.1007/BF02257375; Rodin S, 1996, P NATL ACAD SCI USA, V93, P4537, DOI 10.1073/pnas.93.10.4537	6	69	72	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1253	1253		10.1126/science.1099141	http://dx.doi.org/10.1126/science.1099141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333830				2022-12-01	WOS:000223624600030
J	Munro, AJ				Munro, AJ			Oesophageal cancer: a view over overviews	LANCET			English	Editorial Material									Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland	University of Dundee	Munro, AJ (corresponding author), Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland.	a.j.munro@dundee.ac.uk						ARNOTT SJ, 2004, COCHRANE LIB; BEDENNE L, 2002, AM SOC CLINL ONCOL P, V519; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; *IARC, 2000, GLOBOCAN; MALTHANER R, 2004, COCHRANE LIB; *SCOTT AUD GASTR C, 2002, SCOTT AUD GASTR CANC; Sur RK, 2002, INT J RADIAT ONCOL, V53, P127, DOI 10.1016/S0360-3016(02)02702-5; Wong R, 2004, COCHRANE LIB	8	18	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					566	568		10.1016/S0140-6736(04)16868-2	http://dx.doi.org/10.1016/S0140-6736(04)16868-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313344				2022-12-01	WOS:000223275100010
J	Singer, M; De Santis, V; Vitale, D; Jeffcoate, W				Singer, M; De Santis, V; Vitale, D; Jeffcoate, W			Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; OXYGEN-CONSUMPTION; MITOCHONDRIAL DYSFUNCTION; SKELETAL-MUSCLE; SEPSIS; RAT; HYPERGLYCEMIA; VASOPRESSIN; INHIBITION	Sepsis and other critical illnesses produce a biphasic inflammatory, immune, hormonal, and metabolic response. The acute phase is marked by an abrupt rise in the secretion of so-called stress hormones with an associated increase in mitochondrial and metabolic activity. The combination of severe inflammation and secondary changes in endocrine profile diminish energy production, metabolic rate, and normal cellular processes, leading to multiple organ dysfunction. This perceived failure of organs might instead be a potentially protective mechanism, because reduced cellular metabolism could increase the chances of survival of cells, and thus organs, in the face of an overwhelming insult. We propose that, first, multiple organ failure induced by critical illness is primarily a functional, rather than structural, abnormality. Indeed, it may not be failure as such, but a potentially protective, reactive mechanism. Second, the decline in organ function is triggered by a decrease in mitochondrial activity and oxidative phosphorylation, leading to reduced cellular metabolism. Third, this effect on mitochondria might be the consequence of acute-phase changes in hormones and inflammatory mediators.	UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, London WC1E 6BT, England; UCL, Dept Med, London WC1E 6BT, England; Univ Roma La Sapienza, Dept Anaesthesia, Rome, Italy; City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England	University of London; University College London; University of London; University College London; Sapienza University Rome; University of Nottingham	Singer, M (corresponding author), UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, Gower St, London WC1E 6BT, England.	m.singer@ucl.ac.uk	De Santis, Vincenzo/AAM-7960-2020; Singer, Mervyn/J-4425-2012; Singer, Mervyn/Q-6142-2019	De Santis, Vincenzo/0000-0002-5105-7969; Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350				Acker CG, 2000, KIDNEY INT, V57, P293, DOI 10.1046/j.1523-1755.2000.00827.x; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; BOEKSTEGERS P, 1991, INFECTION, V19, P317, DOI 10.1007/BF01645355; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Boulos M, 2003, CRIT CARE MED, V31, P353, DOI 10.1097/01.CCM.0000050074.82486.B2; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Costamagna ME, 1998, THYROID, V8, P1127, DOI 10.1089/thy.1998.8.1127; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Duclos M, 2001, PFLUG ARCH EUR J PHY, V443, P218, DOI 10.1007/s004240100675; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; King CJ, 1999, CRIT CARE MED, V27, P2518, DOI 10.1097/00003246-199911000-00032; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Lee S, 1999, J NEUROSCI, V19, P7640, DOI 10.1523/JNEUROSCI.19-17-07640.1999; Ligtenberg JJM, 2001, INTENS CARE MED, V27, P1567, DOI 10.1007/s001340101050; Noble JS, 2001, ANAESTHESIA, V56, P124, DOI 10.1046/j.1365-2044.2001.01841.x; Nogueira V, 2002, J BIOENERG BIOMEMBR, V34, P55, DOI 10.1023/A:1013822820840; PALAZZO MG, 1991, INTENS CARE MED, V17, P325, DOI 10.1007/BF01716190; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RIVIER C, 1994, J NEUROSCI, V14, P1985; Robb SJ, 2002, INTENS CARE MED, V28, pS64; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; Scheller K, 2003, INT REV CYTOL, V222, P1; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Venditti P, 2003, ARCH BIOCHEM BIOPHYS, V411, P121, DOI 10.1016/S0003-9861(02)00720-8; WANG XM, 1993, BURNS, V19, P110, DOI 10.1016/0305-4179(93)90030-C; Weekers F, 2003, ENDOCRINOLOGY, V144, P5329, DOI 10.1210/en.2003-0697; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	35	333	365	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					545	548		10.1016/S0140-6736(04)16815-3	http://dx.doi.org/10.1016/S0140-6736(04)16815-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302200				2022-12-01	WOS:000223132700036
J	Stuart, SN; Chanson, JS; Cox, NA; Young, BE; Rodrigues, ASL; Fischman, DL; Waller, RW				Stuart, SN; Chanson, JS; Cox, NA; Young, BE; Rodrigues, ASL; Fischman, DL; Waller, RW			Status and trends of amphibian declines and extinctions worldwide	SCIENCE			English	Article							POPULATION DECLINES; CENTRAL-AMERICA; CLIMATE; TOAD; BIODIVERSITY; MORTALITY; DISEASE; FROGS	The first global assessment of amphibians provides new context for the well-publicized phenomenon of amphibian declines. Amphibians are more threatened and are declining more rapidly than either birds or mammals. Although many declines are due to habitat loss and overutilization, other, unidentified processes threaten 48% of rapidly declining species and are driving species most quickly to extinction. Declines are nonrandom in terms of species' ecological preferences, geographic ranges, and taxonomic associations and are most prevalent among Neotropicai montane, stream-associated species. The lack of conservation remedies for these poorly understood declines means that hundreds of amphibian species now face extinction.	IUCN Species Survival Commiss Conservat, Int Ctr Appl Biodivers Sci, Biodivers Assessment Unit, Washington, DC 20036 USA; Natureserve, Monteverde, Puntarenas, Costa Rica; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA	Conservation International	Stuart, SN (corresponding author), IUCN Species Survival Commiss Conservat, Int Ctr Appl Biodivers Sci, Biodivers Assessment Unit, 1919 M St NW, Washington, DC 20036 USA.	s.stuart@conservation.org	Rodrigues, Ana/GYQ-6273-2022; Fapesp, Biota/F-8655-2017; Rodrigues, Ana S.L./A-5914-2009	Fapesp, Biota/0000-0002-9887-8449; Rodrigues, Ana S.L./0000-0003-4775-0127				Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BirdLife International, 2004, STAT WORLDS BIRDS IN; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Burrowes PA, 2004, HERPETOLOGICA, V60, P141, DOI 10.1655/03-50; CZECHURA G V, 1990, Memoirs of the Queensland Museum, V29, P361; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; DROST CA, 1996, CONSERV BIOL, V10, P415; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; IUCN CONSERVATION INTERNATIONAL AND NATURESERVE, 2004, GLOB AMPH ASS; *IUCN WORLD CONS U, 2003, 2003 IUCN RED LIST T; IUCN - The World Conservation Union, 2001, IUCN RED LIST CAT CR; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lynch John D., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P149; Magin C, 2003, ORYX, V37, P406; MANZANILLA J, 2004, MEM FUND LA SALLE CI, V62, P5; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Ron SR, 2003, J HERPETOL, V37, P116, DOI 10.1670/0022-1511(2003)037[0116:PDOTJT]2.0.CO;2; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	30	2991	3314	28	1314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 3	2004	306	5702					1783	1786		10.1126/science.1103538	http://dx.doi.org/10.1126/science.1103538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	878FA	15486254	Green Submitted			2022-12-01	WOS:000225630800055
J	Viner, R; Hotopf, M				Viner, R; Hotopf, M			Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; HISTORY; ILLNESS; CARE	Objective To study childhood risk factors for chronic fatigue syndrome in adult life. Design Examination of data from the 1970 British birth cohort Participants 16 567 babies born 5-11 April 1970, followed up at 5, 10, 16, and 29-30 years. Main outcome measures Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) identified by self report at age 30 years. Data from childhood from questionnaires given to parents and teachers. Maternal mental health assessed with the malaise inventory. Results 93 (0.8%. 95% confidence interval 0.7 to 1.0) of 11261 participants reported ever having CFS/ME, and 48 (0.4%, 0.3 to 0.6) had the condition currently. Higher risk of CFS/ME was associated with having a limiting longstanding condition in childhood (odds ratio 2.3, 1.4 to 3.9), female sex (2.3, 1.4 to 2.6), and high social class in childhood (2.2, 1.4 to 3.5). Higher levels of exercise in childhood were associated with lower risk (0.5, 0.2 to 0.9). Maternal psychological disorder, psychological problems in childhood, birth weight, birth order, atopy, obesity, school absence, academic ability. and parental illness were not associated with risk of CFS/ME. Conclusions We identified no association between maternal or child psychological distress, academic ability, parental illness, atopy, or birth order and increasing risk of lifetime CFS/ME. Sedentary behaviour increased the risk.	Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England; Inst Psychiat, Dept Psychol Med, London SE5 8AF, England	University of London; University College London; University of London; King's College London	Viner, R (corresponding author), Middlesex Hosp, Royal Free & Univ Coll Med Sch, Dept Paediat, London W1T 3AA, England.	R.Viner@ich.ucl.ac.uk	Hotopf, Matthew/E-4971-2010; Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Hotopf, Matthew/0000-0002-3980-4466				Brimacombe M, 2002, HUM BIOL, V74, P615, DOI 10.1353/hub.2002.0038; BYNNER J, 2002, 1 CLS I ED; Chalder T, 2003, BRIT MED J, V327, P654, DOI 10.1136/bmj.327.7416.654; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Elliot C. D., 1983, BRIT ABILITY SCALES; Endicott NA, 1998, PSYCHOSOM MED, V60, P744, DOI 10.1097/00006842-199811000-00017; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Fisher L, 2003, J PSYCHOSOM RES, V54, P439, DOI 10.1016/S0022-3999(02)00458-0; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Garralda E, 1999, J AM ACAD CHILD PSY, V38, P1515, DOI 10.1097/00004583-199912000-00012; Goldberg D., 1988, USERS GUIDE GEN HLTH; Hall GJ, 1998, J ROY COLL PHYS LOND, V32, P44; HART JG, 1982, BR J ED PSYCHOL, V22, P167; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Irving B, 2002, PREDICTING ADOLESCEN; Krilov LR, 1998, PEDIATRICS, V102, P360, DOI 10.1542/peds.102.2.360; Levine PH, 1997, J PSYCHIATR RES, V31, P7, DOI 10.1016/S0022-3956(96)00058-1; MacDonald KL, 1996, AM J MED, V100, P548, DOI 10.1016/S0002-9343(96)00017-4; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Salit IE, 1997, J PSYCHIATR RES, V31, P59, DOI 10.1016/S0022-3956(96)00050-7; Sullivan PF, 2003, PSYCHOL MED, V33, P263, DOI 10.1017/S0033291702007031; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6	23	70	72	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 23	2004	329	7472					941	943		10.1136/bmj.38258.507928.55	http://dx.doi.org/10.1136/bmj.38258.507928.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KU	15469945	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000224773200014
J	Ahlgren, M; Melbye, M; Wohlfahrt, J; Sorensen, TIA				Ahlgren, M; Melbye, M; Wohlfahrt, J; Sorensen, TIA			Growth patterns and the risk of breast cancer in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH CHARACTERISTICS; DANISH MEASUREMENTS; SEXED TWINS; YOUNG-WOMEN; HEIGHT; WEIGHT; CHILDHOOD; POPULATION; COHORT; NORWAY	BACKGROUND: Adult height and body-mass index influence the risk of breast cancer in women. Whether these associations reflect growth patterns of the fetus or growth during childhood and adolescence is unknown. METHODS: We investigated the association between growth during childhood and the risk of breast cancer in a cohort of 117,415 Danish women. Birth weight, age at menarche, and annual measurements of height and weight were obtained from school health records. We used the data to model individual growth curves. Information on vital status, age at first childbirth, parity, and diagnosis of breast cancer was obtained through linkages to national registries. RESULTS: During 3,333,359 person-years of follow-up, 3340 cases of breast cancer were diagnosed. High birth weight, high stature at 14 years of age, low body-mass index (BMI) at 14 years of age, and peak growth at an early age were independent risk factors for breast cancer. Height at 8 years of age and the increase in height during puberty (8 to 14 years of age) were also associated with breast cancer. The attributable risks of birth weight, height at 14 years of age, BMI at 14 years of age, and age at peak growth were 7 percent, 15 percent, 15 percent, and 9 percent, respectively. No effect of adjusting for age at menarche, age at first childbirth, and parity was observed. CONCLUSIONS: Birth weight and growth during childhood and adolescence influence the risk of breast cancer.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Copenhagen Univ Hosp, Inst Prevent Med, Danish Epidemiol Sci Ctr, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Aarhus University; University of Copenhagen	Ahlgren, M (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	abk@ssi.dk		melbye, mads/0000-0001-8264-6785				Ahlgren M, 2003, INT J CANCER, V107, P997, DOI 10.1002/ijc.11481; Andersson SW, 2001, BRIT J CANCER, V84, P1193, DOI 10.1054/bjoc.2000.1738; De Stavola BL, 2000, BRIT J CANCER, V83, P964, DOI 10.1054/bjoc.2000.1370; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; Friedenreich CM, 2001, EUR J CANCER PREV, V10, P15, DOI 10.1097/00008469-200102000-00003; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Herrinton LJ, 2001, AM J EPIDEMIOL, V154, P618, DOI 10.1093/aje/154.7.618; Hilakivi-Clarke L, 2001, BRIT J CANCER, V85, P1680, DOI 10.1054/bjoc.2001.2109; Howard BA, 2000, J MAMMARY GLAND BIOL, V5, P119, DOI 10.1023/A:1026487120779; Hubinette A, 2001, INT J CANCER, V91, P248, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1025>3.3.CO;2-H; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; Kaijser M, 2001, J NATL CANCER I, V93, P60, DOI 10.1093/jnci/93.1.60; KVALE G, 1988, CANCER-AM CANCER SOC, V62, P1625, DOI 10.1002/1097-0142(19881015)62:8<1625::AID-CNCR2820620828>3.0.CO;2-K; LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99; LEMARCHAND L, 1988, AM J EPIDEMIOL, V128, P137; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Petersen Tove Anne-Grete, 2002, Ugeskr Laeger, V164, P5006; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Rasmussen Soren, 2002, Ugeskr Laeger, V164, P5011; Rostgaard K, 2000, CANCER CAUSE CONTROL, V11, P669, DOI 10.1023/A:1008928204121; Russo J, 1999, ONCOL RES, V11, P169; Sanderson M, 1998, PAEDIATR PERINAT EP, V12, P397; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; SAS Institute, 2003, SAS STAT US GUID VER; Storm HH, 1997, DAN MED BULL, V44, P535; Titus-Ernstoff L, 2002, CANCER EPIDEM BIOMAR, V11, P207; TRETLI S, 1989, INT J CANCER, V44, P23, DOI 10.1002/ijc.2910440105; Vatten LJ, 2002, BRIT J CANCER, V86, P89, DOI 10.1038/sj.bjc.6600011; 2003, STATA BASE REFERENCE	35	294	303	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2004	351	16					1619	1626		10.1056/NEJMoa040576	http://dx.doi.org/10.1056/NEJMoa040576			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	861OU	15483280				2022-12-01	WOS:000224427300008
J	Briffa, JP				Briffa, JP			The prince and the professor - Which emperor is naked?	BRITISH MEDICAL JOURNAL			English	Letter												drjbriffa@aol.com						Baum M, 2004, BRIT MED J, V329, P118, DOI 10.1136/bmj.329.7457.118; VARMAN S, 2004, BRAVO ELECT RESPONSE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 9	2004	329	7470					858	858		10.1136/bmj.329.7470.858	http://dx.doi.org/10.1136/bmj.329.7470.858			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15472283	Green Published			2022-12-01	WOS:000224472800039
J	Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM				Espagne, E; Dupuy, C; Huguet, E; Cattolico, L; Provost, B; Martins, N; Poirie, M; Periquet, G; Drezen, JM			Genome sequence of a polydnavirus: Insights into symbiotic virus evolution	SCIENCE			English	Article							KAPPA-B; GENE; WASP; PARASITOIDS; INHIBITION; RESISTANCE; PROTEINS; FAMILIES; ORIGINS	Little is known of the fate of viruses involved in long-term obligatory associations with eukaryotes. For example, many species of parasitoid wasps have symbiotic viruses to manipulate host defenses and to allow development of parasitoid larvae. The complete nucleotide sequence of the DNA enclosed in the virus particles injected by a parasitoid wasp revealed a complex organization, resembling a eukaryote genomic region more than a viral genome. Although endocellular symbiont genomes have undergone a dramatic loss of genes, the evolution of symbiotic viruses appears to be characterized by extensive duplication of virulence genes coding for truncated versions of cellular proteins.	UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, F-37200 Tours, France; Natl Ctr Sequencage, Genoscope, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS)	Dupuy, C (corresponding author), UFR Sci & Tech, Inst Rech Biol Insecte, CNRS, UMR 6035,UFR Sci & Tech, Parc Grandrnont, F-37200 Tours, France.	catherine.dupuy@univ-tours.fr	POIRIE, MARYLENE/A-2909-2009; Espagne, Eric/GMX-2417-2022; Espagne, Eric/AAF-9794-2019; Dupuy, Catherine/AFK-5583-2022; martins, natalia florencio/AAE-7875-2019; Huguet, Elisabeth/D-3321-2009	Dupuy, Catherine/0000-0002-3947-3580; Drezen, Jean-Michel/0000-0001-7578-635X; Huguet, Elisabeth/0000-0002-0096-0330; Espagne, Eric/0000-0002-5813-498X				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; BECKAGE NE, 1993, INSECT BIOCHEM MOLEC, V23, P643, DOI 10.1016/0965-1748(93)90038-T; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Belle E, 2002, J VIROL, V76, P5793, DOI 10.1128/JVI.76.11.5793-5796.2002; CLEM RJ, 1994, J VIROL, V68, P6759, DOI 10.1128/JVI.68.10.6759-6762.1994; Dahlman DL, 2003, INSECT MOL BIOL, V12, P527, DOI 10.1046/j.1365-2583.2003.00439.x; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; ESPAGNE E, UNPUB; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; PROVOST B, IN PRESS J VIROL; Revilla Y, 1998, J BIOL CHEM, V273, P5405, DOI 10.1074/jbc.273.9.5405; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Stasiak K, 2000, J GEN VIROL, V81, P3059, DOI 10.1099/0022-1317-81-12-3059; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; Teramato T, 2003, J INSECT PHYSIOL, V49, P463, DOI 10.1016/S0022-1910(03)00063-5; Turnbull M, 2002, ADV VIRUS RES, V58, P203, DOI 10.1016/S0065-3527(02)58006-4; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; WEBB BA, 2002, VIRUS TAXONOMY, P253; Whitfield JB, 1997, NATURWISSENSCHAFTEN, V84, P502, DOI 10.1007/s001140050434; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; WHITFIELD JB, 1990, PARASITOL TODAY, V6, P381, DOI 10.1016/0169-4758(90)90146-U	33	200	215	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					286	289		10.1126/science.1103066	http://dx.doi.org/10.1126/science.1103066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15472078				2022-12-01	WOS:000224419700043
J	Coleman, EA; Berenson, RA				Coleman, EA; Berenson, RA			Lost in transition: Challenges and opportunities for improving the quality of transitional care	ANNALS OF INTERNAL MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; OLDER PATIENTS; HOSPITAL-CARE; FOLLOW-UP; DISCHARGE; INTERVENTION; NEEDS	Transitional care has been defined as a set of actions designed to ensure the coordination and continuity of health care as patients transfer between different locations or different levels of care in the same location. Transitional care, which primarily concerns the relatively brief time interval that begins with preparing a patient to leave one setting and concludes when the patient is received in the next setting, poses challenges that distinguish it from other types of care. Many transitions are unplanned, result from unanticipated medical problems, occur in "real time" during nights and on weekends, involve clinicians who may not have an ongoing relationship with the patient, and happen so quickly that formal and informal support mechanisms cannot respond in a timely manner. This article describes the challenges involved in and potential solutions for improving the quality of transitional care.	Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, Aurora, CO 80011 USA; Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Urban Institute	Coleman, EA (corresponding author), Univ Colorado, Div Hlth Care Policy & Res, Hlth Sci Ctr, 13611 E Colfax,Suite 100, Aurora, CO 80011 USA.	Eric.Coleman@uchsc.edu						*AG HEALTHC RES QU, 2000, MED ERR SCOP PROBL; *ASTM INT MASS MED, CONT CAR REC CCR CON; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; BEERS MH, 1992, HOSP FORMUL, V27, P720; BREWSTER L, EMERGENCY ROOM DIVER; Burns LR, 2002, HEALTH AFFAIR, V21, P128, DOI 10.1377/hlthaff.21.4.128; *CAL HLTH CAR FDN, RES PAT EV PERF PEP; Centers for Medicare and Medicaid Services, HEALTHC COMM PROC CO; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Coleman EA, 2004, J AM GERIATR SOC, V52, pS1; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; COLEMAN EA, 2004, IN PRESS HLTH SERV R; COLEMAN EA, 2004, IN PRESS MED CARE; COLEMAN EA, 2002, ASP TRANS CAR C P; COLEMAN EA, 2002, DEV TESTING MEASURE; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Harrison A, 2002, HEALTH SERV RES, V37, P1031, DOI 10.1034/j.1600-0560.2002.64_2.x; *HMO CAR MAN WORKG, ON PAT MAN PLAC MAN; *I MED COMM DAT ST, 2001, KEY CAP EL HLTH REC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; *JOINT COMM ACCR H, 2001, STAND INT STAT 1, P69; Katz T.F., 2000, ANN LONG TERM CARE, V8, P51; KRAMER A, 2003, SUMMARY STATUS ELECT, P1; LEVINE C, 1998, CROSSINGS FAMILY CAR; *MED PAYM ADV COMM, 2003, US MARK COMP FEE FOR, P131; *MED PAYM ADV COMM, US INC IMPR QUAL CAR; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Partnership for Solutions, 2002, CHRON COND MAK CAS O; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; *US DEP HHS OFF IN, 1997, US DEP HLTH HUM SERV; vom Eigen KA, 1999, MED CARE, V37, P33, DOI 10.1097/00005650-199901000-00006; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Weaver F M, 1998, Home Health Care Serv Q, V17, P27; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008	40	453	457	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2004	141	7					533	535		10.7326/0003-4819-141-7-200410050-00009	http://dx.doi.org/10.7326/0003-4819-141-7-200410050-00009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862CR	15466770				2022-12-01	WOS:000224467800005
J	Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM				Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM			Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1 alpha null mice	CELL			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; CONTROLLING MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL COACTIVATOR PGC-1; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; UNCOUPLING PROTEIN; GLUCOSE-PRODUCTION; BINDING-PROTEIN; TRANSGENIC MICE; CDNA CLONING	PGC-1alpha is a coactivator of nuclear receptors and other transcription factors that regulates several metabolic processes, including mitochondrial biogenesis and respiration, hepatic gluconeogenesis, and muscle fiber-type switching. We show here that, while hepatocytes lacking PGC-1alpha are defective in the program of hormone-stimulated gluconeogenesis, the mice have constitutively activated gluconeogenic gene expression that is completely insensitive to normal feeding controls. C/EBPbeta is elevated in the livers of these mice and activates the gluconeogenic genes in a PGC-1alpha-independent manner. Despite having reduced mitochondrial function, PGC-1alpha null mice are paradoxically lean and resistant to diet-induced obesity. This is largely due to a profound hyperactivity displayed by the null animals and is associated with lesions in the striatal region of the brain that controls movement. These data illustrate a central role for PGC-1alpha in the control of energy metabolism but also reveal novel systemic compensatory mechanisms and pathogenic effects of impaired energy homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Mass Gen Inst Neurodegenerat, Dept Neurol, Charlestown, MA 02129 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06520 USA; Univ Ancona, Fac Med, Inst Normal Human Morphol, I-60020 Ancona, Italy; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Yale University; Marche Polytechnic University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	vianna, claudia/I-4991-2012; Shulman, Gerald I./P-7176-2019; St-Pierre, Julie/AGB-3651-2022; Wu, Pei-Hsuan/AAL-1704-2020	Shulman, Gerald I./0000-0003-1529-5668; St-Pierre, Julie/0000-0002-2815-7099; Wu, Pei-Hsuan/0000-0002-6690-0744; CINTI, Saverio/0000-0003-0362-5017; Fan, Melina/0000-0002-6196-8408; Jager, Sibylle/0000-0001-8102-7149; Wu, Zhidan/0000-0001-7289-9420	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK065584, R01DK040936, R01DK061562, R01DK054477, R56DK054477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045242] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54477, DK61562, R01 DK040936, DK40936, DK065584] Funding Source: Medline; NINDS NIH HHS [NS002174, NS045242] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki T T, 1981, Prog Clin Biol Res, V67, P161; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GRONINGER C, 1997, J BIOL CHEM, V272, P26306; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lieberman LS, 2003, ANNU REV NUTR, V23, P345, DOI 10.1146/annurev.nutr.23.011702.073212; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; PARK EA, 1993, J BIOL CHEM, V268, P613; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tritos NA, 2003, BRAIN RES, V961, P255, DOI 10.1016/S0006-8993(02)03961-6; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	941	980	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					121	+		10.1016/j.cell.2004.09.013	http://dx.doi.org/10.1016/j.cell.2004.09.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454086	Bronze, Green Published			2022-12-01	WOS:000224292600014
J	Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW				Verma, R; Peters, NR; D'Onofrio, M; Tochtrop, GP; Sakamoto, KM; Varadan, R; Zhang, MS; Coffino, P; Fushman, D; Deshaies, RJ; King, RW			Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; 26S PROTEASOME; DEUBIQUITINATION; RECONSTITUTION; RECOGNITION; PROTEOMICS; SUBSTRATE; PROTEINS; MITOSIS; SYSTEM	To identify previously unknown small molecules that inhibit cell cycle machinery, we performed a chemical genetic screen in Xenopus extracts. One class of inhibitors, termed ubistatins, blocked cell cycle progression by inhibiting cyclin B proteolysis and inhibited degradation of ubiquitinated Sic1 by purified proteasomes. Ubistatins blocked the binding of ubiquitinated substrates to the proteasome by targeting the ubiquitin-ubiquitin interface of Lys(48)-linked chains. The same interface is recognized by ubiquitin-chain receptors of the proteasome, indicating that ubistatins act by disrupting a critical protein-protein interaction in the ubiquitin-proteasome system.	Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Mattel Childrens Hosp, Div Hematol Oncol,David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; California Institute of Technology; Howard Hughes Medical Institute; University System of Maryland; University of Maryland College Park; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	King, RW (corresponding author), Harvard Univ, Sch Med, Inst Chem & Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; D'ONOFRIO, Mariapina/0000-0002-8699-0847; Sakamoto, Kathleen/0000-0003-0494-8838	NATIONAL CANCER INSTITUTE [P50CA092131, P01CA078048, R21CA108545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R01GM045335, F32GM068276, R01GM065334, R56GM066492] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA92131, CA78048, R21CA108545] Funding Source: Medline; NIGMS NIH HHS [GM65334, GM068276, R01 GM-45335, GM66492] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; FUSHMAN D, UNPUB; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Mayer TU, 2003, TRENDS CELL BIOL, V13, P270, DOI 10.1016/S0962-8924(03)00077-1; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; PETERS N, UNPUB; Pfleger CM, 2000, GENE DEV, V14, P655; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walling LA, 2001, J CELL BIOCHEM, V84, P7, DOI 10.1002/jcb.10075; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	26	153	158	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					117	120		10.1126/science.1100946	http://dx.doi.org/10.1126/science.1100946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459393	Green Accepted			2022-12-01	WOS:000224304000050
J	Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD				Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD			Recycling endosomes supply AMPA receptors for LTP	SCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; SILENT SYNAPSES; ACTIVATION; INSERTION; CELLS; RAB6; TRANSMISSION	Long-term potentiation (LTP) of synaptic strength, the most established cellular model of information storage in the brain, is expressed by an increase in the number of postsynaptic AMPA receptors. However, the source of AMPA receptors mobilized during LTP is unknown. We report that AMPA receptors are transported from recycling endosomes to the plasma membrane for LTP. Stimuli that triggered LTP promoted not only AMPA receptor insertion but also generalized recycling of cargo and membrane from endocytic compartments. Thus, recycling endosomes supply AMPA receptors for LTP and provide a mechanistic link between synaptic potentiation and membrane remodeling during synapse modification.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Brown University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu		Kauer, Julie/0000-0002-3362-1642	NIDA NIH HHS [DA11289] Funding Source: Medline; NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011289] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Knight DE, 2002, TRAFFIC, V3, P298, DOI 10.1034/j.1600-0854.2002.030407.x; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rosenberg M, 2001, J NEUROSCI, V21, P5036, DOI 10.1523/JNEUROSCI.21-14-05036.2001; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	30	544	556	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1972	1975		10.1126/science.1102026	http://dx.doi.org/10.1126/science.1102026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448273				2022-12-01	WOS:000224136000052
J	Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R				Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R			Inhibition of carbonate synthesis in acidic oceans on early Mars	NATURE			English	Article							IMPACT EROSION; IRON; MINERALS	Several lines of evidence have recently reinforced the hypothesis that an ocean existed on early Mars(1-7). Carbonates are accordingly expected to have formed from oceanic sedimentation of carbon dioxide from the ancient martian atmosphere(7,8). But spectral imaging of the martian surface has revealed the presence of only a small amount of carbonate, widely distributed in the martian dust(9). Here we examine the feasibility of carbonate synthesis in ancient martian oceans using aqueous equilibrium calculations. We show that partial pressures of atmospheric carbon dioxide in the range 0.8-4 bar, in the presence of up to 13.5 mM sulphate and 0.8 mM iron in sea water(8), result in an acidic oceanic environment with a pH of less than 6.2. This precludes the formation of siderite, usually expected to be the first major carbonate mineral to precipitate(8). We conclude that extensive interaction between an atmosphere dominated by carbon dioxide and a lasting sulphate- and iron-enriched acidic ocean on early Mars is a plausible explanation for the observed absence of carbonates.	Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain; CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Arizona; University of Arizona	Fairen, AG (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain.	agfairen@cbm.uam.es	FernÃndez-Remolar, David/AAG-8643-2020; Amils, Ricardo/X-2706-2019; Dohm, James/A-3831-2014	FernÃndez-Remolar, David/0000-0003-2409-7444; 				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Barley ME, 1997, NATURE, V385, P55, DOI 10.1038/385055a0; BHATTACHARYYA A, 1983, MODERN CARBONATE ENV; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Bruland K.W., 1983, CHEM OCEANOGR, P157, DOI 10.1016/b978-0-12-588608-6.50009-2.; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; CARR MH, 2003, J GEOPHYS RES-PLANET, V108, DOI [DOI 10.1029/2002JE001963, 10.1029/2002je001963]; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; CLARK BC, 1999, 5 MARS C LUN PLAN I; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Craddock RA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001505; Dohm JM, 2001, J GEOPHYS RES-PLANET, V106, P32943, DOI 10.1029/2000JE001468; Fairen AG, 2003, ICARUS, V165, P53, DOI 10.1016/S0019-1035(03)00144-1; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HUGUENIN RL, 1974, J GEOPHYS RES, V79, P3895, DOI 10.1029/JB079i026p03895; JOHNSON JW, 1991, SUPCRT92 SOFTWARE PA; Kirkland LE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002105; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Moore JM, 2004, NATURE, V428, P711, DOI 10.1038/428711a; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; SCHAEFER MW, 1993, GEOCHIM COSMOCHIM AC, V57, P4619, DOI 10.1016/0016-7037(93)90187-2; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	30	136	144	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					423	426		10.1038/nature02911	http://dx.doi.org/10.1038/nature02911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386004				2022-12-01	WOS:000224000500032
J	Stanfield, RL; Dooley, H; Flajnik, MF; Wilson, IA				Stanfield, RL; Dooley, H; Flajnik, MF; Wilson, IA			Crystal structure of a shark single-domain antibody V region in complex with lysozyme	SCIENCE			English	Article							ANTIGEN RECEPTOR; SOMATIC DIVERSIFICATION; VARIABLE DOMAIN; LOOP STRUCTURES; LIGHT-CHAINS; IMMUNOGLOBULINS; VERTEBRATE; EVOLUTION; FRAGMENT; REARRANGEMENT	Cartilaginous fish are the phylogenetically oldest living organisms known to possess components of the vertebrate adaptive immune system. Key to their immune response are heavy-chain, homodimeric immunoglobulins called new antigen receptors (IgNARs), in which the variable (V) domains recognize antigens with only a single immunoglobulin domain, akin to camelid heavy-chain V domains. The 1.45 angstrom resolution crystal structure of the type I IgNAR V domain in complex with hen egg-white lysozyme (HEL) reveals a minimal antigen-binding domain that contains only two of the three conventional complementarity-determining regions but still binds HEL with nanomolar affinity by means of a binding interface comparable in size to conventional antibodies.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Natl Aquarium, Baltimore, MD 21202 USA	Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Dooley, Helen/N-9872-2018; Stanfield, Robyn/AAH-3190-2019	Dooley, Helen/0000-0002-2570-574X; stanfield, robyn/0000-0001-9521-9184; Flajnik, Martin Francis/0000-0002-2792-5084	NCRR NIH HHS [RR06603] Funding Source: Medline; NIGMS NIH HHS [GM38273] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038273, R01GM038273] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Diaz M, 2002, IMMUNOGENETICS, V54, P501, DOI 10.1007/s00251-002-0479-z; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; FLAJNIK MJ, UNPUB; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HINDS KR, 1986, NATURE, V320, P546, DOI 10.1038/320546a0; KOKUBU F, 1988, EMBO J, V7, P3413, DOI 10.1002/j.1460-2075.1988.tb03215.x; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Nuttall SD, 2002, FEBS LETT, V516, P80, DOI 10.1016/S0014-5793(02)02506-1; Nuttall SD, 2001, MOL IMMUNOL, V38, P313, DOI 10.1016/S0161-5890(01)00057-8; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; Spinelli S, 2001, J MOL BIOL, V311, P123, DOI 10.1006/jmbi.2001.4856; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a	30	199	237	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1770	1773		10.1126/science.1101148	http://dx.doi.org/10.1126/science.1101148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15319492				2022-12-01	WOS:000224039500040
J	Rando, TA				Rando, TA			Artificial sweeteners - Enhancing glycosylation to treat muscular dystrophies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.							BARRESI R, 2004, NAT MED, V117, P953; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192	5	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1254	1256		10.1056/NEJMcibr042066	http://dx.doi.org/10.1056/NEJMcibr042066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371584				2022-12-01	WOS:000223861300017
J	Weinstein, AR; Sesso, HD; Lee, IM; Cook, NR; Manson, JE; Buring, JE; Gaziano, JM				Weinstein, AR; Sesso, HD; Lee, IM; Cook, NR; Manson, JE; Buring, JE; Gaziano, JM			Relationship of physical activity vs body mass index with type 2 diabetes in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; LIFE-STYLE; MELLITUS; EXERCISE; PREVENTION; OBESITY; DISEASE; WEIGHT; HEALTH; DIET	Context Physical inactivity and body mass index (BMI) are established independent risk factors in the development of type 2 diabetes; however, their comparative importance and joint relationship with diabetes are unclear. Objective To examine the relative contributions and joint association of physical activity and BMI with diabetes. Design, Setting, and Participants Prospective cohort study of 37878 women free of cardiovascular disease, cancer, and diabetes with 6.9 years of mean follow-up. Weight, height, and recreational activities were reported at study entry. Normal weight was defined as a BMI of less than 25; overweight, 25 to less than 30; and obese, 30 or higher. Active was defined as expending more than 1000 kcal on recreational activities per week. Main Outcome Measure Incident type 2 diabetes, defined as anew self-reported diagnosis of diabetes. Results During the follow-up, 1361 cases of incident diabetes occurred. Individually, BMI and physical Activity were significant predictors of incident diabetes. Compared with normal-weight individuals, the multivariate-adjusted hazard ratio (HR) was 3.22 (95% confidence interval [CI], 2.69-3.87) for overweight individuals and 9.09 (95% CI, 7.62-10.8) for obese individuals. For overall activity (kilocalories expended per week), compared with the least active first quartile, the multivariate-adjusted HRs were 0.91 (95% CI, 0.79-1.06) for the second quartile, 0.86 (95% CI, 0.74-1.01) for the third, and 0.82 (95% CI, 0.70-0.97) for the fourth (P for trend=.01). In the combined analyses, overweight and obese participants, whether active or inactive, had significantly elevated risks, compared with normal-weight active individuals. The multivariate-adjusted HRS were 1.15 (95% CI, 0.83-1.59) for normal-weight inactive, 3.68 (95% CI, 2.63-5.15) for overweight active, 4.16 (95% CI, 3.05-5.66) for overweight inactive, 11.5 (95% CI, 8.34-15.9) for obese active, and 11.8 (95% CI, 8.75-16.0) for obese inactive participants. Conclusions Although BMI and physical inactivity are independent predictors of incident diabetes, the magnitude of the association with BMI was greater than with physical activity in combined analyses. These findings underscore the critical importance of adiposity as a determinant of diabetes.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston VA Healthcare Syst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Weinstein, AR (corresponding author), Womens Hlth Ctr Hlth Care Associates, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Atrium Suite, Boston, MA 02115 USA.	aweinste@bidmc.harvard.edu	Lee, I-Min/ABD-5409-2021		NCI NIH HHS [CA-4799] Funding Source: Medline; NHLBI NIH HHS [HL-43851, HL-65727] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R03HL065727] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blumenthal JA, 2000, ARCH INTERN MED, V160, P1947, DOI 10.1001/archinte.160.13.1947; Boden G, 2001, ENDOCRIN METAB CLIN, V30, P801, DOI 10.1016/S0889-8529(05)70216-4; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P30; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Folsom AR, 2000, AM J PUBLIC HEALTH, V90, P134, DOI 10.2105/AJPH.90.1.134; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 1996, RES Q EXERCISE SPORT, V67, P206, DOI 10.1080/02701367.1996.10607944; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/s001250050414; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization Expert Committee on Physical Status, 1995, US INT ANTHR REP WHO	27	243	253	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2004	292	10					1188	1194		10.1001/jama.292.10.1188	http://dx.doi.org/10.1001/jama.292.10.1188			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851ZA	15353531	Bronze			2022-12-01	WOS:000223723800018
J	Doherty, RB				Doherty, RB			Assessing the new medicare prescription drug law	ANNALS OF INTERNAL MEDICINE			English	Article								The Medicare Modernization Act (MMA) is the product of a political compromise to attract moderate Republicans and enough Democrats without losing Republican conservatives. The compromise offered more private health plans to beneficiaries while maintaining and improving traditional Medicare's benefits. This compromise did not settle the debate over the legislation, which is a major issue in the 2004 elections. Voters poorly understand the law because of its complexity. In this paper, I explain how the policy decisions made by the U.S. Congress have contributed to the law's complexity and controversy. I examine the new private health plan options that will be offered to beneficiaries, improvements made to traditional Medicare, and the impact of introducing income-based determinations into Medicare. I also discuss the impact of the drug benefit on beneficiaries in different income and assets categories and Congress's decision to prohibit the federal government from directly negotiating prices with drug manufacturers. I conclude by assessing the major claims made by critics and proponents. Both might be more circumspect in their assessments of the law's impact, since it is impossible to predict how a law of such complexity, with so many human variables, will work out in the end. The MMA is a worthwhile but imperfect effort to extend drug coverage to seniors who are most in need. It deserves neither condemnation nor indiscriminate praise but instead a commitment to help it succeed.	Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							*AARP, MED CHANG COULD AFF; Altman DE, 2004, NEW ENGL J MED, V350, P9, DOI 10.1056/NEJMp038224; BALL RM, 1997, MED PREPARING CHALLE; BUSH GW, 2003, REMARKS PRESIDENT SI; Holtz-Eakin D, 2004, COMMUNICATION   0123; *KAIS FAM FDN, 2004, MARCH APR 2004 KAIS; KENNEDY EM, 2003, DINGELL ANNOUNCE THE; 2003, ANG SEN CONTR EUPH W; 2004, PRESCR DRUG COV MED	9	25	25	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					391	395		10.7326/0003-4819-141-5-200409070-00100	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00100			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353431				2022-12-01	WOS:000223733800008
J	Gardner, A; West, SA				Gardner, A; West, SA			Spite among siblings	SCIENCE			English	Editorial Material							POLYEMBRYONIC WASP; COMPETITION		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Gardner, A (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	andy.gardner@ed.ac.uk	West, Stuart A/M-3608-2014; Gardner, Andy/K-5353-2013	West, Stuart A/0000-0003-2152-3153; Gardner, Andy/0000-0002-1304-3734				Donnell DM, 2004, P NATL ACAD SCI USA, V101, P10095, DOI 10.1073/pnas.0403625101; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Giron D, 2004, NATURE, V430, P676, DOI 10.1038/nature02721; GIRON D, 2004, P R SOC B S     0617, DOI DOI 10.1098/RSB1.2004.0205; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0	9	23	24	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1413	1414		10.1126/science.1103635	http://dx.doi.org/10.1126/science.1103635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353789				2022-12-01	WOS:000223761900032
J	Carucci, D				Carucci, D			Know thine enemy	NATURE			English	Article							PLASMODIUM-FALCIPARUM; LIFE-CYCLE; PROTEINS; INVASION; SEQUENCE; GENOME		Fdn Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Carucci, D (corresponding author), Fdn Natl Inst Hlth, Bethesda, MD USA.							BORDECH Z, 2003, PLOS BIOL, V1, pE5; Cowman AF, 2002, SCIENCE, V298, P126, DOI 10.1126/science.1078169; Doolan DL, 2003, J EXP BIOL, V206, P3789, DOI 10.1242/jeb.00615; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642	10	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					944	945		10.1038/430944a	http://dx.doi.org/10.1038/430944a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318241	Bronze			2022-12-01	WOS:000223369800064
J	Hoffman, S				Hoffman, S			Save the children	NATURE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM; MALARIA; GENOMICS; EFFICACY		Sanaria, Rockville, MD USA	Sanaria Inc.	Hoffman, S (corresponding author), Sanaria, Rockville, MD USA.							Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Long CA, 2002, SCIENCE, V297, P345, DOI 10.1126/science.1074484; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202	8	11	16	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					940	941		10.1038/430940a	http://dx.doi.org/10.1038/430940a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318239				2022-12-01	WOS:000223369800062
J	Ridley, R; Toure, Y				Ridley, R; Toure, Y			Winning the drugs war	NATURE			English	Article							DISCOVERY		UNICEF UNDP World Bank WHO Special Programme Res, New York, NY 10017 USA	UNICEF	Ridley, R (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, New York, NY 10017 USA.							Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 2003, AFR MAL REP 2003; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; *MMV, 2004, MED MAL VENT ANN REP; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; World Health Organization, 2004, SCAL HOM BAS MAN MAL	10	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					942	943		10.1038/430942a	http://dx.doi.org/10.1038/430942a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318240				2022-12-01	WOS:000223369800063
J	Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM				Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM			Outcomes of allergy to insect stings in children, with and without venom immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE LOCAL REACTIONS; QUALITY-OF-LIFE; NATURAL-HISTORY; DISCONTINUATION	Background: Children are thought to "outgrow'' the allergy to insect stings, but there are no reports documenting the natural history of this reaction. We studied the outcome of allergic reactions to insect stings in childhood 10 to 20 years afterward in patients who had not received venom immunotherapy and in those who had been treated. Methods: Between 1978 and 1985, we diagnosed allergic reaction to insect stings in 1033 children, of whom 356 received venom immunotherapy. We conducted a survey of these patients by telephone and mail between January 1997 and January 2000, to determine the outcome of stings that occurred in the period from 1987 through 1999. Results: Of the 1033 patients, 512 patients (50 percent) responded, with a mean follow-up period of 18 years, a mean duration of venom immunotherapy of 3.5 years in treated patients, and an incidence of stings of 43 percent. Systemic reactions occurred less frequently in patients who had received venom immunotherapy (2 of 64 patients, or 3 percent) than in untreated patients (19 of 111 patients, or 17 percent; P=0.007). Patients with a history of moderate-to-severe reactions had a higher rate of reaction if they had not been treated (7 of 22 patients, or 32 percent) than if they had received venom immunotherapy (2 of 43 patients, or 5 percent; P=0.007). In patients who had been treated and who had a history of mild (cutaneous) systemic reaction (i.e., one with only cutaneous manifestations), none of the 21 subjects who received stings had a systemic reaction. Conclusions: A clinically important number of children do not outgrow allergic reactions to insect stings. Venom immunotherapy in children leads to a significantly lower risk of systemic reaction to stings even 10 to 20 years after treatment is stopped, and this prolonged benefit is greater than the benefit seen in adults.	Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Golden, DBK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Blvd, Baltimore, MD 21224 USA.	dgolden1@jhmi.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI008270, R01AI008270] Funding Source: NIH RePORTER; NIAID NIH HHS [AI08270] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNARD JH, 1973, J ALLERGY CLIN IMMUN, V52, P259, DOI 10.1016/0091-6749(73)90044-4; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V109, P162, DOI 10.1067/mai.2002.120552; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V110, P174, DOI 10.1067/mai.2002.125827; Golden DBK, 2000, J ALLERGY CLIN IMMUN, V105, P385, DOI 10.1016/S0091-6749(00)90092-7; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.115095; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; GRAFT DF, 1984, J PEDIATR-US, V104, P664, DOI 10.1016/S0022-3476(84)80940-3; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Lerch E, 1998, J ALLERGY CLIN IMMUN, V101, P606, DOI 10.1016/S0091-6749(98)70167-8; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; Light WC, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.114985; MAURIELLO PM, 1984, J ALLERGY CLIN IMMUN, V74, P494, DOI 10.1016/0091-6749(84)90384-1; SCHUBERTH KC, 1988, J ALLERGY CLIN IMMUN, V81, P200, DOI 10.1016/0091-6749(88)90364-8; SCHUBERTH KC, 1982, J PEDIATR-US, V100, P546, DOI 10.1016/S0022-3476(82)80750-6; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305	16	176	185	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					668	674		10.1056/NEJMoa022952	http://dx.doi.org/10.1056/NEJMoa022952			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306668				2022-12-01	WOS:000223225500009
J	Peters, A; von Klot, S; Heier, M; Trentinaglia, I; Hormann, A; Wichmann, HE; Lowel, H				Peters, A; von Klot, S; Heier, M; Trentinaglia, I; Hormann, A; Wichmann, HE; Lowel, H		Cooperative Hlth Res Region Augsbu	Exposure to traffic and the onset of myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARTICULATE AIR-POLLUTION; HEART-RATE-VARIABILITY; HEAVY PHYSICAL EXERTION; CASE-CROSSOVER; BLOOD MARKERS; CAR DRIVERS; MORTALITY; RISK; ASSOCIATION; DISEASE	BACKGROUND: An association between exposure to vehicular traffic in urban areas and the exacerbation of cardiovascular disease has been suggested in previous studies. This study was designed to assess whether exposure to traffic can trigger myocardial infarction. METHODS: We conducted a case-crossover study in which cases of myocardial infarction were identified with the use of data from the Cooperative Health Research in the Region of Augsburg Myocardial Infarction Registry in Augsburg, in southern Germany, for the period from February 1999 to July 2001. There were 691 subjects for whom the date and time of the myocardial infarction were known who had survived for at least 24 hours after the event, completed the registry's standardized interview, and provided information on factors that may have triggered the myocardial infarction. Data on subjects' activities during the four days preceding the onset of symptoms were collected with the use of patient diaries. RESULTS: An association was found between exposure to traffic and the onset of a myocardial infarction within one hour afterward (odds ratio, 2.92; 95 percent confidence interval, 2.22 to 3.83; P<0.001). The time the subjects spent in cars, on public transportation, or on motorcycles or bicycles was consistently linked with an increase in the risk of myocardial infarction. Adjusting for the level of exercise on a bicycle or for getting up in the morning changed the estimated effect of exposure to traffic only slightly (odds ratio for myocardial infarction, 2.73; 95 percent confidence interval, 2.06 to 3.61; P<0.001). The subject's use of a car was the most common source of exposure to traffic; nevertheless, there was also an association between time spent on public transportation and the onset of a myocardial infarction one hour later. CONCLUSIONS: Transient exposure to traffic may increase the risk of myocardial infarction in susceptible persons.	GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-87564 Neuherberg, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Hlth Econ, D-87564 Neuherberg, Germany; Univ Munich, Fac Med, Dept Epidemiol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Peters, A (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, Ingolstadter Landstr 1, D-87564 Neuherberg, Germany.	peters@gsf.de	Heier, Margit/AAT-5280-2020; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022	Peters, Annette/0000-0001-6645-0985; 				Adams HS, 2001, SCI TOTAL ENVIRON, V279, P29, DOI 10.1016/S0048-9697(01)00723-9; Akiyama T, 2001, NEW ENGL J MED, V345, P391, DOI 10.1056/NEJM200108093450601; BEVAN MAJ, 1991, ENVIRON SCI TECHNOL, V25, P788, DOI 10.1021/es00016a026; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; FORASTIERE F, 1994, AM J IND MED, V26, P785, DOI 10.1002/ajim.4700260607; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Ising Hartmut, 1999, Noise Health, V1, P37; Liao DP, 1999, ENVIRON HEALTH PERSP, V107, P521, DOI 10.2307/3434393; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mittleman MA, 2001, CIRCULATION, V103, P2805; MULLER JE, 1994, J AM COLL CARDIOL, V23, P809, DOI 10.1016/0735-1097(94)90772-2; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Pekkanen J, 2000, OCCUP ENVIRON MED, V57, P818, DOI 10.1136/oem.57.12.818; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Praml G, 2000, INT ARCH OCC ENV HEA, V73, P209, DOI 10.1007/s004200050029; Rank J, 2001, SCI TOTAL ENVIRON, V279, P131, DOI 10.1016/S0048-9697(01)00758-6; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2001, ENVIRON HEALTH PERSP, V109, P405, DOI 10.2307/3434788; VANWIJNEN JH, 1995, INT ARCH OCC ENV HEA, V67, P187, DOI 10.1007/BF00626351; Verrier Richard L., 1996, Cardiology Clinics, V14, P289; Williams JE, 2000, CIRCULATION, V101, P2034, DOI 10.1161/01.CIR.101.17.2034; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; [No title captured]	38	688	705	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2004	351	17					1721	1730		10.1056/NEJMoa040203	http://dx.doi.org/10.1056/NEJMoa040203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863TH	15496621				2022-12-01	WOS:000224585200007
J	Lederman, MM; Veazey, RS; Offord, R; Mosier, DE; Dufour, J; Mefford, M; Piatak, M; Lifson, JD; Salkowitz, JR; Rodriguez, B; Blauvelt, A; Hartley, O				Lederman, MM; Veazey, RS; Offord, R; Mosier, DE; Dufour, J; Mefford, M; Piatak, M; Lifson, JD; Salkowitz, JR; Rodriguez, B; Blauvelt, A; Hartley, O			Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; HIV-1 INFECTION; PRIMATE LENTIVIRUSES; LANGERHANS CELLS; RANTES ANALOGS; DC-SIGN; CORECEPTOR; INTERNALIZATION; RESISTANCE; RECEPTORS	Topical agents, such as microbicides, that can protect against human immunodeficiency virus (HIV) transmission are urgently needed. Using a chimeric simian/human immunodeficiency virus (SHIV SF162), which is tropic for the chemokine receptor CCR5, we report that topical application of high doses of PSC-RANTES, an amino terminus-modified analog of the chemokine RANTES, provided potent protection against vaginal challenge in rhesus macaques. These experimental findings have potentially important implications for understanding vaginal transmission of HIV and the design of strategies for its prevention.	Case Western Reserve Univ, Univ Hosp, Dept Med, Cleveland, OH 44106 USA; Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; Univ Geneva, Fac Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva 4, Switzerland; Scripps Res Inst, La Jolla, CA 92037 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA; NCI, Dermatol Branch, Bethesda, MD 20892 USA	Case Western Reserve University; University Hospitals of Cleveland; Tulane University; University of Geneva; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lederman, MM (corresponding author), Case Western Reserve Univ, Univ Hosp, Dept Med, 2061 Cornell Rd, Cleveland, OH 44106 USA.	MXL6@case.edu	Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Mefford, Megan/0000-0003-4441-7134	NCI NIH HHS [N01-CO-124000] Funding Source: Medline; NIAID NIH HHS [AI 36219, AI 51649] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, P01AI051649] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Davis CW, 2004, J EXP MED, V199, P1037, DOI 10.1084/jem.20040426; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; HARTLEY O, UNPUB; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; MOSIER DE, UNPUB; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Sabbe R, 2001, J VIROL, V75, P661, DOI 10.1128/JVI.75.2.661-671.2001; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; VEAZEY RS, UNPUB; Wu L, 2002, P NATL ACAD SCI USA, V99, P1568, DOI 10.1073/pnas.032654399; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	33	304	324	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					485	487		10.1126/science.1099288	http://dx.doi.org/10.1126/science.1099288			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486300				2022-12-01	WOS:000224626500053
J	McClure, SM; Laibson, DI; Loewenstein, G; Cohen, JD				McClure, SM; Laibson, DI; Loewenstein, G; Cohen, JD			Separate neural systems value immediate and delayed monetary rewards	SCIENCE			English	Article							FMRI; PREDICTION; BRAIN; ANTICIPATION; CIRCUITRY; TIME	When humans are offered the choice between rewards available at different points in time, the relative values of the options are discounted according to their expected delays until delivery. Using functional magnetic resonance imaging, we examined the neural correlates of time discounting while subjects made a series of choices between monetary reward options that varied by delay to delivery. We demonstrate that two separate systems are involved in such decisions. Parts of the limbic system associated with the midbrain dopamine system, including paralimbic cortex, are preferentially activated by decisions involving immediately available rewards. In contrast, regions of the lateral prefrontal. cortex and posterior parietal cortex are engaged uniformly by intertemporal choices irrespective of delay. Furthermore, the relative engagement of the two systems is directly associated with subjects' choices, with greater relative fronto-parietal activity when subjects choose longer term options.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Harvard University; National Bureau of Economic Research; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McClure, SM (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	smcclure@princeton.edu	Laibson, David/AAA-7362-2022; Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005842] Funding Source: NIH RePORTER; NIA NIH HHS [AG05842] Funding Source: Medline; NIMH NIH HHS [MH132804, MH065214] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Ainslie G., 1992, PICOECONOMICS; Angeletos GM, 2001, J ECON PERSPECT, V15, P47, DOI 10.1257/jep.15.3.47; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benabou R, 2002, ECON LETT, V77, P419, DOI 10.1016/S0165-1765(02)00158-1; BIEDERMAN J, 2002, J ATTEN DISORD, V6, pS1; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Elster J., 1979, ULYSSES SIRENS STUDI; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Giordano LA, 2002, PSYCHOPHARMACOLOGY, V163, P174, DOI 10.1007/s00213-002-1159-2; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HOEBEL BG, 1985, AM J CLIN NUTR, V42, P1133, DOI 10.1093/ajcn/42.5.1133; Kagel John H., 1995, EC CHOICE THEORY EXP; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; KOOPMANS TC, 1964, ECONOMETRICA, V32, P82, DOI 10.2307/1913736; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; MACMILLAN M, 1992, BRAIN COGNITION, V19, P72, DOI 10.1016/0278-2626(92)90038-N; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; PHELPS ES, 1968, REV ECON STUD, V35, P185, DOI 10.2307/2296547; Rachlin H, 2000, SCI SELF CONTROL; RACHLIN H, 1989, JUDGMENT DECISION CH, pCH7; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHEFRIN HM, 1988, ECON INQ, V26, P609, DOI 10.1111/j.1465-7295.1988.tb01520.x; Smith, 2000, THEORY MORAL SENTIME; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	41	1886	1942	19	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2004	306	5695					503	507		10.1126/science.1100907	http://dx.doi.org/10.1126/science.1100907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	864IF	15486304				2022-12-01	WOS:000224626500058
J	Leman, L; Orgel, L; Ghadiri, MR				Leman, L; Orgel, L; Ghadiri, MR			Carbonyl sulfide-mediated prebiotic formation of peptides	SCIENCE			English	Article							AQUEOUS MEDIUM; AMINO-ACIDS; POLYPHOSPHATES; POLYMERIZATION; ROCKS	Almost all discussions of prebiotic chemistry assume that amino acids, nucleotides, and possibly other monomers were first formed on the Earth or brought to it in comets and meteorites, and then condensed nonenzymatically to form oligomeric products. However, attempts to demonstrate plausibly prebiotic polymerization reactions have met with limited success. We show that carbonyl sulfide (COS), a simple volcanic gas, brings about the formation of peptides from amino acids under mild conditions in aqueous solution. Depending on the reaction conditions and additives used, exposure of alpha-amino acids to COS generates peptides in yields of up to 80% in minutes to hours at room temperature.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Biol Chem, La Jolla, CA 92037 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu		Leman, Luke/0000-0002-1879-5900				Biron JP, 2004, J AM CHEM SOC, V126, P9198, DOI 10.1021/ja048189s; BUNINGH WC, 1970, Patent No. 3507613; DEWEY RS, 1971, J ORG CHEM, V36, P49; FERM RJ, 1957, CHEM REV, V57, P621, DOI 10.1021/cr50016a002; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HERRINGTON DR, 1986, Patent No. 4618723; Hill AR, 1998, ORIGINS LIFE EVOL B, V28, P235; HIRSCHMA.R, 1967, J ORG CHEM, V32, P3415, DOI 10.1021/jo01286a030; Huber C, 2003, SCIENCE, V301, P938, DOI 10.1126/science.1086501; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Kasting James F., 1998, P35; Keefe AD, 1996, ORIGINS LIFE EVOL B, V26, P111, DOI 10.1007/BF01809851; Liu RH, 1997, NATURE, V389, P52, DOI 10.1038/37944; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; SYMONDS RB, 1994, REV MINERAL, V30, P1; *US EPA, PUBL EPA; YAMAGATA Y, 1991, NATURE, V352, P516, DOI 10.1038/352516a0	18	256	266	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					283	286		10.1126/science.1102722	http://dx.doi.org/10.1126/science.1102722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	861MC	15472077				2022-12-01	WOS:000224419700042
J	Wang, Y; Wysocka, J; Sayegh, J; Lee, YH; Perlin, JR; Leonelli, L; Sonbuchner, LS; McDonald, CH; Cook, RG; Dou, Y; Roeder, RG; Clarke, S; Stallcup, MR; Allis, CD; Coonrod, SA				Wang, Y; Wysocka, J; Sayegh, J; Lee, YH; Perlin, JR; Leonelli, L; Sonbuchner, LS; McDonald, CH; Cook, RG; Dou, Y; Roeder, RG; Clarke, S; Stallcup, MR; Allis, CD; Coonrod, SA			Human PAD4 regulates histone arginine methylation levels via demethylimination	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; RECEPTOR; RNA; DIMETHYLAMINOHYDROLASE; ACETYLATION; RESIDUES; PRMT1; H4	Methylation of arginine (Arg) and lysine residues in histories has been correlated with epigenetic forms of gene regulation. Although histone methyltransferases are known, enzymes that demethylate histories have not been identified. Here, we demonstrate that human peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. PAD4 targets multiple sites in histones H3 and H4, including those sites methylated by coactivators CARM1 (H3 Arg(17)) and PRMT1 (H4 Arg(3)). A decrease of histone Arg methylation, with a concomitant increase of citrullination, requires PAD4 activity in human HL-60 granulocytes. Moreover, PAD4 activity is linked with the transcriptional regulation of estrogen-responsive genes in MCF-7 cells. These data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histories.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Cornell Univ, Dept Med Genet, Weill Med Coll, New York, NY 10021 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University; Cornell University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; Baylor College of Medicine; Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, Box 78,1230 York Ave, New York, NY 10021 USA.	alliscd@rockefeller.edu; scc2003@med.cornell.edu	zhang, shijun/K-3688-2013; Lee, Young-Ho/G-2361-2014; Leonelli, Lauriebeth/GYU-8762-2022	Lee, Young-Ho/0000-0001-6415-4912; Leonelli, Lauriebeth/0000-0001-7536-523X; Wang, Yanming/0000-0002-0710-043X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055274, R01DK055274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020] Funding Source: NIH RePORTER; NICHD NIH HHS [HD R01 38353] Funding Source: Medline; NIDDK NIH HHS [DK55274] Funding Source: Medline; NIGMS NIH HHS [GM R01 26020, GM R01 50659] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Georgieva EI, 1999, ANAL BIOCHEM, V269, P399, DOI 10.1006/abio.1999.4050; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SAYEGH J, UNPUB; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WANG Y, UNPUB; XIE H, 1990, Methods (Orlando), V1, P276, DOI 10.1016/S1046-2023(05)80328-7; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	31	702	740	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					279	283		10.1126/science.1101400	http://dx.doi.org/10.1126/science.1101400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15345777				2022-12-01	WOS:000224419700041
J	Roth, J				Roth, J			Spectre of Noah - "Tell me a story!"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jesserothmd@hotmail.com							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2004	292	13					1530	1530		10.1001/jama.292.13.1530	http://dx.doi.org/10.1001/jama.292.13.1530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859HS	15467040				2022-12-01	WOS:000224254600001
J	Van Valkenburgh, B; Wang, XM; Damuth, J				Van Valkenburgh, B; Wang, XM; Damuth, J			Cope's rule, hypercarnivory, and extinction in North American canids	SCIENCE			English	Article							POPULATION-DENSITY; BODY-MASS; EVOLUTION; SIZE	Over the past 50 million years, successive clades of large carnivorous mammals diversified and then declined to extinction. In most instances, the cause of the decline remains a puzzle. Here we argue that energetic constraints and pervasive selection for larger size (Cope's rule) in carnivores lead to dietary specialization (hypercarnivory) and increased vulnerability to extinction. In two major clades of extinct North American canids, the evolution of large size was associated with a dietary shift to hypercarnivory and a decline in species durations. Thus, selection for attributes that promoted individual success resulted in progressive evolutionary failure of their clades.	Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Natl Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara	Van Valkenburgh, B (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	bvanval@ucla.edu	Wang, Xiaoming/I-9033-2019; Self, Casey J/B-6871-2011	Damuth, John/0000-0002-1635-9726; Wang, Xiaoming/0000-0003-1610-3840				Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Baskin J.A., 1998, EVOLUTION TERTIARY M, V1, P144; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jacobs L.L., 1998, EVOLUTION TERTIARY M; McKinney M.L., 1990, P75; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; SKINNER MF, 1984, B AM MUS NAT HIST, V178, P217; Stanley, 1979, MACROEVOLUTION PATTE; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; TEDFORD RH, 1978, NUTR MANAGEMENT DOGS, pM23; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1990, P181; Van Valkenburgh B, 2003, B AM MUS NAT HIST, P147, DOI 10.1206/0003-0090(2003)279<0147:C>2.0.CO;2; Van Valkenburgh Blaire, 2001, P101; VANVALKENBURGH B, 1993, SYM ZOOL S, P15; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 2002, FOSSIL RECORD PREDA, V8, P267; VOORHIES MR, 1990, 8209 U NEBR; Wang XM, 1999, B AM MUS NAT HIST, P1; WANG XM, 1994, B AM MUS NAT HIST, P1	28	185	186	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					101	104		10.1126/science.1102417	http://dx.doi.org/10.1126/science.1102417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459388				2022-12-01	WOS:000224304000045
J	Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI				Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI			Momentous sprint at the 2156 Olympics?	NATURE			English	Article									Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Univ Southampton, Sch Geog, Southampton SO17 1BJ, Hants, England; KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi, Kenya	University of Oxford; University of Southampton	Tatem, AJ (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	andy.tatem@zoology.oxford.ac.uk	Hay, Simon I/F-8967-2015; Atkinson, Peter M/L-9508-2013	Hay, Simon I/0000-0002-0611-7272; Atkinson, Peter/0000-0002-5489-6880	Wellcome Trust [069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; RENDELL M, 2003, OLYMPICS ATHENS ATHE, P338; Vogel G, 2004, SCIENCE, V305, P632, DOI 10.1126/science.305.5684.632; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0	5	53	54	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					525	525		10.1038/431525a	http://dx.doi.org/10.1038/431525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457248	Green Accepted, Bronze			2022-12-01	WOS:000224156700033
J	Tice, MM; Lowe, DR				Tice, MM; Lowe, DR			Photosynthetic microbial mats in the 3,416-Myr-old ocean	NATURE			English	Article							BARBERTON GREENSTONE-BELT; SOUTH-AFRICA; SWAZILAND SUPERGROUP; CHERTS; SEDIMENTOLOGY; GEOCHEMISTRY; MICROFOSSILS; AUSTRALIA	Recent re-evaluations of the geological record of the earliest life on Earth have led to the suggestion that some of the oldest putative microfossils(1) and carbonaceous matter were formed through abiotic hydrothermal processes(2,3). Similarly, many early Archaean ( more than 3,400-Myr-old) cherts have been reinterpreted as hydrothermal deposits rather than products of normal marine sedimentary processes(2,4,5). Here we present the results of a field, petrographic and geochemical study testing these hypotheses for the 3,416-Myr-old Buck Reef Chert, South Africa. From sedimentary structures and distributions of sand and mud, we infer that deposition occurred in normal open shallow to deep marine environments. The siderite enrichment that we observe in deep-water sediments is consistent with a stratified early ocean(6,7). We show that most carbonaceous matter was formed by photosynthetic mats within the euphotic zone and distributed as detrital matter by waves and currents to surrounding environments. We find no evidence that hydrothermal processes had any direct role in the deposition of either the carbonaceous matter or the enclosing sediments. Instead, we conclude that photosynthetic organisms had evolved and were living in a stratified ocean supersaturated in dissolved silica(8,9) 3,416 Myr ago.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Stanford University	Tice, MM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	mtice@pangea.stanford.edu						[Anonymous], 2006, BROCK BIOL MICROORGA; BOGGS S., 1995, PRINCIPLES SEDIMENTO; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; DEWIT MJ, 1982, ECON GEOL, V77, P1783, DOI 10.2113/gsecongeo.77.8.1783; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; LALLI CM, 1997, BIOL OCEANOGRAPHY IN; Lowe DR, 2003, GEOLOGY, V31, P909, DOI 10.1130/G19664.1; LOWE DR, 1999, GEOL S AM S, P83; LOWE DR, 1994, NOBEL S, V84, P24; PARIS I, 1985, J GEOL, V93, P111, DOI 10.1086/628935; Schidlowski M, 2000, MICROBIAL SEDIMENTS, P84; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SIEVER R, 1992, GEOCHIM COSMOCHIM AC, V56, P3265, DOI 10.1016/0016-7037(92)90303-Z; SIMONSON BM, 1993, PRECAMBRIAN RES, V60, P287, DOI 10.1016/0301-9268(93)90052-4; Sumner DY, 1997, PALAIOS, V12, P302, DOI 10.2307/3515333; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Walsh MM, 1999, GEOL S AM S, V329, P115, DOI 10.1130/0-8137-2329-9.115; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3	21	322	348	4	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					549	552		10.1038/nature02888	http://dx.doi.org/10.1038/nature02888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457255				2022-12-01	WOS:000224156700041
J	Cockell, CS; Stokes, MD				Cockell, CS; Stokes, MD			Ecology - Widespread colonization by polar hypoliths	NATURE			English	Editorial Material									British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92037 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of California System; University of California San Diego; Scripps Institution of Oceanography	Cockell, CS (corresponding author), British Antarctic Survey, NERC, High Cross, Cambridge CB3 0ET, England.	csco@bas.ac.uk						BLISS LC, 1984, HOLARCTIC ECOL, V7, P305; BROADY PA, 1981, BRIT PHYCOL J, V16, P231, DOI 10.1080/00071618100650241; Cockell CS, 2003, POLAR BIOL, V26, P62, DOI 10.1007/s00300-002-0438-z; Cockell CS, 2002, METEORIT PLANET SCI, V37, P1287, DOI 10.1111/j.1945-5100.2002.tb01029.x; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; Schlesinger WH, 2003, ECOLOGY, V84, P3222, DOI 10.1890/02-0549; Smith MC, 2000, ANTARCT SCI, V12, P177, DOI 10.1017/S0954102000000237	8	78	84	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					414	414		10.1038/431414a	http://dx.doi.org/10.1038/431414a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386002	Bronze			2022-12-01	WOS:000224000500030
J	Pikarsky, E; Porat, RM; Stein, I; Abramovitch, R; Amit, S; Kasem, S; Gutkovich-Pyest, E; Urieli-Shoval, S; Galun, E; Ben-Neriah, Y				Pikarsky, E; Porat, RM; Stein, I; Abramovitch, R; Amit, S; Kasem, S; Gutkovich-Pyest, E; Urieli-Shoval, S; Galun, E; Ben-Neriah, Y			NF-kappa B functions as a tumour promoter in inflammation-associated cancer	NATURE			English	Article							HEPATOCELLULAR-CARCINOMA; MOUSE MODEL; DNA-DAMAGE; IKK-BETA; LIVER; APOPTOSIS; MICE; ACTIVATION; INHIBITION; TARGET	The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accounting for approximately 20% of human cancer(1). Whereas the causal relationship between carcinogen exposure and cancer has been intensely investigated(2), the molecular and cellular mechanisms linking chronic inflammation to tumorigenesis remain largely unresolved(1). We proposed that activation of the nuclear factor kappaB (NF-kappaB), a hallmark of inflammatory responses(3) that is frequently detected in tumours(4,5), may constitute a missing link between inflammation and cancer. To test this hypothesis, we studied the Mdr2-knockout mouse strain, which spontaneously develops cholestatic hepatitis followed by hepatocellular carcinoma(6), a prototype of inflammation-associated cancer(7). We monitored hepatitis and cancer progression in Mdr2-knockout mice, and here we show that the inflammatory process triggers hepatocyte NF-kappaB through upregulation of tumour-necrosis factor-alpha (TNFalpha) in adjacent endothelial and inflammatory cells. Switching off NF-kappaB in mice from birth to seven months of age, using a hepatocyte-specific inducible IkappaB-super-repressor transgene, had no effect on the course of hepatitis, nor did it affect early phases of hepatocyte transformation. By contrast, suppressing NF-kappaB inhibition through anti-TNFalpha treatment or induction of IkappaB-superrepressor in later stages of tumour development resulted in apoptosis of transformed hepatocytes and failure to progress to hepatocellular carcinoma. Our studies thus indicate that NF-kappaB is essential for promoting inflammation-associated cancer, and is therefore a potential target for cancer prevention in chronic inflammatory diseases.	Hadassah Hebrew Univ Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Hematol Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Pikarsky, E (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	pikarsky, eli/GXV-7099-2022; Galun, Eithan/AAD-9117-2022; Ben-Neriah, Yinon/L-6285-2019	Galun, Eithan/0000-0002-6243-6702; pikarsky, eli/0000-0003-4186-7105				Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lavon I, 2003, CANCER RES, V63, P25; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MAUAD TH, 1994, AM J PATHOL, V145, P1237; MAYO MW, 2000, BIOCHIM BIOPHYS ACTA, V1470, P55; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Staudt LM, 2003, NEW ENGL J MED, V348, P1777, DOI 10.1056/NEJMra020067; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Wang JS, 1999, MUTAT RES-FUND MOL M, V424, P167, DOI 10.1016/S0027-5107(99)00017-2; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419	27	1992	2122	8	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					461	466		10.1038/nature02924	http://dx.doi.org/10.1038/nature02924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15329734				2022-12-01	WOS:000224000500043
J	Beliveau, R; Gingras, D				Beliveau, R; Gingras, D			Green tea: prevention and treatment of cancer by nutraceuticals	LANCET			English	Editorial Material									Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada	University of Quebec; University of Quebec Montreal	Beliveau, R (corresponding author), Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada.	beliveau.richard@uqam.ca						Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; de Botton S, 2004, J CLIN ONCOL, V22, P1404, DOI 10.1200/JCO.2004.09.008; Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855; Gescher AJ, 2001, LANCET ONCOL, V2, P371, DOI 10.1016/S1470-2045(00)00392-2; Lamy S, 2002, CANCER RES, V62, P381; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830	10	32	34	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1021	1022		10.1016/S0140-6736(04)17076-1	http://dx.doi.org/10.1016/S0140-6736(04)17076-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380952				2022-12-01	WOS:000223959300008
J	Levey, DJ; Duncan, RS; Levins, CF				Levey, DJ; Duncan, RS; Levins, CF			Use of dung as a tool by burrowing owls	NATURE			English	Editorial Material							CALEDONIAN CROWS; ECOLOGY		Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Birmingham So Coll, Div Sci & Math, Birmingham, AL 35254 USA	State University System of Florida; University of Florida	Levey, DJ (corresponding author), Univ Florida, Dept Zool, POB 118525, Gainesville, FL 32611 USA.	dlevey@zoo.ufl.edu						Cristol DA, 1997, AUK, V114, P296, DOI 10.2307/4089172; HAUG EA, 1993, BURROWING OWL; HENRICH B, 1988, CONDOR, V90, P270; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; MARTIN DJ, 1973, CONDOR, V75, P446, DOI 10.2307/1366565; ROBINSON SK, 1994, WILSON BULL, V106, P567; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Woodruff R. E., 1973, SCARAB BEETLES FLORI	9	40	45	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					39	39		10.1038/431039a	http://dx.doi.org/10.1038/431039a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343324				2022-12-01	WOS:000223641500031
J	Heathcote, J				Heathcote, J			Abnormal liver function found after an unplanned consultation: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									S View Lodge, Bromley BR1 3DR, Kent, England		Heathcote, J (corresponding author), S View Lodge, Bromley BR1 3DR, Kent, England.	james.heathcote@gp-G84001.nhs.uk							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 28	2004	329	7464					500	500		10.1136/bmj.329.7464.500	http://dx.doi.org/10.1136/bmj.329.7464.500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331476	Green Published			2022-12-01	WOS:000223684600021
J	Sun, HM; Ringdahl, U; Homeister, JW; Fay, WP; Engleberg, NC; Yang, AY; Rozek, LS; Wang, XX; Sjobring, U; Ginsburg, D				Sun, HM; Ringdahl, U; Homeister, JW; Fay, WP; Engleberg, NC; Yang, AY; Rozek, LS; Wang, XX; Sjobring, U; Ginsburg, D			Plasminogen is a critical host pathogenicity factor for group A streptococcal infection	SCIENCE			English	Article							LIGNEOUS CONJUNCTIVITIS; PLASMIN(OGEN) SYSTEM; PROTEIN PAM; VIRULENCE; MICE; DEFICIENCY; STREPTOKINASE; THROMBOSIS; ACTIVATION; PYOGENES	Group A streptococci, a common human pathogen, secrete streptokinase, which activates the host's blood clot-dissolving protein, plasminogen. Streptokinase is highly specific for human plasminogen, exhibiting little or no activity against other mammalian species, including mouse. Here, a transgene expressing human plasminogen markedly increased mortality in mice infected with streptococci, and this susceptibility was dependent on bacterial streptokinase expression. Thus, streptokinase is a key pathogenicity factor and the primary determinant of host species specificity for group A streptococcal infection. In addition, local fibrin clot formation may be implicated in host defense against microbial pathogens.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Lund Univ, Dept Lab Med, Sect Microbiol Immunol & Glycobiol, SE-22184 Lund, Sweden	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Lund University	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01HL057346] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Boyle MDP, 2000, METHODS, V21, P99, DOI 10.1006/meth.2000.0980; Braunwald E, 1996, NEW ENGL J MED, V334, P51, DOI 10.1056/NEJM199601043340113; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Collen D, 1998, NAT MED, V4, P279, DOI 10.1038/nm0398-279; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P863, DOI 10.1111/j.1432-1033.1994.00863.x; Lijnen HR, 1999, BLOOD, V93, P2274, DOI 10.1182/blood.V93.7.2274.407a30_2274_2281; MCCOY HE, 1991, J INFECT DIS, V164, P515, DOI 10.1093/infdis/164.3.515; MCKILLOP C, 1975, NATURE, V255, P638, DOI 10.1038/255638a0; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Schott D, 1998, NEW ENGL J MED, V339, P1679, DOI 10.1056/NEJM199812033392305; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	24	300	310	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1283	1286		10.1126/science.1101245	http://dx.doi.org/10.1126/science.1101245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333838				2022-12-01	WOS:000223624600039
J	Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K				Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K			Has vancomycin-resistant Staphylococcus aureus started going it alone?	LANCET			English	Editorial Material									Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan	Juntendo University	Hiramatsu, K (corresponding author), Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan.	hiram@med.juntendo.ac.jp		cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885				ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; VOSS A, 1994, EUR J CLIN MICROBIOL, V13, P50, DOI 10.1007/BF02026127; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357	9	12	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					565	566		10.1016/S0140-6736(04)16867-0	http://dx.doi.org/10.1016/S0140-6736(04)16867-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313343				2022-12-01	WOS:000223275100009
J	Deroche-Gamonet, V; Belin, D; Piazza, PV				Deroche-Gamonet, V; Belin, D; Piazza, PV			Evidence for addiction-like behavior in the rat	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING; AMPHETAMINE; RELAPSE; PREDICT; VULNERABILITY; MODEL; BRAIN	Although the voluntary intake of drugs of abuse is a behavior largely preserved throughout phylogeny, it is currently unclear whether pathological drug use ("addiction") can be observed in species other than humans. Here, we report that behaviors that resemble three of the essential diagnostic criteria for addiction appear over time in rats trained to self-administer cocaine. As in humans, this addiction-like behavior is present only in a small proportion of subjects using cocaine and is highly predictive of relapse after withdrawal. These findings provide a new basis for developing a true understanding and treatment of addiction.	Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Piazza, PV (corresponding author), Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, Rue Camille St Saens, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	Belin, David/E-1231-2014; Deroche-Gamonet, Véronique/E-5728-2010	Belin, David/0000-0002-7383-372X; Deroche-Gamonet, Veronique/0000-0002-9704-6624				Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1097/00000374-200008000-00004; *AM PSYCH ASS WASH, 2000, DIAGN STAT MAN MENT; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V49, P225, DOI 10.1016/S0376-8716(98)00016-7; DEJONG W, 1994, INT J ADDICT, V29, P681, DOI 10.3109/10826089409047904; DEWIT H, 1986, DRUG ALCOHOL DEPEN, V16, P341, DOI 10.1016/0376-8716(86)90068-2; Enoch Mary-Anne, 2003, Am J Pharmacogenomics, V3, P217, DOI 10.2165/00129785-200303040-00001; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fergusson DM, 2003, ARCH GEN PSYCHIAT, V60, P1033, DOI 10.1001/archpsyc.60.10.1033; GOLDBERG SR, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1306; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kusayama T, 2000, NEUROREPORT, V11, P2511, DOI 10.1097/00001756-200008030-00033; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PICKENS R, 1968, PSYCHOPHARMACOLOGIA, V12, P158, DOI 10.1007/BF00401545; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHUSTER CR, 1969, ANNU REV PHARMACOLOG, V9, P483, DOI 10.1146/annurev.pa.09.040169.002411; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Spanagel R, 1995, PSYCHOPHARMACOLOGY, V122, P369, DOI 10.1007/BF02246268; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	29	790	807	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1014	1017		10.1126/science.1099020	http://dx.doi.org/10.1126/science.1099020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310906				2022-12-01	WOS:000223250700051
J	Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP				Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP			Novel methods for disinfection of prion-contaminated medical devices	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; TISSUE DISTRIBUTION; SCRAPIE AGENT; TRANSMISSION; DECONTAMINATION; INACTIVATION; INFECTIVITY; PROTEIN; HEALTH	Background The unique resistance of prions to classic methods of decontamination, and evidence that prion diseases can be transmitted iatrogenically by medical devices pose a serious infection control challenge to healthcare facilities. In view of the widespread tissue distribution of the variant Creutzfeldt-Jakob disease agent in human beings, new practicable decontamination procedures are urgently needed. Methods We adapted an in-vivo method using stainless steel wires contaminated with prions to the hamster-adapted scrapie strain 263K. A new in-vitro protocol of surface contamination compatible with subsequent biochemical detection of PrPres (protease-resistant form of the prion protein) from the treated surface was developed to explore the mechanisms of action of methods of decontamination under test. These models were used to investigate the effectiveness of innovative physical and chemical methods of prion inactivation. Findings Standard chemical decontamination methods (NaOH IN, NaOCl 20 000 ppm) and autoclaving in water at 134degreesC reduced infectivity by >5.6 log(10) lethal doses; autoclaving without immersion was somewhat less effective (4-4.5 log reduction). Three milder treatments, including a phenolic disinfectant, an alkaline cleaner, and the combination of an enzymatic cleaner and vaporised hydrogen peroxide (VHP) were also effective. VHP alone, which can be compatible with electronic components, achieved an approximately 4.5 log reduction in infectivity (equivalent to autoclaving without water immersion). Interpretation New decontamination procedures are proposed to ensure the safety of medical and surgical instruments as well as surfaces that cannot withstand the currently recommended prion inactivation procedures.	CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, F-92265 Fontenay Aux Roses, France; Anjou Rech Veolia Water, F-94417 St Maurice, France; Steris, Basingstoke, Hants, England; EFS Nord France, F-59800 Lille, France	CEA; Veolia; Universite de Lille - ISITE; Universite de Lille	Comoy, E (corresponding author), CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	emmanuel.comoy@cea.fr		Jas, Christelle/0000-0001-6311-6017	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002957] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 1999, J GEN VIROL, V80, P1079, DOI 10.1099/0022-1317-80-4-1079; Antloga K, 2000, ASAIO J, V46, pS69, DOI 10.1097/00002480-200011000-00040; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; BROWN P, 1982, J INFECT DIS, V145, P683, DOI 10.1093/infdis/145.2.683; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1984, NEW ENGL J MED, V310, P727; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Krause J, 2001, CONTEMP TOP LAB ANIM, V40, P18; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; McDonnell G, 2003, CLIN INFECT DIS, V36, P1152, DOI 10.1086/374668; Race RE, 2004, J VIROL, V78, P2164, DOI 10.1128/JVI.78.4.2164-2165.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TAYLOR DM, 1991, VET MICROBIOL, V27, P19, DOI 10.1016/0378-1135(91)90059-O; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; *WHO, 1999, WHOCDSCSRAPH2003; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	27	163	172	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					521	526		10.1016/S0140-6736(04)16810-4	http://dx.doi.org/10.1016/S0140-6736(04)16810-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302195				2022-12-01	WOS:000223132700031
J	Treanor, J				Treanor, J			Weathering the influenza vaccine crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA	University of Rochester	Treanor, J (corresponding author), Univ Rochester, Med Ctr, Infect Dis Unit, Rochester, NY 14642 USA.							*CDCP, 2004, INT EST POP TARG INF; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor J, 2002, VACCINE, V20, P1099, DOI 10.1016/S0264-410X(01)00440-6; WOOD JM, 1998, TXB INFLUENZA, P333	5	34	35	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 11	2004	351	20					2037	2040		10.1056/NEJMp048290	http://dx.doi.org/10.1056/NEJMp048290			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	869TM	15492296	Bronze			2022-12-01	WOS:000225007200002
J	Korenjak, M; Taylor-Harding, B; Binne, UK; Satterlee, JS; Stevaux, O; Aasland, R; White-Cooper, H; Dyson, N; Brehm, A				Korenjak, M; Taylor-Harding, B; Binne, UK; Satterlee, JS; Stevaux, O; Aasland, R; White-Cooper, H; Dyson, N; Brehm, A			Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes	CELL			English	Article							DNA-REPLICATION; CELL-CYCLE; RETINOBLASTOMA PROTEIN; NEGATIVE REGULATOR; RB; CHROMATIN; RAS; LOCALIZATION; MECHANISMS; TRANSITION	The retinoblastoma tumor suppressor protein (pRb) regulates gene transcription by binding E2F transcription factors. pRb can recruit several repressor complexes to E2F bound promoters; however, native pRb repressor complexes have not been isolated. We have purified E2F/RBF repressor complexes from Drosophila embryo extracts and characterized their roles in E2F regulation. These complexes contain RBF, E2F and Myb-interacting proteins that have previously been shown to control developmentally regulated patterns of DNA replication in follicle cells. The complexes localize to transcriptionally silent sites on polytene chromosomes and mediate stable repression of a specific set of E2F targets that have sex- and differentiation-specific expression patterns. Strikingly, seven of eight complex subunits are structurally and functionally related to C. elegans synMuv class B genes, which cooperate to control vulval differentiation in the worm. These results reveal an extensive evolutionary conservation of specific pRb repressor complexes that physically combine subunits with established roles in the regulation of transcription, DNA replication, and chromatin structure.	Univ Munich, Adolf Butenandt Inst, Lehrstuhl Mol Biol, Munich, Germany; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Univ Bergen, Dept Mol Biol, Bergen, Norway; Univ Bergen, Computat Biol Unit, Bergen, Norway; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Munich; Harvard University; Massachusetts General Hospital; University of Bergen; University of Bergen; University of Oxford	Brehm, A (corresponding author), Univ Munich, Adolf Butenandt Inst, Lehrstuhl Mol Biol, Munich, Germany.	abrehm@lmu.de	White-Cooper, Helen/A-4633-2010	White-Cooper, Helen/0000-0002-3373-8023; Nolan-Stevaux, Olivier/0000-0002-5934-4786	NATIONAL CANCER INSTITUTE [R01CA064402, P01CA095281] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA95281, CA64402, CA95281] Funding Source: Medline; NIGMS NIH HHS [GM53203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Angus SP, 2004, MOL CELL BIOL, V24, P5404, DOI 10.1128/MCB.24.12.5404-5420.2004; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; BEALL EL, 2004, GENES DEV; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Cayirlioglu P, 2001, DEVELOPMENT, V128, P5085; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Frolov MV, 2003, GENE DEV, V17, P723, DOI 10.1101/gad.1031803; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Joaquin M, 2002, ONCOGENE, V21, P7923, DOI 10.1038/sj.onc.1206001; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Owen AB, 2003, GENOME RES, V13, P1828, DOI 10.1101/gr.1125403; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shen WH, 2002, TRENDS PLANT SCI, V7, P505, DOI 10.1016/S1360-1385(02)02351-8; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevaux O, 2002, EMBO J, V21, P4927, DOI 10.1093/emboj/cdf501; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338	46	231	240	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2004	119	2					181	193		10.1016/j.cell.2004.09.034	http://dx.doi.org/10.1016/j.cell.2004.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	863QQ	15479636	Bronze			2022-12-01	WOS:000224577200007
J	Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW				Partridge, EA; Le Roy, C; Di Guglielmo, GM; Pawling, J; Cheung, P; Granovsky, M; Nabi, IR; Wrana, JL; Dennis, JW			Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis	SCIENCE			English	Article							GROWTH; COMPLEX; METASTASIS; EXPRESSION; PATHWAYS; MOUSE; CELLS	The Golgi enzyme beta1,6 N-acetylglucosaminyltransferase V (Mgat5) is upregulated in carcinomas and promotes the substitution of N-glycan with poly N-acetyllactosamine, the preferred ligand for galectin-3 (Gal-3). Here, we report that expression of Mgat5 sensitized mouse cells to multiple cytokines. Gal-3 cross-linked Mgat5-modified N-glycans on epidermal growth factor and transforming growth factor-beta receptors at the cell surface and delayed their removal by constitutive endocytosis. Mgat5 expression in mammary carcinoma was rate limiting for cytokine signaling and consequently for epithelial-mesenchymal transition, cell motility, and tumor metastasis. Mgat5 also promoted cytokine-mediated leukocyte signaling, phagocytosis, and extravasation in vivo. Thus, conditional regulation of N-glycan processing drives synchronous modification of cytokine receptors, which balances their surface retention against loss via endocytosis.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Lab Med & Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Anat Cell Biol & Physiol, Vancouver, BC V6T 1Z3, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of British Columbia; University of British Columbia	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Dennis@mshri.on.ca	Le Roy, Christine/N-3718-2017; Wrana, Jeffrey/F-8857-2013; Nabi, Ivan R/C-5493-2009; Nabi, Ivan/GWZ-5144-2022; Dennis, James/E-7268-2013	Le Roy, Christine/0000-0003-3538-6487; Nabi, Ivan/0000-0002-0670-0513; 				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Gong HC, 1999, CANCER RES, V59, P6239; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MIYOSHI E, 1995, J BIOL CHEM, V270, P6216, DOI 10.1074/jbc.270.11.6216; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Park SC, 2002, MECH AGEING DEV, V123, P917, DOI 10.1016/S0047-6374(02)00029-5; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stroop CJM, 2000, GLYCOBIOLOGY, V10, P901, DOI 10.1093/glycob/10.9.901; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	27	564	595	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					120	124		10.1126/science.1102109	http://dx.doi.org/10.1126/science.1102109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459394				2022-12-01	WOS:000224304000051
J	Ferbitz, L; Maier, T; Patzelt, H; Bukau, B; Deuerling, E; Ban, N				Ferbitz, L; Maier, T; Patzelt, H; Bukau, B; Deuerling, E; Ban, N			Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins	NATURE			English	Article							NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; PEPTIDE; DOMAINS; DNAK; ISOMERASE; CYTOSOL; BINDING; CHAINS	During protein biosynthesis, nascent polypeptide chains that emerge from the ribosomal exit tunnel encounter ribosome-associated chaperones, which assist their folding to the native state(1,2). Here we present a 2.7 Angstrom crystal structure of Escherichia coli trigger factor, the best-characterized chaperone of this type, together with the structure of its ribosome-binding domain in complex with the Haloarcula marismortui large ribosomal subunit. Trigger factor adopts a unique conformation resembling a crouching dragon with separated domains forming the amino-terminal ribosome-binding 'tail', the peptidylprolyl isomerase 'head', the carboxy-terminal 'arms' and connecting regions building up the 'back'. From its attachment point on the ribosome, trigger factor projects the extended domains over the exit of the ribosomal tunnel, creating a protected folding space where nascent polypeptides may be shielded from proteases and aggregation. This study sheds new light on our understanding of co-translational protein folding, and suggests an unexpected mechanism of action for ribosome-associated chaperones.	ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Ban, N (corresponding author), ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland.	e.deuerling@zmbh.uni-heidelberg.de; ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363; Bukau, Bernd/0000-0003-0521-7199; Patzelt, Holger/0000-0001-9886-8374				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kristensen O, 2003, STRUCTURE, V11, P1547, DOI 10.1016/j.str.2003.11.003; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Vogtherr M, 2002, J MOL BIOL, V318, P1097, DOI 10.1016/S0022-2836(02)00112-2	30	292	294	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					590	596		10.1038/nature02899	http://dx.doi.org/10.1038/nature02899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15334087	Green Published			2022-12-01	WOS:000224156700052
J	Testa, G; Harris, J				Testa, G; Harris, J			Ethical aspects of ES cell-derived gametes	SCIENCE			English	Editorial Material							GERM-CELLS; DERIVATION		Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany; Univ Manchester, Manchester Sch Law, Manchester M13 9PL, Lancs, England	Technische Universitat Dresden; University of Manchester	Testa, G (corresponding author), Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany.	testa@mpi-cbg.de		Testa, Giuseppe/0000-0002-9104-0918				Dennis C, 2003, NATURE, V424, P364, DOI 10.1038/424364a; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Golombok S., 1999, WHAT IS PARENT SOCIO, P161; HARRIS J, 2004, CLONING, P52; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kass L R, 1998, Valparaiso Univ Law Rev, V32, P679; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; *NCHS, 1996, FERT FAM PLANN WOM H; Surani MA, 2004, NATURE, V427, P106, DOI 10.1038/427106a; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100	10	25	26	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1719	1719		10.1126/science.1103083	http://dx.doi.org/10.1126/science.1103083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375251	Green Submitted			2022-12-01	WOS:000224039500022
J	Schmid, MF; Sherman, MB; Matsudaira, P; Chiu, W				Schmid, MF; Sherman, MB; Matsudaira, P; Chiu, W			Structure of the acrosomal bundle	NATURE			English	Article							LIMULUS SPERM; F-ACTIN; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; FILAMENTS; SCRUIN; STATE; TWIST; NUCLEOTIDE; RESOLUTION	In the unactivated Limulus sperm, a 60-mum-long bundle of actin filaments crosslinked by the protein scruin is bent and twisted into a coil around the base of the nucleus. At fertilization, the bundle uncoils and fully extends in five seconds to support a finger of membrane known as the acrosomal process. This biological spring is powered by stored elastic energy and does not require the action of motor proteins or actin polymerization(1). In a 9.5-Angstrom electron cryomicroscopic structure of the extended bundle, we show that twist, tilt and rotation of actin scruin subunits deviate widely from a 'standard' F-actin filament. This variability in structural organization allows filaments to pack into a highly ordered and rigid bundle in the extended state and suggests a mechanism for storing and releasing energy between coiled and extended states without disassembly.	Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Whitehead Inst, Dept Biol, Cambridge, MA 02142 USA; MIT, Div Biol Engn, Cambridge, MA 02142 USA	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wah@bcm.tmc.edu	Matsudaira, Paul/H-1475-2012	Matsudaira, Paul/0000-0002-8399-3276; Schmid, Michael/0000-0003-1077-5750				Borovikov YS, 2004, BIOPHYS J, V86, P3020, DOI 10.1016/S0006-3495(04)74351-9; BULLITT ESA, 1988, J CELL BIOL, V107, P597, DOI 10.1083/jcb.107.2.597; DEROSIER D, 1980, J MOL BIOL, V137, P375, DOI 10.1016/0022-2836(80)90163-1; Dominguez R, 2003, BIOPHYS J, V85, P2073, DOI 10.1016/S0006-3495(03)74635-9; Egelman EH, 2001, NAT STRUCT BIOL, V8, P735, DOI 10.1038/nsb0901-735; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Galkin VE, 2003, J MOL BIOL, V325, P623, DOI 10.1016/S0022-2836(02)01309-8; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Orlova A, 2001, J MOL BIOL, V312, P95, DOI 10.1006/jmbi.2001.4945; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Sanders MC, 1996, J BIOL CHEM, V271, P2651, DOI 10.1074/jbc.271.5.2651; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; SCHMID MF, 1993, J MOL BIOL, V230, P384, DOI 10.1006/jmbi.1993.1155; Schmid MF, 2003, J STRUCT BIOL, V144, P195, DOI 10.1016/j.jsb.2003.09.024; Sherman MB, 1999, J MOL BIOL, V294, P139, DOI 10.1006/jmbi.1999.3222; Shin JH, 2004, J MOL BIOL, V337, P255, DOI 10.1016/j.jmb.2004.01.028; Shin JH, 2003, J CELL BIOL, V162, P1183, DOI 10.1083/jcb.200304006; TILNEY LG, 1975, J CELL BIOL, V64, P289, DOI 10.1083/jcb.64.2.289; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51	30	71	71	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					104	107		10.1038/nature02881	http://dx.doi.org/10.1038/nature02881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343340				2022-12-01	WOS:000223641500051
J	Monteleoni, C; Clark, E				Monteleoni, C; Clark, E			Using rapid-cycle quality improvement methodology to reduce feeding tubes in patients with advanced dementia: before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NUTRITION; SURVIVAL; PROLONG	Problem Despite lack of evidence that enteral feeding tubes benefit patients with dementia, and often contrary to the wishes of patient and family, patients with dementia who have difficulty swallowing or reduced food intake often receive feeding tubes when hospitalised for an acute illness. Design We conducted a retrospective chart review of all patients receiving percutaneous endoscopic gastrostomy or jejunostomy tubes between March and September 2002. QI interventions including a palliative care consulting service and educational programmes were instituted. We conducted a second chart review for all patients receiving feeding tubes between March and September 2003. Setting 652 bed urban acute care hospital. Key measures for improvement We measured the number of feeding tubes placed in patients with dementia, the number of feeding tubes placed in patients with dementia capable of taking food by mouth, and the number of feeding tubes placed in patients with dementia with an advance directive stating the wish to forgo artificial nutrition and hydration. Strategies for change Medical and allied health staff received educational programmes on end of life care and on feeding management of patients with dementia. A palliative care consulting team was established. Effects of change After the interventions, the number of feeding tubes Placed in all patients and in patients with dementia was greatly reduced. Lessons learnt Multidisciplinary involvement, including participation by die administration, was essential to effect change in practice. The intensive focus on a particular issue and rapid change led to "culture shift" within the hospital community. The need to establish unified goals of care for each patient was highlighted. Background A growing body of research over the past decade has questioned the utility of placing feeding tubes (percutaneous endoscopic gastrostomy (PEG) or jejunostomy) in patients with advanced dementia.(1) Studies have found no evidence that feeding tubes in this population prevent aspiration,(2,3) prolong life,(4-6) improve overall function,(7) or reduce pressure sores.(8) Additionally, the quality of life of a patient with advanced dementia can be adversely affected when a feeding tube is inserted. The patient may require wrist restraints to prevent pulling on the tube(1-3) or may develop cellulitis at the gastrostomy site, develop decubitus ulcers,(1) be deprived of the social interaction and pleasure surrounding meals,(9,10) and require placement in a nursing home. Unfortunately, many doctors are unfamiliar with this literature or face barriers-attitudinal, institutional, or imposed by the healthcare industry-to applying its findings to their practice.(11) Thus feeding tubes are placed in patients who will not benefit from this intervention and whose quality of life in the terminal stage of their illness will be adversely affected. With the expected increase of elderly people with dementia,(12) a great change in doctors' knowledge, attitudes, and practice is necessary to prevent even greater numbers of patients receiving this futile treatment.	Lenox Hill Hosp, New York, NY 10021 USA	Northwell Health	Monteleoni, C (corresponding author), Lenox Hill Hosp, 100 E 77th St, New York, NY 10021 USA.	cmonteleoni@lenoxhill.net						Ahronheim JC, 1996, CLIN GERIATR MED, V12, P379; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; COBBS EL, 2002, GERIATRICS REV SYLLA, P117; FINUCANE TE, 1995, J AM GERIATR SOC, V43, P447, DOI 10.1111/j.1532-5415.1995.tb05822.x; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; KAW M, 1995, DIGEST DIS SCI, V40, P921; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; Meier DE, 2001, ARCH INTERN MED, V161, P2386; Mitchell SL, 1998, J GERONTOL A-BIOL, V53, pM207, DOI 10.1093/gerona/53A.3.M207; Murphy LM, 2003, ARCH INTERN MED, V163, P1351, DOI 10.1001/archinte.163.11.1351; PECK A, 1991, J AM GERIATR SOC, V39, P732; *UN HOSP FUND, 2003, PALL CAR QUAL IMPR C; [No title captured]	15	75	79	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					491	494		10.1136/bmj.329.7464.491	http://dx.doi.org/10.1136/bmj.329.7464.491			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331474	Green Published			2022-12-01	WOS:000223684600016
J	de Quervain, DJF; Fischbacher, U; Treyer, V; Schelthammer, M; Schnyder, U; Buck, A; Fehr, E				de Quervain, DJF; Fischbacher, U; Treyer, V; Schelthammer, M; Schnyder, U; Buck, A; Fehr, E			The neural basis of altruistic punishment	SCIENCE			English	Article							INCREASING MONETARY REWARD; PREFRONTAL CORTEX; DORSAL STRIATUM; NEURONAL-ACTIVITY; DECISION-MAKING; BRAIN ACTIVITY; RESPONSES; EXPECTATION; COOPERATION; EVOLUTION	Many people voluntarily incur costs to punish violations of social norms. Evolutionary models and empirical evidence indicate that such altruistic punishment has been a decisive force in the evolution of human cooperation. We used (H2O)-O-15 positron emission tomography to examine the neural basis for altruistic punishment of defectors in an economic exchange. Subjects could punish defection either symbolically or effectively. Symbolic punishment did not reduce the defector's economic payoff, whereas effective punishment did reduce the payoff. We scanned the subjects' brains while they learned about the defector's abuse of trust and determined the punishment. Effective punishment, as compared with symbolic punishment, activated the dorsal striatum, which has been implicated in the processing of rewards that accrue as a result of goal-directed actions. Moreover, subjects with stronger activations in the dorsal striatum were willing to incur greater costs in order to punish. Our findings support the hypothesis that people derive satisfaction from punishing norm violations and that the activation in the dorsal striatum reflects the anticipated satisfaction from punishing defectors.	Univ Zurich, Div Psychiat Res, CH-8029 Zurich, Switzerland; Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ Zurich Hosp, PET Ctr, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Psychiat, CH-8091 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8029 Zurich, Switzerland.	quervain@bti.unizh.ch; efehr@iew.unizh.ch	Fischbacher, Urs/H-2693-2014; Treyer, Valerie/G-6986-2018	Fischbacher, Urs/0000-0002-5115-8815; Treyer, Valerie/0000-0002-4584-3031; Schnyder, Ulrich/0000-0003-3556-7990; de Quervain, Dominique/0000-0001-7131-2464				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Arana FS, 2003, J NEUROSCI, V23, P9632; BATSON CD, 1987, J PERS SOC PSYCHOL, V53, P594, DOI 10.1037/0022-3514.53.3.594; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Camerer ColinF., 2003, BEHAV GAME THEORY EX; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Martin-Soelch C, 2003, EUR J NEUROSCI, V18, P680, DOI 10.1046/j.1460-9568.2003.02791.x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; RABIN M, 1993, AM ECON REV, V83, P1281; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Salinas JA, 1998, BEHAV NEUROSCI, V112, P812, DOI 10.1037/0735-7044.112.4.812; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1988, EXP BRAIN RES, V71, P431; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Sober E., 1998, POPUL ENVIRON; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936	41	971	980	3	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1254	1258		10.1126/science.1100735	http://dx.doi.org/10.1126/science.1100735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333831	Green Submitted			2022-12-01	WOS:000223624600031
J	Klein, DE; Nappi, VM; Reeves, GT; Shvartsman, SY; Lemmon, MA				Klein, DE; Nappi, VM; Reeves, GT; Shvartsman, SY; Lemmon, MA			Argos inhibits epidermal growth factor receptor signalling by ligand sequestration	NATURE			English	Article							SECRETED SPITZ; DROSOPHILA; PATHWAY; SULFATE; BINDING; ACTIVATION; PROTEINS	The epidermal growth factor receptor ( EGFR) has critical functions in development and in many human cancers(1-3). During development, the spatial extent of EGFR signalling is regulated by feedback loops comprising both well-understood activators and less well-characterized inhibitors(3,4). In Drosophila melanogaster the secreted protein Argos functions as the only known extracellular inhibitor of EGFR(5), with clearly identified roles in multiple stages of development(3). Argos is only expressed when the Drosophila EGFR (DER) is activated at high levels(6), and downregulates further DER signalling. Although there is ample genetic evidence that Argos inhibits DER activation, the biochemical mechanism has not been established. Here we show that Argos inhibits DER signalling without interacting directly with the receptor, but instead by sequestering the DER-activating ligand Spitz. Argos binds tightly to the EGF motif of Spitz and forms a 1:1 ( Spitz: Argos) complex that does not bind DER in vitro or at the cell surface. Our results provide an insight into the mechanism of Argos function, and suggest new strategies for EGFR inhibitor design.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, Philadelphia, PA 19104 USA; Princeton Univ, Dept Chem Engn, Carl Icahn Lab, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University; Princeton University	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Shvartsman, Stanislav/GPP-4025-2022	Shvartsman, Stanislav/0000-0002-9152-9334; Klein, Daryl/0000-0002-7188-0450; Lemmon, Mark/0000-0002-3379-5319	NATIONAL CANCER INSTITUTE [R01CA125432, R01CA079992] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA125432, R01 CA079992] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Barkai N, 2002, CURR BIOL, V12, pR493, DOI 10.1016/S0960-9822(02)00967-3; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Golembo M, 1996, DEVELOPMENT, V122, P223; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Howes R, 1998, J BIOL CHEM, V273, P4275, DOI 10.1074/jbc.273.7.4275; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vinos J, 2000, ONCOGENE, V19, P3560, DOI 10.1038/sj.onc.1203702; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	27	104	109	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1040	1044		10.1038/nature02840	http://dx.doi.org/10.1038/nature02840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329724				2022-12-01	WOS:000223514900046
J	Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y				Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y			Defective vasculogenesis in systemic sclerosis	LANCET			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; HUMAN CYTOMEGALOVIRUS; RHEUMATOID-ARTHRITIS; ANGIOGENESIS; MOBILIZATION; SCLERODERMA; EXPRESSION; APOPTOSIS; ANTIBODY	Background Typical vascular features of systemic sclerosis include low capillary density and vascular obliteration. The formation and repair of blood vessels in adults involve vasculogenesis, which is mediated through the recruitment of bone-marrow-derived circulating endothelial precursors (CEP). We investigated whether vasculogenesis is impaired in patients with systemic sclerosis. Methods Peripheral blood was obtained from 11 patients with systemic sclerosis, 11 with rheumatoid arthritis, and 11 healthy controls. Factors potentially affecting the CEP number were matched among the three groups. CEP (identified as circulating cells positive for CD34, CD133, and the type 2 receptor for vascular endothelial growth factor) were quantified by cell sorting and three-colour flow cytometry. The circulating concentrations of angiogenic factors were measured by ELISA. The potential of CEP to differentiate into endothelial cells was assessed by the upregulation of von Willebrand factor after in-vitro maturation treatment. Findings The absolute number of CEP was much lower in patients with systemic sclerosis than in patients with rheumatoid arthritis or healthy controls (median 274 [IQR 178-395] vs 1154 [653-1524] and 1074 [713-1186] per 20 mL peripheral blood, respectively; p<0.0001 by Kruskal-Wallis test. Paradoxically, circulating concentrations of most angiogenic factors were significantly higher in patients with systemic sclerosis than in healthy controls. The proportion of CEP that differentiated into endothelial cells was significantly lower in patients with systemic sclerosis than in healthy controls (p<0.0001, Mann-Whitney test). Interpretation Insufficient vascular repair machinery due to defective vasculogenesis might contribute to vasculopathy in systemic sclerosis. Relevance to practice As well as providing an important insight into the pathogenesis of this disorder, these findings suggest that dysregulated vasculogenesis might be important in other disorders with abnormalities in vascular formation, including those with excessive formation of new vessels such as cancer and those with deficient vessel formation such as atherosclerosis. Circulating endothelial precursors could be a novel target for therapeutic strategies for ischaemic complications in patients with systemic sclerosis.	Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan	Keio University; Keio University	Kuwana, M (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kuwanam@sc.itc.keio.ac.jp	Kawakami, Yutaka/E-7429-2013; Yasuoka, Hidekata/AAC-6277-2019; Kuwana, Masataka/L-2918-2013; Yasuoka, Hidekata/L-3041-2013	Kawakami, Yutaka/0000-0003-4836-2855; 				[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bhattacharya V, 2000, BLOOD, V95, P581, DOI 10.1182/blood.V95.2.581; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; CHEN ZY, 1984, AM J MED, V77, P812, DOI 10.1016/0002-9343(84)90517-5; Clements PJ, 1996, SYSTEMIC SCLEROSIS, P389; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Kawaguchi Y, 1999, J RHEUMATOL, V26, P1012; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Mackiewicz Z, 2002, CLIN EXP RHEUMATOL, V20, P641; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Pandey JP, 1998, ARTHRITIS RHEUM, V41, P10, DOI 10.1002/1529-0131(199801)41:1<10::AID-ART2>3.3.CO;2-G; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Schachna L, 2002, CURR OPIN RHEUMATOL, V14, P686, DOI 10.1097/00002281-200211000-00010; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Weber AJ, 2000, JOINT BONE SPINE, V67, P366	31	210	221	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					603	610		10.1016/S0140-6736(04)16853-0	http://dx.doi.org/10.1016/S0140-6736(04)16853-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313361				2022-12-01	WOS:000223275100033
J	Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C				Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C			Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5	NATURE			English	Article							RECOGNITION; FAMILY; JNK	Mitogen-activated protein ( MAP) kinases are essential regulators in immune responses(1), and their activities are modulated by kinases and phosphatases. MAP kinase phosphatase (MKP) is a family of dual-specificity phosphatases whose function is evolutionarily conserved(2,3). A number of mammalian MKPs have been identified so far(2,3), but their specific physiological functions in negative regulation of MAP kinases have not been genetically defined. Here we examine innate and adaptive immune responses in the absence of MKP5. JNK activity was selectively increased in Mkp5 ( also known as Dusp10)-deficient mouse cells. Mkp5-deficient cells produced greatly enhanced levels of pro-inflammatory cytokines during innate immune responses and exhibited greater T-cell activation than their wild-type counterparts. However, Mkp5-deficient T cells proliferated poorly upon activation, which resulted in increased resistance to experimental autoimmune encephalomyelitis. By contrast, Mkp5-deficient CD4(+) and CD8(+) effector T cells produced significantly increased levels of cytokines compared with wild-type cells, which led to much more robust and rapidly fatal immune responses to secondary infection with lymphocytic choriomeningitis virus. Therefore, MKP5 has a principal function in both innate and adaptive immune responses, and represents a novel target for therapeutic intervention of immune diseases.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Massachusetts, Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	richard.flavell@yale.edu; cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon Mercedes, 1997, Genes and Function, V1, P51; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Theodosiou A, 2002, GENOME BIOL, V3	13	185	191	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					793	797		10.1038/nature02764	http://dx.doi.org/10.1038/nature02764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306813				2022-12-01	WOS:000223233600045
J	Gartner, ZJ; Tse, BN; Grubina, R; Doyon, JB; Snyder, TM; Liu, DR				Gartner, ZJ; Tse, BN; Grubina, R; Doyon, JB; Snyder, TM; Liu, DR			DNA-templated organic synthesis and selection of a library of macrocycles	SCIENCE			English	Article							CARBONIC-ANHYDRASE	The translation of nucleic acid libraries into corresponding synthetic compounds would enable selection and amplification principles to be applied to man-made molecules. We used multistep DNA-templated organic synthesis to translate libraries of DNA sequences, each containing three "codons," into libraries of sequence-programmed synthetic small-molecule macrocycles. The resulting DNA-macrocycle conjugates were subjected to in vitro selections for protein affinity. The identity of a single macrocycle possessing known target protein affinity was inferred through the sequence of the amplified DNA template surviving the selection. This work represents the translation, selection, and amplification of libraries of nucleic acids encoding synthetic small molecules rather than biological macromolecules.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	gartner, zev/0000-0001-7803-1219; Snyder, Thomas/0000-0001-7256-7821	NIGMS NIH HHS [R01 GM065865-03, R01 GM065865-04, R01GM065865, R01 GM065865-02, R01 GM065865-01A2, R01 GM065865] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Calderone CT, 2002, ANGEW CHEM INT EDIT, V41, P4104, DOI 10.1002/1521-3773(20021104)41:21<4104::AID-ANIE4104>3.0.CO;2-O; Doyon JB, 2003, J AM CHEM SOC, V125, P12372, DOI 10.1021/ja036065u; Gartner ZJ, 2003, ANGEW CHEM INT EDIT, V42, P1370, DOI 10.1002/anie.200390351; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Gartner ZJ, 2002, J AM CHEM SOC, V124, P10304, DOI 10.1021/ja027307d; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; Halpin DR, 2004, PLOS BIOL, V2, P1022, DOI 10.1371/journal.pbio.0020174; JAIN A, 1994, J MED CHEM, V37, P2100, DOI 10.1021/jm00039a023; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li C., 1997, ORGANIC REACTIONS AQ; Lin HN, 2002, ANGEW CHEM INT EDIT, V41, P4403; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3210, DOI 10.1021/ja00401a049	17	366	406	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1601	1605		10.1126/science.1102629	http://dx.doi.org/10.1126/science.1102629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15319493	Green Accepted			2022-12-01	WOS:000223891200038
J	Coghill, D; Markovitch, H				Coghill, D; Markovitch, H			Use of stimulants for attention deficit hyperactivity disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Definitive diagnosis of attention deficit hyperactivity disorder is complex. David Coghill believes the condition is undertreated, but Harvey Markovitch argues that cut rent uncertainties about diagnosis and treatment mean doctors should be cautious	Univ Dundee, Ctr Child Hlth, Div Pathol & Neurosci Psychiat, Dundee DD3 6HH, Scotland	University of Dundee	Coghill, D (corresponding author), Univ Dundee, Ctr Child Hlth, Div Pathol & Neurosci Psychiat, Dundee DD3 6HH, Scotland.	david.coghill@tpct.scot.nhs.uk; h.marcovitch@btinternet.com	Coghill, David R/B-7244-2009; Coghill, David/ABF-5213-2020; Coghill, David R/X-6449-2018	Coghill, David R/0000-0003-3017-9737; Coghill, David/0000-0003-3017-9737; Coghill, David R/0000-0003-3017-9737				CASTELLANOS FX, 2002, HYPERACTIVITY ATTENT, P336; Hill P, 2001, ARCH DIS CHILD, V84, P404, DOI 10.1136/adc.84.5.404; Huss M, 2002, J Atten Disord, V6 Suppl 1, pS65; Jadad AR, 1999, CAN J PSYCHIAT, V44, P1025, DOI 10.1177/070674379904401009; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; National Institute for Clinical Excellence, 13 NAT I CLIN EXC; Perrin JM, 2001, PEDIATRICS, V108, P1033; Rey JM, 2003, BRIT J PSYCHIAT, V182, P284, DOI 10.1192/bjp.182.4.284; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; *SCOTT INT GUID NE, 2001, ATT DEF HYP DIS CHIL; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019	13	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2004	329	7471					907	909		10.1136/bmj.329.7471.907	http://dx.doi.org/10.1136/bmj.329.7471.907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863MU	15485976	Green Published			2022-12-01	WOS:000224566800027
